Citrus Sinensis ID: 042519
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 427 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SFT7 | 414 | Serine/threonine-protein | yes | no | 0.948 | 0.978 | 0.674 | 1e-162 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.962 | 0.901 | 0.563 | 1e-134 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.735 | 0.742 | 0.659 | 1e-123 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.679 | 0.588 | 0.552 | 7e-92 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.700 | 0.610 | 0.546 | 6e-91 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.681 | 0.683 | 0.537 | 2e-89 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.686 | 0.714 | 0.546 | 7e-88 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.681 | 0.683 | 0.541 | 2e-87 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.686 | 0.714 | 0.521 | 1e-86 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.873 | 0.914 | 0.444 | 3e-86 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 573 bits (1477), Expect = e-162, Method: Compositional matrix adjust.
Identities = 284/421 (67%), Positives = 331/421 (78%), Gaps = 16/421 (3%)
Query: 1 MSCFSCFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNK 60
M+CFSCF + KK+ + + + N KT P + P +++ NN++
Sbjct: 1 MNCFSCFY---FHEKKKVPRDSDNSYRRN--GEVTGRDNNKTHP-ENPKTVNEQNKNNDE 54
Query: 61 EAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG 120
+ NNIAAQTF+FRELATATKNFRQECLIGEGGFGRVYKGKLEKT +VAVKQLDRNG
Sbjct: 55 DKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNG 114
Query: 121 LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP 180
LQGNKEFIVEVLMLSLLHH +LVNLIGYCADG+QRLLVYEYM SLEDHLLD+ P+Q P
Sbjct: 115 LQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIP 174
Query: 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240
+DW TR++IALGAA GLEYLHDKANPPVIYRDLK++NILLD EFNAKLSDFGLAKLGP+G
Sbjct: 175 LDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVG 234
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL 300
DK HVSSRVMGTYGYCAPEYQRTGQLT KSDVY+FGVVLLELITGRR IDTTRP EQNL
Sbjct: 235 DKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNL 294
Query: 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
VTWAQP FK+P+R+P+LADP L+G FP + LNQAVAV+AMC+QEE++VRPLMSDVV+AL
Sbjct: 295 VTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALG 354
Query: 361 FLGSDPDADTATAPVPHKPPPCDHQNMNMMDQNGYYQDEEKSQMERKRAVAEAIQWGCNS 420
FLG+ PD + P P D ++ ++ + ER+RAVAEA++WG S
Sbjct: 355 FLGTAPDGSISVPHYDDPPQPSDETSV----------EDSVAAEERERAVAEAMEWGVAS 404
Query: 421 R 421
R
Sbjct: 405 R 405
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 479 bits (1233), Expect = e-134, Method: Compositional matrix adjust.
Identities = 253/449 (56%), Positives = 306/449 (68%), Gaps = 38/449 (8%)
Query: 1 MSCFSCFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNK 60
M CFSCF S + +KL S ++ S N+ P+ K + +
Sbjct: 1 MGCFSCFDS---SDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKR 57
Query: 61 EAA----GNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL 116
E G IAA TF FRELA AT NF + +GEGGFGRVYKG+L+ T QVVAVKQL
Sbjct: 58 ELLLPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQL 117
Query: 117 DRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP 176
DRNGLQGN+EF+VEVLMLSLLHH NLVNLIGYCADG+QRLLVYE+MPL SLEDHL D+ P
Sbjct: 118 DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP 177
Query: 177 EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236
+++ +DW RMKIA GAAKGLE+LHDKANPPVIYRD KSSNILLD F+ KLSDFGLAKL
Sbjct: 178 DKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKL 237
Query: 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY 296
GP GDK+HVS+RVMGTYGYCAPEY TGQLTVKSDVY+FGVV LELITGR+AID+ P
Sbjct: 238 GPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHG 297
Query: 297 EQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVV 356
EQNLV WA+P F D ++ +LADP L+G FP R L QA+AV++MC+QE+++ RPL++DVV
Sbjct: 298 EQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVV 357
Query: 357 SALSFLGS---DPDADTATAPVPHKPPPCDHQNMNMMDQN------GYYQDEEKSQME-- 405
+ALS+L + DP D + D + ++ +N G D E S+ E
Sbjct: 358 TALSYLANQAYDPSKDDSRRNR-------DERGARLITRNDDGGGSGSKFDLEGSEKEDS 410
Query: 406 -------------RKRAVAEAIQWGCNSR 421
R+RAVAEA WG + R
Sbjct: 411 PRETARILNRDINRERAVAEAKMWGESLR 439
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1140), Expect = e-123, Method: Compositional matrix adjust.
Identities = 211/320 (65%), Positives = 260/320 (81%), Gaps = 6/320 (1%)
Query: 57 NNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL 116
N N + G AQTFTF+ELA AT NFR +C +GEGGFG+V+KG +EK QVVA+KQL
Sbjct: 78 NLNDQVTGKK---AQTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQL 134
Query: 117 DRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP 176
DRNG+QG +EF+VEVL LSL H NLV LIG+CA+G+QRLLVYEYMP SLEDHL +
Sbjct: 135 DRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPS 194
Query: 177 EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236
+KP+DW TRMKIA GAA+GLEYLHD+ PPVIYRDLK SNILL ++ KLSDFGLAK+
Sbjct: 195 GKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKV 254
Query: 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY 296
GP GDKTHVS+RVMGTYGYCAP+Y TGQLT KSD+Y+FGVVLLELITGR+AID T+
Sbjct: 255 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRK 314
Query: 297 EQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVV 356
+QNLV WA+P FKD +P++ DPLLQG++PVRGL QA+A+SAMCVQE+ ++RP++SDVV
Sbjct: 315 DQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVV 374
Query: 357 SALSFLGS---DPDADTATA 373
AL+FL S DP++ ++++
Sbjct: 375 LALNFLASSKYDPNSPSSSS 394
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (866), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 168/304 (55%), Positives = 214/304 (70%), Gaps = 14/304 (4%)
Query: 67 NIAA--QTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEK---------TAQVVAVKQ 115
NI++ + FTF +L +T+NFR E L+GEGGFG V+KG +E+ T VAVK
Sbjct: 122 NISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT 181
Query: 116 LDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG 175
L+ +GLQG+KE++ E+ L L H NLV L+GYC + +QRLLVYE+MP SLE+HL
Sbjct: 182 LNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-- 239
Query: 176 PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235
P+ W RMKIALGAAKGL +LH++A PVIYRD K+SNILLD ++NAKLSDFGLAK
Sbjct: 240 -RSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAK 298
Query: 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPT 295
P KTHVS+RVMGTYGY APEY TG LT KSDVY+FGVVLLE++TGRR++D RP
Sbjct: 299 DAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 358
Query: 296 YEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDV 355
E NLV WA+P D R+ +L DP L+G F ++G + ++A C+ + +RP MSDV
Sbjct: 359 GEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDV 418
Query: 356 VSAL 359
V AL
Sbjct: 419 VEAL 422
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (858), Expect = 6e-91, Method: Compositional matrix adjust.
Identities = 170/311 (54%), Positives = 215/311 (69%), Gaps = 12/311 (3%)
Query: 71 QTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEK---------TAQVVAVKQLDRNGL 121
+ F+F +L AT+NFR E L+GEGGFG V+KG +E+ T VAVK L+ +GL
Sbjct: 122 KKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGL 181
Query: 122 QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPI 181
QG+KE++ E+ L L H NLV L+GYC + +QRLLVYE+MP SLE+HL P+
Sbjct: 182 QGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPL 238
Query: 182 DWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241
W RMKIALGAAKGL +LH++A PVIYRD K+SNILLD E+NAKLSDFGLAK P
Sbjct: 239 PWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEG 298
Query: 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301
KTHVS+RVMGTYGY APEY TG LT KSDVY+FGVVLLE++TGRR++D RP E NLV
Sbjct: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
Query: 302 TWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361
WA+P D R+ +L DP L+G F V+G + ++A C+ +S +RP MS+VV L
Sbjct: 359 EWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKP 418
Query: 362 LGSDPDADTAT 372
L D +A+
Sbjct: 419 LPHLKDMASAS 429
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 163/303 (53%), Positives = 214/303 (70%), Gaps = 12/303 (3%)
Query: 71 QTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKT---------AQVVAVKQLDRNGL 121
+ FTF EL AT+NFR + L+GEGGFG V+KG ++ T VVAVK+L G
Sbjct: 69 KAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGY 128
Query: 122 QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPI 181
QG+KE++ EV L L H NLV L+GYC +GE RLLVYE+MP SLE+HL G + P+
Sbjct: 129 QGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQ--PL 186
Query: 182 DWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241
W RMK+A+GAAKGL +LHD A VIYRD K++NILLD EFN+KLSDFGLAK GP GD
Sbjct: 187 TWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGD 245
Query: 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301
KTHVS++VMGT+GY APEY TG+LT KSDVY+FGVVLLEL++GRRA+D ++ EQ+LV
Sbjct: 246 KTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLV 305
Query: 302 TWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361
WA P+ D + ++ D L G++P +G A +++ C+ ++ +RP MS+V++ L
Sbjct: 306 DWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQ 365
Query: 362 LGS 364
L S
Sbjct: 366 LES 368
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 7e-88, Method: Compositional matrix adjust.
Identities = 165/302 (54%), Positives = 210/302 (69%), Gaps = 9/302 (2%)
Query: 73 FTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQV------VAVKQLDRNGLQGNKE 126
FT EL T TK+FR + ++GEGGFG VYKG ++ +V VAVK L++ GLQG++E
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 127 FIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR 186
++ EV L L H NLV LIGYC + + RLLVYE+M SLE+HL P+ W R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFR--KTTAPLSWSRR 174
Query: 187 MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS 246
M IALGAAKGL +LH+ A PVIYRD K+SNILLD ++ AKLSDFGLAK GP GD+THVS
Sbjct: 175 MMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 247 SRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306
+RVMGTYGY APEY TG LT +SDVY+FGVVLLE++TGR+++D TRP+ EQNLV WA+P
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366
D + Q+ DP L+ ++ VR +A +++ C+ + RPLMSDVV L L
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTG 353
Query: 367 DA 368
DA
Sbjct: 354 DA 355
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 164/303 (54%), Positives = 213/303 (70%), Gaps = 12/303 (3%)
Query: 71 QTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQ---------VVAVKQLDRNGL 121
+ FTF EL ATKNFRQ+ L+GEGGFG V+KG +++T+ VVAVKQL G
Sbjct: 72 KAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGF 131
Query: 122 QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPI 181
QG+KE++ EV L L H NLV L+GYCA+GE RLLVYE+MP SLE+HL G + P+
Sbjct: 132 QGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQ--PL 189
Query: 182 DWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241
W RMK+A+GAAKGL +LH+ A VIYRD K++NILLD +FNAKLSDFGLAK GP GD
Sbjct: 190 TWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGD 248
Query: 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301
THVS++V+GT+GY APEY TG+LT KSDVY+FGVVLLELI+GRRA+D + E +LV
Sbjct: 249 NTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLV 308
Query: 302 TWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361
WA P+ D + ++ D L G++P +G A ++ C+ ++ +RP MS+V+ L
Sbjct: 309 DWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQ 368
Query: 362 LGS 364
L S
Sbjct: 369 LES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (820), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 158/303 (52%), Positives = 215/303 (70%), Gaps = 10/303 (3%)
Query: 71 QTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEK---------TAQVVAVKQLDRNGL 121
++F+F EL +AT+NFR + ++GEGGFG V+KG +++ T V+AVK+L+++G
Sbjct: 54 KSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGW 113
Query: 122 QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPI 181
QG++E++ EV L H +LV LIGYC + E RLLVYE+MP SLE+HL G +P+
Sbjct: 114 QGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPL 173
Query: 182 DWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241
W R+K+ALGAAKGL +LH + VIYRD K+SNILLD E+NAKLSDFGLAK GPIGD
Sbjct: 174 SWKLRLKVALGAAKGLAFLHS-SETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGD 232
Query: 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301
K+HVS+RVMGT+GY APEY TG LT KSDVY+FGVVLLEL++GRRA+D RP+ E+NLV
Sbjct: 233 KSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLV 292
Query: 302 TWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361
WA+P+ + + ++ D LQ ++ + + +S C+ E +RP MS+VVS L
Sbjct: 293 EWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEH 352
Query: 362 LGS 364
+ S
Sbjct: 353 IQS 355
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (817), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 177/398 (44%), Positives = 245/398 (61%), Gaps = 25/398 (6%)
Query: 27 NKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFR 86
++ P +P ++ K Q+ + KE + +++A N IA FT+ EL T NFR
Sbjct: 21 SESPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANPLIA---FTYEELKNITSNFR 77
Query: 87 QECLIGEGGFGRVYKGKLEKTA---QV-----VAVKQLD-RNGLQGNKEFIVEVLMLSLL 137
Q+ ++G GGFG VYKG +++ +V VAVK D N QG++E++ EV+ L L
Sbjct: 78 QDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQL 137
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197
H NLV LIGYC + R+L+YEYM S+E++L P+ W RMKIA GAAKGL
Sbjct: 138 SHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLF--SRVLLPLSWAIRMKIAFGAAKGL 195
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
+LH+ A PVIYRD K+SNILLD ++NAKLSDFGLAK GP+GDK+HVS+R+MGTYGY A
Sbjct: 196 AFLHE-AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAA 254
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317
PEY TG LT SDVY+FGVVLLEL+TGR+++D +RPT EQNL+ WA P K+ + +
Sbjct: 255 PEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLKEKKKVLNI 314
Query: 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDADTATAPVPH 377
DP + E+PV+ + +A ++ C+ RPLM D+V +L L AT
Sbjct: 315 VDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPL-------QATEEEAL 367
Query: 378 KPPPCDHQNMNMMDQ---NGYYQDEEKSQMERKRAVAE 412
PP + ++D+ NG + EE ++E + V E
Sbjct: 368 LVPPVQKAVITIIDEMPKNGLKKVEELKKVEEVKKVIE 405
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 427 | ||||||
| 255560177 | 447 | receptor serine-threonine protein kinase | 0.960 | 0.917 | 0.699 | 1e-171 | |
| 356566421 | 434 | PREDICTED: serine/threonine-protein kina | 0.957 | 0.942 | 0.7 | 1e-169 | |
| 356524523 | 437 | PREDICTED: serine/threonine-protein kina | 0.962 | 0.940 | 0.696 | 1e-165 | |
| 297829254 | 414 | kinase family protein [Arabidopsis lyrat | 0.948 | 0.978 | 0.681 | 1e-163 | |
| 357505343 | 433 | Serine/threonine protein kinase [Medicag | 0.981 | 0.967 | 0.659 | 1e-161 | |
| 18397825 | 414 | protein kinase domain-containing protein | 0.948 | 0.978 | 0.674 | 1e-161 | |
| 28416685 | 414 | At3g07070 [Arabidopsis thaliana] | 0.948 | 0.978 | 0.672 | 1e-160 | |
| 449443897 | 511 | PREDICTED: serine/threonine-protein kina | 0.843 | 0.704 | 0.738 | 1e-155 | |
| 449475515 | 511 | PREDICTED: serine/threonine-protein kina | 0.843 | 0.704 | 0.738 | 1e-155 | |
| 224065334 | 303 | predicted protein [Populus trichocarpa] | 0.700 | 0.986 | 0.856 | 1e-151 |
| >gi|255560177|ref|XP_002521106.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223539675|gb|EEF41257.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1565), Expect = e-171, Method: Compositional matrix adjust.
Identities = 312/446 (69%), Positives = 347/446 (77%), Gaps = 36/446 (8%)
Query: 1 MSCFSCFSS-----RRINTSKKL--QQSPGSPPNKEPAS------PA-----PRHQNLKT 42
MSC SCFSS +R N++K+ Q P SPP ++ A PA P H N K
Sbjct: 1 MSCCSCFSSQKKKPKRTNSTKRSVPQPRPASPPRQKDAQTQVHPRPADIQNHPLHGNPKP 60
Query: 43 KPA---QEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRV 99
KP EP NNNN + G+NNIAAQTFTFRELATATKNFRQECLIGEGGFGRV
Sbjct: 61 KPPTNNHEPHVHKDATNNNNHKEDGSNNIAAQTFTFRELATATKNFRQECLIGEGGFGRV 120
Query: 100 YKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159
YKGKLE T Q+VAVKQLDRNG QGN+EF+VEVLMLSLLHH NLVNLIGYCADG+QRLLVY
Sbjct: 121 YKGKLENTNQIVAVKQLDRNGRQGNREFLVEVLMLSLLHHQNLVNLIGYCADGDQRLLVY 180
Query: 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNIL 219
EYM SLEDHLL++ PEQKP+DWF RMKIALGAAKGLEYLHDKANPPVIYRDLKSSNIL
Sbjct: 181 EYMASGSLEDHLLELPPEQKPLDWFIRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNIL 240
Query: 220 LDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVL 279
LD E+NAKLSDFGLAKLGP+GD+THVSSRVMGTYGYCAPEYQRTGQLTVKSDVY+FGVVL
Sbjct: 241 LDEEYNAKLSDFGLAKLGPVGDRTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYSFGVVL 300
Query: 280 LELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSA 339
LELITGRRAIDTTR T+EQ LVTWAQP FKDPNRYP+LADPLL +FPVRGLNQAVAV+A
Sbjct: 301 LELITGRRAIDTTRSTHEQTLVTWAQPVFKDPNRYPELADPLLDKDFPVRGLNQAVAVAA 360
Query: 340 MCVQEESSVRPLMSDVVSALSFLGSDPDADTATAPVPHKPPPCDHQNMNMMDQNGYYQDE 399
MC+QEE+ VRPLMSDVV+ALSFLG DP+A AT + + + Y E
Sbjct: 361 MCLQEEAGVRPLMSDVVTALSFLGGDPEAAGAT-----------YTTLATLASIPSYTAE 409
Query: 400 EKSQMERKR----AVAEAIQWGCNSR 421
+ + R AVAE ++WG +SR
Sbjct: 410 DDCSEDDMRKPEGAVAEGMEWGSSSR 435
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356566421|ref|XP_003551430.1| PREDICTED: serine/threonine-protein kinase At3g07070-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1546), Expect = e-169, Method: Compositional matrix adjust.
Identities = 308/440 (70%), Positives = 348/440 (79%), Gaps = 31/440 (7%)
Query: 1 MSCFSCF------SSRRINTSKKLQQSPGSPPNKEPASPA-PRHQN----LKTKPAQEPA 49
MSCFSCF +++ N K++QQ P KE A P PR N K P EP
Sbjct: 1 MSCFSCFLPNEKKVAKKPNNRKRIQQPAIHSP-KESAQPVQPRPDNHFNKAKATPQTEPK 59
Query: 50 DDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQ 109
+ KEAN +N NNIAAQTFTFRELA TKNFRQECLIGEGGFGRVYKG+LEKT Q
Sbjct: 60 IN-KEANKDN-----GNNIAAQTFTFRELAAVTKNFRQECLIGEGGFGRVYKGRLEKTNQ 113
Query: 110 VVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLED 169
VAVKQLDRNGLQGN+EF+VEVLMLSLLHH NLVNLIGYCADG+QRLLVYEYMPL +LED
Sbjct: 114 EVAVKQLDRNGLQGNREFLVEVLMLSLLHHQNLVNLIGYCADGDQRLLVYEYMPLGALED 173
Query: 170 HLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLS 229
HLLD+ P+QKP+DWF RMKIAL AAKGLEYLHDKANPPVIYRDLKSSNILLD EFNAKLS
Sbjct: 174 HLLDLQPQQKPLDWFIRMKIALDAAKGLEYLHDKANPPVIYRDLKSSNILLDKEFNAKLS 233
Query: 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAI 289
DFGLAKLGP GDK+HVSSRVMGTYGYCAPEYQRTGQLTVKSDVY+FGVVLLELITGRRAI
Sbjct: 234 DFGLAKLGPTGDKSHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYSFGVVLLELITGRRAI 293
Query: 290 DTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVR 349
D TRPT EQNLV+WA P FKDP+RYP+LADP LQG FP+R L+QAVAV+AMC+ EE SVR
Sbjct: 294 DNTRPTREQNLVSWAYPVFKDPHRYPELADPHLQGNFPMRSLHQAVAVAAMCLNEEPSVR 353
Query: 350 PLMSDVVSALSFLGSDPDAD--TATAPVPHKPPPCDHQN---MNMMDQNGYYQDEEKSQM 404
PL+SD+V+AL+FLG+ P + T APV P + N +N++D + + M
Sbjct: 354 PLVSDIVTALTFLGTAPGSQDLTGIAPVDMSSSPQEANNSAPLNLLDDDIF--------M 405
Query: 405 ERKRAVAEAIQWGCNSRHVA 424
+R+RAVAEAI+WG N+R A
Sbjct: 406 DRQRAVAEAIEWGTNTRSKA 425
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524523|ref|XP_003530878.1| PREDICTED: serine/threonine-protein kinase At3g07070-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1516), Expect = e-165, Method: Compositional matrix adjust.
Identities = 307/441 (69%), Positives = 346/441 (78%), Gaps = 30/441 (6%)
Query: 1 MSCFSCFSS------RRINTSKKLQQSPGSPPNKEPASPA-PRHQNLKTKPAQEPADDHK 53
MSCFSCF+S ++ N +++QQ + P KE A P PR N K P + K
Sbjct: 1 MSCFSCFTSNEKKVAKKPNNGQRIQQPAINSP-KESAQPVQPRPDNNFNKAKATPQTEPK 59
Query: 54 EANNNNKEAAGNNN-----IAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTA 108
NKEA +N IAAQTFTFRELA+ TKNFRQECLIGEGGFGRVYKG+LEKT
Sbjct: 60 I----NKEANKDNGNNNNNIAAQTFTFRELASITKNFRQECLIGEGGFGRVYKGRLEKTN 115
Query: 109 QVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLE 168
Q VAVKQLDRNGLQGN+EF+VEVLMLSLLHH NLVNLIGYCADG+QRLLVYEYMPL SLE
Sbjct: 116 QEVAVKQLDRNGLQGNREFLVEVLMLSLLHHQNLVNLIGYCADGDQRLLVYEYMPLGSLE 175
Query: 169 DHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKL 228
DHLLD+ P+QK +DWF RMKIAL AAKGLEYLHDKANPPVIYRDLKSSNILLD EFNAKL
Sbjct: 176 DHLLDVHPQQKHLDWFIRMKIALDAAKGLEYLHDKANPPVIYRDLKSSNILLDKEFNAKL 235
Query: 229 SDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRA 288
SDFGLAKLGP GDK+HVSSRVMGTYGYCAPEYQRTGQLTVKSDVY+FGVVLLELITGRRA
Sbjct: 236 SDFGLAKLGPTGDKSHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYSFGVVLLELITGRRA 295
Query: 289 IDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSV 348
ID TRPT EQNLVTWA P FKDP+RY +LADPLLQ FP+R L+QAVAV+AMC+ EE SV
Sbjct: 296 IDNTRPTREQNLVTWAYPVFKDPHRYSELADPLLQANFPMRSLHQAVAVAAMCLNEEPSV 355
Query: 349 RPLMSDVVSALSFLGSDPDAD--TATAPVPHKPPPCDHQN---MNMMDQNGYYQDEEKSQ 403
RPL+SDVV+AL+FLG+ P + T APV PP + + N++D +
Sbjct: 356 RPLISDVVTALTFLGTAPGSQDLTGIAPVDLPSPPQEAISSAPFNLLDDDVV-------- 407
Query: 404 MERKRAVAEAIQWGCNSRHVA 424
M+R+RAVAEAI+WG NSR+ A
Sbjct: 408 MDRQRAVAEAIEWGTNSRNKA 428
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297829254|ref|XP_002882509.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297328349|gb|EFH58768.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1495), Expect = e-163, Method: Compositional matrix adjust.
Identities = 287/421 (68%), Positives = 334/421 (79%), Gaps = 16/421 (3%)
Query: 1 MSCFSCFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNK 60
M+CFSCF + KK+ + + + N KT P + P +++ NN++
Sbjct: 1 MNCFSCFY---FHEKKKVPRDSDNSYRRN--GELTGRDNNKTHP-ENPKTVNEQNKNNDE 54
Query: 61 EAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG 120
+ NNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKT +VAVKQLDRNG
Sbjct: 55 DKEVTNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNG 114
Query: 121 LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP 180
LQGNKEFIVEVLMLSLLHH +LVNLIGYCADG+QRLLVYEYMP SLEDHLLD+ P+Q P
Sbjct: 115 LQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMPRGSLEDHLLDLTPDQIP 174
Query: 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240
+DW TR++IALGAAKGLEYLHDKANPPVIYRDLK++NILLD EFNAKLSDFGLAKLGP+G
Sbjct: 175 LDWDTRIRIALGAAKGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVG 234
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL 300
DK HVSSRVMGTYGYCAPEYQRTGQLT KSDVY+FGVVLLELITGRR IDTTRP +EQNL
Sbjct: 235 DKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKHEQNL 294
Query: 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
VTWAQP FK+P+R+P+LADP L+G FP + LNQAVAV+AMC+QEE++VRPLMSDVV+AL
Sbjct: 295 VTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALG 354
Query: 361 FLGSDPDADTATAPVPHKPPPCDHQNMNMMDQNGYYQDEEKSQMERKRAVAEAIQWGCNS 420
FLG+ PD + P P D ++ ++ + ER+RAVAEA++WG S
Sbjct: 355 FLGTAPDGSISVPHYDDPPQPSDETSV----------EDSVAAEERERAVAEAMEWGVAS 404
Query: 421 R 421
R
Sbjct: 405 R 405
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357505343|ref|XP_003622960.1| Serine/threonine protein kinase [Medicago truncatula] gi|355497975|gb|AES79178.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1477), Expect = e-161, Method: Compositional matrix adjust.
Identities = 291/441 (65%), Positives = 335/441 (75%), Gaps = 22/441 (4%)
Query: 1 MSCFSCFSSRRINTSKK------------LQQSPGSPPNKEPASPAPR--HQNLKTKPAQ 46
MSCFSCFSS+ SK+ +Q P ++ + P P +Q K P
Sbjct: 1 MSCFSCFSSQEKKLSKRPNNNNNNNNGKRIQHHPTQITPQKASQPQPENHYQKAKANPPT 60
Query: 47 EPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEK 106
EP + KE N N +NIAAQTFTFRELA T+NFRQE LIGEGGFGRVYKG+LEK
Sbjct: 61 EPKIN-KETNKEN-----GHNIAAQTFTFRELAAITRNFRQENLIGEGGFGRVYKGRLEK 114
Query: 107 TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRS 166
T Q VAVKQLDRNGLQGN+EF+VEVLMLSLLHH NLVNLIGYCADG+QRLLVYE+M L S
Sbjct: 115 TNQEVAVKQLDRNGLQGNREFLVEVLMLSLLHHKNLVNLIGYCADGDQRLLVYEFMLLGS 174
Query: 167 LEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226
LEDHLLD+ P+QKP+DWFTRMKIAL AAKGLEYLHDKANPPVIYRDLKSSNILLD +FNA
Sbjct: 175 LEDHLLDLEPQQKPLDWFTRMKIALDAAKGLEYLHDKANPPVIYRDLKSSNILLDKDFNA 234
Query: 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
KLSDFGLAKLGP GD +HVSSRVMGTYGYCAPEYQRTGQLTVKSD+Y+FGVVLLELITGR
Sbjct: 235 KLSDFGLAKLGPTGDMSHVSSRVMGTYGYCAPEYQRTGQLTVKSDIYSFGVVLLELITGR 294
Query: 287 RAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEES 346
R ID TRP+ EQNLV+W+ P FKDP RYP+LADP L+G FP+R L+QAVAV+AMC+ EE
Sbjct: 295 RTIDNTRPSREQNLVSWSYPVFKDPQRYPELADPKLEGNFPMRSLHQAVAVAAMCLNEEP 354
Query: 347 SVRPLMSDVVSALSFLGSDPDADTATAPVPHKPPPCDHQNMNMMDQNGYYQDEEKSQMER 406
SVRPL+SDVV+ALSFLG DP P P +N D+ S +ER
Sbjct: 355 SVRPLISDVVTALSFLGIDPMNQDPQVLSPIDMPSPTQKNEESSATLSLLDDD--SAVER 412
Query: 407 KRAVAEAIQWGCNSRHVATSM 427
++AV EA++WG N+R+ +S+
Sbjct: 413 QKAVDEAMEWGSNTRNKPSSL 433
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18397825|ref|NP_566298.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|75337179|sp|Q9SFT7.1|Y3707_ARATH RecName: Full=Serine/threonine-protein kinase At3g07070 gi|6642658|gb|AAF20239.1|AC012395_26 putative protein kinase [Arabidopsis thaliana] gi|332640974|gb|AEE74495.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1477), Expect = e-161, Method: Compositional matrix adjust.
Identities = 284/421 (67%), Positives = 331/421 (78%), Gaps = 16/421 (3%)
Query: 1 MSCFSCFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNK 60
M+CFSCF + KK+ + + + N KT P + P +++ NN++
Sbjct: 1 MNCFSCFY---FHEKKKVPRDSDNSYRRN--GEVTGRDNNKTHP-ENPKTVNEQNKNNDE 54
Query: 61 EAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG 120
+ NNIAAQTF+FRELATATKNFRQECLIGEGGFGRVYKGKLEKT +VAVKQLDRNG
Sbjct: 55 DKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNG 114
Query: 121 LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP 180
LQGNKEFIVEVLMLSLLHH +LVNLIGYCADG+QRLLVYEYM SLEDHLLD+ P+Q P
Sbjct: 115 LQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIP 174
Query: 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240
+DW TR++IALGAA GLEYLHDKANPPVIYRDLK++NILLD EFNAKLSDFGLAKLGP+G
Sbjct: 175 LDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVG 234
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL 300
DK HVSSRVMGTYGYCAPEYQRTGQLT KSDVY+FGVVLLELITGRR IDTTRP EQNL
Sbjct: 235 DKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNL 294
Query: 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
VTWAQP FK+P+R+P+LADP L+G FP + LNQAVAV+AMC+QEE++VRPLMSDVV+AL
Sbjct: 295 VTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALG 354
Query: 361 FLGSDPDADTATAPVPHKPPPCDHQNMNMMDQNGYYQDEEKSQMERKRAVAEAIQWGCNS 420
FLG+ PD + P P D ++ ++ + ER+RAVAEA++WG S
Sbjct: 355 FLGTAPDGSISVPHYDDPPQPSDETSV----------EDSVAAEERERAVAEAMEWGVAS 404
Query: 421 R 421
R
Sbjct: 405 R 405
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|28416685|gb|AAO42873.1| At3g07070 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 283/421 (67%), Positives = 331/421 (78%), Gaps = 16/421 (3%)
Query: 1 MSCFSCFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNK 60
M+CFSCF + KK+ + + + N KT P + P +++ NN++
Sbjct: 1 MNCFSCFY---FHEKKKVPRDSDNSYRRN--GEVTGRDNNKTHP-ENPKTVNEQNKNNDE 54
Query: 61 EAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG 120
+ NNIAAQTF+FRELATATKNFRQECLIGEGGFGRVYKGKLEKT +VAVKQLDRNG
Sbjct: 55 DKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNG 114
Query: 121 LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP 180
LQGNKEFIVEVLMLSLLHH +LVNLIGYCADG+QRLLVYEYM SLEDHLLD+ P+Q P
Sbjct: 115 LQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIP 174
Query: 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240
+DW TR++IALGAA GLEYLHD+ANPPVIYRDLK++NILLD EFNAKLSDFGLAKLGP+G
Sbjct: 175 LDWDTRIRIALGAAMGLEYLHDRANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVG 234
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL 300
DK HVSSRVMGTYGYCAPEYQRTGQLT KSDVY+FGVVLLELITGRR IDTTRP EQNL
Sbjct: 235 DKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNL 294
Query: 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
VTWAQP FK+P+R+P+LADP L+G FP + LNQAVAV+AMC+QEE++VRPLMSDVV+AL
Sbjct: 295 VTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALG 354
Query: 361 FLGSDPDADTATAPVPHKPPPCDHQNMNMMDQNGYYQDEEKSQMERKRAVAEAIQWGCNS 420
FLG+ PD + P P D ++ ++ + ER+RAVAEA++WG S
Sbjct: 355 FLGTAPDGSISVPHYDDPPQPSDETSV----------EDSVAAEERERAVAEAMEWGVAS 404
Query: 421 R 421
R
Sbjct: 405 R 405
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449443897|ref|XP_004139712.1| PREDICTED: serine/threonine-protein kinase At3g07070-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1431), Expect = e-155, Method: Compositional matrix adjust.
Identities = 268/363 (73%), Positives = 310/363 (85%), Gaps = 3/363 (0%)
Query: 66 NNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK 125
NNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKG+L+KT QVVAVKQLDRNGLQGN+
Sbjct: 141 NNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGRLDKTNQVVAVKQLDRNGLQGNR 200
Query: 126 EFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFT 185
EF+VEVLMLSLLHH NLVNLIGYCADG+QRLLVYEYMPL SLEDHLLD+ E+K +DW T
Sbjct: 201 EFLVEVLMLSLLHHQNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLPFERKALDWGT 260
Query: 186 RMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV 245
RMK+ LGAA+GLEYLHDKANPPVIYRDLK+SNILLD +FNAKLSDFGLAKLGP+GDK+HV
Sbjct: 261 RMKVGLGAAQGLEYLHDKANPPVIYRDLKASNILLDNDFNAKLSDFGLAKLGPVGDKSHV 320
Query: 246 SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305
SSRVMGTYGYCAPEYQRTGQLT KSDVY+FGVVLLELITG+R ID TRP +QNLV WA
Sbjct: 321 SSRVMGTYGYCAPEYQRTGQLTPKSDVYSFGVVLLELITGKRVIDNTRPAKQQNLVAWAY 380
Query: 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365
P FK+P R+ +LADPLL G+FPVRGLNQAVAV+AMC+ EE++ RPL+SDVV+ALSFLG++
Sbjct: 381 PIFKEPARFKELADPLLGGDFPVRGLNQAVAVAAMCLHEEATARPLISDVVTALSFLGAE 440
Query: 366 PDADTATAPVPHKPPPCDHQNMNMMDQN--GYYQDEEKSQMERKRAVAEAIQWGCNSRHV 423
+ ++ P P D Q++ + Y+ D+E + R+RAVAEAI+WG S+
Sbjct: 441 TTHSSPSSSSGDVPSPVDDQDLINLSNKPVDYFHDDETDEA-RQRAVAEAIEWGATSKQN 499
Query: 424 ATS 426
A +
Sbjct: 500 AAA 502
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449475515|ref|XP_004154477.1| PREDICTED: serine/threonine-protein kinase At3g07070-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1426), Expect = e-155, Method: Compositional matrix adjust.
Identities = 268/363 (73%), Positives = 310/363 (85%), Gaps = 3/363 (0%)
Query: 66 NNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK 125
NNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKG+L+KT QVVAVKQLDRNGLQGN+
Sbjct: 141 NNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGRLDKTNQVVAVKQLDRNGLQGNR 200
Query: 126 EFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFT 185
EF+VEVLMLSLLHH NLVNLIGYCADG+QRLLVYEYMPL SLEDHLLD+ E+K +DW T
Sbjct: 201 EFLVEVLMLSLLHHQNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLPFERKALDWGT 260
Query: 186 RMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV 245
RMK+ LGAA+GLEYLHDKANPPVIYRDLK+SNILLD +FNAKLSDFGLAKLGP+GDK+HV
Sbjct: 261 RMKVGLGAAQGLEYLHDKANPPVIYRDLKASNILLDNDFNAKLSDFGLAKLGPVGDKSHV 320
Query: 246 SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305
SSRVMGTYGYCAPEYQRTGQLT KSDVY+FGVVLLELITG+R ID TRP +QNLV WA
Sbjct: 321 SSRVMGTYGYCAPEYQRTGQLTPKSDVYSFGVVLLELITGKRVIDNTRPAKQQNLVAWAY 380
Query: 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365
P FK+P R+ +LADPLL G+FPVRGLNQAVAV+AMC+ EE++ RPL+SDVV+ALSFLG++
Sbjct: 381 PIFKEPARFKELADPLLGGDFPVRGLNQAVAVAAMCLHEEATARPLISDVVTALSFLGAE 440
Query: 366 PDADTATAPVPHKPPPCDHQNMNMMDQN--GYYQDEEKSQMERKRAVAEAIQWGCNSRHV 423
+ ++ P P D Q++ + Y+ D+E + R+RAVAEAI+WG S+
Sbjct: 441 TTHSSPSSSSGDVPSPVDDQDLINLSNKPVDYFHDDETDEA-RQRAVAEAIEWGATSKQN 499
Query: 424 ATS 426
A +
Sbjct: 500 AAA 502
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065334|ref|XP_002301779.1| predicted protein [Populus trichocarpa] gi|222843505|gb|EEE81052.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1389), Expect = e-151, Method: Compositional matrix adjust.
Identities = 256/299 (85%), Positives = 277/299 (92%)
Query: 65 NNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN 124
+N IAAQTFTFRELA ATKNFR+ECLIGEGGFGRVYKGKL+K QVVAVKQLDRNGLQGN
Sbjct: 5 SNVIAAQTFTFRELAMATKNFRRECLIGEGGFGRVYKGKLDKGGQVVAVKQLDRNGLQGN 64
Query: 125 KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWF 184
+EF+VEVLMLSLLHH NLVNL+GYCADG+QRLLVYEYMP SLEDHLLD+ PEQKP+DWF
Sbjct: 65 REFLVEVLMLSLLHHQNLVNLVGYCADGDQRLLVYEYMPKGSLEDHLLDLTPEQKPLDWF 124
Query: 185 TRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244
+RMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD FNAKLSDFGLAKLGP+G+K H
Sbjct: 125 SRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDKFFNAKLSDFGLAKLGPVGEKLH 184
Query: 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304
VSSRVMGTYGYCAPEYQRTGQLTVKSDVY+FGVV LELITG+R IDTTR EQNLV WA
Sbjct: 185 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYSFGVVFLELITGKRVIDTTRQNNEQNLVAWA 244
Query: 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363
QP FK+P+RYP+LADPLLQG+FPVRGLNQAVAV+AMC+QEE VRPL+SDVVSAL LG
Sbjct: 245 QPVFKEPSRYPELADPLLQGDFPVRGLNQAVAVAAMCLQEEPLVRPLISDVVSALGLLG 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 427 | ||||||
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.948 | 0.978 | 0.660 | 1.3e-141 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.693 | 0.815 | 0.814 | 8.7e-132 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.875 | 0.729 | 0.640 | 1.1e-127 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.737 | 0.809 | 0.735 | 2.1e-125 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.725 | 0.820 | 0.730 | 3.1e-122 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.857 | 0.802 | 0.617 | 1.2e-119 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.679 | 0.751 | 0.721 | 5.3e-117 | |
| TAIR|locus:2075517 | 558 | AT3G02810 [Arabidopsis thalian | 0.810 | 0.620 | 0.639 | 1.1e-116 | |
| TAIR|locus:2171342 | 636 | AT5G16500 [Arabidopsis thalian | 0.843 | 0.566 | 0.599 | 3.4e-113 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.714 | 0.800 | 0.653 | 2.4e-108 |
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1385 (492.6 bits), Expect = 1.3e-141, P = 1.3e-141
Identities = 278/421 (66%), Positives = 322/421 (76%)
Query: 1 MSCFSCFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEXXXXXX 60
M+CFSCF + KK+ + + + N KT P + P +++
Sbjct: 1 MNCFSCFY---FHEKKKVPRDSDNSYRRN--GEVTGRDNNKTHP-ENPKTVNEQNKNNDE 54
Query: 61 XXXXXXXXXXQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG 120
QTF+FRELATATKNFRQECLIGEGGFGRVYKGKLEKT +VAVKQLDRNG
Sbjct: 55 DKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNG 114
Query: 121 LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP 180
LQGNKEFIVEVLMLSLLHH +LVNLIGYCADG+QRLLVYEYM SLEDHLLD+ P+Q P
Sbjct: 115 LQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIP 174
Query: 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240
+DW TR++IALGAA GLEYLHDKANPPVIYRDLK++NILLD EFNAKLSDFGLAKLGP+G
Sbjct: 175 LDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVG 234
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL 300
DK HVSSRVMGTYGYCAPEYQRTGQLT KSDVY+FGVVLLELITGRR IDTTRP EQNL
Sbjct: 235 DKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNL 294
Query: 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
VTWAQP FK+P+R+P+LADP L+G FP + LNQAVAV+AMC+QEE++VRPLMSDVV+AL
Sbjct: 295 VTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALG 354
Query: 361 FLGSDPDADTATAPVPHKPPPCDHQNMNMMDQNGYYQDEEKSQMERKRAVAEAIQWGCNS 420
FLG+ PD + P P D ++ +D ++ ER+RAVAEA++WG S
Sbjct: 355 FLGTAPDGSISVPHYDDPPQPSDETSV---------EDSVAAE-ERERAVAEAMEWGVAS 404
Query: 421 R 421
R
Sbjct: 405 R 405
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1272 (452.8 bits), Expect = 8.7e-132, Sum P(2) = 8.7e-132
Identities = 241/296 (81%), Positives = 270/296 (91%)
Query: 73 FTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVL 132
FTFRELATATKNFRQECLIGEGGFGRVYKGKLE AQVVAVKQLDRNGLQG +EF+VEVL
Sbjct: 35 FTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGLQGQREFLVEVL 94
Query: 133 MLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALG 192
MLSLLHH NLVNLIGYCADG+QRLLVYEYMPL SLEDHLLD+ P QKP+DW TR+KIALG
Sbjct: 95 MLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPLDWNTRIKIALG 154
Query: 193 AAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT 252
AAKG+EYLHD+A+PPVIYRDLKSSNILLD E+ AKLSDFGLAKLGP+GD HVSSRVMGT
Sbjct: 155 AAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGDTLHVSSRVMGT 214
Query: 253 YGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312
YGYCAPEYQRTG LT KSDVY+FGVVLLELI+GRR IDT RP++EQNLVTWA P F+DP
Sbjct: 215 YGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLVTWALPIFRDPT 274
Query: 313 RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDA 368
RY QLADPLL+G++P + LNQA+AV+AMC+ EE +VRPLMSDV++ALSFLG+ ++
Sbjct: 275 RYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSFLGASSNS 330
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1222 (435.2 bits), Expect = 1.1e-127, Sum P(2) = 1.1e-127
Identities = 246/384 (64%), Positives = 291/384 (75%)
Query: 3 CFSCF-SSRRINTSKKLQQSPGSPPNKEPASPAPRHQNL-KTKPAQEPADDHKEXXXXXX 60
C CF SS + SK + S K+ + H +L K+K + P + KE
Sbjct: 4 CLPCFGSSAKDAASKDSVKKELSA--KDGSVTQSHHISLDKSKSRRGP-EQKKELTAPKE 60
Query: 61 XXXXXXXXXXQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG 120
QTFTFRELA ATKNFR ECL+GEGGFGRVYKG+LE T Q+VAVKQLDRNG
Sbjct: 61 GPTAHIAA--QTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRNG 118
Query: 121 LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP 180
LQGN+EF+VEVLMLSLLHH NLVNLIGYCADG+QRLLVYEYMPL SLEDHL D+ P+++P
Sbjct: 119 LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEP 178
Query: 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240
+DW TRM IA GAAKGLEYLHDKANPPVIYRDLKSSNILL ++ KLSDFGLAKLGP+G
Sbjct: 179 LDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVG 238
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL 300
DKTHVS+RVMGTYGYCAPEY TGQLT+KSDVY+FGVV LELITGR+AID R E NL
Sbjct: 239 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNL 298
Query: 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
V WA+P FKD ++P++ADP LQG +P+RGL QA+AV+AMC+QE+++ RPL+ DVV+AL+
Sbjct: 299 VAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALT 358
Query: 361 FLGS---DPDADTATAPVPHKPPP 381
+L S DP+A + PP
Sbjct: 359 YLASQTFDPNAPSGQNSRSGSGPP 382
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1232 (438.7 bits), Expect = 2.1e-125, P = 2.1e-125
Identities = 234/318 (73%), Positives = 275/318 (86%)
Query: 71 QTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVE 130
++F FRELATAT +FRQE LIGEGGFGRVYKGK+EKT QVVAVKQLDRNGLQGN+EF+VE
Sbjct: 57 KSFKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVAVKQLDRNGLQGNREFLVE 116
Query: 131 VLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIA 190
+ LSLLHH NL NLIGYC DG+QRLLV+E+MPL SLEDHLLD+ Q+P+DW +R++IA
Sbjct: 117 IFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRIRIA 176
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM 250
LGAAKGLEYLH+KANPPVIYRD KSSNILL+ +F+AKLSDFGLAKLG +GD +VSSRV+
Sbjct: 177 LGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSSRVV 236
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310
GTYGYCAPEY +TGQLTVKSDVY+FGVVLLELITG+R IDTTRP +EQNLVTWAQP F++
Sbjct: 237 GTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQPIFRE 296
Query: 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD---PD 367
PNR+P+LADPLLQGEFP + LNQAVA++AMC+QEE VRPL+SDVV+ALSF+ ++ P
Sbjct: 297 PNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTALSFMSTETGSPS 356
Query: 368 ADTATAPVPHKPPPCDHQ 385
T TA P P + Q
Sbjct: 357 GLTGTALNPLSPKTVEDQ 374
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1202 (428.2 bits), Expect = 3.1e-122, P = 3.1e-122
Identities = 230/315 (73%), Positives = 268/315 (85%)
Query: 71 QTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVE 130
QTFTF ELATAT+NFR+ECLIGEGGFGRVYKG L T+Q A+KQLD NGLQGN+EF+VE
Sbjct: 59 QTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLVE 118
Query: 131 VLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIA 190
VLMLSLLHH NLVNLIGYCADG+QRLLVYEYMPL SLEDHL DI P ++P+DW TRMKIA
Sbjct: 119 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKIA 178
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM 250
GAAKGLEYLHDK PPVIYRDLK SNILLD ++ KLSDFGLAKLGP+GDK+HVS+RVM
Sbjct: 179 AGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVM 238
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310
GTYGYCAPEY TGQLT+KSDVY+FGVVLLE+ITGR+AID++R T EQNLV WA+P FKD
Sbjct: 239 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLFKD 298
Query: 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS---DPD 367
++ Q+ADP+LQG++P RGL QA+AV+AMCVQE+ ++RPL++DVV+ALS+L S DP
Sbjct: 299 RRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQKFDPL 358
Query: 368 ADTATAPV--PHKPP 380
A + P PP
Sbjct: 359 AQPVQGSLFAPGTPP 373
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1151 (410.2 bits), Expect = 1.2e-119, Sum P(2) = 1.2e-119
Identities = 232/376 (61%), Positives = 275/376 (73%)
Query: 1 MSCFSCFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEXXXXXX 60
M CFSCF S + +KL S ++ S N+ P+ K
Sbjct: 1 MGCFSCFDS---SDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKR 57
Query: 61 XXXXXXXXXXQ----TFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL 116
Q TF FRELA AT NF + +GEGGFGRVYKG+L+ T QVVAVKQL
Sbjct: 58 ELLLPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQL 117
Query: 117 DRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP 176
DRNGLQGN+EF+VEVLMLSLLHH NLVNLIGYCADG+QRLLVYE+MPL SLEDHL D+ P
Sbjct: 118 DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP 177
Query: 177 EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236
+++ +DW RMKIA GAAKGLE+LHDKANPPVIYRD KSSNILLD F+ KLSDFGLAKL
Sbjct: 178 DKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKL 237
Query: 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY 296
GP GDK+HVS+RVMGTYGYCAPEY TGQLTVKSDVY+FGVV LELITGR+AID+ P
Sbjct: 238 GPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHG 297
Query: 297 EQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVV 356
EQNLV WA+P F D ++ +LADP L+G FP R L QA+AV++MC+QE+++ RPL++DVV
Sbjct: 298 EQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVV 357
Query: 357 SALSFLGS---DPDAD 369
+ALS+L + DP D
Sbjct: 358 TALSYLANQAYDPSKD 373
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1132 (403.5 bits), Expect = 5.3e-117, Sum P(2) = 5.3e-117
Identities = 210/291 (72%), Positives = 252/291 (86%)
Query: 73 FTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVL 132
FTFREL ATKNF + +GEGGFGRVYKG++E QVVAVKQLDRNG QGN+EF+VEV+
Sbjct: 70 FTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLVEVM 129
Query: 133 MLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIAL 191
MLSLLHH NLVNL+GYCADG+QR+LVYEYM SLEDHLL++ ++KP+DW TRMK+A
Sbjct: 130 MLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAA 189
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG 251
GAA+GLEYLH+ A+PPVIYRD K+SNILLD EFN KLSDFGLAK+GP G +THVS+RVMG
Sbjct: 190 GAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMG 249
Query: 252 TYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311
TYGYCAPEY TGQLTVKSDVY+FGVV LE+ITGRR IDTT+PT EQNLVTWA P FKD
Sbjct: 250 TYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKDR 309
Query: 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362
++ +ADPLL+G++P++GL QA+AV+AMC+QEE++ RP+MSDVV+AL +L
Sbjct: 310 RKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYL 360
|
|
| TAIR|locus:2075517 AT3G02810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1116 (397.9 bits), Expect = 1.1e-116, Sum P(2) = 1.1e-116
Identities = 227/355 (63%), Positives = 267/355 (75%)
Query: 24 SPPNKEPASPAPRHQNLKTKPAQEPADDHKEXXXXXXXXXXXXXXXXQTFTFRELATATK 83
SP NK+ ++ + N + KP DD + + FTFRELATATK
Sbjct: 9 SPKNKKSSTTNETNDNNEPKP-----DDRRRAEETEEIEQSEGTSL-KIFTFRELATATK 62
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV 143
NFRQECL+GEGGFGRVYKG L+ T QVVAVKQLD++GL GNKEF EVL L L H NLV
Sbjct: 63 NFRQECLLGEGGFGRVYKGTLKSTGQVVAVKQLDKHGLHGNKEFQAEVLSLGQLDHPNLV 122
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
LIGYCADG+QRLLVY+Y+ SL+DHL + + P+DW TRM+IA AA+GL+YLHDK
Sbjct: 123 KLIGYCADGDQRLLVYDYISGGSLQDHLHEPKADSDPMDWTTRMQIAYAAAQGLDYLHDK 182
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP-IGDKTH-VSSRVMGTYGYCAPEYQ 261
ANPPVIYRDLK+SNILLD +F+ KLSDFGL KLGP GDK +SSRVMGTYGY APEY
Sbjct: 183 ANPPVIYRDLKASNILLDDDFSPKLSDFGLHKLGPGTGDKMMALSSRVMGTYGYSAPEYT 242
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321
R G LT+KSDVY+FGVVLLELITGRRA+DTTRP EQNLV+WAQP F+DP RYP +ADP+
Sbjct: 243 RGGNLTLKSDVYSFGVVLLELITGRRALDTTRPNDEQNLVSWAQPIFRDPKRYPDMADPV 302
Query: 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDADTATAPVP 376
L+ +F RGLNQAVA+++MCVQEE+S RPL+SDV+ ALSFL S P D VP
Sbjct: 303 LENKFSERGLNQAVAIASMCVQEEASARPLISDVMVALSFL-SMPTEDGIPTTVP 356
|
|
| TAIR|locus:2171342 AT5G16500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1097 (391.2 bits), Expect = 3.4e-113, Sum P(2) = 3.4e-113
Identities = 226/377 (59%), Positives = 264/377 (70%)
Query: 1 MSCFSCFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEXXXXXX 60
M+CF CF+S++ + + P K +EPA+
Sbjct: 5 MNCFPCFTSQKSRNAPCTTNETNDDNVEHDEFRPPVVATTKRTEEREPAEQQPPV----- 59
Query: 61 XXXXXXXXXXQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG 120
+TF FRELATATKNFRQECL+GEGGFGRVYKG L+ T Q+VAVKQLD++G
Sbjct: 60 ----------KTFNFRELATATKNFRQECLLGEGGFGRVYKGTLQSTGQLVAVKQLDKHG 109
Query: 121 LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP 180
L GNKEF+ EVL L+ L H NLV LIGYCADG+QRLLV+EY+ SL+DHL + P QKP
Sbjct: 110 LHGNKEFLAEVLSLAKLEHPNLVKLIGYCADGDQRLLVFEYVSGGSLQDHLYEQKPGQKP 169
Query: 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP-I 239
+DW TRMKIA GAA+GL+YLHDK P VIYRDLK+SNILLD EF KL DFGL L P
Sbjct: 170 MDWITRMKIAFGAAQGLDYLHDKVTPAVIYRDLKASNILLDAEFYPKLCDFGLHNLEPGT 229
Query: 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN 299
GD +SSRVM TYGY APEY R LTVKSDVY+FGVVLLELITGRRAIDTT+P EQN
Sbjct: 230 GDSLFLSSRVMDTYGYSAPEYTRGDDLTVKSDVYSFGVVLLELITGRRAIDTTKPNDEQN 289
Query: 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
LV WAQP FKDP RYP +ADPLL+ F RGLNQAVA+++MC+QEE + RPL+SDV+ AL
Sbjct: 290 LVAWAQPIFKDPKRYPDMADPLLRKNFSERGLNQAVAITSMCLQEEPTARPLISDVMVAL 349
Query: 360 SFLG-SDPDADTATAPV 375
SFL S D AT P+
Sbjct: 350 SFLSMSTEDGIPATVPM 366
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1071 (382.1 bits), Expect = 2.4e-108, P = 2.4e-108
Identities = 202/309 (65%), Positives = 252/309 (81%)
Query: 71 QTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVE 130
++FTF+ELA AT+NFR+ L+GEGGFGRVYKG+L+ + QVVA+KQL+ +GLQGN+EFIVE
Sbjct: 64 RSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLD-SGQVVAIKQLNPDGLQGNREFIVE 122
Query: 131 VLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIA 190
VLMLSLLHH NLV LIGYC G+QRLLVYEYMP+ SLEDHL D+ Q+P+ W TRMKIA
Sbjct: 123 VLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIA 182
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM 250
+GAA+G+EYLH ANPPVIYRDLKS+NILLD EF+ KLSDFGLAKLGP+GD+THVS+RVM
Sbjct: 183 VGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVM 242
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310
GTYGYCAPEY +G+LTVKSD+Y FGVVLLELITGR+AID + EQNLVTW++P+ KD
Sbjct: 243 GTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKD 302
Query: 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP---D 367
++ L DP L+G++P R LN A+A+ AMC+ EE+ RP + D+V AL +L + +
Sbjct: 303 QKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSHE 362
Query: 368 ADTATAPVP 376
A ++P P
Sbjct: 363 ARNVSSPSP 371
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SFT7 | Y3707_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6745 | 0.9484 | 0.9782 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 427 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-57 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-40 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-20 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 9e-57
Identities = 75/218 (34%), Positives = 111/218 (50%), Gaps = 18/218 (8%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-FIVEVLMLSLLHHDNLVNLIGYC 149
+GEGGFG VY + +KT + VA+K + + E + E+ +L L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
D LV EY SL+D L + + + ++I L +GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 210 YRDLKSSNILLD-CEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRTGQLT 267
+RDLK NILLD KL+DFGL+KL + + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 268 VKSDVYTFGVVLLELITGRRAID-------TTRPTYEQ 298
KSD+++ GV+L EL + I RP+ ++
Sbjct: 173 EKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKE 210
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 2e-52
Identities = 73/199 (36%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 91 IGEGGFGRVYKGKLE----KTAQVVAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG VYKG L+ VAVK L + Q +EF+ E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+G C + E ++V EYMP L D+L K + + AL A+G+EYL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRK--NRPKELSLSDLLSFALQIARGMEYLESK-- 122
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
I+RDL + N L+ K+SDFGL++ D V + APE + G+
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGK 180
Query: 266 LTVKSDVYTFGVVLLELIT 284
T KSDV++FGV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 4e-52
Identities = 71/199 (35%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 91 IGEGGFGRVYKGKLE----KTAQVVAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG VYKGKL+ K VAVK L + Q +EF+ E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+G C + E +V EYM L +L + + + AL A+G+EYL K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRK---NRPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
I+RDL + N L+ K+SDFGL++ D + APE + G+
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGK 179
Query: 266 LTVKSDVYTFGVVLLELIT 284
T KSDV++FGV+L E+ T
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-51
Identities = 76/199 (38%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQL--DRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGY 148
+G G FG VYK K + T ++VAVK L + ++ E+ +L L H N+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
D + LV EY L D+L P+ KIAL +GLEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL-T 267
I+RDLK NILLD K++DFGLAK + + +++ V GT Y APE G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 268 VKSDVYTFGVVLLELITGR 286
K DV++ GV+L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 9e-49
Identities = 75/200 (37%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 91 IGEGGFGRVYKGKL----EKTAQVVAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG VYKG L E T VAVK L + +EF+ E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+G C GE +V EYMP L D L G + D +++AL AKG+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD---LLQMALQIAKGMEYLESK-- 121
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
++RDL + N L+ K+SDFGL++ D + APE + G+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 266 LTVKSDVYTFGVVLLELITG 285
T KSDV++FGV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 13/204 (6%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLV 143
+ +GEG FG+VY + +KT ++VA+K + + ++ ++E I+ E+ +L L H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPID-WFTRMKIALGAAKGLEYLHD 202
L D ++ LV EY L D L ++ + R LEYLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEAR-FYLRQILSALEYLHS 115
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
K +++RDLK NILLD + + KL+DFGLA+ + +++ V GT Y APE
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLL 169
Query: 263 TGQLTVKSDVYTFGVVLLELITGR 286
D+++ GV+L EL+TG+
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 4e-45
Identities = 87/289 (30%), Positives = 129/289 (44%), Gaps = 50/289 (17%)
Query: 91 IGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLI 146
+GEG FG VYKGKL+ VAVK L + + K+F+ E ++ L H N+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLD-----IGPEQKPIDWFTRMKIALGAAKGLEYLH 201
G C + E LV EYM L D+L PE+ + + A+ AKG+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS------RVMGTYGY 255
K ++RDL + N L+ + K+SDFGL++ D + R M
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM----- 174
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314
APE + G T KSDV++FGV+L E+ T G A P+ P
Sbjct: 175 -APESLKDGIFTSKSDVWSFGVLLWEIFTLG------------------ATPY---PGLS 212
Query: 315 PQ-LADPLLQGEFPVRGLN--QAVA-VSAMCVQEESSVRPLMSDVVSAL 359
+ + + L +G + + + C Q + RP S++V L
Sbjct: 213 NEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 7e-40
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVL-----MLSLLH 138
+ + L+G G FG VY + T +++AVK ++ L G+ E +E L +LS L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQ 57
Query: 139 HDNLVNLIGYCADGEQR-LLVY-EYMPLRSLEDHLLDIGPEQKP-IDWFTRMKIALGAAK 195
H N+V G D E+ L ++ EY+ SL L G +P I +TR + +
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-----E 112
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
GL YLH +++RD+K +NIL+D + KL+DFG AK + + V GT +
Sbjct: 113 GLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGRR 287
APE R + +D+++ G ++E+ TG+
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 75/222 (33%), Positives = 110/222 (49%), Gaps = 25/222 (11%)
Query: 73 FTFRELATATKNFRQECLIGEGGFGRVYKGKLE----KTAQVVAVKQLDRNG-LQGNKEF 127
F R L K +Q +GEG FG+V + + T + VAVK L+ +G Q +F
Sbjct: 1 FEKRHL----KFIKQ---LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF 53
Query: 128 IVEVLMLSLLHHDNLVNLIGYCADGEQR--LLVYEYMPLRSLEDHLLDIGPEQKP-IDWF 184
E+ +L L H+N+V G C R L+ EY+P SL D+L + I+
Sbjct: 54 EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLK 109
Query: 185 TRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244
+ + KG++YL + I+RDL + NIL++ E K+SDFGLAK+ P +
Sbjct: 110 RLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY 166
Query: 245 VSS--RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ Y APE RT + + SDV++FGV L EL T
Sbjct: 167 YVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 74/259 (28%), Positives = 120/259 (46%), Gaps = 36/259 (13%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IG+GGFG VYK + ++T + VA+K + + ++ I E+ +L H N+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIA---LGAAKGLEYLHDKANPP 207
++ +V E+ SL+D LL + T +IA KGLEYLH
Sbjct: 68 KKDELWIVMEFCSGGSLKD-LLKSTNQT-----LTESQIAYVCKELLKGLEYLHSNG--- 118
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT 267
+I+RD+K++NILL + KL DFGL+ T + ++GT + APE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 268 VKSDVYTFGVVLLELITGR---------RAIDTTR--PTYE-QNLVTWAQPF-------- 307
K+D+++ G+ +EL G+ +A+ +N W+ F
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235
Query: 308 FKDPNRYPQLADPLLQGEF 326
K+P + P A+ LL+ F
Sbjct: 236 QKNPEKRPT-AEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-32
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDN 141
N++ LIG G FG VYKG +T VA+KQ+ ++ K + E+ +L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEY 199
+V IG + ++ EY SL + G PE + ++ +GL Y
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAY 114
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA-KLGPIGDKTHVSSRVMGTYGYCAP 258
LH++ VI+RD+K++NIL + KL+DFG+A KL + V+GT + AP
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAP 168
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGR 286
E + SD+++ G ++EL+TG
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-31
Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYC 149
IG+G FG V G Q VAVK L + F+ E +++ L H NLV L+G
Sbjct: 13 TIGKGEFGDVMLGDYRG--QKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVV 69
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
G +V EYM SL D+L G + I ++ AL +G+EYL +K +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FV 124
Query: 210 YRDLKSSNILLDCEFNAKLSDFGLAK---LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL 266
+RDL + N+L+ + AK+SDFGLAK G K V + APE R +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKF 176
Query: 267 TVKSDVYTFGVVLLELIT-GR 286
+ KSDV++FG++L E+ + GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIV-EVLMLSLLHHDN 141
+ IG+G FG+VY + + ++ +K++D + + + +E + EV +L L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPI------DWFTRMKIALGAAK 195
++ + + +V EY L + E KP DWF ++ L
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA--- 115
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
L+YLH + +++RD+K NI L KL DFG++K+ + ++ V+GT Y
Sbjct: 116 -LKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYY 169
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGRRA 288
+PE + KSD+++ G VL EL T +
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 6e-30
Identities = 74/217 (34%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEV-----LMLSLLH 138
++R +GEG FG VY + K VA+K L L+ + + ++ SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVL-AKKLESKSKEVERFLREIQILASLNH 56
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
N+V L + D LV EY+ SLED LL + P+ + I LE
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALE 115
Query: 199 YLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLAK-LGPIGDKTHV---SSRVMGTY 253
YLH K +I+RD+K NILLD + KL DFGLAK L G + + S +GT
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 254 GYCAPEY---QRTGQLTVKSDVYTFGVVLLELITGRR 287
GY APE + SD+++ G+ L EL+TG
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 21/213 (9%)
Query: 85 FRQECLIGEGGFGRVYKG----KLEKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHH 139
+ ++G G FG VYKG + EK VA+K L + + NKE + E +++ + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLD----IGPEQKPIDWFTRMKIALGAAK 195
++V L+G C Q L+ + MPL L D++ + IG Q ++W ++ AK
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNWCVQI------AK 120
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
G+ YL +K +++RDL + N+L+ + K++DFGLAKL + +K + + +
Sbjct: 121 GMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRR 287
A E T KSDV+++GV + EL+T G +
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 71/224 (31%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 77 ELATATKNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGL-QGNKEFIVE 130
E+ + F +E +GEG FG+VYKG+L +A VA+K L N + +EF E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 131 VLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLL------DIGPE------Q 178
++S L H N+V L+G C + +++EY+ L + L+ D+G E +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 179 KPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238
+D + IA+ A G+EYL ++ ++RDL + N L+ K+SDFGL++
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLEL 282
D V S+ + + PE G+ T +SD+++FGVVL E+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQ-----VVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
+GEG FG+V+ G+ +VAVK L + K+F E +L+ H+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 145 LIGYCADGEQRLLVYEYMP-------LRSLEDH---LLDIGPEQKPIDWFTRMKIALGAA 194
G C +G+ ++V+EYM LRS L + ++IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG 254
G+ YL A+ ++RDL + N L+ + K+ DFG+++ D V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ PE + T +SDV++FGVVL E+ T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 55/222 (24%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-----FIVEVLMLSLLHHDNLVNL 145
IGEG +G+VYK + +KT ++VA+K++ ++ KE I E+ +L L H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 146 IGYCADGEQR--LLVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK------ 195
+ +V+EYM L L D +K K
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDS--------------PEVKFTESQIKCYMKQL 109
Query: 196 --GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV--SSRVMG 251
GL+YLH +++RD+K SNIL++ + KL+DFGLA+ P + ++RV+
Sbjct: 110 LEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVI- 163
Query: 252 TYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
T Y PE Y + D+++ G +L EL G+
Sbjct: 164 TLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 8/202 (3%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
+ F E +G G FG V++G + +V A+K L + L ++F EV L L H +L
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
++L C+ GE ++ E M SL L PE + + + + +A A+G+ YL +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
+ I+RDL + NIL+ + K++DFGLA+L I + ++SS Y + APE
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 263 TGQLTVKSDVYTFGVVLLELIT 284
G + KSDV++FG++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 76/204 (37%), Positives = 110/204 (53%), Gaps = 17/204 (8%)
Query: 90 LIGEGGFGRV----YKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+G+G FG V Y + T +VVAVK+L + + ++F E+ +L L HDN+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 146 IGYC-ADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
G C + G + L LV EY+P SL D+L ++ +D + A KG+EYL K
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG---TYGYCAPEY 260
++RDL + NIL++ E K+ DFGL K+ P DK + R G + Y APE
Sbjct: 128 R---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APES 182
Query: 261 QRTGQLTVKSDVYTFGVVLLELIT 284
+ +V SDV++FGVVL EL T
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 30/208 (14%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLIG 147
+G+G FG+V + + T ++ A+K L + + KE + E +LS ++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 148 YCA--DGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMK-----IALGAAKGLE 198
+ A E+ LV EY P L HL G E+ R + I L LE
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-------RARFYAAEIVLA----LE 107
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
YLH +IYRDLK NILLD + + KL+DFGLAK + + ++ GT Y AP
Sbjct: 108 YLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFC-GTPEYLAP 162
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGR 286
E D ++ GV+L E++TG+
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 69/203 (33%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLM-LSLLHHDNLVNLIGY- 148
+G G G V K T +++AVK + N+ ++L L +LH N ++G+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 149 --CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
+ + EYM SL D +L Q I KIA+ KGL YLH+K
Sbjct: 66 GAFYNNGDISICMEYMDGGSL-DKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK- 121
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD---KTHVSSRVMGTYGYCAPEYQRT 263
+I+RD+K SNIL++ KL DFG++ G + + KT V GT Y APE +
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVS--GQLVNSLAKTFV-----GTSSYMAPERIQG 173
Query: 264 GQLTVKSDVYTFGVVLLELITGR 286
+VKSD+++ G+ L+EL TGR
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLIGYC 149
IGEG G VYK T + VA+K++ + NKE I+ E+L++ H N+V+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA---KGLEYLHDKANP 206
G++ +V EYM SL D + Q + +IA +GLEYLH +
Sbjct: 85 LVGDELWVVMEYMDGGSLTDII-----TQNFVR-MNEPQIAYVCREVLQGLEYLHSQ--- 135
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
VI+RD+KS NILL + + KL+DFG A+L K + V+GT + APE +
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPYWMAPEVIKRKD 192
Query: 266 LTVKSDVYTFGVVLLELITG 285
K D+++ G++ +E+ G
Sbjct: 193 YGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 71/200 (35%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V+ G T +V AVK L + G + F+ E ++ L HD LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
+ E +V EYM SL D L E K + + +A A+G+ YL + I+
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRTGQLT 267
RDL + NIL+ K++DFGLA+L I D + + G + APE G+ T
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARL--IEDDEYTAR--EGAKFPIKWTAPEAANYGRFT 182
Query: 268 VKSDVYTFGVVLLELIT-GR 286
+KSDV++FG++L E++T GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVK--QLDRNGLQGNKEFIVEVLMLSLLHHDN 141
+ + ++G+G G VYK + + T ++ A+K +D + K+ + E+ L
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPY 60
Query: 142 LVNLIG-YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
+V G + +GE + V EYM SL D L +G +P+ IA KGL+YL
Sbjct: 61 VVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYL 115
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGYCAPE 259
H K + +I+RD+K SN+L++ + K++DFG++K L D+ + + V GT Y +PE
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPE 170
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGR 286
+ + +D+++ G+ LLE G+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 87/300 (29%), Positives = 145/300 (48%), Gaps = 33/300 (11%)
Query: 66 NNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL-DRNGLQGN 124
++ +++ T ++ ++ K +E +I G G YKGK K VK++ D N + +
Sbjct: 676 DSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS 732
Query: 125 KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWF 184
E+ + L H N+V LIG C + L++EY+ ++L + L ++ W
Sbjct: 733 -----EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-------SWE 780
Query: 185 TRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244
R KIA+G AK L +LH + +P V+ +L I++D + L L L K
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF 839
Query: 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304
+SS Y APE + T +T KSD+Y FG++L+EL+TG+ D + ++V WA
Sbjct: 840 ISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWA 892
Query: 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAM-----CVQEESSVRPLMSDVVSAL 359
+ + D + DP ++G+ V NQ V M C + + RP +DV+ L
Sbjct: 893 RYCYSDCH-LDMWIDPSIRGDVSV---NQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 91 IGEGGFGRV----YKGKLEKTAQVVAVKQLDR-NGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG+V Y + T ++VAVK L R G Q + E+ +L L+H+N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 146 IGYCADGEQR--LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
G C++ + L+ EY+PL SL D+L P+ K ++ + A +G+ YLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHK-LNLAQLLLFAQQICEGMAYLHSQ 126
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH-VSSRVMGTYGYCAPEYQR 262
I+RDL + N+LLD + K+ DFGLAK P G + + V + A E +
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 263 TGQLTVKSDVYTFGVVLLELIT 284
+ + SDV++FGV L EL+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 68/203 (33%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 90 LIGEGGFGRVYKGK----LEKTAQVVAVKQLDRNGLQGN-KEFIVEVLMLSLLHHDNLVN 144
+G+G FG V +G+ K V AVK L + L +F+ E ++ L H+NL+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPV-AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
L G ++V E PL SL D L I T A+ A G+ YL K
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESKR 117
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS---RVMGTYGYCAPEYQ 261
I+RDL + NILL + K+ DFGL + P + +V +V + +CAPE
Sbjct: 118 ---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 262 RTGQLTVKSDVYTFGVVLLELIT 284
RT + SDV+ FGV L E+ T
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQL----DRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
+GEG +G VYK + +KT ++VA+K++ + G+ + E+ +L L H N+V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHPNIVKLL 64
Query: 147 GYCADGEQRLLVYEYMP--LRS-LEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
+ LV+EY L+ L+ + P I + +GL Y H
Sbjct: 65 DVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNL--IKSIMYQLL-----RGLAYCHSH 117
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT 263
+++RDLK NIL++ + KL+DFGLA+ I +T+ + V+ T Y APE
Sbjct: 118 R---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPE---- 168
Query: 264 GQLTVKSDVYTFGV-------VLLELITGR 286
+ + S Y+ V + E+ITG+
Sbjct: 169 --ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 67/200 (33%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-FIVEVLMLSLLHHDNLVNLIGY 148
IG+G FG VYKG L K VAVK K F+ E +L H N+V LIG
Sbjct: 2 KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKI---ALGAAKGLEYLHDKAN 205
C + +V E +P SL L +K + T K+ +L AA G+EYL K
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
I+RDL + N L+ K+SDFG+++ G T + APE G+
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 266 LTVKSDVYTFGVVLLELITG 285
T +SDV+++G++L E +
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQ--LDRNGLQGN---KEFIVEVLMLSLLHHDNLVN 144
L+G G FG VY+G AVK+ L +G G K+ E+ +LS L H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP-IDWFTRMKIALGAAKGLEYLHDK 203
+G + + + E +P SL L G +P I +TR + GLEYLHD+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-----LGLEYLHDR 121
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM-----GTYGYCAP 258
++RD+K +NIL+D KL+DFG+AK V G+ + AP
Sbjct: 122 N---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAP 170
Query: 259 EY-QRTGQLTVKSDVYTFGVVLLELITGR 286
E + G + +D+++ G +LE+ TG+
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 16/206 (7%)
Query: 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLIG 147
+IG G VY + VA+K++D Q + + + EV +S +H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAAKGLEYLHDKA 204
G++ LV Y+ SL LDI P IA KGLEYLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTH-VSSRVMGTYGYCAPE--Y 260
I+RD+K+ NILL + + K++DFG+ A L GD+T V +GT + APE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 261 QRTGQLTVKSDVYTFGVVLLELITGR 286
Q G K+D+++FG+ +EL TG
Sbjct: 180 QVHG-YDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIV--EVLMLSLL-H 138
+F+ +IGEG F V K ++T + A+K LD+ L + K V E +L+ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
H ++ L D E V EY P L ++ G TR A LE
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKC-TRFYAAE-ILLALE 116
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG------------------PIG 240
YLH K +I+RDLK NILLD + + K++DFG AK+ I
Sbjct: 117 YLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
+ +GT Y +PE SD++ G ++ +++TG+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 4e-23
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGY 148
IG+G FG V+K + +V A+KQ+D + + +E I E +L+ L ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPID--WFTRMKIALGAAKGLEYLHDKANP 206
D + +V EY L L P D W + + GL +LH K
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLHSKK-- 121
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL 266
+++RD+KS N+ LD N K+ D G+AKL + D T+ ++ ++GT Y +PE
Sbjct: 122 -ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 267 TVKSDVYTFGVVLLELITGRRAID 290
KSDV+ GVVL E TG+ D
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 6e-23
Identities = 68/203 (33%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 91 IGEGGFGRVYKGK-LEKTAQV--VAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLI 146
+G G FG V KG L K+ + VAVK L + + K EF+ E +++ L H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
G C GE +LV E PL L +L P + A A G+ YL K
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESKH 115
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTY--GYCAPEYQ 261
++RDL + N+LL AK+SDFG+++ LG + + G + + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPECI 170
Query: 262 RTGQLTVKSDVYTFGVVLLELIT 284
G+ + KSDV+++GV L E +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 89/282 (31%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 90 LIGEGGFGRVYKGKLEKTAQV---VAVKQLDR-NGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+IG+G FG VY G L + AVK L+R L+ ++F+ E +++ H N+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 146 IGYCADGE-QRLLVYEYMPLRSLEDHLLDIGPEQKPI--DWFTRMKIALGAAKGLEYLHD 202
+G C E L+V YM L + + P D + L AKG+EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRS--ETHNPTVKDL---IGFGLQVAKGMEYL-- 114
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR----VMGTYGYCAP 258
A+ ++RDL + N +LD F K++DFGLA+ I DK + S + A
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318
E +T + T KSDV++FGV+L EL+T R A P Y F D Y
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT-RGA-----PPYPD-----VDSF--DITVYLLQG 218
Query: 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
LLQ E+ L + V C + +RP S++VS +
Sbjct: 219 RRLLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-22
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIG 147
+G+GGFG V +++ T ++ A K+LD+ L +G + + E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 148 YCADGEQRL-LVYEYMPLRSLEDHLLDIG----PEQKPIDWFTRMKIALGAAKGLEYLHD 202
Y + + L LV M L+ H+ ++G PE + I F +I G LE+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAI--FYAAQIICG----LEHLHQ 113
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
+ ++YRDLK N+LLD N ++SD GLA G K + GT GY APE +
Sbjct: 114 RR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQ 167
Query: 263 TGQLTVKSDVYTFGVVLLELITGR 286
D + G L E+I GR
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 75/241 (31%), Positives = 112/241 (46%), Gaps = 28/241 (11%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
F +GEG +G VYK ++T QVVA+K + +E I E+ +L +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAAKGLEYLH 201
G +V EY S+ D ++ I K T +IA KGLEYLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD-IMKI--TNKT---LTEEEIAAILYQTLKGLEYLH 116
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY- 260
I+RD+K+ NILL+ E AKL+DFG++ G + D + V+GT + APE
Sbjct: 117 SNK---KIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 261 QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ-LAD 319
Q G K+D+++ G+ +E+ G+ P + F PN+ P L+D
Sbjct: 172 QEIGYNN-KADIWSLGITAIEMAEGKPPYSDIHPM---------RAIFMIPNKPPPTLSD 221
Query: 320 P 320
P
Sbjct: 222 P 222
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 74/207 (35%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLM---LSLLHHD--NLVN 144
IG G G+VYK + +KT V+AVKQ+ R G NKE +LM + L HD +V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVK 78
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
GY + E M L+ L I Q PI K+ + K L YL +K
Sbjct: 79 CYGYFITDSDVFICMELMST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLA-KLGPIGDKTHVSSRVMGTYGYCAPEY--- 260
VI+RD+K SNILLD N KL DFG++ +L + K +R G Y APE
Sbjct: 135 G--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK--TRSAGCAAYMAPERIDP 188
Query: 261 -QRTGQLTVKSDVYTFGVVLLELITGR 286
+ +++DV++ G+ L+EL TG+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 86 RQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLVN 144
EC IG+G FG VYK ++T QVVA+K +D + E I E+ LS +
Sbjct: 5 LLEC-IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIA---LGAAKGLEYLH 201
G G + ++ EY S D LL G IA GLEYLH
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGK-------LDETYIAFILREVLLGLEYLH 115
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR---VMGTYGYCAP 258
++ I+RD+K++NILL E + KL+DFG++ G T S+ +GT + AP
Sbjct: 116 EEG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAP 167
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITG 285
E + K+D+++ G+ +EL G
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 64/207 (30%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV----------EVLMLSLLHHD 140
IG+G FG+V + T ++ A+K + NK+ V E +L L+H
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYM-------NKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
LVNL D E LV + + L HL + F +I L LEYL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA----LEYL 116
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
H K +I+RD+K NILLD + + ++DF +A T +S GT GY APE
Sbjct: 117 HSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEV 170
Query: 261 QRTGQLTVKSDVYTFGVVLLELITGRR 287
+V D ++ GV E + G+R
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 78/288 (27%), Positives = 126/288 (43%), Gaps = 41/288 (14%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG+V+ + E+ +VAVK L ++F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQK-----------PIDWFTRMKIALGAA 194
G C +G L+V+EYM L L GP+ K + + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG 254
G+ YL A+ ++RDL + N L+ K+ DFG+++ D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314
+ PE + T +SD+++FGVVL E+ T + QP+++ N
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK-----------------QPWYQLSN-- 230
Query: 315 PQLADPLLQG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
+ + + QG E P + A+ C Q E R ++ D+ S L
Sbjct: 231 TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 37/249 (14%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIG 147
I +G +GRV+ K + T + A+K + + + + + E +LS +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 148 YCADGEQRL-LVYEYMP---LRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLH 201
Y G++ L LV EY+P L SL ++ +G E + + +AL EYLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVARIYIAEIVLAL------EYLH 110
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS------SRVMGTYGY 255
+ +I+RDLK NIL+D + KL+DFGL+K+G + + +++ R++GT Y
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAI-----DTTRPTYEQNLVTWAQPFFKD 310
APE + D ++ G +L E + G I +T + QN++ + +D
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG---IPPFHGETPEEIF-QNILNGKIEWPED 223
Query: 311 PNRYPQLAD 319
+ D
Sbjct: 224 VEVSDEAID 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 69/200 (34%), Positives = 110/200 (55%), Gaps = 19/200 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IGEG FG V +G E T Q VAVK + + + F+ E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 151 DGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
L +V E M +L + L G + ++ +L A+G+EYL K ++
Sbjct: 70 --HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL--LQFSLDVAEGMEYLESKK---LV 122
Query: 210 YRDLKSSNILLDCEFNAKLSDFGLAKLGPIG-DKTHVSSRVMGTYGYCAPEYQRTGQLTV 268
+RDL + NIL+ + AK+SDFGLA++G +G D + + + + APE + + +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSS 176
Query: 269 KSDVYTFGVVLLELITGRRA 288
KSDV+++GV+L E+ + RA
Sbjct: 177 KSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 71/213 (33%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL--DRNGLQGNKEFIV---EVLMLSLLH 138
N+R+ L+G+G FGRVY T + +AVKQ+ D + + KE E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
H+ +V G D E + EYMP S++D L G + + TR K +G+E
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TR-KYTRQILEGVE 118
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGYCA 257
YLH +++RD+K +NIL D N KL DFG +K L I V GT + +
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 258 PE------YQRTGQLTVKSDVYTFGVVLLELIT 284
PE Y R K+DV++ G ++E++T
Sbjct: 176 PEVISGEGYGR------KADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-21
Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 43/270 (15%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQ--LDRNGLQGNKE-------FIVEVLMLSLLHHD 140
LIG G FG VY G + +++AVKQ L E+ +L L H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAKGLEY 199
N+V +G D + + EY+P S+ L + G E+ + F R + KGL Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-----KGLNY 121
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-----LGPIGDKTHVSSRVMGTYG 254
LH++ +I+RD+K +NIL+D + K+SDFG++K S + G+
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVF 177
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGR---------RAI----DTTRPTYEQNLV 301
+ APE + T K+D+++ G +++E++TG+ +AI + P N+
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS 237
Query: 302 TWAQPFFK-----DPNRYPQLADPLLQGEF 326
+ A F + D N+ P A LL+ F
Sbjct: 238 SEAIDFLEKTFEIDHNKRPT-AAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 12/200 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQ-LDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYC 149
+GEG G V K +L+ T + A+K K+ + E+ + +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 150 ADGEQRLL--VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
D + EY SL+ + I KIA KGL YLH +
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--- 125
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLA-KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL 266
+I+RD+K SNILL + KL DFG++ +L T GT Y APE +
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPERIQGKPY 180
Query: 267 TVKSDVYTFGVVLLELITGR 286
++ SDV++ G+ LLE+ R
Sbjct: 181 SITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 56/214 (26%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV--EVLMLSLLHHDN 141
+ + ++G G FG V+ + + ++V +KQ+ + ++ E +L LL H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG----PEQKPIDWFTRMKIALGAAKGL 197
++ + + ++V EY P +L +++ E + +F ++ +AL
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------ 114
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNA-KLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
++H K +++RDLK+ NILLD K+ DFG++K+ + K+ + V+GT Y
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYI 168
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELITGRRAID 290
+PE KSD++ G VL EL + +RA +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGY 148
IGEG +G VYK + + T ++VA+K++ K + E+ +L L+H N++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
LV+E+M D I Q+ + +GL + H +
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SHG--I 119
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKTH-VSSRVMGTYGYCAPE-YQRTG 264
++RDLK N+L++ E KL+DFGLA+ P+ TH V +R Y APE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174
Query: 265 QLTVKSDVYTFGVVLLELITGR 286
+ D+++ G + EL++ R
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G +G VY+G +K + VAVK L + ++ +EF+ E ++ + H NLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
++ E+M +L D+L + ++ ++ + +A + +EYL K I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKS 270
RDL + N L+ K++DFGL++L GD + + APE + ++KS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 271 DVYTFGVVLLELIT 284
DV+ FGV+L E+ T
Sbjct: 187 DVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V++G T V AVK L + G K+F+ E ++ L H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
E +V E M SL ++L + + +A A G+ YL + I+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLP--QLIDMAAQVASGMAYLEAQN---YIH 126
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY--GYCAPEYQRTGQLTV 268
RDL + N+L+ K++DFGLA++ I + + +R + + APE + ++
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARV--IKEDIY-EAREGAKFPIKWTAPEAALYNRFSI 183
Query: 269 KSDVYTFGVVLLELIT-GR 286
KSDV++FG++L E++T GR
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIV-EVLMLSLLHHDNLVNLIGY 148
IG+G FG V K + + +++ K++D + + K+ +V EV +L L H N+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 149 CADGEQRLLVYEYMP-------------LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK 195
D + L Y M + ++ E+ T++ +AL
Sbjct: 68 IIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYI----EEEFIWRILTQLLLAL---- 118
Query: 196 GLEYLHDKANPP--VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD---KTHVSSRVM 250
H++++P V++RDLK +NI LD N KL DFGLAK+ KT+V
Sbjct: 119 --YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV----- 171
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
GT Y +PE KSD+++ G ++ EL
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-21
Identities = 68/226 (30%), Positives = 115/226 (50%), Gaps = 23/226 (10%)
Query: 77 ELATATKNFRQECLIGEGGFGRVYKGKL----EKTAQVVAVKQL-DRNGLQGNKEFIVEV 131
EL + F +E +GE FG++YKG L AQ+VA+K L D N Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 132 LMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLL------DIGPE-------Q 178
+++ LHH N+V L+G + +++EY+ L + L+ D+G +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 179 KPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238
+D + IA+ A G+EYL ++ +++DL + NIL+ + + K+SD GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
D V + + + PE G+ + SD+++FGVVL E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-21
Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V+ GK V A+K + R G +FI E ++ L H NLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDV-AIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA----KGLEYLHDKANP 206
+V EYM L ++L E+K + L + +EYL
Sbjct: 70 KQRPIFIVTEYMANGCLLNYL----RERKGK---LGTEWLLDMCSDVCEAMEYLESNG-- 120
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRT 263
I+RDL + N L+ + K+SDFGLA+ + D + SS GT + PE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDY 175
Query: 264 GQLTVKSDVYTFGVVLLELITG 285
+ + KSDV++FGV++ E+ +
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 8e-21
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQ-LDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLI 146
++GEG +G V K + + T ++VA+K+ + + K+ + EV +L L H+N+VNL
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
+ LV+EY+ LE LL+ P P D L + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQL--LQAIAYCHSHN-- 120
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL 266
+I+RD+K NIL+ KL DFG A+ + ++ V T Y APE L
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE------L 172
Query: 267 TVKS-------DVYTFGVVLLELITGR 286
V DV+ G ++ EL+ G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 8e-21
Identities = 66/205 (32%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK--EFIV-EVLMLSLLHHDNLVNLIG 147
+G GGFGRV K++ + A+K + + + E I E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
D + ++ EY L L D G ++ R IA EYLH++
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARFYIA-CVVLAFEYLHNRG--- 113
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE------YQ 261
+IYRDLK N+LLD KL DFG AK G KT GT Y APE Y
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGYD 170
Query: 262 RTGQLTVKSDVYTFGVVLLELITGR 286
+ D ++ G++L EL+TGR
Sbjct: 171 FS------VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 82 TKNFRQECLIGEGGFGRVYKG----KLEKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSL 136
R+ L+G G FG V+KG + + VA+K + DR+G Q +E +L +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 137 LHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLL----DIGPEQKPIDWFTRMKIALG 192
L H +V L+G C G LV + PL SL DH+ + P Q+ ++W ++
Sbjct: 66 LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNWCVQI----- 118
Query: 193 AAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT 252
AKG+ YL + +++R+L + NILL + +++DFG+A L DK + S
Sbjct: 119 -AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174
Query: 253 YGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ A E G+ T +SDV+++GV + E+++
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 91 IGEGGFGRVYKGKLE--KTAQV---VAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
+G+G FG VY+G + + VA+K + + ++ EF+ E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHL------LDIGPEQKPIDWFTRMKIALGAAKGLE 198
L+G + G+ L+V E M L+ +L + P P +++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
YL K ++RDL + N ++ + K+ DFG+ + D + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELIT 284
E + G T KSDV++FGVVL E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 35/208 (16%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV----------EVLMLSLLHHD 140
+G G FGRV + + + + A+K L K IV E +L + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILS-------KAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLE 198
LVNL G D LV EY+P L HL G PE P+ F ++ L LE
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE--PVARFYAAQVVLA----LE 115
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
YLH ++YRDLK N+LLD + K++DFG AK + +T+ + GT Y AP
Sbjct: 116 YLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYLAP 167
Query: 259 E-YQRTGQLTVKSDVYTFGVVLLELITG 285
E G D + G+++ E++ G
Sbjct: 168 EIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQ--LDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGY 148
IG G FG+VY T +++AVK+ + N + KE E+ +L LL H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
E+ + EY +LE+ LL+ G + +D L +GL YLH +
Sbjct: 68 EVHREKVYIFMEYCSGGTLEE-LLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM----GTYGYCAPEYQRTG 264
++RD+K +NI LD KL DFG A + + T + GT Y APE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 265 QLTVK---SDVYTFGVVLLELITGRR 287
+ +D+++ G V+LE+ TG+R
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 29/215 (13%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQ--LDRNGLQGNKEFIV--------EVLMLSLLHH 139
LIG+G +GRVY T +++AVKQ L + E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 140 DNLVNLIGYCADGEQRLLVY-EYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAKGL 197
N+V +G E+ L ++ EY+P S+ L G E++ + +FT + +GL
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGL 121
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM---GTYG 254
YLH K +++RDLK+ N+L+D + K+SDFG++K D + + + M G+
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQNMSMQGSVF 175
Query: 255 YCAPEYQRTGQ--LTVKSDVYTFGVVLLELITGRR 287
+ APE + + K D+++ G V+LE+ GRR
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG+V+ + K +VAVK L L K+F E +L+ L H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPE------------QKPIDWFTRMKIALGA 193
G C DG+ ++V+EYM L L GP+ + + + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
A G+ YL A+ ++RDL + N L+ K+ DFG+++ D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 254 GYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ PE + T +SDV++FGV+L E+ T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 90 LIGEGGFGRVYKGKL-----EKTAQVVAVKQL---DRNGLQGNKEFIVEVLMLSLLHHDN 141
+G G FG V+ K E +V VK L LQ EF E+ M L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ--SEFRRELDMFRKLSHKN 69
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLL-----DIGPEQKPIDWFTRMKIALGAAKG 196
+V L+G C + E ++ EY L L+ L D + P+ ++ + A G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
+++L +N ++RDL + N L+ + K+S L+K + + + +
Sbjct: 130 MDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWL 185
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELIT 284
APE + + KSDV++FGV++ E+ T
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVNLIGY 148
IGEG G V+K K +T + VA+K++ L+G + + E+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 149 CADGEQRLLVYEYMP------LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
G +LV EYMP LR E L PE + + + RM + KG+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMPSDLSEVLRDEERPL----PEAQ-VKSYMRMLL-----KGVAYMHA 117
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY-- 260
+++RDLK +N+L+ + K++DFGLA+L + S +V T Y APE
Sbjct: 118 NG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLY 173
Query: 261 -QRTGQLTVKSDVYTFGVVLLELITGR 286
R V D++ G + EL+ G
Sbjct: 174 GARKYDPGV--DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-20
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 17/209 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLD-RNGLQGNKEFIV-EV-LMLSLLHHD 140
+F+ +G+G +G VYK K Q A+K++D + Q +E V E+ ++ S+ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP- 59
Query: 141 NLVNLIGY---CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197
N+I Y DG + +V EY P L + ++K I +I + +GL
Sbjct: 60 ---NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
+ LH++ +++RDLKS+NILL K+ D G++K+ K +++ +GT Y A
Sbjct: 117 QALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMA 169
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGR 286
PE + + KSD+++ G +L E+ T
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 29/229 (12%)
Query: 77 ELATATKNFRQECLIGEGGFGRVYKGKLEKTA-----QVVAVKQL-DRNGLQGNKEFIVE 130
E+ +T F +E +GE FG+VYKG L TA Q VA+K L D+ +EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 131 VLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLL------DIGPEQ------ 178
+M S L H N+V L+G + +++ Y L + L+ D+G
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 179 ---KPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235
+P D+ I A G+E+L ++ V+++DL + N+L+ + N K+SD GL +
Sbjct: 119 STLEPADFV---HIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
D + + + +PE G+ ++ SD++++GVVL E+ +
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 9e-20
Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 14/197 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLIGYC 149
IG+G G VY T Q VA+KQ++ Q KE I+ E+L++ H N+VN +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
G++ +V EY+ SL D + + ++ I R + + LE+LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSNQ---VI 137
Query: 210 YRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTV 268
+RD+KS NILL + + KL+DFG A++ P K S ++GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 194
Query: 269 KSDVYTFGVVLLELITG 285
K D+++ G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQ---VVAVKQLDRNGLQGNK--EFIVEVLMLSLLHHDNLVNL 145
IG G FG V +G+L+ + VA+K L + G + +F+ E ++ H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
G +++ EYM SL D L + + + G A G++YL +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSL-DKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
++RDL + NIL++ K+SDFGL++ + T+ + + APE +
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 266 LTVKSDVYTFGVVLLELIT 284
T SDV++FG+V+ E+++
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 69/198 (34%), Positives = 106/198 (53%), Gaps = 11/198 (5%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V+ G +V AVK L + G + F+ E ++ L HD LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKV-AVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
+ E +V EYM SL D L D E + + + +A A G+ Y+ ++ N I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYI-ERMN--YIH 125
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR-VMGTYGYCAPEYQRTGQLTVK 269
RDL+S+NIL+ K++DFGLA+L I D + + + + APE G+ T+K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 270 SDVYTFGVVLLELITGRR 287
SDV++FG++L EL+T R
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 90 LIGEGGFGRVYKGKLE------KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNL 142
+G G FG VY+G VAVK L + Q KEF+ E ++S +H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFT---RMKIALGAAKGLEY 199
V L+G C E + ++ E M L +L D E+ T + I L AKG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 200 LHDKANPPVIYRDLKSSNILL-----DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG 254
L I+RDL + N L+ D + K+ DFGLA+ D +
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ APE G+ T +SDV++FGV++ E++T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 3e-19
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 41/222 (18%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI-----VEVLMLSLLH 138
+ + +GEG + VYK + ++T ++VA+K++ + K+ I E+ +L L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 139 HDNLVNLIG-YCADGEQRL-LVYEYMP--LRSL-EDHLLDIGP-EQKPIDWFTRMKIALG 192
H N++ L+ + + LV+E+M L + +D + + P + K M + L
Sbjct: 61 HPNIIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKSIVLTPADIKSY-----MLMTL- 112
Query: 193 AAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD-KTHVSSRVMG 251
+GLEYLH +++RDLK +N+L+ + KL+DFGLA+ G ++ +V+
Sbjct: 113 --RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKMTHQVV- 164
Query: 252 TYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
T Y APE Y V D+++ G + EL+
Sbjct: 165 TRWYRAPELLFGARHY------GVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLM-----LSLL-HHDNLV 143
++G+G FG+V +L+ T ++ AVK L ++ + + + VE M L+L H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLT 59
Query: 144 NLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
L C + RL V EY+ L H+ G +P F +I LG L++LH+
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLHE 114
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
+ +IYRDLK N+LLD E + K++DFG+ K G +G T +S GT Y APE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILS 169
Query: 263 TGQLTVKSDVYTFGVVLLELITGR 286
D + GV+L E++ G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-19
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLD---RNGLQGNKEFIV---EVLMLSLLHHDNLV 143
++G+G +G VY G L Q++AVKQ++ N L KE+ EV +L L H N+V
Sbjct: 7 VLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPI-DWFTRMKIALGAAKGLEYLHD 202
+G C D + E++P S+ L GP +P+ +T+ + G+ YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK----LGPIGDKTHVSSRVMGTYGYCAP 258
V++RD+K +N++L KL DFG A+ +G G +++ + GT + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGR 286
E KSD+++ G + E+ TG+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 73/282 (25%), Positives = 131/282 (46%), Gaps = 29/282 (10%)
Query: 87 QECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNL 142
++ +IG G FG V++G L+ + VA+K L + + +F+ E ++ H N+
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
+ L G + +++ EYM +L+ +L D E ++ G A G++YL D
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSD 125
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGYCAPEYQ 261
++RDL + NIL++ K+SDFGL++ L + T+ +S + APE
Sbjct: 126 MN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321
+ T SDV++FG+V+ E+++ RP ++ + K N +L P+
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGE-----RPYWDMS----NHEVMKAINDGFRLPAPM 233
Query: 322 LQGEFPVRGLNQAVAVSAM-CVQEESSVRPLMSDVVSALSFL 362
AV + C Q++ + RP D+V+ L L
Sbjct: 234 --------DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 74/218 (33%), Positives = 110/218 (50%), Gaps = 39/218 (17%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-----FIVEVLMLSLLHHDNLVNL 145
IGEG +G+VYK + + T ++VA+K++ L KE I E+ +L L+H N+VNL
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 146 IGYCADGEQRL----------LVYEYMP---LRSLEDHLLDIGPEQKPIDWFTRMKIALG 192
D + L LV+EYM + LE L+ + I F MK L
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH--IKSF--MKQLL- 126
Query: 193 AAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT 252
+GL Y H K ++RD+K SNILL+ + KL+DFGLA+L + +++V+ T
Sbjct: 127 --EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-T 180
Query: 253 YGYCAPEY----QRTGQLTVKSDVYTFGVVLLELITGR 286
Y PE +R G DV++ G +L EL T +
Sbjct: 181 LWYRPPELLLGEERYGPAI---DVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-19
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 79 ATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH 138
A K + IG+G FG V G VAVK + + + F+ E +++ L
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLR 57
Query: 139 HDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197
H NLV L+G + + L +V EYM SL D+L G + + +K +L + +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAM 115
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGYC 256
EYL +AN ++RDL + N+L+ + AK+SDFGL K D + + +
Sbjct: 116 EYL--EANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WT 166
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELIT-GR 286
APE R + + KSDV++FG++L E+ + GR
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 71/245 (28%), Positives = 114/245 (46%), Gaps = 30/245 (12%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLL-HHDNLVNL 145
++G+G FG+V+ +L+ T Q A+K L ++ + + + +VE +LSL H L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
E V EY+ L H+ P F +I G L++LH K
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSKG- 116
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
++YRDLK NILLD + + K++DFG+ K +GD + GT Y APE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQK 172
Query: 266 LTVKSDVYTFGVVLLELITGR------------RAIDTTRPTYEQNLVTWAQP-----FF 308
D ++FGV+L E++ G+ ++I P Y + L A+ F
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 309 KDPNR 313
++P R
Sbjct: 233 REPER 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLI-GYC 149
+G+G FG+VYK + ++T A K + + ++F+VE+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIG-----PEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
+ + +L+ E+ +L+ +L++ P+ + + + L + L +LH
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYV-----CRQML---EALNFLHSHK 123
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY---- 260
VI+RDLK+ NILL + + KL+DFG++ + +GT + APE
Sbjct: 124 ---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACE 178
Query: 261 -QRTGQLTVKSDVYTFGVVLLELITGR 286
+ K+D+++ G+ L+EL
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V+ G VA+K L + G + F+ E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
E ++ EYM SL D L PE + + +A A+G+ ++ K I+
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY--GYCAPEYQRTGQLTV 268
RDL+++NIL+ K++DFGLA+ + + ++R + + APE G T+
Sbjct: 126 RDLRAANILVSETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 269 KSDVYTFGVVLLELIT-GR 286
KSDV++FG++L E++T GR
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 11/206 (5%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
++ R E +G+G FG V+ G T +V A+K L + G + F+ E ++ L H+ L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
V L ++ E +V EYM SL D L G K + + +A A G+ Y+ +
Sbjct: 64 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYV-E 119
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR-VMGTYGYCAPEYQ 261
+ N ++RDL+++NIL+ K++DFGLA+L I D + + + + APE
Sbjct: 120 RMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRR 287
G+ T+KSDV++FG++L EL T R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 76/267 (28%), Positives = 123/267 (46%), Gaps = 28/267 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI-VEVLMLSLLHHDNLVNLIGYC 149
IG+G FG V+KG +T QVVA+K +D + E I E+ +LS + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
G + ++ EY+ S D LL G P D F + KGL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLRAG----PFDEFQIATMLKEILKGLDYLHSEKK---I 123
Query: 210 YRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVK 269
+RD+K++N+LL + + KL+DFG+A G + D + +GT + APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 270 SDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVR 329
+D+++ G+ +EL G P L+ P+ P L GEF +
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------------PKNNPPTLTGEF-SK 227
Query: 330 GLNQAVAVSAMCVQEESSVRPLMSDVV 356
+ + C+ ++ S RP +++
Sbjct: 228 PFKEFIDA---CLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 30/208 (14%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQ-LDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLIG 147
L+GEG +G V K K ++T Q+VA+K+ L+ + K+ + E+ ML L H+NLVNLI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP--IDWFTRMKIALGAAKGLEYLHDKAN 205
++ LV+E++ DH + E+ P +D K +G+E+ H +
Sbjct: 68 VFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGYCAPEYQRTG 264
+I+RD+K NIL+ KL DFG A+ L G+ V + + T Y APE
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPE----- 170
Query: 265 QLTVKS-------DVYTFGVVLLELITG 285
L V D++ G ++ E++TG
Sbjct: 171 -LLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG+V+ + E+ +VAVK L K+F E +L+ L H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGP------EQKPIDWFTR---MKIALGAAKG 196
G C +G+ ++V+EYM L L GP E T+ + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
+ YL A+ ++RDL + N L+ K+ DFG+++ D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELIT 284
PE + T +SDV++ GVVL E+ T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 91 IGEGGFGRVYK----GKLEKTAQ-VVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
IG+G FGRV++ G L +VAVK L + +F E +++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQK------------------PIDWFTR 186
L+G CA G+ L++EYM L + L P + P+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 187 MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS 246
+ IA A G+ YL ++ ++RDL + N L+ K++DFGL++ D S
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 247 SRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ PE + T +SDV+ +GVVL E+ +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 90 LIGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVN 144
++GEG FG V +G+L + + VAVK + + + +EF+ E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 145 LIGYCADGEQR------LLVYEYMPLRSLEDHLL----DIGPEQKPIDWFTRMKIALGAA 194
LIG C + +++ +M L LL PE+ P+ T +K + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ--TLLKFMVDIA 123
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD---KTHVSSRVMG 251
G+EYL +N I+RDL + N +L + ++DFGL+K GD + ++ +
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV- 179
Query: 252 TYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ A E T KSDV+ FGV + E+ T
Sbjct: 180 --KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 91 IGEGGFGRV----YKGKLEKTAQVVAVKQLD-RNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG+V Y + + T + VAVK L +G + E+ +L L+H+N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 146 IGYCADGEQR--LLVYEYMPLRSLEDHLLDIGPEQK-PIDWFTRMKIALGAAKGLEYLHD 202
G C + L+ E++P SL+++L P K I+ ++K A+ KG++YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL-----GPIGDKTHVSSRVMGTYGYCA 257
+ ++RDL + N+L++ E K+ DFGL K K + S V + A
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYA 180
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELIT 284
PE + + SDV++FGV L EL+T
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 89 CLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQGN-KEFIVEVLMLSLL-HHDN 141
+GEG FG+V K + VAVK L + + + + + E+ M+ ++ H N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLD---IGPEQKPIDWFTR---------MKI 189
++NL+G C +V EY +L D L G P D +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 190 ALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV 249
A A+G+E+L K I+RDL + N+L+ + K++DFGLA+ I +
Sbjct: 138 AYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTT 192
Query: 250 MG--TYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
G + APE T +SDV++FGV+L E+ T
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 20/200 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V+ G + +V AVK L + G + F+ E ++ L HD LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 151 DGEQRLLVYEYMPLRSLEDHL-LDIGPE---QKPIDWFTRMKIALGAAKGLEYLHDKANP 206
E ++ EYM SL D L D G + K ID+ ++ A+G+ Y+ K
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAYIERKN-- 123
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY--GYCAPEYQRTG 264
I+RDL+++N+L+ K++DFGLA++ I D + ++R + + APE G
Sbjct: 124 -YIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEY-TAREGAKFPIKWTAPEAINFG 179
Query: 265 QLTVKSDVYTFGVVLLELIT 284
T+KSDV++FG++L E++T
Sbjct: 180 SFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 24/220 (10%)
Query: 91 IGEGGFGR--VYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLI 146
+G+G FG +Y+ + E + VV K+++ L + ++ + E+++LSLL H N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLD----IGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
+ D L+ EY +L D ++ + E+ + + ++ A+ Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS------YIH- 118
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
KA +++RD+K+ NI L KL DFG++K+ +G + ++ V+GT Y +PE +
Sbjct: 119 KAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQ 174
Query: 263 TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT 302
+ KSD++ G VL EL+T +R D T P NLV
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 91 IGEGGFGRVYKGK-LEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYC 149
IG G FG V+ G LEK VA+K + R G ++FI E ++ L H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRK--VAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
+ LV+E+M L D+L ++ T + + L +G+ YL VI
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 210 YRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRTGQL 266
+RDL + N L+ K+SDFG+ + + D + SS GT + +PE +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSST--GTKFPVKWSSPEVFSFSKY 178
Query: 267 TVKSDVYTFGVVLLELIT 284
+ KSDV++FGV++ E+ +
Sbjct: 179 SSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLD--RNGLQGNKEFIVEVL-----MLSLLHHDNL 142
+G G F Y+ + KT ++AVKQ+ RN +E +VE L +++ L+H ++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 143 VNLIG-YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
+ ++G C D L V E+M S+ L G ++ + + +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAV----IINYTEQLLRGLSYLH 120
Query: 202 DKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLA-KLGPIGDKT-HVSSRVMGTYGYCAP 258
+ +I+RD+K +N+L+D +++DFG A +L G +++GT + AP
Sbjct: 121 ENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGR 286
E R Q DV++ G V++E+ T +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 71/198 (35%), Positives = 100/198 (50%), Gaps = 19/198 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLIG 147
IG G FG VY + +T +VVA+K++ +G Q N+++ I EV L L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
LV EY L S D +L++ +KP+ I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASD-ILEV--HKKPLQEVEIAAICHGALQGLAYLH---SHE 135
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY---QRTG 264
I+RD+K+ NILL KL+DFG A L + +S V GT + APE G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFV-GTPYWMAPEVILAMDEG 189
Query: 265 QLTVKSDVYTFGVVLLEL 282
Q K DV++ G+ +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 4e-18
Identities = 67/206 (32%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
++ R + +G+G FG V+ G T +V A+K L + G + F+ E ++ L HD L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
V L ++ E +V E+M SL D L + + K + + +A A G+ Y+ +
Sbjct: 64 VPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYI-E 119
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR-VMGTYGYCAPEYQ 261
+ N I+RDL+++NIL+ K++DFGLA+L I D + + + + APE
Sbjct: 120 RMN--YIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRR 287
G+ T+KSDV++FG++L EL+T R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 4e-18
Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 34/270 (12%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI-VEVLMLSLLHHDNLVNLIGYC 149
IG+G FG VYKG +T +VVA+K +D + E I E+ +LS + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
G + ++ EY+ S D LL GP E+ I R + KGL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREIL-----KGLDYLHSERK--- 122
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTV 268
I+RD+K++N+LL + + KL+DFG+A G + D + +GT + APE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 269 KSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEF-- 326
K+D+++ G+ +EL G P L+ P+ + P L+G++
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-------------PKNSPPTLEGQYSK 227
Query: 327 PVRGLNQAVAVSAMCVQEESSVRPLMSDVV 356
P + +A C+ ++ RP +++
Sbjct: 228 PFKEFVEA------CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 70/215 (32%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLM--------LSL 136
FR ++G G FG+V + +KT ++ A+K L + + E VE LM +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58
Query: 137 LHHDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK 195
H LVNL C E + V EY L H+ D F+ + AA
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT--------DVFSEPRAVFYAAC 109
Query: 196 ---GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK--LGPIGDKTHVSSRVM 250
GL+YLH+ ++YRDLK N+LLD E K++DFGL K +G GD+T S
Sbjct: 110 VVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT---STFC 162
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITG 285
GT + APE T D + GV++ E++ G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 66/215 (30%), Positives = 111/215 (51%), Gaps = 26/215 (12%)
Query: 88 ECLIGEGGFGRVYKGKLEKTAQVV--AVKQLDRNGLQGN-KEFIVEVLMLSLL-HHDNLV 143
E +IGEG FG+V + ++K + A+K L + + ++F E+ +L L HH N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHL-----LDIGP----EQKPIDWFTR---MKIAL 191
NL+G C + + EY P +L D L L+ P E T ++ A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG 251
A G++YL +K I+RDL + N+L+ +K++DFGL++ G++ +V + MG
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV-KKTMG 178
Query: 252 TYG--YCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ A E T KSDV++FGV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQL--DRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
IGEG +G V+K + +T Q+VA+K+ + K + E+ ML L H NLVNLI
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
+ LV+EY L + L+ P + + KI + + + H K N
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVL--NELEKNP--RGVPEHLIKKIIWQTLQAVNFCH-KHN- 120
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKT-HVSSRVMGTYGYCAPEYQRT 263
I+RD+K NIL+ + KL DFG A++ GP D T +V++R Y APE
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE---- 170
Query: 264 GQLTVKS-------DVYTFGVVLLELITG 285
L V DV+ G V EL+TG
Sbjct: 171 --LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-18
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 107 TAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHHDNLVNLI--GYCADGEQRLL-VYE 160
T VA+K L + + + F E + + L+H N+V L+ G G L V+E
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFE 59
Query: 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220
Y+P R+L + L G + M L A L H++ +++RDLK NI++
Sbjct: 60 YVPGRTLREVLAADGA-LPAGETGRLMLQVLDA---LACAHNQG---IVHRDLKPQNIMV 112
Query: 221 ---DCEFNAKLSDFGLAKLGP---IGDKTHVS--SRVMGTYGYCAPEYQRTGQLTVKSDV 272
+AK+ DFG+ L P D ++ + V+GT YCAPE R +T SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 273 YTFGVVLLELITGRRAID--TTRPTYEQNL 300
Y +G++ LE +TG+R + + Q L
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAEILYQQL 202
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIG 147
+G+GGFG V +++ T ++ A K+LD+ L+ G K ++E +L ++ +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 148 YCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
Y + + L LV M L+ H+ ++G ++ ++ + + G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL 266
++YRD+K N+LLD + N +LSD GLA G ++ GT GY APE +
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171
Query: 267 TVKSDVYTFGVVLLELITGR 286
+ D + G + E++ GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
+G G FG VY+G + VAVK L + Q +F++E L++S +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQK---PIDWFTRMKIALGAAKGLEYLH 201
LIG + R ++ E M L+ L + P + + + A AKG +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 202 DKANPPVIYRDLKSSNILLDCEFN---AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
+ I+RD+ + N LL C+ AK++DFG+A+ R M + P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 259 EYQRTGQLTVKSDVYTFGVVLLEL 282
E G T K+DV++FGV+L E+
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSL-LHHDNLVNL 145
++G+G FG+V +L+ T + A+K L ++ + + + +VE +L+L H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 146 IGYCA--DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
+C E V EY+ L H+ G + F +I G L++LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKK 115
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT 263
+IYRDLK N+LLD + + K++DFG+ K G+ +S GT Y APE +
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 264 GQLTVKSDVYTFGVVLLELITGR 286
+ D ++FGV+L E++ G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-18
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH---DNLVNLIG 147
+G G G V K K T V+A K + ++ I+ L ++H +V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR--ELQIMHECRSPYIVSFYG 70
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
+ + E+M SL+ GP I KIA+ +GL YL++
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVHR-- 124
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT 267
+++RD+K SNIL++ KL DFG++ G + + ++ +GT Y +PE + G+ T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS--IADTFVGTSTYMSPERIQGGKYT 180
Query: 268 VKSDVYTFGVVLLELITGR 286
VKSDV++ G+ ++EL G+
Sbjct: 181 VKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 79/290 (27%), Positives = 139/290 (47%), Gaps = 44/290 (15%)
Query: 90 LIGEGGFGRVYKG----KLEKTAQVVAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVN 144
++G G FG VYKG + E VA+K L+ G + N EF+ E L+++ + H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 145 LIGYCADGEQRLLVYEYMP----LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
L+G C +L V + MP L + +H +IG Q ++W ++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIG-SQLLLNWCVQI------AKGMMYL 125
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
++ +++RDL + N+L+ + K++DFGLA+L +K + + + A E
Sbjct: 126 EERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 261 QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320
+ T +SDV+++GV + EL+T +P+ P R ++ D
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT-----------------FGGKPYDGIPTR--EIPDL 223
Query: 321 LLQGEF----PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366
L +GE P+ ++ V C ++ RP ++ + S + DP
Sbjct: 224 LEKGERLPQPPICTID-VYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLIG 147
+G+GGFG V ++ T ++ A K+L++ L+ K + +VE +L+ +H +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 148 YCADGEQRL-LVYEYMPLRSLEDHLLDIGPE----QKPIDWFTRMKIALGAAKGLEYLHD 202
Y + L LV M L H+ ++ E +P F +I G LE+LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHLHQ 115
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
+ +IYRDLK N+LLD + N ++SD GLA + D + GT G+ APE +
Sbjct: 116 RR---IIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 263 TGQLTVKSDVYTFGVVLLELITGR 286
+ D + GV L E+I R
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 32/269 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI-VEVLMLSLLHHDNLVNLIGYC 149
IG+G FG V+KG +T +VVA+K +D + E I E+ +LS + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
+ ++ EY+ S D L E P+D I KGL+YLH + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSEKK---I 123
Query: 210 YRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVK 269
+RD+K++N+LL KL+DFG+A G + D + +GT + APE + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 270 SDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEF--P 327
+D+++ G+ +EL G P + F P P P L+G + P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPM---------KVLFLIPKNNP----PTLEGNYSKP 228
Query: 328 VRGLNQAVAVSAMCVQEESSVRPLMSDVV 356
++ +A C+ +E S RP +++
Sbjct: 229 LKEFVEA------CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLV 143
+++ LIG G +G VY+GK T +VVA+K ++ + + I EV +LS L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 144 NLIGYCA---DGEQRLLVYEYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAKGLEY 199
N+ Y G + ++ EY S+ L+ GP +K I R + L+Y
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLV-----ALKY 116
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259
+H VI+RD+K++NIL+ N KL DFG+A L + S +GT + APE
Sbjct: 117 IH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMAPE 171
Query: 260 YQRTGQL-TVKSDVYTFGVVLLELITG 285
G+ K+D+++ G+ + E+ TG
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 17/216 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHHDNLVNLIG 147
+G G FGRV K + T + A+K L + + K+ E +L L H +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
D + + E++ L HL G + F ++ L EYLH K
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEYLHSKD--- 138
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT 267
+IYRDLK N+LLD + + K++DFG AK P D+T + GT Y APE ++
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAPEVIQSKGHG 193
Query: 268 VKSDVYTFGVVLLELITGRRAI--DTTRPTYEQNLV 301
D +T GV+L E I G DT YE+ L
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229
|
Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 71/198 (35%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLHHDNLVNLIG 147
IG G FG VY T +VVAVK++ +G Q N ++ I EV L L H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
LV EY L S D LL++ +KP+ I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASD-LLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY---QRTG 264
+I+RD+K+ NILL KL+DFG A K+ ++ +GT + APE G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 265 QLTVKSDVYTFGVVLLEL 282
Q K DV++ G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLML-SLLHHDNLVNLIG- 147
+IGEG +G+VYK + +KT Q+VA+K +D +E E +L +H N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 148 -----YCADGEQRLLVYEYMPLRSLED---HLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
+ +Q LV E S+ D L G ++ +W I +GL Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAY--ILRETLRGLAY 128
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSR--VMGTYGYC 256
LH+ VI+RD+K NILL KL DFG+ A+L + + R +GT +
Sbjct: 129 LHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL-----DSTLGRRNTFIGTPYWM 180
Query: 257 APE-----YQRTGQLTVKSDVYTFGVVLLELITG 285
APE Q +SDV++ G+ +EL G
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-17
Identities = 68/198 (34%), Positives = 98/198 (49%), Gaps = 19/198 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLHHDNLVNLIG 147
IG G FG VY + +T +VVA+K++ +G Q N ++ I EV L + H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
LV EY L S D LL++ +KP+ I GA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYC-LGSASD-LLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY---QRTG 264
+I+RD+K+ NILL KL+DFG A + ++ +GT + APE G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILAMDEG 199
Query: 265 QLTVKSDVYTFGVVLLEL 282
Q K DV++ G+ +EL
Sbjct: 200 QYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-17
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL--DRNGLQGNKE---FIVEVLMLSLLH 138
N+R L+G G FG VY T + +AVKQ+ D + + +KE E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 139 HDNLVNLIGYCADGEQRLL--VYEYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAK 195
HD +V G D E++ L EYMP S++D L G + +TR + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL-----Q 117
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK------LGPIGDKTHVSSRV 249
G+ YLH +++RD+K +NIL D N KL DFG +K + G K+ V
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-----V 169
Query: 250 MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
GT + +PE K+DV++ ++E++T
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 27/207 (13%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-----FIVEVLMLSLLHHDNLVNL 145
IGEG +G VYK + + T ++VA+K++ L+ E I E+ +L L+H N+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 146 --IGYCADGEQRL-LVYEY--MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
+ + E +L LV+E+ + L+ D G + I + + +G+ Y
Sbjct: 64 LDVVHS---ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL-----QGIAYC 115
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
H V++RDLK N+L+D E KL+DFGLA+ + +T+ V T Y APE
Sbjct: 116 HSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 170
Query: 261 QRTG-QLTVKSDVYTFGVVLLELITGR 286
Q + D+++ G + E++ R
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 72/252 (28%), Positives = 123/252 (48%), Gaps = 15/252 (5%)
Query: 65 NNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN 124
+ I + T + K + + IG+G G V+ T Q VA+KQ++ Q
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPK 59
Query: 125 KEFIV-EVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDW 183
KE I+ E+L++ L + N+VN + G++ +V EY+ SL D + + ++ I
Sbjct: 60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA 119
Query: 184 FTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDK 242
R + + LE+LH AN VI+RD+KS N+LL + + KL+DFG A++ P K
Sbjct: 120 VCRECL-----QALEFLH--AN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV- 301
S ++GT + APE K D+++ G++ +E++ G P L+
Sbjct: 172 ---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 302 TWAQPFFKDPNR 313
T P ++P +
Sbjct: 229 TNGTPELQNPEK 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 21/209 (10%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLI 146
++G+G FG+V + + T ++ A+K L ++ + + + +VE +L+L + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 147 GYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
C RL V EY+ L H+ +G ++P F +IA+G L +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFLHSKG- 121
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE---YQR 262
+IYRDLK N++LD E + K++DFG+ K G KT + GT Y APE YQ
Sbjct: 122 --IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYIAPEIIAYQP 177
Query: 263 TGQLTVKS-DVYTFGVVLLELITGRRAID 290
G KS D + FGV+L E++ G+ D
Sbjct: 178 YG----KSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 21/200 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IG G +G VYK + T ++VA+K + + E+ ML H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 151 DGEQRLLVYEYMPLRSLED--HLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
++ +V EY SL+D + + I + R KGL YLH+
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKGLAYLHETG---K 122
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR---VMGTYGYCAPEY---QR 262
I+RD+K +NILL + + KL+DFG++ T ++ +GT + APE +R
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 263 TGQLTVKSDVYTFGVVLLEL 282
G K D++ G+ +EL
Sbjct: 178 KGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-17
Identities = 65/194 (33%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLIGY 148
L+G+G FG V+KG L+ V AVK + Q K +F+ E +L H N+V LIG
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
C QR +Y M L D L + ++ + +K AL AA G+ YL K
Sbjct: 61 CT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT-YGYCAPEYQRTGQLT 267
I+RDL + N L+ K+SDFG+++ D + SS + + APE G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 268 VKSDVYTFGVVLLE 281
+SDV+++G++L E
Sbjct: 173 SESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 90 LIGEGGFGRVYKGKLEKTA--QVVAVKQLDRNGLQGN-KEFIVEVLMLSLL-HHDNLVNL 145
+IGEG FG+V K +++K A+K++ + + ++F E+ +L L HH N++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHL-----LDIGP-------EQKPIDWFTRMKIALGA 193
+G C L EY P +L D L L+ P + + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
A+G++YL K I+RDL + NIL+ + AK++DFGL++ G + +V + MG
Sbjct: 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTMGRL 173
Query: 254 G--YCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ A E T SDV+++GV+L E+++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-17
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V GK + VA+K + + G EFI E ++ L H+ LV L G C
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
+V EYM L ++L + G +P K +G+ YL K I+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK---DVCEGMAYLESKQ---FIH 123
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRTGQLT 267
RDL + N L+D + K+SDFGL++ + D + SS +G+ + PE + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFS 179
Query: 268 VKSDVYTFGVVLLELIT 284
KSDV+ FGV++ E+ +
Sbjct: 180 SKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 67/198 (33%), Positives = 98/198 (49%), Gaps = 19/198 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLHHDNLVNLIG 147
IG G FG VY + + ++VVA+K++ +G Q N ++ I EV L L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
LV EY L S D LL++ +KP+ + GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASD-LLEV--HKKPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY---QRTG 264
+I+RD+K+ NILL KL DFG A + ++ +GT + APE G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVILAMDEG 189
Query: 265 QLTVKSDVYTFGVVLLEL 282
Q K DV++ G+ +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 9e-17
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-----FIVEVLMLSLLHHDNLVNL 145
IGEG +G VYKG+ +KT Q+VA+K++ L+ +E I E+ +L L H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+ L++E++ + L+ + LD P+ + +D +G+ + H +
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKY-LDSLPKGQYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
V++RDLK N+L+D + KL+DFGLA+ G V + + T Y APE
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 266 L-TVKSDVYTFGVVLLELITGR 286
+ D+++ G + E+ T +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 67/209 (32%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDN 141
FRQ ++G+GGFG V ++ T ++ A K+L++ ++ G + E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 142 LVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK---GL 197
+VNL Y + + L LV M L+ H+ ++G F + AA+ GL
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FEEERALFYAAEILCGL 115
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
E LH + +YRDLK NILLD + ++SD GLA P G+ + RV GT GY A
Sbjct: 116 EDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMA 169
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGR 286
PE + T+ D + G ++ E+I G+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 61/193 (31%), Positives = 92/193 (47%), Gaps = 9/193 (4%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVNLIGY 148
IG G FG V+ G+L VAVK R L + +F+ E +L H N+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
C Q+ +Y M L D L + E + +++ AA G+EYL K
Sbjct: 62 CT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTV 268
I+RDL + N L+ + K+SDFG+++ G + APE G+ +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 269 KSDVYTFGVVLLE 281
+SDV++FG++L E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 15/211 (7%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL--DRNGLQGNKEFIV---EVLMLSLLH 138
N+R+ L+G+G FGRVY T + +A KQ+ D + +KE E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 139 HDNLVNLIGYCAD-GEQRLLVY-EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
H+ +V G D E+ L ++ EYMP S++D L G + + TR K +G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV---TR-KYTRQILEG 118
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGY 255
+ YLH +++RD+K +NIL D N KL DFG +K L I V GT +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
+PE K+DV++ G ++E++T +
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLM-----LSLLHHDNLVN 144
++G+G FG+V +L+++ ++ AVK L ++ + + + VE M LSL + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD--VECTMTEKRILSLARNHPFLT 59
Query: 145 LIGYCADGEQRLL-VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
+ C RL V E++ L H+ + F +I L +LHDK
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SALMFLHDK 115
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT 263
+IYRDLK N+LLD E + KL+DFG+ K G KT +S GT Y APE +
Sbjct: 116 G---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQE 170
Query: 264 GQLTVKSDVYTFGVVLLELITG 285
D + GV+L E++ G
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV 143
NF + IGEG G V + T + VAVK++D Q + EV+++ H N+V
Sbjct: 23 NFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMK------IALGAAKGL 197
+ G++ +V E++ +L D I TRM + L K L
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIATVCLAVLKAL 128
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
+LH + VI+RD+KS +ILL + KLSDFG + + ++GT + A
Sbjct: 129 SFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMA 183
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITG 285
PE + D+++ G++++E++ G
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 68/226 (30%), Positives = 112/226 (49%), Gaps = 15/226 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLIGYC 149
IG+G G VY T Q VA++Q++ Q KE I+ E+L++ + N+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
G++ +V EY+ SL D + + ++ I R + + LE+LH VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSNQ---VI 138
Query: 210 YRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTV 268
+RD+KS NILL + + KL+DFG A++ P K S ++GT + APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 195
Query: 269 KSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV-TWAQPFFKDPNR 313
K D+++ G++ +E+I G P L+ T P ++P +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 91 IGEGGFGRVY--KGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGY 148
IGEG FG++Y K K + V+ L + ++ + EV++L+ + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 149 CADGEQRLLVYEYMP----LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
+ + +V EY ++ + + E + + WF ++I+LG L+++HD+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLG----LKHIHDRK 121
Query: 205 NPPVIYRDLKSSNILLDCE-FNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT 263
+++RD+KS NI L AKL DFG+A+ + D ++ +GT Y +PE +
Sbjct: 122 ---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQN 176
Query: 264 GQLTVKSDVYTFGVVLLELIT 284
K+D+++ G VL EL T
Sbjct: 177 RPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL--DRNGLQGNKE---FIVEVLMLSLLH 138
N+R L+G+G FGRVY T + +AVKQ+ D + +KE E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 139 HDNLVNLIGYCADGEQRLL--VYEYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAK 195
H+ +V G D +R L E+MP S++D L G + +TR + +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL-----E 117
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYG 254
G+ YLH +++RD+K +NIL D N KL DFG +K L I V GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
+ +PE K+D+++ G ++E++T +
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 81/316 (25%), Positives = 134/316 (42%), Gaps = 52/316 (16%)
Query: 84 NFRQECLI-----GEGGFGRVYKGKLEKTAQV----------------VAVKQLDRNGLQ 122
F + L+ GEG FG V+ ++ + VAVK L + +
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60
Query: 123 GNK-EFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLED-----HLLDIGP 176
+ +F+ EV +LS L N++ L+G C D + ++ EYM L HL D
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 177 EQKP----------IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226
I + + + +AL A G++YL ++ ++RDL + N L+
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTI 177
Query: 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
K++DFG+++ GD + R + + A E G+ T SDV+ FGV L E++
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237
Query: 287 RAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPV--RGLNQAVAVSAMCVQE 344
+ T EQ ++ A FF+D R L P P +GL + + C
Sbjct: 238 KEQPYGELTDEQ-VIENAGEFFRDQGRQVYLFRP------PPCPQGLYE---LMLQCWSR 287
Query: 345 ESSVRPLMSDVVSALS 360
+ RP SD+ + L+
Sbjct: 288 DCRERPSFSDIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 27/271 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V+ GK +V A+K + G ++FI E ++ L H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
+ +V E+M L ++L Q + + + +G+EYL + I+
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKS 270
RDL + N L+ K+SDFG+ + + D+ SS + PE + + KS
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 271 DVYTFGVVLLELITGRRAIDTTRPTYE-QNLVTWAQPFFKDPNRYPQLADPLLQGEFPVR 329
DV++FGV++ E+ T + + YE +++ ++ P+LA
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR-----PKLAS---------- 227
Query: 330 GLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
V C E+ RP ++++ A++
Sbjct: 228 --MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 77/294 (26%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 85 FRQECLIGEGGFGRVYKGKL----EKTAQVVAVKQLDRN-GLQGNKEFIVEVLMLSLLHH 139
++ ++G G FG VYKG E VA+K L N + NKE + E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLD----IGPEQKPIDWFTRMKIALGAAK 195
+ L+G C +L V + MP L D++ + IG Q ++W ++ AK
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIG-SQDLLNWCVQI------AK 120
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
G+ YL + +++RDL + N+L+ + K++DFGLA+L I + + + +
Sbjct: 121 GMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315
A E + T +SDV+++GV + EL+T A+P+ P R
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMT-----------------FGAKPYDGIPAR-- 218
Query: 316 QLADPLLQGEF---PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366
++ D L +GE P + C +S RP ++V S + DP
Sbjct: 219 EIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 13/207 (6%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF-IVEVLMLSLLHHDNL 142
NF+Q +GEG + VYKG+ T ++VA+K++ + +G I E+ ++ L H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
V L + +LV+EYM + L+ ++ D + +D T KG+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY-- 260
V++RDLK N+L++ KL+DFGLA+ I T S+ V+ T Y AP+
Sbjct: 119 NR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV-TLWYRAPDVLL 173
Query: 261 -QRTGQLTVKSDVYTFGVVLLELITGR 286
RT ++ D+++ G ++ E+ITGR
Sbjct: 174 GSRTYSTSI--DIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 68/226 (30%), Positives = 112/226 (49%), Gaps = 15/226 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLIGYC 149
IG+G G VY T Q VA+KQ++ Q KE I+ E+L++ + N+VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
G++ +V EY+ SL D + + ++ I R + + L++LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSNQ---VI 137
Query: 210 YRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTV 268
+RD+KS NILL + + KL+DFG A++ P K S ++GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 194
Query: 269 KSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV-TWAQPFFKDPNR 313
K D+++ G++ +E++ G P L+ T P ++P R
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 30/213 (14%)
Query: 88 ECL--IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-FIV----EVLMLSLLHHD 140
E L I EG +G VY+ + +KT ++VA+K+L ++ KE F + E+ +L L H
Sbjct: 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHP 64
Query: 141 NLVNL--IGYCADGEQRLLVYEYMP--LRSLEDHLLD--IGPEQKPIDWFTRMKIALGAA 194
N+V + + ++ ++ +V EY+ L+SL + + + E K M L
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK-----CLMLQLL--- 116
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG 254
G+ +LHD +++RDLK+SN+LL+ K+ DFGLA+ G ++++ T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLW 171
Query: 255 YCAPE-YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y APE + + D+++ G + EL+T +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN--L 142
FRQ ++G+GGFG V ++ T ++ A K+L++ ++ K + + +L N
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 143 VNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK---GLE 198
V + Y + + L LV M L+ H+ +G F + AA+ GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-----FEEGRAVFYAAEICCGLE 116
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
LH + ++YRDLK NILLD + ++SD GLA P G + RV GT GY AP
Sbjct: 117 DLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAP 170
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGR 286
E + + T D + G +L E+I G+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL---DRNGLQGNKEFIVEVLMLSLLHHD 140
+ + +G G FGRV+ + + A+K + + L+ + E +L + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 141 NLVNLIGYCADGEQRLL--VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
++ L + + +QR L + EY+P L +L + G F +I LE
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA----LE 115
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
YLH K ++YRDLK NILLD E + KL+DFG AK + D+T + GT Y AP
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYLAP 167
Query: 259 E-YQRTGQLTVKSDVYTFGVVLLELITG 285
E Q G D + G+++ E++ G
Sbjct: 168 EVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDN-LVNL 145
++G+G FG+V +L+ + AVK L ++ + + + +VE +L+L + L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK---GLEYLHD 202
E V E++ L H+ D G F + AA+ GL++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-------FDLYRATFYAAEIVCGLQFLHS 114
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
K +IYRDLK N++LD + + K++DFG+ K GD +S GT Y APE +
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQ 169
Query: 263 TGQLTVKSDVYTFGVVLLELITGR 286
+ T D ++FGV+L E++ G+
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IGEG G V + T + VAVK++D Q + EV+++ HH+N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
G++ +V E++ +L D + ++ I + L + L YLH++ VI+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQG---VIH 141
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKS 270
RD+KS +ILL + KLSDFG + + ++GT + APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 271 DVYTFGVVLLELITG 285
D+++ G++++E+I G
Sbjct: 200 DIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 17/198 (8%)
Query: 91 IGEGGFGRVYKG--KLEKTAQVVAVKQL--DRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
+G G FG V KG K++K+ + VAVK L D N E + E ++ L + +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
G C + E +LV E L L L + K + ++ + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTY--GYCAPEYQRT 263
++RDL + N+LL + AK+SDFGL+K LG D+ + ++ G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 264 GQLTVKSDVYTFGVVLLE 281
+ + KSDV++FGV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 19/209 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVL-----MLSLLHHDNLVNL 145
I +G FG VY K T A+K L ++ + + + V M+ + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAKL 62
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+ LV EY+ + +G P DW + IA G+E LH +
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDW-AKQYIA-EVVLGVEDLHQRG- 117
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+I+RD+K N+L+D + KL+DFGL++ G + + +GT Y APE
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVG 169
Query: 266 LTVKSDVYTFGVVLLELITGRRAIDTTRP 294
SD ++ G V+ E + G P
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V+ K +V AVK + + G + F+ E ++ L HD LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 151 DGEQRLLVYEYMPLRSLEDHLL-DIGPEQ---KPIDWFTRMKIALGAAKGLEYLHDKANP 206
E ++ E+M SL D L D G +Q K ID+ ++ A+G+ ++ +
Sbjct: 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIEQRN-- 122
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR-VMGTYGYCAPEYQRTGQ 265
I+RDL+++NIL+ K++DFGLA++ I D + + + APE G
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 266 LTVKSDVYTFGVVLLELIT-GR 286
T+KSDV++FG++L+E++T GR
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 74/273 (27%), Positives = 114/273 (41%), Gaps = 47/273 (17%)
Query: 84 NFRQECL-----IGEGGFGRVY-------KGKLEKTAQ---------VVAVKQL----DR 118
F ++ L +GEG FG V+ + EK +VAVK L
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 119 NGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMP-------LRSLEDHL 171
N ++F+ EV +LS L N+ L+G C ++ EYM L+
Sbjct: 61 NAR---EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117
Query: 172 LDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231
+ K + + T + +A A G+ YL + ++RDL + N L+ + K++DF
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADF 174
Query: 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDT 291
G+++ D V R + A E G+ T KSDV+ FGV L E++T R
Sbjct: 175 GMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR---- 230
Query: 292 TRPTYE----QNLVTWAQPFFKDPNRYPQLADP 320
YE Q ++ A FF+D R L P
Sbjct: 231 -EQPYEHLTDQQVIENAGHFFRDDGRQIYLPRP 262
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 91 IGEGGFGRVYKGKLEKTA-----QVVAVKQLDRNGLQGN-KEFIVEVLMLSLLHHDNLVN 144
+GEG FG+V K + VAVK L N ++ + E +L ++H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHL--------------------LDIGPEQKPIDWF 184
L G C+ LL+ EY SL L P+++ +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 185 TRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244
+ A ++G++YL A +++RDL + N+L+ K+SDFGL++ D
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
S+ + A E T +SDV++FGV+L E++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDN--LVN 144
+IG GGFG VY + T ++ A+K LD+ + QG + E +MLSL+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 145 LIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
+ Y +L + + M L HL G + F +I LG LE++H++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG----LEHMHNR 116
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQR 262
V+YRDLK +NILLD + ++SD GLA K H S +GT+GY APE Q+
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQK 169
Query: 263 TGQLTVKSDVYTFGVVLLELITG 285
+D ++ G +L +L+ G
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 30/217 (13%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL----DRNGLQGNKEFIVEVLMLSLLH 138
F + IGEG +G VY+ + + ++VA+K++ +R+G+ + + E+ +L L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLR 64
Query: 139 HDNLVNL----IGYCADGEQRLLVYEY--MPLRSLEDHLLDIGPEQKPIDWFTRMK-IAL 191
H N+V L +G D LV EY L SL D++ E +++K + L
Sbjct: 65 HPNIVELKEVVVGKHLD--SIFLVMEYCEQDLASLLDNMPTPFSE-------SQVKCLML 115
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG 251
+GL+YLH+ +I+RDLK SN+LL + K++DFGLA+ G + +
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVV 170
Query: 252 TYGYCAPE--YQRTGQLTVKSDVYTFGVVLLELITGR 286
T Y APE T T D++ G +L EL+ +
Sbjct: 171 TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 35/219 (15%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVA-------VKQLDRNGLQGNKEFIVEVLMLSL 136
+F + +G G G V K + ++A +K RN Q +E L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRE-------LKV 52
Query: 137 LHHDNLVNLIGY----CADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIA 190
LH N ++G+ +DGE + + E+M SL+ L G PE KI+
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEN------ILGKIS 105
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM 250
+ +GL YL +K +++RD+K SNIL++ KL DFG++ G + D +++ +
Sbjct: 106 IAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 159
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAI 289
GT Y +PE + TV+SD+++ G+ L+E+ GR I
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDN--LVN 144
+IG GGFG VY + T ++ A+K LD+ + QG + E +MLSL+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 145 LIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK---GLEYL 200
+ Y +L + + M L HL G F+ ++ AA+ GLE++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-------FSEAEMRFYAAEIILGLEHM 113
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
H++ V+YRDLK +NILLD + ++SD GLA K H S +GT+GY APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166
Query: 261 QRTGQLTVKS-DVYTFGVVLLELITG 285
+ G S D ++ G +L +L+ G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 79/301 (26%), Positives = 130/301 (43%), Gaps = 59/301 (19%)
Query: 85 FRQECLIGEGGFGRVYKGKL-------EKTAQVVAVK------QLDRNGLQGNKEFIVEV 131
L+ EG FGR++ G L E+ V VK Q+ + E
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL--------LLQES 59
Query: 132 LMLSLLHHDNLVNLIGYCA-DGEQRLLVYEYMPLRSLEDHLLD--IGPEQKPIDWFTR-- 186
+L L H N++ ++ C DGE ++Y YM +L+ L +G P T+
Sbjct: 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 187 MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGP-----IG 240
+ +A+ A G+ YLH + VI++D+ + N ++D E K++D L++ L P +G
Sbjct: 120 VHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299
D + + M A E + + SDV++FGV+L EL+T G+ P +E
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FE-- 227
Query: 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
+ + KD R Q P+ ++ AV A C + RP S +V L
Sbjct: 228 MAA----YLKDGYRLAQ----------PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
Query: 360 S 360
+
Sbjct: 274 T 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 32/225 (14%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI-----VEVLMLSLLHHDNLVN 144
IG G FG V K + + ++AVK++ KE ++V+M S +V
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDEKEQKRLLMDLDVVMRSS-DCPYIVK 67
Query: 145 LIGYCADGEQRLLVYEYMPLRSLE-------DHLLDIGPEQKPIDWFTRMKIALGAAKGL 197
G + E M + SL+ + L + PE+ KIA+ K L
Sbjct: 68 FYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEE------ILGKIAVATVKAL 120
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
YL K +I+RD+K SNILLD N KL DFG++ G + D +R G Y A
Sbjct: 121 NYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI-AKTRDAGCRPYMA 175
Query: 258 PE----YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ 298
PE R G V+SDV++ G+ L E+ TG+ ++Q
Sbjct: 176 PERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ 219
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYC 149
++G+G +G VY + T +A+K++ + + E+ + S L H N+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLD-IGP---EQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
++ + E +P SL L GP ++ I ++T+ + +GL+YLHD
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDNQ- 128
Query: 206 PPVIYRDLKSSNILLDCEFNA-KLSDFG----LAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
+++RD+K N+L++ K+SDFG LA + P + GT Y APE
Sbjct: 129 --IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPEV 180
Query: 261 QRTGQ--LTVKSDVYTFGVVLLELITGR 286
G +D+++ G ++E+ TG+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQ--LDRNGLQGNKEFIVEVLMLSLLHHDN 141
NF++ IGEG +G VYK + + T +VVA+K+ LD I E+ +L L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
+V L+ + LV+E++ + L+ + P+ L +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH 117
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
V++RDLK N+L++ E KL+DFGLA+ + +T+ V T Y APE
Sbjct: 118 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 172
Query: 262 RTGQL-TVKSDVYTFGVVLLELITGRRAI 289
+ + D+++ G + E++T RRA+
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 61/209 (29%), Positives = 111/209 (53%), Gaps = 20/209 (9%)
Query: 85 FRQECLIGEGGFGRVYKG----KLEKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHH 139
F++ ++G G FG VYKG + EK VA+K+L + + NKE + E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLD----IGPEQKPIDWFTRMKIALGAAK 195
++ L+G C +L + + MP L D++ + IG Q ++W ++ AK
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIG-SQYLLNWCVQI------AK 120
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
G+ YL ++ +++RDL + N+L+ + K++DFGLAKL +K + + +
Sbjct: 121 GMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
A E T +SDV+++GV + EL+T
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 24/161 (14%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQ----LDRNGLQGNKEFIVEVLMLSLL---HHDNL 142
IGEG +G VYK + T + VA+K+ L G+ + + E+ +L L H N+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST--LREIALLKQLESFEHPNI 63
Query: 143 VNLIGYCA----DGEQRL-LVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK 195
V L+ C D E +L LV+E++ L + G + I R + +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL-----R 118
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236
G+++LH +++RDLK NIL+ + K++DFGLA++
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQL----DRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
++GEG FGR + + Q A+K++ + ++ +++ E ++L+ + H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 146 I-GYCADGEQRLLVYEYMP----LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
+ ADG +V EY ++ ++ + PE + WF +M + G++++
Sbjct: 64 KESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
H+K V++RD+KS NI L KL DFG A+L + + +GT Y PE
Sbjct: 117 HEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL--LTSPGAYACTYVGTPYYVPPEI 171
Query: 261 QRTGQLTVKSDVYTFGVVLLELIT 284
KSD+++ G +L EL T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 67/256 (26%), Positives = 114/256 (44%), Gaps = 29/256 (11%)
Query: 91 IGEGGFGRVY------------KGKLEKTAQ--VVAVKQL--DRNGLQGNKEFIVEVLML 134
+GEG FG V+ +G E Q +VAVK L D N +F+ E+ ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN-DFLKEIKIM 71
Query: 135 SLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHL--------LDIGPEQKPIDWFTR 186
S L + N++ L+G C + ++ EYM L L +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 187 MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS 246
+ +A+ A G++YL A+ ++RDL + N L+ + K++DFG+++ GD +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 247 SRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306
R + + A E G+ T SDV+ FGV L E+ T + + + EQ ++
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VIENTGE 247
Query: 307 FFKDPNRYPQLADPLL 322
FF++ R L+ L
Sbjct: 248 FFRNQGRQIYLSQTPL 263
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 67/228 (29%), Positives = 98/228 (42%), Gaps = 40/228 (17%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRN-GLQGNKEFIVE--VLMLSLLHHDNLVNLIG 147
+G G +G V K + T ++AVK++ Q K +++ + M S+ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFYG 67
Query: 148 YCADGEQRLLVYEYM--PLRSLEDHLLDIG---PEQKPIDWFTRMKIALGAAKGLEYLHD 202
+ E M L + D G PE I KIA+ K LEYLH
Sbjct: 68 ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPE--DI----LGKIAVSIVKALEYLHS 121
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFG--------LAKLGPIGDKTHVSSRVMGTYG 254
K + VI+RD+K SN+L++ KL DFG +AK G K
Sbjct: 122 KLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP----------- 168
Query: 255 YCAPEY----QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ 298
Y APE VKSDV++ G+ ++EL TGR D+ + ++Q
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-15
Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 88 ECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNL 142
E +IG G FG V +G+L+ K VA+K L ++G + ++F+ E ++ H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
++L G +++ E+M +L+ L + I ++ G A G++YL +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSE 124
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKTHVSSRVMG---TYGYCA 257
++RDL + NIL++ K+SDFGL++ D T+ SS +G + A
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKIPIRWTA 179
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELIT-GRR 287
PE + T SDV+++G+V+ E+++ G R
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 90 LIGEGGFGRVYKG---KLEKTAQVVAVKQLDRNGLQGNKE-FIVEVLMLSLLHHDNLVNL 145
IGEG FG VY+G E VAVK +E F+ E ++ H ++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWF---TRMKIALGAAKGLEYLHD 202
IG + +V E PL L +L Q + + + + L YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL------QVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV-SSRVMGTYGYCAPEYQ 261
K ++RD+ + N+L+ KL DFGL++ + D+++ +S+ + APE
Sbjct: 126 KR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESI 180
Query: 262 RTGQLTVKSDVYTFGVVLLELI 283
+ T SDV+ FGV + E++
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-15
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDN 141
FR ++G+GGFG V ++ T ++ A K+L++ ++ G + E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 142 LVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK---GL 197
+V+L Y + + L LV M L+ H+ ++G F + AA+ GL
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-----FDEERAVFYAAEITCGL 115
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
E LH + ++YRDLK NILLD + ++SD GLA P G+ + RV GT GY A
Sbjct: 116 EDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMA 169
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGR 286
PE + + T D + G ++ E+I G+
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 90 LIGEGGFGRVYKGKLEKTA--QVVAVKQLDRNGLQGN-KEFIVEVLMLSLL-HHDNLVNL 145
+IGEG FG+V K +++K A+K++ + + ++F E+ +L L HH N++NL
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHL-----LDIGPE-------QKPIDWFTRMKIALGA 193
+G C L EY P +L D L L+ P + + A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
A+G++YL K I+RDL + NIL+ + AK++DFGL++ G + +V + MG
Sbjct: 134 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTMGRL 185
Query: 254 G--YCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ A E T SDV+++GV+L E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 66/199 (33%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVE-VLMLSLLHHDNLVNLI 146
IG+G FG+V K + + AVK L + + KE + E ++L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
++ V +Y+ L HL +P F +IA L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIA----SALGYLHSLN-- 116
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL 266
+IYRDLK NILLD + + L+DFGL K G KT +S GT Y APE R
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPY 173
Query: 267 TVKSDVYTFGVVLLELITG 285
D + G VL E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 21/209 (10%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLI 146
++G+G FG+V + + T ++ A+K L ++ + + + +VE +L+L + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 147 GYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
C RL V EY+ L H+ +G ++P F +I++G L +LH +
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLHRRG- 121
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM-GTYGYCAPE---YQ 261
+IYRDLK N++LD E + K++DFG+ K + V++R GT Y APE YQ
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPEIIAYQ 176
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRRAID 290
G+ D + +GV+L E++ G+ D
Sbjct: 177 PYGK---SVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQ-----VVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVN 144
+G+G FG VY+G + + VA+K ++ ++ EF+ E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPE------QKPIDWFTRMKIALGAAKGLE 198
L+G + G+ L++ E M L+ +L + PE Q P +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
YL+ AN ++RDL + N ++ +F K+ DFG+ + D + + + +P
Sbjct: 134 YLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELIT 284
E + G T SDV++FGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 8e-15
Identities = 70/229 (30%), Positives = 110/229 (48%), Gaps = 50/229 (21%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL-D--RNGLQGNKEFIVEVLMLS-LLH 138
+ + +G+G +G V+K +T +VVA+K++ D RN + F E++ L L
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGD 65
Query: 139 HDNLVNLIG-YCADGEQRL-LVYEYMP------LRS--LED-HLLDIGPEQKPIDWFTRM 187
H N+V L+ A+ ++ + LV+EYM +R+ LED H +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH---------------KR 110
Query: 188 KIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL---GPIGDKTH 244
I K L+Y+H N VI+RDLK SNILL+ + KL+DFGLA+ +
Sbjct: 111 YIMYQLLKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGV-------VLLELITGR 286
V + + T Y APE + + S YT GV +L E++ G+
Sbjct: 168 VLTDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 91 IGEGGFGRVYKGK---LEKTAQV--VAVKQLDRNGLQGNKEFIV-EVLMLSLL-HHDNLV 143
+G G FG+V + L K+ V VAVK L +E ++ E+ ++S L +H+N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
NL+G C G L++ EY L + L + + + + AKG+ +L K
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG-----TYGYCAP 258
I+RDL + N+LL K+ DFGLA+ D + S+ V+ + AP
Sbjct: 161 N---CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAP 212
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELIT 284
E T +SDV+++G++L E+ +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 66/192 (34%), Positives = 97/192 (50%), Gaps = 41/192 (21%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN-KE-F----IVEVLMLSLLHHDNLVN 144
IG+G FG V+K + +KT Q+VA+K++ L N KE F + E+ +L LL H+N+VN
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 145 LIGYC---ADGEQR-----LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------MKIA 190
LI C A R LV+E+ +H L G FT MK+
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFC------EHDL-AGLLSNKNVKFTLSEIKKVMKML 128
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK---LGPIGDKTHVSS 247
L GL Y+H +++RD+K++NIL+ + KL+DFGLA+ L ++
Sbjct: 129 L---NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 248 RVMGTYGYCAPE 259
RV+ T Y PE
Sbjct: 183 RVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 21/201 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIG-YC 149
+G+G FG+VYK K ++T + A K ++ + ++++VE+ +L+ +H +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 150 ADGEQRLLVYEYMPLRSLEDHL--LDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
DG+ +++ E+ P +++ + LD G + I R + + L+YLH
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSMK--- 130
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT-HVSSRVMGTYGYCAPEY-----Q 261
+I+RDLK+ N+LL + + KL+DFG++ KT +GT + APE
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV---KTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 262 RTGQLTVKSDVYTFGVVLLEL 282
+ K+D+++ G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 78/289 (26%), Positives = 134/289 (46%), Gaps = 37/289 (12%)
Query: 84 NFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHH 139
+ E +IG G FG V G+L+ K VA+K L + + +F+ E ++ H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIA---LGAAKG 196
N+++L G + ++V EYM SL+ L +K FT +++ G A G
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL------RKHDGQFTVIQLVGMLRGIASG 118
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG---TY 253
++YL D ++RDL + NIL++ K+SDFGL+++ + D + G
Sbjct: 119 MKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPI 173
Query: 254 GYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313
+ APE + T SDV+++G+V+ E+++ RP +E + Q K
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWEMS----NQDVIKAIEE 224
Query: 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362
+L P+ + P L+Q + C Q++ + RP +VS L L
Sbjct: 225 GYRLPAPM---DCPA-ALHQ---LMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLIGYC 149
+GEG + VYKG+ + T +VA+K++ +G I EV +L L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
+ LV+EY+ + L+ +L D G I+ +GL Y H + V+
Sbjct: 74 HTEKSLTLVFEYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK---VL 126
Query: 210 YRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRTGQLTV 268
+RDLK N+L++ KL+DFGLA+ I KT+ + V T Y P+ + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 269 KSDVYTFGVVLLELITGR 286
+ D++ G + E+ TGR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 23/239 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IGEG G V ++ + ++VAVK++D Q + EV+++ H+N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
G++ +V E++ +L D + ++ I + L K L LH + VI+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQG---VIH 139
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKS 270
RD+KS +ILL + KLSDFG + + ++GT + APE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 271 DVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD-----PLLQG 324
D+++ G++++E++ G P Y A +D N P+L + P L+G
Sbjct: 198 DIWSLGIMVIEMVDG-------EPPYFNEPPLKAMKMIRD-NLPPKLKNLHKVSPSLKG 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 27/222 (12%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEV-----LMLSLLHHDNLVN 144
+IG G + +V +L+KT ++ A+K + + L + E I V + + +H LV
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKE-LVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 145 LIGYCADGEQRL-LVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLH 201
L C E RL V E++ L H+ PE+ F +I+L L +LH
Sbjct: 61 LHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHA--RFYSAEISLA----LNFLH 113
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK--LGPIGDKTHVSSRVMGTYGYCAPE 259
++ +IYRDLK N+LLD E + KL+D+G+ K + P GD T S GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT---STFCGTPNYIAPE 166
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGRRAID--TTRPTYEQN 299
R D + GV++ E++ GR D +QN
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 8/204 (3%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL---DRNGLQGNKEFIVEVLMLSLLH 138
NF+ E IG+G F VYK +VVA+K++ + + ++ + E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
H N++ + + + +V E L + +++ I T K + LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
++H K +++RD+K +N+ + KL D GL + KT + ++GT Y +P
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175
Query: 259 EYQRTGQLTVKSDVYTFGVVLLEL 282
E KSD+++ G +L E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 71/236 (30%), Positives = 114/236 (48%), Gaps = 30/236 (12%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVL----MLSLLHHDNLVNLI 146
+G+GG+G+V+ K + T ++VA+K++ ++ L E + VL +L+ + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTKSEWLVKLL 67
Query: 147 GYCADGEQRLLVYEYMP---LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
D E L EY+P R+L ++L + + + M A+ A L Y+H
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGYIH-- 124
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT 263
RDLK N L+D + KL+DFGL+K G T+ +S V+G+ Y APE R
Sbjct: 125 -------RDLKPENFLIDASGHIKLTDFGLSK----GIVTYANS-VVGSPDYMAPEVLRG 172
Query: 264 GQLTVKSDVYTFGVVLLELITGRR--AIDTTRPTYEQNLVTWAQ----PFFKDPNR 313
D ++ G +L E + G + T T+E NL W + P + DP
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-NLKYWKETLQRPVYDDPRF 227
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK--EFIVEVLMLSLLHHDNLVNLIGY 148
IGEG FG+ K ++ + +K+++ + + + E EV +LS + H N+V Y
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ---Y 64
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIG-------PEQKPIDWFTRMKIALGAAKGLEYLH 201
E+ +Y M D I PE + +DWF ++ +AL +++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVH 118
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
D+ +++RD+KS NI L + KL DFG+A++ + ++ +GT Y +PE
Sbjct: 119 DRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEIC 173
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRRAID 290
KSD++ G VL E+ T + A +
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 26/207 (12%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQ--LDRNGLQGNKEFIVEVLMLSLLHHDNLVNL--I 146
IGEG +G VYK + T + +A+K+ L++ I E+ +L + H N+V L +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 147 GYCADGEQRL-LVYEYMPLRSLEDHLLDIGPE----QKPIDWFTRMKIALGAAKGLEYLH 201
+ E+RL LV+EY+ L L+ H +D P+ + I + + +G+ Y H
Sbjct: 70 VHS---EKRLYLVFEYLDL-DLKKH-MDSSPDFAKNPRLIKTYLYQIL-----RGIAYCH 119
Query: 202 DKANPPVIYRDLKSSNILLDCEFNA-KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE- 259
V++RDLK N+L+D NA KL+DFGLA+ I +T V T Y APE
Sbjct: 120 SHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEI 174
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGR 286
+ + D+++ G + E++ +
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 68/237 (28%), Positives = 110/237 (46%), Gaps = 47/237 (19%)
Query: 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN-KE-FIV----EVLM 133
+ +++ +GEG FG VYK + KT +VVA+K++ L N K+ F + E+ +
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALREIKI 60
Query: 134 LSLLHHDNLVNLIGYCAD-----GEQRLLVYEYMPLRSLEDHLL-------DIGPEQKPI 181
L L H N+V LI + +R VY P DH L + + I
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM---DHDLSGLLENPSVKLTESQI 117
Query: 182 DWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL----- 236
+ M L +G+ YLH+ +++RD+K++NIL+D + K++DFGLA+
Sbjct: 118 KCY--MLQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 237 ----GPIGDKTHVSSRVMGTYGYCAPEY---QRTGQLTVKSDVYTFGVVLLELITGR 286
G G T + ++ T Y PE +R + T D++ G V E+ T R
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER--RYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 78/264 (29%), Positives = 119/264 (45%), Gaps = 46/264 (17%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLM-LSLLHHDNLVNLIGYC 149
+G+G +G VYK T +A+K++ R L +K +++M L +LH ++ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESK--FNQIIMELDILHKAVSPYIVDFY 65
Query: 150 ADGEQRLLVY---EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
VY EYM SL D L G + I +I KGL++L ++ N
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLA-KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+I+RD+K +N+L++ KL DFG++ L KT++ G Y APE ++G
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGG 177
Query: 266 L------TVKSDVYTFGVVLLELITGR---------------RAI-DTTRPTYEQNLVTW 303
TV+SDV++ G+ +LE+ GR AI D PT
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 304 AQPFF-----KDPNR---YPQLAD 319
AQ F K PNR Y QL +
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDN 141
FR ++G+GGFG V ++ T ++ A K+L++ ++ G + E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 142 LVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIG----PEQKPIDWFTRMKIALGAAKG 196
+V+L Y + + L LV M L+ H+ ++G EQ+ I + + G
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL------CCG 114
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
LE L + ++YRDLK NILLD + ++SD GLA P G+ V RV GT GY
Sbjct: 115 LEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYM 168
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELITGR 286
APE + T D + G ++ E+I G+
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLI 146
++G+G FG+V + + T ++ A+K L ++ + + + +VE +L+L + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 147 GYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
C RL V EY+ L + +G ++P F +IA+G L +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFFLHSKG- 121
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE---YQR 262
+IYRDLK N++LD E + K++DFG+ K T + GT Y APE YQ
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQP 177
Query: 263 TGQLTVKSDVYTFGVVLLELITGRRAID 290
G+ D + FGV+L E++ G+ +
Sbjct: 178 YGK---SVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLI 146
++G+G FG+V +L+ T +V A+K L ++ + + + + E +L+L + +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 147 GYCADGEQRLL-VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK---GLEYLHD 202
C + RL V EY+ + D + I +K F + AA+ L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYV---NGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHR 114
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
VIYRDLK NILLD E + KL+DFG+ K G + T ++ GT Y APE +
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQ 169
Query: 263 TGQLTVKSDVYTFGVVLLELITGR 286
+ D + GV++ E++ G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 67/255 (26%), Positives = 116/255 (45%), Gaps = 30/255 (11%)
Query: 91 IGEGGFGRVYKGKLE----------------KTAQVVAVKQL--DRNGLQGNKEFIVEVL 132
+GEG FG V+ + E +VAVK L D N N +F+ E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN-DFLKEIK 71
Query: 133 MLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP-------IDWFT 185
++S L N++ L+ C + ++ EYM L L P++ I + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 186 RMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV 245
+ +A A G++YL ++ ++RDL + N L+ + K++DFG+++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 246 SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305
R + + + E G+ T SDV+ FGV L E++T + ++ + EQ ++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTG 247
Query: 306 PFFKDPNRYPQLADP 320
FF+D R L P
Sbjct: 248 EFFRDQGRQVYLPKP 262
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF-IVEVLMLSLLHHDNLVNLIGY 148
+IG G + +V +L+KT ++ A+K + + + +++ V+ N L+G
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 149 --CADGEQRLL-VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
C E RL V EY+ L H+ + F +I+L L YLH++
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHERG- 116
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG--PIGDKTHVSSRVMGTYGYCAPEYQRT 263
+IYRDLK N+LLD E + KL+D+G+ K G P GD T S GT Y APE R
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTT---STFCGTPNYIAPEILRG 170
Query: 264 GQLTVKSDVYTFGVVLLELITGRRAID 290
D + GV++ E++ GR D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 73/237 (30%), Positives = 110/237 (46%), Gaps = 24/237 (10%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVN--LIG 147
+IG G + +V +L+K Q+ A+K + + L + E I V + N L+G
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKE-LVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 148 Y--CADGEQRL-LVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHD 202
C RL LV EY+ L H+ PE+ + + IAL +LH+
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIAL------NFLHE 114
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK--LGPIGDKTHVSSRVMGTYGYCAPEY 260
+ +IYRDLK N+LLD + + KL+D+G+ K LGP GD T S GT Y APE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPEI 167
Query: 261 QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA-QPFFKDPNRYPQ 316
R + D + GV++ E++ GR D + N + Q + P R P+
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR 224
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLIGYC 149
+GEG + V+KG+ + T +VA+K++ +G I EV +L L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL-GAAKGLEYLHDKANPPV 208
+ LV+EY+ + L+ ++ D G I +KI L +GL Y H + V
Sbjct: 74 HTDKSLTLVFEYLD-KDLKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHRRK---V 125
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR-TGQLT 267
++RDLK N+L++ KL+DFGLA+ + KT+ + V T Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYS 183
Query: 268 VKSDVYTFGVVLLELITGR 286
+ D++ G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 9e-14
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 91 IGEGGFGRVYKGK---LEKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
IG G FG+V G+ A+VV VK+L F+ EV L+H N++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLL-DIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
G C + LLV E+ PL L+++L + G + ++A A GL +LH +A+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ---- 261
I+ DL N L + + K+ D+GLA D + APE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 262 ---RTGQLTVKSDVYTFGVVLLELIT 284
T KS++++ GV + EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 41/227 (18%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN----KEFIVEVLMLSLLHHDNLVNL 145
LIG+GG G VY ++ VA+K++ R L N K F+ E + + L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 146 IGYCADGEQRLLVYEYMP------LRSL------EDHLLDIGPEQKPIDWFTRMKIALGA 193
C+DG+ VY MP L+SL ++ L E+ + F + + A
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL----------------G 237
+EY+H K V++RDLK NILL + D+G A
Sbjct: 125 --TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ +++GT Y APE + +D+Y GV+L +++T
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 69/246 (28%), Positives = 109/246 (44%), Gaps = 27/246 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQV--VAVKQLD-----RNGLQGNKEFIVEVLMLSLLHHDNLV 143
+GEG FG V +G+L + + VAVK + R+ ++ +F+ E + + H N++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHPNVM 63
Query: 144 NLIGYCADGEQR------LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRM--KIALGAAK 195
LIG C + +++ +M L LL P T+M K A
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
G+EYL K+ I+RDL + N +L+ N ++DFGL+K GD +
Sbjct: 124 GMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315
A E T KSDV++FGV + E+ T + T P E + + + + NR
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQ---TPYPGVENSEI---YDYLRQGNRLK 234
Query: 316 QLADPL 321
Q D L
Sbjct: 235 QPPDCL 240
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 90 LIGEGGFGRVYKGKLEK---TAQVVAVKQL--DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
++G+G FG V + +L+ + Q VAVK L D +EF+ E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 145 LIGYC--ADGEQRL----LVYEYMPLRSLEDHLL--DIGPEQKPIDWFTRMKIALGAAKG 196
LIG + + RL ++ +M L LL IG E + T ++ + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
+EYL K I+RDL + N +L+ ++DFGL+K GD +
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELIT 284
A E T SDV+ FGV + E++T
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQV--VAVKQLDRNGLQGN-KEFIVEVLMLSLL-HHDN 141
+GEG FG+V + EK +V VAVK L + + + + I E+ M+ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHL---------LDIGPEQKPIDWFTRMKI--- 189
++NL+G C ++ EY +L ++L P Q P + + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 190 ALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV 249
A A+G+EYL A+ I+RDL + N+L+ + K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 250 MGTYG-----YCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
T G + APE T +SDV++FGV+L E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLIG 147
+GEG + VYKG+ + T Q+VA+K++ +G I E +L L H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 148 YCADGEQRLLVYEYMPL---RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
+ LV+EY+ + ++D + + F ++ GL Y H +
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCHQRR 123
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP------ 258
V++RDLK N+L+ KL+DFGLA+ + KT+ S+ V+ T Y P
Sbjct: 124 ---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWYRPPDVLLGS 178
Query: 259 -EYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ 298
EY + L D++ G + E+ TGR + +Q
Sbjct: 179 TEY--STSL----DMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 18/228 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLIG 147
IG+G FG+V + + T ++ A+K + + + E + E +L+ ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
E+ LV ++ L HL G F ++ LE LH K N
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA----LENLH-KFN-- 113
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT 267
VIYRDLK NILLD + + L DFGL KL D ++ GT Y APE T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYT 171
Query: 268 VKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315
D +T GV+L E++TG P Y++N+ + ++P R+P
Sbjct: 172 KAVDWWTLGVLLYEMLTG------LPPFYDENVNEMYRKILQEPLRFP 213
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQ-----VVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVN 144
+G+G FG VY+G + VAVK ++ + L+ EF+ E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQ-----KPIDWFTRM-KIALGAAKGLE 198
L+G + G+ L+V E M L+ +L + PE +P M ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
YL+ K ++RDL + N ++ +F K+ DFG+ + D + + + AP
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELIT 284
E + G T SD+++FGVVL E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 65/200 (32%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE----FIVEVLMLSLLHHDNLVNL 145
+IG+G FG+V K + AVK L + + KE ++L L H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
E+ V +Y+ L HL +P F A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF----YAAEVASAIGYLHSLN- 116
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+IYRDLK NILLD + + L+DFGL K G ++T +S GT Y APE R
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEP 172
Query: 266 LTVKSDVYTFGVVLLELITG 285
D + G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IGEG G V + + + + VAVK +D Q + EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
GE+ ++ E++ +L D + ++ I + + L YLH + VI+
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQG---VIH 140
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKS 270
RD+KS +ILL + KLSDFG I ++GT + APE +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 271 DVYTFGVVLLELITG 285
D+++ G++++E++ G
Sbjct: 199 DIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 91 IGEGGFGRVYKG--KLEKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLIG 147
+G G FG V KG K+ K VA+K L + + E + E ++ L + +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
C + E +LV E L L ++ I +++ + G++YL K
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTY--GYCAPEYQRTG 264
++RDL + N+LL + AK+SDFGL+K LG D ++ +R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 265 QLTVKSDVYTFGVVLLE 281
+ + +SDV+++G+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 6e-13
Identities = 70/265 (26%), Positives = 118/265 (44%), Gaps = 43/265 (16%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV---EVLMLSLLHHDNLVNLIG 147
IG G +G VYK + T ++ A+K + L+ ++F V E++M+ H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
++ + E+ SL+D GP + I + +R + +GL YLH K
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK- 127
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE---YQRT 263
++RD+K +NILL + KL+DFG++ I +GT + APE +R
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 264 GQLTVKSDVYTFGVVLLEL---------ITGRRAI-----DTTRPTYEQNLVTWAQPFF- 308
G D++ G+ +EL + RA+ +P ++ + W+ F
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243
Query: 309 -------KDPNRYPQLADPLLQGEF 326
K+P + P A+ LLQ F
Sbjct: 244 FVKMALTKNPKKRPT-AEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNLVNLIG- 147
+G G FG V + + T Q VA+K++ + + K E+ +L L H+N+++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 148 YCADGEQRLLVYEYMPLRSLEDH-LLDIGP-EQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+ + E V E L + H LL P E++ I +F +GL+Y+H
Sbjct: 78 FISPLEDIYFVTE---LLGTDLHRLLTSRPLEKQFIQYF-----LYQILRGLKYVHSAG- 128
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
V++RDLK SNIL++ + K+ DFGLA++ +VS+R Y APE T Q
Sbjct: 129 --VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQ 181
Query: 266 -LTVKSDVYTFGVVLLELITGR 286
V+ D+++ G + E++ G+
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 47/227 (20%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL---DRNGLQGNKEFIVEVLMLSLLHH 139
++ IGEG +G V + T VA+K++ + + + E+ +L H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTF--CQRTLREIKILRRFKH 62
Query: 140 DNLVNL------IGYCADGEQRLLVYEYMP------LRSLE---DHLLDIGPEQKPIDWF 184
+N++ + + + + +V E M +++ DH I +F
Sbjct: 63 ENIIGILDIIRPPSFESFNDV-YIVQELMETDLYKLIKTQHLSNDH----------IQYF 111
Query: 185 TRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244
+ +GL+Y+H AN V++RDLK SN+LL+ + K+ DFGLA+ I D H
Sbjct: 112 LYQIL-----RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEH 160
Query: 245 VSSRVMGTY----GYCAPEYQRTGQLTVKS-DVYTFGVVLLELITGR 286
+ + Y Y APE + K+ D+++ G +L E+++ R
Sbjct: 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 91 IGEGGFGRVYKGKLEK---TAQVVAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVNLI 146
IG G FG+V G++ AQVV VK+L + +Q +F+ E L H NL+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDI-GPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
G C + LLV E+ PL L+ +L E D T ++A A GL +LH K N
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNN 120
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY--QRT 263
I+ DL N LL + K+ D+GL+ D ++ + APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 264 GQLTV-----KSDVYTFGVVLLEL 282
G L V +S+V++ GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 51/200 (25%), Positives = 101/200 (50%), Gaps = 19/200 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G+G FG+VYK + ++T + A K +D + ++++VE+ +L+ H N+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
++ E+ +++ +L++ ++P+ + + L YLH+ +I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIH 126
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR---VMGTYGYCAPEY-----QR 262
RDLK+ NIL + + KL+DFG++ T R +GT + APE +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 263 TGQLTVKSDVYTFGVVLLEL 282
K+DV++ G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 1e-12
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI----VEVLMLSLLHHDNLVNLI 146
+G+G FG VY + ++T ++VA+K++ + +E + V+ L L H N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKK-FYSWEECMNLREVKSLR-KLNEHPNIVKLK 64
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDI--GPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
+ ++ V+EYM E +L + + KP I +GL ++H K
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH-KH 118
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK----THVSSRVMGTYGYCAPEY 260
+RDLK N+L+ K++DFGLA+ I + +VS+R Y APE
Sbjct: 119 G--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WYRAPE- 168
Query: 261 QRTGQLTVKS-------DVYTFGVVLLELITGR 286
+ ++S D++ G ++ EL T R
Sbjct: 169 -----ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 90 LIGEGGFGRVYKGKLEKTA-----QVVAVKQLDRNGLQGNKEFIV----EVLMLSLLHHD 140
++G+GG+G+V++ + K ++ A+K L + + N++ E +L + H
Sbjct: 3 VLGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
+V+LI G + L+ EY+ L HL G + F +I+L LE+L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHL 116
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI-GDKTHVSSRVMGTYGYCAPE 259
H + +IYRDLK NILLD + + KL+DFGL K G TH GT Y APE
Sbjct: 117 HQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPE 170
Query: 260 -YQRTGQLTVKSDVYTFGVVLLELITG 285
R+G D ++ G ++ +++TG
Sbjct: 171 ILMRSGH-GKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 24/215 (11%)
Query: 91 IGEGGFGRVYKGK---LEKTAQ----VVAVKQLDRNGLQGN-KEFIVEVLMLSLL-HHDN 141
+GEG FG+V + + ++K+ VAVK L N + + I E+ ++ L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHL-------LDIGPE-----QKPIDWFTRMKI 189
++NL+G C ++ EY +L + L D + ++ + + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 190 ALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV 249
A A+G+EYL + I+RDL + N+L+ + K++DFGLA+ D +S
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 250 MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ APE T +SDV++FG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLIGYC 149
+GEG + VYKG Q+VA+K + +G I E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 150 ADGEQRLLVYEYMPL---RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
E V+EYM + + H + P + F + +GL Y+H +
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIHGQH-- 123
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRTGQ 265
+++RDLK N+L+ KL+DFGLA+ I +T+ S V T Y P+
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATD 180
Query: 266 LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTW 303
+ D++ G + +E++ G+ A +EQ W
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 91 IGEGGFGRVYKGKL-------EKTAQVVAVKQLDRNGLQGN-KEFIVEVLMLSLL-HHDN 141
+GEG FG+V + K A VAVK L + + + + + E+ M+ ++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKI 189
++NL+G C ++ EY +L ++L P + + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 190 ALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV 249
A+G+EYL A+ I+RDL + N+L+ K++DFGLA+ D ++
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DVNNIDYYK 194
Query: 250 MGTYG-----YCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
T G + APE T +SDV++FGV++ E+ T
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 36/216 (16%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLD-RNGLQGNKEFI-VEVLMLSLLHHDNLVN---- 144
+G+G +G V + + +K+L+ RN + ++ E +LS L H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 145 ----------LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA 194
++G+C G+ Y L+ + LL PE + ++WF ++ +AL
Sbjct: 68 WEGEDGLLYIVMGFCEGGDL------YHKLKEQKGKLL---PENQVVEWFVQIAMAL--- 115
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG 254
+YLH+K +++RDLK+ N+ L K+ D G+A++ + ++ ++S ++GT
Sbjct: 116 ---QYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAID 290
Y +PE KSDV+ G + E+ T + A +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
+F + +G G G V K + + + ++A K + + I+ L +LH N
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR--ELQVLHECNS 62
Query: 143 VNLIGYC----ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
++G+ +DGE + + E+M SL+ L E K I K+++ +GL
Sbjct: 63 PYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLA 117
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
YL +K +++RD+K SNIL++ KL DFG++ G + D +++ +GT Y +P
Sbjct: 118 YLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSP 171
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGRRAI 289
E + +V+SD+++ G+ L+EL GR I
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 85/240 (35%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF--------IV-EVLMLSLLHHD 140
IG G +G V ++T + VA+K++ + F I+ E+ +L L H+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 141 NLVNLIG-------------YCADGEQRLLVYEYMP------LRS----LEDHLLDIGPE 177
N++ L+ Y +V E M ++S +DH
Sbjct: 60 NIIGLLDILRPPSPEDFNDVY--------IVTELMETDLHKVIKSPQPLTDDH------- 104
Query: 178 QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237
I +F + +GL+YLH AN VI+RDLK SNIL++ + K+ DFGLA+
Sbjct: 105 ---IQYFLYQIL-----RGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR-- 151
Query: 238 PIGDKTHVSSRVMGTY----GYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
D + Y Y APE Y T D+++ G + EL+T +
Sbjct: 152 -GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 69/270 (25%), Positives = 108/270 (40%), Gaps = 45/270 (16%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHHDNLVNLI 146
+IG G FG V+ + + T QV A+K L ++ + + E +L+ +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHL--LDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
D E LV EYMP L + L D+ PE+ + + +AL + L ++H
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIH--- 124
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAK------------------LGPIGDKTHVS 246
RD+K NIL+D + + KL+DFGL K L
Sbjct: 125 ------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 247 SR---------VMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRR--AIDTTRPT 295
+GT Y APE R ++ D ++ GV+L E++ G DT + T
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 296 YEQNLVTWAQPF-FKDPNRYPQLADPLLQG 324
Y ++ W + F A L+
Sbjct: 239 Y-NKIINWKESLRFPPDPPVSPEAIDLICR 267
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLIGYC 149
+GEG + V+KG+ + T +VA+K++ +G I EV +L L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL-GAAKGLEYLHDKANPPV 208
LV+EY+ L+ +L + G +KI + +GL Y H + +
Sbjct: 73 HTERCLTLVFEYLD-SDLKQYLDNCGNLMS----MHNVKIFMFQLLRGLSYCHKRK---I 124
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRTGQLT 267
++RDLK N+L++ + KL+DFGLA+ + KT+ + V T Y P+ + + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 268 VKSDVYTFGVVLLELITGR 286
D++ G +L E+ TGR
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 50/224 (22%)
Query: 91 IGEGGFGRVYKGKLE--KTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNL 145
IG G +GRVYK K + K + A+K+ + Q ++ E+ +L L H+N+V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 146 IGYCADGEQRL--LVYEYMPLRSLEDHLLDI-----GPEQKPIDWFTRMKIALGAAKGLE 198
+ + + L+++Y E L I ++ I + G+
Sbjct: 68 VEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNA----KLSDFGLAKL--GPI-----GDKTHVSS 247
YLH V++RDLK +NIL+ E K+ D GLA+L P+ D
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP----- 174
Query: 248 RVMGTYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELIT 284
V+ T Y APE Y T D++ G + EL+T
Sbjct: 175 -VVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 8/202 (3%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL---DRNGLQGNKEFIVEVLMLSLLHHD 140
NFR E IG G F VY+ VA+K++ D + + I E+ +L L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
N++ + + +V E L + +++ I T K + LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
H + V++RD+K +N+ + KL D GL + KT + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 261 QRTGQLTVKSDVYTFGVVLLEL 282
KSD+++ G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV---EVLMLSLLHHDNLVNLIG 147
+G G +G VYK + T ++ AVK + L+ +F + E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
E+ + EY SL+D GP + I + R + +GL YLH K
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK- 127
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE---YQRT 263
++RD+K +NILL + KL+DFG+A I +GT + APE ++
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 264 GQLTVKSDVYTFGVVLLEL 282
G D++ G+ +EL
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 70/220 (31%), Positives = 100/220 (45%), Gaps = 52/220 (23%)
Query: 90 LIGEGGFGRVY---KGKLEKTAQVVAVKQL--------DRNGLQGNKEFIVEVLMLSLLH 138
++G+G FG+V+ K Q+ A+K L DR + ++ + EV +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRM----------- 187
H +V L Y E +L Y+ L L D FTR+
Sbjct: 57 HPFIVKL-HYAFQTEGKL----YLILDFLRGG-----------DLFTRLSKEVMFTEEDV 100
Query: 188 KIALGA-AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS 246
K L A L++LH +IYRDLK NILLD E + KL+DFGL+K +K S
Sbjct: 101 KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 247 SRVMGTYGYCAPE-YQRTGQLTVKSDVYTFGVVLLELITG 285
GT Y APE R G T +D ++FGV++ E++TG
Sbjct: 158 --FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 24/276 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL---DRNGLQGNKEFIVEVLMLSLLHHD 140
NF+ E IG G F VY+ + VA+K++ + + ++ + E+ +L L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 141 NLVN-LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
N++ L + D E + V E L + +++ I T K + +E+
Sbjct: 63 NVIKYLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259
+H + V++RD+K +N+ + KL D GL + KT + ++GT Y +PE
Sbjct: 122 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPE 176
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319
KSD+++ G +L E+ A+ + + NL + Q + Q
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMA----ALQSPFYGDKMNLFSLCQ-------KIEQCDY 225
Query: 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDV 355
P L E L + V +MC+ + RP + V
Sbjct: 226 PPLPTEHYSEKLRELV---SMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 5e-12
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLML-SLLHHDNLVNLIGY 148
L+G G +G+VYKG+ KT Q+ A+K +D G + +E E+ ML HH N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 149 CAD------GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
+Q LV E+ S+ D + + +W I +GL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ 129
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSR--VMGTYGYCAPE 259
VI+RD+K N+LL KL DFG+ A+L D+T V R +GT + APE
Sbjct: 130 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPYWMAPE 181
Query: 260 Y-----QRTGQLTVKSDVYTFGVVLLELITG 285
KSD+++ G+ +E+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI-----VEVLMLSLLHHDNLVNL 145
IG+G FG+VY+ + + T ++ A+K L + + KE +L+ +LL +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 146 IGYCADGEQRL-LVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHD 202
+ + + L LV +YM L HL G E + + + +AL E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL------EHLHK 114
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE--Y 260
++YRDLK NILLD + L DFGL+K +KT ++ GT Y APE
Sbjct: 115 Y---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLL 169
Query: 261 QRTGQLTVKSDVYTFGVVLLELITG 285
G T D ++ GV++ E+ G
Sbjct: 170 DEKG-YTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVK----QLDRNGLQGNKEFIVEVLMLSLLH---HDNLV 143
IG G +G VYK + + VA+K Q + +GL + + EV +L L H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST--VREVALLKRLEAFDHPNIV 65
Query: 144 NLIGYCA----DGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
L+ CA D E ++ LV+E++ + L +L + P P + + +GL+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQF--LRGLD 122
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
+LH +++RDLK NIL+ KL+DFGLA+ I + V+ T Y AP
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAP 176
Query: 259 EYQRTGQLTVKSDVYTFGVVLLEL 282
E D+++ G + E+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 65/234 (27%), Positives = 116/234 (49%), Gaps = 23/234 (9%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV 143
+F + +G G G V+K + + ++A K + + I+ L +LH N
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR--ELQVLHECNSP 63
Query: 144 NLIGYC----ADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGL 197
++G+ +DGE + + E+M SL+ L G PEQ K+++ KGL
Sbjct: 64 YIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQ------ILGKVSIAVIKGL 116
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
YL +K +++RD+K SNIL++ KL DFG++ G + D +++ +GT Y +
Sbjct: 117 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMS 170
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311
PE + +V+SD+++ G+ L+E+ GR I P ++ + + P DP
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDP 222
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 67/225 (29%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 88 ECL--IGEGGFGRVYKGK-LEKTAQVVAVK----QLDRNGLQGNKEFIVEVL-MLSLLHH 139
EC+ IGEG +G+V+K + L+ + VA+K Q G+ + V VL L H
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63
Query: 140 DNLVNLIGYCA----DGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA 194
N+V L C D E +L LV+E++ + L +L + P + M L
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQL--L 120
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG 254
+GL++LH V++RDLK NIL+ KL+DFGLA+ I + V+ T
Sbjct: 121 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLW 174
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN 299
Y APE D+++ G + E+ RR +P + +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMF--RR-----KPLFRGS 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 31/142 (21%)
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK--LGPIGDKTHVSSRVMGTYG 254
L++LH +IYRD+K NILLD E + L+DFGL+K L ++ + GT
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIE 171
Query: 255 YCAPEYQRTGQLTVKS--DVYTFGVVLLELITG----------------RRAIDTTRPTY 296
Y APE R G D ++ GV+ EL+TG R I ++P +
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF 231
Query: 297 EQNLVTWAQPFF-----KDPNR 313
+ + A+ F KDP +
Sbjct: 232 PKTMSAEARDFIQKLLEKDPKK 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 84/273 (30%), Positives = 126/273 (46%), Gaps = 36/273 (13%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLML-SLLHHDNLVNLIG-- 147
IG+G +G+VYK +K + AVK LD ++E E +L SL +H N+V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 148 YCAD---GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
Y AD G Q LV E S+ + + + + +D I GA GL++LH
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--- 145
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYCAPEY--- 260
N +I+RD+K +NILL E KL DFG+ A+L + + S +GT + APE
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPEVIAC 202
Query: 261 --QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP-NRYPQL 317
Q + DV++ G+ +EL G P ++ + V + FK P N P L
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDG------DPPLFDMHPV---KTLFKIPRNPPPTL 253
Query: 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP 350
P E R N + + C+ ++ RP
Sbjct: 254 LHP----EKWCRSFNHFI---SQCLIKDFEARP 279
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQL----DRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
IGEG +G V+K K +T ++VA+K++ D G+ + + E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 147 GYCADGEQRLLVYEY--MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
++ LV+EY L+ D ID KGL + H
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSC------NGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235
V++RDLK N+L++ KL+DFGLA+
Sbjct: 120 ---VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 66/244 (27%), Positives = 110/244 (45%), Gaps = 33/244 (13%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLIGYC 149
+GEG + VYKGK + ++VA+K + +G I E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 150 ADGEQRLLVYEYMPL---RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
E LV+EY+ + ++ H + PE + F ++ GL Y+H +
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY-- 123
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRTGQ 265
+++RDLK N+L+ KL+DFGLA+ + +H S + T Y P+ + +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 266 LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ-----------NLVTW----AQPFFKD 310
+ D++ G + +E+I G A + +Q N TW + P FK
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK- 239
Query: 311 PNRY 314
P R+
Sbjct: 240 PERF 243
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 36/221 (16%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQ--VVAVKQLDRNGLQGN-KEFIVEVLMLSLL-HHDN 141
+GEG FG+V + +K + VAVK L + + + + E+ M+ ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHL-------LDIG------PEQKPIDWFTRMK 188
++NL+G C ++ EY +L ++L +D PE++ + + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ-LTFKDLVS 138
Query: 189 IALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR 248
A A+G+EYL A+ I+RDL + N+L+ + K++DFGLA+ D ++
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DVHNIDYY 190
Query: 249 VMGTYG-----YCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
T G + APE T +SDV++FGV+L E+ T
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 53/220 (24%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNLVNLIGY 148
+G G +G+V KT + VA+K+L R K E+ +L + H+N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 149 CADGEQRLLVYEYMPLRSLED--------HLLD-----IGPEQKPIDWFTRMKIALGAAK 195
+ P SLED HL+ I QK D + + +
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILR 129
Query: 196 GLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
GL+Y+H A +I+RDLK SNI + DCE K+ DFGLA+ +V++R
Sbjct: 130 GLKYIH-SAG--IIHRDLKPSNIAVNEDCEL--KILDFGLARHTDDEMTGYVATR----- 179
Query: 254 GYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y APE Y +T D+++ G ++ EL+TG+
Sbjct: 180 WYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 68/242 (28%), Positives = 101/242 (41%), Gaps = 34/242 (14%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL-----DRNGLQGNKEFIVEVLMLSLLHH 139
F + L+ E GR Y K+ K +VA ++ + LQ ++ + L S H
Sbjct: 8 FGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH 67
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSL-EDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
D L ++ Y GE L + R ED G E L+
Sbjct: 68 DRLCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAE---------------IVSALD 109
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
YLH + N V+YRDLK N++LD + + K++DFGL K G I D + + GT Y AP
Sbjct: 110 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAP 165
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318
E D + GVV+ E++ GR P Y Q+ + + R+P+
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFELILMEEIRFPRTL 219
Query: 319 DP 320
P
Sbjct: 220 SP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 59/296 (19%)
Query: 22 PGSPPNKEPASPAPRHQNLKTKPAQEP-------ADDHKEA-----------NNNNKEAA 63
P PP P RH K++P + P D A ++++ ++
Sbjct: 3 PIQPPPGVPLPSTARHTT-KSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSS 61
Query: 64 GNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG 123
+ + + + EL + IG G G VYK T ++ A+K + G
Sbjct: 62 ASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRLYALKVI-----YG 109
Query: 124 NKEFIV------EVLMLSLLHHDNLVNLIG-YCADGEQRLLVYEYMPLRSLEDHLLDIGP 176
N E V E+ +L ++H N+V + +GE ++L+ E+M SLE I
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGT--HIAD 166
Query: 177 EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK- 235
EQ D +A G+ YLH + +++RD+K SN+L++ N K++DFG+++
Sbjct: 167 EQFLAD------VARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217
Query: 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRT----GQLT-VKSDVYTFGVVLLELITGR 286
L D + S +GT Y +PE T G D+++ GV +LE GR
Sbjct: 218 LAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLML-SLLHHDNLVNLIGY 148
++G G +G+VYKG+ KT Q+ A+K +D + +E +E+ ML HH N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 149 ------CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
+Q LV E+ S+ D + + DW I +GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSR--VMGTYGYCAPE 259
VI+RD+K N+LL KL DFG+ A+L D+T V R +GT + APE
Sbjct: 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPYWMAPE 191
Query: 260 Y-----QRTGQLTVKSDVYTFGVVLLELITG 285
+SD+++ G+ +E+ G
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 91 IGEGGFGRVY-----KGKLEKTAQV---VAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDN 141
+G+G FG VY K E+ +V + V +L+ N +Q N E +LS L H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPA 63
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLD------IGPEQKPIDWFTRMKIALGAAK 195
+V + + ++ EY R L+ L + E + +WF ++ +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
G+ Y+H + +++RDLK+ NI L K+ DFG+++L + +++ GT Y
Sbjct: 118 GVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYY 171
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLEL 282
+PE + KSD+++ G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 65/238 (27%), Positives = 96/238 (40%), Gaps = 43/238 (18%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVL----MLSLLH 138
K+F++ L+G+G GRV+ +L+ T ++ A+K LD+ + + + VL +L+ L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLD 59
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK--- 195
H L L LV +Y P L LL P + + AA+
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKC----LSEEVARFYAAEVLL 114
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT-----HVSSRVM 250
LEYLH ++YRDLK NILL + LSDF L+K + SR
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 251 ----------------------GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
GT Y APE D +T G++L E++ G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE----FIVEVLMLSLLHHDNLVNL 145
+IG+G FG+V K + + AVK L + + KE ++L + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLD--IGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
E+ V +++ L HL PE + + + ALG YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG------YLH-- 113
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG-PIGDKTHVSSRVMGTYGYCAPEYQR 262
+ ++YRDLK NILLD + + L+DFGL K G D T + GT Y APE R
Sbjct: 114 -SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIR 169
Query: 263 TGQLTVKSDVYTFGVVLLELITG 285
D + G VL E++ G
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 61/202 (30%), Positives = 85/202 (42%), Gaps = 16/202 (7%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLI 146
L+G+G FG+V + + T + A+K L + + E + E +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 147 GYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
Y RL V EY L HL + F +I L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LGYLHSCD- 115
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG-PIGDKTHVSSRVMGTYGYCAPEYQRTG 264
V+YRDLK N++LD + + K++DFGL K G G GT Y APE
Sbjct: 116 --VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLEDN 170
Query: 265 QLTVKSDVYTFGVVLLELITGR 286
D + GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 35/218 (16%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL----QGNKEFIVEVLMLSLLHHDNLVNL 145
LI G +G VY + ++T Q A+K++++ L Q + F VE +L+ + +V++
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM 66
Query: 146 IGYCADGEQRLL--VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
+C+ +R L V EY+ L +IG P+D RM A LEYLH
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVD-MARMYFA-ETVLALEYLH-- 118
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV-------------SSRVM 250
N +++RDLK N+L+ + KL+DFGL+K+G + T++ +V
Sbjct: 119 -NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 251 GTYGYCAPEY---QRTGQLTVKSDVYTFGVVLLELITG 285
GT Y APE Q G+ D + G++L E + G
Sbjct: 178 GTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 67/289 (23%), Positives = 129/289 (44%), Gaps = 45/289 (15%)
Query: 90 LIGEGGFGRVYKGKLEKTAQ-VVAVKQLDRNGLQGNK----------EFIVEVLML-SLL 137
+G G FG VYK + + Q ++A+K+++ + K + + EV ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG------PEQKPIDWFTRMKIAL 191
H N+V + ++ +V + + L +H + E++ + F +M +AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG 251
YLH + +++RDL +NI+L + ++DFGLAK ++ ++S V+G
Sbjct: 127 ------RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQK--QPESKLTS-VVG 175
Query: 252 TYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311
T Y PE + K+DV+ FG +L ++ T P Y N+++ A +
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKIVE-- 227
Query: 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
+ +PL +G + V C+ ++ RP + V + +S
Sbjct: 228 ----AVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 9e-11
Identities = 71/289 (24%), Positives = 124/289 (42%), Gaps = 41/289 (14%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGLQGNKE--FIVEVLMLSLL 137
K+ + E ++G G FG + +G L+ K VA+ L R G + F+ E L L
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQF 63
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197
H N+V L G G ++V EYM +L+ L + + M + G A G+
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGM 120
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG--- 254
+YL + +++ L + +L++ + K+S F + DK+ M
Sbjct: 121 KYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVL 173
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE---QNLVTWAQPFFKDP 311
+ APE + + SDV++FG+V+ E+++ RP ++ Q+++ + F+ P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE-----RPYWDMSGQDVIKAVEDGFRLP 228
Query: 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
P+ LL + C Q+E RP S + S LS
Sbjct: 229 A--PRNCPNLLH------------QLMLDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 34/216 (15%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNLVN---- 144
IG G +G V ++ + VA+K++ + K + E+ +L HDN++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP-----IDWFTRMKIALGAAKGLEY 199
L AD + +V + M E L I +P I +F + L +GL+Y
Sbjct: 73 LRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYF--LYQLL---RGLKY 122
Query: 200 LHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKL---GPIGDKTHVSSRVMGTYG 254
+H AN VI+RDLK SN+L+ DCE ++ DFG+A+ P K ++ V T
Sbjct: 123 IH-SAN--VIHRDLKPSNLLVNEDCEL--RIGDFGMARGLSSSPTEHKYFMTEYV-ATRW 176
Query: 255 YCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAI 289
Y APE + + T D+++ G + E++ GRR +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-FIVEVLMLSLLHHDNLVNLIGY 148
LI E +YKG ++ + G + + E+ L + +N++ + G+
Sbjct: 27 LIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86
Query: 149 CADGEQRL----LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
D L L+ EY L + L ++K + + T++ +A+ KGL L+
Sbjct: 87 IIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYT 142
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG 264
N P Y++L S + L+ + K+ GL K+ +V+ V +Y +
Sbjct: 143 NKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS--- 197
Query: 265 QLTVKSDVYTFGVVLLELITGR 286
+ T+K D+Y+ GVVL E+ TG+
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 28/203 (13%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVK--QLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGY 148
+G G G VYK T +++AVK LD ++ K+ + E L +L+ + +IG+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSE---LEILYKCDSPYIIGF 64
Query: 149 CADG--EQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
E R+ + E+M SL D I PE +IA+ KGL YL +
Sbjct: 65 YGAFFVENRISICTEFMDGGSL-DVYRKI-PEH------VLGRIAVAVVKGLTYLW---S 113
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAK--LGPIGDKTHVSSRVMGTYGYCAPEYQRT 263
+++RD+K SN+L++ KL DFG++ + I KT+V GT Y APE
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA-KTYV-----GTNAYMAPERISG 167
Query: 264 GQLTVKSDVYTFGVVLLELITGR 286
Q + SDV++ G+ +EL GR
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 69/238 (28%), Positives = 105/238 (44%), Gaps = 26/238 (10%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLI 146
L+G+G FG+V + + T + A+K L + + E + E +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 147 GYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK---GLEYLHD 202
Y RL V EY L HL ++ + FT + A+ LEYLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL-----SRERV--FTEERARFYGAEIVSALEYLHS 113
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
+ V+YRD+K N++LD + + K++DFGL K G I D + + GT Y APE
Sbjct: 114 RD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLE 168
Query: 263 TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320
D + GVV+ E++ GR P Y Q+ + + R+P+ P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFPRTLSP 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 66/239 (27%), Positives = 110/239 (46%), Gaps = 34/239 (14%)
Query: 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVL 132
+L ++F +IG G FG V + + + QV A+K L + + + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 133 MLSLLHHDNLVNLIGYCADGEQRLL--VYEYMP---LRSLEDHLLDIGPEQKPIDWFTRM 187
+++ + + +V L + A + + L V EYMP L +L + DI PE+ + +
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DI-PEKWARFYTAEV 151
Query: 188 KIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA-KLGPIGDKTHVS 246
+AL A + ++H RD+K N+LLD + KL+DFG K+ G
Sbjct: 152 VLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDANG--MVRC 200
Query: 247 SRVMGTYGYCAPEYQRT----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301
+GT Y +PE ++ G + D ++ GV L E++ G DT P Y +LV
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DT--PFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 28/230 (12%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV----EVLMLSLLH 138
K+F + L+G G FG V + + T + A+K + ++ L +E + E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISN 59
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMP---LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK 195
+ L D + LV EY P L SL + D E + + +A+ +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG-LAKLGPIGDKTHVSSRVMGTYG 254
+ Y+H RD+K N+L+D + KL+DFG A+L +K S +GT
Sbjct: 120 QMGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPD 168
Query: 255 YCAPEYQRT------GQLTVKSDVYTFGVVLLELITGRR--AIDTTRPTY 296
Y APE T G V+ D ++ GV+ E+I GR T+ TY
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF----IVEVLMLSLLHHDNLVNL 145
++GEG +G V K + ++T ++VA+K+ + + N+E + E+ ML L +N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+ LV+EY+ LE LL+ P P + L K + + H
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQL--IKAIHWCHKND- 120
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+++RD+K N+L+ KL DFG A+ G + + V T Y +PE
Sbjct: 121 --IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAP 177
Query: 266 LTVKSDVYTFGVVLLELITGR 286
D+++ G +L EL G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 55/259 (21%), Positives = 100/259 (38%), Gaps = 45/259 (17%)
Query: 45 AQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKL 104
A E DD + K+ A + + + T T G GRV+
Sbjct: 41 ASESDDDDDDGLIPTKQKARE---VVASLGYTVIKTLTP----------GSEGRVFVATK 87
Query: 105 EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV------ 158
V +K G +G ++E ++L ++H +++ + G +V
Sbjct: 88 PGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS 141
Query: 159 --YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSS 216
Y Y+ RS +P+ + I +GL YLH + +I+RD+K+
Sbjct: 142 DLYTYLTKRS------------RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTE 186
Query: 217 NILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFG 276
NI ++ + D G A+ P+ + + GT APE + K+D+++ G
Sbjct: 187 NIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAG 243
Query: 277 VVLLELITGRRAIDTTRPT 295
+VL E++ I P+
Sbjct: 244 IVLFEMLAYPSTIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 61/248 (24%), Positives = 114/248 (45%), Gaps = 28/248 (11%)
Query: 50 DDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQ 109
D+ + ++NNN + R + K+++ +IG G FG VY+ T++
Sbjct: 36 DEEERSHNNNAGEDEDEEKMIDNDINR---SPNKSYKLGNIIGNGSFGVVYEAICIDTSE 92
Query: 110 VVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGY----CADGEQRLL----VYEY 161
VA+K++ ++ N+ E+L++ L+H N++ L Y C ++ + V E+
Sbjct: 93 KVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEF 148
Query: 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD 221
+P +++ ++ + F + + L Y+H K + +RDLK N+L+D
Sbjct: 149 IP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLID 204
Query: 222 CEFNA-KLSDFGLAK--LGPIGDKTHVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGV 277
+ KL DFG AK L +++ SR Y APE T D+++ G
Sbjct: 205 PNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGC 259
Query: 278 VLLELITG 285
++ E+I G
Sbjct: 260 IIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 47/217 (21%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNLVNLIGY 148
+G G +G V KT VAVK+L R + K E+ +L + H+N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 149 CADGEQRLLVYEYMPLRSLED--------HLL-----DIGPEQKPIDWFTRMKIALGAAK 195
+ P RSLE+ HL+ +I QK D + I +
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILR 131
Query: 196 GLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG-- 251
GL+Y+H + +I+RDLK SN+ + DCE K+ DFGLA+ H + G
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCEL--KILDFGLAR--------HTDDEMTGYV 178
Query: 252 -TYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGR 286
T Y APE D+++ G ++ EL+TGR
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 33/83 (39%), Positives = 47/83 (56%)
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT 267
+I+RD+KS+NILL KL DFG +K+ V GT Y APE R +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 268 VKSDVYTFGVVLLELITGRRAID 290
K+D+++ GV+L EL+T +R D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 51/225 (22%), Positives = 98/225 (43%), Gaps = 39/225 (17%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLD----RNGLQGNKEFI----------VEVLMLSL 136
+GEG +G+V K T ++VA+K++ N + +++ + E+ +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 137 LHHDNLVNLIGYCADGEQRLLVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRMKIALGAA 194
+ H+N++ L+ +G+ LV + M L+ + D + + Q I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKC-------ILLQIL 129
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-------LGPIGDKTHVSS 247
GL LH ++RDL +NI ++ + K++DFGLA+ + +
Sbjct: 130 NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 248 RVMGTYG-----YCAPE-YQRTGQLTVKSDVYTFGVVLLELITGR 286
R T Y APE + D+++ G + EL+TG+
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVK----QLDRNGLQGNKEFIVEVLMLSLLHHDN-LVNL 145
IGEG +G+VYK + + T ++VA+K ++D G+ + E+ +L +L +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIVRL 66
Query: 146 IGY----CADGEQRL-LVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
+ +G+ L LV+EY+ L+ D + +P+ T KG+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD--SNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNA-KLSDFGLAKLG--PIGDKTHVSSRVMGTYGY 255
+ H V++RDLK N+L+D + K++D GL + P+ TH + T Y
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWY 177
Query: 256 CAPEYQRTG-QLTVKSDVYTFGVVLLELITG 285
APE + D+++ G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 84/328 (25%), Positives = 134/328 (40%), Gaps = 60/328 (18%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-----EVLM------LSLLH 138
+IG G FG V KL+ +V A+K L++ + E +VL+ ++ LH
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 139 H-----DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGA 193
+ +NL ++ Y G+ L L ED L PE + M IA+ +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTL------LSKFEDRL----PEDMARFYLAEMVIAIDS 117
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
L Y+H RD+K NIL+D + +L+DFG + L + D T SS +GT
Sbjct: 118 VHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTP 167
Query: 254 GYCAPEYQRT-----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF 308
Y +PE + G+ + D ++ GV + E++ G P Y ++LV
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIM 221
Query: 309 KDPNRY---PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365
R+ Q+ D + +R L +C +E + + D F G D
Sbjct: 222 NHKERFQFPAQVTDVSEDAKDLIRRL--------ICSREHRLGQNGIEDFKQHPFFTGID 273
Query: 366 PD-ADTATAP-VPHKPPPCDHQNMNMMD 391
D AP +P P D N ++ D
Sbjct: 274 WDNIRNCEAPYIPEVSSPTDTSNFDVDD 301
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 91 IGEGGFGRVYKG---------KLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN 141
+G+G F +++KG +L KT V +K LD++ ++ F M+S L H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTE--VLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
LV G C G++ ++V EY+ SL D L I W ++++A A L +L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISW--KLEVAKQLAWALHFLE 117
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT--YGYCAPE 259
DK + + ++ + N+LL E + K + KL G V + + + PE
Sbjct: 118 DKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 260 YQRTGQ-LTVKSDVYTFGVVLLELITG 285
Q L++ +D ++FG L E+ +G
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 63/246 (25%), Positives = 104/246 (42%), Gaps = 39/246 (15%)
Query: 91 IGEGGFGRVYKGKLEKTAQV----------VAVKQLDRNGLQGNKEFIVEVLMLSLLHHD 140
+G+G F +YKG L + + V +K L + + + F ++S L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLSHK 61
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
+LV L G C E ++V EY+ L D L + W + +A A L YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPL-DVFLHREKNNVSLHWK--LDVAKQLASALHYL 117
Query: 201 HDKANPPVIYRDLKSSNILL-------DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
DK +++ ++ NIL+ KLSD G+ + + R+
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 254 GYCAPEYQRTGQ--LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311
+ APE R GQ LT+ +D ++FG LLE+ + +T + E+ F++D
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER------FYQDQ 222
Query: 312 NRYPQL 317
+R P
Sbjct: 223 HRLPMP 228
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLI 146
L+G+G FG+V + + + + A+K L + + E + E +L H L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 147 GYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
Y + RL V EY+ L HL E+ + TR A L+YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGA-EIVSALDYLHSGK- 115
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
++YRDLK N++LD + + K++DFGL K G I D + + GT Y APE
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 266 LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN 299
D + GVV+ E++ GR P Y Q+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR------LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 47/233 (20%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVE--VLM------LSLLH 138
+IG G FG V K++ T QV A+K L++ + E F E VL+ ++ LH
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 139 H-----DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGA 193
+ +NL ++ Y G+ L L ED L PE + M +A+ +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTL------LSKFEDRL----PEDMARFYLAEMVLAIDS 117
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
L Y+H RD+K N+LLD + +L+DFG + L + D T S+ +GT
Sbjct: 118 VHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTP 167
Query: 254 GYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301
Y +PE + G+ + D ++ GV + E++ G P Y ++LV
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG------ETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 82/283 (28%), Positives = 122/283 (43%), Gaps = 44/283 (15%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLML-SLLHHDNLVNLIG-- 147
IG+G +G+V+K +K AVK LD ++E E +L +L H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 148 YCAD---GEQRLLVYEYMPLRSLED---HLLDIGPE-QKPIDWFTRMKIALGAAKGLEYL 200
Y D G+Q LV E S+ D L G ++PI + I A GL++L
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY----ILHEALMGLQHL 140
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
H I+RD+K +NILL E KL DFG++ + + +GT + APE
Sbjct: 141 H---VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 261 -----QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP-NRY 314
Q + DV++ G+ +EL G + P + FK P N
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---------RALFKIPRNPP 246
Query: 315 PQLADP-LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVV 356
P L P L EF N + C+ ++ RP +SD++
Sbjct: 247 PTLHQPELWSNEF-----NDFI---RKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 60/200 (30%), Positives = 87/200 (43%), Gaps = 13/200 (6%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE----FIVEVLMLSLLHHDNLVNL 145
+IG+G FG+V + + + AVK L + + KE ++L + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
++ V +Y+ L HL +P F +IA L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA----SALGYLHSLN- 116
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
++YRDLK NILLD + + L+DFGL K + T +S GT Y APE
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQP 172
Query: 266 LTVKSDVYTFGVVLLELITG 285
D + G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 52/221 (23%)
Query: 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLHHDNLVNL 145
+G G +G V ++T + VA+K+L R Q K E+ +L + H+N++ L
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 146 I-----GYCADGEQRL-LVYEYM--PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197
+ D Q LV YM L+ + H L E K + + + GL
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLS---EDK-VQYLVYQML-----CGL 130
Query: 198 EYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG---T 252
+Y+H +I+RDLK N+ + DCE K+ DFGLA+ H + + G T
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCEL--KILDFGLAR--------HADAEMTGYVVT 177
Query: 253 YGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y APE Y +T D+++ G ++ E++TG+
Sbjct: 178 RWYRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 54/218 (24%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF--IVEVL-------MLSLLHHDN 141
IGEG F V K + KT + A+K + K F + +V + L H N
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 142 LVNLIGYCADGEQRLL----------VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL 191
++ LI D + L +YE + R L PE++ + ++
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK---RPL---PEKRVKSYMYQL---- 109
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK----THVSS 247
K L+++H + +RD+K NIL+ + KL+DFG + I K ++S+
Sbjct: 110 --LKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYIST 161
Query: 248 RVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELIT 284
R Y APE T G K D++ G V E+++
Sbjct: 162 R-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNLVNLIGY 148
IG G FG V+ + + VA+K++ L K E+ ML HDN+++ +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 149 CADGEQRLL--VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL-GAAKGLEYLHDKAN 205
+Y L + H + + P+ D +K+ L +GL+YLH A
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD---HVKVFLYQILRGLKYLH-SAG 123
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG- 264
+++RD+K N+L++ K+ DFGLA++ + H++ V+ Y Y APE G
Sbjct: 124 --ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEIL-MGS 179
Query: 265 -QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT 302
T D+++ G + EL+ R P + +L+T
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 13/202 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQV--VAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVNLIG 147
IG G FG+V ++ V V VK+L N + EF+ + +L H N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
C + LLV+EY L L+ +L ++ ++A A G+ ++H K N
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-KHN-- 119
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY--QRTGQ 265
++ DL N L + K+ D+G+ D + APE + G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 266 L-----TVKSDVYTFGVVLLEL 282
L T S+V+ GV L EL
Sbjct: 180 LITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
LE+LH +IYRD+K NILLD + L+DFGL+K D+ + GT Y
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEY 172
Query: 256 CAPEYQRTGQLTVKS--DVYTFGVVLLELITG 285
AP+ R G D ++ GV++ EL+TG
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 47/233 (20%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-----EVLM------LSLLH 138
+IG G FG V K++ T ++ A+K L++ + E VL+ ++ LH
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 139 H----DNLVNLI-GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGA 193
+ +N + L+ Y G+ L L ED L PE + M +A+ +
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTL------LSKFEDRL----PEDMARFYIAEMVLAIHS 117
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
L Y+H RD+K N+LLD + +L+DFG + L D T SS +GT
Sbjct: 118 IHQLHYVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTP 167
Query: 254 GYCAPEYQRT-----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301
Y +PE + G+ + D ++ GV + E++ G P Y ++LV
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 70/268 (26%), Positives = 112/268 (41%), Gaps = 50/268 (18%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK--EFIVEVLMLSLLHHDNLVNLIG- 147
IG G FG V+ K ++T + K + GL+ + + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 148 YCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
+ Q+L ++ E+ L ++ I+ + I L Y H+ +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 207 P----VIYRDLKSSNILLDCEFN-----------------AKLSDFGLAKLGPIGDKTHV 245
P V++RDLK NI L AK+ DFGL+K IG ++
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--NIGIESMA 198
Query: 246 SSRVMGTYGYCAPE--YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTW 303
S V GT Y +PE T KSD++ G ++ EL +G+
Sbjct: 199 HSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK----------------- 240
Query: 304 AQPFFKDPNRYPQLADPLLQG-EFPVRG 330
PF K N + QL L +G + P++G
Sbjct: 241 -TPFHK-ANNFSQLISELKRGPDLPIKG 266
|
Length = 1021 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
LE+LH ++YRD+K NILLD E + L+DFGL+K +K S GT Y
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYM 173
Query: 257 APEYQRTGQLTVKS-DVYTFGVVLLELITG 285
APE R K+ D ++ G+++ EL+TG
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 54/200 (27%), Positives = 82/200 (41%), Gaps = 23/200 (11%)
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLE 198
N+V L Y + LV ++ L H+ PE+ W M +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG-LAKLGPIGDKTHVSSRVMGTYGYCA 257
LH + ++ RDL +NILLD + +L+ F +++ D V + YCA
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP-FFKDPNRYPQ 316
PE + T D ++ G +L EL+TG + + P+ T P + + R
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEEAR--S 207
Query: 317 LADPLLQGEFPVRGLNQAVA 336
L LLQ P L VA
Sbjct: 208 LLQQLLQFN-PTERLGAGVA 226
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 32/238 (13%)
Query: 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVL 132
R+L +++ +IG G FG V + + T +V A+K L + + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 133 MLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFT-RMKIAL 191
+++ + +V L D +V EYMP L + + + +K ++T + +AL
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG----LAKLGPIGDKTHVSS 247
A + ++H RD+K N+LLD + KL+DFG + K G + T V
Sbjct: 156 DAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 204
Query: 248 RVMGTYGYCAPEYQRT----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301
GT Y +PE ++ G + D ++ GV L E++ G DT P Y +LV
Sbjct: 205 ---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DT--PFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNLVNLIGY 148
+G G +G V + Q VAVK+L R L + E+ +L + H+N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 149 ---CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
E VY L + L +I QK D + I +GL+Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGAD--LNNIVKCQKLSDEHVQFLI-YQLLRGLKYIHSAG- 138
Query: 206 PPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE---- 259
+I+RDLK SN+ + DCE ++ DFGLA+ +V++R Y APE
Sbjct: 139 --IIHRDLKPSNVAVNEDCEL--RILDFGLARQADDEMTGYVATR-----WYRAPEIMLN 189
Query: 260 ---YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y +T D+++ G ++ EL+ G+
Sbjct: 190 WMHYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 30/206 (14%)
Query: 91 IGEGGFGRVYKGKLE-KTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLI 146
+G G FGRV + + VA+K+ +++ + K+ E +L+ ++H VNL
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 147 GYCADGEQRLLVYEYMP-------LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
G D LV E++ LR + D+G F +I L EY
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-------CFYAAQIVLI----FEY 146
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259
L ++YRDLK N+LLD + K++DFG AK+ + +T+ + GT Y APE
Sbjct: 147 LQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDTRTYT---LCGTPEYIAPE 198
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITG 285
+D +T G+ + E++ G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G G V+ + VAVK++ Q K + E+ ++ L HDN+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 151 DGEQRL--------------LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
L +V EYM + L EQ P+ +G
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM------ETDLANVLEQGPLSEEHARLFMYQLLRG 126
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLAKLGPIGD-----KTHVSSRVM 250
L+Y+H AN V++RDLK +N+ ++ E K+ DFGLA+ I D K ++S ++
Sbjct: 127 LKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLAR---IVDPHYSHKGYLSEGLV 180
Query: 251 GTYGYCAPE-YQRTGQLTVKSDVYTFGVVLLELITGR 286
+ Y +P T D++ G + E++TG+
Sbjct: 181 TKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 62/235 (26%), Positives = 107/235 (45%), Gaps = 26/235 (11%)
Query: 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVL 132
R+L +++ +IG G FG V + + + +V A+K L + + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 133 MLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFT-RMKIAL 191
+++ + +V L D + +V EYMP L + + + +K ++T + +AL
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA-KLGPIGDKTHVSSRVM 250
A + +H RD+K N+LLD + KL+DFG K+ G + V
Sbjct: 156 DAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAV- 204
Query: 251 GTYGYCAPEYQRT----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301
GT Y +PE ++ G + D ++ GV L E++ G DT P Y +LV
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG----DT--PFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 12/97 (12%)
Query: 196 GLEYLHDKANPPVIYRDLKSSNIL--LDCEFNAKLSDFGLAK---LGPIGDKTHVSSRVM 250
GL+Y+H AN V++RDLK N+L DCE K+ DFGLA+ P + ++ V
Sbjct: 117 GLKYIH-SAN--VLHRDLKPGNLLVNADCEL--KICDFGLARGFSENPGENAGFMTEYV- 170
Query: 251 GTYGYCAPEYQRTGQLTVKS-DVYTFGVVLLELITGR 286
T Y APE + Q K+ DV++ G +L EL+ +
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 64/271 (23%), Positives = 99/271 (36%), Gaps = 33/271 (12%)
Query: 90 LIGEGGFGR--VYKGKLEKTAQVVAVKQ--LDRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
LIG+ V+ K + T +VAVK+ LD + K E++ L H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAAKGLEYLHD 202
+ + +V M S ED L PE + IA L+Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-----LPELAIAFILKDVLNALDYIHS 119
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLA--------KLGPIGDKTHVSSRVMGTYG 254
K I+R +K+S+ILL + LS + + + D S + +
Sbjct: 120 KG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP--- 173
Query: 255 YCAPE--YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY---EQNLVTWAQPFFK 309
+ +PE Q KSD+Y+ G+ EL G T E+ V P
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLL 231
Query: 310 DPNRYPQLADPLLQGEFPVRGLNQAVAVSAM 340
D + YP D + Q N +V
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHP 262
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 2/102 (1%)
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT 267
+++RDLKS+NI L KL DFG +K V+S GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 268 VKSDVYTFGVVLLELITGRRAID--TTRPTYEQNLVTWAQPF 307
K+D+++ GV+L EL+T R + R +Q L PF
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
|
Length = 478 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 46/188 (24%)
Query: 118 RNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE---YMPLRSLEDHLL-- 172
+ G + + E+L L L+H+N++ + + +L E YM + + L
Sbjct: 201 KAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSF 252
Query: 173 ----DIGPEQKPIDWFTR--MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226
+ +P+ TR MK L A +EY+HDK +I+RD+K NI L+C+
Sbjct: 253 MYDEAFDWKDRPLLKQTRAIMKQLLCA---VEYIHDKK---LIHRDIKLENIFLNCDGKI 306
Query: 227 KLSDFGLA----------KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFG 276
L DFG A G +G S ++ GYC ++T D+++ G
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC--------EIT---DIWSCG 355
Query: 277 VVLLELIT 284
++LL++++
Sbjct: 356 LILLDMLS 363
|
Length = 501 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 34/151 (22%), Positives = 54/151 (35%), Gaps = 17/151 (11%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLV-NLIG 147
L+ G RVY L + +K ++E EV +L LL V ++
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADRER--EVAILQLLARKGLPVPKVLA 60
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
L+ E+ +E LD E++ D ++ L LH
Sbjct: 61 SGESDGWSYLLMEW-----IEGETLDEVSEEEKEDIAEQLAELLAK------LHQLPLLV 109
Query: 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238
+ + DL NIL+D + D+ A GP
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 66/242 (27%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 89 CLIGEGGFGRVYKGKLE--KTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
C +G G +G VYK K + K + A+KQ++ G+ + E+ +L L H N+++L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQ 64
Query: 147 G-YCADGEQRL-LVYEYMPLRSLEDHLLDI-------GPEQKPIDWFTRMKIAL--GAAK 195
+ + ++++ L+++Y E L I +KP+ M +L
Sbjct: 65 KVFLSHADRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCE----FNAKLSDFGLAK-----LGPIGDKTHVS 246
G+ YLH AN V++RDLK +NIL+ E K++D G A+ L P+ D
Sbjct: 120 GIHYLH--AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD----L 172
Query: 247 SRVMGTYGYCAPEYQRTGQLTVKS-DVYTFGVVLLELITG-------RRAIDTTRPTYEQ 298
V+ T+ Y APE + K+ D++ G + EL+T + I T+ P +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
Query: 299 NL 300
L
Sbjct: 233 QL 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNL 142
++ + +IG+G +G V T + VA+K+++ + + E+ +L LL H ++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 143 VNLIGYCADGEQR-----LLVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK 195
V + +R +V+E M L + D+ PE + ++
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR------- 114
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS-SRVMGTYG 254
L+Y+H AN V +RDLK NIL + + K+ DFGLA++ T + + + T
Sbjct: 115 ALKYIH-TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 255 YCAPEYQRT--GQLTVKSDVYTFGVVLLELITGR 286
Y APE + + T D+++ G + E++TG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 41/214 (19%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLHHDNLVNLIG 147
+G G +G V +T VA+K+L R Q K E+ +L + H+N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 148 -YCADGEQRLL--VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAAKGLEYLH 201
+ D Y MP D+G K + + +I KGL+Y+H
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGT-----DLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIH 135
Query: 202 DKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG---TYGYC 256
+I+RDLK N+ + DCE K+ DFGLA+ S + G T Y
Sbjct: 136 AAG---IIHRDLKPGNLAVNEDCEL--KILDFGLAR--------QTDSEMTGYVVTRWYR 182
Query: 257 APE----YQRTGQLTVKSDVYTFGVVLLELITGR 286
APE + Q TV D+++ G ++ E++TG+
Sbjct: 183 APEVILNWMHYTQ-TV--DIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 63/229 (27%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNLVNLIGY 148
IG G +G V K +T + VA+K++ + K + E+ +L L H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71
Query: 149 CADGEQR------LLVYEYMP------LRS----LEDH-------LLDIGPEQKPIDWFT 185
R +VYE M +RS +DH LL
Sbjct: 72 IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLL------------- 118
Query: 186 RMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV 245
+GL+Y+H AN V++RDLK SN+LL+ + K+ DFGLA+ T
Sbjct: 119 ---------RGLKYIH-SAN--VLHRDLKPSNLLLNANCDLKICDFGLART------TSE 160
Query: 246 SSRVMGTY----GYCAPE-YQRTGQLTVKSDVYTFGVVLLELITGRRAI 289
M Y Y APE + T DV++ G + EL+ GR+ +
Sbjct: 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 34/111 (30%), Positives = 50/111 (45%), Gaps = 5/111 (4%)
Query: 180 PIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA-KLGP 238
P+ + I + L YLH + +I+RD+K+ NI LD NA L DFG A KL
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAI 289
D GT +PE K+D+++ G+VL E+ +
Sbjct: 238 HPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 79/366 (21%), Positives = 133/366 (36%), Gaps = 82/366 (22%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDN--LVNLIG 147
+G G FG V T + A+K L ++ L N+ V+ L DN +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
D + V +Y+P + L+ + PE + + +A+ + + ++H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH---- 124
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLA---------------------KLGP------ 238
RD+K NIL+D + + KL+DFGL + P
Sbjct: 125 -----RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 239 -----IGD----------KTH---VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLL 280
GD K H ++ ++GT Y APE T D ++ GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 281 ELITGRRAIDTTRPTYEQ-NLVTWAQPFFKDPN--RYPQLADPLLQGEFPVRGLNQAVAV 337
E++ G+ PT Q ++ W P P+ D +
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVD----------------LI 283
Query: 338 SAMCVQEESSVRPLMSDVVSALSFLGS-DPDADTATAPVPHKPP---PCDHQNMNMMDQN 393
+ +C E + +D + A F D +D T P P+ P P D N + +++
Sbjct: 284 TKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEE 343
Query: 394 GYYQDE 399
+ D
Sbjct: 344 SPWNDA 349
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 44/242 (18%)
Query: 89 CLIGEGGFGRVYKGKLE--KTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
C +G G +G VYK K + K + A+KQ++ G+ + E+ +L L H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQ 64
Query: 147 G-YCADGEQRL-LVYEYMPLRSLEDHLLDI-------GPEQKPIDWFTRMKIAL--GAAK 195
+ + ++++ L+++Y E L I +KP+ M +L
Sbjct: 65 KVFLSHSDRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCE----FNAKLSDFGLAK-----LGPIGDKTHVS 246
G+ YLH AN V++RDLK +NIL+ E K++D G A+ L P+ D
Sbjct: 120 GIHYLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD----L 172
Query: 247 SRVMGTYGYCAPEYQRTGQLTVKS-DVYTFGVVLLELITG-------RRAIDTTRPTYEQ 298
V+ T+ Y APE + K+ D++ G + EL+T + I T+ P +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
Query: 299 NL 300
L
Sbjct: 233 QL 234
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 44/166 (26%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVK----------------QLDRNGLQGNK-EFIVEVLM 133
I G FG+VY G+ + +++ AVK Q +R+ L +K FIV L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVH-LY 70
Query: 134 LSLLHHDNLVNLIGYCADGEQRLLVYEYM---PLRSLEDHLLDIGPEQKPIDWFTRMKIA 190
SL +N+ LV EY+ ++SL H+ E+ + + + + +A
Sbjct: 71 YSLQSANNV-------------YLVMEYLIGGDVKSLL-HIYGYFDEEMAVKYISEVALA 116
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236
L +YLH +I+RDLK N+L+ E + KL+DFGL+K+
Sbjct: 117 L------DYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV---SSRVM 250
A+G+E+L A+ I+RDL + NILL K+ DFGLA+ D +V +R+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 237
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ APE T +SDV++FGV+L E+ +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 67/267 (25%), Positives = 113/267 (42%), Gaps = 69/267 (25%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVL----MLSLLHHDNLVNL 145
+IG G FG V + + T + A+K+L ++ + KE + V +L+ + +V L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKL 66
Query: 146 IGYCA--DGEQRLLVYEYMPLRSLEDHLL--DIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
Y + D L+ EY+P + L+ D E++ TR IA ++ +H
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIA-ETILAIDSIH 118
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG-DKTHVSS------------- 247
K I+RD+K N+LLD + + KLSDFGL G K+H +
Sbjct: 119 -KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHRTEFYRILSHALPSNF 171
Query: 248 ---------------------RVM-----GTYGYCAPE-YQRTGQLTVKSDVYTFGVVLL 280
R + GT Y APE + +TG + D ++ GV++
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMY 230
Query: 281 ELITGRRAI--DTTRPTYEQNLVTWAQ 305
E++ G D + TY + ++ W +
Sbjct: 231 EMLVGYPPFCSDNPQETY-RKIINWKE 256
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 11/114 (9%)
Query: 175 GPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234
+ P+D ++ + A+G+++L K I+RD+ + N+LL AK+ DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 235 KLGPIGDKTHVSSRVMGT----YGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ + D +V V G + APE TV+SDV+++G++L E+ +
Sbjct: 260 R-DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV---SSRVM 250
AKG+E+L A+ I+RDL + NILL K+ DFGLA+ D +V +R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ APE T++SDV++FGV+L E+ +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV---SSRVM 250
A+G+E+L A+ I+RDL + NILL K+ DFGLA+ D +V S+R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL- 238
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ APE T +SDV++FGV+L E+ +
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 53/220 (24%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR---NGLQGNKEFIVEVLMLSLLHHDNLVNLIG 147
IG G G V T Q VA+K+L R N + + VLM L++H N++ L+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLM-KLVNHKNIIGLLN 82
Query: 148 YCADGEQRLLVYEYMPLRSLED--------HLLD------IGPEQKPIDWFTRMKIALGA 193
+ P +SLE+ L+D I Q +D RM L
Sbjct: 83 V------------FTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLD-HERMSYLLYQ 126
Query: 194 AK-GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT 252
G+++LH + +I+RDLK SNI++ + K+ DFGLA+ G ++ V+
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTR 181
Query: 253 YGYCAPE------YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y Y APE Y+ D+++ G ++ E+I G
Sbjct: 182 Y-YRAPEVILGMGYKE------NVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR---NGLQGNKEFIVEVLMLSL 136
T K ++Q IG G G V VAVK+L R N + + E+++L
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKC 76
Query: 137 LHHDNLVNLIGY------CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIA 190
++H N+++L+ + + LV E M + +++ E RM
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHE--------RMSYL 128
Query: 191 L-GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV 249
L G+++LH +I+RDLK SNI++ + K+ DFGLA +T ++ +
Sbjct: 129 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA-------RTACTNFM 178
Query: 250 MGTY----GYCAPEYQRTGQLTVKSDVYTFGVVLLELITG 285
M Y Y APE D+++ G ++ EL+ G
Sbjct: 179 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 80 TATKNFRQECLIGEGGFGRV---YKGKLEKTAQVVAVKQLDR---NGLQGNKEFIVEVLM 133
T K ++ IG G G V Y LE+ VA+K+L R N + + E+++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAY-RELVL 76
Query: 134 LSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLED--------HLLDIG---PEQKPID 182
+ ++H N++ L+ + P +SLE+ L+D Q +D
Sbjct: 77 MKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 124
Query: 183 WFTRMKIALGAAK-GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241
RM L G+++LH +I+RDLK SNI++ + K+ DFGLA+ G
Sbjct: 125 -HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GT 178
Query: 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
++ V+ Y Y APE D+++ G ++ E+I G
Sbjct: 179 SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 3e-05
Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 27/233 (11%)
Query: 80 TATKNFRQECLIGEGGFGRV---YKGKLEKTAQVVAVKQLDR---NGLQGNKEFIVEVLM 133
T K ++ IG G G V Y L++ VA+K+L R N + + E+++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAY-RELVL 69
Query: 134 LSLLHHDNLVNLIGYCADGEQRLLVYE--YMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL 191
+ ++H N+++L+ ++ L ++ Y+ + ++ +L + Q +D +
Sbjct: 70 MKCVNHKNIISLLNVFTP-QKSLEEFQDVYLVMELMDANLCQV--IQMELDHERMSYLLY 126
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG 251
G+++LH +I+RDLK SNI++ + K+ DFGLA+ G ++ V+
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVT 181
Query: 252 TYGYCAPEYQRTGQLTVKSDVYTFGVVLLELI------TGRRAIDTTRPTYEQ 298
Y Y APE D+++ G ++ E++ GR ID EQ
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 80/369 (21%), Positives = 140/369 (37%), Gaps = 84/369 (22%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDN--LVNLIG 147
+G G FG V + T + A+K L ++ L N+ V+ L DN +V L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
D + V +Y+P + L+ +G PE + + A+ + + ++H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH---- 124
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLA------------------------------- 234
RD+K NIL+D + + KL+DFGL
Sbjct: 125 -----RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 235 --------KLGPI---GDKTH---VSSRVMGTYGYCAPE-YQRTGQLTVKSDVYTFGVVL 279
+L P+ + H ++ ++GT Y APE RTG T D ++ GV+L
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL 238
Query: 280 LELITGRRAIDTTRPTYEQ-NLVTWAQPFFKDPNR--YPQLADPLLQGEFPVRGLNQAVA 336
E++ G+ P Q ++ W P P+ +D +++
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK------------- 285
Query: 337 VSAMCVQEESSVRPLMSDVVSALSFLGS-DPDADTATAPVPHKPP---PCDHQNMNMMDQ 392
+C E + +D + A F + D +D P+ P P D N + +D
Sbjct: 286 ---LCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDP 342
Query: 393 NGYYQDEEK 401
+ + D++K
Sbjct: 343 DKLWSDDDK 351
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
AKG+ +L K I+RDL + NILL K+ DFGLA+ D + S+ V+
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGN 275
Query: 254 G-----YCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ APE T +SDV+++G++L E+ +
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 7/93 (7%)
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFN-AKLSDFGLAKLGPIGDKTHVSS-RVMG 251
A G+E+L A+ ++RDL + N+L+ CE K+ DFGLA+ + D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLI-CEGKLVKICDFGLAR-DIMRDSNYISKGSTFL 303
Query: 252 TYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ APE T SDV++FG++L E+ T
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 64/244 (26%), Positives = 96/244 (39%), Gaps = 59/244 (24%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR-NGLQGNKEFIVEVLMLSLLHHDN--LVNLIG 147
IG G FG V + T + A+K L + + L N+ V+ L DN +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIA-LGAAKGLEYLHDKA 204
D + V +Y+P + L+ +G E R IA L A +E +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED-----LARFYIAELTCA--IESVH--- 118
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGL------------------------------A 234
I+RD+K NIL+D + + KL+DFGL +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 235 KLGPIGDKTHVSSRV-----------MGTYGYCAPE-YQRTGQLTVKSDVYTFGVVLLEL 282
++ K R +GT Y APE RTG T D ++ GV+L E+
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEM 237
Query: 283 ITGR 286
+ G+
Sbjct: 238 LVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS-RVMGT 252
A+G+E+L A+ ++RDL + N+LL K+ DFGLA+ + D +VS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLP 302
Query: 253 YGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ APE T SDV+++G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 29/79 (36%), Positives = 42/79 (53%), Gaps = 9/79 (11%)
Query: 91 IGEGGFGRVYK------GKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLL-HHDNL 142
+G G FG+V + GK E VAVK L + +E ++ E+ +LS L H N+
Sbjct: 46 LGAGAFGKVVEATAFGLGK-EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104
Query: 143 VNLIGYCADGEQRLLVYEY 161
VNL+G C G L++ EY
Sbjct: 105 VNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 61/270 (22%), Positives = 108/270 (40%), Gaps = 54/270 (20%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLS--LLHHDN 141
+F +IG G FG V + + T + A+K L + + KE + + L+ D
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADG 60
Query: 142 --LVNLIGYCADGEQRLLVYEYMPLRSLEDHLL--DIGPEQKPIDWFTRMKIALGAAKGL 197
+V + D L+ E++P + L+ D E+ + +A+ A L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA---------------KLGPIGD- 241
++H RD+K N+LLD + + KLSDFGL P D
Sbjct: 121 GFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 242 -----------------KTHVSSRVMGTYGYCAPE-YQRTGQLTVKSDVYTFGVVLLELI 283
+ ++ +GT Y APE + +TG + D ++ GV++ E++
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEML 230
Query: 284 TGRRAI--DTTRPTYEQNLVTWAQPFFKDP 311
G +T + TY + ++ W + P
Sbjct: 231 IGYPPFCSETPQETYRK-VMNWKETLVFPP 259
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 28/78 (35%), Positives = 41/78 (52%), Gaps = 7/78 (8%)
Query: 91 IGEGGFGRV-----YKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLL-HHDNLV 143
+G G FG+V Y A VAVK L + +E ++ E+ +LS L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 144 NLIGYCADGEQRLLVYEY 161
NL+G C G L++ EY
Sbjct: 103 NLLGACTVGGPTLVITEY 120
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 38/110 (34%), Positives = 55/110 (50%), Gaps = 20/110 (18%)
Query: 189 IALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI---GDKTHV 245
I GA +GL YLH I+R++K+S+IL+ + LS GL+ L + G K V
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160
Query: 246 -------SSRVMGTYGYCAPEYQRTG--QLTVKSDVYTFGVVLLELITGR 286
S+ V+ + +PE R VKSD+Y+ G+ EL TGR
Sbjct: 161 VYDFPQFSTSVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 26/95 (27%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG 254
+ ++YLH+ +I+RD+K+ NI ++ + L DFG A P+ + GT
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGTIA 248
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAI 289
APE D+++ G+VL E+ T ++
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 60/270 (22%), Positives = 111/270 (41%), Gaps = 52/270 (19%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR-NGLQGNKEFIVEVLMLSLLHHDN 141
++F +IG G FG V + + T V A+K L + + L+ + + L+ D+
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 142 L--VNLIGYCADGEQRLLVYEYMPLRSLEDHLL--DIGPEQKPIDWFTRMKIALGAAKGL 197
L V + D L+ E++P + L+ D E++ + +A+ + L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT-------------- 243
++H RD+K N+LLD + + KLSDFGL +T
Sbjct: 121 GFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 244 -------------------HVSSRVMGTYGYCAPE-YQRTGQLTVKSDVYTFGVVLLELI 283
++ +GT Y APE + +TG + D ++ GV++ E++
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEML 230
Query: 284 TGRRAI--DTTRPTYEQNLVTWAQPFFKDP 311
G +T + TY++ ++ W + P
Sbjct: 231 IGYPPFCSETPQETYKK-VMNWKETLIFPP 259
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 38/215 (17%)
Query: 91 IGEGGFGRVYKGKL-------------EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL 137
+G G ++Y G L EK +V+ +K LD + + F M+ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVI-LKVLDPSHRDISLAFFETASMMRQV 61
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197
H ++V L G C + ++V E++ L+ L + + + + K+A A L
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLD---LFMHRKSDVLTTPWKFKVAKQLASAL 118
Query: 198 EYLHDKANPPVIYRDLKSSNILL-------DCEFNAKLSDFGLAKLGPIGDKTHVSSR-- 248
YL DK +++ ++ + NILL +C KLSD G+ PI V SR
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PIT----VLSRQE 167
Query: 249 VMGTYGYCAPE-YQRTGQLTVKSDVYTFGVVLLEL 282
+ + APE + + L++ +D ++FG L E+
Sbjct: 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 26/161 (16%)
Query: 133 MLSLLHHDNLVNLIGYCADGEQRLLVYEYM---PLRSLEDHLLDIGPEQKPIDWFTRMKI 189
++S + H +L + G C G + ++V E++ PL D L + P+ W ++ +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL----DVCLRKEKGRVPVAW--KITV 122
Query: 190 ALGAAKGLEYLHDKANPPVIYRDLKSSNILLD----CEFNA---KLSDFGLAKLGPIGDK 242
A A L YL DK +++ ++ + NILL E + KLSD G++ + +
Sbjct: 123 AQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSRE 178
Query: 243 THVSSRVMGTYGYCAPE-YQRTGQLTVKSDVYTFGVVLLEL 282
V R+ + APE L+ +D ++FG LLE+
Sbjct: 179 ERV-ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 427 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.68 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.27 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.88 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.86 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.82 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.48 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.48 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.43 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.35 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.3 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.24 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.16 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.12 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.08 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.04 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.03 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.93 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.69 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.65 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.64 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.61 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.57 | |
| PLN02236 | 344 | choline kinase | 97.52 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.42 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.41 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.37 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.13 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.12 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.07 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.04 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.91 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.87 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.85 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.6 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.34 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.25 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.05 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.02 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.85 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.79 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.57 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-56 Score=431.27 Aligned_cols=291 Identities=57% Similarity=0.947 Sum_probs=256.8
Q ss_pred cccccCHHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEE
Q 042519 69 AAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGY 148 (427)
Q Consensus 69 ~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 148 (427)
....|++.++..++++|...++||+|+||.||+|...+ |..||||++.........+|.+|+.++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56789999999999999999999999999999999987 48999998876543314569999999999999999999999
Q ss_pred EEcCC-eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCee
Q 042519 149 CADGE-QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 149 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
|.+.+ ..+||||||++|+|.++|+..... +++|..+++|+.++|+||+|||....++|||||||++|||||+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 599999999999999999874433 899999999999999999999999988999999999999999999999
Q ss_pred EeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 042519 228 LSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 228 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
|+|||+|+..+.. .........||.+|+|||++..+..+.|+|||||||+|+||++|+.+.+...+.....+..|+.+.
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999765431 121111118999999999999999999999999999999999999999887767777899999888
Q ss_pred hcCCCCCCcccccccC-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 308 FKDPNRYPQLADPLLQ-GEFPV-RGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+.+. .+.+++|+.+. +.++. .....+..++.+|++.+|.+||+|.+|+++|..+..
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 8875 88999999987 66664 688889999999999999999999999999965543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=406.01 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=218.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.+|...++||+|||+.||.+++..+|+.||+|++.+... ...+.+.+|++|.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 569999999999999999999999999999999987543 33466889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|+|..++|..+++ ..+++++.++..+..||+.||.|||+++ |+|||||..|+||+++.+|||+|||+|.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999998885 4578999999999999999999999999 99999999999999999999999999987432
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
......+.||||.|.|||++....++..+||||+|||+|-||+|++||++.. +.+.+..+-...-
T Consensus 171 --~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~~Y------- 235 (592)
T KOG0575|consen 171 --DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLNEY------- 235 (592)
T ss_pred --cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhcCc-------
Confidence 3345667999999999999999999999999999999999999999998642 2222222222211
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..|........+||..+|+.+|.+|||+++|+.+-.+
T Consensus 236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 1233455678899999999999999999999998655
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=381.94 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=215.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC-eeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE-QRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 159 (427)
..+.+..++||+|..|+||+++++.+++.+|+|++..+.. ...+++.+|+++++..+||+||++||.|.... .+.|+|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 3456778899999999999999999999999999954432 34577899999999999999999999999988 599999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||++|+|++++... +.+++.....|+.+|++||.|||. .+ ||||||||+||||+..|.|||||||.++...
T Consensus 158 EYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred hhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 999999999998653 569999999999999999999996 77 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. ...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+.. ....+.+..+..+ ..+
T Consensus 231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~Ll~~Iv~~--ppP--- 300 (364)
T KOG0581|consen 231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFELLCAIVDE--PPP--- 300 (364)
T ss_pred hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHHHHHHhcC--CCC---
Confidence 22 4567899999999999999999999999999999999999999997642211 1222222222221 111
Q ss_pred ccccCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 319 DPLLQGEFPV-RGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+|. ....++.+++..||++||.+||++.++++|-+..+
T Consensus 301 ------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 301 ------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred ------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 1122 25678999999999999999999999999976543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-53 Score=388.81 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=212.2
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc-------hHHHHHHHHHHhhcCCCCeeeEEEEEEcCC
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG-------NKEFIVEVLMLSLLHHDNLVNLIGYCADGE 153 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 153 (427)
..+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..... .....+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 5678999999999999999999999999999999997653322 223578999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC---CCeeEee
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE---FNAKLSD 230 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkl~D 230 (427)
..|+||||+.||+|.+.+.. .+.+.+.....++.|++.||.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999864 456777778899999999999999999 9999999999999665 7799999
Q ss_pred cCCcccCCCCCccceeccccccccccCccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 042519 231 FGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ---LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 231 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
||+|+... ......+.||||.|.|||++.+.. +..++|+||+||+||-+|+|..||....... + ...++
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s---l~eQI 394 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S---LKEQI 394 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c---HHHHH
Confidence 99999733 445567899999999999998654 3458899999999999999999997542221 0 11111
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+ +.+. .....-....++..++|.+||..||++|||+.|++++-|.-
T Consensus 395 ~~--G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 395 LK--GRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred hc--Cccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 11 1110 00011235667899999999999999999999999998864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=378.83 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=205.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
..+|.+.+.||+|+||+||+|+++.++..||||.+.+.. ....+.+..|+.+|+.++|||||++++++.+.+.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467899999999999999999999999999999998764 334455788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC------CCeeEeecCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE------FNAKLSDFGL 233 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~------~~vkl~DFG~ 233 (427)
|||.||+|.+||+.. ..+++..+..++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999754 47999999999999999999999999 9999999999999764 4589999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
|+... ......+.||++-|||||++..++|+.|+|+||+|+|||+|++|+.||+...+. +... .++.+..
T Consensus 162 AR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~------eL~~-~~~k~~~ 231 (429)
T KOG0595|consen 162 ARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK------ELLL-YIKKGNE 231 (429)
T ss_pred hhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH------HHHH-HHhcccc
Confidence 99754 334556799999999999999999999999999999999999999999864432 2222 2222222
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
...... ......+.+++...++.++.+|-+..+-..+
T Consensus 232 ~~~~~~--------~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 232 IVPVLP--------AELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred ccCchh--------hhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 222221 1222234466666677777777666655443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-52 Score=380.31 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=213.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.++||+|+||+||.++.+++++.||+|++++..... .+....|..+|..++||.||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999999999999999998765543 34567899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
+||+.||.|..+|. ....+++..+.-++..|+.||.|||+++ ||||||||+|||||.+|+++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999995 4567889989999999999999999999 9999999999999999999999999999632
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.......++|||+.|||||++.+..|+..+|+||||+++|||++|.+||... +...+...+......
T Consensus 177 --~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~------~~~~~~~~I~~~k~~----- 243 (357)
T KOG0598|consen 177 --KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE------DVKKMYDKILKGKLP----- 243 (357)
T ss_pred --cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc------cHHHHHHHHhcCcCC-----
Confidence 2233455689999999999999999999999999999999999999999753 333344444333201
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHHHh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP----LMSDVVSALS 360 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP----s~~evl~~L~ 360 (427)
..+.-...+..+++...|+.||++|. ++.+|.++-.
T Consensus 244 ------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hpf 283 (357)
T KOG0598|consen 244 ------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPF 283 (357)
T ss_pred ------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcc
Confidence 11222345788999999999999995 4666655543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-53 Score=371.22 Aligned_cols=260 Identities=24% Similarity=0.366 Sum_probs=216.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEE-EEEcCCe-eEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIG-YCADGEQ-RLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 157 (427)
..+|+++++||+|+||+||++.+..+|..+|.|.++-...+ ..++...|+.+|++|+|||||++++ .|.++.. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35699999999999999999999999999999999754433 3466889999999999999999998 4555554 899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC-CCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN-PPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
|||+|.+|+|.+.++....+.+.+++..+|+++.|++.||..+|++-. ..|+||||||.||+|+.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999999888889999999999999999999999999431 2399999999999999999999999999997
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.. .........+|||.||+||.+.+.+|+.+|||||+||++|||+.-+.||... ++...-.. +.+ +.++.
T Consensus 178 l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~K-I~q-gd~~~ 247 (375)
T KOG0591|consen 178 LS--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKK-IEQ-GDYPP 247 (375)
T ss_pred hc--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHH-HHc-CCCCC
Confidence 43 3344456789999999999999999999999999999999999999999764 22221111 111 12211
Q ss_pred ccccccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 317 LADPLLQGEFP-VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 317 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.| ..+...+..+|..|+..||..||+...++..+.
T Consensus 248 ---------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 248 ---------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 22 567789999999999999999999655555553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=388.35 Aligned_cols=257 Identities=36% Similarity=0.528 Sum_probs=212.1
Q ss_pred CccccceeccCCceEEEEEEECCCCcE-EEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcCC-eeEEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQV-VAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADGE-QRLLVY 159 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 159 (427)
.+.+.+.||+|+||+||+|.++ |.. ||||++....... .+.|.+|+.+|.+|+|||||+++|+|.+.. ..++||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3455566999999999999998 455 9999997654333 458999999999999999999999999887 799999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-CeeEeecCCcccCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDFGLAKLGP 238 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DFG~a~~~~ 238 (427)
||+++|+|.++++.. ....+++..++.++.||++||.|||+++. ||||||||+||||+.++ ++||||||+++...
T Consensus 120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999764 46789999999999999999999999985 89999999999999997 99999999998632
Q ss_pred CCCccceeccccccccccCccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQR--TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....+... +..... .+.
T Consensus 196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~~-~~~--- 263 (362)
T KOG0192|consen 196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVVV-GGL--- 263 (362)
T ss_pred ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHh-cCC---
Confidence 211 2233478999999999999 56899999999999999999999999987654111 111111 111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+...+..+...+..++.+||+.||..||++.+++..|+.+..
T Consensus 264 ------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 264 ------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 112233366788899999999999999999999999997755
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=373.94 Aligned_cols=262 Identities=27% Similarity=0.321 Sum_probs=219.0
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCee
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 155 (427)
...++|.+++.||.|+|++|++|+.+.+++.||||++.+.... ....+..|-..|.+| .||.|++|+..|.|...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3457899999999999999999999999999999999775432 335567898999999 699999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
|+|+||+++|+|.++|.+. ..+++.....++.+|+.||+|||++| ||||||||+|||||.+|++||+|||.|+
T Consensus 150 YFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999765 46889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc---------ce--eccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 042519 236 LGPIGDKT---------HV--SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 236 ~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~ 304 (427)
........ .. ...++||..|.+||++..+..+..+|||+||||||+|+.|.+||...++- -..
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------liF 296 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------LIF 296 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------HHH
Confidence 75432221 11 14589999999999999999999999999999999999999999865421 112
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
+.++.-.- .++...+..+.+|+.+.|..||.+|++..+|.+|.-+-.-++
T Consensus 297 qkI~~l~y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 297 QKIQALDY------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred HHHHHhcc------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 22222111 223333467889999999999999999999999976554443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-50 Score=356.47 Aligned_cols=268 Identities=24% Similarity=0.283 Sum_probs=214.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
+.|+.+.++|+|+||+||+|++++||+.||||++..+..+. .+-..+|+.+|++|+|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999999999999999996654322 2446889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
||+. ++.+.|.. ....++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+....
T Consensus 82 ~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9984 55555654 3456888899999999999999999999 99999999999999999999999999997542
Q ss_pred CccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch--------hhhhhhhhhcCC
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN--------LVTWAQPFFKDP 311 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~--------~~~~~~~~~~~~ 311 (427)
.....+..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|....+.+.-. +..--+.+|...
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 4445677889999999998877 789999999999999999999999887655433211 111123344443
Q ss_pred CCCCcccccccCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 NRYPQLADPLLQG-----EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 ~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..+..+.-+.... ..-......+++++..||+.||.+|++-++++.+-
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 3333322222222 11223455889999999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=347.31 Aligned_cols=256 Identities=26% Similarity=0.333 Sum_probs=217.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch---HHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|+..+.||.|+||.|.+++.+.+|..||+|++++...... +...+|..+|+.+.||+++++++.|.+.+.+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4679999999999999999999999999999999987654433 4457799999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||++||.|..+|++ ..++++..+.-++.+|+.||+|||+++ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999975 356888999999999999999999999 9999999999999999999999999999743
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
. ...+.||||.|+|||++....|+.++|+|||||++|||+.|..||....+ ......+....-.++.
T Consensus 196 ~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~v~fP~-- 262 (355)
T KOG0616|consen 196 G-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGKVKFPS-- 262 (355)
T ss_pred C-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCcccCCc--
Confidence 2 25678999999999999999999999999999999999999999987655 2223333333333333
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCC-----CCHHHHHHHHhhcCCCCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVR-----PLMSDVVSALSFLGSDPD 367 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-----Ps~~evl~~L~~~~~~~~ 367 (427)
.....+.+|+...|+.|-.+| +...+|..|-|+-...+.
T Consensus 263 ----------~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 263 ----------YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred ----------ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 334477899999999999999 456677777776655543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=372.86 Aligned_cols=258 Identities=31% Similarity=0.436 Sum_probs=215.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
...+...+.||+|.||.||+|.+++ ...||+|.++.. ....+.|.+|+.+|++|+|+|||+++++|..++.++|||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 3456677899999999999999986 347999999665 34457788999999999999999999999998899999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
|+.|+|.++|.. .....+...+.+.++.||++|++||++++ +|||||-..||||++++.+||+|||+|+.. ..+
T Consensus 283 m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~ 356 (468)
T KOG0197|consen 283 MPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI-GDD 356 (468)
T ss_pred cccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc-CCC
Confidence 999999999986 35677888999999999999999999999 999999999999999999999999999942 222
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.........-..-|.|||.+..+.++.|||||||||+||||+| |+.|+...... + +...+..+.++
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------e-v~~~le~GyRl------ 423 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------E-VLELLERGYRL------ 423 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------H-HHHHHhccCcC------
Confidence 2223333445668999999999999999999999999999999 88888754321 1 11222223332
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..|..++..+++++..||+.+|++|||+..+...|+.+..
T Consensus 424 ----p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 ----PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ----CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 4477788999999999999999999999999999886644
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=370.20 Aligned_cols=257 Identities=26% Similarity=0.363 Sum_probs=217.6
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccC----CC-cchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN----GL-QGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQ 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 154 (427)
...+|.+.+.||+|+||+|++|.+..+|..||+|++++. .. ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 357899999999999999999999999999999988764 12 22345668999999999 9999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC-CCeeEeecCC
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGL 233 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkl~DFG~ 233 (427)
+++||||+.||+|.+++.. ..++.+..+..++.|++.||+|||+++ |+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999965 467888999999999999999999999 9999999999999999 9999999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCC-CC-ccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ-LT-VKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.. +.......+....
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRKIRKGE 239 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHHHhcCC
Confidence 98753 2334566789999999999999877 75 8899999999999999999999873 2223333333333
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
-.++..+. ...+..++.+||..+|.+|+++.+|+++-|...
T Consensus 240 ~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 FKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 33333221 457889999999999999999999998887765
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=377.33 Aligned_cols=243 Identities=27% Similarity=0.417 Sum_probs=209.8
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCee
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQR 155 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 155 (427)
...++|++.++||+|+||+|+++..+.+++.||||++++.... +.+..+.|..|+...+ ||.++.|+.+|...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3457899999999999999999999999999999999987654 3455677888887776 99999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
|+||||+.||++..+. ....+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999965544 4467999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
... .....++++||||.|+|||++.+..|+.++|+|||||+|||||.|..||...+..
T Consensus 517 e~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------- 574 (694)
T KOG0694|consen 517 EGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------- 574 (694)
T ss_pred ccC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------------
Confidence 743 2334577899999999999999999999999999999999999999999854322
Q ss_pred cccccccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 042519 316 QLADPLLQG--EFPVRGLNQAVAVSAMCVQEESSVRPLM 352 (427)
Q Consensus 316 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~ 352 (427)
+++|.++.. .+|.....+.+.+++++|..+|++|..+
T Consensus 575 e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222222222 3466677889999999999999999866
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=365.85 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=219.7
Q ss_pred HHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch---HHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 79 ATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 79 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
+...++|+++++||+|+||.||+|+.+.||..+|+|+++++..... ..+..|-.+|....+|+||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 3456789999999999999999999999999999999998766544 4467799999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
||||||++||++..+|. ....|++..+..++.+++.||+-||+.| +|||||||+|+|||..|++||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999995 4567999999999999999999999999 9999999999999999999999999984
Q ss_pred cCCC----------------------CCccc----ee-------------------ccccccccccCccccccCCCCccc
Q 042519 236 LGPI----------------------GDKTH----VS-------------------SRVMGTYGYCAPEYQRTGQLTVKS 270 (427)
Q Consensus 236 ~~~~----------------------~~~~~----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~ 270 (427)
-... .+... .. ...+|||.|+|||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 2110 00000 00 115799999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCccc-chhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 042519 271 DVYTFGVVLLELITGRRAIDTTRPTYE-QNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVR 349 (427)
Q Consensus 271 DvwSlGvil~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 349 (427)
|+||||||+||||.|.+||....|... ..+..|...+. ++. ......+..+||.+||. ||.+|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-----fP~----------~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-----FPE----------EVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-----CCC----------cCcccHHHHHHHHHHhc-CHHHh
Confidence 999999999999999999988766533 34555543221 111 11122678899999999 99999
Q ss_pred C---CHHHHHHHHhhcCCCCC
Q 042519 350 P---LMSDVVSALSFLGSDPD 367 (427)
Q Consensus 350 P---s~~evl~~L~~~~~~~~ 367 (427)
. .+.||.+|-++-.-.|+
T Consensus 434 LG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 434 LGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred cCcccHHHHhcCCccccCCcc
Confidence 7 48888888877666654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=354.52 Aligned_cols=267 Identities=26% Similarity=0.360 Sum_probs=218.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch-HHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN-KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.+.|++.++||.|..++||+|+...+++.||||+++....... ..+.+|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4679999999999999999999999999999999987655444 778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC-CC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG-PI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~-~~ 239 (427)
||.+|++.+.+..... ..+++..+..|+.++++||.|||.+| .||||||+.||||+.+|.|||+|||.+... ..
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999987643 45899999999999999999999999 999999999999999999999999986542 22
Q ss_pred CCcccee-ccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 240 GDKTHVS-SRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 240 ~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
+...... ..++||++|||||++.. ..|+.|+||||||++..||.+|+.||....|.. .+. .+-.+..+.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl------~tLqn~pp~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLL------LTLQNDPPT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHH------HHhcCCCCC
Confidence 3222223 66799999999999643 579999999999999999999999998776542 111 111122222
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+.-..+..+-.......+.+++..||+.||++|||+++++.+-.+
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 221111112222334578899999999999999999999987544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=371.52 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=216.8
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
-|++++.||.|+.|.|-+|++..||+.+|||++.+.... ....+.+|+.||+.+.|||++++|+++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 488999999999999999999999999999999765221 12447889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|.|++++.. .+++++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-
T Consensus 93 yv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe--- 162 (786)
T KOG0588|consen 93 YVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE--- 162 (786)
T ss_pred ecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc---
Confidence 9999999999964 567899999999999999999999999 999999999999999999999999999863
Q ss_pred CccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.....-.+.||+|.|+|||++.+.+| +.++||||+|||||.||+|+.||++ .++...+..... +.+
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV~~--G~f----- 229 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKVQR--GVF----- 229 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHHHc--Ccc-----
Confidence 23344567899999999999999988 5899999999999999999999984 334443332222 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+.|..+..++.+|+.+||..||++|.|++||++|.+-.+-
T Consensus 230 -----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 230 -----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred -----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 2234555688999999999999999999999999876554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=365.23 Aligned_cols=271 Identities=24% Similarity=0.320 Sum_probs=218.3
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHH--HHHHHHHhhcC-CCCeeeEEEEEEcCC-eeE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF--IVEVLMLSLLH-HDNLVNLIGYCADGE-QRL 156 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 156 (427)
.-++|.+.+.||.|+||.||+|+.+.+|..||||.+++.... .++. .+|+..|++|+ |||||+|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 457899999999999999999999999999999999766433 3443 57999999999 999999999999888 999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+|||||+ .+|.+.+++ ....+++..+..|+.||++||+|+|.+| +.||||||+|||+..+..|||+|||+|+.
T Consensus 87 fVfE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999998 799999887 4688999999999999999999999999 99999999999999899999999999996
Q ss_pred CCCCCccceeccccccccccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhh----------hhh
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT----------WAQ 305 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~----------~~~ 305 (427)
... ....+..+.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++.|....+.+.-...- |..
T Consensus 160 v~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 432 23456788999999999875 5789999999999999999999999997655432211110 100
Q ss_pred ---hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 306 ---PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 306 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..-.-.-.+++..-..+..-.+. ...++.+++..|++.||.+|||+.+++++--+..
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 00000112233332333323333 6778999999999999999999999999875543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=368.66 Aligned_cols=249 Identities=30% Similarity=0.416 Sum_probs=220.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..... .+.+.+|++|++.|+|||||.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46889999999999999999999999999999998765433 4568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+.| +|..+|. ....+++..+..|+.+++.||.|||+++ |+|||+||.|||++.+|.+|+||||+|+.. .
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m--~ 151 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAM--S 151 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhc--c
Confidence 9985 9999985 4567999999999999999999999999 999999999999999999999999999974 3
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
..+.+.+.+.|||-|||||...++.|+..+|+||+|||+|||++|++||-. ..+......+..++...
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~v~~------ 219 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDPVKP------ 219 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCCCCC------
Confidence 455667889999999999999999999999999999999999999999964 34555555555554333
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
|......+..++...|.+||.+|.+..+++.|-
T Consensus 220 ------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 220 ------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred ------cccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 335566888999999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=332.39 Aligned_cols=267 Identities=24% Similarity=0.328 Sum_probs=212.8
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.+|...++||+|.||.||+|++..+|+.||||+++.....+ .....+|+..|+.++|+||+.|+++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999999999999999997654332 2457899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
||+ .+|+..+++ ....+...++..++.++++||+|||+++ |+||||||.|+|++++|.+||+|||+++.....
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 998 799998876 5678899999999999999999999999 999999999999999999999999999986554
Q ss_pred CccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc----------
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK---------- 309 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 309 (427)
+... +..+.|.+|.|||.+.+ ..|+..+||||.|||+.||+.|.+-|....+-+ .+.... ..++
T Consensus 155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If-~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIF-RALGTPTPDQWPEM 229 (318)
T ss_pred Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHH-HHcCCCCcccCccc
Confidence 4333 33378999999998765 579999999999999999999887665443221 111111 1111
Q ss_pred ----CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 310 ----DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 310 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
+-..+.....+.+.. .-......+.+++..++..||.+|+++.|++++-.+-
T Consensus 230 ~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred cccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 001111122222222 2233455679999999999999999999999986543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=352.50 Aligned_cols=261 Identities=28% Similarity=0.417 Sum_probs=209.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC--eeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE--QRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 159 (427)
..+|...+.||+|+||.||++.+..+|...|||.+........+.+.+|+.+|.+|+|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345788899999999999999999999999999987653333667899999999999999999999754444 689999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-CCCeeEeecCCcccCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-EFNAKLSDFGLAKLGP 238 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkl~DFG~a~~~~ 238 (427)
||+++|+|.+++...+. .+++..+..+..||++||+|||+++ ||||||||+||||+. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999977432 6999999999999999999999999 999999999999999 7999999999988643
Q ss_pred C-CCccceeccccccccccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 239 I-GDKTHVSSRVMGTYGYCAPEYQRTGQ-LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 239 ~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
. ...........||+.|||||++..+. ...++|||||||++.||+||..||.... ....+....... ...+
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~-~~~P- 242 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGRE-DSLP- 242 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhcc-CCCC-
Confidence 2 12222234578999999999998633 3459999999999999999999997530 111111111111 1122
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+|...+....+++..|++.+|++|||+.+++++.....
T Consensus 243 --------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 243 --------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred --------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 334445678889999999999999999999999986543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=327.68 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=218.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++++.||+|.||.||+|+.+.++-.||+|++.++... -..++.+|+++.+.|+||||+++++||.+...+||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46799999999999999999999999999999999776532 235788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
+||.+.|+|...|... ....+++.....++.|++.||.|+|.++ |+||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999753 4466788888999999999999999999 9999999999999999999999999998633
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.....+.|||..|++||...+..++..+|+|++|++.||++.|.+||+... ..+..+.+.+-.-
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~------~~etYkrI~k~~~------ 239 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS------HSETYKRIRKVDL------ 239 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh------hHHHHHHHHHccc------
Confidence 334567899999999999999999999999999999999999999998643 1222222222211
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+|........++|..|+..+|.+|....|++++-|..
T Consensus 240 ------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 240 ------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred ------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 12344556888999999999999999999999987753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=352.10 Aligned_cols=266 Identities=25% Similarity=0.314 Sum_probs=210.3
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--CeeE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQRL 156 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 156 (427)
..+.|+.++.||+|.||.||+|++..+|+.||+|++..... .......+|+.||++|.||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 45679999999999999999999999999999999976542 3335568899999999999999999988876 6899
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
||+|||+ -+|..++.. ....+++.++..++.||+.||+|||+++ |+|||||.+|||||.+|.+||+|||+|++
T Consensus 195 lVFeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence 9999998 588887754 4567899999999999999999999999 99999999999999999999999999997
Q ss_pred CCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC---
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN--- 312 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 312 (427)
+...... ..+..+-|++|.|||.+.+ ..|+.++|+||+||||.||+.|++.|........ +..+|+.-+
T Consensus 268 y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ------l~kIfklcGSP~ 340 (560)
T KOG0600|consen 268 YTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ------LHKIFKLCGSPT 340 (560)
T ss_pred ccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH------HHHHHHHhCCCC
Confidence 5544332 3455678999999998876 5799999999999999999999998876543211 111111000
Q ss_pred -------CCC--ccccc------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 313 -------RYP--QLADP------LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 313 -------~~~--~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.++ ..+.+ .+.+. ........++|+..+|..||.+|.|+.++++.=.+
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 111 00110 01100 11223567889999999999999999999987543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=361.12 Aligned_cols=263 Identities=26% Similarity=0.370 Sum_probs=205.6
Q ss_pred hhCccccceeccCCceEEEEEEEC-----CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC-C
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE-----KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG-E 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 153 (427)
.++|++.++||+|+||.||+|.+. .++..||||++..... .....+.+|+.++..+ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 578999999999999999999852 3456899999865432 2335688899999999 899999999988764 4
Q ss_pred eeEEEEeecCCCChhhhhhhcCC---------------------------------------------------------
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGP--------------------------------------------------------- 176 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 176 (427)
.+++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 58899999999999999865321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccc
Q 042519 177 -EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255 (427)
Q Consensus 177 -~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y 255 (427)
....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1235788899999999999999999999 999999999999999999999999999753222211122234567889
Q ss_pred cCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHH
Q 042519 256 CAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQA 334 (427)
Q Consensus 256 ~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 334 (427)
+|||++.+..++.++|||||||++|||++ |..||....... ... ....+.... ..+......+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~-~~~~~~~~~----------~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFC-QRLKDGTRM----------RAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHH-HHHhcCCCC----------CCCCCCCHHH
Confidence 99999998899999999999999999997 999997543211 111 111111110 1122334578
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 335 VAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 335 ~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+++.+||+.||++||++.++++.|+.+.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=356.95 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=200.8
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.+|+..+.||+|+||.||+|++..+|+.||||++...... ....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 5577889999999999999999999999999998654322 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+.. ...+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~- 221 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT- 221 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc-
Confidence 9999986532 3456778889999999999999999 999999999999999999999999998763221
Q ss_pred ccceeccccccccccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRT-----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
........||..|+|||++.. ...+.++|||||||++|||++|+.||........ .......... .
T Consensus 222 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~--~--- 292 (353)
T PLN00034 222 -MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAICMS--Q--- 292 (353)
T ss_pred -cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhcc--C---
Confidence 112234579999999998753 2345689999999999999999999974322111 1100000000 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
....+......+.+++..||+.||++||++.|++++-+....
T Consensus 293 ------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 293 ------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 001122344678999999999999999999999999776554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=361.59 Aligned_cols=254 Identities=26% Similarity=0.370 Sum_probs=217.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
...|.....||+|..|.||.|+...+++.||||.+........+-+.+|+.+|+.++|+|||.+++.|..++.+++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 34678888999999999999999999999999999988777778899999999999999999999999888999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
|+||+|.+.+. ...+++.++..|+.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||++.......
T Consensus 352 m~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999884 455999999999999999999999999 9999999999999999999999999988643322
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
....+.+|||.|||||++....|++++||||||++++||+-|.+||-...|.....+ +.. +..+.+
T Consensus 424 --~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------Ia~-ng~P~l---- 489 (550)
T KOG0578|consen 424 --SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IAT-NGTPKL---- 489 (550)
T ss_pred --CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------Hhh-cCCCCc----
Confidence 246678999999999999999999999999999999999999999976443321111 111 111121
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..+......+.+++.+||+.|+.+|+++.|+|+|-.
T Consensus 490 ---k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 490 ---KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred ---CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 123445578899999999999999999999999853
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=348.08 Aligned_cols=262 Identities=26% Similarity=0.361 Sum_probs=212.5
Q ss_pred HHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--------------chHHHHHHHHHHhhcCCCCeee
Q 042519 79 ATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--------------GNKEFIVEVLMLSLLHHDNLVN 144 (427)
Q Consensus 79 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~ 144 (427)
....+.|++.+.||+|.||+|-+|++..+++.||||++.+.... ..+...+|+.+|++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34467899999999999999999999999999999999653221 1246788999999999999999
Q ss_pred EEEEEEc--CCeeEEEEeecCCCChhhhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC
Q 042519 145 LIGYCAD--GEQRLLVYEYMPLRSLEDHLLDIGPEQKP-IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD 221 (427)
Q Consensus 145 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~ 221 (427)
|+++..+ .+.+|||+|||..|.+... ....+ +++.++++++.+++.||+|||.++ ||||||||+|+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 9999876 4689999999998887543 23444 999999999999999999999999 99999999999999
Q ss_pred CCCCeeEeecCCcccCCCC---CccceeccccccccccCccccccCC----CCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 042519 222 CEFNAKLSDFGLAKLGPIG---DKTHVSSRVMGTYGYCAPEYQRTGQ----LTVKSDVYTFGVVLLELITGRRAIDTTRP 294 (427)
Q Consensus 222 ~~~~vkl~DFG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~ell~g~~p~~~~~~ 294 (427)
++|+|||+|||.+.....+ +........+|||.|+|||.+.++. .+.+.||||+||+||+|+.|+.||...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-- 322 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-- 322 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--
Confidence 9999999999998864332 1222234578999999999887632 357899999999999999999999753
Q ss_pred cccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 295 TYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
...+....+..++..++. ..++...+.+||+++|++||++|.++.+|..|.|....
T Consensus 323 ----~~~~l~~KIvn~pL~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 323 ----FELELFDKIVNDPLEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ----hHHHHHHHHhcCcccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 233333334444333332 22445688899999999999999999999999986554
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=358.32 Aligned_cols=264 Identities=29% Similarity=0.424 Sum_probs=212.0
Q ss_pred HHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 78 LATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 78 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.....+.+.+...||+|.||+||+|+|.++ ||||+++..... ..+.|.+|+..+++-+|.||+-+.|||.....
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 334455677889999999999999999875 999999765543 44779999999999999999999999998776
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
.||+.+|.|.+|+.+|+.. ...++..+.+.|+.||++|+.|||.++ |||||||..||||.++++|||+|||++.
T Consensus 463 AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999873 467889999999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCCccceeccccccccccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRT---GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
.-..-..........|...|||||+++. .+|++.+||||||+++|||++|..||.....+ +.+.. ...+.
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIifm-----VGrG~ 609 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIFM-----VGRGY 609 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEEE-----ecccc
Confidence 5222222222334568889999999864 47999999999999999999999999832211 11111 11111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 313 RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..++.. ....++++++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 610 l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 610 LMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111111 1134567789999999999999999999999998877655
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=347.36 Aligned_cols=251 Identities=21% Similarity=0.330 Sum_probs=214.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHH---HHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
..+|++.+.||+|.||+|-+|.....|+.||||.|+++.....++ +++|++||+.|+||||+.++.+|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 567999999999999999999999999999999998876665544 67899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||..+|.|.+|+. ....+++.++..++.||+.|+.|+|.++ ++|||||.+|||||.++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999995 4567999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLT-VKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
......++||+|-|.+||++++.+|. +.+|-|||||+||-|+.|..||+..+ ....+.++.. +.+.
T Consensus 205 ---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~--GaYr-- 271 (668)
T KOG0611|consen 205 ---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISR--GAYR-- 271 (668)
T ss_pred ---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhc--cccc--
Confidence 23456789999999999999999884 78999999999999999999998642 1222222211 1110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
....+....-||+|||..+|++|.|+.+|..+-|.
T Consensus 272 ---------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 272 ---------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred ---------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 11122345579999999999999999999999763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=347.63 Aligned_cols=251 Identities=25% Similarity=0.276 Sum_probs=208.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||+|.++.+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 368999999999999999999999999999999865422 23456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999864 346888999999999999999999999 99999999999999999999999999875322
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...........
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~------- 215 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAGKL------- 215 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCc-------
Confidence 1 22457999999999999989999999999999999999999999754321 11111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhcC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~~ 363 (427)
.++......+.+++.+||+.||.+||+ +.+++++-+...
T Consensus 216 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 216 -----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred -----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 112223457889999999999999995 999999877643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=343.19 Aligned_cols=258 Identities=26% Similarity=0.370 Sum_probs=208.1
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.|+..+.||+|+||.||+|.+..+|+.||+|.+...... ....+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378889999999999999999999999999998654322 22456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998887643 2346889999999999999999999999 999999999999999999999999999763222
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... . ........
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~-~~~~~~~~--------- 220 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--E-VDRRVKED--------- 220 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--H-HHHHhhcc---------
Confidence 1 2234579999999999999999999999999999999999999997643321110 0 11111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhcC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFLG 363 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~~ 363 (427)
...++......+.+|+..||+.||.+||+ +.+++++-+...
T Consensus 221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 00122234467889999999999999997 899998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=331.41 Aligned_cols=265 Identities=28% Similarity=0.331 Sum_probs=217.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHH---HHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.+.|++.+.||.|.-|+||+++.++++..+|+|++++......+. ...|.+||+.+.||.++.||..|+.+...|||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 456888999999999999999999999999999998876654443 45699999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
||||+||+|...++.+ ..+.+++..+..++..|+-||+|||-.| ||+|||||+||||.++|+|.|+||.++....
T Consensus 156 meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999998877664 5678899999999999999999999999 9999999999999999999999999874321
Q ss_pred C---------------------------------CCc---------------------cceeccccccccccCccccccC
Q 042519 239 I---------------------------------GDK---------------------THVSSRVMGTYGYCAPEYQRTG 264 (427)
Q Consensus 239 ~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~ 264 (427)
. ... ......++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 1 000 0011236799999999999999
Q ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCC
Q 042519 265 QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQE 344 (427)
Q Consensus 265 ~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 344 (427)
..+.++|+|+|||+|||||.|..||...... +.+. .++.++..++.. ......+.+||++.|.+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~--~Tl~----NIv~~~l~Fp~~----------~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK--ETLR----NIVGQPLKFPEE----------PEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCch--hhHH----HHhcCCCcCCCC----------CcchhHHHHHHHHHhcc
Confidence 9999999999999999999999999765322 2222 223333333321 13456788999999999
Q ss_pred CCCCCCC----HHHHHHHHhhcCCCCC
Q 042519 345 ESSVRPL----MSDVVSALSFLGSDPD 367 (427)
Q Consensus 345 ~P~~RPs----~~evl~~L~~~~~~~~ 367 (427)
||++|.. +.||.+|--+-+..|.
T Consensus 375 dP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred ChhhhhccccchHHhhcCccccCCChh
Confidence 9999998 9999998655544443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=329.91 Aligned_cols=274 Identities=22% Similarity=0.278 Sum_probs=213.9
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCeeE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQRL 156 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 156 (427)
..++|+..+.|++|+||.||+|+++.+++.||+|+++...... --...+|+.+|.+++|||||.+..+... -+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3467999999999999999999999999999999997654221 1335789999999999999999988764 46799
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+|||||+ .+|...+.... .++...++..+..|+++||+|||.++ |+||||||+|+|+...|.+||+|||+|+.
T Consensus 154 ~VMe~~E-hDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeHHHHH-hhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence 9999998 68988887643 67888899999999999999999999 99999999999999999999999999997
Q ss_pred CCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hhhh-------hhhh
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LVTW-------AQPF 307 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~~~-------~~~~ 307 (427)
+.. .....+..+-|.+|.|||.+.+ ..|+.+.|+||+|||+.||+++++.|......+..+ +... .++-
T Consensus 227 ygs--p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 227 YGS--PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred hcC--CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 543 3444567789999999998876 469999999999999999999999886544322111 1110 0110
Q ss_pred hcC-----CCCCCcccccccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 308 FKD-----PNRYPQLADPLLQGEFPVR-GLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 308 ~~~-----~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+.. .-.+++.....+...+... ..+.-++|+..+|..||.+|.|+++.+++=++..
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 100 0112222223333333332 4567889999999999999999999999866544
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=320.28 Aligned_cols=268 Identities=24% Similarity=0.283 Sum_probs=218.6
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC-----e
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE-----Q 154 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 154 (427)
...++|++.+.||+|||+-||+++.-.++..||+|++.....++.+..++|++..++++|||+++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 34678999999999999999999999999999999998887778888999999999999999999998775443 4
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.||++.|...|+|.+.+......+..+++.+++.|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999999887777788999999999999999999999987 57999999999999999999999999998
Q ss_pred ccCCCCCccce-------eccccccccccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 042519 235 KLGPIGDKTHV-------SSRVMGTYGYCAPEYQRT---GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 235 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~ 304 (427)
...+..-.... ......|..|.|||.+.- ...+.++|||||||+||+|+.|..||+....
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 76432221111 112346788999998863 4578999999999999999999999975322
Q ss_pred hhhhcCCCCCCcc-cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 305 QPFFKDPNRYPQL-ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 305 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.++.+.-. ....+.-.-....+..+.+++.+||+.||.+||++.+++..++.+.
T Consensus 247 -----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 -----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111110 1111111112236678999999999999999999999999998653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=349.77 Aligned_cols=252 Identities=27% Similarity=0.335 Sum_probs=208.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|+++.+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 3679999999999999999999999999999999875422 2345678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999864 346788889999999999999999999 9999999999999999999999999998642
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....+. ............
T Consensus 170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~----- 233 (329)
T PTZ00263 170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILAGRLK----- 233 (329)
T ss_pred CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCCcC-----
Confidence 21 22357999999999999999999999999999999999999999654321 111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhcC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~~ 363 (427)
++......+.+++..||+.||.+||+ +.+++.+-+.-.
T Consensus 234 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 234 -------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 11123356789999999999999996 799998876543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=348.56 Aligned_cols=246 Identities=24% Similarity=0.288 Sum_probs=202.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLR 165 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 165 (427)
++||+|+||.||+|+++.+|+.||||++.+... .....+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 479999999999999999999999999975432 22345678999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccce
Q 042519 166 SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV 245 (427)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 245 (427)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence 99998854 356889999999999999999999999 999999999999999999999999998752211 122
Q ss_pred eccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCC
Q 042519 246 SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGE 325 (427)
Q Consensus 246 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (427)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~------------~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEI------------R 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCCC------------C
Confidence 34467999999999999999999999999999999999999999653211 11111111111 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhh
Q 042519 326 FPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSF 361 (427)
Q Consensus 326 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~ 361 (427)
++......+.+++.+||+.||++|| ++.+++++-+.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f 254 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence 2233456788999999999999999 89999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=342.50 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=206.5
Q ss_pred hhCccccceeccCCceEEEEEEECC----------------CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK----------------TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVN 144 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 144 (427)
.++|++.++||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4679999999999999999998643 345799999875432 23456889999999999999999
Q ss_pred EEEEEEcCCeeEEEEeecCCCChhhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 042519 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP---------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209 (427)
Q Consensus 145 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 209 (427)
+++++.+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999998865321 1234778889999999999999999999 99
Q ss_pred eccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh--CCC
Q 042519 210 YRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT--GRR 287 (427)
Q Consensus 210 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~--g~~ 287 (427)
||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999976433332223334556889999999988899999999999999999987 556
Q ss_pred CCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 288 AIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 288 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
||...... .........+........ ...+..++..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQGRQVY-------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhcccccc-------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77643321 122222222211111000 0112234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.38 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=205.8
Q ss_pred hhCccccceeccCCceEEEEEEE-----CCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 154 (427)
.++|++.+.||+|+||.||+|.+ ..++..||||+++.... ...+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999974 34567899999865432 2345678899999999 79999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC----------------------------------------------------------
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGP---------------------------------------------------------- 176 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 176 (427)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999865321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc
Q 042519 177 -------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT 243 (427)
Q Consensus 177 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 243 (427)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1235788899999999999999999999 999999999999999999999999999764332221
Q ss_pred ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 244 HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...... ..... ........
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~----~~~~~~~~-------- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYK----MIKEGYRM-------- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHH----HHHhCccC--------
Confidence 22223345678999999999999999999999999999998 88888654221 11111 11111100
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+...+.++.+++..||+.||++||++.+|++.|+.
T Consensus 337 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 --LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0111224578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.90 Aligned_cols=258 Identities=25% Similarity=0.344 Sum_probs=210.3
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||+|++..+++.||||++.+... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368999999999999999999999999999999975422 23456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999854 346888999999999999999999999 99999999999999999999999999975322
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ-NLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 318 (427)
......||+.|+|||++.+..++.++|||||||++|||++|..||....+.... .+..|.. .+ ..+...
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~----~~~~~~ 223 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-TL----QRPVYD 223 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-cc----cCCCCC
Confidence 234567999999999999989999999999999999999999999764332110 0111100 00 001000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+ ........+.+++..||+.+|.+||++.+++++.+...
T Consensus 224 ~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 224 D------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred c------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 0 01234567889999999999999999999999876544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=364.24 Aligned_cols=262 Identities=23% Similarity=0.256 Sum_probs=215.2
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEE-EEc------C
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGY-CAD------G 152 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~ 152 (427)
...++++.++|.+|||+.||+|.+.+.|..||+|++...+....+.+.+|+.+|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3567899999999999999999999988999999998777778888999999999998 9999999993 221 2
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
-+++|.||||.||.|-+++..+.. ..|++.++++|+.++++||++||... +||||||||-+||||+.+|+.||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 367899999999999999987543 34999999999999999999999987 789999999999999999999999999
Q ss_pred CcccCCCCCccce-------eccccccccccCcccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 042519 233 LAKLGPIGDKTHV-------SSRVMGTYGYCAPEYQ---RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT 302 (427)
Q Consensus 233 ~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~ 302 (427)
.+......-.... .-...-|+.|+|||++ .+..++.|+|||+|||+||-|+....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 9864211110000 1123468999999977 4678999999999999999999999999864321
Q ss_pred hhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 042519 303 WAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365 (427)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 365 (427)
.+++....-.....+...+.+||+.||+.+|.+||++-+|+..+..+...
T Consensus 265 -------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 -------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 12222222222357888999999999999999999999999999877543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=345.36 Aligned_cols=250 Identities=28% Similarity=0.399 Sum_probs=211.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
..|+..+.||+|.||.||+|.+..+++.||+|+++.... ...+++.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 457777899999999999999999999999999986543 3457788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
|.||++.+.|.. ...+.+..+.-++.+++.||.|||.++ .+|||||+.||||..+|.+||+|||.+.....
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~-- 163 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN-- 163 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec--
Confidence 999999998843 334477778889999999999999999 99999999999999999999999999876432
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
......+++|||.|||||++....|+.|+||||||++.|||++|.+|+....|.... +- +++-.-+.
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl---------fl----Ipk~~PP~ 230 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL---------FL----IPKSAPPR 230 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE---------Ee----ccCCCCCc
Confidence 233346789999999999999889999999999999999999999999887663111 11 11112223
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
+.+ .....+.+++..||+.+|+.||++.+++.+
T Consensus 231 L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 LDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 332 344578899999999999999999999987
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=354.63 Aligned_cols=262 Identities=26% Similarity=0.368 Sum_probs=206.0
Q ss_pred hhCccccceeccCCceEEEEEEECCC-----CcEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT-----AQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 154 (427)
.++|++.+.||+|+||.||+|++... +..||||++...... ....+.+|+.+++.+ +|+||++++++|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 46799999999999999999986443 357999999754322 335678899999999 79999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC----------------------------------------------------------
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGP---------------------------------------------------------- 176 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 176 (427)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864211
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceecc
Q 042519 177 --------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR 248 (427)
Q Consensus 177 --------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 248 (427)
...++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1235788899999999999999999999 99999999999999999999999999875432222222223
Q ss_pred ccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCC
Q 042519 249 VMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFP 327 (427)
Q Consensus 249 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (427)
..+++.|+|||++.+..++.++|||||||++|+|++ |+.||....... .... ....... ...+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~~~~----------~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKRGYQ----------MSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHcccC----------ccCC
Confidence 345678999999988899999999999999999997 999997543211 1111 1111000 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 328 VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 328 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...+..+.+++..||+.||++||++.++++.|+.+
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 12246788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=346.02 Aligned_cols=247 Identities=23% Similarity=0.295 Sum_probs=202.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLR 165 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 165 (427)
++||+|+||.||+++++.+|..||+|++.+... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 479999999999999999999999999975432 23356778999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccce
Q 042519 166 SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV 245 (427)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 245 (427)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 99988854 346889999999999999999999999 999999999999999999999999998753211 122
Q ss_pred eccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCC
Q 042519 246 SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGE 325 (427)
Q Consensus 246 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (427)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........... .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~~------------~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEDI------------K 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCCc------------c
Confidence 33467999999999999889999999999999999999999999753221 11111111111 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhc
Q 042519 326 FPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFL 362 (427)
Q Consensus 326 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~ 362 (427)
++......+.+++.+||+.||++|| ++.+++++.+..
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 255 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 1223345788999999999999997 899999886543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=345.25 Aligned_cols=248 Identities=25% Similarity=0.308 Sum_probs=202.9
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLR 165 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 165 (427)
++||+|+||.||+++++.+|..||+|++..... .....+.+|+.+++.++||||++++++|...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 479999999999999999999999999975422 23345678999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccce
Q 042519 166 SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV 245 (427)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 245 (427)
+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCc
Confidence 99988854 346889999999999999999999999 999999999999999999999999998752221 112
Q ss_pred eccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCC
Q 042519 246 SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGE 325 (427)
Q Consensus 246 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (427)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~~~~~------------ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEEIR------------ 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCCC------------
Confidence 23467999999999999999999999999999999999999999754321 111111111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcC
Q 042519 326 FPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLG 363 (427)
Q Consensus 326 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~ 363 (427)
++......+.+++..||+.||.+|| ++.+++++-+...
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 1223346788999999999999998 8999998865544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=364.16 Aligned_cols=255 Identities=22% Similarity=0.257 Sum_probs=210.0
Q ss_pred CccccceeccCCceEEEEEEECCC-CcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKT-AQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
.|.+.+.||+|+||.||+|....+ +..||+|.+..........+.+|+.+++.++||||++++++|..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 489999999999999999998877 7889999876554444556788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++|+|.+++........++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988765445567899999999999999999999999 99999999999999999999999999986433322
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .......... ...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~--~~~------- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYG--KYD------- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC--CCC-------
Confidence 2234556799999999999999999999999999999999999999965321 1111111111 110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..+......+.+++..||+.+|++||++.+++.+
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1122334678899999999999999999998764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=345.18 Aligned_cols=269 Identities=22% Similarity=0.273 Sum_probs=210.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||.||++++..+|..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999999999999999875432 223568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+. |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999864 3458899999999999999999998632 999999999999999999999999998753221
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh-hhhcCCCCCC----
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ-PFFKDPNRYP---- 315 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~---- 315 (427)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +..... +.........
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccC
Confidence 2234579999999999999899999999999999999999999996543211 111000 0000000000
Q ss_pred ------------------------ccccccc----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 316 ------------------------QLADPLL----QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 316 ------------------------~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+.+... ...........+.+++.+||+.||++|||+.+++++.+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 0000000 00001124567899999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=369.60 Aligned_cols=263 Identities=27% Similarity=0.427 Sum_probs=221.3
Q ss_pred hhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
..+.+..+.||+|.||+||+|+..+ ....||||.++..... ...+|++|++++..|+|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3455667889999999999998743 3467999999876555 678999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCC------C----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC
Q 042519 156 LLVYEYMPLRSLEDHLLDIGP------E----QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN 225 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 225 (427)
++|+|||..|+|.++|..... . ..+++..+.+.|+.|||.|+.||-++. +|||||-..|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999975432 1 234889999999999999999999999 999999999999999999
Q ss_pred eeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 042519 226 AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 226 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~ 304 (427)
|||+|||+++.....+.........-...||+||.+..++||.+||||||||+|||+++ |+.||...... . +
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---E----V 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---E----V 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---H----H
Confidence 99999999997666666555545556778999999999999999999999999999999 99988754321 1 1
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
....+++.. -..|.+++..++.|+..||+.+|++||+++||-..|+....
T Consensus 715 Ie~i~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IECIRAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 122222211 24477888999999999999999999999999999986544
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=342.92 Aligned_cols=244 Identities=27% Similarity=0.312 Sum_probs=200.4
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 91 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
||+|+||.||+|++..+++.||+|++.+.. ......+..|+.++..++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986532 22345577899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceec
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 247 (427)
.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccc
Confidence 999864 346889999999999999999999999 999999999999999999999999998753221 12234
Q ss_pred cccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCC
Q 042519 248 RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFP 327 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (427)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ............. ++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~~~------------~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEPLR------------FP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCC------------CC
Confidence 56799999999999999999999999999999999999999975321 2222222222111 12
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHhh
Q 042519 328 VRGLNQAVAVSAMCVQEESSVRPL---MSDVVSALSF 361 (427)
Q Consensus 328 ~~~~~~l~~li~~cl~~~P~~RPs---~~evl~~L~~ 361 (427)
......+.+++..||+.||.+||+ +.+++.+-+.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~ 250 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCc
Confidence 233457889999999999999975 6777776543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=338.36 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=203.8
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|++.+.||.|+||.||+|+++.++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 569999999999999999999999999999999865432 2334677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 98 5998888642 345788899999999999999999999 9999999999999999999999999987532221
Q ss_pred ccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhh-hhh-------hhhhcCCC
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV-TWA-------QPFFKDPN 312 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~-~~~-------~~~~~~~~ 312 (427)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ... ++.+....
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 12234568999999998865 56899999999999999999999999754322111000 000 00000000
Q ss_pred CCCcccccccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 313 RYPQLADPLLQGE----FPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 313 ~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.+.....+..... ........+.+++..||+.||.+|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 0001110000000 0112245678999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=338.88 Aligned_cols=269 Identities=23% Similarity=0.306 Sum_probs=204.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||.||+|+++.+++.||||++...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46799999999999999999999999999999998754322 23456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+. ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 688887764 2356888899999999999999999999 999999999999999999999999998753221
Q ss_pred CccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC-------
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN------- 312 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 312 (427)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....+... ...........+.
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred --CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccch
Confidence 122234568999999998865 4588999999999999999999999976432211 1110100000000
Q ss_pred -CCCcccccccCCCCC---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 313 -RYPQLADPLLQGEFP---------VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 313 -~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+...........+ ......+.+++..||+.||++|||+.+++++-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 000000000000000 0123467899999999999999999999998664
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=338.14 Aligned_cols=268 Identities=20% Similarity=0.264 Sum_probs=205.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||.||+|+++.++..||+|++..... .....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 469999999999999999999999999999999875432 234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|++++.|..+. . ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~-~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLE-E---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHH-h---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99977665443 2 2346889999999999999999999999 999999999999999999999999999864322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hhhh--------hhhhhcCC
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LVTW--------AQPFFKDP 311 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~~~--------~~~~~~~~ 311 (427)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +... ...+..+
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN- 231 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc-
Confidence 21 12234578999999999998899999999999999999999999997643221100 0000 0000111
Q ss_pred CCCCcccccccCC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 NRYPQLADPLLQG------EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 ~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
........+.... .........+.+++.+||+.||++|||+.+++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp 285 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 0000000010000 11112446799999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=347.94 Aligned_cols=253 Identities=24% Similarity=0.308 Sum_probs=217.3
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe-eEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ-RLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 159 (427)
++|...+++|+|+||.+++++++..+..|++|.+...... ..+....|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5799999999999999999999999999999999765433 33467889999999999999999999998888 99999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
+||+||+|.+.+.... ..-+++..+..++.|++.||.|||++. |+|||||+.|||++.++.|+|+|||+|+....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998753 567899999999999999999999988 99999999999999999999999999997543
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.. ......+||+.|++||++.+.+|+.|+|||||||++|||++-+++|...+. ......+...
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~Li~ki~~~--------- 221 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SELILKINRG--------- 221 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HHHHHHHhhc---------
Confidence 32 345678999999999999999999999999999999999999999986432 1222222111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.....+..+..++..++..||+.+|+.||++.+++.+.
T Consensus 222 --~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 222 --LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred --cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 12234566778999999999999999999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=336.46 Aligned_cols=245 Identities=21% Similarity=0.337 Sum_probs=199.5
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEc----CCeeEEEEee
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCAD----GEQRLLVYEY 161 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 161 (427)
..||+|++|.||+|.+. |+.||||.+....... .+.+.+|+.++.+++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 67999999999999984 8899999997654333 3567799999999999999999999876 4578999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
+++|+|.+++.. ...+++...+.++.+++.||.|||+. + ++||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999864 34688999999999999999999985 6 889999999999999999999999998753221
Q ss_pred CccceeccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .............
T Consensus 177 -----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~---- 241 (283)
T PHA02988 177 -----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKNNSL---- 241 (283)
T ss_pred -----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCCCC----
Confidence 123468899999999976 68999999999999999999999999754321 1111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 242 ------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 ------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 122234567899999999999999999999999998654
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=333.08 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=204.8
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 91 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
||+|+||+||++.++.+|+.||+|.+...... ..+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998654322 224567899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceec
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 247 (427)
..++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9888654445567899999999999999999999999 9999999999999999999999999987533222 1233
Q ss_pred cccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCC
Q 042519 248 RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFP 327 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (427)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ............. ..+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~------------~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILNDSV------------TYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcccCC------------CCc
Confidence 45799999999999999999999999999999999999999975432111 1111111111110 122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcC
Q 042519 328 VRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLG 363 (427)
Q Consensus 328 ~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~ 363 (427)
......+.+++..||+.||++|| ++.+++++-+.-.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 33456788999999999999999 7788888765533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.62 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=200.8
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHH---hhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLML---SLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
|++.+.||+|+||.||+|.++.+|+.||||++.+... ...+.+..|..++ ..++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 6788999999999999999999999999999975421 2234455665554 567799999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999988874 346899999999999999999999999 9999999999999999999999999987522
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. .......+|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+......
T Consensus 153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~~----- 219 (324)
T cd05589 153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDEVR----- 219 (324)
T ss_pred CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-----
Confidence 21 12234567999999999999999999999999999999999999999754321 111112211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSF 361 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~ 361 (427)
++......+.+++.+||+.||.+|| ++.+++++.+.
T Consensus 220 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f 260 (324)
T cd05589 220 -------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260 (324)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence 1222346778999999999999999 68888877543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.67 Aligned_cols=258 Identities=24% Similarity=0.292 Sum_probs=210.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE------ 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 153 (427)
.++|.+.+.||+|+||+||+|++..+|+.||||++..... .....+.+|+.++..++|+||+++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 4689999999999999999999999999999999876533 23345778999999999999999988775432
Q ss_pred --eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 154 --QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 154 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEec
Confidence 368999999999999999765555667899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
|+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~~- 260 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLAG- 260 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcC-
Confidence 999864333222334457899999999999999999999999999999999999999975321 1222221111
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
... ..+......+.+++..||+.+|.+||++.+++++-
T Consensus 261 -~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 261 -RYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred -CCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 110 12233456788999999999999999999999864
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=334.74 Aligned_cols=259 Identities=29% Similarity=0.460 Sum_probs=209.8
Q ss_pred hCccccceeccCCceEEEEEEECCCC-----cEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTA-----QVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
++|++.+.||+|+||.||+|.....+ ..||+|.+..... .....+.+|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 56899999999999999999986655 6799999865432 22356788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC
Q 042519 157 LVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF 224 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 224 (427)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||+++ |+|+||||+|||++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999875421 1156888999999999999999999999 99999999999999999
Q ss_pred CeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 042519 225 NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTW 303 (427)
Q Consensus 225 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~ 303 (427)
.++|+|||+++.....+.........+++.|+|||++.+..++.++|||||||++|||++ |..||....+. .+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999976433332223344567889999999988899999999999999999998 99998754321 11111
Q ss_pred hhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 304 AQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.... ... ..+..++..+.+++..||+.+|.+||++.+|+++|..
T Consensus 239 ----i~~~-~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRSR-QLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcC-CcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1110 000 1233456789999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.65 Aligned_cols=254 Identities=24% Similarity=0.257 Sum_probs=215.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch---HHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 157 (427)
...|++.+.||+|.||.||+++.+.+|+.+|+|.+.+...... ..+.+|+.+|+.+. |||||.+++.|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4679999999999999999999999999999999987665443 57899999999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC----CCeeEeecCC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE----FNAKLSDFGL 233 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~vkl~DFG~ 233 (427)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999764 3999999999999999999999999 9999999999999533 5799999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... ......-
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-
Confidence 997543 445667899999999999999999999999999999999999999998654321111 1111111
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
......-......+.+++..||..||.+|+++.++++|.|
T Consensus 256 -------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 256 -------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred -------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1111122334568889999999999999999999999866
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=343.42 Aligned_cols=248 Identities=25% Similarity=0.308 Sum_probs=201.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLR 165 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 165 (427)
+.||+|+||.||++.+..+|..||+|++.+... .....+..|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 479999999999999999999999999975422 22345677999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 166 SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GA 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cc
Confidence 99988853 3468999999999999999999997 68 999999999999999999999999998753211 11
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ............
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~~~~----------- 214 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEIR----------- 214 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcCCCC-----------
Confidence 223467999999999999999999999999999999999999999653321 111111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcC
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLG 363 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~ 363 (427)
++......+.+++.+||+.||++|+ ++.+++++.+...
T Consensus 215 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 215 -FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 1222345788999999999999996 8999998865543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.93 Aligned_cols=259 Identities=24% Similarity=0.272 Sum_probs=203.3
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.|++.+.||+|+||+||+|++..+++.||||++.+... .....+..|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58899999999999999999999999999999976432 223567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999864 345888899999999999999999999 999999999999999999999999997532100
Q ss_pred Cc---------------------------------------------cceeccccccccccCccccccCCCCccchHHHH
Q 042519 241 DK---------------------------------------------THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTF 275 (427)
Q Consensus 241 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 275 (427)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHH--ccCCCCCCCCCHH
Q 042519 276 GVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAM--CVQEESSVRPLMS 353 (427)
Q Consensus 276 Gvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~P~~RPs~~ 353 (427)
||++|||++|..||....+.... .......... .+ .........+.+++.+ |+..++..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~-~~-------~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ------LKVINWENTL-HI-------PPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH------HHHHcccccc-CC-------CCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999999764432111 0011000000 00 0011223567778876 5666777799999
Q ss_pred HHHHHHhhcC
Q 042519 354 DVVSALSFLG 363 (427)
Q Consensus 354 evl~~L~~~~ 363 (427)
+++.+-+.-.
T Consensus 301 ~~l~hp~f~~ 310 (381)
T cd05626 301 DIKAHPFFSE 310 (381)
T ss_pred HHhcCcccCC
Confidence 9999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=343.93 Aligned_cols=252 Identities=24% Similarity=0.283 Sum_probs=206.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCC-cEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTA-QVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|.+.+.||+|+||.||+|.++.++ ..||+|++..... .....+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457999999999999999999976654 6899999865422 234567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999864 346889999999999999999999999 999999999999999999999999999863
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||....+. ............
T Consensus 182 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~~~---- 246 (340)
T PTZ00426 182 DT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGIIY---- 246 (340)
T ss_pred CC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCCCC----
Confidence 22 123467999999999999888999999999999999999999999754321 111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcC
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLG 363 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~ 363 (427)
++......+.+++.+||+.+|++|+ ++.+++++-+.-.
T Consensus 247 --------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 247 --------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred --------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 1222335678999999999999995 8999999876543
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=345.78 Aligned_cols=265 Identities=18% Similarity=0.206 Sum_probs=203.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
..+|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.|+||||++++++|......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999999999999999753 23467899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~- 235 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI- 235 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence 96 788888754 346889999999999999999999999 999999999999999999999999999752211
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc-----chhhhhhhhhhcCCCCCCc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE-----QNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 316 (427)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||-....... ..+.......-..+..++.
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 11223346799999999999998999999999999999999999988743221110 0000000000000000000
Q ss_pred --------c---------cccccCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 317 --------L---------ADPLLQGEF--PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 317 --------~---------~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+ ..+.....+ ....+..+.+++.+||+.||.+|||+.|++++-+.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 0 000000000 01235578899999999999999999999998765
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=323.44 Aligned_cols=269 Identities=22% Similarity=0.311 Sum_probs=208.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCC-eeeEEEEEEcCC-----
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDN-LVNLIGYCADGE----- 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 153 (427)
...|...++||+|+||+||+|+.+.+|+.||+|++...... .-....+|+.+++.|+|+| ||.|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577778899999999999999999999999999765442 2245689999999999999 999999999877
Q ss_pred -eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 154 -QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 154 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
.+++|+||+. -+|.+++.........++...+..+..||+.||+|||+++ |+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7899999998 7999999876543356777889999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
+|+..... ....+..++|.+|.|||++.+. .|+...||||+|||++||++++.-|....+.. .+.. ....++-+
T Consensus 166 lAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~-If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFR-IFRLLGTP 240 (323)
T ss_pred hHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHH-HHHHcCCC
Confidence 99964322 2234567899999999999876 79999999999999999999999887654311 1111 11111111
Q ss_pred --CCCCccc---cc--ccCCCC-CH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 --NRYPQLA---DP--LLQGEF-PV-------RGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 --~~~~~~~---~~--~~~~~~-~~-------~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
...+.+. +- ...... +. .......+++.+||+.+|.+|.|+..+++|-
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 1111110 00 000000 11 1114788999999999999999999999984
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.18 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=202.4
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||.||+|+++.+++.||+|++++... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 479999999999999999999999999976432 2234577899999888 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 999988753 356899999999999999999999999 999999999999999999999999998742211 12
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc--cchhhhhhhh-hhcCCCCCCcccccc
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY--EQNLVTWAQP-FFKDPNRYPQLADPL 321 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~ 321 (427)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||+...... ......+... .......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 223 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-------- 223 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--------
Confidence 2345679999999999999999999999999999999999999997432211 1111122211 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHhhc
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPL------MSDVVSALSFL 362 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs------~~evl~~L~~~ 362 (427)
.+......+.+++..||+.||.+|++ +.+++++-+..
T Consensus 224 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~ 266 (329)
T cd05588 224 ----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266 (329)
T ss_pred ----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 12223457889999999999999997 78888876553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=337.90 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=202.0
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCC-CCeeeEEEEEEcCCeeEEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHH-DNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 159 (427)
+|++.+.||+|+||.||+|+++.+++.||||++.+.. ....+.+..|..++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4889999999999999999999999999999987542 2234557788899998876 46888999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998854 345788999999999999999999999 99999999999999999999999999874222
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...........
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~~------- 218 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQSIMEHNV------- 218 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCC-------
Confidence 11 1233467999999999999999999999999999999999999999754321 11111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM-----SDVVSALS 360 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~~L~ 360 (427)
.++......+.+++.+||+.+|.+|++. .+++++-+
T Consensus 219 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~ 259 (324)
T cd05587 219 -----SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAF 259 (324)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCC
Confidence 1122234578899999999999999986 67776643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=330.46 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=205.4
Q ss_pred hhCccccceeccCCceEEEEEEEC---CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|.++ ..+..||+|.++.... .....+.+|+.++..++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467999999999999999999875 4467899999876432 223568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998652 346899999999999999999999999 999999999999999999999999987642
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... ..... ..+....
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~-~~~~~~~-- 227 (266)
T cd05064 158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKA-VEDGFRL-- 227 (266)
T ss_pred cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHH-HHCCCCC--
Confidence 2111 111122345678999999999999999999999999999875 99999754321 11111 1111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+..++..+.+++..||+.+|.+||++.+|++.|..+
T Consensus 228 --------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11233456788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=349.21 Aligned_cols=259 Identities=23% Similarity=0.281 Sum_probs=205.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 468999999999999999999999999999999975422 22345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999864 345899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCccc------------------------------------eeccccccccccCccccccCCCCccchHHHHHHHHHHHH
Q 042519 240 GDKTH------------------------------------VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELI 283 (427)
Q Consensus 240 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 283 (427)
..... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 011346999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHh
Q 042519 284 TGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL---MSDVVSALS 360 (427)
Q Consensus 284 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~~L~ 360 (427)
+|..||....+.. ...........+ .... .......+.+++..|+. +|.+|++ +.+++++-+
T Consensus 234 ~G~~Pf~~~~~~~------~~~~i~~~~~~~-~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 234 VGYPPFCSDNPQE------TYRKIINWKETL-QFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred cCCCCCCCCCHHH------HHHHHHcCCCcc-CCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 9999997643221 111111100000 0000 01223567789999996 9999998 999999866
Q ss_pred hcC
Q 042519 361 FLG 363 (427)
Q Consensus 361 ~~~ 363 (427)
...
T Consensus 299 ~~~ 301 (364)
T cd05599 299 FKG 301 (364)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=338.00 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=200.1
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||.||+|+++.+++.||||++.+.. ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987542 22335566788888766 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 999988854 346889999999999999999999999 999999999999999999999999998753211 12
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~----------- 214 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEVV----------- 214 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCCCC-----------
Confidence 234567999999999999989999999999999999999999999754321 112222221111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHhh
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLM------SDVVSALSF 361 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~~L~~ 361 (427)
.+......+.+++..||+.||.+||++ .+++++-+.
T Consensus 215 -~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f 256 (320)
T cd05590 215 -YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256 (320)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence 122234578899999999999999998 777777554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=343.35 Aligned_cols=242 Identities=26% Similarity=0.388 Sum_probs=204.8
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
++-||.|+.|.||+|+.+ ++.||||+++.- -..++..|++|+|+||+.+.|+|.....+|||||||..|-|
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 456999999999999998 788999987422 23478889999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceec
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 247 (427)
...|+. ..++.......+..+|+.|+.|||.+. |||||||.-||||..+..|||+|||.++..... ....
T Consensus 200 ~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 200 YEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 999964 566777888899999999999999999 999999999999999999999999999863222 2344
Q ss_pred cccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCC
Q 042519 248 RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFP 327 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (427)
.++||..|||||++.+.+.+.|+|||||||+|||||||..||.+.... ..- +.-+ ...+.-..|
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AII-----wGVG-------sNsL~LpvP 333 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AII-----WGVG-------SNSLHLPVP 333 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeE-----Eecc-------CCcccccCc
Confidence 589999999999999999999999999999999999999999754321 111 1111 223333456
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 328 VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 328 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+++.+.-|++.||+..|..||++++|+.||+....
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 6778899999999999999999999999999986654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=338.96 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=207.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcE----EEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQV----VAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
..+|++.+.||+|+||.||+|++..++.. ||+|.+..... ...+.+.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 35699999999999999999998766654 89999865432 3346788899999999999999999999865 567
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999998752 345888899999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..............++..|+|||++.+..++.++|||||||++|||++ |..||...... .+. .........+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~~ 231 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS----SILEKGERLP 231 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHhCCCCCC
Confidence 443322222223345678999999999999999999999999999998 99998754221 111 1112111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
. +..+...+.+++..||+.+|.+||++.+++..|..+...+
T Consensus 232 ~----------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 232 Q----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred C----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1 1123356889999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=325.81 Aligned_cols=262 Identities=21% Similarity=0.317 Sum_probs=212.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||+|++..+++.||||.+..... .....+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 579999999999999999999999999999998764322 22345788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.........+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988765444566889999999999999999999999 99999999999999999999999999876432
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.. .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...... ...+.... ... ..+.
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~-~~~-~~~~--- 227 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKI-EQC-DYPP--- 227 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHH-hcC-CCCC---
Confidence 21 1122356888999999998888999999999999999999999998643211 11111111 110 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.........+.+++.+||+.+|++||++.+|++.|+.++
T Consensus 228 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 -----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 112234567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=330.08 Aligned_cols=263 Identities=25% Similarity=0.348 Sum_probs=206.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC-----eeEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE-----QRLL 157 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 157 (427)
-.|...+++|.|+||.||.|....+++.||||+.-.+. +.-.+|+.+|+.+.|||||+|..+|.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34778899999999999999999999999999975432 23347999999999999999998886432 3468
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC-CCeeEeecCCccc
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLAKL 236 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkl~DFG~a~~ 236 (427)
|||||+ .+|.+.++.....+..++...+.-+..||.+||.|||+.+ |+||||||+|||+|.+ |.+||||||.|+.
T Consensus 100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999999 7999999876666778888889999999999999999999 9999999999999977 8999999999998
Q ss_pred CCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC-----
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD----- 310 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 310 (427)
...+... ....-|..|+|||.+.+ ..|+.+.||||.||++.||+.|+.-|...... ..++.... .++-
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik-~lG~Pt~e~ 249 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIK-VLGTPTRED 249 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHH-HhCCCCHHH
Confidence 5544433 33456778999998765 57999999999999999999999999764322 22222211 1111
Q ss_pred ---------CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 311 ---------PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 311 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
...++++.......-+......++.+++.++|+.+|.+|.++.|++.+-
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 1122333322222224455667899999999999999999999999764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=347.58 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=207.5
Q ss_pred hhCccccceeccCCceEEEEEEECCC-----CcEEEEEEeccCCC-cchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT-----AQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 154 (427)
.++|++.++||+|+||.||+|.+... +..||||++..... ...+.+.+|+.++..+. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 56799999999999999999987533 34699999965433 23456889999999996 9999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC----------------------------------------------------------
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGP---------------------------------------------------------- 176 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 176 (427)
.+|||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998865321
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC
Q 042519 177 ----------------------------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC 222 (427)
Q Consensus 177 ----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 222 (427)
....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 1134788888999999999999999999 999999999999999
Q ss_pred CCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 042519 223 EFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLV 301 (427)
Q Consensus 223 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~ 301 (427)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~- 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF- 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH-
Confidence 99999999999875432222222233457788999999998899999999999999999997 99998653211 001
Q ss_pred hhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 302 TWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.......... ..+...+..+.+++..||+.+|++||++.+|.++|+.+.
T Consensus 350 ---~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 ---YNKIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHHHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0111111111 112234567899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=346.27 Aligned_cols=257 Identities=25% Similarity=0.304 Sum_probs=209.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||+|++..+|+.||||++..... .....+..|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 468999999999999999999999999999999975422 33456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999998653 56889999999999999999999999 99999999999999999999999999875432
Q ss_pred CC---------------------------ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 042519 240 GD---------------------------KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTT 292 (427)
Q Consensus 240 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~ 292 (427)
.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001223457999999999999999999999999999999999999999765
Q ss_pred CCcccchhhhhhhhhhc--CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhhcC
Q 042519 293 RPTYEQNLVTWAQPFFK--DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-MSDVVSALSFLG 363 (427)
Q Consensus 293 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~~L~~~~ 363 (427)
.... ....+.. ....++. .......+.+++..||+ +|.+||+ +.+++++.+...
T Consensus 234 ~~~~------~~~~i~~~~~~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 234 TLQE------TYNKIINWKESLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred CHHH------HHHHHhccCCcccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 4211 1111111 1111111 01134678899999997 9999999 999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=352.15 Aligned_cols=272 Identities=19% Similarity=0.292 Sum_probs=199.6
Q ss_pred HHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCC------CCeeeEEEEEEc
Q 042519 78 LATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH------DNLVNLIGYCAD 151 (427)
Q Consensus 78 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 151 (427)
+....++|++.++||+|+||+||+|.+..+++.||||+++... .....+..|+.++..++| .++++++++|..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3344678999999999999999999999999999999986432 223445667777776654 458999998876
Q ss_pred C-CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCC-----
Q 042519 152 G-EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEF----- 224 (427)
Q Consensus 152 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~----- 224 (427)
. ...++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 4 5788999988 5788888864 3468999999999999999999998 48 99999999999998765
Q ss_pred -----------CeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 042519 225 -----------NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTR 293 (427)
Q Consensus 225 -----------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~ 293 (427)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999876421 12345689999999999999999999999999999999999999997644
Q ss_pred Ccccchhhh---------hh--------hhhhcCCCCCCccccc-----ccCCC--CCHHHHHHHHHHHHHccCCCCCCC
Q 042519 294 PTYEQNLVT---------WA--------QPFFKDPNRYPQLADP-----LLQGE--FPVRGLNQAVAVSAMCVQEESSVR 349 (427)
Q Consensus 294 ~~~~~~~~~---------~~--------~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~l~~li~~cl~~~P~~R 349 (427)
......... |. ..++.....+....++ ..... ........+.+||..||+.||.+|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 321111100 00 0001000000000000 00000 001123467899999999999999
Q ss_pred CCHHHHHHHHhhcC
Q 042519 350 PLMSDVVSALSFLG 363 (427)
Q Consensus 350 Ps~~evl~~L~~~~ 363 (427)
||+.|+++|-+...
T Consensus 430 ~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 430 LNARQMTTHPYVLK 443 (467)
T ss_pred CCHHHHhcCccccc
Confidence 99999999876654
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=338.55 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=200.4
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||.||+|+++.+++.||+|++.+... .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976432 2234567788888776 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CC
Confidence 999888753 356899999999999999999999999 999999999999999999999999998752211 11
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc--cchhhhhhhh-hhcCCCCCCcccccc
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY--EQNLVTWAQP-FFKDPNRYPQLADPL 321 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~ 321 (427)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+... ......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------- 222 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------- 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------
Confidence 2344679999999999999999999999999999999999999996432211 1111122211 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHhh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPL------MSDVVSALSF 361 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs------~~evl~~L~~ 361 (427)
.++......+.+++.+||+.||++||+ +.+++++-+.
T Consensus 223 ---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f 265 (329)
T cd05618 223 ---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence 122233457889999999999999998 5788877544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=331.59 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=208.7
Q ss_pred hhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|.+.+.||+|+||.||+|.+.. ++..||||.+...... ....+.+|+.+++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568889999999999999998753 3578999998765443 346788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC
Q 042519 156 LLVYEYMPLRSLEDHLLDIG----------PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN 225 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 225 (427)
++||||+++++|.+++...+ .....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997642 22355788999999999999999999999 999999999999999999
Q ss_pred eeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 042519 226 AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 226 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~ 304 (427)
++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH
Confidence 99999999875322222222233456788999999999999999999999999999998 99998654321 111111
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.. +... ..+...+..+.+++..||+.+|++||++.||++.|.
T Consensus 238 ----~~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ----TQ-GRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----Hc-CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11 1110 112234467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=352.41 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=203.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--------C
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--------E 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 153 (427)
..+|++.++||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999999999999999985432 2345799999999999999999887432 2
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-CeeEeecC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDFG 232 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DFG 232 (427)
.+++||||++ ++|.+++.........+++..+..++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4678999998 5788877655445677999999999999999999999999 99999999999998665 69999999
Q ss_pred CcccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... .+....+ .+..+
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~-~~~~p 290 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQ-VLGTP 290 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCCC
Confidence 998643222 2234578999999998865 468999999999999999999999997543221 1111110 00000
Q ss_pred --------------CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 312 --------------NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 312 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..++......+...++...+.++.+|+.+||+.||.+|||+.|++++-+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 01111111111112233345688999999999999999999999998765
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=332.40 Aligned_cols=263 Identities=27% Similarity=0.404 Sum_probs=211.0
Q ss_pred hhCccccceeccCCceEEEEEEE-----CCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.++|.+.+.||+|+||+||++.. ..++..+|+|.+..........+.+|+.++.+++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46799999999999999999985 3345679999987655455667899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCee
Q 042519 157 LVYEYMPLRSLEDHLLDIG---------PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
+||||+++++|.+++.... .....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999987543 12345899999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhh
Q 042519 228 LSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQP 306 (427)
Q Consensus 228 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~ 306 (427)
|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||....... . ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~---~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V---IEC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHH
Confidence 999999975432222222233446778999999998899999999999999999998 899986543211 1 111
Q ss_pred hhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
. ... ..... +......+.+++.+||+.+|.+||++.+++..|+.+..
T Consensus 235 i-~~~-~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 I-TQG-RVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred H-HcC-CcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1 111 11110 11223568999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=335.49 Aligned_cols=244 Identities=27% Similarity=0.389 Sum_probs=195.2
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhh-cCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSL-LHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||.||+|++..+++.||||+++.... .....+..|..++.. ++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999975421 223445556666654 4799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999988854 346889999999999999999999999 9999999999999999999999999997532222 2
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~------------ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILNDRP------------ 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCC------------
Confidence 234567999999999999989999999999999999999999999754321 11111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHH
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMS-DVVSAL 359 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~~L 359 (427)
.++......+.+++..||+.+|++||++. +++++-
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~ 249 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHP 249 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCc
Confidence 11222345778999999999999999875 565543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=340.41 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=207.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.+++.++|+||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4789999999999999999999999999999999875432 233568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|+++++|.+++.. ...+++..+..++.+++.||.|||+. + |+|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999864 34578889999999999999999975 6 99999999999999999999999999875322
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh-hhcCC-------
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP-FFKDP------- 311 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~------- 311 (427)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....... +...... .....
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE---LELMFGCPVEGDPAESETSP 229 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH---HHHHhcCcccCCccccccCc
Confidence 1 1234578999999999998899999999999999999999999997543211 1000000 00000
Q ss_pred --------------CCCC-----cccccccCCC---CC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 312 --------------NRYP-----QLADPLLQGE---FP-VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 312 --------------~~~~-----~~~~~~~~~~---~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...+ .+.+...... .+ .....++.+++.+||+.||++||++.|++++-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 0000 0000000000 00 1134568899999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=346.03 Aligned_cols=260 Identities=20% Similarity=0.240 Sum_probs=205.3
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
..++|++.+.||+|+||.||+++++.+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999999865321 223457789999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999998853 35788899999999999999999999 999999999999999999999999999864
Q ss_pred CCCCccceeccccccccccCccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTG----QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+......
T Consensus 193 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~ 265 (370)
T cd05621 193 DETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNS 265 (370)
T ss_pred ccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcc
Confidence 2211 1122356799999999998753 3789999999999999999999999754321 111112111111
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhhcC
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSV--RPLMSDVVSALSFLG 363 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~L~~~~ 363 (427)
. .. .........+.+++..||..++.+ |+++.+++++-+...
T Consensus 266 ~-~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 266 L-NF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred c-CC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 0 00 001123456778899999865543 899999999976544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.44 Aligned_cols=259 Identities=22% Similarity=0.242 Sum_probs=207.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+++++.++..||+|++.+... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 5689999999999999999999999999999999965321 2334567899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999998853 35788888899999999999999999 9999999999999999999999999987532
Q ss_pred CCCccceeccccccccccCccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTG----QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+.......
T Consensus 194 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~ 266 (370)
T cd05596 194 ANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSL 266 (370)
T ss_pred CCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcC
Confidence 211 1122346799999999998643 4789999999999999999999999754321 1111121111100
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhhcC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSV--RPLMSDVVSALSFLG 363 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~L~~~~ 363 (427)
... ........+.+++..||+.+|.+ |+++.+++++-+...
T Consensus 267 -~~~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 267 -TFP-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred -CCC-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 000 01123467889999999999988 999999999976543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=324.79 Aligned_cols=268 Identities=24% Similarity=0.344 Sum_probs=208.6
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEecc--CCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc-----C
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-----G 152 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 152 (427)
.....|...+.||+|+||.|+.+.++.+|+.||||++.. ......+...+|+.+|+.++|+||+.+++.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 345667778899999999999999999999999999973 333445667889999999999999999998865 4
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
+.+|+|+|+|+ .+|.+.++ .+..++...+..++.||+.||.|+|+-+ |+||||||+|+|++.+..+||||||
T Consensus 99 ~DvYiV~elMe-tDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHHh-hHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 67899999995 78888774 3455999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhh---------
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT--------- 302 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~--------- 302 (427)
+|+...........+..+.|.+|.|||++. ...||.+.||||+|||+.||++|+.-|...+....-.+..
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 999754332334456788999999999764 5689999999999999999999999986543321100000
Q ss_pred --------hhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 303 --------WAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 303 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.+.++.+.-...+. .....-++ ......++|+.+||..||.+|+|++|.+++-
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~---~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPK---QPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCC---CCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 01122221111111 11111111 3345788999999999999999999999986
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=337.56 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=200.4
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||.||+|+++.+++.||||++.+... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999875422 2334566788888765 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GV 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cc
Confidence 999988854 346888999999999999999999999 999999999999999999999999998753221 12
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+. ............
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~~~----------- 214 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDDVL----------- 214 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCC-----------
Confidence 234567999999999999889999999999999999999999999754321 111222221111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHHHhh
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRP-------LMSDVVSALSF 361 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RP-------s~~evl~~L~~ 361 (427)
++......+.+++..||+.||++|| ++.+++++-+.
T Consensus 215 -~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 215 -YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 1122345788999999999999999 88899888654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=343.09 Aligned_cols=258 Identities=22% Similarity=0.279 Sum_probs=201.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||+||+|.++.+++.||||++.+... .....+..|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468999999999999999999999999999999975422 22345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999864 356899999999999999999999999 99999999999999999999999999875321
Q ss_pred CCcc---------------------------------ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCC
Q 042519 240 GDKT---------------------------------HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286 (427)
Q Consensus 240 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~ 286 (427)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0112457999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccchhhhhhhhhhc--CCCCCCcccccccCCCCCHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHHHhhc
Q 042519 287 RAIDTTRPTYEQNLVTWAQPFFK--DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQ--EESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 287 ~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~RPs~~evl~~L~~~ 362 (427)
.||....+.. ....... ....++. . ......+.+++.+++. .++..||++.|++++-+.-
T Consensus 234 ~Pf~~~~~~~------~~~~i~~~~~~~~~p~--------~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~ 297 (363)
T cd05628 234 PPFCSETPQE------TYKKVMNWKETLIFPP--------E--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE 297 (363)
T ss_pred CCCCCCCHHH------HHHHHHcCcCcccCCC--------c--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence 9997543221 1111111 0000110 0 0122355666666433 3444679999999986554
Q ss_pred C
Q 042519 363 G 363 (427)
Q Consensus 363 ~ 363 (427)
.
T Consensus 298 ~ 298 (363)
T cd05628 298 G 298 (363)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=340.07 Aligned_cols=267 Identities=20% Similarity=0.317 Sum_probs=201.2
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----CeeE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG-----EQRL 156 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 156 (427)
+|++.++||+|+||.||+|+++.+|..||||++.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999999999999999986432 22334678899999999999999999988643 3579
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 789888753 346899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCc-cceeccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC--
Q 042519 237 GPIGDK-THVSSRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP-- 311 (427)
Q Consensus 237 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 311 (427)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..........+
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~ 229 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITDLLGTPSP 229 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 322111 112234679999999999875 6789999999999999999999999965432110 00000000000
Q ss_pred --------CCCCccccc-------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 312 --------NRYPQLADP-------LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 312 --------~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
......... .....+ ......+.+++..||+.+|++||++.+++++-+..
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~ 294 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence 000000000 000000 01235678999999999999999999999986653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=330.56 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=208.8
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
+|++.++||+|+||.||++.+..+++.||+|++...... ....+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488889999999999999999989999999998654322 22446789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|+|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888653 2356899999999999999999999999 999999999999999999999999998764322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ............
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~--------- 221 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVERRVKEDQ--------- 221 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHHHhhhcc---------
Confidence 1 12345789999999999988999999999999999999999999975432110 011111111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcCC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLGS 364 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~ 364 (427)
..++......+.+++..||+.||.+|| ++.+++++-+....
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 112233456788999999999999999 88899988665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.67 Aligned_cols=259 Identities=22% Similarity=0.242 Sum_probs=207.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|.+.+.||+|+||+||+|+++.+|+.||+|++..... .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468999999999999999999999999999999976432 23355778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998653 346899999999999999999999999 99999999999999999999999999976432
Q ss_pred CCccceeccccccccccCccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQR------TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||...... .....+... ..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~-~~ 226 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNF-QR 226 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcC-CC
Confidence 221 1233457999999999986 456789999999999999999999999754321 111111111 00
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..... ........+.+++..||+ +|.+||++.+++.+-+...
T Consensus 227 ~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 227 FLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred ccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 00000 011234578899999998 9999999999998865543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=321.38 Aligned_cols=256 Identities=23% Similarity=0.293 Sum_probs=213.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHH---HHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
-++|..+++||+|.||+|.+++.+.+|+.||+|++++.......+. ..|-.+|+..+||.+..|...|...+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4678999999999999999999999999999999988776665554 4588899999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||..||.|.-+|. ....+++.....+-..|+.||.|||+++ ||+||||.+|+|||.+|++||+|||+++...
T Consensus 247 MeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999998884 4567888888889999999999999999 9999999999999999999999999998632
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.......++||||.|+|||++....|+.++|+|.+||++|||+||+.||...+. .....-++....
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh------~kLFeLIl~ed~------ 385 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH------EKLFELILMEDL------ 385 (516)
T ss_pred --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch------hHHHHHHHhhhc------
Confidence 233456789999999999999999999999999999999999999999975322 112222222222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLGS 364 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~ 364 (427)
.+|.....+...|+...|..||.+|. .+.||.++--+..-
T Consensus 386 ------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 386 ------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred ------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 23444455778899999999999995 46777776544433
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=340.13 Aligned_cols=263 Identities=26% Similarity=0.377 Sum_probs=205.0
Q ss_pred hhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEc-CC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCAD-GE 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 153 (427)
.++|++.++||+|+||.||+|...+ +++.||+|++..... .....+..|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4679999999999999999997543 357899999865432 2234577899999999 79999999998864 45
Q ss_pred eeEEEEeecCCCChhhhhhhcCCC--------------------------------------------------------
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPE-------------------------------------------------------- 177 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 177 (427)
.++++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999988643211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceecccccccccc
Q 042519 178 -QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256 (427)
Q Consensus 178 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 256 (427)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136889999999999999999999999 9999999999999999999999999998643322222223345677899
Q ss_pred CccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHH
Q 042519 257 APEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAV 335 (427)
Q Consensus 257 aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 335 (427)
|||++.+..++.++|||||||++|||++ |..||....... .+ .......... ..+......+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~~----------~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EF----CRRLKEGTRM----------RAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HH----HHHHhccCCC----------CCCccCCHHHH
Confidence 9999999999999999999999999998 999996533211 11 1111111110 11223345789
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 336 AVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 336 ~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+++.+||+.+|++||++.+++++|..+.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=335.73 Aligned_cols=249 Identities=25% Similarity=0.334 Sum_probs=201.2
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 159 (427)
+|++.+.||+|+||.||+|+++.++..||||++.+... .....+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48889999999999999999999999999999976432 2223456677777776 4899999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999988854 345888999999999999999999999 99999999999999999999999999875321
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~i~~~~~------- 218 (323)
T cd05616 154 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHNV------- 218 (323)
T ss_pred C--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-------
Confidence 1 12234567999999999999999999999999999999999999999754321 11111221111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHH
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM-----SDVVSAL 359 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~~L 359 (427)
.++......+.+++.+||+.+|.+|++. .+++++-
T Consensus 219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~ 258 (323)
T cd05616 219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 258 (323)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCC
Confidence 1122344678899999999999999984 6776653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=349.52 Aligned_cols=258 Identities=21% Similarity=0.222 Sum_probs=202.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||++.++.+++.||||++.+... .....+.+|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 368999999999999999999999999999999865321 23355778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999864 346888899999999999999999999 99999999999999999999999999863211
Q ss_pred CCcc---------------------------------------------ceeccccccccccCccccccCCCCccchHHH
Q 042519 240 GDKT---------------------------------------------HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYT 274 (427)
Q Consensus 240 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 274 (427)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCC---CC
Q 042519 275 FGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVR---PL 351 (427)
Q Consensus 275 lGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps 351 (427)
|||++|||++|..||....+.. ............ .+.+ .......+.+++..||+ +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~-~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHE------TYRKIINWRETL-YFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHH------HHHHHHccCCcc-CCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 9999999999999997543211 111111100000 0000 01223567899999997 66665 59
Q ss_pred HHHHHHHHhhc
Q 042519 352 MSDVVSALSFL 362 (427)
Q Consensus 352 ~~evl~~L~~~ 362 (427)
+.+++++-+..
T Consensus 299 ~~~~l~hp~~~ 309 (377)
T cd05629 299 AHEIKSHPFFR 309 (377)
T ss_pred HHHHhcCCCcC
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=335.00 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=196.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhh-cCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSL-LHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||.||+|+++.+|..||+|++++... .....+..|..++.. ++||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999975421 233455667777765 4799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++...... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999988854 346888999999999999999999999 9999999999999999999999999987422211 2
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~~~~~~------------ 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESIRVDTP------------ 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC------------
Confidence 234567999999999999999999999999999999999999999754321 11111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHhh
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMS-DVVSALSF 361 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~~L~~ 361 (427)
.++......+.+++..||+.||++||++. +++++-+.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f 251 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence 11112345778999999999999999984 66655443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=328.56 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=204.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc----EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ----VVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.++|++.+.||+|+||+||+|.+..++. .+++|.+..... ....++..|+.++..+.||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 3578999999999999999999977776 477777754322 223556778888999999999999998864 5578
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 85 ~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 89999999999999865 2346899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..............++..|+|||++.++.++.++|||||||++|||++ |..||....+.. ... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~~ 231 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPD----LLEKGERLA 231 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCCcCC
Confidence 433332223344567788999999998899999999999999999998 999997543221 111 111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
. +..+...+.+++..||..+|++||++.|+++.|..+..
T Consensus 232 ---~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 ---Q-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0 11123467889999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=329.32 Aligned_cols=260 Identities=24% Similarity=0.402 Sum_probs=204.7
Q ss_pred HhhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
..++|++.+.||+|+||.||+|.+++ ++..||+|.+..... .....+.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999998753 356799999864322 234567889999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeE
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPE------QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKL 228 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl 228 (427)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653321 234678889999999999999999999 999999999999999999999
Q ss_pred eecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhh
Q 042519 229 SDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... .... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~---~- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR---F- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---H-
Confidence 99999875332222222223345778999999998899999999999999999999 78888654321 1111 1
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.... .... .+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 234 ~~~~-~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEG-GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcC-CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111 1110 11223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=335.30 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=199.3
Q ss_pred ceeccCCceEEEEEEEC---CCCcEEEEEEeccCCC----cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 89 CLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL----QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+.||+|+||.||+++.. .+++.||||++.+... .....+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999863 4688999999875322 2234567899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ...+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 153 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE- 153 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence 999999998854 345788888899999999999999999 999999999999999999999999998743221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~~--------- 217 (323)
T cd05584 154 -GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGKL--------- 217 (323)
T ss_pred -CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC---------
Confidence 12233467999999999999888999999999999999999999999754321 11111211111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSF 361 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~ 361 (427)
..+......+.+++.+||+.+|++|| ++.+++++-+.
T Consensus 218 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~ 259 (323)
T cd05584 218 ---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259 (323)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence 11222345788999999999999999 89998887654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=314.21 Aligned_cols=258 Identities=20% Similarity=0.230 Sum_probs=211.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.+.|.+.++||+|.|+.||++.+..+|+.+|+|+++.... .+.+++.+|+.|.+.|+|||||+|.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 5678999999999999999999999999999999865432 35678899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---CCCeeEeecCCccc
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---EFNAKLSDFGLAKL 236 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkl~DFG~a~~ 236 (427)
|+|.|++|..-+-.. ..+++..+-.++.||+++|.|+|.++ |||||+||.|+||-+ .--+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999997666432 56788888899999999999999999 999999999999943 34599999999987
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.. .........|||.|||||++...+|+..+|||+.|||||-||.|..||.... .....+.+.+..-.++.
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~------~~rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHRLYEQIKAGAYDYPS 233 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc------HHHHHHHHhccccCCCC
Confidence 54 3334556789999999999999999999999999999999999999997522 12223333332212111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.. =....+...+|+++||..||.+|.|+.|.+.+-|...
T Consensus 234 ----~~----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 234 ----PE----WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ----cc----cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 00 1123357789999999999999999999999877543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=335.01 Aligned_cols=266 Identities=29% Similarity=0.398 Sum_probs=223.9
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc-hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG-NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
..+...+.++||+|.||.|.+|...+ +..||||.++...... ..+|..|+.+|.+|+||||++|+|+|..++.+++|+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34667888999999999999999876 7899999998765444 478999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|||.+|+|.+++..+.... +.-.....|+.||+.|++||.+.+ +|||||.+.|+|+|.++++||+|||+++-...
T Consensus 615 EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999998754322 455566789999999999999999 99999999999999999999999999997777
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT--GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
++......+.+-...|||+|.+..++++.++|||+||+++||+++ ...||..... ...++-...++...+.-.-+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcceec
Confidence 777777778888899999999999999999999999999999765 7788876433 23333344444443322222
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..|..++..+++++.+||..|-++||+++++...|...
T Consensus 767 -------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 -------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 23556778999999999999999999999999998754
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=337.40 Aligned_cols=265 Identities=19% Similarity=0.304 Sum_probs=199.2
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
....+|++.+.||+|+||.||+|++..++..||+|+.... ....|+.+++.++|+||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3456799999999999999999999999999999985432 2346899999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|++. ++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9996 688888864 3457899999999999999999999999 99999999999999999999999999975221
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc--------hhhhhhhhhhcCC
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ--------NLVTWAQPFFKDP 311 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~ 311 (427)
........||+.|+|||++.+..++.++|||||||++|||+++..++-...+.... .+.......-..+
T Consensus 210 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 210 ---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 11223467999999999999999999999999999999999866554322222100 0111110000001
Q ss_pred CCCCc-----cc----c--cccCCCC-------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 312 NRYPQ-----LA----D--PLLQGEF-------PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 312 ~~~~~-----~~----~--~~~~~~~-------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..++. +. + ....... .......+.++|..||+.||.+|||+.|++++-+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 11110 00 0 0000000 0112345667999999999999999999998754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=325.00 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=207.6
Q ss_pred hhCccccceeccCCceEEEEEEECCC---CcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|.++.+ ...||||.+...... ....+.+|+.+++.++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 35799999999999999999998654 457999998654322 23568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999998653 346899999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... .......+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~----~~~~~~~~- 228 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKA----VEDGYRLP- 228 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHH----HHcCCCCC-
Confidence 32222222223345678999999998899999999999999999998 99998653221 11111 11111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+..++..+.+++.+||+.+|++||++.+|+++|..+
T Consensus 229 ---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1223346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=342.75 Aligned_cols=267 Identities=19% Similarity=0.211 Sum_probs=202.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
...|.+.+.||+|+||.||+|.+..++..||||.... ..+.+|+.++++|+|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5579999999999999999999999999999996422 2356899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+. ++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 96 788888754 2346899999999999999999999999 9999999999999999999999999998643322
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC-Ccc----cchhhhhhhhhhcCCCCCCc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTR-PTY----EQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~ 316 (427)
.........||+.|+|||++.+..++.++|||||||+||||++|..++-... ... ...+...+.........++.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2222335679999999999999999999999999999999999887653221 111 11111111110000000110
Q ss_pred cccc------------ccCC-----CCC--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 317 LADP------------LLQG-----EFP--VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 317 ~~~~------------~~~~-----~~~--~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.... .... .+. ......+.+|+.+||+.||.+|||+.|++++-++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 0000 0000 000 0123468899999999999999999999998654
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=346.49 Aligned_cols=256 Identities=21% Similarity=0.221 Sum_probs=200.2
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.|++.++||+|+||.||+|++..+++.||+|++.+... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999988642 45788889999999999999999999 999999999999999999999999997531100
Q ss_pred C---------------------------------------------ccceeccccccccccCccccccCCCCccchHHHH
Q 042519 241 D---------------------------------------------KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTF 275 (427)
Q Consensus 241 ~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 275 (427)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0001123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---H
Q 042519 276 GVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL---M 352 (427)
Q Consensus 276 Gvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~ 352 (427)
||++|||++|+.||....+.... .......... ...........+.+++..++ .+|.+|++ +
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~------~~i~~~~~~~--------~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQ------MKVINWQTSL--------HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHH------HHHHccCCCc--------CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 99999999999999765432111 0111100000 00001122345667777765 49999997 8
Q ss_pred HHHHHHHhh
Q 042519 353 SDVVSALSF 361 (427)
Q Consensus 353 ~evl~~L~~ 361 (427)
.+++++-+.
T Consensus 300 ~ei~~hp~f 308 (382)
T cd05625 300 DEIKAHPFF 308 (382)
T ss_pred HHHhcCCCc
Confidence 898887554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=323.04 Aligned_cols=249 Identities=26% Similarity=0.347 Sum_probs=198.5
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 469999999999999998999999998764432 2345688999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceec
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 247 (427)
.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999864 2346889999999999999999999999 9999999999999999999999999987532211111111
Q ss_pred cccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCC
Q 042519 248 RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEF 326 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (427)
...++..|+|||.+.++.++.++|||||||++|+|++ |..||....+.. .. ....... ....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~----~~~~~~~----------~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TR----EAIEQGV----------RLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HH----HHHHcCC----------CCCC
Confidence 1123456999999998899999999999999999998 888886543211 11 1111100 0111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 327 PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 327 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.71 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=200.4
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||+||+|.++.++..||||++.+.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997542 22334567788888877 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GV 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CC
Confidence 999988854 346899999999999999999999999 999999999999999999999999998752211 11
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ............
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~~~~~----------- 214 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILEDEVR----------- 214 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCC-----------
Confidence 233457999999999999999999999999999999999999999754321 111111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHhh
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLM-----SDVVSALSF 361 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~~L~~ 361 (427)
++......+.+++.+||+.||.+||++ .+++++-+.
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~ 255 (318)
T cd05570 215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255 (318)
T ss_pred -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCc
Confidence 122234678899999999999999999 998887544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=325.06 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=208.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
.+|.+.+.||+|+||.||+|.++.+++.||+|.+... ......+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4688899999999999999999999999999998654 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++++|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998653 2356889999999999999999999999 99999999999999999999999999876432211
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ...... ....
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~-~~~~--------- 222 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELL-EKGY--------- 222 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH-HCCC---------
Confidence 1 1112334667999999998899999999999999999998 89988643211 111111 1100
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 223 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0112223456789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=330.75 Aligned_cols=262 Identities=27% Similarity=0.442 Sum_probs=211.5
Q ss_pred hCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.+|.+.+.||+|+||.||+|.+.. ++..+++|.+..........+.+|+.+++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 568889999999999999998643 456799999876655555678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC
Q 042519 158 VYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN 225 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 225 (427)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975431 2245889999999999999999999999 999999999999999999
Q ss_pred eeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 042519 226 AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 226 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~ 304 (427)
++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||....+.. ...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~-- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE-- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence 99999999975433222222334557888999999998899999999999999999998 999986543211 111
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.... ..... .+...+..+.+++.+||+.+|++||++.+|++.|..+..
T Consensus 237 --~~~~-~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 --CITQ-GRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --HHhC-CCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111 11111 112234578899999999999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.47 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=198.1
Q ss_pred hCccccceeccCCceEEEEEEECC-CCcEEEEEEeccCCCc--chHHHHHHHHHHhhc---CCCCeeeEEEEEE-----c
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEK-TAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLL---HHDNLVNLIGYCA-----D 151 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 151 (427)
++|++.+.||+|+||.||+|++.. ++..||+|.+...... ....+.+|+.+++.+ .||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999999854 4688999998654322 223456677776665 6999999999885 3
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 152 GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 152 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
....++||||++ ++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999997 6999988653 2345889999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc--
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK-- 309 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-- 309 (427)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+... +.... ....
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~~~i~-~~~~~~ 228 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKIL-DVIGLP 228 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHH-HHhCCC
Confidence 999764322 223456789999999999888999999999999999999999999976543211 11100 0000
Q ss_pred CCCCCCc-------ccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 310 DPNRYPQ-------LADPLLQG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 310 ~~~~~~~-------~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.+...+. ........ .........+.+++.+||+.||++||++.+++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp 288 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 288 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence 0000000 00000000 00112345678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=335.23 Aligned_cols=257 Identities=24% Similarity=0.279 Sum_probs=203.3
Q ss_pred CccccceeccCCceEEEEEEEC---CCCcEEEEEEeccCCC----cchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL----QGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQR 155 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 155 (427)
+|++.+.||+|+||.||+++.. .++..||+|++.+... ...+.+..|+.++..++ |+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999874 4689999999865322 22345678999999995 99999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999864 345889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......... ............
T Consensus 154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~-- 228 (332)
T cd05614 154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILKCDP-- 228 (332)
T ss_pred cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhcCCC--
Confidence 5322221 122346799999999998765 4789999999999999999999999754322111 111111111111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhc
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFL 362 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~ 362 (427)
.++......+.+++.+||+.||++|| ++.+++++-+.-
T Consensus 229 ----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 271 (332)
T cd05614 229 ----------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271 (332)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 11223345778999999999999999 788998886543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.71 Aligned_cols=258 Identities=21% Similarity=0.223 Sum_probs=202.8
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||+|++..+++.||||++.+... .....+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 369999999999999999999999999999999865322 23355778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999864 345788888999999999999999999 99999999999999999999999999752110
Q ss_pred CC-----------------------------------------ccceeccccccccccCccccccCCCCccchHHHHHHH
Q 042519 240 GD-----------------------------------------KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVV 278 (427)
Q Consensus 240 ~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 278 (427)
.. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHH
Q 042519 279 LLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP---LMSDV 355 (427)
Q Consensus 279 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~ev 355 (427)
+|||++|+.||....+..... ......... .+ .........+.+++.+|+ .+|.+|+ ++.++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~------~i~~~~~~~-~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQL------KVINWETTL-HI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHH------HHhccCccc-cC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999997654321111 111000000 00 001122345677777766 5999999 89999
Q ss_pred HHHHhhc
Q 042519 356 VSALSFL 362 (427)
Q Consensus 356 l~~L~~~ 362 (427)
+++-+.-
T Consensus 299 l~h~~~~ 305 (376)
T cd05598 299 KAHPFFK 305 (376)
T ss_pred hCCCCcC
Confidence 9986644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=335.97 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=201.3
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||+||+|++..+++.||+|++.+... .....+..|..++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976432 2234577888888887 599999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CC
Confidence 999988753 346899999999999999999999999 999999999999999999999999998742211 12
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh-cCCCCCCcccccccC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF-KDPNRYPQLADPLLQ 323 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 323 (427)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.............+..... ..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------- 221 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR---------- 221 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------
Confidence 2345679999999999999999999999999999999999999997543322222222222211 11111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHhh
Q 042519 324 GEFPVRGLNQAVAVSAMCVQEESSVRPL------MSDVVSALSF 361 (427)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~~P~~RPs------~~evl~~L~~ 361 (427)
.+......+.+++.+||+.||.+|++ +.+++++-+.
T Consensus 222 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f 263 (327)
T cd05617 222 --IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF 263 (327)
T ss_pred --CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCC
Confidence 12223456789999999999999998 4677776543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.58 Aligned_cols=245 Identities=27% Similarity=0.339 Sum_probs=195.8
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHH-HHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVL-MLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||+||+|+++.+|+.||||++.+... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 479999999999999999999999999865422 12233444544 56789999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ...
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCC
Confidence 999998854 346889999999999999999999999 99999999999999999999999999875321 122
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .............
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~----------- 214 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKPLR----------- 214 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCCCC-----------
Confidence 23456799999999999999999999999999999999999999975321 1112222221111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHh
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLM----SDVVSALS 360 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~----~evl~~L~ 360 (427)
.+......+.+++.+||+.||.+||++ .+++++-+
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~ 253 (323)
T cd05575 215 -LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253 (323)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence 111234578899999999999999987 46666544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=326.72 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=211.5
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
...+|++.+.||.|+||.||+|.+.. +..+|+|.+..........+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 35679999999999999999999988 88999999987765566788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999753 3356889999999999999999999999 999999999999999999999999999764221
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
........++..|+|||++....++.++||||||+++|+|++ |+.||...... ...... . ....
T Consensus 158 --~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~---~-~~~~------ 222 (261)
T cd05148 158 --VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQI---T-AGYR------ 222 (261)
T ss_pred --cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH---H-hCCc------
Confidence 111223446778999999988899999999999999999998 89999654311 111111 1 1101
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01123344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=336.88 Aligned_cols=269 Identities=23% Similarity=0.257 Sum_probs=203.8
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC-----
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE----- 153 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 153 (427)
..++|++.+.||+|+||.||++.+..+|..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999999999999999986542 233456778999999999999999999986543
Q ss_pred -eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 154 -QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 154 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
..++||||++ ++|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 5799999997 56766653 24778888999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc--------------
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ-------------- 298 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~-------------- 298 (427)
+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 169 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred Ccccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9975321 12233457899999999999999999999999999999999999999754321100
Q ss_pred --hhhhhhhhhhcCCCCCCc-----ccccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 299 --NLVTWAQPFFKDPNRYPQ-----LADPLLQ---GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 299 --~~~~~~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+......+......... +...... ..........+.+++.+||+.||++|||+.|++++-+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 000000111111111110 0000000 001112345688999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=331.75 Aligned_cols=244 Identities=28% Similarity=0.385 Sum_probs=195.8
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhh-cCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSL-LHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
+.||+|+||+||+|++..+++.||||++.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997642 1233445667777765 5899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999998854 346888999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~~----------- 214 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------ELFQSIRMDNPC----------- 214 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-----------
Confidence 233467999999999999889999999999999999999999999754321 111111111000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHH
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMS-DVVSAL 359 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~~L 359 (427)
++......+.+++.+||+.+|++||++. +++++-
T Consensus 215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~ 249 (316)
T cd05619 215 -YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHP 249 (316)
T ss_pred -CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCc
Confidence 1122335678999999999999999997 666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=320.67 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=213.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||+|.+..+|+.||+|.++... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999899999999886432 223456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.........+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998765545567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... +.......+.. ....
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~--~~~~---- 226 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK--CDYP---- 226 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc--CCCC----
Confidence 21 112335688899999999988899999999999999999999999864321 11111111111 0000
Q ss_pred cccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 320 PLLQGEFP-VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..+ ......+.+++..||+.+|++||++.+|++.|..+.
T Consensus 227 -----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 -----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111 134567889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=311.97 Aligned_cols=258 Identities=23% Similarity=0.314 Sum_probs=209.6
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc----ch----HHHHHHHHHHhhcC-CCCeeeEEEEEEc
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ----GN----KEFIVEVLMLSLLH-HDNLVNLIGYCAD 151 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~----~~~~~E~~~l~~l~-h~niv~l~~~~~~ 151 (427)
.-..|.-.++||.|..++|-++.++.+|..+|+|++...... .. +.-..|+.||+++. ||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345688889999999999999999999999999999643221 11 23456999999985 9999999999999
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 152 GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 152 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
....++|+|.|+.|.|+++|. ....+++.....|+.|+.+|++|||.++ ||||||||+|||++++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 999999999999999999995 4567999999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCcccccc------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT------GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~ 305 (427)
|++.....+. .....||||+|+|||.+.. ..|+..+|+|++|||+|-||.|.+||--.. .-...
T Consensus 168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlML 237 (411)
T KOG0599|consen 168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLML 237 (411)
T ss_pred ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHH
Confidence 9998765444 3467899999999998853 468899999999999999999999995211 11111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+.. +.+ +.-.+ -=.+......+||.+||+.||.+|.|++|++.+-+.+
T Consensus 238 R~Ime-Gky-qF~sp-----eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 238 RMIME-GKY-QFRSP-----EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHHh-ccc-ccCCc-----chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 11111 111 00011 1124556788999999999999999999999987764
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=323.08 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=205.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 46799999999999999999999999999999998765444556678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998854 346889999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+.... ..+. . ... .
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~----~--~~~---~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMS----K--SNF---Q 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeee----c--CCC---C
Confidence 1123356889999999874 345788999999999999999999998644322110 0000 0 000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.+... ........+.+++.+||+.+|++||++.+++++|
T Consensus 228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 0112346788999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=323.32 Aligned_cols=262 Identities=22% Similarity=0.316 Sum_probs=212.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||+|.++.++..+|||.+..... .....+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468889999999999999999998999999998865332 22356788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988764445567899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|..||...... .......... ...
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~--~~~----- 225 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ--CDY----- 225 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhc--CCC-----
Confidence 21 1223456889999999999888999999999999999999999998643221 1111111100 000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+ ...+......+.+++.+||+.+|++|||+.+|++.+..+.
T Consensus 226 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 P---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 0011234567889999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.55 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=205.4
Q ss_pred hCccccceeccCCceEEEEEEEC----CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLE----KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
++|++.+.||+|+||.||+|.+. .++..|++|.+..... .....+.+|+.+++.++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 56888999999999999999863 3567899999865332 233568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC
Q 042519 158 VYEYMPLRSLEDHLLDIGP-------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF 224 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 224 (427)
||||+++++|.+++..... ....+++...+.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 1245788999999999999999999999 99999999999999999
Q ss_pred CeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 042519 225 NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTW 303 (427)
Q Consensus 225 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~ 303 (427)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....+. .+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999976433322223334456778999999988889999999999999999998 88888653221 11111
Q ss_pred hhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 304 AQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
. ...... ..+......+.+++..||+.+|++||++.+++++|..
T Consensus 239 ~----~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 110100 0122234578899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=330.13 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=218.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch--HHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.-|.+.+.||+|.|+.|-+|++.-+|..||||++++...+.. ..+.+|+..|+.++|||||+||++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 458888999999999999999999999999999998776554 457899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe-CCCCCeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL-DCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~vkl~DFG~a~~~~~ 239 (427)
+-++|+|.+||.+ ....+.+..+.+++.||+.|+.|+|+.. +|||||||+|+.+ ..-|-|||+|||++..+..
T Consensus 98 LGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999987 4567999999999999999999999999 9999999999876 6678899999999976544
Q ss_pred CCccceeccccccccccCccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLT-VKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
+. ...+.||++.|-|||++.+..|+ +++||||||||||-|+||+.||+..++... +-.++
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------------LTmIm 232 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------------LTMIM 232 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------------hhhhh
Confidence 33 45678999999999999998887 679999999999999999999986544311 11222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
|-.. ..|.....++.+||..||..||.+|.+.++|...-|--.
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 2211 346677889999999999999999999999998876443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=326.84 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=195.8
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 91 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
||+|+||.||+++.+.+|+.||+|.+...... ....+..|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998653322 223456799999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceec
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 247 (427)
.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence 9888653 3345888999999999999999999999 999999999999999999999999998754322 1223
Q ss_pred cccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCC
Q 042519 248 RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFP 327 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (427)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ............. .. . ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~--~~-~--------~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDE--VK-F--------EH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhccc--cc-c--------cc
Confidence 4568999999999998889999999999999999999999997543211 1111111111110 00 0 01
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 042519 328 VRGLNQAVAVSAMCVQEESSVRPLMSDVVS 357 (427)
Q Consensus 328 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 357 (427)
......+.+++..||+.||++||++.|+++
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 123457889999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=343.25 Aligned_cols=262 Identities=30% Similarity=0.442 Sum_probs=211.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc---E-EEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ---V-VAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
.++..+.++||+|.||.||+|+.+..+. . ||||...... .....++.+|++++++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3445566899999999999999875422 3 8999987522 3455789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
+++|||+|+||+|.++|... ...++..+.+.++.+.+.||+|||+++ ++||||-..|+|++.++.+||+|||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999763 236999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceec-cccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 235 KLGPIGDKTHVSS-RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 235 ~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
+... ...... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||...... +....+..++
T Consensus 310 ~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~- 379 (474)
T KOG0194|consen 310 RAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNG- 379 (474)
T ss_pred cCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcC-
Confidence 8633 111111 1134568999999999999999999999999999999 88888764322 1111111211
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCC
Q 042519 313 RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDA 368 (427)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 368 (427)
.+...+...+..+..++..||..+|++||+|.++.+.|+.+......
T Consensus 380 ---------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 ---------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11223345567888899999999999999999999999988765444
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=330.61 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=208.1
Q ss_pred HhhCccccceeccCCceEEEEEEECCC-----CcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCC
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKT-----AQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGE 153 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 153 (427)
..++|++.+.||+|+||.||++.+... ...+|+|.+..... .....+.+|+.++..+ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 356799999999999999999998643 37899999875422 2335578899999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIG------------PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD 221 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~ 221 (427)
..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 9999999999999999986532 23456889999999999999999999999 99999999999999
Q ss_pred CCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 042519 222 CEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNL 300 (427)
Q Consensus 222 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~ 300 (427)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence 999999999999986433222222222345678999999988899999999999999999998 999886533211
Q ss_pred hhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.. ......... ..+......+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 243 --~~-~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 --LF-KLLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred --HH-HHHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11 111111100 11223346788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=340.68 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=205.9
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-C-----CCeeeEEEEEEcCCeeEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-H-----DNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 157 (427)
+|.+.++||+|+||.|.+|.+..|++.||||+++.. .....+...|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788999999999999999999999999999999654 344566678999999997 4 379999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC--CeeEeecCCcc
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF--NAKLSDFGLAK 235 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--~vkl~DFG~a~ 235 (427)
|+|.+. .+|.++|+.. ....++...+..++.||+.||.+||+.+ |||+||||+||||...+ .|||+|||++.
T Consensus 266 VfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999997 7999999874 4456889999999999999999999999 99999999999996543 69999999998
Q ss_pred cCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hhh------------
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LVT------------ 302 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~~------------ 302 (427)
.....- ...+.+..|.|||++.+.+|+.+.||||||||++||++|.+.|....+.+... +.+
T Consensus 340 ~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 340 FESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 733222 24566777999999999999999999999999999999987775543321100 000
Q ss_pred h--hhhhhcCCCCCCc-----------------------cccc-------ccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 042519 303 W--AQPFFKDPNRYPQ-----------------------LADP-------LLQGEFPVRGLNQAVAVSAMCVQEESSVRP 350 (427)
Q Consensus 303 ~--~~~~~~~~~~~~~-----------------------~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 350 (427)
+ ...++......+. ..+. .+...........+.+++++||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0 0111111000000 0000 000011123345789999999999999999
Q ss_pred CHHHHHHHHhhc
Q 042519 351 LMSDVVSALSFL 362 (427)
Q Consensus 351 s~~evl~~L~~~ 362 (427)
|..++++|-+.-
T Consensus 495 tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 495 TPAQALNHPFLT 506 (586)
T ss_pred CHHHHhcCcccc
Confidence 999999997644
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=322.06 Aligned_cols=255 Identities=26% Similarity=0.342 Sum_probs=206.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-----chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-----GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
++|.+.+.||+|+||.||.|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999999999999998654321 23457889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999988642 45788899999999999999999999 999999999999999999999999998753
Q ss_pred CCCCccc-eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDKTH-VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....... . ........ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~-~--- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP-T--- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----H-HHHHhccC-C---
Confidence 2211111 1133568889999999999889999999999999999999999997542211 0 00111100 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
....+......+.+++..||..+|.+||++.+++++.+
T Consensus 225 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 225 ------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred ------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 01122334457889999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=336.77 Aligned_cols=265 Identities=21% Similarity=0.242 Sum_probs=207.5
Q ss_pred HHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC
Q 042519 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG 152 (427)
Q Consensus 76 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 152 (427)
..+....++|++.+.||+|+||.||+|+++.+++.||+|++.+... .....+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3444556899999999999999999999999999999999864321 2234567899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999998853 34788888999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG----QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
++....... .......+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+.
T Consensus 188 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~ 260 (371)
T cd05622 188 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM 260 (371)
T ss_pred ceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 997643221 1122356799999999998653 3789999999999999999999999754321 1111222
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhhcC
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSV--RPLMSDVVSALSFLG 363 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~L~~~~ 363 (427)
....... .. ........+.+++..||..++.+ |+++.+++++.+.-.
T Consensus 261 ~~~~~~~-~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 261 NHKNSLT-FP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred cCCCccc-CC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 1111100 00 01234457788999999844433 789999999986543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=326.45 Aligned_cols=266 Identities=27% Similarity=0.384 Sum_probs=208.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCC----------------cEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTA----------------QVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVN 144 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 144 (427)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+..... .....+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457999999999999999999876543 5689999875533 23456888999999999999999
Q ss_pred EEEEEEcCCeeEEEEeecCCCChhhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCc
Q 042519 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP-------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSN 217 (427)
Q Consensus 145 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 217 (427)
+++++..++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999876431 1236899999999999999999999999 9999999999
Q ss_pred eEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCc
Q 042519 218 ILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT--GRRAIDTTRPT 295 (427)
Q Consensus 218 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~--g~~p~~~~~~~ 295 (427)
||++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999875433332223344557788999999988889999999999999999998 6677764322
Q ss_pred ccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 296 YEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..........+......... ..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11222222222211111110 112233467999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=320.48 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=201.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
++|++.+.||+|+||.||++.++. +..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 568899999999999999998875 5679999986443 33467888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999988652 235889999999999999999999999 99999999999999999999999999875322211
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... .... .... .... .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~---~i~~-~~~~---~--- 221 (256)
T cd05114 156 -TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVE---MISR-GFRL---Y--- 221 (256)
T ss_pred -eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HHHC-CCCC---C---
Confidence 11122335668999999998899999999999999999999 89998654321 1111 1111 1110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.+......+.+++.+||+.+|++||++.++++.|
T Consensus 222 ----~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 ----RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0111235789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=325.00 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=205.2
Q ss_pred hhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999999987 6788999988644322 235688899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC---CeeEe
Q 042519 156 LLVYEYMPLRSLEDHLLDIGP---EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF---NAKLS 229 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkl~ 229 (427)
++||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ ++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999876432 1235899999999999999999999999 99999999999998765 59999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||....... + .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~---~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V---MEFVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHHHH
Confidence 9999986422211111122234567999999998899999999999999999997 999997543221 1 11111
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.. .. ...+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 236 ~~-~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GG-GR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cC-Cc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 11 1112233467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=320.54 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=205.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.+.. +..||+|.++... ...+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4679999999999999999999765 5789999986543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999986532 356899999999999999999999999 9999999999999999999999999998643211
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. .......++..|+|||++.+..++.++||||||+++|+|++ |+.||....... ... ........
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~------ 223 (261)
T cd05068 158 Y-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQGYRM------ 223 (261)
T ss_pred c-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCCC------
Confidence 1 11111223457999999998899999999999999999999 999996543211 111 11110000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 ----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1122334678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=332.78 Aligned_cols=245 Identities=27% Similarity=0.337 Sum_probs=194.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHH-HHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEV-LMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||.||+|++..+|+.||+|++.+... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999865422 1223344454 467889999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.... ...
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCC
Confidence 999888753 356788889999999999999999999 99999999999999999999999999875221 122
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ............
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~------------ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHKPL------------ 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcCCC------------
Confidence 23456799999999999988999999999999999999999999975421 111222222111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHh
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMS----DVVSALS 360 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~----evl~~L~ 360 (427)
..+......+.+++.+||+.+|.+||+.. +++++.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence 11223345788999999999999999754 6655543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=337.47 Aligned_cols=270 Identities=22% Similarity=0.227 Sum_probs=206.1
Q ss_pred HhhCccccceeccCCceEEEEEEECC--CCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEK--TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
...+|++.+.||+|+||.||++...+ ++..||+|.+... ....+|+.+++.++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 35679999999999999999998643 4678999987543 3456799999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
||++. ++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 165 ~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99996 68888883 3457899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc-chhhhhhhhhhcCCCCCCcc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE-QNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 317 (427)
............||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+......+...+..++..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 33332233456799999999999999999999999999999999999999965443221 11111111000000000000
Q ss_pred c-----------ccccCCC--CC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 318 A-----------DPLLQGE--FP-----VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 318 ~-----------~~~~~~~--~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
. ....... .+ ......+.+++.+||+.||++||++.+++.+-++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 0 0000000 00 112356788999999999999999999999976644
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=361.53 Aligned_cols=263 Identities=30% Similarity=0.435 Sum_probs=216.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc-----EEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ-----VVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
..+.+..+.||+|.||.||.|...+... .||||.+.+.. .+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456677899999999999999864333 49999987653 45567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 156 LLVYEYMPLRSLEDHLLDIGP---EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
+|++|||.+|+|..+|++.+. ....+...+.+.++.||++|+.||++++ +|||||...|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987532 2566889999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
+|+.....+.........-...|||||.+..+.++.|+|||||||+|||+++ |..||...... +....+ ..+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~~~-~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLLDV-LEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHHHH-HhC
Confidence 9995333333322222233458999999999999999999999999999999 88999765432 111112 222
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+++ ..|..++..+++|+..||+.+|++||++..+++.+..+..
T Consensus 921 gRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 921 GRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred Ccc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 332 2367788899999999999999999999999998877654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=331.09 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=200.4
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 159 (427)
+|+..++||+|+||.||+|+++.+|+.||+|++.+... .....+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47788999999999999999999999999999875422 23345677888888876 577888999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998854 346899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....+. ............
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~~~------ 219 (323)
T cd05615 154 D--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIMEHNVS------ 219 (323)
T ss_pred C--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC------
Confidence 1 12233467999999999999889999999999999999999999999754321 111122221111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHH
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM-----SDVVSAL 359 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~~L 359 (427)
++......+.+++.+||+.+|.+|++. .+++++-
T Consensus 220 ------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~ 258 (323)
T cd05615 220 ------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHA 258 (323)
T ss_pred ------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCc
Confidence 122334577899999999999999974 5666653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=327.98 Aligned_cols=266 Identities=24% Similarity=0.372 Sum_probs=204.1
Q ss_pred hhCccccceeccCCceEEEEEEECCC--------------CcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT--------------AQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLI 146 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~ 146 (427)
.++|++.+.||+|+||.||++.+.++ ...||+|.+..... .....+.+|+.++..++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46799999999999999999987543 23599999865422 2345688999999999999999999
Q ss_pred EEEEcCCeeEEEEeecCCCChhhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCce
Q 042519 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGP--------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNI 218 (427)
Q Consensus 147 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 218 (427)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999864321 1124788899999999999999999999 99999999999
Q ss_pred EeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCcc
Q 042519 219 LLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT--GRRAIDTTRPTY 296 (427)
Q Consensus 219 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~--g~~p~~~~~~~~ 296 (427)
|++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 999999999999999875433222222233445778999999988899999999999999999998 55677643221
Q ss_pred cchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 297 EQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.........+......... ..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 --QVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111111110000 011123468999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=325.67 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=207.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCC-----cEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTA-----QVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||.||+|.++..+ ..||+|.+..... .....+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467999999999999999999986543 7899999865432 3345678899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEe
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPE------QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLS 229 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~ 229 (427)
++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999998754322 234788899999999999999999999 9999999999999999999999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...... .... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~----~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLK----FV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHH----HH
Confidence 9999875433222222233456788999999988889999999999999999998 99998643321 1111 11
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..... .. .+...+..+.+++..||+.+|++|||+.++++.|+
T Consensus 235 ~~~~~-~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGH-LD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCC-CC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111 11 11223567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=326.46 Aligned_cols=252 Identities=34% Similarity=0.535 Sum_probs=197.3
Q ss_pred cccceeccCCceEEEEEEEC----CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 86 RQECLIGEGGFGRVYKGKLE----KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 86 ~~~~~Lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.+.+.||.|.||.||+|.+. ..+..|+||.+..... ...+.+.+|+..+.+++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999998 4567899999955332 235788999999999999999999999998888999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|+|.++|... ....+++..++.|+.||+.||.|||+++ |+|+||+++|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999874 3467899999999999999999999999 999999999999999999999999999865322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
..........+...|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+ .+....
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~---~~~~~-~~~~~~----- 224 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---E---IIEKL-KQGQRL----- 224 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---H---HHHHH-HTTEET-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c---ccccc-cccccc-----
Confidence 22333344557788999999998889999999999999999999 77888654221 1 11111 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..+..++..+.+++..||+.+|++||++.++++.|
T Consensus 225 -----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 -----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11223456788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=326.71 Aligned_cols=260 Identities=26% Similarity=0.376 Sum_probs=205.8
Q ss_pred CccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
+|++.+.||+|+||.||+|.... ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998753 235799998865432 234568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCc
Q 042519 158 VYEYMPLRSLEDHLLDIGP--------------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSN 217 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 217 (427)
|+||+.+++|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999998864321 1245789999999999999999999999 9999999999
Q ss_pred eEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 042519 218 ILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTY 296 (427)
Q Consensus 218 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~ 296 (427)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999875332222112233456778999999988889999999999999999998 99998654322
Q ss_pred cchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 297 EQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+... ..... ....+......+.+++..||+.+|++||++.++++.|+.+.
T Consensus 237 --~~~~~----~~~~~----------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 --RLFNL----LKTGY----------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --HHHHH----HhCCC----------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11111 11110 01112234467889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=322.56 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=203.3
Q ss_pred ccccceeccCCceEEEEEEECCC---CcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe-----
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ----- 154 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 154 (427)
|.+.+.||+|+||.||+|....+ +..||+|.+..... .....+..|+..++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999997653 47899999875432 223568889999999999999999998876554
Q ss_pred -eEEEEeecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 155 -RLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 155 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
.++|+||+++++|..++.... .....+++..++.++.|++.||.|||+++ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999886543 23356899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .+ .... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~---~~~~-~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EI---YDYL-RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHH-Hc
Confidence 99986433322222222345678999999988899999999999999999999 88888653321 11 1111 11
Q ss_pred CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
+.. . ..+......+.+++.+||+.||++||++.++++.|..+
T Consensus 231 ~~~-~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNR-L---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC-C---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 0 11223456889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=335.18 Aligned_cols=245 Identities=24% Similarity=0.278 Sum_probs=197.6
Q ss_pred ceeccCCceEEEEEEE---CCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecC
Q 042519 89 CLIGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 163 (427)
+.||+|+||.||+++. +.+|+.||+|++...... ....+..|+.++.+++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999886 357899999999754322 23456779999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT 243 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 243 (427)
+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~ 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--E 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--C
Confidence 9999998854 346899999999999999999999999 999999999999999999999999998753222 1
Q ss_pred ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccC
Q 042519 244 HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQ 323 (427)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (427)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ............
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~~~~~---------- 216 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILKAKLG---------- 216 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHcCCCC----------
Confidence 2233467999999999999888999999999999999999999999754321 111112111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 042519 324 GEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALS 360 (427)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~ 360 (427)
.+......+.+++..||+.||++||+ +.+++.+.+
T Consensus 217 --~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 217 --MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 12223457789999999999999999 555665533
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=324.18 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=206.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc----EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ----VVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.++|++.++||+|+||+||+|.+..+|. .||+|++..... .....+.+|+.++..++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 4678999999999999999999877666 489999865432 2345678899999999999999999999764 578
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+++||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999865 2346889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..............+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..+. ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLL----EKGERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HCCCcCC
Confidence 433222211222345678999999998899999999999999999998 8999865432 1122211 1111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
.+......+.+++..||+.||++||++.++++.|..+...+
T Consensus 232 ----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 ----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 11223457889999999999999999999999998876644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.79 Aligned_cols=239 Identities=26% Similarity=0.335 Sum_probs=191.1
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHH-HHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEV-LMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
+.||+|+||.||+|+++.+++.||+|++.+... .....+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999999999999999875422 1222334443 456789999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
++|.+++.. ...+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ...
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCC
Confidence 999998854 345778888899999999999999999 99999999999999999999999999875221 122
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ............
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~----------- 214 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKPLQ----------- 214 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCcC-----------
Confidence 234567999999999999999999999999999999999999999754321 111122221111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMSD 354 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 354 (427)
.+......+.+++..||+.+|.+||++.+
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 215 -LKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 11223457889999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=321.00 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=205.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4679999999999999999999764 6679999986543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999998653 3356788899999999999999999999 9999999999999999999999999998643221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. .......++..|+|||++....++.++|||||||++|+|++ |..||...... ..... .......+
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~~----- 224 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSA----LQRGYRMP----- 224 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHH----HHcCCCCC-----
Confidence 1 11223346678999999998889999999999999999998 99999653221 11111 11111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 -----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=325.54 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=209.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
..+|++.+.||+|+||.||+|.+..++..|++|.+..........+.+|+.+++.+.|+||+++++++..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35799999999999999999999999999999999876666667788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998843 35788999999999999999999999 9999999999999999999999999987532221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.. .+. ...... .+.
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~-~~~~~~--~~~----- 235 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALY-LIATNG--TPE----- 235 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHH-HHhcCC--CCC-----
Confidence 11233568899999999998889999999999999999999999997543211 000 011110 000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+ ..+......+.+++.+||..+|++||++.+++++-+.
T Consensus 236 ~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~ 273 (296)
T cd06654 236 L--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (296)
T ss_pred C--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence 0 1122344678899999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=326.68 Aligned_cols=259 Identities=26% Similarity=0.352 Sum_probs=205.5
Q ss_pred hCccccceeccCCceEEEEEEECCC-----CcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKT-----AQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.+|++.+.||+|+||.||+|.+..+ +..||||++...... ....+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4588889999999999999987543 578999998754322 2356788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC
Q 042519 157 LVYEYMPLRSLEDHLLDIG------------PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF 224 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 224 (427)
+++||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 12345788899999999999999999999 99999999999999999
Q ss_pred CeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 042519 225 NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTW 303 (427)
Q Consensus 225 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~ 303 (427)
.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||...... .+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HH
Confidence 999999999876433322222334456788999999988889999999999999999998 88888653221 11
Q ss_pred hhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 304 AQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...... ... ...+...+..+.+++..||+.+|.+||++.+|+..|+.
T Consensus 236 ~~~i~~-~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRN-RQV----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHc-CCc----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 111 01123345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=326.68 Aligned_cols=270 Identities=23% Similarity=0.335 Sum_probs=205.4
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|.+.+.||+|+||.||+|+++.++..||+|.+...... ....+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5699999999999999999999999999999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
++ ++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 98 5888887652 345788899999999999999999999 9999999999999999999999999987532221
Q ss_pred ccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--------hhhhcCC-
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA--------QPFFKDP- 311 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~- 311 (427)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||............... ++.+...
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12234568899999998865 46899999999999999999999999765432111110000 0000000
Q ss_pred ----CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 312 ----NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 312 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...+........ .........+.+++.+||+.||.+|||+.|++++-+..
T Consensus 237 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 237 EFKNYNFPKYKPQPLI-NHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290 (309)
T ss_pred hhhhhhcCccCCCchh-hhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence 000000000000 00112345678999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=323.75 Aligned_cols=269 Identities=28% Similarity=0.416 Sum_probs=204.3
Q ss_pred ccccceeccCCceEEEEEEE----CCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--CeeEE
Q 042519 85 FRQECLIGEGGFGRVYKGKL----EKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQRLL 157 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 157 (427)
|.+.+.||+|+||+||++.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988653 45678999999875432 2345678899999999999999999988653 46789
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999854 35899999999999999999999999 999999999999999999999999998864
Q ss_pred CCCCccc-eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDKTH-VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
....... ......++..|+|||++.+..++.++||||||+++|+|++|..||......... ......... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~-~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQM-TVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhccccccc-chhhhhh
Confidence 3322111 112234566799999998888999999999999999999999998654322110 000000000 0001111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..+.......+...+..+.+++..||+.+|++||++.++++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112223445578999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=327.16 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=206.5
Q ss_pred hhCccccceeccCCceEEEEEEE-----CCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 154 (427)
.++|.+.+.||+|+||.||++.+ ..++..||+|.++.... ...+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 46799999999999999999975 33456899999875432 2335688899999999 79999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.++||||+++|+|.+++.... ...+++.+.+.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999986522 234899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
+...............++..|+|||++.+..++.++|||||||++|+|++ |..||....... ... ........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~ 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFY----KLIKEGYR 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHH----HHHHcCCc
Confidence 75433222112223456788999999998899999999999999999998 999986543211 111 11111100
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
. ..+......+.+++.+||+.+|++||++.++++.|..+
T Consensus 263 ~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 M----------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 01112345788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=323.80 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=207.3
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.|+..++||+|+||.||++.+..+++.||+|.+....... ...+..|+.+++.++|+||+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999999999999999986543322 2346789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999988653 2346889999999999999999999999 999999999999999999999999998753322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.......... . ....... ..
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~--~-~~~~~~~---~~----- 221 (285)
T cd05630 156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--E-VERLVKE---VQ----- 221 (285)
T ss_pred c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH--H-HHhhhhh---hh-----
Confidence 1 1223478999999999999899999999999999999999999997543211100 0 0111110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhcC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFLG 363 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~~ 363 (427)
...+......+.+++..||+.||++||+ +.+++++-+...
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 222 ---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred ---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 0112223456889999999999999999 899999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=332.52 Aligned_cols=243 Identities=26% Similarity=0.318 Sum_probs=193.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHH-HHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVL-MLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||+||+|++..+|+.||+|++.+... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999865421 22234455544 56779999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999888753 356889999999999999999999999 999999999999999999999999998752211 12
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ............
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~~~----------- 214 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKPLV----------- 214 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCCcc-----------
Confidence 234567999999999999999999999999999999999999999754321 111112211100
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHH
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMS----DVVSA 358 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~----evl~~ 358 (427)
.+......+.+++..||+.+|.+||++. +++++
T Consensus 215 -~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 215 -LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 0112335678999999999999999875 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=339.12 Aligned_cols=262 Identities=26% Similarity=0.364 Sum_probs=206.3
Q ss_pred hhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCCcc-hHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGLQG-NKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 154 (427)
.++|.+.+.||+|+||.||+|++.+ ++..||||+++...... .+.+..|+.++..+. ||||++++++|.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 4568889999999999999999643 45689999997643322 346888999999998 9999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC----------------------------------------------------------
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGP---------------------------------------------------------- 176 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 176 (427)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999865321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 177 ------------------------------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 177 ------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1134677888999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~ 299 (427)
+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~---- 348 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN---- 348 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch----
Confidence 9999999999999975322221112223457888999999998889999999999999999998 88898643211
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
............. ..+......+.+++..||+.+|.+||++.+|++.|+.+
T Consensus 349 --~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 --EQFYNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --HHHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111111110 11223346889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.92 Aligned_cols=270 Identities=21% Similarity=0.247 Sum_probs=207.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|++.+.||+|+||.||++.+..++..+|+|.+...... ....+.+|+.++..++||||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3689999999999999999999999999999998654222 235578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+ ++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999998642 568889999999999999999998 47 999999999999999999999999998753221
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC------
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY------ 314 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 314 (427)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||.........................
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 1234578999999999988889999999999999999999999996433211110000000000000000
Q ss_pred ----------CcccccccCC---CC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 315 ----------PQLADPLLQG---EF-PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 315 ----------~~~~~~~~~~---~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..+.+..... .. .......+.+++.+||+.+|++||++.+++++.+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 0000000000 00 0123456889999999999999999999999987644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=323.53 Aligned_cols=259 Identities=28% Similarity=0.431 Sum_probs=206.7
Q ss_pred hhCccccceeccCCceEEEEEEEC-----CCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE-----KTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
..+|...++||+|+||.||++... .++..+|+|.+..........+.+|+.+++.++|+||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356888999999999999999753 346789999987665555677899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC
Q 042519 157 LVYEYMPLRSLEDHLLDIGP-----------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN 225 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 225 (427)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999875431 1135789999999999999999999999 999999999999999999
Q ss_pred eeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 042519 226 AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 226 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~ 304 (427)
+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||........ .
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~ 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------I 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------H
Confidence 99999999875432222122233445788999999998899999999999999999998 8999865432111 1
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
... ...... ..+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 235 ~~~-~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECI-TQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHH-HcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111 110000 111223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=326.01 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=205.2
Q ss_pred hhCccccceeccCCceEEEEEEECC----------------CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK----------------TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVN 144 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 144 (427)
.++|++.+.||+|+||.||++.+.. ++..||+|.+..... .....+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3579999999999999999986542 345799999875432 23467889999999999999999
Q ss_pred EEEEEEcCCeeEEEEeecCCCChhhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCc
Q 042519 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPE-------QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSN 217 (427)
Q Consensus 145 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 217 (427)
+++++...+..++||||+++++|.+++...... ...+++.+++.++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 999999999999999999999999998764321 234778899999999999999999999 9999999999
Q ss_pred eEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCc
Q 042519 218 ILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT--GRRAIDTTRPT 295 (427)
Q Consensus 218 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~--g~~p~~~~~~~ 295 (427)
||++.++.++|+|||++................+++.|++||+..++.++.++|||||||++|||++ |..||....+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875433222222233445678999999888889999999999999999998 67788654322
Q ss_pred ccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 296 YEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
. .......++........ ...+..++..+.+++.+||+.||.+||++.+|++.|.
T Consensus 241 ~---~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 Q---VIENTGEFFRDQGRQVY-------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHHhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 11111111111100000 0112223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=321.89 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=200.9
Q ss_pred ccccceeccCCceEEEEEEECCCCc--EEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC------Ce
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQ--VVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG------EQ 154 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 154 (427)
|.+.++||+|+||.||+|.+..++. .||+|.++... ......+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999987765 59999886542 23345678899999999999999999987532 24
Q ss_pred eEEEEeecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 155 RLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
.++||||+++|+|.+++.... .....+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998875322 23355899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
+++...............+++.|++||++.+..++.++|||||||++|||++ |..||...... .+ . ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~---~-~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EI---Y-DYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH---H-HHHHcC
Confidence 9986433222111223346778999999999899999999999999999999 88888653221 11 1 111211
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.... .+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 1122345688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=319.99 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=202.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|++.++||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35788899999999999999999999999999986542 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999996542 3678888999999999999999999 999999999999999999999999998753221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchh-hhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL-VTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 320 (427)
......||..|+|||++.+..++.++|||||||++|+|++|+.||........... .......... ....+
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~--- 220 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--DPPVL--- 220 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--CCCCC---
Confidence 22346789999999999988999999999999999999999999975332211110 1111111100 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
........+.+++.+||+.+|.+||++.+++++.+.
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 221 -----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred -----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 011233568899999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=334.10 Aligned_cols=269 Identities=21% Similarity=0.254 Sum_probs=203.6
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG----- 152 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 152 (427)
...++|++.+.||+|+||.||++.+..+++.||||.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 346789999999999999999999999999999999865432 2335677899999999999999999988643
Q ss_pred -CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 153 -EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 153 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
...++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 35799999997 56766663 24788889999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch------------
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN------------ 299 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~------------ 299 (427)
|+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 164 g~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 164 GLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99975322 122334578999999999999899999999999999999999999997543211000
Q ss_pred ----hhhhhhhhhcCCCCCC-----cccccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 300 ----LVTWAQPFFKDPNRYP-----QLADPLLQ---GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 300 ----~~~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+......+........ ......+. ...+......+.+++.+||+.||++|||+.|++++-+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 0000011111111100 00000000 01112234578899999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=328.40 Aligned_cols=263 Identities=26% Similarity=0.364 Sum_probs=206.2
Q ss_pred hhCccccceeccCCceEEEEEEECC-------CCcEEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-------TAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 152 (427)
.++|.+.+.||+|+||.||++++.. ++..+|+|.+.... ......+..|+.++..+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3679999999999999999998743 23569999987542 23345678899999999 799999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+++ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999976432 1235889999999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~ 299 (427)
+.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 9999999999999875432221111222234568999999998889999999999999999998 88888643211
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..... ...... ...+......+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus 250 --~~~~~-~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 250 --ELFKL-LKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred --HHHHH-HHcCCC----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11111 111100 01122344688899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=323.54 Aligned_cols=264 Identities=29% Similarity=0.423 Sum_probs=203.5
Q ss_pred hCccccceeccCCceEEEEEEE----CCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCeeE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKL----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQRL 156 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 156 (427)
.+|++.+.||+|+||.||++.. ..++..||+|.+..........+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788999999999999999984 45688999999876655556678899999999999999999998754 34689
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999998642 345889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccce-eccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc---------hhhhhhhh
Q 042519 237 GPIGDKTHV-SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ---------NLVTWAQP 306 (427)
Q Consensus 237 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~---------~~~~~~~~ 306 (427)
......... .....++..|+|||++.+..++.++|||||||++|||++|..++......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 433222111 11122345699999999889999999999999999999988765432111000 00000000
Q ss_pred hhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...... .-..+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 238 ~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111100 0011233456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=318.09 Aligned_cols=251 Identities=27% Similarity=0.357 Sum_probs=207.4
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|.+.+.||+|+||.||+|.++.+++.|++|.+.... ......+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999999999999999986543 23446678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~- 154 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN- 154 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc-
Confidence 9999999998763 2457889999999999999999999999 999999999999999999999999998764322
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ........ ...+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~--~~~~------ 219 (256)
T cd08529 155 -TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILKIIR--GVFP------ 219 (256)
T ss_pred -cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHc--CCCC------
Confidence 22233456889999999999989999999999999999999999999754311 11111111 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122345678999999999999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.29 Aligned_cols=259 Identities=22% Similarity=0.268 Sum_probs=202.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||+++++.+++.||||++.... ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999999999999999996532 223356778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999854 346889999999999999999999999 99999999999999999999999999864321
Q ss_pred CCcc---------------------------------ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCC
Q 042519 240 GDKT---------------------------------HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286 (427)
Q Consensus 240 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~ 286 (427)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHhhcC
Q 042519 287 RAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL---MSDVVSALSFLG 363 (427)
Q Consensus 287 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~~L~~~~ 363 (427)
.||....+... ........... . ..+ .......+.+++.+++. +|.+|++ +.+++++-+.-.
T Consensus 234 ~Pf~~~~~~~~------~~~i~~~~~~~-~-~p~------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 234 PPFCSETPQET------YRKVMNWKETL-V-FPP------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCCCCHHHH------HHHHHcCCCce-e-cCC------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 99976543211 11111100000 0 000 00123467778877664 9999984 788888765443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=323.33 Aligned_cols=267 Identities=27% Similarity=0.333 Sum_probs=209.2
Q ss_pred cCHHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEE-
Q 042519 73 FTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCA- 150 (427)
Q Consensus 73 ~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 150 (427)
+.++.+....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344555566789999999999999999999999999999999976432 2335678899999999 6999999999884
Q ss_pred ----cCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCe
Q 042519 151 ----DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226 (427)
Q Consensus 151 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 226 (427)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 446789999999999999988654444567889999999999999999999999 9999999999999999999
Q ss_pred eEeecCCcccCCCCCccceeccccccccccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 042519 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301 (427)
Q Consensus 227 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~ 301 (427)
+|+|||+++...... .......|++.|+|||++.. ..++.++|||||||++|+|++|+.||....+.. .+.
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF 239 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh
Confidence 999999987532211 12233568999999998853 457899999999999999999999997543211 000
Q ss_pred hhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 302 TWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
. ... .....+.. +......+.+++.+||+.+|++||++.+++++++
T Consensus 240 ~----~~~--~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 240 K----IPR--NPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred h----ccc--cCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 0 000 00011111 1122356889999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=320.53 Aligned_cols=255 Identities=30% Similarity=0.447 Sum_probs=205.6
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchH--HHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK--EFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
|++.+.||+|+||+||++++..+++.||+|++......... ...+|+.+++.++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 77889999999999999999999999999999876543332 2356999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++++|.+++. ....+++..++.++.||++||.+||+.+ |+|+||||+|||++.++.++|+|||++... ...
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 9999999996 2456899999999999999999999999 999999999999999999999999998753 122
Q ss_pred cceeccccccccccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhh-hhhhhhcCCCCCCccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT-WAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 320 (427)
........++..|+|||++. +..++.++||||||+++|+|++|..||............. ........ .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~ 222 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS---------S 222 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH---------H
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc---------c
Confidence 23344567899999999998 8889999999999999999999999998652111111111 01000000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
... .......+.+++..||+.||++||++.+++++-+
T Consensus 223 ~~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 223 SQQ---SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp TTS---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred ccc---cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 000 0001268999999999999999999999998643
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=335.35 Aligned_cols=268 Identities=22% Similarity=0.350 Sum_probs=204.4
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC-----eeE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE-----QRL 156 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 156 (427)
+|++.+.||+|+||.||++.+..+|+.||||++.... ......+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999899999999986532 223456788999999999999999999998776 789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+|+||+. ++|.+.+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 67877774 3456899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhh-h------------
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV-T------------ 302 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~-~------------ 302 (427)
..... ........+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+....... .
T Consensus 153 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 43222 1122335688999999998764 5799999999999999999999999765432111000 0
Q ss_pred ---hhh-hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 303 ---WAQ-PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 303 ---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
... .+.......+... ... .........+.+++.+||+.||.+|||+.+++++-+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLP-VLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred hhHHHHHHHHhCCCCCCchH-Hhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 000 0011111111000 000 011122467889999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=321.53 Aligned_cols=255 Identities=26% Similarity=0.367 Sum_probs=203.2
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC------C
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG------E 153 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 153 (427)
+.+.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.++..+ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4577899999999999999999999999999999986543 3446778899999988 699999999998753 4
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 689999999999999998653 2356889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
+...... ........|++.|+|||++. +..++.++|||||||++|||++|..||....+.... . ...
T Consensus 158 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~-~~~ 229 (272)
T cd06637 158 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----F-LIP 229 (272)
T ss_pred ceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----H-HHh
Confidence 8753221 12234467899999999986 346888999999999999999999999654322111 0 000
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.. ..... .+......+.+++.+||+.+|.+||++.+++++-
T Consensus 230 ~~--~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 270 (272)
T cd06637 230 RN--PAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270 (272)
T ss_pred cC--CCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence 00 00111 1112345788999999999999999999998763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=329.51 Aligned_cols=261 Identities=21% Similarity=0.221 Sum_probs=201.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||++++..+++.||+|++.+... .....+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 469999999999999999999999999999999865321 23345788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998642 346889999999999999999999999 99999999999999999999999999875322
Q ss_pred CCccceeccccccccccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT-----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
.. ........||+.|+|||++.. ..++.++|||||||++|+|++|+.||..... ..............
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~ 227 (331)
T cd05597 155 DG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHF 227 (331)
T ss_pred CC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence 21 112233569999999999863 4578899999999999999999999975322 11111111111111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHhhcC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQE--ESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~P~~RPs~~evl~~L~~~~ 363 (427)
. +.. ........+.+++..||.. ++..|+++.+++++-+...
T Consensus 228 ~-~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 228 Q-FPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred c-CCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 0 000 0111345677788887654 4444889999999976543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=322.03 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=209.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
..+|++.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999999989999999999776555567788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998843 45788899999999999999999999 9999999999999999999999999987532221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+..... ..... ..+.
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~--~~~~----- 234 (297)
T cd06656 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATN--GTPE----- 234 (297)
T ss_pred --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccC--CCCC-----
Confidence 12234568899999999998889999999999999999999999996543221100 00000 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...+......+.+++.+||+.+|++||++.+++++-+.
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (297)
T cd06656 235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272 (297)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 01123344667899999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.64 Aligned_cols=268 Identities=22% Similarity=0.273 Sum_probs=202.9
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC------
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG------ 152 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 152 (427)
..++|++.+.||+|+||.||++.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999999999999999986532 22345677899999999999999999987643
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
...++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999997 57777663 24778889999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhh---------h-
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV---------T- 302 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~---------~- 302 (427)
+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .
T Consensus 172 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9975322 12233457899999999999999999999999999999999999999754322110000 0
Q ss_pred ------hhhhhhcCCCCCC-----ccccccc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 303 ------WAQPFFKDPNRYP-----QLADPLL---QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 303 ------~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
....+..+..... .+..... ...........+.+++.+||+.||.+|||+.+++++-+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 0000001000000 0000000 001111223578899999999999999999999998665
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=325.90 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=208.3
Q ss_pred hhCccccceeccCCceEEEEEEEC-------CCCcEEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE-------KTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 152 (427)
.++|.+.+.||+|+||.||+|++. ..+..||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 577999999999999999999753 234579999986542 23346688999999999 799999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
...++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999976432 1245788899999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~ 299 (427)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999986433222222233446678999999988889999999999999999998 7788754321
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+... ....... ..+..+...+.+++.+||+.+|.+||++.++++.|..+..
T Consensus 246 -~~~~~~-~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 246 -EELFKL-LKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -HHHHHH-HHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 111111 1111110 1122345678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=321.76 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=207.3
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
+.|++.+.||+|+||.||+|.+..++..+++|.+..........+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34788899999999999999999999999999997665555667888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++++|..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..... .
T Consensus 85 ~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~ 156 (282)
T cd06643 85 AGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 156 (282)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc--c
Confidence 99999888754 2356899999999999999999999999 99999999999999999999999999875321 1
Q ss_pred cceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 243 THVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
........|++.|+|||++. +..++.++|||||||++|+|++|+.||....+.. ... ..... ....+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~----~~~~~--~~~~~ 228 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLL----KIAKS--EPPTL 228 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHH----HHhhc--CCCCC
Confidence 11223456899999999884 4557889999999999999999999987543211 111 11110 00000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+......+.+++..||+.+|.+||++.+++++-+..
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 266 (282)
T cd06643 229 -------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266 (282)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence 01223346788999999999999999999999887643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=326.96 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=202.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcE--EEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQV--VAVKQLDRNG-LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|.++.++.. +++|.+.... ......+.+|+.++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 35789999999999999999999877754 5777765422 22345678899999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC
Q 042519 158 VYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN 225 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 225 (427)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999875431 1246889999999999999999999999 999999999999999999
Q ss_pred eeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 042519 226 AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 226 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~ 304 (427)
+||+|||++..... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY 233 (303)
T ss_pred EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHH
Confidence 99999999863211 111111234567999999988889999999999999999998 99998643221 111
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
... ...... ..+......+.+++.+||+.+|++||++.++++.|..+.
T Consensus 234 ~~~-~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 234 EKL-PQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHH-hcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 110000 011123456889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.61 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=205.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc---EEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ---VVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|+..+.||+|+||.||+|++..++. .+|+|.+.... ....+.+..|+.++..++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578889999999999999999876554 79999986543 2334568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999865 2356889999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCccce-eccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 238 PIGDKTHV-SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 238 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+ ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i-~~~~~~~ 230 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAI-NDGFRLP 230 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHH-hcCCCCC
Confidence 32221111 111223457999999998889999999999999999997 99999653321 111111 1111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+...+..+.+++.+||+.+|++||++.+|++.|..+
T Consensus 231 ----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1123346788999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=325.16 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=203.3
Q ss_pred hCccccceeccCCceEEEEEEECCCCc--EEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQ--VVAVKQLDRNG-LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 158 (427)
++|++.++||+|+||.||+|..+.++. .+++|.++... ....+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 478999999999999999999877664 46888876422 23345688899999999 699999999999999999999
Q ss_pred EeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCe
Q 042519 159 YEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 226 (427)
+||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999865321 1235889999999999999999999999 9999999999999999999
Q ss_pred eEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhh
Q 042519 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 227 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~ 305 (427)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYE 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence 99999998642111 11111223457999999998889999999999999999997 99999654321 1111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.... .. ....+......+.+++..||+.+|.+||++.++++.|..+..
T Consensus 230 ~~~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 230 KLPQ-GY----------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHhc-CC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 00 001122234678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=318.35 Aligned_cols=256 Identities=22% Similarity=0.345 Sum_probs=207.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.+.|++.+.||+|+||.||+|++..++..|++|.+..........+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 46799999999999999999999999999999999776555567788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|..++... ...+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 91 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~-- 162 (292)
T cd06644 91 CPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK-- 162 (292)
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc--
Confidence 9999998877542 346899999999999999999999999 99999999999999999999999999865221
Q ss_pred ccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.........+++.|+|||++. ...++.++|||||||++|+|++|..||....+. ......... ..+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~--~~~~ 234 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS--EPPT 234 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcC--CCcc
Confidence 111223456888999999884 345788999999999999999999999754321 111111111 0000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
. ..+......+.+++.+||+.+|++||++.+++++-+
T Consensus 235 ~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 235 L-------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred C-------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0 112233457889999999999999999999998754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.86 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=202.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
++|++.+.||+|+||.||+|.+.+ +..+|+|.+.... .....+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 568899999999999999998865 4569999986543 33467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
.+++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE- 154 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc-
Confidence 999999998653 236899999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
........++..|+|||++.+..++.++|||||||++|+|++ |..||....... . ...... ....
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~---~~~~~~-~~~~------- 220 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---T---VEKVSQ-GLRL------- 220 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H---HHHHhc-CCCC-------
Confidence 111122345678999999988889999999999999999998 999987543211 1 111111 1110
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..+......+.+++..||+.+|.+||++.++++.|+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112467889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.16 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=198.1
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhc---CCCCeeeEEEEEEc-----CC
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLL---HHDNLVNLIGYCAD-----GE 153 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 153 (427)
+|++.+.||+|+||.||+|+++.+|+.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488899999999999999999999999999998654322 223456677766655 69999999998864 34
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5799999998 5898888653 2345899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC--
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP-- 311 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 311 (427)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ +.... .....+
T Consensus 155 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~-~~~~~~~~ 228 (288)
T cd07863 155 ARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIF-DLIGLPPE 228 (288)
T ss_pred cccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHH-HHhCCCCh
Confidence 9764321 122345689999999999988999999999999999999999999965432211 11100 000000
Q ss_pred CCCCc-------ccccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 NRYPQ-------LADPLLQ---GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 ~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
...+. ...+... ..........+.+++.+||+.||++||++.+++.+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp 286 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 00000 0000000 011123346788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=318.72 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=204.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|.+.+.||+|+||.||+|.+..+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 45789999999999999999999999999999998765444455678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ...+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~-- 158 (267)
T cd06645 88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA-- 158 (267)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC--
Confidence 999999998854 346889999999999999999999999 99999999999999999999999999875321
Q ss_pred ccceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.........|++.|+|||++. ...++.++|||||||++|+|++|..||....+.... .. ........+.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~~----~~~~~~~~~~-- 230 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FL----MTKSNFQPPK-- 230 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--Hh----hhccCCCCCc--
Confidence 112223457899999999874 456889999999999999999999998654322110 00 0000000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
... .......+.+++.+||+.+|++||++.+++++
T Consensus 231 ---~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 ---LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 01123467899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=316.73 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=205.4
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
+|++.+.||.|+||.||++.+..++..||+|.++... ....+.+..|+.+++.++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4888999999999999999999999999999986432 233456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++++|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 999999988643 2345788999999999999999999999 999999999999999999999999998754221
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ........ ....
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~--~~~~------- 218 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVCQ--GSYK------- 218 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHhc--CCCC-------
Confidence 22233467899999999999888999999999999999999999999753221 11111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..+......+.+++.+||+.+|++||++.+++..
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122334568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=316.66 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=201.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
.+|++.+.||+|+||.||+|.++. +..+|+|.+..... ....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 458899999999999999999874 66799999865432 3456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~- 154 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ- 154 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc-
Confidence 999999998653 236889999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
........++..|+|||++.+..++.++||||||+++|+|++ |..||....+.. ... . ......
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~-~~~~~~-------- 219 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE---S-VSAGYR-------- 219 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH---H-HHcCCc--------
Confidence 111112234457999999998899999999999999999999 899987543221 111 1 111000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
...+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 --LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011222456789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=351.44 Aligned_cols=261 Identities=22% Similarity=0.306 Sum_probs=204.9
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCee
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQR 155 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 155 (427)
...++|++.+.||+|+||+||+|++..++..||+|++...... ....+..|+.++..|+|||||+++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3457899999999999999999999999999999998754322 34568889999999999999999998864 4568
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEeccCCCCceEeCC---------
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN----PPVIYRDLKSSNILLDC--------- 222 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~Dlkp~NIll~~--------- 222 (427)
||||||+++++|.++|.........+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997654445679999999999999999999998531 23999999999999964
Q ss_pred --------CCCeeEeecCCcccCCCCCccceeccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 042519 223 --------EFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAIDTT 292 (427)
Q Consensus 223 --------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~~~~ 292 (427)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||||||+|++|..||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 234899999999753221 12234579999999999854 45889999999999999999999999753
Q ss_pred CCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 293 RPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
... ...... +.... .+. .......+.+||..||+.+|.+||++.+++.+-+
T Consensus 247 ~~~-----~qli~~-lk~~p---~lp--------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 247 NNF-----SQLISE-LKRGP---DLP--------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CcH-----HHHHHH-HhcCC---CCC--------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 221 111111 11111 100 0112457889999999999999999999996543
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.14 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=210.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
.+|++.+.||.|+||.||+|.+..+|+.|++|.+..........+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999999999999999997665555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++++|..++.. ..+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~- 169 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ- 169 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc-
Confidence 99999998843 45889999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.... ...... ....+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~--~~~~~----- 235 (296)
T cd06655 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATN--GTPEL----- 235 (296)
T ss_pred -ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhc--CCccc-----
Confidence 1123456889999999999888999999999999999999999999764432111 011111 00000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+......+.+++.+||+.+|++||++.+++.+=+.-
T Consensus 236 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 236 --QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred --CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 01223345788999999999999999999999986653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.44 Aligned_cols=252 Identities=32% Similarity=0.461 Sum_probs=206.6
Q ss_pred ceeccCCceEEEEEEECCC---CcEEEEEEeccCCCcc-hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGLQG-NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
+.||+|+||.||+|.+... +..|++|.+....... ...+.+|+.++..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999999866 8899999997654433 56788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 165 RSLEDHLLDIGPE-----QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 165 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
++|.+++...... ...+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998764211 467899999999999999999999999 99999999999999999999999999987543
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
...........+++.|+|||.+....++.++||||||+++|+|++ |..||....+. .+.. . ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~-~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLE---Y-LRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---H-HHcCCC-----
Confidence 332223344567889999999988899999999999999999999 69999765221 1111 1 111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
...+...+..+.+++.+||+.+|++||++.+++++|+
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0112233568899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=331.27 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=202.2
Q ss_pred hhCccccceeccCCceEEEEEEEC-----CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEc-CC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE-----KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCAD-GE 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 153 (427)
.++|++.+.||+|+||.||+|.+. .+++.||||+++.... .....+.+|+.++..+ +|+||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 467999999999999999999853 4578899999975432 2335678899999999 68999999998765 45
Q ss_pred eeEEEEeecCCCChhhhhhhcCC---------------------------------------------------------
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGP--------------------------------------------------------- 176 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 176 (427)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999865321
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceecccc
Q 042519 177 ------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM 250 (427)
Q Consensus 177 ------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 250 (427)
....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124678888999999999999999999 9999999999999999999999999987532222111122334
Q ss_pred ccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHH
Q 042519 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVR 329 (427)
Q Consensus 251 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (427)
++..|+|||++.+..++.++||||||+++|+|++ |..||...... .... ......... . .+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~~~~-~---------~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC----RRLKEGTRM-R---------APDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHH----HHHhccCCC-C---------CCCC
Confidence 5678999999988899999999999999999997 88888653221 0111 111111110 0 0111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 330 GLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 330 ~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
....+.+++..||+.+|++||++.+++++|+.+-
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2346889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=318.06 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=204.4
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.|+..+.||+|+||+||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+.+.+++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377788999999999999999999999999998654322 22346789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999888653 2346899999999999999999999999 999999999999999999999999998753222
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||........ .............
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~~-------- 222 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLETEE-------- 222 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhcccc--------
Confidence 1 12345789999999999988999999999999999999999999975432111 1111111111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALS 360 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~ 360 (427)
.++......+.+++..||+.+|++||+ +.+++.+-+
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChh
Confidence 112223456789999999999999999 778887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=331.20 Aligned_cols=260 Identities=20% Similarity=0.216 Sum_probs=202.8
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||+++++.+++.||+|++.+... .....+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999865321 22344678899999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999998652 346888999999999999999999999 99999999999999999999999999875432
Q ss_pred CCccceeccccccccccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT-----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
.. ........||+.|+|||++.+ +.++.++|||||||++|+|++|+.||...... .............
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~ 227 (331)
T cd05624 155 DG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERF 227 (331)
T ss_pred CC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcc
Confidence 21 112234579999999999875 56889999999999999999999999754321 1111111111111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhhc
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSV--RPLMSDVVSALSFL 362 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~L~~~ 362 (427)
.+ ... .......+.+++.+||..++.+ |+++.+++++.+..
T Consensus 228 -~~-p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~ 270 (331)
T cd05624 228 -QF-PSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE 270 (331)
T ss_pred -cC-CCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence 00 000 0123457888999988866544 56899998886543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.84 Aligned_cols=257 Identities=24% Similarity=0.410 Sum_probs=204.3
Q ss_pred hCccccceeccCCceEEEEEEECCCCc---EEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQ---VVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.+|++.+.||+|+||.||+|.++.+++ .||||.+.... ......+..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 458899999999999999999987664 69999986542 22346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999988653 346889999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCccceec-ccc--ccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 239 IGDKTHVSS-RVM--GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 239 ~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
......... ... .+..|+|||++.+..++.++|||||||++|||++ |..||...... ....+.. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~~~~~ 230 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----QDYRL 230 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----cCCcC
Confidence 222111111 111 2457999999998899999999999999999886 99998654321 1111111 11111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+...+..+.+++..||+.+|.+||++.+++..|+.+
T Consensus 231 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 ----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11123345788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=351.96 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=205.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.++||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4799999999999999999999999999999998754322 2356888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 160 EYMPLRSLEDHLLDIGP-------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
||++|++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998865321 1234567788999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCc----------------cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc
Q 042519 233 LAKLGPIGDK----------------THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY 296 (427)
Q Consensus 233 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~ 296 (427)
+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976411110 001123579999999999999999999999999999999999999996532110
Q ss_pred cchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhc
Q 042519 297 EQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-LMSDVVSALSFL 362 (427)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~ 362 (427)
.. . ......+... . .....+..+.+++.+||+.||++|| ++.++++.|+..
T Consensus 239 ---i~-~-~~~i~~P~~~----~------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ---IS-Y-RDVILSPIEV----A------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ---hh-h-hhhccChhhc----c------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0 0000000000 0 0112345688999999999999996 577777777655
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.66 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=209.0
Q ss_pred HhhCccccceeccCCceEEEEEEECC----CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEc-CCe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEK----TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-GEQ 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 154 (427)
..++|++.++||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35789999999999999999999876 357899998864422 234567889999999999999999998776 567
Q ss_pred eEEEEeecCCCChhhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEee
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPE----QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSD 230 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~D 230 (427)
.+++++|+++++|.+++...... ...+++..++.++.|++.||+|||+++ ++|+||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998764322 256899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhc
Q 042519 231 FGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFK 309 (427)
Q Consensus 231 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 309 (427)
||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||....+. .+..+ ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAY----LK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHH----HH
Confidence 999985433322222233456778999999988889999999999999999998 99999754321 11111 11
Q ss_pred CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 310 DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...... .+..++..+.+++.+||+.+|++||++.++++.|..+.
T Consensus 234 ~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111110 11223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=314.40 Aligned_cols=256 Identities=24% Similarity=0.333 Sum_probs=209.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||.|+||.||+|.+..+++.+++|.+..........+.+|+.+++.++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35799999999999999999999988999999999766555667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~- 154 (262)
T cd06613 82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT- 154 (262)
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh-
Confidence 9999999988652 256889999999999999999999999 999999999999999999999999998753221
Q ss_pred ccceeccccccccccCccccccC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTG---QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
........++..|+|||++.+. .++.++||||||+++|+|++|..||....+... ... .... .+ .
T Consensus 155 -~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~----~~~~--~~---~ 222 (262)
T cd06613 155 -IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL----ISKS--NF---P 222 (262)
T ss_pred -hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HHhc--cC---C
Confidence 1122345688899999998776 889999999999999999999999975432211 110 0010 00 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
...+ .........+.+++.+||+.+|.+||++.+|+.+
T Consensus 223 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 223 PPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred Cccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001 1123456678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=320.51 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=205.5
Q ss_pred HhhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
..++|++.++||+|+||.||+|..+. .+..||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35789999999999999999997652 345799999865432 223457789999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeE
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGP------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKL 228 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl 228 (427)
.++||||+++|+|.+++..... ....+.+..+..++.|++.||.|||+++ |+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975331 1234567788899999999999999999 999999999999999999999
Q ss_pred eecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhh
Q 042519 229 SDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...... ......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH
Confidence 99999875332222222222345678999999998899999999999999999998 78888643221 111111
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
. ..... ..+......+.+++.+||+.+|++||++.++++.|....
T Consensus 235 ~-~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 M-DGGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H-cCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1 11110 011223468899999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.49 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=205.1
Q ss_pred hhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4679999999999999999999753 578899999865432 2345688899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCc
Q 042519 156 LLVYEYMPLRSLEDHLLDIG------------------PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSN 217 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 217 (427)
++||||+++++|.+++.... .....+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986432 12235788899999999999999999999 9999999999
Q ss_pred eEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 042519 218 ILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTY 296 (427)
Q Consensus 218 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~ 296 (427)
||++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999875322221111222345667999999988899999999999999999997 88888543221
Q ss_pred cchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 297 EQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.... .+...... ..+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 240 -----~~~~-~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 -----EVIY-YVRDGNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred -----HHHH-HHhcCCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1111 11111110 012223467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=315.76 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=203.8
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 34555566789999999999999999999999999877655566778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-CCCeeEeecCCcccC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPI--DWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-EFNAKLSDFGLAKLG 237 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkl~DFG~a~~~ 237 (427)
|+++++|.+++.... ..+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++...
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 86 QVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred cCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999987532 234 77888899999999999999999 999999999999976 678999999998753
Q ss_pred CCCCccceeccccccccccCccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQ--LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
.... .......|++.|+|||++.... ++.++||||||+++|+|++|+.||....... ...+.......
T Consensus 160 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~~----- 229 (268)
T cd06624 160 AGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKI----- 229 (268)
T ss_pred ccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhcc-----
Confidence 2211 1223346889999999986543 7899999999999999999999996432211 11111111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
....+......+.+++.+||+.+|.+||++.+++++-
T Consensus 230 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 230 -------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred -------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 1112333456788999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=335.30 Aligned_cols=246 Identities=24% Similarity=0.377 Sum_probs=208.6
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCChhh
Q 042519 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLED 169 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 169 (427)
+||+|.||+||-|++..+...+|||.+........+-+..|+.+.+.|+|.|||+++|.+.+++.+-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999999999999999987777777889999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC-CCCCeeEeecCCcccCCCCCcccee
Q 042519 170 HLLDIGPEQKPI--DWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD-CEFNAKLSDFGLAKLGPIGDKTHVS 246 (427)
Q Consensus 170 ~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~ 246 (427)
+|...- .++ ++.++..+-.||++||.|||.+. |||||||-+|+||+ -.|.+||+|||.++... .....+
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~T 733 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCT 733 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCccc
Confidence 997633 345 77888889999999999999999 99999999999994 67899999999998632 233345
Q ss_pred ccccccccccCccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 247 SRVMGTYGYCAPEYQRTG--QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 247 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
.++.||..|||||++..+ .|+.++|||||||++.||.||++||-......... +.-.+++ ...
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---FkVGmyK------------vHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---FKVGMYK------------VHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---hhhccee------------cCC
Confidence 678899999999999765 58999999999999999999999996543221111 0001111 122
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..|.....+...+|.+|..+||.+||++.++++-
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 4577788899999999999999999999999985
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=325.54 Aligned_cols=260 Identities=21% Similarity=0.219 Sum_probs=202.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.++||+|+||.||+++++.+++.||+|++.+.. ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46899999999999999999999999999999986422 122344778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999652 346888899999999999999999999 99999999999999999999999999875322
Q ss_pred CCccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
. ........+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..............
T Consensus 155 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~ 227 (332)
T cd05623 155 D-GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERF 227 (332)
T ss_pred C-CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccc
Confidence 1 122233467999999999986 34688999999999999999999999975422 11111121111111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCC--CCCCHHHHHHHHhhc
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESS--VRPLMSDVVSALSFL 362 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~--~RPs~~evl~~L~~~ 362 (427)
. . + .........+.+++.+|+..++. .|+++.+++++-+..
T Consensus 228 ~-~--p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~ 270 (332)
T cd05623 228 Q-F--P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT 270 (332)
T ss_pred c-C--C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence 0 0 0 00112345778888888865444 478999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=312.84 Aligned_cols=251 Identities=27% Similarity=0.350 Sum_probs=207.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
++|++.+.||+|+||.||+|.+..++..|++|.+..... ...+.+|+.+++.++|+||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 579999999999999999999998899999999865432 678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 99999999864 3457899999999999999999999999 9999999999999999999999999988643222
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+..... ....... .
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---------~~~~~~~----~-- 217 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---------MIPNKPP----P-- 217 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---------hhccCCC----C--
Confidence 12233558889999999998899999999999999999999999997543321100 0000000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
....+......+.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 001123345678999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=324.29 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=206.2
Q ss_pred hhCccccceeccCCceEEEEEEECC-------CCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-------TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 152 (427)
.++|.+.+.||+|+||.||+|.+.. ....+|+|.+..... .....+..|+.++..+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4678999999999999999998632 345799999865432 2345678899999999 599999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
...++||||+++|+|.+++..... ....+++.++..++.||+.||.|||+++ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999976421 2245889999999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~ 299 (427)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---E 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999975432221111122234567999999988899999999999999999999 88888653221 1
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+.. ........ ..+..+...+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 245 ~~~----~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 LFK----LLREGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHH----HHHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111 11111100 1122334578899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=317.74 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=201.8
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|++.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 488899999999999999999999999999998654322 235678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+. ++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 98 68988876533 2356899999999999999999999999 999999999999999999999999998753222
Q ss_pred ccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh-------hhcCCC-
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP-------FFKDPN- 312 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~- 312 (427)
........+++.|+|||++.+. .++.++|||||||++|+|++|+.||........ ....... .+....
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchh
Confidence 1122334678899999988654 578999999999999999999999975432110 0000000 000000
Q ss_pred ------CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 313 ------RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 313 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..+......+. ........++.+++.+||+.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000 0011234577899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=321.97 Aligned_cols=268 Identities=24% Similarity=0.345 Sum_probs=205.0
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|.+.+.||.|+||.||+|+++.++..||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 579999999999999999999999999999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 98 6898888652 346788999999999999999999999 9999999999999999999999999987532221
Q ss_pred ccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC--CCCCccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP--NRYPQLA 318 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 318 (427)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ........+..+ ...+.+.
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhh
Confidence 12233457889999998865 457899999999999999999999997543211 010000000000 0000000
Q ss_pred ---------ccccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 319 ---------DPLLQG----EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 319 ---------~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+.... .........+.+++.+||+.||.+|||+.|++++-+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 000000 00112345678999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=314.34 Aligned_cols=247 Identities=27% Similarity=0.396 Sum_probs=196.0
Q ss_pred eeccCCceEEEEEEE--CCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCC
Q 042519 90 LIGEGGFGRVYKGKL--EKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLR 165 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 165 (427)
.||+|+||.||+|.+ ..++..+|+|++..... ...+.+..|+.+++.+.|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 45678999999865432 23456888999999999999999999886 45678999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc-
Q 042519 166 SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH- 244 (427)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~- 244 (427)
+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999854 346889999999999999999999999 9999999999999999999999999997643222111
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQ 323 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (427)
......++..|+|||.+....++.++|||||||++|||++ |..||...... ..... ...... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----i~~~~~-~-------- 217 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQM----IESGER-M-------- 217 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCCCC-C--------
Confidence 1122334578999999988889999999999999999998 99999754321 11111 111111 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 324 GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+...+..+.+++..||+.||++||++.+|.+.|+.
T Consensus 218 -~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 -ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1122344678899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.57 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=216.0
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
|.+.++||+|+||.||+|.++.+|..+|||.+... .+.+++..|+.+++++..+++|++||.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 77888999999999999999999999999998654 5678999999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|++.+.+.. ..+++.+.++..++...++||+|||... -+|||||..||||+-+|..||+|||.+... .+...
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQL--TDTMA 184 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQL--TDTMA 184 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchh--hhhHH
Confidence 999998876 5688999999999999999999999998 899999999999999999999999998652 22333
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
...++.|||-|||||++..-.|+.++||||||++..||.-|++||.+..|... +|--+...+..+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------IFMIPT~PPPTF------ 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------IFMIPTKPPPTF------ 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------eEeccCCCCCCC------
Confidence 34567899999999999999999999999999999999999999987665321 121111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..|.....++.++++.||-..|++|-|+.+++++-
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 22566778999999999999999999999999985
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=315.05 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=208.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
..|+..+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.+.|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 457788899999999999999998899999999875432 3345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998843 45888899999999999999999999 9999999999999999999999999987543222
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......++..|+|||++.+..++.++|+|||||++|||++|..||....+.... ... . ..
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~~-~----------~~ 216 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FLI-P----------KN 216 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hhh-h----------cC
Confidence 1223356888999999998888999999999999999999999999754322100 000 0 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.....+...+..+.+++..||+.+|++||++.+++.+-+.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 0112234566788999999999999999999999998664
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=313.85 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=202.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.+..+ ..||+|++.... .....+.+|+.+++.++|+||+++++++.+ ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 35699999999999999999998765 459999987543 234578899999999999999999998754 567999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999998653 2346789999999999999999999999 9999999999999999999999999997543222
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||....+.. . .... ......
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~---~~~~-~~~~~~------ 222 (262)
T cd05071 157 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V---LDQV-ERGYRM------ 222 (262)
T ss_pred c-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---H---HHHH-hcCCCC------
Confidence 1 11223446778999999988899999999999999999999 888886543211 1 1111 110000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1123345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=316.69 Aligned_cols=253 Identities=26% Similarity=0.344 Sum_probs=207.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|++.+.||.|+||.||+|++..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999999999999999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999853 27899999999999999999999999 9999999999999999999999999997643221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||....+.. ....... ...+.+..
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~--~~~~~~~~-- 220 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIPK--NNPPSLEG-- 220 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhhh--cCCCCCcc--
Confidence 22334568889999999998889999999999999999999999997543211 0000000 01111110
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
. .....+.+++..||..+|++||++++++++-+.
T Consensus 221 ---~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 221 ---N---KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred ---c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 0 134578899999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=324.91 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=207.5
Q ss_pred hhCccccceeccCCceEEEEEEECCC-------CcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT-------AQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 152 (427)
..+|++.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.++.++ +|+||++++++|...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35689999999999999999986432 23689998865422 2346788999999999 799999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
...++++||+++|+|.+++..... ....+++.+++.++.|++.||.|||+++ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 999999999999999999875321 2345788999999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~ 299 (427)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 9999999999999875332221111222334567999999998899999999999999999998 8888864321
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
....... ...... ..+......+.+++..||+.+|.+||++.++++.|+.+....
T Consensus 243 -~~~~~~~-~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 -EELFKLL-KEGHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -HHHHHHH-HcCCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111111 111100 112233457889999999999999999999999999886533
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.88 Aligned_cols=246 Identities=24% Similarity=0.273 Sum_probs=192.4
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhc---CCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLL---HHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 91 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
||+|+||+||+|+++.+++.||||++.+..... ......|..++..+ .||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999986542222 22344566666554 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999988854 356889999999999999999999999 9999999999999999999999999987532221 2
Q ss_pred eeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccC
Q 042519 245 VSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQ 323 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (427)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ............++ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~---~---- 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAFGKVRFP---K---- 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHcCCCCCC---C----
Confidence 23456799999999998754 4899999999999999999999999753221 11111111111111 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHHHhhc
Q 042519 324 GEFPVRGLNQAVAVSAMCVQEESSVRP----LMSDVVSALSFL 362 (427)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~~P~~RP----s~~evl~~L~~~ 362 (427)
......+.+++.+||+.||.+|| ++.+++++-+..
T Consensus 219 ----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 219 ----NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred ----ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence 11235678999999999999998 677887765543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=327.57 Aligned_cols=266 Identities=21% Similarity=0.283 Sum_probs=201.3
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG----- 152 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 152 (427)
...++|.+.+.||+|+||.||+|.+..++..||||++..... .....+.+|+.+++.++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 346789999999999999999999999999999999865422 2334577899999999999999999987643
Q ss_pred -CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 153 -EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 153 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
...+++++++ +++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 4568999988 589988773 346899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
|+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+..+.. ....
T Consensus 163 g~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~-~~~~ 234 (343)
T cd07878 163 GLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIME-VVGT 234 (343)
T ss_pred ccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-HhCC
Confidence 99986322 1234578999999999876 578999999999999999999999996543211 1110000 0000
Q ss_pred C-----------------CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 311 P-----------------NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 311 ~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+ ...+......+.. ........+.+++.+||+.||.+|||+.+++++-+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0 0000000000000 00011235789999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=315.08 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=203.3
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---------hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---------NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
+|.+.+.||+|+||.||+|.+..++..||+|.+....... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999998889999999986543322 1457789999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999864 245788889999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCc----cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 235 KLGPIGDK----THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 235 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
+....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAI----FKIGE- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHH----HHHhc-
Confidence 76432111 11122356889999999999888999999999999999999999999753221 000 00000
Q ss_pred CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
. .....+......+.+++.+||+.+|.+||++.+++++
T Consensus 227 -~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 -N---------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -c---------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 0111223345678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=317.13 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=207.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc----EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ----VVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
..+|++.+.||+|+||.||+|.++.+|. .+|+|.+..... .....+.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3678999999999999999999876664 589998866543 234568889999999999999999999987 7889
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999998653 345899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..............++..|+|||.+....++.++||||||+++|||++ |+.||...... .+.. . +......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~---~-~~~~~~~- 230 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPD---L-LEKGERL- 230 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH---H-HhCCCCC-
Confidence 443222222222234568999999988899999999999999999998 99999764321 1111 1 1111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+..+...+.+++..||..+|.+||++.++++.|..+..
T Consensus 231 ---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 ---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111233468899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=312.30 Aligned_cols=250 Identities=31% Similarity=0.477 Sum_probs=205.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 467899999999999999999876 78899999976543 456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999998653 2236899999999999999999999999 9999999999999999999999999998642111
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
....++..|+|||++..+.++.++||||||+++|+|++ |..||...... .+.. .......
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~------- 217 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----HVEKGYR------- 217 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHhcCCC-------
Confidence 12334567999999988899999999999999999997 99998654221 1111 1111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...+...+..+.+++.+||+.+|++||++.+++++|..
T Consensus 218 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 ---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 01122334678899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=315.29 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=204.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCC---cEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTA---QVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.++..... ....+..|+.++..++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357899999999999999999986444 37999998654322 23567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++... ...+++.+++.++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999998653 346889999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCccce-eccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 238 PIGDKTHV-SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 238 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
........ .....++..|+|||++.+..++.++|||||||++|++++ |..||...... ..... ..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~~~~ 229 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKA----IEEGYRLP 229 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHH----HhCCCcCC
Confidence 33221111 112223567999999998899999999999999999886 99998654321 11111 11111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 230 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 ----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1122345788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=316.18 Aligned_cols=264 Identities=25% Similarity=0.387 Sum_probs=203.6
Q ss_pred hCccccceeccCCceEEEEEEE----CCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--Cee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKL----EKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQR 155 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 155 (427)
..|++.+.||+|+||.||+++. ..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999985 4568899999986543 23345688999999999999999999998875 568
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999998642 245899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc--------ccchhhhhhhh
Q 042519 236 LGPIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPT--------YEQNLVTWAQP 306 (427)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~--------~~~~~~~~~~~ 306 (427)
........ .......++..|+|||++.+..++.++|||||||++|+|++++.|+...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 64322211 1223455777899999998888999999999999999999987765321110 00000000001
Q ss_pred hhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
........ ..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 238 ~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111110 11223456899999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=321.48 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=191.5
Q ss_pred cceeccCCceEEEEEEEC--CCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCeeEEEEeecC
Q 042519 88 ECLIGEGGFGRVYKGKLE--KTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQRLLVYEYMP 163 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 163 (427)
.++||+|+||.||+|+++ .++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999976 367899999986542 23557789999999999999999998854 456889999987
Q ss_pred CCChhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe----CCCCCeeEeecCCc
Q 042519 164 LRSLEDHLLDIG-----PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL----DCEFNAKLSDFGLA 234 (427)
Q Consensus 164 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~vkl~DFG~a 234 (427)
++|.+++.... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 68888775322 12235889999999999999999999999 9999999999999 46678999999999
Q ss_pred ccCCCCCc-cceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch------hhhhhhh
Q 042519 235 KLGPIGDK-THVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN------LVTWAQP 306 (427)
Q Consensus 235 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~------~~~~~~~ 306 (427)
+....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 86432211 112234678999999999876 458999999999999999999999997543221100 0000000
Q ss_pred hhcCCC--------CCC---cccccccCC------------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 307 FFKDPN--------RYP---QLADPLLQG------------EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 307 ~~~~~~--------~~~---~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
....+. ..+ .+....... .........+.+++..||+.||.+|||+.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 000000 000 000000000 00001123578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=316.66 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=211.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||+||++.+..+|..||+|++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 3678999999999999999999999999999999865432 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|+++++|.+++.. ...+++..+..++.+++.+|.|||+ .+ ++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999988754 3468899999999999999999997 47 99999999999999999999999999864321
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc-----cchhhhhhhhhhcCCCCC
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY-----EQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 314 (427)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+.. ...+..+........ .
T Consensus 157 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 230 (284)
T cd06620 157 S----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--P 230 (284)
T ss_pred h----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--C
Confidence 1 1224578999999999988899999999999999999999999998644321 111222222222111 0
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+. + .....+..+.+++.+||+.||.+||++.|++++.+.+..
T Consensus 231 ~~-----~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 231 PR-----L---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CC-----C---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00 0 011244578899999999999999999999998876554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=318.12 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=208.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||.|+||.||+|.+..++..||+|.+..........+..|+.+++.++|+||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45699999999999999999999988999999999766555556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST- 156 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc-
Confidence 9999999988652 346899999999999999999999999 999999999999999999999999998753221
Q ss_pred ccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
........|++.|+|||++. ...++.++||||||+++|+|++|+.||....+.. ........ ..+.
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~--~~~~ 227 (280)
T cd06611 157 -LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILKS--EPPT 227 (280)
T ss_pred -ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhcC--CCCC
Confidence 11223456899999999874 3457889999999999999999999997543211 11111110 0000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+ ..+......+.+++..||+.+|.+||++.+++++-+.
T Consensus 228 ~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 228 L-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred c-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 0 0122334578899999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=310.59 Aligned_cols=248 Identities=28% Similarity=0.381 Sum_probs=199.6
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
++||+|+||.||++.+.. ++.||+|.+...... ....+.+|+.+++++.|+||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999988 999999998765443 446788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceec
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 247 (427)
.+++... ...+++..++.++.+++.+|.|||+++ ++||||||+|||++.++.++|+|||++.............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9998652 346788999999999999999999999 9999999999999999999999999987532211111111
Q ss_pred cccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCC
Q 042519 248 RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEF 326 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (427)
...++..|+|||++.++.++.++|||||||++|+|++ |..||....+... ... ...... ...
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~~~----~~~~~~----------~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RER----IESGYR----------MPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---HHH----HhcCCC----------CCC
Confidence 2234567999999988899999999999999999999 8888865432211 111 111000 011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 327 PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 327 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2234467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=327.28 Aligned_cols=257 Identities=22% Similarity=0.290 Sum_probs=200.5
Q ss_pred HHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccC--CCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCee
Q 042519 79 ATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN--GLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQR 155 (427)
Q Consensus 79 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 155 (427)
......|++++.||+||.++||++...+ ...||+|++... +.+...-|.+|+..|.+|+ |.+||+|++|-..++.+
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3446779999999999999999999876 456777765432 2234466899999999997 99999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
|+||||-+ .+|.++|..... -++...+..+..|++.++.++|..| |||.||||.|+|+- .|.+||+|||+|.
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred EEEeeccc-ccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhc
Confidence 99999865 799999876432 2332367788999999999999999 99999999999994 5689999999999
Q ss_pred cCCCCCccceeccccccccccCccccccC-----------CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTG-----------QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~ 304 (427)
..............+||+.||+||.+... ..++++||||||||||+|+.|+.||.... + .|.
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~~a 580 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--QIA 580 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--HHH
Confidence 87666666667788999999999988532 25689999999999999999999997431 1 111
Q ss_pred hhhhcCCCCCCcccccccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVR-GLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.+..+.++...-+|+.- ...+++++++.||+.||.+||++.++|++-
T Consensus 581 --------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 581 --------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred --------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 11122222222222211 112389999999999999999999999974
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=317.59 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=205.8
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+.|+..+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 447778899999999999999998899999999875432 3345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999874 346889999999999999999999999 9999999999999999999999999987533221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||....+... ... ... .. .+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~-~~~-~~-----~~- 219 (277)
T cd06642 156 --IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFL-IPK-NS-----PP- 219 (277)
T ss_pred --hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhh-hhc-CC-----CC-
Confidence 122335688899999999988899999999999999999999999875432210 000 010 00 01
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.........+.+++.+||+.+|.+||++.+++++-+.
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 220 ---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256 (277)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence 1122345678899999999999999999999998653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=312.44 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=200.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEE-cCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA-DGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~ 161 (427)
++|++.+.||+|+||.||++... |..||+|.+... ...+.+.+|+.+++.++|+|++++++++. .++..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 57899999999999999999876 678999998644 23457889999999999999999999764 55678999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 9999999998653 2345889999999999999999999999 999999999999999999999999998753221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... .......... ..
T Consensus 156 ----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~-~~------- 217 (256)
T cd05082 156 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEKG-YK------- 217 (256)
T ss_pred ----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcC-CC-------
Confidence 122345668999999998899999999999999999997 9998864321 1111111110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 218 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 ---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 01122345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=314.89 Aligned_cols=264 Identities=30% Similarity=0.453 Sum_probs=206.4
Q ss_pred hCccccceeccCCceEEEEEEECC----CCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEK----TAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQR 155 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 155 (427)
..|++.+.||+|+||.||+|.+.. ++..||||.+...... ....+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 467888999999999999999753 4789999999765443 35678999999999999999999999887 5678
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+|+||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999998653 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccc-eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc--------hhhhhhhh
Q 042519 236 LGPIGDKTH-VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ--------NLVTWAQP 306 (427)
Q Consensus 236 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~--------~~~~~~~~ 306 (427)
......... ......++..|++||.+.+..++.++||||||+++|||++|..|+......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 643222111 111233456799999998889999999999999999999999988643221100 00111111
Q ss_pred hhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
....... ...+..++..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 238 ~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGER----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCc----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111 111223446789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=312.38 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=204.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.++||+|+||.||+|..+. ++.||+|.+.... .....+.+|+.+++.++|+||+++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4679999999999999999998765 6789999987554 34567889999999999999999999875 4568999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+.+++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999988653 3356889999999999999999999999 9999999999999999999999999987643211
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
........++..|+|||++....++.++||||||+++|+|++ |+.||...... .... . .......
T Consensus 157 -~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~---~-~~~~~~~------ 222 (260)
T cd05067 157 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ---N-LERGYRM------ 222 (260)
T ss_pred -cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH---H-HHcCCCC------
Confidence 111223446778999999998899999999999999999999 99999754321 1111 1 1111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=321.07 Aligned_cols=258 Identities=26% Similarity=0.323 Sum_probs=207.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||+|....+++.||+|.+...... ....+..|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688999999999999999999999999999999765433 3356788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999988642 2356899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCcc---------------------------ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 042519 240 GDKT---------------------------HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTT 292 (427)
Q Consensus 240 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~ 292 (427)
.... .......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0112346889999999999888999999999999999999999999754
Q ss_pred CCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHHHhh
Q 042519 293 RPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL----MSDVVSALSF 361 (427)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~evl~~L~~ 361 (427)
... ... ..........+ ........+.+++.+||+.+|++||+ +.+++.+-+.
T Consensus 236 ~~~--~~~----~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 236 NRD--ETF----SNILKKEVTFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred chH--HHH----HHHhcCCccCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 321 111 11111111110 01114578999999999999999999 8888876443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=311.91 Aligned_cols=254 Identities=29% Similarity=0.405 Sum_probs=202.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 4578999999999999999998774 56799999865433 34678899999999999999999998854 568999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999998653 2345889999999999999999999999 9999999999999999999999999997543221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. .......++..|+|||++.+..++.++||||||+++|+|++ |..||...... .....+ ......
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~-~~~~~~------ 222 (260)
T cd05070 157 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQV-ERGYRM------ 222 (260)
T ss_pred c-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHH-HcCCCC------
Confidence 1 11122345668999999988889999999999999999999 88888653211 111111 111010
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122344678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=311.65 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=195.7
Q ss_pred eeccCCceEEEEEEEC--CCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCC
Q 042519 90 LIGEGGFGRVYKGKLE--KTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRS 166 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 166 (427)
.||+|+||.||+|.+. ..+..||+|++...... ..+.+.+|+.+++.++|+||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999875 44667999998655322 23568899999999999999999998864 57899999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccce-
Q 042519 167 LEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV- 245 (427)
Q Consensus 167 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~- 245 (427)
|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9998864 2356899999999999999999999999 99999999999999999999999999875322221111
Q ss_pred eccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 246 SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 246 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
.....+++.|+|||++.+..++.++|||||||++|+|++ |..||....+.. .. ........ .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~----------~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VM----SFIEQGKR----------L 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HH----HHHHCCCC----------C
Confidence 111223578999999988889999999999999999996 999997543221 11 11111111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+......+.+++..||+.+|++||++.+|++.|..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 1223345688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=314.68 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=196.9
Q ss_pred ceeccCCceEEEEEEECCCCc--EEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQ--VVAVKQLDRNG-LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||.||+|.+..++. .+++|.+.... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999988775 46888876432 23345688899999999 799999999999999999999999999
Q ss_pred CChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 165 RSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 165 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
++|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999875321 1235789999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
++..... .........+..|+|||++....++.++|||||||++|||++ |..||...... ...... ...
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~-~~~ 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKL-PQG 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHH-hCC
Confidence 9863211 111111234567999999988899999999999999999997 99999653211 111111 110
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
... ..+......+.+++.+||+.+|.+||++.+++..|..+
T Consensus 228 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 000 11122345788999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=321.78 Aligned_cols=268 Identities=18% Similarity=0.201 Sum_probs=199.5
Q ss_pred ccceeccC--CceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 87 QECLIGEG--GFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 87 ~~~~Lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
+.++||+| +|++||++.++.+|+.||+|.++.... .....+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 789999999999999999999975432 22345677999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986532 245889999999999999999999999 99999999999999999999999986543211110
Q ss_pred -c----ceeccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc---C--
Q 042519 243 -T----HVSSRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK---D-- 310 (427)
Q Consensus 243 -~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~-- 310 (427)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ........... +
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccccc
Confidence 0 01122356778999999875 468999999999999999999999997533211 00000000000 0
Q ss_pred ----------------CCCCCc---------ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 311 ----------------PNRYPQ---------LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 311 ----------------~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...... .................+.+++..||+.||++|||+.+++++-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 000000 000000001122345678899999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=311.40 Aligned_cols=251 Identities=21% Similarity=0.296 Sum_probs=204.5
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc-CCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-GEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 160 (427)
+|++.+.||+|++|.||++.++.+++.||+|.+..... ...+.+.+|+.+++.++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999999999999999865432 234567889999999999999999998764 446789999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|.+++... ....+++.+++.++.+++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998753 2346899999999999999999999999 999999999999999999999999998764222
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
........|++.|+|||++.+..++.++||||||+++|+|++|+.||..... .......... ..+
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~--~~~----- 220 (257)
T cd08223 156 --CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEG--KLP----- 220 (257)
T ss_pred --CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc--CCC-----
Confidence 1223446789999999999998999999999999999999999999874321 1111111111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..+......+.+++.+||+.+|.+||++.+++++
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1123345678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=317.46 Aligned_cols=266 Identities=22% Similarity=0.259 Sum_probs=200.8
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|++.+.||+|+||.||+|++..+|+.||+|.+...... ....+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488889999999999999999999999999998654222 234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+. ++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 6888877542 356899999999999999999999999 9999999999999999999999999987532221
Q ss_pred ccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc-----------
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK----------- 309 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 309 (427)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..|+........ .+. .....+.
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLK-RIFRLLGTPTEESWPGVS 229 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHH-HHHHHhCCCChHHhHHhh
Confidence 112334678899999988764 478999999999999999999998754322111 000 0000000
Q ss_pred C---CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 310 D---PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 310 ~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
. .......................+.+++..||+.||.+|||+.+++++-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 0 00000000000000111223467889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=312.07 Aligned_cols=250 Identities=30% Similarity=0.427 Sum_probs=201.0
Q ss_pred ceeccCCceEEEEEEECC-CCc--EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEK-TAQ--VVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|++|.||+|.+.. ++. .||||.+..... ...+.+.+|+.++++++|+||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 333 699999987665 455678899999999999999999999988 889999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999876432 56899999999999999999999999 9999999999999999999999999998643322211
Q ss_pred -eeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 245 -VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 245 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
......++..|+|||++.+..++.++|||||||++|+|++ |..||...... +............
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~-------- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGERL-------- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCCcC--------
Confidence 1223457788999999998899999999999999999998 99998644221 1111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011223467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=311.05 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=197.8
Q ss_pred ceeccCCceEEEEEEECCCC---cEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTA---QVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
++||+|+||.||+|.+...+ ..||+|.+...... ....+.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876544 78999998765443 3456888999999999999999999876 4568999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
++|.+++... ..+++..++.++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999653 36889999999999999999999999 9999999999999999999999999987543222211
Q ss_pred e-eccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 245 V-SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 245 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||....+. ....+.. .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~~~~-------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SGERL-------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCCcC--------
Confidence 1 111223567999999998899999999999999999998 99999754321 1111111 11100
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11223346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=312.41 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=207.0
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCeeEEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQRLLVY 159 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 159 (427)
+|++.+.||.|+||.||++.+..++..||+|.+..... ...+.+..|+.+++.++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48888999999999999999999999999999875433 223557789999999999999999998764 45679999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH-----DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
||+++++|.+++.........+++..++.++.||+.||.||| +.+ |+|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999775555678999999999999999999999 777 999999999999999999999999999
Q ss_pred ccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ....... .. ...
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~-~~~ 227 (265)
T cd08217 158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASKI-KE-GKF 227 (265)
T ss_pred ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHHH-hc-CCC
Confidence 8643222 112345689999999999988899999999999999999999999975431 1111111 11 111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
...+......+.+++.+||+.+|++||++.+|+++
T Consensus 228 ---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 12233445688999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=315.36 Aligned_cols=252 Identities=28% Similarity=0.418 Sum_probs=199.9
Q ss_pred ceeccCCceEEEEEEECCCC------cEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 89 CLIGEGGFGRVYKGKLEKTA------QVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+.||+|+||.||+|+++... ..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999986544 6799998865432 3456788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-----CeeEeecCC
Q 042519 162 MPLRSLEDHLLDIGP---EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-----NAKLSDFGL 233 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~vkl~DFG~ 233 (427)
+++++|.+++..... ....+++.+++.++.|++.||.|||+.+ ++|+||||+|||++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999976432 2245788999999999999999999999 99999999999999887 899999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
+................++..|+|||++.++.++.++|||||||++|+|++ |..||...... .... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~----~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQ----HVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHH----HHhcCC
Confidence 875432222222223345778999999999999999999999999999998 99998643321 1111 111111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 313 RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.. ..+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 231 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 112234567889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=310.58 Aligned_cols=256 Identities=28% Similarity=0.361 Sum_probs=193.8
Q ss_pred ceeccCCceEEEEEEECC--CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCC
Q 042519 89 CLIGEGGFGRVYKGKLEK--TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLR 165 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 165 (427)
+.||+|+||.||+|.... ++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998653 456799999865432 22346788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 166 SLEDHLLDIGP-EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 166 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
+|.+++..... .....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999875432 2335667788889999999999999999 9999999999999999999999999987532222222
Q ss_pred eeccccccccccCccccccC-------CCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 245 VSSRVMGTYGYCAPEYQRTG-------QLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
......|+..|+|||++.+. .++.++||||||+++|||++ |..||....+... .... .. .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~--~~---~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYT--VR---EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH--hh---cccCC
Confidence 22345678889999988642 35789999999999999996 9999975432211 1110 00 01111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..++.+. ......+.+++..|+ .+|++||++.+|+..|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 122345778999998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=315.31 Aligned_cols=260 Identities=24% Similarity=0.341 Sum_probs=204.2
Q ss_pred HHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEc--
Q 042519 75 FRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCAD-- 151 (427)
Q Consensus 75 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 151 (427)
...+....+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.++..+ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3444455678999999999999999999999999999999986543 2345678899999888 69999999999853
Q ss_pred ----CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCee
Q 042519 152 ----GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 152 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
.+..+++|||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 467899999999999999886532 345788888999999999999999999 99999999999999999999
Q ss_pred EeecCCcccCCCCCccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 042519 228 LSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT 302 (427)
Q Consensus 228 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~ 302 (427)
|+|||++...... ........|++.|+|||++. ...++.++|||||||++|+|++|..||....+.....
T Consensus 162 l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 162 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 9999998753211 11223456899999999875 3468889999999999999999999996543221100
Q ss_pred hhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 303 WAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
. ... ..... ......+..+.+++..||+.||.+||++.+++++
T Consensus 237 ---~-~~~-~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 ---L-IPR-NPPPK--------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ---h-Hhh-CCCCC--------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 000 00000 0112344678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=317.65 Aligned_cols=264 Identities=26% Similarity=0.341 Sum_probs=207.7
Q ss_pred HHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC-
Q 042519 75 FRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG- 152 (427)
Q Consensus 75 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 152 (427)
...+....++|.+.+.||+|+||.||++....+++.+|+|++.... .....+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3444455788999999999999999999999999999999986542 2345677899999988 799999999998753
Q ss_pred ----CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeE
Q 042519 153 ----EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKL 228 (427)
Q Consensus 153 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl 228 (427)
...++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 3589999999999999988754445567899999999999999999999999 999999999999999999999
Q ss_pred eecCCcccCCCCCccceeccccccccccCccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 042519 229 SDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-----QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTW 303 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~ 303 (427)
+|||++....... .......|+..|+|||++... .++.++|||||||++|+|++|+.||....+. ..+..
T Consensus 170 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~- 244 (291)
T cd06639 170 VDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFK- 244 (291)
T ss_pred eecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHH-
Confidence 9999987533221 112335688999999988643 3689999999999999999999999754322 11111
Q ss_pred hhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 304 AQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.... ....+. .+......+.+++.+||+.+|++||++.+++++-
T Consensus 245 ---~~~~--~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 245 ---IPRN--PPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred ---HhcC--CCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 1110 011111 1122345788999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=320.36 Aligned_cols=261 Identities=28% Similarity=0.443 Sum_probs=205.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc----EEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ----VVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
..+|+..+.||+|+||.||+|.+..+|. .||+|.+...... ....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 4678899999999999999999877675 4788887654322 234678899999999999999999998764 467
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 89999999999999865 2345888999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..............++..|+|||++.+..++.++|||||||++|||++ |..||..... .....+ .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~ 231 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDL----LEKGERLP 231 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHCCCCCC
Confidence 433222222223445778999999998899999999999999999997 8999865321 111111 11111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
. +..+...+.+++..||..+|++||++.++++.|..+...+
T Consensus 232 ~----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 232 Q----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 1123356889999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=329.47 Aligned_cols=251 Identities=29% Similarity=0.385 Sum_probs=210.3
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.|.-++.||.|+||.||.|++..+.+.||||++..+..+. .+++..|+..|++|+|||++.+.|||..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4666778999999999999999999999999998765544 4678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
||- |+-.+.+.- ..+++.+.++..|..+.+.||+|||+.+ .||||||..||||++.|.|||+|||.|.+...
T Consensus 107 YCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 997 788887765 4578999999999999999999999999 99999999999999999999999999986433
Q ss_pred CccceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
...++|||.|||||++. .+.|+-++||||||++..||.-.++|+-.++.... + ..+.. +.
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------L-YHIAQ-Ne---- 241 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-YHIAQ-NE---- 241 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------H-HHHHh-cC----
Confidence 23578999999999874 57899999999999999999999998765432111 1 11111 11
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+.+. ..++...+..++..||+.-|.+|||..+++.+-..+.
T Consensus 242 -sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 242 -SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred -CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 12222 4567788999999999999999999999998864443
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=319.43 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=205.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
+.|.....||+|+||.||++.+..++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34555577999999999999999899999999987655555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~- 172 (292)
T cd06658 102 EGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV- 172 (292)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence 99999988742 35788999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
.......|+..|+|||++.+..++.++||||||+++|||++|..||....+... + ... .. ... ...
T Consensus 173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~----~~~-~~--~~~----~~~ 238 (292)
T cd06658 173 -PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--M----RRI-RD--NLP----PRV 238 (292)
T ss_pred -ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHH-Hh--cCC----Ccc
Confidence 122345689999999999888899999999999999999999999975432110 0 000 00 000 000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.. .......+.+++..||+.+|.+||++.+++++-+..
T Consensus 239 ~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~ 276 (292)
T cd06658 239 KD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276 (292)
T ss_pred cc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence 00 112345678899999999999999999999985543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=309.26 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=207.5
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|+..++||.|+||.||.++...++..+++|.+.... ......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4889999999999999999999999999999986543 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999986532 356889999999999999999999999 9999999999999999999999999987643222
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||....+. ........ .....
T Consensus 156 --~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~--~~~~~----- 220 (256)
T cd08221 156 --SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQ--GNYTP----- 220 (256)
T ss_pred --ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc--CCCCC-----
Confidence 1233456899999999998888999999999999999999999999653221 11111111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.+......+.+++..||+.+|.+||++.++++++
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 ----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1123345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=311.85 Aligned_cols=268 Identities=25% Similarity=0.310 Sum_probs=203.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||.||+|+++.+|+.||+|++..... ...+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468999999999999999999999999999999865432 223557889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|..++. ....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999888877653 2345899999999999999999999999 999999999999999999999999999864332
Q ss_pred CccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hhh----hhh---hhhcCC
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LVT----WAQ---PFFKDP 311 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~~----~~~---~~~~~~ 311 (427)
.. ......++..|+|||++.+ ..++.++||||||+++|+|++|..||....+..... +.. +.. ..+...
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 2233457889999999875 467899999999999999999999997544321110 000 000 000000
Q ss_pred CCCCcccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 NRYPQLADPLLQGEFP-----VRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
........+......+ ......+.+++.+||+.+|++||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~ 284 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence 0000000000000000 12346788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=297.81 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=200.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++.+.+..||.|+.|.|++++.+.+|..+|||.+.++... ..+.+...+.++.+.+ +|+||+.+|||..+..+++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 35566778899999999999999999999999999876433 3345666777666555 899999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|.|. ..++.++.. ...++++..+-++...+++||.||..+.. |+|||+||+|||+|+.|++||||||++-...
T Consensus 171 elMs-~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlv- 243 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLV- 243 (391)
T ss_pred HHHH-HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceee-
Confidence 9985 456666655 34568999999999999999999998865 9999999999999999999999999987532
Q ss_pred CCccceeccccccccccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT---GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.....++..|.+.|||||.+.- ..|+..+||||||++|+||.||+.||....-.. ..+.. .+. ..+
T Consensus 244 --dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e~ltk----vln---~eP- 312 (391)
T KOG0983|consen 244 --DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-EVLTK----VLN---EEP- 312 (391)
T ss_pred --cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-HHHHH----HHh---cCC-
Confidence 2334566789999999998853 468999999999999999999999997643221 11111 111 111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
+.+... ......+.+++..||+.|+.+||.+.+++++-
T Consensus 313 ---P~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 313 ---PLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred ---CCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 112111 11346788999999999999999999999975
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.70 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=203.8
Q ss_pred CccccceeccCCceEEEEEEECC-CCcEEEEEEeccCCC----------cchHHHHHHHHHHhh-cCCCCeeeEEEEEEc
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEK-TAQVVAVKQLDRNGL----------QGNKEFIVEVLMLSL-LHHDNLVNLIGYCAD 151 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 151 (427)
+|++.+.||+|+||.||+|.++. +++.+|+|.+..... .....+..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 678999998853221 122446678887765 789999999999999
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEee
Q 042519 152 GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSD 230 (427)
Q Consensus 152 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~D 230 (427)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||||+|||++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886544455678999999999999999999996 66 99999999999999999999999
Q ss_pred cCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 231 FGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 231 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
||++....... ......|+..|++||++.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~~~- 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKIVE- 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHHhh-
Confidence 99998633222 234466899999999999888999999999999999999999998653221 11111111
Q ss_pred CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.... +.. .......+.+++.+||+.||++||++.|+.+++.
T Consensus 228 -~~~~----~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 -AVYE----PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -ccCC----cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000 000 1123457889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=310.96 Aligned_cols=253 Identities=26% Similarity=0.344 Sum_probs=198.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-----cchHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-----QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQR 155 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 155 (427)
.+|+..+.||+|+||.||+|.+..++..|++|.+..... .....+.+|+.+++.++|+||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368899999999999999999999999999999864322 123457889999999999999999998875 3677
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999864 235788899999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCC-ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 236 LGPIGD-KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 236 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
...... .........++..|+|||++.+..++.++|||||||++|+|++|+.||....... . ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~-~~~~~~~~--- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----A-IFKIATQP--- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----H-HHHHhcCC---
Confidence 532211 1111223568889999999998889999999999999999999999997542210 0 00011100
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
....++......+.+++ .||..+|++||++.+|+++-
T Consensus 226 -------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp 262 (266)
T cd06651 226 -------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP 262 (266)
T ss_pred -------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence 01122333445566676 68889999999999998863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.50 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=202.6
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc----------chHHHHHHHHHHhhcCCCCeeeEEEEEEcCC
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ----------GNKEFIVEVLMLSLLHHDNLVNLIGYCADGE 153 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 153 (427)
+|.+.+.||.|+||.||+|....+|+.||+|.+...... ..+.+..|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999989999999988532111 1235678999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998653 46888899999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ--LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
+................|+..|+|||++.... ++.++|+||||+++|+|++|..||...... ... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~-~~~~~~- 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAM-FKLGNK- 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHH-HHhhcc-
Confidence 87533222122233456889999999987654 889999999999999999999999643211 111 111110
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.....+. ..........+.+++..||+.+|.+||++.+|+++-
T Consensus 228 ~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 228 RSAPPIP-----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred ccCCcCC-----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 0001111 111123456888999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=313.34 Aligned_cols=259 Identities=25% Similarity=0.325 Sum_probs=202.0
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHH-HhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLM-LSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||.||+|+++.+|+.||+|.+..... .....+..|+.+ ++.++|+||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468999999999999999999999999999999876432 222345556554 666789999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|++ ++|.+++.........+++..++.++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 789888876544556799999999999999999999997 7 99999999999999999999999999875321
Q ss_pred CCccceeccccccccccCcccccc----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
. .......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||....... .. ....... ...
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~-~~~~~~~--~~~ 226 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF----QQ-LKQVVEE--PSP 226 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH----HH-HHHHHhc--CCC
Confidence 1 11233568889999998864 457899999999999999999999996432111 11 0011110 001
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+. ....+..+.+++..||..+|.+||++.+++++-+...
T Consensus 227 ~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 227 QLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred CCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 110 1123467889999999999999999999999765433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=309.46 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=205.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.+++ +..||||.+.... .....+.+|+.+++.++|+||+++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 5789999999999999999999865 5779999987543 3456788999999999999999999999998999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ....+++..+..++.+++.||.|||+++ |+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999998653 2346899999999999999999999999 9999999999999999999999999987643211
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
........++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... ...... ..
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~---~~~~~~-~~------- 222 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVL---EQVERG-YR------- 222 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHcC-CC-------
Confidence 111122334568999999998889999999999999999998 99999654321 111 111110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ---MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111224578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=310.60 Aligned_cols=264 Identities=25% Similarity=0.293 Sum_probs=209.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--CeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 159 (427)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++||||++++++|.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 368889999999999999999999999999999875433 2345688999999999999999999988653 4689999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.........+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987654445567889999999999999999999999 99999999999999999999999999875322
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc--ccchhhhhhhhhhcCCCCCCcc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPT--YEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......+.. . ...+.+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~-~~~~~~ 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----N-MPNPEL 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----c-CCchhh
Confidence 11 12356788999999999889999999999999999999999999765321 1111111111 1 011111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.+... ........+.+++.+||+.+|++|||+.|++++-+.
T Consensus 229 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 229 KDEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred ccCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 11100 011245678999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=307.40 Aligned_cols=247 Identities=28% Similarity=0.393 Sum_probs=196.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
++||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 47999999999999875 5788999998655332 234578899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceec
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 247 (427)
.+++... ...+++..++.++.+++.+|.|||+++ ++||||||+||+++.++.+||+|||++....... .....
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~ 152 (250)
T cd05085 80 LSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSG 152 (250)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc-cccCC
Confidence 9988642 345789999999999999999999999 9999999999999999999999999987532111 11111
Q ss_pred cccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCC
Q 042519 248 RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEF 326 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (427)
...++..|+|||++.++.++.++||||||+++|+|++ |..||....... ... . ...... ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~---~-~~~~~~----------~~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---ARE---Q-VEKGYR----------MSC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH---H-HHcCCC----------CCC
Confidence 2234667999999998899999999999999999998 999996543211 111 1 111100 011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 327 PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 327 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2233467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.60 Aligned_cols=257 Identities=28% Similarity=0.372 Sum_probs=205.7
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCC------
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGE------ 153 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 153 (427)
..++|++.+.||+|+||.||+|.++.++..+++|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35789999999999999999999998899999999875533 346788999999998 6999999999997644
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999988765434567899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
+...... ........|+..|+|||++.. ..++.++|||||||++|+|++|..||....+.. .+. ...
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----~~~ 231 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALF----KIP 231 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHH----Hhh
Confidence 8753221 122334568999999998753 347789999999999999999999997432211 111 111
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
.. ....+ ..+......+.+++.+||..||++|||+.+++++
T Consensus 232 ~~--~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RN--PPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cc--CCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 01110 1122355688899999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=314.30 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=200.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|++.+.||+|+||.||+|.++.+++.||||.+...... ....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 6799999999999999999999988999999998654322 234567899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
++ ++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 98 5999888653 246889999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC--CCC----
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP--NRY---- 314 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~---- 314 (427)
.......++..|+|||++.+ ..++.++||||||+++|+|++|+.||........+. .........+ ...
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL--HKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH--HHHHHhcCCCChhhhhhhh
Confidence 11223356888999998865 458899999999999999999999996543211110 0000000000 000
Q ss_pred ----------CcccccccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 315 ----------PQLADPLLQGEF-PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 315 ----------~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.......+.... .......+.+++..||+.+|++||++.+++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~ 289 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence 000000000000 011125778999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=314.22 Aligned_cols=240 Identities=24% Similarity=0.416 Sum_probs=191.6
Q ss_pred ceeccCCceEEEEEEECCCCc-------EEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQ-------VVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+.||+|+||.||+|.++..+. .|++|.+........+.+.+|+.+++.+.||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999999866544 3888888665444456788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC--------eeEeecCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN--------AKLSDFGL 233 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------vkl~DFG~ 233 (427)
+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998653 336889999999999999999999999 999999999999987765 69999998
Q ss_pred cccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCC-CCCCCCCCcccchhhhhhhhhhcCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGR-RAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
+..... .....++..|+|||++.+ ..++.++|||||||++|+|++|. .||....+... .......
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------~~~~~~~ 221 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------LQFYEDR 221 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------HHHHHcc
Confidence 864321 223567889999999976 45799999999999999999985 55543322110 1111111
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.. .+......+.+++..||+.+|++||++.++++.|
T Consensus 222 ~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 HQ------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred cc------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11 1222235688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=308.20 Aligned_cols=253 Identities=28% Similarity=0.417 Sum_probs=201.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
++|++.+.||+|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++.. +..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 5689999999999999999998764 459999876543 334668889999999999999999998754 5688999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999998653 2345789999999999999999999999 99999999999999999999999999975432211
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||....+. .... . .......
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~---~-~~~~~~~------- 222 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLE---Q-VERGYRM------- 222 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-HHcCCCC-------
Confidence 11222346678999999988899999999999999999999 89998754321 1111 1 1111000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=314.25 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=205.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|++.+.||+|+||.||++++..+|..||+|.+..... .....+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 368899999999999999999999999999999865322 2235688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
+++++|..++.... ....+++..+..++.+++.||.|||+ .+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999988876421 23478999999999999999999997 47 999999999999999999999999998753221
Q ss_pred CccceeccccccccccCccccccC------CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTG------QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
......|++.|+|||++.+. .++.++|||||||++|+|++|..||...... ........... ...
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~--~~~ 227 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAIVD--GDP 227 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHHhh--cCC
Confidence 12334688899999998544 3588999999999999999999999653221 11111111110 000
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+......+.+++.+||+.+|++||++.+++++-+...
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 228 ---------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred ---------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence 1123335677889999999999999999999999866433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=310.23 Aligned_cols=253 Identities=25% Similarity=0.310 Sum_probs=200.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-----cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--Cee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-----QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQR 155 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 155 (427)
.+|++.+.||+|+||.||.|.+..+|..||||.+..... .....+.+|+.+++.+.|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468999999999999999999999999999999854221 1234678899999999999999999998763 467
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++++|.+++... ..+++...+.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999988642 35788889999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCc-cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 236 LGPIGDK-THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 236 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||....... .. ......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~-~~~~~~~--- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AI-FKIATQP--- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HH-HHHhcCC---
Confidence 5322111 111223568899999999988889999999999999999999999997532111 10 0111110
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.....+......+.+++..|+. +|++||++++++++-
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 226 -------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred -------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 0112244455678889999985 999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=316.84 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=190.8
Q ss_pred ceeccCCceEEEEEEECC--CCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEK--TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 164 (427)
.+||+|+||.||+|+.+. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 589999999999999764 56789999986543 23467889999999999999999998853 567899999987
Q ss_pred CChhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe----CCCCCeeEeecCCcc
Q 042519 165 RSLEDHLLDIG-----PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL----DCEFNAKLSDFGLAK 235 (427)
Q Consensus 165 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~vkl~DFG~a~ 235 (427)
++|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57877765321 12335888999999999999999999999 9999999999999 567789999999998
Q ss_pred cCCCCCcc-ceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-------hhhhhhh
Q 042519 236 LGPIGDKT-HVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-------LVTWAQP 306 (427)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-------~~~~~~~ 306 (427)
........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... +.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~-~ 239 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF-S 239 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH-H
Confidence 64322211 11234578999999999876 458999999999999999999999997543221100 00000 0
Q ss_pred hhc-----------CCCCCCcccccccC------------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 307 FFK-----------DPNRYPQLADPLLQ------------GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 307 ~~~-----------~~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.+. .......+...... ..........+.+++.+||+.||.+|||+.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 000 00000000000000 000111234688899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=309.19 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=206.1
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|++.+.||+|+||.||++....+|+.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 48889999999999999999999999999999865422 2345788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+.+++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988652 2245788999999999999999999999 9999999999999999999999999987532221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||..... .......... ...
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~--~~~------ 219 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRG--SYP------ 219 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcC--CCC------
Confidence 112335688899999999988999999999999999999999999865321 1111111111 111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..+......+.+++.+||+.+|.+||++.+|+++-
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~ 254 (256)
T cd08218 220 ---PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKN 254 (256)
T ss_pred ---CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence 11223456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=298.29 Aligned_cols=255 Identities=22% Similarity=0.235 Sum_probs=203.6
Q ss_pred hhCcccc-ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEc----CCee
Q 042519 82 TKNFRQE-CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCAD----GEQR 155 (427)
Q Consensus 82 ~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 155 (427)
+++|.+. ++||-|-.|+|..+.++.+|+.+|+|++. +....++|+++.-.. .|||||.++++|++ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 5667665 68999999999999999999999999984 335667788765444 59999999998764 4567
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---CCCeeEeecC
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---EFNAKLSDFG 232 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkl~DFG 232 (427)
.+|||+|+||.|+..+.+. ....+++.++..|..||..|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 8999999999999999875 4567899999999999999999999999 999999999999954 5569999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
+|+.-. ......+.|.||.|.|||++....|+..+|+||+|||+|-||+|.+||...... -+..-...-+.. +
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~-g 282 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRT-G 282 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhc-c
Confidence 999622 223345678999999999999999999999999999999999999999754321 010000000000 0
Q ss_pred CCCcccccccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 313 RYPQLADPLLQGEFPV----RGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 313 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.-.||. ...+...++|+.+|..+|++|.|+.+++++-|.-.
T Consensus 283 ----------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 283 ----------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred ----------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 002332 34567889999999999999999999999877543
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=308.10 Aligned_cols=240 Identities=22% Similarity=0.345 Sum_probs=189.3
Q ss_pred ceeccCCceEEEEEEECCC------------CcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 89 CLIGEGGFGRVYKGKLEKT------------AQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
+.||+|+||.||+|..... ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986432 2358999887655444567788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC-------eeEe
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN-------AKLS 229 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------vkl~ 229 (427)
+||||+++++|..++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999888754 2346899999999999999999999999 999999999999987664 8999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccc-cCCCCccchHHHHHHHHHHHH-hCCCCCCCCCCcccchhhhhhhhh
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGVVLLELI-TGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
|||++..... .....++..|+|||++. +..++.++|||||||++|||+ .|..||....... . ..+
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~-~~~ 221 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------K-ERF 221 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------H-HHH
Confidence 9999875321 12345788899999886 467899999999999999998 4877775432111 0 011
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
... .. .. .......+.+++.+||+.||.+||++.++++.|
T Consensus 222 ~~~--~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 YEG--QC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Hhc--Cc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 111 00 00 011235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=311.74 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=200.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc-hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG-NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
+++|++.+.||+|+||.||+|....+|..||+|.+....... ...+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467999999999999999999999999999999986543332 3456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+. ++|.+++.. ....+.+..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 788777654 2345778888899999999999999999 999999999999999999999999998753221
Q ss_pred CccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh----------hhhc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ----------PFFK 309 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~----------~~~~ 309 (427)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....+........|.. ....
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 1 11233457889999999875 357899999999999999999999997554321111110000 0000
Q ss_pred CCCCCCcccccccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 310 DPNRYPQLADPLLQGEF-----PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 310 ~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
.+............... .......+.+++.+|++.||++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000000 00123577899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=319.41 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=211.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.+.|+..++||+||||.||-++.+.||+.||.|.+.+.... +.....+|-.||.+++.+.||.+-..|+..+.+|||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 56788999999999999999999999999999998765432 234467899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
+..|+||+|.-+|.+.+. ..+++..+..++.+|+-||++||..+ ||+|||||+|||||+.|+++|+|+|+|...+
T Consensus 264 LtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999877653 67899999999999999999999999 9999999999999999999999999998755
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.+.. ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||...-..... .+.-+....++.
T Consensus 339 ~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--eEvdrr~~~~~~------ 407 (591)
T KOG0986|consen 339 EGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--EEVDRRTLEDPE------ 407 (591)
T ss_pred CCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--HHHHHHHhcchh------
Confidence 4332 23348999999999999999999999999999999999999999643211100 011111112111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSF 361 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~ 361 (427)
.++....+++.++....|+.||++|.. +.+|.+|--+
T Consensus 408 ------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfF 449 (591)
T KOG0986|consen 408 ------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFF 449 (591)
T ss_pred ------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccc
Confidence 334455668889999999999999964 4567666533
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.86 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=204.4
Q ss_pred hCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
++|++.+.||.|+||.||+|+.+. +...|++|.+...... ....+.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 678999999999999999999754 3467999988654333 3467889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQ-----KPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
+||||+++++|.+++....... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987543221 26899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... . ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~---~-~~ 233 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNR---L-QA 233 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHH---H-Hc
Confidence 9987432211 112223456778999999988889999999999999999999 78888643221 11111 1 10
Q ss_pred CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.... ...+...+..+.+++.+||+.+|++||++.+++..|+
T Consensus 234 -~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000 0011223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=311.75 Aligned_cols=239 Identities=24% Similarity=0.375 Sum_probs=188.4
Q ss_pred eeccCCceEEEEEEECCC------------------------CcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeE
Q 042519 90 LIGEGGFGRVYKGKLEKT------------------------AQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 145 (427)
.||+|+||.||+|.+..+ ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999985321 23589999866544445668889999999999999999
Q ss_pred EEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-
Q 042519 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF- 224 (427)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~- 224 (427)
++++.+....++||||+++|+|..++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999988864 3356888999999999999999999999 99999999999997654
Q ss_pred ------CeeEeecCCcccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHH-hCCCCCCCCCCcc
Q 042519 225 ------NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELI-TGRRAIDTTRPTY 296 (427)
Q Consensus 225 ------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-~g~~p~~~~~~~~ 296 (427)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3899999997642211 12357788999998865 56899999999999999995 6999887543321
Q ss_pred cchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 297 EQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
. . ..+......+ ......+.+++..||+.+|++||++.++++.|
T Consensus 230 ~---~----~~~~~~~~~~------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 K---E----RFYEKKHRLP------------EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H---H----HHHHhccCCC------------CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1 1 1111111111 11124688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=306.12 Aligned_cols=260 Identities=27% Similarity=0.349 Sum_probs=208.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|++.+.||.|+||.||+|.+..++..+++|++..... .....+.+|+.+++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468999999999999999999988899999999865432 2456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999865321 346889999999999999999999999 9999999999999999999999999987643332
Q ss_pred cc--ceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 242 KT--HVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 242 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. .......|+..|+|||++... .++.++|+|||||++|+|++|+.||....+.. ....... .........
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~---~~~~~~~~~- 230 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQ---NDPPSLETG- 230 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhc---CCCCCcCCc-
Confidence 22 123445689999999998776 78999999999999999999999997543321 1111110 111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
.........+.+++..||+.+|++||++.+++++
T Consensus 231 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 231 ------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ------cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0012345678899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=323.45 Aligned_cols=255 Identities=24% Similarity=0.291 Sum_probs=216.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch--HHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
...|.+.+.||+|.|++|.+|++..++..||||.|++...... +.+.+|+.+|..|+|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4679999999999999999999999999999999988765433 55889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+.+|.+++++... ..+.+..+..++.|++++++|||+++ |||||||++||||+.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999764 34555788889999999999999999 9999999999999999999999999998754
Q ss_pred CCccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
......+.||++.|.|||++.+..| ++.+|+||+|++||-|++|..||+... +..+-
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--------------------lk~Lr 264 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--------------------LKELR 264 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--------------------ccccc
Confidence 3445677999999999999998776 589999999999999999999998532 11222
Q ss_pred ccccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 319 DPLLQG--EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 319 ~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
++.+.+ ..+.-...++-++++++|-.+|.+|+++.++.++-|.-....
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 222222 123334457789999999999999999999999887654433
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=317.69 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=205.7
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
|.....||+|+||.||+|.+..++..||+|.+..........+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44556799999999999999988999999999765555566788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
++|..++.. ..+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++....... .
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~ 172 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 172 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence 999987732 45889999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
......|+..|+|||++.+..++.++|||||||++|||++|..||....+.. ......... ....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~--~~~~------- 237 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKRLRDSP--PPKL------- 237 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhccC--CCCc-------
Confidence 2234568999999999998889999999999999999999999997543211 011111100 0000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.........+.+++..||+.+|.+||++.+++++-.....
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 0011223567899999999999999999999998665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=311.95 Aligned_cols=257 Identities=25% Similarity=0.312 Sum_probs=209.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|.+.+.||+|+||.||++....++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36799999999999999999999888999999998765555566788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999998853 35788899999999999999999999 9999999999999999999999999887533222
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......|++.|++||++....++.++|||||||++|+|++|+.||....+.... ....... .+.
T Consensus 170 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~~~--~~~----- 234 (293)
T cd06647 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG--TPE----- 234 (293)
T ss_pred --cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhcCC--CCC-----
Confidence 1223356889999999998888999999999999999999999999754322110 0000000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+......+.+++..||+.+|++||++.+++.+-+...
T Consensus 235 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 235 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 0112234457889999999999999999999999866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=309.25 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=200.9
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ------GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
+|++.+.||+|+||.||+|... +|..+|+|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4788999999999999999874 6889999998643211 12457789999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999998542 45788999999999999999999999 999999999999999999999999998753
Q ss_pred CCC----CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 238 PIG----DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 238 ~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
... ..........|+..|+|||++.+..++.++|||||||++|+|++|..||........ . . ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~---~-~~~~~~~~ 226 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--M---F-YIGAHRGL 226 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--H---H-HhhhccCC
Confidence 211 111122345689999999999988899999999999999999999999975432110 0 0 00000001
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
.+ ..+......+.+++.+||+.+|.+||++.+++++
T Consensus 227 ~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 MP---------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CC---------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11 1122345678899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=338.66 Aligned_cols=267 Identities=25% Similarity=0.408 Sum_probs=222.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCc---EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQ---VVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
....+.++||.|.||.|++|+++..|+ .||||.++.... ..+.+|..|+.||.++.||||++|.|+......+.||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345678999999999999999987664 699999976543 3457899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
+|||++|+|+.+|+.. ...+.+.+...++.+|+.|+.||-+.+ +|||||...||||+.+...||+|||+++...
T Consensus 709 TEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999874 355888899999999999999999999 9999999999999999999999999999643
Q ss_pred CCCccceeccccc--cccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 239 IGDKTHVSSRVMG--TYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 239 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
... ....++..| ...|.|||.+...++|.+||||||||++||.++ |.+||-.+... +....+ .
T Consensus 783 dd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVIkaI----e------ 848 (996)
T KOG0196|consen 783 DDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKAI----E------ 848 (996)
T ss_pred cCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HHHHHH----H------
Confidence 322 222333333 358999999999999999999999999999887 99998654322 211111 1
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCCCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDADTATA 373 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~~ 373 (427)
.-.+-..|.+++..|.+|++.|||+|-..||.+.+|+.+|+++...|......+
T Consensus 849 ----~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~ 902 (996)
T KOG0196|consen 849 ----QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIA 902 (996)
T ss_pred ----hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccC
Confidence 112224577889999999999999999999999999999999999887554433
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=310.01 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=190.8
Q ss_pred ceeccCCceEEEEEEECC--CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCC
Q 042519 89 CLIGEGGFGRVYKGKLEK--TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLR 165 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 165 (427)
+.||+|+||.||+|.... ....+++|.+..... .....+.+|+.+++.++|+||+++++++......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 345788888754432 22346788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 166 SLEDHLLDIGPE-QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 166 sL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
+|.+++...... ....++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999998764322 233567788899999999999999999 9999999999999999999999999987532222111
Q ss_pred eeccccccccccCcccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 245 VSSRVMGTYGYCAPEYQRT-------GQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||....+.. . ....... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~~--~~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V---LKQVVRE--QDIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHhhc--cCcc
Confidence 1233456778999998742 457889999999999999999 788886543211 0 1111111 1111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
+..+.+ +......+.+++..|+ .||++||++.+|++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111211 2233456677888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=309.45 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=203.9
Q ss_pred hhCccccceeccCCceEEEEEEECCC---CcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|.+.+.||+|+||.||+|.+... ...|+||...... ....+.+.+|+.+++.+.|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 45688999999999999999987643 3469999886554 2344678899999999999999999999876 45789
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++... ...+++..++.++.+++.||+|||+.+ ++|+||||+|||++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999998652 345899999999999999999999999 999999999999999999999999998764
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... ........++..|+|||++....++.++||||||+++|||++ |..||...... ..... +......
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~----~~~~~~~-- 227 (270)
T cd05056 158 EDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR----IENGERL-- 227 (270)
T ss_pred cccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----HHcCCcC--
Confidence 3221 111222334567999999988889999999999999999986 99999654321 11111 1111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+...+..+.+++.+|+..+|.+||++.++++.|..+..
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1122334678899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=313.52 Aligned_cols=268 Identities=23% Similarity=0.320 Sum_probs=204.8
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||.||+|.++.+++.||+|.++.... .....+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368999999999999999999999999999999865422 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|++++.|..++. ....+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999766655442 2345889999999999999999999999 999999999999999999999999998764333
Q ss_pred CccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchh-hhhh-------hhhhcCC
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL-VTWA-------QPFFKDP 311 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~-~~~~-------~~~~~~~ 311 (427)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... .... ...+...
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 22 122346688999999999887 889999999999999999999999975432211000 0000 0000000
Q ss_pred C-----CCCccccc-ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 312 N-----RYPQLADP-LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 312 ~-----~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
. .+....+. .....++......+.+++..||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00000000 00001222336789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=306.16 Aligned_cols=238 Identities=26% Similarity=0.428 Sum_probs=191.4
Q ss_pred ceeccCCceEEEEEEECCCC----------cEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 89 CLIGEGGFGRVYKGKLEKTA----------QVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999998766 35888887654333 6778899999999999999999999988 778999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-------CeeEeec
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-------NAKLSDF 231 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~vkl~DF 231 (427)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999987532 26889999999999999999999999 99999999999999888 7999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccC--CCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG--QLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
|++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||....... ... .+
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~----~~ 219 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KER----FY 219 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHH----HH
Confidence 99875322 2234567789999999876 78999999999999999999 577776543211 011 11
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
......+ ......+.+++..||+.+|.+||++.++++.|
T Consensus 220 ~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 220 QDQHRLP------------MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hcCCCCC------------CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1111110 00116788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=314.87 Aligned_cols=268 Identities=25% Similarity=0.341 Sum_probs=203.0
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||.||+|.++.+++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3688999999999999999999988999999998654322 23567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|..+... ...+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9998888776542 345899999999999999999999999 999999999999999999999999998753322
Q ss_pred CccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc-chhhhhhh-------hhhcC-
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE-QNLVTWAQ-------PFFKD- 310 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~-~~~~~~~~-------~~~~~- 310 (427)
. .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||........ ..+..+.. ..+..
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 22234568899999998875 4578899999999999999999999864432110 00000000 00000
Q ss_pred ----CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 311 ----PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 311 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
....+..................+.+++.+||+.+|++||++.+++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 284 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence 0000000000000001123456789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.49 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=203.1
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-----cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-----QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
+|+..+.||+|+||.||+|....++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999998899999999865432 2345688899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999864 245788999999999999999999999 9999999999999999999999999987632
Q ss_pred CCCccceeccccccccccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQ-LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
... ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||....+. ......... ...+
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~-~~~~-- 221 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRS-KELP-- 221 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhc-ccCC--
Confidence 222 233456889999999987766 899999999999999999999999754311 111111110 0111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..+......+.+++.+||+.+|.+||++.+++.+
T Consensus 222 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 -------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1122334678899999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.66 Aligned_cols=275 Identities=19% Similarity=0.243 Sum_probs=193.6
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCC-cEEEEEEe--------------cc---CCCcchHHHHHHHHHHhhcCCCC
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTA-QVVAVKQL--------------DR---NGLQGNKEFIVEVLMLSLLHHDN 141 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~-~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~n 141 (427)
...++|++.+.||+|+||+||+|..+... ..+++|.+ .+ ........+.+|+.++..++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34678999999999999999998765322 22222211 00 11122345778999999999999
Q ss_pred eeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 142 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
|+++++++.+.+..++|++++. ++|.+++..... .........+..|+.||+.||.|||+++ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999986 677777654221 1223345667789999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCC-CCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRA-IDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p-~~~~~~~~~~~ 299 (427)
+.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|..+ |..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999998643221 1223346799999999999999999999999999999999998754 43322211111
Q ss_pred hhhhhhhhhcCCCCCCc-------------------ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 300 LVTWAQPFFKDPNRYPQ-------------------LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
+......+......++. .+...+. .......+.+++.+||+.||.+||++.|++++-+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR---NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH---hcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 11111100000000000 0000000 0112345778899999999999999999999876
Q ss_pred hc
Q 042519 361 FL 362 (427)
Q Consensus 361 ~~ 362 (427)
+-
T Consensus 457 f~ 458 (501)
T PHA03210 457 FS 458 (501)
T ss_pred hh
Confidence 53
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=306.95 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=201.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
.+|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+..|+.+++.++|||++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 468889999999999999998864 6789999986543 33467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
.+++|.+++... ...+++..++.++.+++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 154 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ- 154 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc-
Confidence 999999988642 345788999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
........++..|+|||++.++.++.++||||||+++|||++ |..||...... ......... .. ...
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~-~~---~~~-- 222 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETINAG-FR---LYK-- 222 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHhCC-CC---CCC--
Confidence 111122335678999999998899999999999999999998 99998753321 111111110 00 001
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
+......+.+++.+||+.+|++||++.++++.|
T Consensus 223 -----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 -----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111236789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=330.78 Aligned_cols=257 Identities=20% Similarity=0.321 Sum_probs=216.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.+-|.++..||.|+||+||+|.++.++...|.|+|........+++.-|++||..+.||+||+|++.|..++.+++..||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 45688899999999999999999999999999999887778888999999999999999999999999889999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
|.||-++..+.. -..+|.+.++..++.|++.||.|||+++ |||||||..|||++-+|.|+|+|||.+... ..
T Consensus 111 C~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~ 182 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN--KS 182 (1187)
T ss_pred cCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc--hh
Confidence 999999988876 3568999999999999999999999999 999999999999999999999999997642 22
Q ss_pred ccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.......+.|||.|||||+.. ..+|+.++||||||++|.||..+.+|-....+. ..+..+.+ ...+.
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaK--SePPT 254 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK--SEPPT 254 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhh--cCCCc
Confidence 223356689999999999864 568999999999999999999999887654432 11111111 22222
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
++. |..+...+.+++.+||..+|..||++.+++++-+.
T Consensus 255 Llq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv 292 (1187)
T KOG0579|consen 255 LLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFV 292 (1187)
T ss_pred ccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence 222 45667788999999999999999999999988643
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=311.86 Aligned_cols=266 Identities=22% Similarity=0.269 Sum_probs=203.3
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-----chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-----GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... ....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999999988999999999765433 234567899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+ +++|.+++... ...+++..++.++.||++||.|||+++ |+|+||||+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999998642 236899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC-------
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD------- 310 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 310 (427)
... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..+|....+... +.... ..+..
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~ 228 (298)
T cd07841 154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIF-EALGTPTEENWP 228 (298)
T ss_pred CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHH-HHcCCCchhhhh
Confidence 322 12233456788999998854 4678999999999999999999877765432111 00000 00000
Q ss_pred -CCCCCcccccccCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 311 -PNRYPQLADPLLQGE-----FPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 311 -~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
............... ........+.+++.+||+.+|++||++.+++++=+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~ 285 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccc
Confidence 000000000000001 112335678899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=315.38 Aligned_cols=271 Identities=22% Similarity=0.281 Sum_probs=203.1
Q ss_pred CccccceeccCCceEEEEEEECC--CCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--CeeE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEK--TAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQRL 156 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 156 (427)
+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999988 89999999997633 33346678899999999999999999999988 8899
Q ss_pred EEEeecCCCChhhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC----CCCeeEeec
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQ-KPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC----EFNAKLSDF 231 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~~vkl~DF 231 (427)
+||||++ ++|.+++....... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999998 57777765443332 37899999999999999999999999 999999999999999 999999999
Q ss_pred CCcccCCCCCc-cceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc-------hhhh
Q 042519 232 GLAKLGPIGDK-THVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ-------NLVT 302 (427)
Q Consensus 232 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~-------~~~~ 302 (427)
|++........ ........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886432222 112234568899999998765 45889999999999999999999999765433200 0000
Q ss_pred hhhhhhc-----------CCCCCCcccccccCCCCC---------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 303 WAQPFFK-----------DPNRYPQLADPLLQGEFP---------V--RGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 303 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.. ..+. .........+......++ . .....+.+++.+||+.||++|||+.+++++-
T Consensus 237 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 237 IF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence 00 0000 000000000000000111 0 2335688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=309.11 Aligned_cols=266 Identities=24% Similarity=0.313 Sum_probs=205.1
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|++.+.||+|+||.||+|.+..+|..||+|++..... .....+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 48889999999999999999998999999999876542 2245688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 89999988653 256899999999999999999999999 9999999999999999999999999988643322
Q ss_pred ccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC---------
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP--------- 311 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 311 (427)
. .......|+..|+|||++.+. .++.++||||||+++|+|++|..+|....+.. ........+..+
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhcc
Confidence 1 122345689999999988654 46899999999999999999988776433211 111111100000
Q ss_pred --CCCCcccccccC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 312 --NRYPQLADPLLQ----GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 312 --~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.....+...... ..........+.+++.+||+.+|++||++++++++-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 000000000000 0001123478899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=310.25 Aligned_cols=249 Identities=27% Similarity=0.338 Sum_probs=206.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||++.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468999999999999999999999999999999865432 23456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|.|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999998643 56889999999999999999999999 99999999999999999999999999886432
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ...........
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~------- 215 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILEGKV------- 215 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCc-------
Confidence 2 23457899999999998888999999999999999999999999754311 11111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSF 361 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~ 361 (427)
.++......+.+++.+||+.+|.+|+ ++.+++++-+.
T Consensus 216 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 257 (290)
T cd05580 216 -----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257 (290)
T ss_pred -----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence 11222346788999999999999999 88888877543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=309.49 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=205.4
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ------GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
+|+..+.||+|+||.||++....+++.||+|++...... ....+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999999999999998654311 23567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-CeeEeecCCccc
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDFGLAKL 236 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DFG~a~~ 236 (427)
|+||+++++|.+++.. ..++++..+..++.||+.||.|||+++ ++|+||||+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999998864 346888999999999999999999999 99999999999998776 599999999876
Q ss_pred CCCCCc--cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 237 GPIGDK--THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 237 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
...... ........|+..|+|||++.+..++.++||||||+++|+|++|..||....... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~----- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIAS----- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhc-----
Confidence 432211 111233568899999999988889999999999999999999999996432211 1111111100
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.......+......+.+++..||+.+|++||++.+++.+-
T Consensus 226 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~ 265 (268)
T cd06630 226 -----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265 (268)
T ss_pred -----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence 0111123445567889999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=306.03 Aligned_cols=252 Identities=32% Similarity=0.445 Sum_probs=202.4
Q ss_pred ccccceeccCCceEEEEEEECCCC----cEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTA----QVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
+++.+.||.|+||.||++.+...+ ..||+|.+...... ....+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999999998766 89999999665433 4567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999986532 122899999999999999999999999 99999999999999999999999999986433
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ......... ....
T Consensus 156 ~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~-~~~~---- 223 (258)
T smart00219 156 DDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEYLKK-GYRL---- 223 (258)
T ss_pred ccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhc-CCCC----
Confidence 32111 112337789999999988889999999999999999998 7888865221 111111111 1100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 224 ------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11122456788999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.42 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=191.8
Q ss_pred eeccCCceEEEEEEECCC--CcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCC
Q 042519 90 LIGEGGFGRVYKGKLEKT--AQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRS 166 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 166 (427)
.||+|+||.||+|..... ...+++|.+..... .....+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999976433 23567777654432 344678899999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcccee
Q 042519 167 LEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS 246 (427)
Q Consensus 167 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 246 (427)
|.+++..........++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999765433455677788899999999999999999 999999999999999999999999998642222211223
Q ss_pred ccccccccccCcccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 247 SRVMGTYGYCAPEYQRT-------GQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 247 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||....+. ......... ....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~--~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKD--QQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh--cccccC
Confidence 34568899999998743 245789999999999999997 56677543221 111111111 111222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
++.+.. .....+.+++..|| .+|.+||++.+|++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222221 23356778999999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=311.66 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=201.0
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||.||++.+..+++.|++|.+..... .....+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368899999999999999999999999999999876532 22346778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999854 245889999999999999999999999 99999999999999999999999999864211
Q ss_pred CCcc-------------ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 042519 240 GDKT-------------HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306 (427)
Q Consensus 240 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~ 306 (427)
.... .......|+..|+|||++.+..++.++|||||||++|||++|..||....+. .+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 1000 0112346788999999998888999999999999999999999999643221 11111
Q ss_pred hhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
........+ .. ....+..+.+++.+||+.+|++||+..++.+.|
T Consensus 228 ~~~~~~~~~-----~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 228 VISDDIEWP-----EG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred HHhcccCCC-----Cc----cccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 111100000 00 112345688999999999999999854444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=304.49 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=209.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|++.+.||+|++|.||+|.+..+++.|++|++..... .....+..|+.++..++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999999999999999876544 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
+++++|.+++... ..+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999998643 568999999999999999999999 99 999999999999999999999999998764322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|..||............ ...... ...
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~~~--~~~----- 221 (264)
T cd06623 154 LD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAICDG--PPP----- 221 (264)
T ss_pred CC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHHhcC--CCC-----
Confidence 21 123456888999999999889999999999999999999999999765431111111 111110 000
Q ss_pred ccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 321 LLQGEFPVR-GLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 321 ~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..+.. .+..+.+++..||+.+|++||++.+++++=
T Consensus 222 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~ 257 (264)
T cd06623 222 ----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHP 257 (264)
T ss_pred ----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCH
Confidence 11222 456889999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=307.80 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=203.5
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcC---CCCeeeEEEEEEcCCeeEEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLH---HDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 159 (427)
.|+..+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++ |+|++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778899999999999999999999999999986543 233456788999999987 999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998743 36889999999999999999999999 99999999999999999999999999876433
Q ss_pred CCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. .......|+..|+|||++.++ .++.++|||||||++|+|++|..||......... .. ... ...+.
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~----~~~-~~~~~-- 221 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---ML----IPK-SKPPR-- 221 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---hc----ccc-CCCCC--
Confidence 22 222345689999999988654 5689999999999999999999999754321110 00 000 00111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+.. ......+.+++..||+.+|++||++.+++.+-+.
T Consensus 222 ---~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 222 ---LED---NGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred ---CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 111 0134578899999999999999999999987654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=306.23 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=202.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4679999999999999999998764 5679999886542 334678889999999999999999999887 778999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999998653 2346788899999999999999999999 9999999999999999999999999987533221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. .......++..|+|||++....++.++|||||||++|+|++ |+.||...... ..... .......
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~------ 222 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERGYRM------ 222 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhCCCCC------
Confidence 1 11222345677999999998889999999999999999998 89998754221 11111 1111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112334578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=306.89 Aligned_cols=252 Identities=29% Similarity=0.422 Sum_probs=192.1
Q ss_pred ceeccCCceEEEEEEECC---CCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEE-cCCeeEEEEeecC
Q 042519 89 CLIGEGGFGRVYKGKLEK---TAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCA-DGEQRLLVYEYMP 163 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 163 (427)
+.||+|+||.||+|.+.. .+..||+|.+.... ......+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998753 34579999985432 233467788999999999999999999775 4556899999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT 243 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 243 (427)
+++|.+++... ...+.+..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998652 234677788899999999999999999 999999999999999999999999998753221110
Q ss_pred --ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhC-CCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 244 --HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITG-RRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 244 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.......++..|+|||++.+..++.++|||||||++|||++| ..||..... ..+... ... ....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~---~~~-~~~~------ 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVY---LLQ-GRRL------ 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---Hhc-CCCC------
Confidence 111233467789999999888999999999999999999995 555543221 111111 111 1000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..+...+..+.+++..||+.+|++||++.++++.|+.+.
T Consensus 222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001122357889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=308.36 Aligned_cols=252 Identities=26% Similarity=0.351 Sum_probs=205.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+-|++.+.||.|+||.||+|.+..++..||||.+..... .....+.+|+.++..++|+||+++++++..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 347788999999999999999998899999999865432 2335678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ..+++..+..++.+++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999998842 46889999999999999999999999 9999999999999999999999999987533221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||....+. ........ ...+
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~--~~~~------ 219 (277)
T cd06641 156 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPK--NNPP------ 219 (277)
T ss_pred --hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhc--CCCC------
Confidence 1123356888999999998888999999999999999999999999653321 11111100 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+......+.+++.+||+.+|.+||++.+++++-..
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 256 (277)
T cd06641 220 ---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256 (277)
T ss_pred ---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 1122344678899999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=305.12 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=204.1
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|+..+.||+|+||.||++....++..+|+|.+..... .....+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58889999999999999999999999999999876432 2345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-CeeEeecCCcccCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDFGLAKLGPIG 240 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DFG~a~~~~~~ 240 (427)
+++++|.+++... ....+++..++.++.+++.+|.|||+++ |+|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999653 2345889999999999999999999999 99999999999998654 5799999999864322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ......... ....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~--~~~~---- 220 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSG--TFAP---- 220 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhc--CCCC----
Confidence 1 223356889999999999888999999999999999999999999754321 111111110 0111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
.+......+.+++..||+.+|.+|||+.+++++
T Consensus 221 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 -----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 112234578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=347.86 Aligned_cols=267 Identities=25% Similarity=0.288 Sum_probs=218.4
Q ss_pred HHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC
Q 042519 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG 152 (427)
Q Consensus 76 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 152 (427)
..+....++|++.++||+|+||.|.+++++.+++.||+|++++... ....-|+.|-.+|..-+.+-|+.++..|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4455567899999999999999999999999999999999987432 3345688899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
.++|+|||||+||+|..+|.+. .++++.-+..++..|+.||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999998553 26899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccc----c-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQR----T-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
.+-... .+........+|||.|.+||++. + +.|+..+|+||+||++|||+.|..||.. .+++.-+..+
T Consensus 221 sClkm~-~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KI 293 (1317)
T KOG0612|consen 221 SCLKMD-ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKI 293 (1317)
T ss_pred hHHhcC-CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHH
Confidence 987643 23444566789999999999985 2 5799999999999999999999999864 3444444333
Q ss_pred hcC--CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHhhcCCCCC
Q 042519 308 FKD--PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL---MSDVVSALSFLGSDPD 367 (427)
Q Consensus 308 ~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~~L~~~~~~~~ 367 (427)
+.- .-.+|.. ...+....+||...+ .+|+.|.. +.++..|..+..-.|.
T Consensus 294 m~hk~~l~FP~~----------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 294 MNHKESLSFPDE----------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred hchhhhcCCCcc----------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChh
Confidence 322 1112211 234567778887766 46777887 9999999988777664
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=325.47 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=218.5
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
...+.....+||.|.||.||.|.|+.....||||.++.+. -..++|..|+.+|+.++|||+|+|+|+|..+...|||+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 3445566678999999999999999999999999996553 456889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
||..|+|.+||... ....++....+.++.||..|++||..++ +|||||...|+||.++..|||+|||+++++..
T Consensus 344 fM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg- 417 (1157)
T KOG4278|consen 344 FMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTG- 417 (1157)
T ss_pred cccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcC-
Confidence 99999999999875 3455677778899999999999999999 99999999999999999999999999998543
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
+............-|.|||-+....++.|+|||+|||+|||+.| |..||...+ +.+.+ . ++.
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY-~----------LLE 480 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVY-G----------LLE 480 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHH-H----------HHh
Confidence 33333344445678999999999999999999999999999999 888886432 11111 1 122
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 365 (427)
.-.+-.-|..|+..+++|++.||+..|++||++.|+-+.++.+...
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 2222344777888999999999999999999999999999887653
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=309.23 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=205.2
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecC
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 163 (427)
.|...+.||+|++|.||++.+..++..+++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 45556799999999999999998899999999876554555668899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT 243 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 243 (427)
+++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||+|+||+++.++.++|+|||++...... .
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~ 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--V 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC--C
Confidence 9999998854 45888999999999999999999999 999999999999999999999999988753221 1
Q ss_pred ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccC
Q 042519 244 HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQ 323 (427)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (427)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||....+. ......... ..+.. .
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~--~~~~~-----~ 236 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN--LPPKL-----K 236 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc--CCCCC-----c
Confidence 1223356899999999998888999999999999999999999999653321 111111111 00000 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 324 GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.+......+.+++.+||+.+|++||++.+++++-+.
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHccCccc
Confidence 011234578999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=306.76 Aligned_cols=257 Identities=26% Similarity=0.345 Sum_probs=208.4
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|+..+.||.|+||.||++.++.+++.||+|.+..... .....+.+|+.+++.++||||+++++++......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 357888999999999999999999999999999876543 3345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999986532 678889999999999999999999 88 999999999999999999999999998753211
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. .....++..|+|||++.+..++.++||||||+++|+|++|..||....... .............. .+
T Consensus 155 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~--~~----- 222 (265)
T cd06605 155 L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP--PP----- 222 (265)
T ss_pred H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC--CC-----
Confidence 1 112678899999999998899999999999999999999999997543211 11122222221110 00
Q ss_pred ccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVR-GLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+.. ....+.++|..||..+|++||++.+++.+-+.
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 223 ----RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred ----CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 01111 45678899999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=305.40 Aligned_cols=246 Identities=30% Similarity=0.462 Sum_probs=198.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
++|++.+.||+|+||.||++.. +++.||+|.+... .....+.+|+.+++.++|+|++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 5689999999999999999875 4788999998653 2346788999999999999999999998764 479999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999998653 2346788999999999999999999999 999999999999999999999999998753211
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
......+..|+|||++.++.++.++|||||||++|+|++ |+.||...... ..... .......
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~~~~------- 216 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC-VEKGYRM------- 216 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH-HhCCCCC-------
Confidence 112334567999999998899999999999999999998 99998754321 11111 1111000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 217 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 217 ---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 112234467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=316.15 Aligned_cols=272 Identities=22% Similarity=0.257 Sum_probs=206.1
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG----- 152 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 152 (427)
...++|++.+.||+|+||.||+|.+..+|+.||||.+.+.. ......+.+|+.+++.++|+||++++++|...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34678999999999999999999999999999999986532 22335677899999999999999999988643
Q ss_pred -CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 153 -EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 153 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 35799999997 688887742 2788899999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-h----------
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-L---------- 300 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~---------- 300 (427)
|+++..... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.......... +
T Consensus 163 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 163 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred ccceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999863221 11233568899999999999999999999999999999999999997543211000 0
Q ss_pred -----hhhhhhhhcCCC-----CCCcccc----cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 301 -----VTWAQPFFKDPN-----RYPQLAD----PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 301 -----~~~~~~~~~~~~-----~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
......+..... .+.++.. +......+......+.+++.+||+.||++||++.+++++-+...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 000000111000 0001111 111111122345678899999999999999999999998765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.60 Aligned_cols=267 Identities=22% Similarity=0.314 Sum_probs=203.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcC--CeeEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQRLLV 158 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 158 (427)
++|++.+.||.|+||.||+|.++.+++.+|+|.++...... ...+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999999999999999997543322 23467899999999999999999999877 889999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||++ ++|.+++... ...+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99998 5998887653 236899999999999999999999999 9999999999999999999999999988643
Q ss_pred CCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hhhhh-------hhhhc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LVTWA-------QPFFK 309 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~~~~-------~~~~~ 309 (427)
... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.......... +.... ++.+.
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 321 122334578899999988754 46899999999999999999999997543321100 00000 00000
Q ss_pred -----CCCCCCcccccccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 310 -----DPNRYPQLADPLLQGEFPVR-GLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 310 -----~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
............+...++.. ....+.+++..||+.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00011111111112222222 45678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.49 Aligned_cols=252 Identities=30% Similarity=0.371 Sum_probs=202.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
..|...+.||+|+||.||+|.+..+|+.||+|.+...... ....+.+|+.+++.++||||++++++|.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5588899999999999999999988999999998654322 2346788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 677777654 2346899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCccceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
. ....|++.|+|||++. .+.++.++||||||+++|||++|..||........ ...... ...+.
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~--~~~~~ 233 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ--NDSPT 233 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhc--CCCCC
Confidence 1 2346888999999874 45688999999999999999999999865432111 000000 00000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..+......+.+++.+||+.+|++||++.+++.+.+...
T Consensus 234 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 234 --------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred --------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 012234567899999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=306.57 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=200.1
Q ss_pred ccccceeccCCceEEEEEEEC---CCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC------
Q 042519 85 FRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE------ 153 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 153 (427)
|.+.++||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999864 3578999999865432 23456788999999999999999999886542
Q ss_pred eeEEEEeecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
..+++++|+.+|+|.+++.... .....+++...+.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875422 22335788899999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
|+++...............+++.|++||.+....++.++|||||||++|+|++ |..||..... ..+..+. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~----~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYL----IK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHH----Hc
Confidence 99886433222222223445678999999998889999999999999999999 8888865422 1111111 11
Q ss_pred CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..... .+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 1122346889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.83 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=204.0
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|.+.+.||+|+||.||+|.+..++..|++|.+...... ....+..|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 488889999999999999999988999999999766543 456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999998854 235788899999999999999999999 9999999999999999999999999987643322
Q ss_pred ccce--eccccccccccCccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 242 KTHV--SSRVMGTYGYCAPEYQRTGQ---LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 242 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... ... +.......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~-----~~~~~~~~~~ 226 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIM-----FHVGAGHKPP 226 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHH-----HHHhcCCCCC
Confidence 2111 12356888999999998766 8899999999999999999999997543111 000 0000011111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
+.. .......+.+++.+||+.+|.+||++.+++.+
T Consensus 227 ~~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 227 IPD-------SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCc-------ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 110 11224567899999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=305.42 Aligned_cols=248 Identities=25% Similarity=0.320 Sum_probs=194.0
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHH---hhcCCCCeeeEEEEEEcCCeeEEEEeecC
Q 042519 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLML---SLLHHDNLVNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 163 (427)
+||+|+||.||++.+..+++.||+|.+.+..... ...+.+|..++ ....|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999986543221 12234444333 33479999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT 243 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 243 (427)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 9999988854 346899999999999999999999999 999999999999999999999999998643221
Q ss_pred ceeccccccccccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 244 HVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
......|++.|+|||.+. +..++.++|||||||++|+|++|..||..........+... ... .
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~------------~ 214 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT------------V 214 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hhc------------C
Confidence 122346899999999886 45689999999999999999999999975433211111110 000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcC
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLG 363 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~ 363 (427)
....+......+.+++..||+.||++|| ++.+++++.++..
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 1112333456888999999999999999 6999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=309.87 Aligned_cols=270 Identities=23% Similarity=0.318 Sum_probs=203.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcC--CeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 157 (427)
.++|++.+.||+|+||.||+|.++.+|+.||+|.+....... ...+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999999999999999986543222 23456799999999999999999998765 56899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+. ++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999997 5888887652 356899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC-----
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP----- 311 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 311 (427)
.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....+... ..........+
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIW 233 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhc
Confidence 3222 11223346788999998865 5689999999999999999999999975443211 11000100000
Q ss_pred ---CCCCc-----ccccccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 312 ---NRYPQ-----LADPLLQG--EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 312 ---~~~~~-----~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+. +....... .........+.+++..||+.||++||++.+++++-+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00000 00000000 000112456789999999999999999999999877643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=314.21 Aligned_cols=267 Identities=24% Similarity=0.325 Sum_probs=201.2
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccC--CCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC--Cee
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN--GLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG--EQR 155 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 155 (427)
..++|++.+.||+|+||.||+|.+..+|..+|+|++... .......+..|+.++.++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 357899999999999999999999988999999998543 223345577899999999 999999999998653 468
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999998 699888743 26788899999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCcc---ceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 236 LGPIGDKT---HVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 236 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
........ .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....+... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~ 232 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPP 232 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCC
Confidence 64332221 12334568999999998754 5678999999999999999999999965332210 00000000000
Q ss_pred ----------CCCCcccc-------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 312 ----------NRYPQLAD-------PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 312 ----------~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.....+.+ ....... ......+.+++.+||+.+|++||++.+++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~ 297 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence 00000000 0000001 114567899999999999999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=306.91 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=201.1
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|+..+.||.|+||.||+|++..+|..||||.+..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48889999999999999999999999999999865432 2235688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 6898888653 3456899999999999999999999999 9999999999999999999999999987532221
Q ss_pred ccceeccccccccccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC---------
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQ-LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP--------- 311 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 311 (427)
.......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||....... .+..... ....+
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFR-TLGTPDEVVWPGVT 229 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-HhCCCChhhhhhhh
Confidence 1123345788999999887644 6889999999999999999999996543211 1111000 00000
Q ss_pred ------CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 ------NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..++......+. .........+.+++.+||+.||++||++.+++.+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 282 (284)
T cd07860 230 SLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP 282 (284)
T ss_pred HHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence 000110000000 00112335678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=307.69 Aligned_cols=267 Identities=21% Similarity=0.273 Sum_probs=200.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCe-----
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQ----- 154 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 154 (427)
++|++.+.||+|+||.||+|.+..+|+.||||.+..... .....+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468999999999999999999999999999999865432 22356788999999995 6999999999987665
Q ss_pred eEEEEeecCCCChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-CCCeeEeecC
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPE-QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-EFNAKLSDFG 232 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkl~DFG 232 (427)
.++||||++ ++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 899999998 4898888654332 457899999999999999999999999 999999999999998 8899999999
Q ss_pred CcccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+... +..... ....+
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~-~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFK-LLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHH-HhCCC
Confidence 9875322111 1222356888999998865 4579999999999999999999999975432211 000000 00000
Q ss_pred CC--CCcc------------cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 NR--YPQL------------ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 ~~--~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.. .+.. ....+. .........+.++|..||+.+|.+||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~ 292 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcCC
Confidence 00 0000 000000 00112456788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=316.77 Aligned_cols=268 Identities=20% Similarity=0.277 Sum_probs=200.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----Cee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG-----EQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 155 (427)
+++|++.+.||+|+||.||+|.+..+|..||||.+.... ......+..|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999999999999999986432 22345577899999999999999999987654 357
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++|+||+. ++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 99999997 58877763 346899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCc-cceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC-
Q 042519 236 LGPIGDK-THVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN- 312 (427)
Q Consensus 236 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 312 (427)
....... ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ........+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 5322211 111233578999999998654 568999999999999999999999996532110 0000111111000
Q ss_pred -CCCcccccc-------c--CCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 313 -RYPQLADPL-------L--QGE-----FPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 313 -~~~~~~~~~-------~--~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
....+.+.. . ... ........+.+++.+||+.+|++||++.+++++-+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~ 295 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 000000000 0 000 001224578899999999999999999999998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=307.52 Aligned_cols=258 Identities=26% Similarity=0.335 Sum_probs=210.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.+.|+..+.||+|+||.||+|.+..++..|++|++..... ....+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4668888999999999999999998899999999976543 456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999997632 47899999999999999999999999 9999999999999999999999999986533221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......++..|++||++.+..++.++|||||||++|+|++|..||....+... ...... .......
T Consensus 171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~~--~~~~~~~--- 237 (286)
T cd06614 171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLITT--KGIPPLK--- 237 (286)
T ss_pred --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh--cCCCCCc---
Confidence 122334578899999999888899999999999999999999999975432210 001111 0111100
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+......+.+++.+||+.+|.+||++.+++++.....
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 238 ----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 11224467889999999999999999999998776544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=309.87 Aligned_cols=260 Identities=25% Similarity=0.309 Sum_probs=200.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|...+.||+|+||.||++.+..++..||+|.+..... .....+..|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 356677899999999999999999999999999875433 23456788999999996 9999999999999999999999
Q ss_pred ecCCCChhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 161 YMPLRSLEDHLLDI-GPEQKPIDWFTRMKIALGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 161 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|+. ++|.++.... ......+++..+..++.+++.||+|||+. + |+||||||+|||++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 987 5665543221 11236789999999999999999999975 7 9999999999999999999999999987532
Q ss_pred CCCccceeccccccccccCccccccC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTG---QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... .......... ...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~--~~~- 228 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK--GDP- 228 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC--CCC-
Confidence 211 12334688899999998765 689999999999999999999999975431 1111111111 011
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+.+....+......+.+++.+||+.+|++||++.+|+.+-+.
T Consensus 229 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 229 ----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred ----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 111111222355678999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=302.84 Aligned_cols=251 Identities=26% Similarity=0.348 Sum_probs=199.9
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 91 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
||+|+||+||+|.++.+|+.||+|.+..... .....+..|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999999999999999999865432 2234567899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceec
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 247 (427)
.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccc
Confidence 99986532 246899999999999999999999999 99999999999999999999999999875322 11223
Q ss_pred cccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCC
Q 042519 248 RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFP 327 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (427)
...++..|+|||++.+..++.++|||||||++|+|++|+.||........ ............ ...+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~------------~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEELKRRTLEMA------------VEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHHHHhcccccc------------ccCC
Confidence 34678899999999888899999999999999999999999975432111 011111111100 0112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcC
Q 042519 328 VRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLG 363 (427)
Q Consensus 328 ~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~ 363 (427)
......+.+++..||+.+|.+|| ++.+++++-+...
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 23356788999999999999999 7777887765533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=299.82 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=208.8
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--CeeEEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQRLLVY 159 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 159 (427)
+|+..+.||+|++|.||+|.+..++..|++|++..... ...+.+.+|+.++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47888999999999999999998999999999876543 3456788999999999999999999999988 8999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++... ..+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998653 27899999999999999999999999 99999999999999999999999999886443
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
...........++..|+|||.+....++.++||||||+++|+|++|..||...... ........ .....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~----- 222 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIG-SSGEP----- 222 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhcc-ccCCC-----
Confidence 33211234466889999999998888999999999999999999999999765411 11111110 00111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
...+......+.+++.+|++.+|.+||++.+++.+-
T Consensus 223 ----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 223 ----PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred ----cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 112333357899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=310.56 Aligned_cols=252 Identities=29% Similarity=0.383 Sum_probs=202.9
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.|...+.||+|+||.||++++..++..||+|.+...... ....+..|+.+++.++|+|++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 477888999999999999999989999999998654322 23467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+. |+|.+.+.. ....+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 106 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred CCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 997 588777654 2456899999999999999999999999 99999999999999999999999999875322
Q ss_pred CccceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.....|++.|+|||++. .+.++.++|||||||++|+|++|..||...... ......... .. ..
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~-~~-~~- 243 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-ES-PT- 243 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhc-cC-CC-
Confidence 22346888999999873 457899999999999999999999998653211 001111111 00 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.........+.+++.+||+.+|.+||++.+++++++.+..
T Consensus 244 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 -------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0112334578899999999999999999999999887554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=305.08 Aligned_cols=250 Identities=25% Similarity=0.291 Sum_probs=205.5
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
+|++.+.||.|+||.||+|.+..++..||+|.+.+... ...+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48889999999999999999999999999999976432 234678889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+.+++|.+++... ..+++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998542 47889999999999999999999999 999999999999999999999999998764322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ..........
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~---------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET---------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------
Confidence 1 2234568889999999988889999999999999999999999998654321 1111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHH
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM--SDVVSA 358 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~--~evl~~ 358 (427)
.....+...+..+.+++.+||+.+|.+||++ .|++++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 0111223344788899999999999999999 666543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=297.50 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=207.6
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecC
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 163 (427)
+|+..+.||+|++|.||++.+..++..+++|++..........+.+|+.+++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47888999999999999999998899999999977655456788999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT 243 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 243 (427)
+++|.+++... ...+++..+..++.|++.+|.|||..+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999988652 257899999999999999999999999 99999999999999999999999999876433221
Q ss_pred ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccC
Q 042519 244 HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQ 323 (427)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (427)
.....|+..|++||++.+..++.++||||||+++|+|++|+.||........ ...... .....+..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~--~~~~~~~~---- 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFKIAT--NGPPGLRN---- 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHh--cCCCCcCc----
Confidence 3345688999999999888899999999999999999999999975432110 000000 11111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 324 GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
+......+.+++..||+.||++||++.+++++
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 ---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124678999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=304.93 Aligned_cols=265 Identities=25% Similarity=0.371 Sum_probs=203.2
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
+|++.+.||.|++|.||+|++..+|..||||.+...... ....+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588899999999999999999999999999998765433 3456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
+ ++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 D-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred C-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 8 58888886543 2356899999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC--------CC
Q 042519 243 THVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP--------NR 313 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~ 313 (427)
.......++..|++||++.+ ..++.++|||||||++|+|++|..||........ ..... .....+ ..
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIF-RIMGTPTESTWPGISQ 230 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHH-HHhCCCChhhHHHHhc
Confidence 11233457889999998865 3578999999999999999999999975433211 11000 000000 00
Q ss_pred CCccccccc------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 314 YPQLADPLL------QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 314 ~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
.+.+..... ...........+.+++..||+.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 001112335678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=300.96 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=210.3
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|++.+.||.|+||.||++.+..++..|++|++..... .....+..|+.+++.++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 48888999999999999999998999999999976543 3456688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.........+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999775434578999999999999999999999999 9999999999999999999999999987643222
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ......... ...
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~--~~~------ 221 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKG--QYP------ 221 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcC--CCC------
Confidence 2334457899999999998888999999999999999999999999654321 111111111 111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..+......+.+++.+||..+|++||++.+++++
T Consensus 222 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 ---PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1122344678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=350.79 Aligned_cols=263 Identities=29% Similarity=0.498 Sum_probs=211.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
...|...++||+|+||.||+|++..++..||||.+...... ...|+.++++++|||||+++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45678888999999999999999888999999998643221 23468889999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++|+|.+++. .++|..+..++.||+.||+|||....++|+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 99999999984 37899999999999999999995533449999999999999999888875 665543211
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+.... ....+..|....+.. .......++.
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 908 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMWIDPS 908 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhheeCcc
Confidence 1223688999999999999999999999999999999999999964322 234456665544332 2333445555
Q ss_pred cCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 322 LQG--EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 322 ~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+.. ..+.....++.+++.+||+.+|++||+|.+|++.|+.+..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 433 2345667788999999999999999999999999987654
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=308.58 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=198.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCC------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGE------ 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 153 (427)
-++|++.+.||+|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999999999999999998643222 2234567999999999999999999987654
Q ss_pred --eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 154 --QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 154 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
..++||||+. ++|.+.+.. ....+++.+++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 4599999997 588887754 2346899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcc--ceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh---
Q 042519 232 GLAKLGPIGDKT--HVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ--- 305 (427)
Q Consensus 232 G~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~--- 305 (427)
|++......... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||....+...........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998754322211 112234578899999988654 47899999999999999999999997654321111111100
Q ss_pred --hhhcCCCCC--------Cc----ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 306 --PFFKDPNRY--------PQ----LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 306 --~~~~~~~~~--------~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..+...... +. .....+. +......+.+++.+||+.||.+||++.+++++-+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 000000000 00 0000000 0011245678999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=302.99 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=208.6
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|++.+.||+|+||.||++.++.+++.+++|.+..... .....+..|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 48889999999999999999999999999999875432 2345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998765444567899999999999999999999999 999999999999999999999999999864332
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
......|++.|++||.+.+..++.++|+||||+++|+|++|+.||...... ...... .. ...+
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~-~~-~~~~------ 219 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYKV-QR-GKYP------ 219 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-hc-CCCC------
Confidence 222356888999999999888999999999999999999999999754321 111111 10 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..+......+.+++..||+.+|.+||++.+++++
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ---PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1223455778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=302.95 Aligned_cols=260 Identities=21% Similarity=0.249 Sum_probs=197.2
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCeeeEEEEEEcC--CeeEEEEe
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLH-HDNLVNLIGYCADG--EQRLLVYE 160 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 160 (427)
|++.+.||+|+||.||+|.+..++..||+|.+...... .......|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67788999999999999999999999999998654222 2233456888888886 99999999999987 88999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|++ ++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 6888877542 356899999999999999999999999 999999999999999 99999999999753222
Q ss_pred CccceeccccccccccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh-----------
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF----------- 308 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~----------- 308 (427)
. ......++..|+|||++. ++.++.++|||||||++|||++|..||....+.. .........
T Consensus 153 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 P---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred C---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhh
Confidence 1 122356788999999764 4567899999999999999999999997644321 111111100
Q ss_pred cCCCC----CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 309 KDPNR----YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 309 ~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..... .+......+. ......+..+.+++.+||+.+|++||++.+++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~ 280 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLR-KLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280 (282)
T ss_pred cccccccccCcccccccHH-HHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence 00000 0000000000 01123467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=299.52 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=204.2
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|.+.+.||+|+||.||+|.++.+|..||+|.+..... ...+.+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47889999999999999999999999999999865422 2345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC-eeEeecCCcccCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN-AKLSDFGLAKLGPIG 240 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-vkl~DFG~a~~~~~~ 240 (427)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++. ++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~- 154 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND- 154 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC-
Confidence 9999999998653 2345789999999999999999999999 999999999999988864 69999999875322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ..+...... .....
T Consensus 155 -~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~--~~~~~---- 221 (257)
T cd08225 155 -SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ--GYFAP---- 221 (257)
T ss_pred -CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc--ccCCC----
Confidence 12222334689999999999888899999999999999999999999864321 111211111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
........+.+++.+||+.+|++||++.+++.+-
T Consensus 222 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 222 -----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred -----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 1122335788999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=297.81 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=197.6
Q ss_pred HHHHHHhhCcccccee--ccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC
Q 042519 76 RELATATKNFRQECLI--GEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG 152 (427)
Q Consensus 76 ~~~~~~~~~y~~~~~L--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 152 (427)
.+.....++|++.+.+ |+|+||.||++..+.++..+|+|.+........ |+.....+ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3344455677887776 999999999999999999999999865432221 22222222 699999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-CeeEeec
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDF 231 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DF 231 (427)
+..++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 9999999999999999998642 37899999999999999999999999 99999999999999998 9999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
|++..... .....|+..|+|||++.+..++.++||||||+++|+|++|..||....... .....+.... ...
T Consensus 155 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~ 226 (267)
T PHA03390 155 GLCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QKK 226 (267)
T ss_pred ccceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-ccc
Confidence 99875321 123468899999999998899999999999999999999999997443221 1112221111 100
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHH
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-MSDVVSAL 359 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~~L 359 (427)
. .........+.+++..||+.+|.+||+ +++++++=
T Consensus 227 ~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~ 263 (267)
T PHA03390 227 L------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP 263 (267)
T ss_pred C------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence 0 111234567889999999999999996 69998764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=304.32 Aligned_cols=264 Identities=23% Similarity=0.301 Sum_probs=200.9
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
|++.+.||.|++|.||+|.++.+|..||+|++...... ....+.+|+.+++.++|+|++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67788999999999999999989999999998754322 2356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
+ ++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~- 153 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV- 153 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence 6 68999886532 246899999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC-----------
Q 042519 243 THVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD----------- 310 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 310 (427)
.......+++.|+|||++.+. .++.++||||||+++|+|++|..||....+... +..........
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhc
Confidence 112233568899999988654 578999999999999999999999975432211 11110000000
Q ss_pred C---CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 311 P---NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 311 ~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
+ ..++....... ..........+.+++.+||+.+|.+||++.+++++-
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 231 PDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred hhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 0 00000000000 011122336788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=300.71 Aligned_cols=247 Identities=27% Similarity=0.342 Sum_probs=201.8
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 91 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
||.|+||.||+|++..++..||+|++.+... .....+.+|+.+++.++|+||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999999999999999976433 2335688899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceec
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 247 (427)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999864 245888999999999999999999999 9999999999999999999999999998643322 223
Q ss_pred cccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCC
Q 042519 248 RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFP 327 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (427)
...|++.|++||++.+..++.++|+||||+++|+|++|..||...... ............ ....++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~----------~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGN----------GKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccC----------CCCCCC
Confidence 356889999999998888999999999999999999999999765421 111111111100 011122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhh
Q 042519 328 VRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSF 361 (427)
Q Consensus 328 ~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~ 361 (427)
......+.+++..||+.+|++||+ +.|++++-+.
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 233568899999999999999999 8898887654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.12 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=208.9
Q ss_pred CccccceeccCCceEEEEEEECC----CCcEEEEEEeccC-CCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEK----TAQVVAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.....+.||.|.||.||+|.... ..-.||||..+.+ .....+.|..|..+++.+.||||++|+|+|.+ ...+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34556789999999999998743 2346999998763 34556789999999999999999999999986 568999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
||.++.|.|..||.. +...++......++.||+.+|+|||+.. +|||||...|||+.+..-|||+|||+++...
T Consensus 469 mEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 469 MELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 999999999999986 4567888999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
....... +...-..-|||||.++...++.++|||-|||++||++. |..||......+ +-..
T Consensus 543 d~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------VI~~ 604 (974)
T KOG4257|consen 543 DDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------VIGH 604 (974)
T ss_pred ccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------eEEE
Confidence 4443332 23444568999999999999999999999999999887 999997542211 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
+..--+-..|..++..|+.++.+||+.+|.+||.+.++...|..+
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 111222245788899999999999999999999999998887544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=320.46 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=209.3
Q ss_pred CccccceeccCCceEEEEEEECCCC---cEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTA---QVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.....++||+|.||.|++|.|...+ ..||||++...... ...+|.+|+.+|.+|+|+|+++|||+..+ ....+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3456678999999999999996432 46999999776554 56889999999999999999999999987 7788999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|++++|+|.+.|++ .....+.......++.||+.||.||.+++ +|||||-..|+||-....|||||||+.+....
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999987 35566777888899999999999999999 99999999999999999999999999997655
Q ss_pred CCccceec-cccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 240 GDKTHVSS-RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 240 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.+..+... ...-...|+|||.++...++.++|||+|||+||||++ |..||-..... .+ -+.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------qI-------L~~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------QI-------LKN 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------HH-------HHh
Confidence 54443322 2234557999999999999999999999999999999 77888654321 11 112
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
+|...+-..+..++++++++++.||..+|++||++..|.+.+
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 222233345778899999999999999999999999997554
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=305.66 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=202.0
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCC
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRS 166 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 166 (427)
...+||+|+||.||++..+.+|..||||.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 34679999999999999999999999999865544455668889999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcccee
Q 042519 167 LEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS 246 (427)
Q Consensus 167 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 246 (427)
|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~ 173 (292)
T cd06657 104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR 173 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccc
Confidence 9987732 35788999999999999999999999 9999999999999999999999999987532211 122
Q ss_pred ccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCC
Q 042519 247 SRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEF 326 (427)
Q Consensus 247 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (427)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||....... .... ... ..+. .+..
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~----~~~--~~~~----~~~~-- 238 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IRD--NLPP----KLKN-- 238 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHh--hCCc----ccCC--
Confidence 34568899999999988889999999999999999999999987532211 0111 110 0000 0000
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 327 PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 327 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.......+.+++.+||+.+|.+||++.+++++=+...
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~ 275 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhc
Confidence 1123346788999999999999999999999754433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=299.60 Aligned_cols=253 Identities=25% Similarity=0.294 Sum_probs=201.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-----CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--Cee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-----LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQR 155 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 155 (427)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46899999999999999999999999999999875321 12335678899999999999999999998764 468
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998854 245788899999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCc-cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 236 LGPIGDK-THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 236 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||....... . .......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~----~~~~~~~~--- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--A----IFKIATQP--- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--H----HHHHHcCC---
Confidence 5322111 111223568899999999998889999999999999999999999997532211 0 11111110
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.....+......+.+++..||+ +|..||+..+++.+.
T Consensus 226 -------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 226 -------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred -------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 1112344455788999999999 579999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=310.64 Aligned_cols=272 Identities=19% Similarity=0.263 Sum_probs=205.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc----CCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD----GEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 155 (427)
.++|++.+.||+|+||.||+|..+.+|..||+|++..... .....+.+|+.++..++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4789999999999999999999999999999999875422 334567789999999999999999998753 3568
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 688888743 345899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCcc--ceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC-
Q 042519 236 LGPIGDKT--HVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP- 311 (427)
Q Consensus 236 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 311 (427)
........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........ +. ........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~--~~-~~~~~~g~~~ 232 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ--LK-LILSVLGSPS 232 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH--HH-HHHHHhCCCh
Confidence 53322211 11234578999999998865 4689999999999999999999999965432211 00 000000000
Q ss_pred ---------CCCCcccccc-cCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 312 ---------NRYPQLADPL-LQGEF-----PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 312 ---------~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.......+.. ..... .......+.+++..||+.+|++||++.+++.+.+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0000000000 00000 11235678999999999999999999999998776433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.55 Aligned_cols=270 Identities=21% Similarity=0.263 Sum_probs=200.3
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||.||+|.++.+|+.||+|.+..... .....+.+|+.+++.++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 468999999999999999999999999999999865432 223567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-CCCeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-EFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkl~DFG~a~~~~~ 239 (427)
|++ ++|.+++... ....+++..+..++.||+.||+|||+++ |+|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 997 6888877542 2334678888899999999999999999 999999999999985 55799999999975322
Q ss_pred CCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hhhhh----hhhhcCCCC
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LVTWA----QPFFKDPNR 313 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~~~~----~~~~~~~~~ 313 (427)
. ........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....+..... ..... ...+.....
T Consensus 156 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 P--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred C--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 1 112233467889999998865 457899999999999999999999997643321100 00000 000000000
Q ss_pred CCccccc--ccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 314 YPQLADP--LLQG----EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 314 ~~~~~~~--~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.+..... .... .........+.+++.+||+.+|++||++.+++++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~ 286 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 0000000 0000 001123456889999999999999999999998754
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=303.11 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=201.5
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--CeeEEEEe
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQRLLVYE 160 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 160 (427)
|++.+.||.|+||.||+|.+..+|+.+|+|.+.... ......+.+|+.+++.++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999999999999999997653 22345678899999999999999999999988 89999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|++ ++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 998 5888887542 257899999999999999999999999 999999999999999999999999998864332
Q ss_pred CccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC--CCCCCcc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD--PNRYPQL 317 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 317 (427)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .......... ....+..
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGV 229 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccc
Confidence 21 11233456788999997764 4678999999999999999999999976443211 0000000000 0000000
Q ss_pred c--------------ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 318 A--------------DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 318 ~--------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
. ...+...+...+...+.+++..||+.+|.+||++.+++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 0 00000011111256789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.29 Aligned_cols=243 Identities=27% Similarity=0.371 Sum_probs=201.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchH---HHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK---EFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 157 (427)
..+|..+.+||+|+||+|.++..+++.+.||||++++....... --+.|-.+|.... -|.+++++.+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 45688899999999999999999999999999999886543332 2345667776654 6789999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+.||+|.-++.+.+. +.+..+..++..|+-||-|||+++ ||+||||.+|||||.+|++||+|||+++..
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999876543 555567788999999999999999 999999999999999999999999999864
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
...+ ....++||||.|+|||++..++|+..+|+|||||+|||||.|+.||+..+.. +..+.+....
T Consensus 501 i~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------elF~aI~ehn------ 566 (683)
T KOG0696|consen 501 IFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQAIMEHN------ 566 (683)
T ss_pred ccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHcc------
Confidence 4333 3456799999999999999999999999999999999999999999864432 1222222211
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL 351 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs 351 (427)
-.+|.....+...+....|...|.+|..
T Consensus 567 ------vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 ------VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1346666778899999999999999953
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.25 Aligned_cols=249 Identities=24% Similarity=0.299 Sum_probs=194.1
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHH---HHhhcCCCCeeeEEEEEEcCCeeEEEEeecC
Q 042519 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVL---MLSLLHHDNLVNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 163 (427)
+||+|+||.||+|.+..+++.||+|.+.+..... ...+..|.. +++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987643221 122333433 3445679999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT 243 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 243 (427)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 9999988853 346899999999999999999999999 999999999999999999999999998753221
Q ss_pred ceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 244 HVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
......|+..|+|||++.++ .++.++|||||||++|+|++|+.||............ ......
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~------------ 214 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTM------------ 214 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhhcc------------
Confidence 12235789999999998754 6899999999999999999999999754322111100 000000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcCC
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLGS 364 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~ 364 (427)
....+......+.+++..||..+|.+|| ++.+++++-+....
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 0011222346788999999999999999 99999987665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=288.46 Aligned_cols=272 Identities=23% Similarity=0.316 Sum_probs=208.4
Q ss_pred CHHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcC
Q 042519 74 TFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADG 152 (427)
Q Consensus 74 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 152 (427)
.|.++...++ ++||+|+|+.|--++...+|..||||++.+.....+..+.+|++++...+ |+||++|+++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3455544444 58999999999999999999999999999886667778899999999997 99999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC---eeEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN---AKLS 229 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkl~ 229 (427)
...|||||.|.||+|..+|.+ ...+++.++.++..+|+.||.|||.+| |.||||||+|||...... ||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999964 456899999999999999999999999 999999999999966544 8999
Q ss_pred ecCCcccCCCC-----CccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch
Q 042519 230 DFGLAKLGPIG-----DKTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN 299 (427)
Q Consensus 230 DFG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~ 299 (427)
||.+..-.... ..+....+.+|+..|||||+.. ...|+.++|.||||||||-||+|..||...-..+-
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC-- 299 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC-- 299 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--
Confidence 99886421111 1111234578999999999763 24689999999999999999999999965433211
Q ss_pred hhhhhhhhhcCCCC--CCcccccccCC--CCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 300 LVTWAQPFFKDPNR--YPQLADPLLQG--EFPV----RGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 300 ~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~----~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.|-.. +..+ -..++..+-.+ ++|. .+..+..+++...|..++.+|.++..++++-+.-.-
T Consensus 300 --GWdrG---e~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 300 --GWDRG---EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred --CccCC---CccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 01000 0000 00011111111 2332 345677889999999999999999999987765443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=311.65 Aligned_cols=269 Identities=21% Similarity=0.297 Sum_probs=202.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----Ce
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG-----EQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 154 (427)
.++|.+.+.||+|+||.||+|++..++..||||.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999999999999999986532 22334567899999999999999999988654 35
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999997 788888753 356899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hhhhhhh------
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LVTWAQP------ 306 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~~~~~~------ 306 (427)
....... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||.......... +......
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 8643221 22234568889999998764 468999999999999999999999996542110000 0000000
Q ss_pred -hhcCCC------CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 307 -FFKDPN------RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 307 -~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...... ......+.... .........+.+++.+||+.+|++||++.+++++-+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~ 294 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence 000000 00000000000 0112345678899999999999999999999999543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=305.30 Aligned_cols=267 Identities=22% Similarity=0.266 Sum_probs=198.5
Q ss_pred ceeccC--CceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEG--GFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
..||+| +||+||++.+..+|+.||+|++...... ..+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 9999999999999999999998754322 235678899999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc-
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT- 243 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~- 243 (427)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999887643 245888999999999999999999999 999999999999999999999999865321111100
Q ss_pred c----eeccccccccccCccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh-h---------
Q 042519 244 H----VSSRVMGTYGYCAPEYQRTG--QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP-F--------- 307 (427)
Q Consensus 244 ~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~-~--------- 307 (427)
. ......++..|+|||++.+. .++.++|||||||++|+|++|..||....... ........ .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 0 01112355679999998763 47899999999999999999999997543211 11000000 0
Q ss_pred ------hcC---------------CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 308 ------FKD---------------PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 308 ------~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
+.. ...........+....+......+.+++.+||+.||++|||+.+++++-+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 000 0000011111112222344667899999999999999999999999887653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=301.30 Aligned_cols=257 Identities=16% Similarity=0.167 Sum_probs=187.4
Q ss_pred hhCccccceeccCCceEEEEEEECCC---CcEEEEEEeccCCCcchH-----------HHHHHHHHHhhcCCCCeeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGLQGNK-----------EFIVEVLMLSLLHHDNLVNLIG 147 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l~~ 147 (427)
.++|++.++||+|+||.||+|.+..+ +..+|+|+.......... ....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46799999999999999999999877 667788865332211111 1122334556678999999999
Q ss_pred EEEcCC----eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC
Q 042519 148 YCADGE----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE 223 (427)
Q Consensus 148 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 223 (427)
++.... ..+++++++. .++.+.+... ...++..+..++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 766543 3467788765 4666655432 23567788899999999999999999 9999999999999999
Q ss_pred CCeeEeecCCcccCCCCCcc-----ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc
Q 042519 224 FNAKLSDFGLAKLGPIGDKT-----HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ 298 (427)
Q Consensus 224 ~~vkl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~ 298 (427)
+.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999764322111 1122356999999999999999999999999999999999999999765322111
Q ss_pred h---hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 299 N---LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 299 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
. ..++...+... . . .....+..+.+++..|++.+|++||++.++++.|
T Consensus 243 ~~~~~~~~~~~~~~~--~--------~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEG--K--------I---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhh--h--------h---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 01111111110 0 0 0112246788999999999999999999999876
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=302.03 Aligned_cols=267 Identities=26% Similarity=0.312 Sum_probs=201.2
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC----
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE---- 153 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 153 (427)
...++|++.+.||+|+||.||+|.++.+|+.||+|.++.... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999999999999999865432 22345678999999999999999999987655
Q ss_pred ------eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCee
Q 042519 154 ------QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 154 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
..++|+||+++ +|.+.+.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999985 77777654 2346899999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 042519 228 LSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306 (427)
Q Consensus 228 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~ 306 (427)
|+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.. ...
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~-~~~ 232 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLEL-ISR 232 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHH
Confidence 999999876433221 11222346778999998764 457899999999999999999999997543221 1111 111
Q ss_pred hhcCC--CCCCcccc--------------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 307 FFKDP--NRYPQLAD--------------PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 307 ~~~~~--~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
....+ ...+.+.. ...... ....+..+.+++..||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10000 00000000 000000 01134678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=291.11 Aligned_cols=249 Identities=28% Similarity=0.422 Sum_probs=205.9
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|++.+.||+|++|.||++.+..+++.|++|.+..... .....+.+|+.++++++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47889999999999999999998899999999977654 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999988643 56899999999999999999999999 9999999999999999999999999998643322
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+. ..... ... ....
T Consensus 154 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~--~~~~------ 217 (254)
T cd06627 154 K--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFR-IVQ--DDHP------ 217 (254)
T ss_pred c--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHH-Hhc--cCCC------
Confidence 2 123456888999999998888899999999999999999999999754311 10000 000 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..+......+.+++.+||..+|++||++.+++.+
T Consensus 218 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 ---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ---CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1122334678899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.05 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=197.6
Q ss_pred cccceeccCCceEEEEEEECCCCcEEEEEEeccCC----CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe--eEEEE
Q 042519 86 RQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG----LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ--RLLVY 159 (427)
Q Consensus 86 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 159 (427)
+...+||+|+|-+||+|.+..+|..||.-.++... ....+.|..|+.+|+.|+|+||++++++|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45578999999999999999999999876654322 2334678899999999999999999999987665 78999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-CCCeeEeecCCcccCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-EFNAKLSDFGLAKLGP 238 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkl~DFG~a~~~~ 238 (427)
|.+..|+|..|+.++ +.++...+..|+.||++||.|||++. +||||||||-+||||+. -|.|||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999764 45778889999999999999999986 78999999999999965 5899999999998632
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc--CCCCCCc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK--DPNRYPQ 316 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 316 (427)
. .+ ...+.|||.|||||+.. ..|+..+||||||++++||+|+.+||.--. +-...++.... .+..+..
T Consensus 198 ~---s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 198 K---SH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred c---cc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCHHHhhc
Confidence 2 22 22378999999999887 789999999999999999999999996432 11122222111 1111222
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
+- ..++.++|.+||.. .++||++.|+|..-
T Consensus 268 V~------------dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 268 VK------------DPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred cC------------CHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 22 24778999999999 99999999999874
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=296.28 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=197.5
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 91 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
||.|+||.||++++..+|+.|++|.+..... .....+.+|+.+++.++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999876543 3345678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc-----
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK----- 242 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~----- 242 (427)
.+++... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998653 36899999999999999999999999 99999999999999999999999999875332211
Q ss_pred -cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 243 -THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 243 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
........++..|++||++....++.++||||||+++|+|++|..||....+. .............+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~---- 223 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILNGKIEWPED---- 223 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCcCCCcc----
Confidence 11233456888999999998888999999999999999999999999754321 1111111110111100
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
......+.+++..||+.+|.+||++.++.+.|
T Consensus 224 ------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 224 ------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred ------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 01256788999999999999999994444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=303.45 Aligned_cols=247 Identities=30% Similarity=0.393 Sum_probs=198.4
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
|...+.||+|+||.||+|++..+|..|++|++...... ....+..|+.+++.++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999998654332 234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+. ++|.+++.. ....+++.+++.++.||+.+|.|||+++ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 97 688777754 2356899999999999999999999999 99999999999999999999999999864211
Q ss_pred ccceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||........ ...... ...+...
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~--~~~~~~~ 241 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ--NDSPTLQ 241 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHh--cCCCCCC
Confidence 22456889999999984 45688999999999999999999999865432111 111111 0111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.......+.+++.+||+.+|.+||++.+++.+-+
T Consensus 242 --------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 242 --------SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred --------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 1123346889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=317.54 Aligned_cols=258 Identities=24% Similarity=0.321 Sum_probs=196.9
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC------CeeEE
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG------EQRLL 157 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 157 (427)
|...+.||+|+||.||+|+++.+|+.||||.++... ....+...+|+++|++|+|+|||++++.-+.. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 556678999999999999999999999999997744 34456678899999999999999999876543 35689
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC--CCC--CeeEeecCC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD--CEF--NAKLSDFGL 233 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~vkl~DFG~ 233 (427)
|||||.+|||...|.+- .+...|++.+.+.++.+++.||.|||+++ |+||||||.||++- .+| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999998764 35678999999999999999999999999 99999999999993 334 369999999
Q ss_pred cccCCCCCccceeccccccccccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
|+..+.+. ....++||..|++||... .+.|+..+|.|||||++|+.+||..||.............|.. ..+.+.
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~-~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI-ITKKPS 246 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh-hccCCC
Confidence 99643322 566789999999999998 4889999999999999999999999997654432211122211 111221
Q ss_pred CCCcccccccC------------CCCCHHHHHHHHHHHHHccCCCCCCCC
Q 042519 313 RYPQLADPLLQ------------GEFPVRGLNQAVAVSAMCVQEESSVRP 350 (427)
Q Consensus 313 ~~~~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~~P~~RP 350 (427)
..........+ ..........+-..+..+|..+|.+|-
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11111111111 122233444556677778888888887
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=292.47 Aligned_cols=244 Identities=22% Similarity=0.264 Sum_probs=190.8
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch---HHHHHHHHH-HhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLM-LSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
+.||.|+||.||+|.+..+|+.||+|.+.+...... ..+..|..+ ...++|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999876433222 233445444 4456899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999998854 246888999999999999999999999 99999999999999999999999999875322
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... .............+.
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~-------- 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSRRINWPE-------- 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcccCCCC--------
Confidence 23456888999999998888999999999999999999999999754321 111111111001100
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMS---DVVSAL 359 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~---evl~~L 359 (427)
.....+...+.+++.+||+.+|++||++. |++.+-
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 11113456789999999999999999665 555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.91 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=203.1
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
|++.+.||.|++|.||+|.+..+|+.+++|.+...... ....+..|+.+++.++|+||+++++++.+++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999999989999999998765333 3456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
+ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 D-TDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 8 5888887652 357899999999999999999999999 9999999999999999999999999987643322
Q ss_pred cceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC--CCCCCcccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD--PNRYPQLAD 319 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 319 (427)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.......... ... ..... +.......+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF--KIF-RTLGTPDPEVWPKFTS 228 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-HHcCCCchHhcccchh
Confidence 122334578889999998776 78999999999999999999999996543321100 000 00000 000000000
Q ss_pred -----------c--ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 320 -----------P--LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 320 -----------~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
. .............+.+++..||+.||.+||++.+++.+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~ 281 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence 0 000011223467899999999999999999999998763
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=304.09 Aligned_cols=252 Identities=29% Similarity=0.352 Sum_probs=201.3
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
+.|...+.||+|+||.||+|++..++..+|+|.+..... .....+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 447778899999999999999999999999999864322 22345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+. |+|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9997 688777654 2345889999999999999999999999 99999999999999999999999999875322
Q ss_pred CCccceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.....|++.|+|||++. .+.++.++|||||||++|+|++|..||....... ....... ...+.
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~--~~~~~ 233 (308)
T cd06634 168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ--NESPA 233 (308)
T ss_pred ------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhh--cCCCC
Confidence 12356888999999874 3568899999999999999999999986532210 0000011 01110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.........+.+++.+||+.+|.+||++.+++.+.+...
T Consensus 234 --------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred --------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 011234467889999999999999999999999877655
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.49 Aligned_cols=256 Identities=27% Similarity=0.358 Sum_probs=206.5
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.+-+|.....||.|.||.||.|.+.++|+..|+|.+.-.. ......+.+|..++..|+|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3456778889999999999999999999999999885432 23345678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
||||.+|+|.+.+... .-.++.-...+-.|++.|++|||++| ||||||||.||||+.+|.+|++|||.|....
T Consensus 1313 MEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999988542 23455555567889999999999999 9999999999999999999999999998643
Q ss_pred CCC--ccceeccccccccccCccccccC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 239 IGD--KTHVSSRVMGTYGYCAPEYQRTG---QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 239 ~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
... .........||+.|||||++.+. ....++|||||||++.||+||++||...+. +|+.-+--.-+.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGH 1458 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccC
Confidence 221 11223356899999999999753 466899999999999999999999975432 333322222233
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.++ +|.....+-.+++..||+.||+.|.++.+++++=
T Consensus 1459 ~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1459 KPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 333 3445667888999999999999999999988864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.73 Aligned_cols=267 Identities=21% Similarity=0.291 Sum_probs=205.1
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC-----eeE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE-----QRL 156 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 156 (427)
+|++.+.||.|+||.||+|++..++..||||.+.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999999889999999987643 334467888999999999999999999988775 789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||||++ ++|.+++.. ...+++..++.++.+|+.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 588888753 337899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCc-cceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC----
Q 042519 237 GPIGDK-THVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD---- 310 (427)
Q Consensus 237 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 310 (427)
...... ........++..|+|||++.+. .++.++||||||+++|+|++|+.||........ .......+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 229 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEE 229 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChh
Confidence 433221 0112335678899999999887 789999999999999999999999976543210 0000000000
Q ss_pred ------CCCCCcccccccC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 311 ------PNRYPQLADPLLQ------GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 311 ------~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.......+..... ..........+.+++.+||+.+|.+||++.+++++-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 0000000000000 00111235678899999999999999999999998554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=287.87 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=207.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhh-cCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSL-LHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|+++++||+|+|++|.+++++.+.+.||+|++++.-. .+......|-.+..+ -+||.+|.|..+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 5789999999999999999999999999999999977433 233445566666655 469999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
|.||++||+|.-++. .+..+++..+..+...|+.||.|||+.| ||+||||.+|+|+|.+|++||+|+|+++..
T Consensus 329 vieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999987774 4567999999999999999999999999 999999999999999999999999999863
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc-ccchhhhhhhhh-hcCCCCCC
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPT-YEQNLVTWAQPF-FKDPNRYP 315 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~ 315 (427)
. .....++++||||.|.|||++.+..|...+|+|+|||+++||+.|+.||+...-. .+++..+++.+. +....++
T Consensus 402 l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri- 478 (593)
T KOG0695|consen 402 L--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI- 478 (593)
T ss_pred C--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc-
Confidence 2 2334567899999999999999999999999999999999999999999754322 223444443332 2222222
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC------CHHHHHHH
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP------LMSDVVSA 358 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP------s~~evl~~ 358 (427)
|.........+++..|++||.+|. .++++..+
T Consensus 479 -----------prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 479 -----------PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred -----------cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence 222334556788999999999994 35555554
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=294.64 Aligned_cols=262 Identities=22% Similarity=0.306 Sum_probs=197.7
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhc---CCCCeeeEEEEEEcCCe-----
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLL---HHDNLVNLIGYCADGEQ----- 154 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 154 (427)
|++.+.||+|+||.||+|+++.++..||+|.+....... ...+.+|+.++..+ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999999889999999996543221 23456677766655 59999999999988776
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.+++|||+. ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999998 58988886532 235899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc-CC--
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK-DP-- 311 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~-- 311 (427)
....... ......++..|+|||++.+..++.++|||||||++|+|++|..||....... .+......... ..
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHh
Confidence 7643221 1223457889999999998899999999999999999999999987543221 11111110000 00
Q ss_pred ---------CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 312 ---------NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 312 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
........... ..........+.+++.+||+.||++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000000 01112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=298.22 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=199.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||.||+|.++.++..||||.+...... ....+..|+.++..+. |+||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 36789999999999999999999998999999999764332 3344566777666665 999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
||+. ++|.+++... ...+++..+..++.|++.||.|||+ .+ |+||||+|+||+++.++.+||+|||++....
T Consensus 94 e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9986 5777766542 3478999999999999999999997 47 9999999999999999999999999987532
Q ss_pred CCCccceeccccccccccCccccccCC----CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQ----LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...... .+......... .
T Consensus 167 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~--~ 236 (296)
T cd06618 167 DSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE--P 236 (296)
T ss_pred CCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC--C
Confidence 211 122345788999999987543 889999999999999999999999653211 11111111111 0
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..... .......+.+++.+||+.+|.+||++.+++++.+..
T Consensus 237 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 237 PSLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred CCCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 01000 012345789999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.29 Aligned_cols=252 Identities=27% Similarity=0.340 Sum_probs=205.8
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 158 (427)
++|.+.+.||+|+||.||+|....+|..||+|++..... .....+..|+.+++.++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 468999999999999999999999999999999876432 22356778999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999998653 36899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCc------------------cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 042519 239 IGDK------------------THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL 300 (427)
Q Consensus 239 ~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~ 300 (427)
.... ........|+..|+|||++....++.++||||||+++|+|++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 228 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----- 228 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence 2221 01223356789999999998888999999999999999999999999865311
Q ss_pred hhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHH
Q 042519 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM----SDVVSAL 359 (427)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~----~evl~~L 359 (427)
......... ...++......+.+++..||+.+|.+||++ .+++++-
T Consensus 229 -~~~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 229 -LTFQKILKL------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred -HHHHHHHhc------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 001111111 111222335678899999999999999999 8887753
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.12 Aligned_cols=248 Identities=27% Similarity=0.331 Sum_probs=202.0
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCC
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLR 165 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 165 (427)
.++||+|.||+||-|+++.+|+.||||+|++-... ....+++|+.||+++.||.||.+...|+..+.+|+|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 37899999999999999999999999999875433 33668899999999999999999999999999999999997 5
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC---CCeeEeecCCcccCCCCCc
Q 042519 166 SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE---FNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkl~DFG~a~~~~~~~~ 242 (427)
+..+.+.. .+...+++.....++.||+.||.|||.++ |+|+||||+||||.+. -++||||||+|++...
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--- 719 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--- 719 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch---
Confidence 55555544 35678999888899999999999999999 9999999999999554 4699999999997432
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
......++|||.|+|||++.+..|+..-|+||+|||+|--|+|..||...++..++. .+.+ |-. +.
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI-QNAa---FMy----Pp------ 785 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI-QNAA---FMY----PP------ 785 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh-hccc---ccc----CC------
Confidence 334566899999999999999999999999999999999999999997654322111 1100 000 00
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..=.+.....+++|...|+..-.+|-+....+.+.|
T Consensus 786 --~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 786 --NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred --CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 001234457889999999999999999988877765
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=304.64 Aligned_cols=267 Identities=21% Similarity=0.290 Sum_probs=200.5
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC-----
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE----- 153 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 153 (427)
..++|++.+.||+|+||.||+|.+..+|..||||++..... .....+.+|+.+++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 46789999999999999999999999999999999865322 22345778999999999999999999987653
Q ss_pred -eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 154 -QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 154 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
..++||||+ +++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 578988774 346889999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc-hhh--------h
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ-NLV--------T 302 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~-~~~--------~ 302 (427)
++..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+. .
T Consensus 164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9875322 1223467889999998875 45889999999999999999999999754321100 000 0
Q ss_pred hhhhhhcCC-----CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 303 WAQPFFKDP-----NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 303 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
+...+.... ...+......+. .........+.+++.+||+.||++||++.+++.+-+.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~ 302 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence 000000000 000000000000 01112344688999999999999999999999775543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=302.13 Aligned_cols=271 Identities=23% Similarity=0.285 Sum_probs=198.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcC-------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADG------- 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 152 (427)
.++|++.+.||.|+||.||+|.++.+++.||||++...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999999999999999998654322 224567899999999999999999987543
Q ss_pred -CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 153 -EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 153 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
...++|+||+. ++|...+.. ....+++..+..++.|+++||.|||+++ |+|+||||+|||++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 34699999997 577776653 3456899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcc---------ceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-h
Q 042519 232 GLAKLGPIGDKT---------HVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-L 300 (427)
Q Consensus 232 G~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~ 300 (427)
|++......... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||....+..... +
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 998753222111 11223467889999998765 458899999999999999999999997543321100 0
Q ss_pred hhhhhh----hhcCCCCCCcccccccCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 301 VTWAQP----FFKDPNRYPQLADPLLQGEFP-------VRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 301 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
...... .+......+...+.......+ ......+.+++.+||+.+|++|||+.+++.+-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~ 309 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP 309 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence 000000 000000001100000000000 11225788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=303.54 Aligned_cols=270 Identities=20% Similarity=0.290 Sum_probs=202.4
Q ss_pred hhCcc-ccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--------------hHHHHHHHHHHhhcCCCCeeeEE
Q 042519 82 TKNFR-QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--------------NKEFIVEVLMLSLLHHDNLVNLI 146 (427)
Q Consensus 82 ~~~y~-~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 146 (427)
.++|. +.+.||.|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35565 4578999999999999999999999999986543221 12467899999999999999999
Q ss_pred EEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCe
Q 042519 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226 (427)
Q Consensus 147 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 226 (427)
+++..++..++||||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 99999999999999997 689888853 345889999999999999999999999 9999999999999999999
Q ss_pred eEeecCCcccCCCCC------------ccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 042519 227 KLSDFGLAKLGPIGD------------KTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTR 293 (427)
Q Consensus 227 kl~DFG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~ 293 (427)
+|+|||++....... .........+++.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987533110 01111223568889999998764 47899999999999999999999997654
Q ss_pred CcccchhhhhhhhhhcCCCC--CCcc------------cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 294 PTYEQNLVTWAQPFFKDPNR--YPQL------------ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~--~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
+... ..........+.. ++.. ...... .........+.+++..||+.+|++||++.+++.+-
T Consensus 239 ~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 239 EIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 3211 1111111111000 0000 000000 00112346788999999999999999999999987
Q ss_pred hhcC
Q 042519 360 SFLG 363 (427)
Q Consensus 360 ~~~~ 363 (427)
+...
T Consensus 315 ~~~~ 318 (335)
T PTZ00024 315 YFKS 318 (335)
T ss_pred ccCC
Confidence 7643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=328.31 Aligned_cols=257 Identities=24% Similarity=0.340 Sum_probs=191.4
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC------
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG------ 152 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 152 (427)
+-..+|+..++||+||||.||+++++-+|..||||+|.... ......+.+|+..|++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34578999999999999999999999999999999997653 22234578899999999999999987432100
Q ss_pred --------------------------------------------------------------------------------
Q 042519 153 -------------------------------------------------------------------------------- 152 (427)
Q Consensus 153 -------------------------------------------------------------------------------- 152 (427)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 042519 153 ---------------------------------EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199 (427)
Q Consensus 153 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 199 (427)
..+||-||||+..+|.+++.... ..-.....++++.+|++||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHH
Confidence 12467899998666666654321 111467789999999999999
Q ss_pred HhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC----------------CCCccceeccccccccccCcccccc
Q 042519 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP----------------IGDKTHVSSRVMGTYGYCAPEYQRT 263 (427)
Q Consensus 200 LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~ 263 (427)
+|+.| ||||||||.||||++++.|||+|||+|.... .+......+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999997511 0111223456789999999999976
Q ss_pred C---CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHH
Q 042519 264 G---QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAM 340 (427)
Q Consensus 264 ~---~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 340 (427)
. .|+.|+|+||||||++||+. ||.+.= -......-+++ +.++.- ..+.......-..+|.+
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM------ERa~iL~~LR~-g~iP~~------~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM------ERASILTNLRK-GSIPEP------ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchH------HHHHHHHhccc-CCCCCC------cccccccchHHHHHHHH
Confidence 5 49999999999999999985 465421 01111111121 222211 22333444566789999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 042519 341 CVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 341 cl~~~P~~RPs~~evl~~ 358 (427)
+++.||++|||+.|+|..
T Consensus 854 Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HhcCCCccCCCHHHHhhc
Confidence 999999999999999874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=307.25 Aligned_cols=271 Identities=21% Similarity=0.259 Sum_probs=200.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC---------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--------- 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 152 (427)
..+|.+.+.||.|+||.||+|.+..+|..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999999999999999999776656667788999999999999999999776543
Q ss_pred -----CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-CCCe
Q 042519 153 -----EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-EFNA 226 (427)
Q Consensus 153 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~v 226 (427)
...++||||++ ++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 68888774 245889999999999999999999999 999999999999974 5678
Q ss_pred eEeecCCcccCCCCCc-cceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 042519 227 KLSDFGLAKLGPIGDK-THVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 227 kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~ 304 (427)
+|+|||++........ ........|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999875322111 111123457889999997654 56889999999999999999999999765432111100000
Q ss_pred hhhhc--CC----CCCCcccc-cccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 305 QPFFK--DP----NRYPQLAD-PLLQGEF-----PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 305 ~~~~~--~~----~~~~~~~~-~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.+... .. ...+.... ....... .......+.+++..||+.||.+||++.+++.+-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 00000 00 00000000 0000000 11234578899999999999999999999987554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=297.36 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=202.2
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-----cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-----QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
+|.+.+.||+|+||.||++++..++..+++|+++.... .....+..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 48888999999999999999987777777777654221 2233566789999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
+||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988765555677999999999999999999999999 999999999999975 569999999987642
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. ........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......... ...+
T Consensus 157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~--~~~~--- 223 (260)
T cd08222 157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE--GPTP--- 223 (260)
T ss_pred CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc--CCCC---
Confidence 22 122334568889999999988889999999999999999999999986432 1111111111 1111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 224 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 ------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1234555788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=303.47 Aligned_cols=273 Identities=22% Similarity=0.277 Sum_probs=203.4
Q ss_pred HHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-
Q 042519 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG- 152 (427)
Q Consensus 76 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 152 (427)
..+....++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.++.+++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 4455677999999999999999999999998999999999875422 2235577899999999999999999988643
Q ss_pred -----CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCee
Q 042519 153 -----EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 153 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
...+++++++ +++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888877 689988773 245889999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hhhhhh
Q 042519 228 LSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LVTWAQ 305 (427)
Q Consensus 228 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~~~~~ 305 (427)
|+|||++..... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.....
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999875321 1234568899999998865 568899999999999999999999996543211100 000000
Q ss_pred ----hhhcCCC---------CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 306 ----PFFKDPN---------RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 306 ----~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.....-. ..+........ .........+.+++..||+.||.+||++.+++++-+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 0000000 00000000000 000012456889999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=297.66 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=199.2
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEeec
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
|++.+.||+|+||+||+|....+++.|+||.+...... ......+|+..+..++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67788999999999999999988999999998654322 2223456889999999 999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
+++|.+++.... ...+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 689998886532 356899999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeccccccccccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhhhh----hcCC----C
Q 042519 243 THVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ-NLVTWAQPF----FKDP----N 312 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~-~~~~~~~~~----~~~~----~ 312 (427)
......++..|+|||++. ...++.++|+||||+++|+|++|+.||......... ....+.... +.+. .
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 123356888999999875 456799999999999999999999999654332110 000000000 0000 0
Q ss_pred CC----CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 313 RY----PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 313 ~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.. +......+.... ......+.+++.+||+.+|++||++.|++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~ 281 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281 (283)
T ss_pred cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence 00 000000000001 11246788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=289.98 Aligned_cols=279 Identities=22% Similarity=0.255 Sum_probs=206.5
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCc----EEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc-CC
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQ----VVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-GE 153 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 153 (427)
....|+..+.||+|.||.||+|..++++. .+|||.++.... .-.....+|+.+++.|+|+||+.|..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 35679999999999999999997655433 689999965422 223567899999999999999999998877 78
Q ss_pred eeEEEEeecCCCChhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC----CCeeE
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIG-PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE----FNAKL 228 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~vkl 228 (427)
.+++++||.+ -+|.+.++.++ ...+.++...+..|+.||+.|+.|||++. |+||||||.||||..+ |.|||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 8999999998 68988887544 33457888999999999999999999999 9999999999999777 89999
Q ss_pred eecCCcccCCCCCccc-eeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch---hhhh
Q 042519 229 SDFGLAKLGPIGDKTH-VSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN---LVTW 303 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~---~~~~ 303 (427)
+|||+++.+...-... ....++-|.+|.|||.+.+. .||.+.|||++|||+.||++-.+.|...+...... ..+-
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999754332222 23456789999999988764 68999999999999999999998886543322111 1111
Q ss_pred hhhhhc---CC--CCCCcc---------cccccCCCCCHH-----------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 304 AQPFFK---DP--NRYPQL---------ADPLLQGEFPVR-----------GLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 304 ~~~~~~---~~--~~~~~~---------~~~~~~~~~~~~-----------~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
+..++. -+ ...+.+ +...-...+... .....++|+..+|..||-+|.|+++.+++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111111 00 111111 111111111110 11237889999999999999999999998
Q ss_pred HhhcC
Q 042519 359 LSFLG 363 (427)
Q Consensus 359 L~~~~ 363 (427)
.-+..
T Consensus 338 ~yF~~ 342 (438)
T KOG0666|consen 338 PYFTE 342 (438)
T ss_pred ccccc
Confidence 75543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=295.41 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=200.7
Q ss_pred CccccceeccCCceEEEEEEEC---CCCcEEEEEEeccCCC----cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL----QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 155 (427)
+|++.+.||.|+||.||++... .+|..||+|++..... ...+.+.+|+.++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999999874 4689999999865322 2235577899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999864 345788899999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCccceeccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
...... ........|+..|+|||++.. ..++.++||||||+++|+|++|..||...... ...............
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~- 229 (290)
T cd05613 154 EFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP- 229 (290)
T ss_pred eccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC-
Confidence 532221 112234568999999999875 34788999999999999999999999643221 111222222211111
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhh
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSF 361 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~ 361 (427)
.++......+.+++..||+.+|++|| ++.+++.+-..
T Consensus 230 -----------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 271 (290)
T cd05613 230 -----------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271 (290)
T ss_pred -----------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence 11223446788999999999999997 77888776443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=301.91 Aligned_cols=267 Identities=22% Similarity=0.286 Sum_probs=201.5
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc-CCeeE
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-GEQRL 156 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 156 (427)
..+++|++.+.||.|+||.||+|.+..+++.||||++.+... .....+..|+.++..++||||++++++|.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 457889999999999999999999999999999999865322 234567789999999999999999999875 56789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+|+||+. ++|.+++. ...+++..+..++.|+++||.|||+.+ |+||||+|+|||++.++.++|+|||++..
T Consensus 87 lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELLG-TDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehhc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999985 68988774 345788888899999999999999999 99999999999999999999999999875
Q ss_pred CCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc-hhhh--------hhhh
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ-NLVT--------WAQP 306 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~-~~~~--------~~~~ 306 (427)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+.+ +...
T Consensus 158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 321 1123467889999998765 56899999999999999999999999654321110 0000 0000
Q ss_pred hhcCCCCCCcccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 307 FFKDPNRYPQLADPLLQGEFP-----VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.... ........-......+ ......+.+++.+||+.+|++||++.+++.+-+.
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 233 ICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred ccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 0000 0000000000001111 1234678899999999999999999999887543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.18 Aligned_cols=260 Identities=20% Similarity=0.232 Sum_probs=193.2
Q ss_pred CceEEEEEEECCCCcEEEEEEeccC--CCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCChhhhhh
Q 042519 95 GFGRVYKGKLEKTAQVVAVKQLDRN--GLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLL 172 (427)
Q Consensus 95 ~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 172 (427)
++|.||.++...+++.||||++... .......+..|+.+++.++|+||+++++++.+.+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4455666666668999999998754 22344678899999999999999999999999999999999999999999987
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc-----cceec
Q 042519 173 DIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK-----THVSS 247 (427)
Q Consensus 173 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~-----~~~~~ 247 (427)
... ...+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+........ .....
T Consensus 92 ~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 THF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 542 345788899999999999999999999 99999999999999999999999998864322111 11123
Q ss_pred cccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh----hhhc------CCCCCC
Q 042519 248 RVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ----PFFK------DPNRYP 315 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~----~~~~------~~~~~~ 315 (427)
...++..|+|||++.. ..++.++|||||||++|||++|..||....... .+..... ..+. ......
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcC
Confidence 3457788999999875 358899999999999999999999997643221 1111000 0000 000000
Q ss_pred c----ccccc----cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 316 Q----LADPL----LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 316 ~----~~~~~----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
. ..+.. ............+.+++..||+.+|++||++.+++++-+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 0 00000 0111223345678899999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=302.10 Aligned_cols=266 Identities=20% Similarity=0.251 Sum_probs=196.6
Q ss_pred CccccceeccCCceEEEEEEECCC--CcEEEEEEeccCCC--cchHHHHHHHHHHhhcC-CCCeeeEEEEEEc----CCe
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKT--AQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLH-HDNLVNLIGYCAD----GEQ 154 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~----~~~ 154 (427)
+|++.+.||+|+||.||++++..+ +..||+|.+..... .....+.+|+.++..++ |+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478889999999999999999888 88999999864321 22456778999999994 9999999987543 245
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.+++++|+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899886 689888743 456899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCc--cceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc-------------c
Q 042519 235 KLGPIGDK--THVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE-------------Q 298 (427)
Q Consensus 235 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~-------------~ 298 (427)
+....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 75332211 111234578999999998765 4689999999999999999999999975432100 0
Q ss_pred hhhhhhh----hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 299 NLVTWAQ----PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 299 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.+..+.. .+.......+. ..+. .........+.+++.+||+.+|++||++.+++.+=+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPK---KPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCC---cchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 0000000 00000000000 0000 0001124578899999999999999999999988654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=305.00 Aligned_cols=260 Identities=21% Similarity=0.298 Sum_probs=196.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC------C
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG------E 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 153 (427)
.++|.+.+.||+|+||.||+|++..+|..||||++.+... .....+.+|+.+++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 4789999999999999999999998999999999865422 2234578899999999999999999998754 3
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++|+||+. .+|..++ ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4689999997 4676654 235788999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC-
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP- 311 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 311 (427)
++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+... ......+
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~-~~~~~~~~ 235 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQI-LKVTGVPG 235 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HHhcCCCC
Confidence 8753221 223467889999999876 468999999999999999999999997543211 00000 0000000
Q ss_pred ---------C-------CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 312 ---------N-------RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 312 ---------~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
. ..+......+... .......+.+++..||+.||++||++.+++.+-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~ 299 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHH-hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0 0000000000000 0112356789999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=294.01 Aligned_cols=265 Identities=24% Similarity=0.340 Sum_probs=202.4
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
|+..+.||+|+||.||+|+...+++.||+|.+.... ......+..|+.+++.++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999999999999999997653 223456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
+ ++|.+++.... ..+++..++.++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 69999986532 46899999999999999999999999 99999999999999999999999999876432221
Q ss_pred cceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc-hhhhh-------hhhhhcC---
Q 042519 243 THVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ-NLVTW-------AQPFFKD--- 310 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~-~~~~~-------~~~~~~~--- 310 (427)
......++..|+|||++.+. .++.++|||||||++|||++|+.||......... .+... .+....+
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 22234567789999998766 7899999999999999999999999654321100 00000 0000000
Q ss_pred -CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 311 -PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 311 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
...++..........++ .....+.+++..||+.+|++||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred ccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 00111111111111111 1256799999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=293.51 Aligned_cols=255 Identities=23% Similarity=0.293 Sum_probs=198.9
Q ss_pred CccccceeccCCceEEEEEEEC---CCCcEEEEEEeccCCC----cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL----QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 155 (427)
+|++.+.||+|+||.||+++.. .++..||||.+.+... .....+..|+.++..+ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999864 4578899999865322 2234577899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998853 345888999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCccceeccccccccccCccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ--LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
...... ........|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...... ...............
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~- 229 (288)
T cd05583 154 EFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSKP- 229 (288)
T ss_pred cccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccCC-
Confidence 643222 11123356889999999987654 788999999999999999999999643211 111111111111111
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..+......+.+++.+||+.+|++|||+.++.+.|.
T Consensus 230 -----------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 230 -----------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred -----------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 112223457789999999999999999877766553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.44 Aligned_cols=260 Identities=25% Similarity=0.315 Sum_probs=200.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHH-hhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLML-SLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++.+-+..||.|+||+|++-.++.+|+..|||.|..... .....+..|++.. +.-+.||||+++|.+..+...++.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 445566789999999999999999999999999987655 3445677787764 44569999999999999999999999
Q ss_pred ecCCCChhhhhhh-cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLD-IGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
.|+ .||..+-.. ..-....+++...-.|....+.||.||...-. ||||||||+||||+..|.|||||||++-...
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv- 219 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV- 219 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH-
Confidence 997 677654332 11245678888888899999999999998754 9999999999999999999999999986421
Q ss_pred CCccceeccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.....+.-.|...|||||.+.. ..|+.+|||||||++|||+.||..|+..+....+ ...+-.. +..+.+
T Consensus 220 --~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe----ql~~Vv~---gdpp~l 290 (361)
T KOG1006|consen 220 --DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE----QLCQVVI---GDPPIL 290 (361)
T ss_pred --HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH----HHHHHHc---CCCCee
Confidence 2233455678888999998853 3589999999999999999999999986543211 1111112 223333
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
....- .......+..+|..||-+|-++||.+.+++++-
T Consensus 291 ~~~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 291 LFDKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred cCccc----ccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 22221 123456788999999999999999999988764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=321.29 Aligned_cols=146 Identities=29% Similarity=0.378 Sum_probs=132.3
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+..|+.++..++|+||+++++++......||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999999999999999997543322 356788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
||+.+++|.+++... ..+++..++.|+.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998642 35788899999999999999999999 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=291.50 Aligned_cols=271 Identities=21% Similarity=0.259 Sum_probs=210.0
Q ss_pred HHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-C-CC----eeeEEEE
Q 042519 75 FRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-H-DN----LVNLIGY 148 (427)
Q Consensus 75 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~n----iv~l~~~ 148 (427)
+......+++|.+...||+|.||.|..+.+..++..||||+++.- ....+...-|+.+|.++. + |+ +|.+.+|
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 344444588999999999999999999999999999999998543 344556677999999995 2 22 7889999
Q ss_pred EEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC------
Q 042519 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC------ 222 (427)
Q Consensus 149 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------ 222 (427)
|.-.++.|||+|.+. -|+.++|... ...+++...+..++.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 160 FdyrghiCivfellG-~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 160 FDYRGHICIVFELLG-LSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhccCceEEEEeccC-hhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEE
Confidence 999999999999883 6999999763 4567888899999999999999999999 999999999999932
Q ss_pred --------------CCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCC
Q 042519 223 --------------EFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRA 288 (427)
Q Consensus 223 --------------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p 288 (427)
+..|+|+|||.|..... ..+.++.|..|.|||++.+-.++.++||||+||||+||.+|...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 34589999999986322 22567889999999999999999999999999999999999999
Q ss_pred CCCCCCcccchhhhh-----------------hhhhhcCCCCCC--ccc-----ccccCC--------CCCHHHHHHHHH
Q 042519 289 IDTTRPTYEQNLVTW-----------------AQPFFKDPNRYP--QLA-----DPLLQG--------EFPVRGLNQAVA 336 (427)
Q Consensus 289 ~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~--~~~-----~~~~~~--------~~~~~~~~~l~~ 336 (427)
|.+.+... .+ .. ...++..+ .+. +.- ...... .....+...|++
T Consensus 309 FqtHen~E--HL-aMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 309 FQTHENLE--HL-AMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cccCCcHH--HH-HHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 98765321 11 11 11122111 110 000 000000 122345668999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 337 VSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 337 li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
|+..||..||.+|+|+.|++++-.+
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSHPFF 409 (415)
T ss_pred HHHHHHccCccccccHHHHhcCHHh
Confidence 9999999999999999999998654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=294.63 Aligned_cols=273 Identities=29% Similarity=0.426 Sum_probs=212.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhh--cCCCCeeeEEEEEEcCC----ee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSL--LHHDNLVNLIGYCADGE----QR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~ 155 (427)
.......++||+|.||.||+|... ++.||||++.. +..+.|.+|-.|.+. ++|+||++++++-..+. .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 345667789999999999999997 58999999864 456778888888765 56999999999877665 88
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEeccCCCCceEeCCCCCeeEe
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA------NPPVIYRDLKSSNILLDCEFNAKLS 229 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dlkp~NIll~~~~~vkl~ 229 (427)
+||++|.+.|+|.++|.. ..++|....+|+..+++||+|||+.. +++|+|||||..||||..+++..|+
T Consensus 284 wLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 999999999999999954 67999999999999999999999753 4679999999999999999999999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccccCC-CC-----ccchHHHHHHHHHHHHhCCCCCCC-CCCcccch---
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ-LT-----VKSDVYTFGVVLLELITGRRAIDT-TRPTYEQN--- 299 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlGvil~ell~g~~p~~~-~~~~~~~~--- 299 (427)
|||+|.....+.........+||..|||||++.+.- +. .+.||||+|.+||||++...-+.. ..+.+...
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999998766555444455589999999999997632 22 468999999999999997655432 22222111
Q ss_pred ------hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCC
Q 042519 300 ------LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDA 368 (427)
Q Consensus 300 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 368 (427)
-.+-.+...-.....+.+.+....+ ..+..+.+.+..||+.|++.|.|+.=|-+.++.+...+..
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1111222222234444555544443 2356788899999999999999999999999988776554
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=303.86 Aligned_cols=267 Identities=21% Similarity=0.280 Sum_probs=202.3
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe----
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ---- 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 154 (427)
..++|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.+++.++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999999999999999986532 2233556789999999999999999988876554
Q ss_pred --eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 155 --RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 155 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 4799888743 46899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ +.. .......+
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~-i~~~~~~~ 235 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKR-IMNLVGTP 235 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHhcCCC
Confidence 98753221 233467889999998865 3678999999999999999999999975432110 000 00000000
Q ss_pred C----------CCCccccc---ccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 312 N----------RYPQLADP---LLQGEF---PVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 312 ~----------~~~~~~~~---~~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
. .....+.. .....+ .......+.+++.+||+.+|++|||+.+++++-+.-..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 0 00000000 000000 01125678999999999999999999999998655433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=285.50 Aligned_cols=241 Identities=29% Similarity=0.355 Sum_probs=197.3
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 91 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
||.|+||.||++.+..+++.||+|.+...... ....+..|+.+++.++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 79999999999999988999999998765432 335678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceec
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 247 (427)
.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 9998642 36899999999999999999999999 9999999999999999999999999987633221 1234
Q ss_pred cccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCC
Q 042519 248 RVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFP 327 (427)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (427)
...++..|++||.+.+...+.++|+||||+++|+|++|..||..... ............ .++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~------------~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDPL------------RFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCCC------------CCC
Confidence 45688899999999888889999999999999999999999965432 111111111111 122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH---HHHHHH
Q 042519 328 VRGLNQAVAVSAMCVQEESSVRPLM---SDVVSA 358 (427)
Q Consensus 328 ~~~~~~l~~li~~cl~~~P~~RPs~---~evl~~ 358 (427)
......+.+++..||..||++||++ .+++++
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 2235678899999999999999999 565554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=308.45 Aligned_cols=244 Identities=24% Similarity=0.290 Sum_probs=201.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 160 (427)
...|.+...+|.|+|+.|-.+.+..+++..++|++.+.. .+..+|+.++... +||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888888999999999999999999999999997652 2233466555444 59999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe-CCCCCeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL-DCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~vkl~DFG~a~~~~~ 239 (427)
.+.++-|.+.+... +.....+..|+.+|+.++.|||++| ||||||||+|||+ +..++++|+|||.++....
T Consensus 397 ~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999888877542 2223677789999999999999999 9999999999999 6999999999999986433
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
. ..+.+-|..|.|||++....|+.++||||||++||+||+|+.||...... . ++..
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~--------------ei~~ 524 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----I--------------EIHT 524 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----H--------------HHHH
Confidence 2 33456788999999999999999999999999999999999999865432 1 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
....+.+.........+|+.+||+.||.+||++.++..+-|.
T Consensus 525 ~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 525 RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 122223335566788899999999999999999999999876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=257.89 Aligned_cols=265 Identities=22% Similarity=0.263 Sum_probs=201.0
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+|...++||+|.||+||+|+++++++.||+|.++....+. -....+|+.+++.|+|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666789999999999999999999999999986543322 25678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
|. .+|..+... -...++...+..++.|+++||.|+|+++ ++||||||+|+||+.+|.+||+|||+++... -
T Consensus 83 cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafg--i 153 (292)
T KOG0662|consen 83 CD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFG--I 153 (292)
T ss_pred hh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcC--C
Confidence 97 688888765 4567888999999999999999999999 9999999999999999999999999998643 2
Q ss_pred ccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh--c--CCCCCC
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFF--K--DPNRYP 315 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~--~--~~~~~~ 315 (427)
...-.+..+-|.+|.+|.++-+. -|+...|+||.|||+.||.. |++.|... +..++ +....+.+- . .-..+.
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddq-lkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQ-LKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHH-HHHHHHHhCCCccccCCccc
Confidence 33334455679999999998765 58999999999999999998 55445432 22211 111111100 0 001112
Q ss_pred cccccccCCCCC---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 316 QLADPLLQGEFP---------VRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 316 ~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
++.|......++ +.....-.+++...|.-+|..|.+++..+++-
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 222222221111 11223446788889999999999999988864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=282.82 Aligned_cols=220 Identities=22% Similarity=0.219 Sum_probs=178.6
Q ss_pred CCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCChhhhhhh
Q 042519 94 GGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLD 173 (427)
Q Consensus 94 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 173 (427)
|.||.||+++++.+++.||+|.+.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999996543 233455555566799999999999999999999999999999998864
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccc
Q 042519 174 IGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253 (427)
Q Consensus 174 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~ 253 (427)
. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+...... .....++.
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 3 35889999999999999999999999 999999999999999999999999987643221 12345677
Q ss_pred cccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHH
Q 042519 254 GYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQ 333 (427)
Q Consensus 254 ~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (427)
.|+|||++.+..++.++||||+|+++|||++|..|+...... ... ......+......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~----------~~~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INT----------HTTLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccc----------ccccCCcccCCHH
Confidence 899999998888999999999999999999999877532110 000 0000122233467
Q ss_pred HHHHHHHccCCCCCCCCCH
Q 042519 334 AVAVSAMCVQEESSVRPLM 352 (427)
Q Consensus 334 l~~li~~cl~~~P~~RPs~ 352 (427)
+.+++.+||+.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 8899999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=302.95 Aligned_cols=261 Identities=27% Similarity=0.338 Sum_probs=218.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
..+++.+..||-||||.|=++..+.....+|+|++++....+ .+.+..|-.+|...+.|.||++|..|.+...+|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 356677788999999999999988766669999998765433 34467799999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
||-|-||.|+..|.+. ..++..+...++..+++|++|||+++ ||+|||||+|+||+.+|.+||.|||+|+...
T Consensus 499 mEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999999999999764 45777788889999999999999999 9999999999999999999999999999754
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.+. .+-++||||.|.|||++.+...+.++|.||||+++||||+|.+||...+|...-++. ++.
T Consensus 572 ~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkG-------- 634 (732)
T KOG0614|consen 572 SGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKG-------- 634 (732)
T ss_pred cCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhh--------
Confidence 433 345799999999999999999999999999999999999999999987664322211 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhcCCCCCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFLGSDPDA 368 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~~~~~~~ 368 (427)
.-.-++|..+.....+++++....+|.+|.. +.+|..|-|+..-++..
T Consensus 635 --id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 635 --IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred --hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence 1112445666678889999999999999975 88999999988776653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=297.33 Aligned_cols=211 Identities=25% Similarity=0.308 Sum_probs=179.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch---HHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
..-|..++.||-|+||+|.+++..++...||+|.+.+.+...+ .....|..||..-..+-||+||..|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4457788899999999999999999999999999977654333 3356799999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC-
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG- 237 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~- 237 (427)
|+|++||++..+|... .-+.+..+..++..+..|+++.|..| +|||||||+|||||.+|+|||+|||++.-+
T Consensus 708 MdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999999764 34677778888999999999999999 999999999999999999999999998421
Q ss_pred --------CCCCccce-------------------------------eccccccccccCccccccCCCCccchHHHHHHH
Q 042519 238 --------PIGDKTHV-------------------------------SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVV 278 (427)
Q Consensus 238 --------~~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 278 (427)
..++.... ....+||+.|+|||++....|+..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 11110000 011579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCcccch
Q 042519 279 LLELITGRRAIDTTRPTYEQN 299 (427)
Q Consensus 279 l~ell~g~~p~~~~~~~~~~~ 299 (427)
||||+.|+.||....|...+.
T Consensus 861 l~em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred HHHHhhCCCCccCCCCCccee
Confidence 999999999998887766553
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=290.75 Aligned_cols=262 Identities=26% Similarity=0.330 Sum_probs=203.0
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccC--CCcc-----hHHHHHHHHHHhhcCCCCeeeEEEEEE-c
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN--GLQG-----NKEFIVEVLMLSLLHHDNLVNLIGYCA-D 151 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~-~ 151 (427)
...++|-++.+||+|||+.||+|.+....+.||||+-..+ ..+. .+...+|..|.+.|.||.||++|+||. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3467788899999999999999999888899999986432 2222 133567999999999999999999996 5
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC---CCCCeeE
Q 042519 152 GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD---CEFNAKL 228 (427)
Q Consensus 152 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~vkl 228 (427)
.+..|-|+|||+|.+|+-||+ ..+.+++.++..|+.||+.||.||.... +||||-||||.||||. .-|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence 567889999999999998886 4567899999999999999999999886 7799999999999994 4578999
Q ss_pred eecCCcccCCCCCcc-----ceeccccccccccCccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch
Q 042519 229 SDFGLAKLGPIGDKT-----HVSSRVMGTYGYCAPEYQRTG----QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN 299 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~ 299 (427)
+|||+++++...... .......||.+|++||.+.-+ ..+.|+||||+|||+|..+.|+.||+..... ++
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--Qd 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QD 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HH
Confidence 999999986544332 234557799999999987533 5789999999999999999999999854321 11
Q ss_pred hhhhhhhhhcCCCCCCcccccccCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQG-EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
+... ..+++. .... ...+....+...+|++||+..-++|....++...-
T Consensus 693 ILqe-NTIlkA----------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dp 742 (775)
T KOG1151|consen 693 ILQE-NTILKA----------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDP 742 (775)
T ss_pred HHhh-hchhcc----------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCc
Confidence 1110 111111 1000 11123345778999999999999998887776653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.92 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=217.4
Q ss_pred ccccceeccCCceEEEEEEECCCCc----EEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQ----VVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.+..++||+|+||+||+|.+-..|+ +||||++.... .....++..|+.+|.+|.|||+++|+++|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 4556899999999999999965554 68999886543 345678999999999999999999999998766 88999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
+|+++|+|.+|++. .+..+.....+.|..||++||.|||.+. +|||||-..||||..-..+||.|||+++....
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987 4567888899999999999999999999 99999999999999999999999999998666
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.+.........-.+-|||-|.+....|+.++|||||||++|||+| |..|++...- +.+..+++.+.+++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-------~eI~dlle~geRLs--- 920 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-------EEIPDLLEKGERLS--- 920 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-------HHhhHHHhccccCC---
Confidence 555554444445667999999999999999999999999999999 9898875432 12223344444433
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPD 367 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 367 (427)
-|..+..+++.++.+||..|+..||+++++...+..+.+++.
T Consensus 921 -------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 921 -------QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred -------CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 266677899999999999999999999999999988877654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=283.68 Aligned_cols=269 Identities=25% Similarity=0.313 Sum_probs=203.8
Q ss_pred HHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhh--cCCCCeeeEEEEEEcC----
Q 042519 79 ATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSL--LHHDNLVNLIGYCADG---- 152 (427)
Q Consensus 79 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~---- 152 (427)
++...+..+.+.||+|.||.||+|+++ |+.||||++... +...+.+|.+|.+. |+|+||+.+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 455677889999999999999999998 789999999643 34556777777764 7999999998865433
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCeEeccCCCCceEeCCCCCee
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-----KANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
.+++||++|.+.|||.+||. ...++....++++..++.||++||- +|.+.|.|||||..||||..+|...
T Consensus 282 TQLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 46899999999999999994 4678999999999999999999995 5678899999999999999999999
Q ss_pred EeecCCcccCCCCCc--cceeccccccccccCccccccCC----C--CccchHHHHHHHHHHHHhCC----------CCC
Q 042519 228 LSDFGLAKLGPIGDK--THVSSRVMGTYGYCAPEYQRTGQ----L--TVKSDVYTFGVVLLELITGR----------RAI 289 (427)
Q Consensus 228 l~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlGvil~ell~g~----------~p~ 289 (427)
|+|+|+|........ .......+||..|||||++...- + -..+||||||+++||+.... .||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 999999976433321 12234468999999999986532 1 14589999999999998532 455
Q ss_pred CCCCCcccchhhhhhhhhhcCCCCCCcccccccCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 290 DTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG-EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
....|.+... .+.... -... -..+.+.. ..+......+.++++.||..+|..|.|+--|...|..+..
T Consensus 437 yd~Vp~DPs~-eeMrkV-----VCv~-~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDPSF-EEMRKV-----VCVQ-KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCCCH-HHHhcc-----eeec-ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 5444332211 110000 0001 11112211 2345677889999999999999999999999999987764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=305.60 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=216.9
Q ss_pred HHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEE----
Q 042519 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCA---- 150 (427)
Q Consensus 76 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~---- 150 (427)
+.+..-++.|++.++||.|.+|.||+++.+.+++..|+|++.... +..+++..|..||+.+. |||++.++++|.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 333344678999999999999999999999999999999986653 45577888999998886 999999999986
Q ss_pred -cCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEe
Q 042519 151 -DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLS 229 (427)
Q Consensus 151 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~ 229 (427)
.++.++||||||.+||..++++... ...+.|..+..|+..++.||.+||.+. ++|||||-.|||++.++.|||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 3578999999999999999998754 678999999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccCCCCCccceeccccccccccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~ 304 (427)
|||.+..... ......+..|||.|||||++.. ..|+..+|+||||++..||--|.+|+-++.|..
T Consensus 166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------- 235 (953)
T KOG0587|consen 166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------- 235 (953)
T ss_pred eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------
Confidence 9999875322 2233456789999999999964 347889999999999999999999998776541
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.+|.-+ . ++...-..+....+.+.++|..||..|..+||++.+++++-
T Consensus 236 -aLF~Ip----R--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 236 -ALFLIP----R--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred -hhccCC----C--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 122211 1 11112223677889999999999999999999999998764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=256.38 Aligned_cols=207 Identities=25% Similarity=0.318 Sum_probs=174.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.+....+..||+|++|.|-+.++..+|...|+|.+..... +......+|+.+..+. .+|.+|.++|...++..+++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 4556667789999999999999999999999999965433 3334566777775554 5999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|.|+ .||..+-.+.......+++.-.-+|+..+++||.|||++-. |+|||+||+|||++.+|+|||||||++-....
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9997 78988877766678889999999999999999999999865 99999999999999999999999999875321
Q ss_pred CCccceeccccccccccCcccccc----CCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT----GQLTVKSDVYTFGVVLLELITGRRAIDTTRP 294 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~ell~g~~p~~~~~~ 294 (427)
....+...|...|+|||.+.. ..|+-++||||||+++.||.+++.||+.+..
T Consensus 202 ---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 202 ---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred ---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 222333567788999998853 4799999999999999999999999987643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.89 Aligned_cols=268 Identities=19% Similarity=0.218 Sum_probs=174.7
Q ss_pred HhhCccccceeccCCceEEEEEEECCC----CcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEE------EE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKT----AQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGY------CA 150 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 150 (427)
..++|.+.+.||+|+||.||+|++..+ +..||||++..... .+....+ .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999988 89999998754321 1111111 1111122222222111 24
Q ss_pred cCCeeEEEEeecCCCChhhhhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 042519 151 DGEQRLLVYEYMPLRSLEDHLLDIGPE----------------QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLK 214 (427)
Q Consensus 151 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 214 (427)
.+...++|+||+.+++|.+++...... ........+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567889999999999999988643210 001123345679999999999999999 9999999
Q ss_pred CCceEeCC-CCCeeEeecCCcccCCCCCccceeccccccccccCccccccC----------------------CCCccch
Q 042519 215 SSNILLDC-EFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG----------------------QLTVKSD 271 (427)
Q Consensus 215 p~NIll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 271 (427)
|+|||++. ++.+||+|||+++..... .........||+.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 589999999999753322 12234457899999999965322 2445679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCcc-------cchhhhhhhhhhcCCCCCCcccccccCCCC--CHHHHHHHHHHHHHcc
Q 042519 272 VYTFGVVLLELITGRRAIDTTRPTY-------EQNLVTWAQPFFKDPNRYPQLADPLLQGEF--PVRGLNQAVAVSAMCV 342 (427)
Q Consensus 272 vwSlGvil~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl 342 (427)
||||||+||||+++..+++...... ......|....... ....+...+ .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-------ASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-------cchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999776544211000 00111111100000 000000000 0011224558999999
Q ss_pred CCCCCCCCCHHHHHHHHhhcC
Q 042519 343 QEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 343 ~~~P~~RPs~~evl~~L~~~~ 363 (427)
+.||++|||+.+++++-+...
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDR 455 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCC
Confidence 999999999999999876544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.44 Aligned_cols=261 Identities=30% Similarity=0.427 Sum_probs=208.8
Q ss_pred hhCccccceeccCCceEEEEEEECC-------CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcC-CCCeeeEEEEEEcC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-------TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLH-HDNLVNLIGYCADG 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 152 (427)
.++..+.+.||+|.||.|++|...+ ....||||.++.... ...+.+..|+.++..+. |+||+.++|+|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 4455667799999999999998541 145799999876543 34567889999999986 99999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIG---P-------EQ--KPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
...++|+||+..|+|.++|...+ . .. ..++....+.++.||+.|++||++.. +|||||-..|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999998755 1 01 23889999999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccc--cccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCccc
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG--TYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYE 297 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~ 297 (427)
..+..+||+|||+++.....+.... ....| ...|||||.+....|+.++|||||||+||||++ |..||....+.
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-- 528 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-- 528 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--
Confidence 9999999999999986433332221 21222 335999999999999999999999999999999 88888652211
Q ss_pred chhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 298 QNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+. .+++++.+. ..|..+..+++++++.||+.+|++||++.++.+.++..
T Consensus 529 ~~l~----~~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 EELL----EFLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHH----HHHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1111 133333332 33666678999999999999999999999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=265.28 Aligned_cols=240 Identities=29% Similarity=0.376 Sum_probs=195.4
Q ss_pred CceEEEEEEECCCCcEEEEEEeccCCCcc-hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCChhhhhhh
Q 042519 95 GFGRVYKGKLEKTAQVVAVKQLDRNGLQG-NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLD 173 (427)
Q Consensus 95 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 173 (427)
+||.||+|.+.++|+.+++|++....... ...+.+|+..+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999989999999997665544 67889999999999999999999999999999999999999999998865
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccc
Q 042519 174 IGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253 (427)
Q Consensus 174 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~ 253 (427)
.. .+++..++.++.+++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 32 2888999999999999999999999 9999999999999999999999999998643322 233456888
Q ss_pred cccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHH
Q 042519 254 GYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQ 333 (427)
Q Consensus 254 ~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (427)
.|++||.+....++.++||||||+++|+|++|..||...... ..+.... ......... ........
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~---~~~~~~~~~---------~~~~~~~~ 216 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKI---GKPKPPFPP---------PEWKISPE 216 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH---hccCCCCcc---------ccccCCHH
Confidence 999999998888999999999999999999999999753111 1111111 111000000 00003457
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 334 AVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 334 l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
+.+++.+||..+|++||++.+++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhhC
Confidence 8899999999999999999999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=269.52 Aligned_cols=273 Identities=22% Similarity=0.341 Sum_probs=202.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEc--------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-------- 151 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 151 (427)
...|+-..+||+|.||.||+|+.+++|+.||+|++-... ...-....+|+.+|..|+|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 356777789999999999999999999999999864322 2223557889999999999999999887753
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 152 GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 152 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
...+|+|+.+|+ .+|...|.+ ....++..++.++..+++.||.|+|... |+|||+|+.|+||+.+|.+||+||
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence 245799999998 588887754 4467888999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcc--ceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 042519 232 GLAKLGPIGDKT--HVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 232 G~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
|+++........ ...+..+-|.+|++||.+.+ ..|+++.|||..|||+.||.++.+-+..........+.. .+.
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is---~Lc 245 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS---QLC 245 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH---HHh
Confidence 999754333222 12344567999999998765 579999999999999999999988776543321111111 111
Q ss_pred cC--CCCCCccc----------ccccCCCCC--HHH------HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 309 KD--PNRYPQLA----------DPLLQGEFP--VRG------LNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 309 ~~--~~~~~~~~----------~~~~~~~~~--~~~------~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+. +...+... .+.-.+.+. .+. .+...+|+..+|..||.+|+++.+++.+-.+.+.
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 00 00011100 001111100 111 2367899999999999999999999999876543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=266.66 Aligned_cols=269 Identities=19% Similarity=0.264 Sum_probs=199.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-----C---CCeeeEEEEEE---
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-----H---DNLVNLIGYCA--- 150 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~--- 150 (427)
..+|.+.++||.|.|++||+|.+..+.+.||+|+.+. .....+....|+.+|++++ | .+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3789999999999999999999999999999999743 3445566788999999885 2 36999999996
Q ss_pred -cCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC------
Q 042519 151 -DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE------ 223 (427)
Q Consensus 151 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~------ 223 (427)
.+.++|+|+|++ |.+|..+|... ..+.++...+.+|+.||+.||.|||.... |||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~ 230 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAK 230 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhh
Confidence 467999999998 47899988764 55778889999999999999999999875 9999999999999311
Q ss_pred -----C--------------------------------------------------------------------------
Q 042519 224 -----F-------------------------------------------------------------------------- 224 (427)
Q Consensus 224 -----~-------------------------------------------------------------------------- 224 (427)
+
T Consensus 231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n 310 (590)
T KOG1290|consen 231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN 310 (590)
T ss_pred hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 042519 225 -------------------------------------------------------------------------------- 224 (427)
Q Consensus 225 -------------------------------------------------------------------------------- 224 (427)
T Consensus 311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d 390 (590)
T KOG1290|consen 311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD 390 (590)
T ss_pred ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence
Q ss_pred -CeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc-cc--chh
Q 042519 225 -NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPT-YE--QNL 300 (427)
Q Consensus 225 -~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~-~~--~~~ 300 (427)
.+||+|||-|.-. ....+.-..|..|.|||++.+..|+..+||||++|++|||+||...|+..... +. .+.
T Consensus 391 i~vKIaDlGNACW~-----~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 391 IRVKIADLGNACWV-----HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred eeEEEeeccchhhh-----hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 0233333333210 01112223577899999999999999999999999999999999999754332 11 111
Q ss_pred hhhh------------------hhhhcCCCCCCcccc-------cccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 042519 301 VTWA------------------QPFFKDPNRYPQLAD-------PLLQG--EFPVRGLNQAVAVSAMCVQEESSVRPLMS 353 (427)
Q Consensus 301 ~~~~------------------~~~~~~~~~~~~~~~-------~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ 353 (427)
...+ +.+|...+.+..+-. ..+.. .++.+...++.+++.-||+.+|++|||+.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 1111 112222222221110 11111 56777888999999999999999999999
Q ss_pred HHHHHHhh
Q 042519 354 DVVSALSF 361 (427)
Q Consensus 354 evl~~L~~ 361 (427)
+++++-|-
T Consensus 546 ~cl~hPwL 553 (590)
T KOG1290|consen 546 QCLKHPWL 553 (590)
T ss_pred HHhcCccc
Confidence 99998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=286.70 Aligned_cols=266 Identities=21% Similarity=0.284 Sum_probs=184.3
Q ss_pred HhhCccccceeccCCceEEEEEEEC----------------CCCcEEEEEEeccCCCcchHH--------------HHHH
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLE----------------KTAQVVAVKQLDRNGLQGNKE--------------FIVE 130 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 130 (427)
..++|++.++||+|+||.||+|... ..++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3678999999999999999999752 235679999986543222222 3346
Q ss_pred HHHHhhcCCCCe-----eeEEEEEEc--------CCeeEEEEeecCCCChhhhhhhcCC--------------------C
Q 042519 131 VLMLSLLHHDNL-----VNLIGYCAD--------GEQRLLVYEYMPLRSLEDHLLDIGP--------------------E 177 (427)
Q Consensus 131 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 177 (427)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 667777653 3567999999999999999864211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccC
Q 042519 178 QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257 (427)
Q Consensus 178 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 257 (427)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123567788899999999999999999 99999999999999999999999999875322211 11112335789999
Q ss_pred ccccccCC--------------------C--CccchHHHHHHHHHHHHhCCC-CCCCCCCcc------cchhhhhhhhhh
Q 042519 258 PEYQRTGQ--------------------L--TVKSDVYTFGVVLLELITGRR-AIDTTRPTY------EQNLVTWAQPFF 308 (427)
Q Consensus 258 PE~~~~~~--------------------~--~~~~DvwSlGvil~ell~g~~-p~~~~~~~~------~~~~~~~~~~~~ 308 (427)
||.+.... + ..+.||||+|||+|+|++|.. ||....... ..++..|.. .
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~ 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence 99875322 1 134799999999999999875 664321110 111111110 0
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHHhh
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEES---SVRPLMSDVVSALSF 361 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~RPs~~evl~~L~~ 361 (427)
.. ... +- ...........+++.++|..+| .+|+|+.|+++|-+.
T Consensus 457 ~~-~~~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 457 KG-QKY----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred cc-cCC----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 00 000 00 0112234677889999999766 689999999998765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=256.14 Aligned_cols=255 Identities=20% Similarity=0.318 Sum_probs=197.1
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEE-EEcCCeeEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGY-CADGEQRLLV 158 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~lv 158 (427)
..+.|.+.+.||+|.||.+.+++++++...+++|.+.+. .....+|.+|...--.|. |.||+.-|+. |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 357799999999999999999999999999999998665 356688999988766665 9999988774 6667788899
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe-C-CCCCeeEeecCCccc
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL-D-CEFNAKLSDFGLAKL 236 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-~-~~~~vkl~DFG~a~~ 236 (427)
+||++.|+|...+. ...+.+.....++.|+++||.|||+++ +||||||.+|||| + +...|||||||+.+.
T Consensus 101 qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999998873 456888889999999999999999999 9999999999999 2 334799999999875
Q ss_pred CCCCCccceeccccccccccCcccccc---C--CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRT---G--QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
.. . ......-+..|.+||.... + ...+.+|||.||+|+|.+|+|..||+.. ........+|.+-.-+..
T Consensus 173 ~g--~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 173 VG--T---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cC--c---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcccC
Confidence 21 1 1222334567999997643 2 2467899999999999999999999843 344455555544322222
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
...+..+.+ ....+..+.++-|..++++|--+.++..+.
T Consensus 247 ~~~P~~F~~---------fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PALPKKFNP---------FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccCchhhcc---------cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 333333332 234678889999999999996666665554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=287.38 Aligned_cols=249 Identities=26% Similarity=0.337 Sum_probs=188.9
Q ss_pred ccccceeccCCceE-EEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEeec
Q 042519 85 FRQECLIGEGGFGR-VYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 85 y~~~~~Lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
|.-.+++|.|+-|+ ||+|... |+.||||.+-.. ...-..+|+..|+.-. |||||++++.-.+....||+.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 45557899999886 7999997 789999998533 2234578999998875 999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---C--CCeeEeecCCcccC
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---E--FNAKLSDFGLAKLG 237 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~vkl~DFG~a~~~ 237 (427)
. .+|.+++...........-...+.+..|+++||++||+.+ ||||||||+||||+. + ..++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 8 7999999763111111111445678899999999999999 999999999999965 3 46899999999986
Q ss_pred CCCCccc-eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhC-CCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 238 PIGDKTH-VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITG-RRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 238 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..+.... ......||-+|+|||++....-+.++|||||||++|+.++| .+||+..-... .+ +......+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~N-------Il~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-AN-------ILTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hh-------hhcCcccee
Confidence 5443332 24567799999999999988888999999999999999985 89998542110 01 111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.+ ....++ +..+||.+|++++|..||++.+|+.|-
T Consensus 734 ~L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 734 HL-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred ee-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 10 001112 778999999999999999999999764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=258.07 Aligned_cols=266 Identities=21% Similarity=0.322 Sum_probs=197.5
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccC--CCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----CeeEE
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN--GLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG-----EQRLL 157 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 157 (427)
.+-.+.||-|+||.||.+.+..+|+.||+|++..- .....+.+.+|+.+|..++|.|++..++...-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44557899999999999999999999999998542 223346678899999999999999988876533 34677
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
++|.|. .+|.+.+ -....++...+.-++.||++||.|||+-+ |+||||||.|+|++++..+||||||+++..
T Consensus 135 ~TELmQ-SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQ-SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHH-hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 888886 5665554 45677888888899999999999999999 999999999999999999999999999975
Q ss_pred CCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhh-hh-----------
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT-WA----------- 304 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~-~~----------- 304 (427)
...+..+. +..+-|..|.|||++.+. .|+.+.||||+|||+.||+..+..|....|.....+.. .+
T Consensus 207 e~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 54444333 344568889999999874 69999999999999999999999888766543222111 11
Q ss_pred ----hh-hhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 305 ----QP-FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 305 ----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
+. .+..+.+.+.+ .....-..+.....+...+...++..||.+|.+..+.+.++.
T Consensus 286 CEGAk~H~LR~~~k~Ps~-~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDT-QRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCc-cceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00 01111111100 000000112233446678888999999999999999988874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=269.69 Aligned_cols=283 Identities=20% Similarity=0.202 Sum_probs=214.6
Q ss_pred CCCccccccCHHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC------
Q 042519 65 NNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH------ 138 (427)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------ 138 (427)
++......|.+........+|.+....|+|-|++|..|.+...|..||||+|..+. .-...=..|+++|.+|+
T Consensus 414 NWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 414 NWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPED 492 (752)
T ss_pred CcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchh
Confidence 33444556777777788899999999999999999999999889999999997653 22334467999999997
Q ss_pred CCCeeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCce
Q 042519 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNI 218 (427)
Q Consensus 139 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 218 (427)
--|+++|+-.|...+++|||+|-+. .+|.+.|...+ ....|....+..++.|+..||..|...+ |+|.||||+||
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNi 567 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNI 567 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccce
Confidence 2478999999999999999999886 79999998876 5567888899999999999999999999 99999999999
Q ss_pred EeCCCC-CeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc
Q 042519 219 LLDCEF-NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE 297 (427)
Q Consensus 219 ll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~ 297 (427)
||++.. .+||||||.|....... .+.+.-+..|.|||++.+-.|+...|+||+||+||||.||+..|.......
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~- 642 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ- 642 (752)
T ss_pred EeccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH-
Confidence 998765 57999999997643222 122334455999999999999999999999999999999999886543221
Q ss_pred chhhh-----------------hhhhhhcCCCCCC----------------ccccc------ccCC--CCC---HHHHHH
Q 042519 298 QNLVT-----------------WAQPFFKDPNRYP----------------QLADP------LLQG--EFP---VRGLNQ 333 (427)
Q Consensus 298 ~~~~~-----------------~~~~~~~~~~~~~----------------~~~~~------~~~~--~~~---~~~~~~ 333 (427)
.+.- +..+.|.....+- ..+.+ .+.+ .++ ......
T Consensus 643 -MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~ 721 (752)
T KOG0670|consen 643 -MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ 721 (752)
T ss_pred -HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence 1110 0111111110000 00001 1111 122 234567
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 334 AVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 334 l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
+.+|+..||..||++|.+..+.|.|-
T Consensus 722 ~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 722 LRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred HHHHHHHHhccChhhcCCHHHHhcCC
Confidence 88899999999999999999998874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=271.73 Aligned_cols=198 Identities=22% Similarity=0.325 Sum_probs=172.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch--------HHHHHHHHHHhhcC---CCCeeeEEEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--------KEFIVEVLMLSLLH---HDNLVNLIGYCA 150 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---h~niv~l~~~~~ 150 (427)
..+|...+.||.|+||.|++|.++.+...|+||.|.+...-.. -.+-.|+.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468999999999999999999999999999999977543211 12345999999998 999999999999
Q ss_pred cCCeeEEEEeec-CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEe
Q 042519 151 DGEQRLLVYEYM-PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLS 229 (427)
Q Consensus 151 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~ 229 (427)
+++.+||+||-- ++-+|++++. .+..+++.++..|+.||+.|+++||+++ |||||||-+|+.++.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 999999999975 4668888884 5677999999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCC
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAID 290 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~ 290 (427)
|||.+..... .....++||..|.|||++.+..| +..-|||++|++||-++....||.
T Consensus 713 dfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999876322 23456889999999999999887 567899999999999999888874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=252.80 Aligned_cols=268 Identities=25% Similarity=0.372 Sum_probs=216.0
Q ss_pred HHHHHHHhhCccccceeccCCceEEEEEEECCC-----CcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEE
Q 042519 75 FRELATATKNFRQECLIGEGGFGRVYKGKLEKT-----AQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGY 148 (427)
Q Consensus 75 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~ 148 (427)
..++.....+++...++-+|.||.||.|.+++. .+.|.+|.++... ......+..|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 455666677889999999999999999987642 2346666664332 2233456788899999999999999998
Q ss_pred EEc-CCeeEEEEeecCCCChhhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC
Q 042519 149 CAD-GEQRLLVYEYMPLRSLEDHLLDIG----PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE 223 (427)
Q Consensus 149 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 223 (427)
+.+ ....++++.++.-|+|..+|...+ .....+...+...++.|++.|++|||..+ |||.||...|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 764 566788999999999999997322 23455777788899999999999999999 9999999999999999
Q ss_pred CCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 042519 224 FNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVT 302 (427)
Q Consensus 224 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~ 302 (427)
.+|||+|=.+++..-..+.............||+||.+.+..|+.++|||||||+||||+| |+.|+-..+|..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 9999999999987656665555555556778999999999999999999999999999999 888887655432
Q ss_pred hhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 303 WAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...+++++.++.+ |.+++++++.++.-||..+|++||+++++..-|..+
T Consensus 507 -m~~ylkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 507 -MEHYLKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -HHHHHhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 2233455444433 667889999999999999999999999999988654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-31 Score=237.60 Aligned_cols=212 Identities=35% Similarity=0.524 Sum_probs=185.1
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCChhh
Q 042519 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLED 169 (427)
Q Consensus 91 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 169 (427)
||+|++|.||++....+++.+++|++...... ....+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999988999999998765432 34678899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-CCCeeEeecCCcccCCCCCccceecc
Q 042519 170 HLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-EFNAKLSDFGLAKLGPIGDKTHVSSR 248 (427)
Q Consensus 170 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~ 248 (427)
++.... ..+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 986421 46889999999999999999999999 999999999999999 89999999999986433221 1233
Q ss_pred ccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCC
Q 042519 249 VMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFP 327 (427)
Q Consensus 249 ~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (427)
..+...|++||.+... .++.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 5578889999999877 888999999999999998
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 328 VRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 328 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..+.+++..|++.+|++||++.++++++
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4677999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=236.80 Aligned_cols=263 Identities=17% Similarity=0.274 Sum_probs=199.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcC--CeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADG--EQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 158 (427)
.++|++.+.+|+|.|+.||.|.+..+++.++||+++.. ....+.+|+.||..|. ||||++|++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 57899999999999999999999988999999999653 4567889999999998 99999999998764 456799
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC-CCeeEeecCCcccC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLAKLG 237 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkl~DFG~a~~~ 237 (427)
+||+.+.+..... ..++...+..++.+++.||.|+|+.| |+|||+||.|+++|.. ..++|+|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999988776654 34677788889999999999999999 9999999999999865 46999999999875
Q ss_pred CCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh------------
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA------------ 304 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~------------ 304 (427)
-.+.... ..+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-...+.+++- +..+
T Consensus 184 Hp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL-VkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH-HHHHHHhChHHHHHHH
Confidence 4433222 2345667889998754 568999999999999999999999997665544332 1111
Q ss_pred hhh-hcCCCCCCcccccccCC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 305 QPF-FKDPNRYPQLADPLLQG--------EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 305 ~~~-~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+ +.-+..+..++....+. .-..-...+.++++...|..|-++|+|+.|.+.+-.+
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 110 00011111111111110 0001123678899999999999999999999887543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=236.23 Aligned_cols=200 Identities=34% Similarity=0.438 Sum_probs=174.2
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecC
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 163 (427)
|.+.+.||.|++|.||++.+..+++.+++|.+...... ....+.+|+..+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56778999999999999999988999999999776544 56778899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT 243 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 243 (427)
+++|.+++..... .+++.....++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~- 153 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA- 153 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence 9999999865321 1788999999999999999999998 99999999999999999999999999886433221
Q ss_pred ceeccccccccccCcccc-ccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 042519 244 HVSSRVMGTYGYCAPEYQ-RTGQLTVKSDVYTFGVVLLELITGRRAIDT 291 (427)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ell~g~~p~~~ 291 (427)
.......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122345678889999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=267.38 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=207.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|+....+|.|+||.||+++++.+++..|+|+++........-+..|+.+++..+|+|||-+++.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 57899999999999999999999999999999999887767777788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
|.+|+|.+.-+ ...++++.++.......+.||+|||+.+ =+|||||-.|||+++.|.+|++|||.+... ..
T Consensus 94 cgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi--ta 164 (829)
T KOG0576|consen 94 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI--TA 164 (829)
T ss_pred cCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh--hh
Confidence 99999988653 4577999999999999999999999999 799999999999999999999999997642 22
Q ss_pred ccceeccccccccccCcccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQ---RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.......+.||+.|||||+. +.+.|...+|||++|+...||---+.|-....|... +.- ..+..-+.+.+-
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--l~L----mTkS~~qpp~lk 238 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--LFL----MTKSGFQPPTLK 238 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--HHH----hhccCCCCCccc
Confidence 22334568899999999976 457899999999999999999887776543332211 000 011111112222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
| .......+.++++.||-.+|.+||+++.++++
T Consensus 239 D-------k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 239 D-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred C-------CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 2 23345678899999999999999999887663
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=241.88 Aligned_cols=265 Identities=23% Similarity=0.271 Sum_probs=199.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC------C
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG------E 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 153 (427)
..+|.-.+.+|.|.- .|..+.+.-.+..||+|++.... ....+...+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456778888999988 78888888889999999975441 23345567899999999999999999998643 4
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..|+|||+|. .+|.+.+. -.++-..+..|+.|++.|+.|||+.+ |+||||||+||++..++.+||+|||+
T Consensus 95 e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 5799999997 78888775 34677788899999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc----------------cc
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPT----------------YE 297 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~----------------~~ 297 (427)
++.. +.....+..+.|..|.|||++.+..|...+||||+|||+.||++|..-|....-- .-
T Consensus 165 ar~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 165 ARTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 9852 2334556678899999999999988999999999999999999999888532110 00
Q ss_pred chhhhhhhhhhcCC-----CCCCc-ccccccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 298 QNLVTWAQPFFKDP-----NRYPQ-LADPLLQG--EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 298 ~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..+...+..+.... -.+.+ +.|..... +.+......+.+++.+||-.+|++|-++.++|+|--
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 01111111111100 00111 11111111 111223456788999999999999999999999863
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=242.38 Aligned_cols=270 Identities=23% Similarity=0.306 Sum_probs=199.4
Q ss_pred HHHHhhCccccceeccCCceEEEEEEECC---CCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCC
Q 042519 78 LATATKNFRQECLIGEGGFGRVYKGKLEK---TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGE 153 (427)
Q Consensus 78 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 153 (427)
+....+.|...++||.|.|++||++.+.. ..+.||+|.+...+ .-..+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44456789999999999999999999876 68899999997653 3345789999999987 999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC-CCeeEeecC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFG 232 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkl~DFG 232 (427)
...+|+||++..+..++... ++...+..++..++.||.++|.+| ||||||||+|+|.+.. +.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999999999888887743 567888899999999999999999 9999999999999754 557899999
Q ss_pred CcccCC-----------------C--CCc-----------------------cceeccccccccccCcccccc-CCCCcc
Q 042519 233 LAKLGP-----------------I--GDK-----------------------THVSSRVMGTYGYCAPEYQRT-GQLTVK 269 (427)
Q Consensus 233 ~a~~~~-----------------~--~~~-----------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 269 (427)
+|.... . +.. ........||++|.|||++.. ...+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 986100 0 000 000112359999999998864 567899
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCCcccch--hhh---h------h---hh--hhcCCC---------CCCcc-cccccC
Q 042519 270 SDVYTFGVVLLELITGRRAIDTTRPTYEQN--LVT---W------A---QP--FFKDPN---------RYPQL-ADPLLQ 323 (427)
Q Consensus 270 ~DvwSlGvil~ell~g~~p~~~~~~~~~~~--~~~---~------~---~~--~~~~~~---------~~~~~-~~~~~~ 323 (427)
+||||.|||++-+++++.||-......... +.. + + .. ++...+ .+..+ ......
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 999999999999999999995443322110 000 0 0 00 001000 00001 000001
Q ss_pred --------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 324 --------GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 324 --------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
.......+..+++++.+|+..||.+|.++++.|.+-
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 111122334789999999999999999999999985
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=272.89 Aligned_cols=200 Identities=19% Similarity=0.258 Sum_probs=142.3
Q ss_pred hcCC-CCeeeEEEEE-------EcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 042519 136 LLHH-DNLVNLIGYC-------ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207 (427)
Q Consensus 136 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 207 (427)
.++| .||++++++| ...+.+++++||+. ++|.++|.. ....+++..++.++.||++||.|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4455 5788888887 23345677889875 799999864 2456899999999999999999999999
Q ss_pred eEeccCCCCceEeCCC-------------------CCeeEeecCCcccCCCCCc--------------cceecccccccc
Q 042519 208 VIYRDLKSSNILLDCE-------------------FNAKLSDFGLAKLGPIGDK--------------THVSSRVMGTYG 254 (427)
Q Consensus 208 ivH~Dlkp~NIll~~~-------------------~~vkl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~ 254 (427)
|+||||||+||||+.. +.+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4456666666553110000 000112468999
Q ss_pred ccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHH
Q 042519 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQA 334 (427)
Q Consensus 255 y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 334 (427)
|+|||++.+..++.++|||||||+||||++|..|+..... ......... . .+. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~~------~----~~~-----~~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHRV------L----PPQ-----ILLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHhh------c----Chh-----hhhcCHHH
Confidence 9999999999999999999999999999999887653210 011110000 0 000 00112345
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 335 VAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 335 ~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..++.+||+.+|.+||++.+++++.+.
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhchhh
Confidence 678899999999999999999998764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=208.12 Aligned_cols=167 Identities=22% Similarity=0.197 Sum_probs=126.5
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|+|.+++.. ....+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 689998865 2456999999999999999999999886 999999999999999 9998863221
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+....... .+. ..
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~--------~~~-~~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPAD--------DPR-DR 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccC--------Ccc-cc
Confidence 1268999999999999999999999999999999999999996532211 1111111111000 000 00
Q ss_pred CCCHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 325 EFPVRGLN--QAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 325 ~~~~~~~~--~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+..... .+.+++.+||+.+|.+||++.++++++..+
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11122233 689999999999999999999999999764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-26 Score=220.91 Aligned_cols=262 Identities=21% Similarity=0.198 Sum_probs=197.0
Q ss_pred CccccceeccCCceEEEEEEECCCC-cEEEEEEeccCCCcchHHHHHHHHHHhhcCC----CCeeeEEEEE-EcCCeeEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTA-QVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH----DNLVNLIGYC-ADGEQRLL 157 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 157 (427)
+|.+.+.||+|+||.||+|.+..++ ..+|+|............+..|..++..+.. .++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999998764 6799998766543333367788888888873 6899999999 57788899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC-----CCeeEeecC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE-----FNAKLSDFG 232 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~vkl~DFG 232 (427)
||+.+ |.+|.++..... ...++..+.+.|+.|++.+|++||+.| ++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 589999765543 578999999999999999999999999 9999999999999765 358999999
Q ss_pred Ccc--cCCCCCcc----c-e-eccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 042519 233 LAK--LGPIGDKT----H-V-SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 233 ~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~ 304 (427)
+++ ........ . . ...+.||..|+++....+...+.+.|+||++.++.+|+.|..||......... ....
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~--~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK--SKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH--HHHH
Confidence 998 32111111 1 1 23456999999999999999999999999999999999999999654432211 1110
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.. ... ..... .....+..+.++...+-..+...+|....+...|.....
T Consensus 251 ~~-~~~-----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 251 KD-PRK-----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HH-hhh-----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 00 000 00000 111223445555555666899999999999998866543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=224.38 Aligned_cols=166 Identities=17% Similarity=0.122 Sum_probs=129.6
Q ss_pred HHhhCccccceeccCCceEEEEEEECC-CCcEEEEEEeccCC-----CcchHHHHHHHHHHhhcCCCCeee-EEEEEEcC
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEK-TAQVVAVKQLDRNG-----LQGNKEFIVEVLMLSLLHHDNLVN-LIGYCADG 152 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~ 152 (427)
...++|.+.+.||+|+||+||+|.++. ++..||||++.... ......+.+|+.+|..++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 346789999999999999999999876 67888999875331 112455889999999999999985 4432
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC-CCCceEeCCCCCeeEeec
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDL-KSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~vkl~DF 231 (427)
+..++||||++|++|.. +. .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 45799999999999963 21 10 1 1357889999999999999 999999 999999999999999999
Q ss_pred CCcccCCCCCccce------eccccccccccCcccccc
Q 042519 232 GLAKLGPIGDKTHV------SSRVMGTYGYCAPEYQRT 263 (427)
Q Consensus 232 G~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 263 (427)
|+++.......... .....+++.|+|||++..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99986433221111 135678999999998864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-24 Score=205.93 Aligned_cols=261 Identities=32% Similarity=0.424 Sum_probs=198.9
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCC-CeeeEEEEEEcCCeeEEEEe
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHD-NLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e 160 (427)
|.+.+.||.|+||.||++.+. ..+++|.+....... ...+.+|+.++..+.|+ +++++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 677889999999999999998 679999987654433 56788899999999988 79999999988777899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-CeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DFG~a~~~~~ 239 (427)
++.+++|.+++...... ..+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999666542211 36888999999999999999999999 99999999999999998 799999999875333
Q ss_pred CCccc----eeccccccccccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 240 GDKTH----VSSRVMGTYGYCAPEYQRT---GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 240 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
..... ......||..|++||.+.+ ..++...|+||+|++++++++|..||...... .........+.....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~ 232 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPT 232 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCC
Confidence 22221 3456789999999999987 57899999999999999999999997654321 000111111111111
Q ss_pred C-CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 313 R-YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 313 ~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
. ....... .........+.+++..|+..+|..|.+..+....
T Consensus 233 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 PSLASPLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccccCc----cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 0000000 0002233577889999999999999999887775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-27 Score=238.70 Aligned_cols=259 Identities=18% Similarity=0.212 Sum_probs=193.5
Q ss_pred cccceeccCCceEEEEEEECCCCcEEEEEEeccC--CCcch----HHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 86 RQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN--GLQGN----KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 86 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
....++|.|.+|.|+.+......+.++.|.+... ..... ..+..|+.+-..|.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998888887766666666655311 11111 11556888888999999988777777666666669
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|||++ +|..++.. ...+...++-.++.|++.||.|||+.| |.|||||++|+++..+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99998 99998854 245777888899999999999999999 99999999999999999999999999876444
Q ss_pred CCcc--ceeccccccccccCccccccCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 240 GDKT--HVSSRVMGTYGYCAPEYQRTGQLTV-KSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 240 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... .....++|+..|+|||++.+..|.+ ..||||.|++++.|++|+.||......+.+.... ......
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------~~~~~~-- 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------NYSDQR-- 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh------cccccc--
Confidence 3333 5667889999999999999988875 6899999999999999999997654433321000 000000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
-...-....-...+.....++.++|+.+|.+|-|+.+|++.=|.
T Consensus 545 -~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 545 -NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred -ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 00000001122344567789999999999999999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=202.22 Aligned_cols=202 Identities=24% Similarity=0.307 Sum_probs=173.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 160 (427)
.-.|+++++||+|+||.++.|.+--+++.||||.-... ....++..|....+.|. .++|..++.+..++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 45699999999999999999999999999999985433 34567888999888886 7899999998888989999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-----CeeEeecCCcc
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-----NAKLSDFGLAK 235 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~vkl~DFG~a~ 235 (427)
.+ |-||++++.- ....++..+++.+|.|++.-++|+|++. +|+|||||+|+||...+ .|.|+|||+|+
T Consensus 105 LL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 98 4799887654 4567899999999999999999999999 99999999999996543 48999999999
Q ss_pred cCCCCCccc-----eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 042519 236 LGPIGDKTH-----VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTT 292 (427)
Q Consensus 236 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~ 292 (427)
.+....... ......||..||+-....+...+...|+-|||-++++.|-|..||...
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 754433221 134567999999999999999999999999999999999999999764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=196.79 Aligned_cols=205 Identities=22% Similarity=0.275 Sum_probs=172.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 160 (427)
..+|++.+.||.|+||.+|+|....+|+.||||+-... .....+..|..+...|+ -..|..+..|+.+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 57899999999999999999999999999999986443 34466788999999998 4678888889999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC---CCeeEeecCCcccC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE---FNAKLSDFGLAKLG 237 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkl~DFG~a~~~ 237 (427)
.+ |-||++++.- ....++..+.+-++.|++.-|+|+|.++ +|||||||+|+|..-+ ..+.|+|||+|+.+
T Consensus 92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 98 4799887654 4566888899999999999999999999 9999999999999644 45899999999864
Q ss_pred CCCCcc-----ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc
Q 042519 238 PIGDKT-----HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPT 295 (427)
Q Consensus 238 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~ 295 (427)
...... .......||..|.+-....+...+...|+-|+|.+|.++.-|..||+...+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 322211 1134567999999999888888899999999999999999999999876544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=192.59 Aligned_cols=172 Identities=12% Similarity=0.102 Sum_probs=133.3
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHH---------HHHHHHHHhhcCCCCeeeEEEEEE
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---------FIVEVLMLSLLHHDNLVNLIGYCA 150 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~ 150 (427)
...++|++.++||.|+||.||++.. ++..+|||++.......... +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3478999999999999999999655 36679999996543332222 578999999999999999998866
Q ss_pred cC--------CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC
Q 042519 151 DG--------EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC 222 (427)
Q Consensus 151 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 222 (427)
.. ...+|||||++|.+|.++.. ++. ....+++.+|..||..+ ++||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 43 35789999999999987631 222 24568899999999999 999999999999999
Q ss_pred CCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHH
Q 042519 223 EFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELI 283 (427)
Q Consensus 223 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 283 (427)
+| ++|+|||.......... .. .++....|+.++|+|+||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a---~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKA---KD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhh---HH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 98 99999998875321110 00 1344456778999999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=193.37 Aligned_cols=236 Identities=19% Similarity=0.258 Sum_probs=152.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCC----------CCeeeEEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHH----------DNLVNLIGYC 149 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~~ 149 (427)
..+...+.||.|+++.||.+.+..+|+.+|||++..... ...+.+.+|......+.+ -.++.-++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 346677899999999999999999999999999854432 233556666655544332 1122222221
Q ss_pred ---------EcC---C-----eeEEEEeecCCCChhhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 042519 150 ---------ADG---E-----QRLLVYEYMPLRSLEDHLLD---IGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209 (427)
Q Consensus 150 ---------~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 209 (427)
... . ..+++|+-+. ++|.+.+.. .......+....++.+..|+++.+++||+.| ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 111 1 2356777775 788777543 2222233455566777789999999999999 99
Q ss_pred eccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCcccccc--------CCCCccchHHHHHHHHHH
Q 042519 210 YRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT--------GQLTVKSDVYTFGVVLLE 281 (427)
Q Consensus 210 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~e 281 (427)
|+||||+|+|++.+|.++|+||+..... +. .... ...+..|.+||.... -.++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~--g~--~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRA--GT--RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEET--TE--EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeec--Cc--eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999987652 11 1111 344577999997643 257899999999999999
Q ss_pred HHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 042519 282 LITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVR 349 (427)
Q Consensus 282 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 349 (427)
|.||+.||+...+...... .-..+. +.++.+..||..+|+.+|.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999986543321111 112334 677899999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=191.43 Aligned_cols=248 Identities=20% Similarity=0.322 Sum_probs=193.5
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
..+..+|.+...|..|+|++.+ ..+++|++..... ...++|..|.-.|+.+.||||+.+++.|....++.++..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 4455678999999999999985 4577777754332 33467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE-eccCCCCceEeCCCCCeeEe--ecCCcccCCC
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI-YRDLKSSNILLDCEFNAKLS--DFGLAKLGPI 239 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv-H~Dlkp~NIll~~~~~vkl~--DFG~a~~~~~ 239 (427)
+.|+|+..|+.. ....++..++.+++.++++|++|||+... ++ ---|....+++|++.+.+|+ |--++..
T Consensus 270 p~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsfq--- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--- 342 (448)
T ss_pred cchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeeee---
Confidence 999999999864 45667888999999999999999999873 44 34688999999999988764 3222211
Q ss_pred CCccceeccccccccccCccccccCCC---CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQL---TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.......|.|++||.+...+- -.++|+|||+++||||.|...||....+..-...
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---------------- 400 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---------------- 400 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----------------
Confidence 111234678999999976553 3679999999999999999999987655422211
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+.-.-++-..|+....-+..++.-|+..||.+||.+..|+-.|+.+.
T Consensus 401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11123334556677778889999999999999999999999888653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-25 Score=224.22 Aligned_cols=251 Identities=23% Similarity=0.238 Sum_probs=182.9
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-CcchHHHHH---HHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIV---EVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
+|...+.||.+.|=+|.+|++.+ |. |+||++-+.. ....+.+.+ |+. ...++|||.+.+..+.......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68888999999999999999986 55 9999986544 233344433 444 56678999999988877778888998
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC--
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG-- 237 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~-- 237 (427)
+|+. .+|.+.| ..+.-+...+...|+.|++.||..+|..| |+|||||.+||||+.-+.+.|+||..-+..
T Consensus 101 qyvk-hnLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVK-HNLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHh-hhhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 8887 5888887 34445677788889999999999999999 999999999999999999999999887631
Q ss_pred CC---CCccceeccccccccccCccccccC----------C-CCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 042519 238 PI---GDKTHVSSRVMGTYGYCAPEYQRTG----------Q-LTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVT 302 (427)
Q Consensus 238 ~~---~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~ 302 (427)
+. .+......+...-.+|+|||.+... . .+++.||||+||++.||++ |+++|+-. .+..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh
Confidence 11 1222233334445679999987431 2 6789999999999999999 78888631 1111
Q ss_pred hhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 303 WAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
++.++. ......+.. -+...+..++..|++.||++|.++++.++...++
T Consensus 247 -----Yr~~~~--~~~e~~Le~----Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 -----YRSGNA--DDPEQLLEK----IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -----HhccCc--cCHHHHHHh----CcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111110 000000000 0012567899999999999999999999985443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=184.63 Aligned_cols=138 Identities=17% Similarity=0.123 Sum_probs=107.5
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--c-------h-----------------HHHHHHHHHHhhcCCCC
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--G-------N-----------------KEFIVEVLMLSLLHHDN 141 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n 141 (427)
...||+|+||.||+|.+. +|+.||||+++..... . . .....|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 7999999999654211 1 0 11234899999998777
Q ss_pred eeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEeccCCCCceEe
Q 042519 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL-HDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 142 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp~NIll 220 (427)
+.....+.. ...+|||||+++++|...+. ....++...+..++.|++.+|.|| |+.+ |+||||||+|||+
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 643332222 22389999999877765432 234688899999999999999999 6888 9999999999999
Q ss_pred CCCCCeeEeecCCccc
Q 042519 221 DCEFNAKLSDFGLAKL 236 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~ 236 (427)
+ ++.++|+|||++..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 57899999999975
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=177.92 Aligned_cols=139 Identities=17% Similarity=0.086 Sum_probs=110.0
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--------------------------hHHHHHHHHHHhhcCCCC
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--------------------------NKEFIVEVLMLSLLHHDN 141 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 141 (427)
.+.||+|+||.||+|.+. +|+.||||+++...... ...+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 79999999987653210 112356889999999998
Q ss_pred eeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEe
Q 042519 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILL 220 (427)
Q Consensus 142 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll 220 (427)
+.....+.... .+|||||++++++..... ....++......++.|++.+|.+||+ .+ |+||||||+|||+
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 75544443332 489999999876544322 22456778889999999999999999 88 9999999999999
Q ss_pred CCCCCeeEeecCCcccC
Q 042519 221 DCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~ 237 (427)
+ ++.++|+|||++...
T Consensus 152 ~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 152 H-DGKPYIIDVSQAVEL 167 (190)
T ss_pred E-CCCEEEEEcccceec
Confidence 8 889999999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-24 Score=211.19 Aligned_cols=226 Identities=25% Similarity=0.322 Sum_probs=178.7
Q ss_pred eeccCCceEEEEEEE---CCCCcEEEEEEeccCCCcch--HHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEeecC
Q 042519 90 LIGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 163 (427)
++|+|.||.|++++. .+.|..||+|++++...... .....|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998754 34577899999876433221 13445778888887 9999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT 243 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 243 (427)
+|.|...+.. ...+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++......
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-- 151 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-- 151 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence 9999888743 344566666777888999999999999 9999999999999999999999999998633222
Q ss_pred ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccC
Q 042519 244 HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQ 323 (427)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (427)
..|||..|||||+++ .....+|+||||++++||++|..||.. +....+.+..-
T Consensus 152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~~~----------- 204 (612)
T KOG0603|consen 152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKAEL----------- 204 (612)
T ss_pred ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhhcc-----------
Confidence 129999999999998 678899999999999999999999975 11222222111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 042519 324 GEFPVRGLNQAVAVSAMCVQEESSVRPLM 352 (427)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 352 (427)
..|......+.+++..++..+|..|...
T Consensus 205 -~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 -EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2244555667788888888999998754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=188.18 Aligned_cols=198 Identities=21% Similarity=0.227 Sum_probs=140.8
Q ss_pred CCCCeeeEEEEEEcC---------------------------CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHH
Q 042519 138 HHDNLVNLIGYCADG---------------------------EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIA 190 (427)
Q Consensus 138 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 190 (427)
+|||||+++.+|.+. ..+|+||..++ .+|.+++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 499999999887542 35689999887 699999843 445666777889
Q ss_pred HHHHHHHHHHhhCCCCCeEeccCCCCceEe--CCCC--CeeEeecCCcccCCCCC----ccceeccccccccccCccccc
Q 042519 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILL--DCEF--NAKLSDFGLAKLGPIGD----KTHVSSRVMGTYGYCAPEYQR 262 (427)
Q Consensus 191 ~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~vkl~DFG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~ 262 (427)
.|+++|+.|||.++ |.|||+|.+|||| |+++ .+.|+|||++-...... .........|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999999 4443 47899999975422110 111122345788899999886
Q ss_pred cCC------CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHH
Q 042519 263 TGQ------LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVA 336 (427)
Q Consensus 263 ~~~------~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 336 (427)
..+ .-.|+|.|+.|.+.||+++...||....... .+... +++ ..++ ..+..++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~-----Yqe-~qLP---------alp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT-----YQE-SQLP---------ALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh-----hhh-hhCC---------CCcccCChHHHH
Confidence 432 2358999999999999999999997532110 11111 111 1111 224445567889
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHh
Q 042519 337 VSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 337 li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
++...|+.||++|++..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999998766655553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=173.68 Aligned_cols=186 Identities=18% Similarity=0.109 Sum_probs=137.7
Q ss_pred cccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc----hHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEe
Q 042519 86 RQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG----NKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 86 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 160 (427)
.+...|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+.+|++|. |+++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3457899999999997766 36778877765443211 124778999999996 5889999886 44699999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC-CCCceEeCCCCCeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDL-KSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|+.|.+|.+.+.. ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999888654311 11346789999999999999 999999 79999999999999999999985332
Q ss_pred CCcc----ce-------eccccccccccCccccccC-CCC-ccchHHHHHHHHHHHHhCCCCCCC
Q 042519 240 GDKT----HV-------SSRVMGTYGYCAPEYQRTG-QLT-VKSDVYTFGVVLLELITGRRAIDT 291 (427)
Q Consensus 240 ~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~ell~g~~p~~~ 291 (427)
.... .. .....+++.|++|+...-- ..+ ...++++.|+-+|.++|++.++-.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 2210 00 1112367788888844321 223 567999999999999999877643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=206.54 Aligned_cols=197 Identities=21% Similarity=0.234 Sum_probs=156.7
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC---CCCeeeEEEEEEcCCeeE
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH---HDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 156 (427)
.....|.+.+.||+|+||+||+|...+ |+.||+|+-+...... |.--..++.+|+ -+.|..+..++.-.+..+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 345678889999999999999999988 9999999976543221 111123333333 234555555555667789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC-------CCCCeeEe
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD-------CEFNAKLS 229 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~vkl~ 229 (427)
||+||.+.|+|.+++. ..+.+++...+.++.|++..|+.||..+ |||+||||+|+||. .+.-++|+
T Consensus 771 lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 9999999999999985 6678999999999999999999999999 99999999999993 23458999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCC
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRR 287 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~ 287 (427)
|||.+-.+...-........++|-.+-.+|+..+..+++.+|.|.|+.+++.||.|++
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999864332223334556788999999999999999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=173.90 Aligned_cols=137 Identities=20% Similarity=0.220 Sum_probs=107.5
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-----CCCCeeeEEEEEEcCC---eeE
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-----HHDNLVNLIGYCADGE---QRL 156 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~ 156 (427)
+.-.+.||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||+++++++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34457899999999995 6666655 69998765445567789999999999 5799999999998864 333
Q ss_pred -EEEee--cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEeccCCCCceEeCC----CCCeeE
Q 042519 157 -LVYEY--MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL-EYLHDKANPPVIYRDLKSSNILLDC----EFNAKL 228 (427)
Q Consensus 157 -lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~vkl 228 (427)
+|+|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 557999999954 224444 35577778777 9999999 999999999999974 347999
Q ss_pred eecCCc
Q 042519 229 SDFGLA 234 (427)
Q Consensus 229 ~DFG~a 234 (427)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-22 Score=203.72 Aligned_cols=212 Identities=25% Similarity=0.326 Sum_probs=149.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
..+|..++.|..|+||.||+++++.+.+.+|+|+ ++....-+ + ++..-..|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilR----n---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILR----N---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhh----c---cccccCCccee------------------
Confidence 4679999999999999999999999999999954 33321110 0 22222233333
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
|+-...++.. .+++.. .+.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++......
T Consensus 136 ---gDc~tllk~~----g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccC----CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 3333334322 223221 267899999999 9999999999999999999999999987532211
Q ss_pred ccc-------------eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 042519 242 KTH-------------VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 242 ~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
... ....++|||.|.|||++....|...+|||++|+|+||.+.|..||....+.. .+..++
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhh
Confidence 111 1234689999999999999999999999999999999999999998765432 222223
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM 352 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 352 (427)
.+...+++- ......++.+++...|+.+|..|.-.
T Consensus 272 sd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 272 SDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 332222222 12233578899999999999999643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=188.55 Aligned_cols=218 Identities=28% Similarity=0.400 Sum_probs=164.0
Q ss_pred HhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-Eecc
Q 042519 134 LSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV-IYRD 212 (427)
Q Consensus 134 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~D 212 (427)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++.+|+.||.|||... | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4578899999999999999999999999999999999876 5678999999999999999999999887 5 9999
Q ss_pred CCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccC-------CCCccchHHHHHHHHHHHHhC
Q 042519 213 LKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-------QLTVKSDVYTFGVVLLELITG 285 (427)
Q Consensus 213 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ell~g 285 (427)
|+..|+++|....+||+|||+.................-..-|.|||.+.+. ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998764321111111122234459999998763 146789999999999999999
Q ss_pred CCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 286 RRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 286 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..||+........ .+.+....+.. ...+.+.+... ......+..++..||..+|.+||++..|-..+..+..
T Consensus 155 ~~~~~~~~~~~~~--~eii~~~~~~~---~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP--DEIILRVKKGG---SNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCCh--HHHHHHHHhcC---CCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999875443332 11121221101 11111211110 0233478899999999999999999999999875443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=167.57 Aligned_cols=143 Identities=17% Similarity=0.116 Sum_probs=111.8
Q ss_pred hCccccceeccCCceEEEEEE-ECCCCcEEEEEEeccCCCc------------------------chHHHHHHHHHHhhc
Q 042519 83 KNFRQECLIGEGGFGRVYKGK-LEKTAQVVAVKQLDRNGLQ------------------------GNKEFIVEVLMLSLL 137 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 137 (427)
.-|.+.+.||+|+||.||+|. +..+|+.||||++...... ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 6678999999998754211 001246799999999
Q ss_pred CCCC--eeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCC
Q 042519 138 HHDN--LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKS 215 (427)
Q Consensus 138 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 215 (427)
.+.+ +.+++++ ...++||||+++++|...+. ....+.......++.||+.+|.+||+.+. |+||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCCh
Confidence 7533 3444443 23589999999888876542 22345566678899999999999999875 99999999
Q ss_pred CceEeCCCCCeeEeecCCccc
Q 042519 216 SNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 216 ~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||+++ ++.++|+|||.+..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=162.36 Aligned_cols=134 Identities=22% Similarity=0.278 Sum_probs=112.3
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--------hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--------NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
+.||+|++|.||+|.+ .|..+++|+........ ...+.+|+.++..+.|+++.....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999988 46779999865432211 1346779999999999998877777777788899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
|++|++|.+++... .. ....++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999988532 11 77889999999999999999 99999999999999 78999999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-20 Score=182.00 Aligned_cols=176 Identities=24% Similarity=0.343 Sum_probs=129.4
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
.+|+.|++|.-.+|.++|.... .....++...+.++.|++.|++| ++ .+|+|+||.||++..+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999996543 34456778889999999999999 77 89999999999999999999999999
Q ss_pred cccCCCCC----ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 042519 234 AKLGPIGD----KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 234 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
........ .....+...||..||+||.+.+..|+.++||||||+||+||+. -...|+... ...-+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhh
Confidence 87543322 1223456789999999999999999999999999999999998 222222110 00011
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVV 356 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 356 (427)
.+ +.++ +....+.| .-+.|+.+++...|.+||++.++.
T Consensus 473 r~-g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 473 RD-GIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hc-CCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence 11 1111 11111112 335789999999999999554443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-19 Score=157.19 Aligned_cols=130 Identities=22% Similarity=0.310 Sum_probs=105.0
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeccCCCc--------chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--------GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.||+|+||.||+|.+. |..+++|........ ....+.+|+.++..+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999864 678999986543211 124466799999999988765555555566677999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
++|++|.+.+.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998874311 0 78899999999999999 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.7e-19 Score=156.45 Aligned_cols=141 Identities=18% Similarity=0.077 Sum_probs=109.5
Q ss_pred HHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc----------------------chHHHHHHHHHHh
Q 042519 78 LATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ----------------------GNKEFIVEVLMLS 135 (427)
Q Consensus 78 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 135 (427)
+......|.+.+.||+|+||.||++.+. +|+.||||++...... .......|+.++.
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3333445888999999999999999886 6999999987643210 0112567888888
Q ss_pred hcCCCC--eeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC
Q 042519 136 LLHHDN--LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDL 213 (427)
Q Consensus 136 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 213 (427)
.+.|++ +...++. ...++||||+++++|...... .....++.+++.++.++|+.+ |+||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 888774 4444442 345899999999998765320 234578889999999999999 999999
Q ss_pred CCCceEeCCCCCeeEeecCCccc
Q 042519 214 KSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 214 kp~NIll~~~~~vkl~DFG~a~~ 236 (427)
||+||+++.++.++|+|||++..
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CcccEEEcCCCcEEEEECCcccc
Confidence 99999999999999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.3e-19 Score=179.28 Aligned_cols=137 Identities=23% Similarity=0.304 Sum_probs=111.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-C-------cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-L-------QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 153 (427)
...|...+.||+|+||+||+|.+.... +++|+..... . .....+.+|+.++..++|++++....++.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344567789999999999999886543 4444322111 1 11245778999999999999998888887777
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++||||+++++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|||+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 8899999999999999874 34678999999999999999 9999999999999 678899999999
Q ss_pred ccc
Q 042519 234 AKL 236 (427)
Q Consensus 234 a~~ 236 (427)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=146.77 Aligned_cols=134 Identities=21% Similarity=0.136 Sum_probs=96.9
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHH----------------------HHHHHHHHhhcCCCC--
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKE----------------------FIVEVLMLSLLHHDN-- 141 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n-- 141 (427)
.+.||+|+||.||+|.+. +|+.||||++....... ... ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999987 68999999986532211 111 134555566655433
Q ss_pred eeeEEEEEEcCCeeEEEEeecCCCChhhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceE
Q 042519 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDH-LLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNIL 219 (427)
Q Consensus 142 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIl 219 (427)
+.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. .+ |+|+||||+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 4444443 235899999998554322 21110 01 5567899999999999999 88 999999999999
Q ss_pred eCCCCCeeEeecCCccc
Q 042519 220 LDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 220 l~~~~~vkl~DFG~a~~ 236 (427)
++ ++.++|+|||.+..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 89999999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.6e-19 Score=181.32 Aligned_cols=262 Identities=23% Similarity=0.250 Sum_probs=195.0
Q ss_pred CccccceeccCCceEEEEEEEC-CCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLE-KTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 159 (427)
.|.+.+-||+|.|+.|-..... .....+|+|.+.... .........|..+-..+. |.|++++++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4667777999999999988774 334567777775543 122233445778878887 999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEeccCCCCceEeCCCC-CeeEeecCCcccC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH-DKANPPVIYRDLKSSNILLDCEF-NAKLSDFGLAKLG 237 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DFG~a~~~ 237 (427)
+|..++++...+.. ......+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|...
T Consensus 101 ~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Cccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999887731 12224455566778999999999999 888 99999999999999999 9999999999876
Q ss_pred CC-CCccceeccccc-cccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 238 PI-GDKTHVSSRVMG-TYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 238 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++...... .....|. ......
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~----~~~~~~ 250 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWK----SNKGRF 250 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeec----cccccc
Confidence 55 444455566788 9999999998874 55688999999999999999999997654332 1111111 111111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
... ..........+++..++..+|..|.+.+++...-+...
T Consensus 251 ~~~--------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 251 TQL--------PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccC--------ccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 111 11223346678888899999999999988877655444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.2e-17 Score=136.37 Aligned_cols=135 Identities=21% Similarity=0.134 Sum_probs=113.4
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCC--CCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH--DNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+.++..++| .++++++.++...+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35689999999999999864 6799999865432 4578889999999986 5899999998888889999999998
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+.+..+ +......++.+++.+|.+||.....+++|+||+|.|||++..+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777543 4456677889999999999996434499999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.6e-17 Score=146.96 Aligned_cols=134 Identities=22% Similarity=0.224 Sum_probs=103.8
Q ss_pred ceec-cCCceEEEEEEECCCCcEEEEEEeccCCC-------------cchHHHHHHHHHHhhcCCCCe--eeEEEEEEcC
Q 042519 89 CLIG-EGGFGRVYKGKLEKTAQVVAVKQLDRNGL-------------QGNKEFIVEVLMLSLLHHDNL--VNLIGYCADG 152 (427)
Q Consensus 89 ~~Lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 152 (427)
.+|| .||.|+||.+... +..++||.+..... .....+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 5687 8999999998875 67899998854211 122456789999999998875 6677664432
Q ss_pred C----eeEEEEeecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCee
Q 042519 153 E----QRLLVYEYMPL-RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 153 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
. ..++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 689888743 234443 3568899999999999 99999999999999999999
Q ss_pred EeecCCccc
Q 042519 228 LSDFGLAKL 236 (427)
Q Consensus 228 l~DFG~a~~ 236 (427)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=154.24 Aligned_cols=251 Identities=23% Similarity=0.264 Sum_probs=184.2
Q ss_pred hCccccceecc--CCceEEEEEEE--CCCCcEEEEEEecc--CCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCee
Q 042519 83 KNFRQECLIGE--GGFGRVYKGKL--EKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQR 155 (427)
Q Consensus 83 ~~y~~~~~Lg~--G~~g~V~~~~~--~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 155 (427)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+. ........-.+|+.....++ |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677788999 99999999999 88899999998332 22233333356777777776 99999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEeccCCCCceEeCCC-CCeeEee
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK----GLEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSD 230 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkl~D 230 (427)
++-+|++. .+|..+.... ..-++....+.++.+... ||..+|+.+ |+|-|+||.||++..+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 99999986 7888877653 334666777888888888 999999999 9999999999999999 8899999
Q ss_pred cCCcccCCCCCccc---eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 042519 231 FGLAKLGPIGDKTH---VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 231 FG~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
||+......+.... ......|...|++||..+ +-++...|||++|.++.+..+|.......-- ..|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W---- 335 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSW---- 335 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCc----
Confidence 99987644433222 123336778899999887 4789999999999999999998765533210 111
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
......+ +..++-......+..++..+++.+|..|++...+..+
T Consensus 336 ~~~r~~~-------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 336 SQLRQGY-------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccccccc-------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1111110 1111111122345558889999999999998776653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.9e-16 Score=140.31 Aligned_cols=209 Identities=23% Similarity=0.250 Sum_probs=148.1
Q ss_pred HHHhhcCCCCeeeEEEEEEcC-----CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 042519 132 LMLSLLHHDNLVNLIGYCADG-----EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206 (427)
Q Consensus 132 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 206 (427)
.-|-++-|-|||+++.|+.+. ....++.|||.-|+|..+|++.......+......+++.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 445566799999999998754 3578999999999999999988778888888888999999999999999986 7
Q ss_pred CeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC--ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh
Q 042519 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD--KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284 (427)
Q Consensus 207 ~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 284 (427)
+|+|+++..+-|++..+|-+||.--.-........ .........+.++|.+||+=.....+.++|||+||....+|..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 89999999999999999988874221111111000 1111223456789999998877788899999999999999998
Q ss_pred CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 285 GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 285 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
|..--....... ..-.......+.. -+.+ -..++..|++..|..||+|++++-|.-.
T Consensus 278 lEiq~tnseS~~-~~ee~ia~~i~~l-------en~l------------qr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 278 LEIQSTNSESKV-EVEENIANVIIGL-------ENGL------------QRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred heeccCCCccee-ehhhhhhhheeec-------cCcc------------ccCcCcccccCCCCCCcchhhhhcCcee
Confidence 764211111100 0000011111111 1111 1256778999999999999999887633
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.2e-14 Score=141.43 Aligned_cols=139 Identities=21% Similarity=0.137 Sum_probs=96.6
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch----------------------------------------HHHH
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN----------------------------------------KEFI 128 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 128 (427)
+.||.|++|.||+|+.+ +|+.||||+.+....... -++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999987 489999999854321100 0134
Q ss_pred HHHHHHhhcC----CCCeeeEEEEE-EcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 042519 129 VEVLMLSLLH----HDNLVNLIGYC-ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK-GLEYLHD 202 (427)
Q Consensus 129 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~ 202 (427)
+|+..+.++. |.+-+.+-.++ ......+|||||++|++|.+...... ...+ ...++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence 4555554442 33333333333 22345799999999999988764311 1122 3345566555 4788999
Q ss_pred CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 203 ~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
.| ++|+|+||.||+++.++.++|+|||++...
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 99 999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.2e-13 Score=133.35 Aligned_cols=170 Identities=18% Similarity=0.183 Sum_probs=130.1
Q ss_pred EEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCC
Q 042519 101 KGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP 180 (427)
Q Consensus 101 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~ 180 (427)
.|..+.++..|.|+..+.+.........+-+..|+.|+||||+++++.++.....|||+|-+. .|..++...+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence 466777888999999877655334456778889999999999999999999999999999984 6777775532
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccc
Q 042519 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260 (427)
Q Consensus 181 l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 260 (427)
.......+.||+.||.|||..++ ++|++|.-+.|+|+..|..||++|.++........ ......---.|..|+.
T Consensus 103 --~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 103 --KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 45566678899999999986665 99999999999999999999999998764322221 0111111223667775
Q ss_pred cccCCCCccchHHHHHHHHHHHHhC
Q 042519 261 QRTGQLTVKSDVYTFGVVLLELITG 285 (427)
Q Consensus 261 ~~~~~~~~~~DvwSlGvil~ell~g 285 (427)
+.... -..|.|-|||++++++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 54322 456999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=119.14 Aligned_cols=131 Identities=18% Similarity=0.088 Sum_probs=97.1
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCee-eEEEEEEcCCeeEEEEeecCCCC
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV-NLIGYCADGEQRLLVYEYMPLRS 166 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs 166 (427)
.+.|+.|.++.||++... +..|++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 357899999999999875 67899999754421 223467899999888755544 455443 234589999999988
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 167 LEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA--NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 167 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+.... . ....++.+++++|..||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76430 0 11245678999999999987 22259999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.2e-13 Score=135.96 Aligned_cols=144 Identities=18% Similarity=0.174 Sum_probs=94.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc----------------------------------hH---
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG----------------------------------NK--- 125 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~--- 125 (427)
..|+. +.||.|++|.||+|+.+.+|+.||||++++..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34666 68999999999999999889999999986542100 00
Q ss_pred ---HHHHHHHHHhhcC----CCCeeeEEEEEEc-CCeeEEEEeecCCCChhhh--hhhcCCCCCCCCHHHHHHHHHHHHH
Q 042519 126 ---EFIVEVLMLSLLH----HDNLVNLIGYCAD-GEQRLLVYEYMPLRSLEDH--LLDIGPEQKPIDWFTRMKIALGAAK 195 (427)
Q Consensus 126 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~i~~ 195 (427)
++.+|+..+.++. +.+.+.+-.++.+ ....+|||||+.|+.|.+. +...+.....+....+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 1334554444442 4444444444432 4567899999999999774 2221111112222222333333
Q ss_pred HHHHHhhCCCCCeEeccCCCCceEeCCCC----CeeEeecCCcccC
Q 042519 196 GLEYLHDKANPPVIYRDLKSSNILLDCEF----NAKLSDFGLAKLG 237 (427)
Q Consensus 196 ~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkl~DFG~a~~~ 237 (427)
+...| ++|+|+||.||+++.+| .++++|||++...
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 34577 99999999999999888 9999999998754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.8e-12 Score=111.77 Aligned_cols=136 Identities=13% Similarity=0.072 Sum_probs=97.8
Q ss_pred cceeccCCceEEEEEEECC------CCcEEEEEEeccCCC----------------------cchHHH----HHHHHHHh
Q 042519 88 ECLIGEGGFGRVYKGKLEK------TAQVVAVKQLDRNGL----------------------QGNKEF----IVEVLMLS 135 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~ 135 (427)
...||.|--+.||.|...+ .+..+|||+.+.+.. .....+ .+|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998654 357899999742110 001122 36899998
Q ss_pred hcCC--CCeeeEEEEEEcCCeeEEEEeecCCCChhh-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEec
Q 042519 136 LLHH--DNLVNLIGYCADGEQRLLVYEYMPLRSLED-HLLDIGPEQKPIDWFTRMKIALGAAKGLEYL-HDKANPPVIYR 211 (427)
Q Consensus 136 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~ 211 (427)
++.. -++.+++++ ...+|||||+.+..+.. .+.+ ..++..+...+..+++.+|..| |..+ |||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 8863 455666654 45689999997654422 2221 2344455667788999999999 8888 9999
Q ss_pred cCCCCceEeCCCCCeeEeecCCccc
Q 042519 212 DLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 212 Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
||++.|||++ ++.+.|+|||.+..
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCcee
Confidence 9999999996 46899999998875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.7e-13 Score=134.71 Aligned_cols=248 Identities=20% Similarity=0.197 Sum_probs=177.4
Q ss_pred hhCccccceeccCCceEEEEEEEC-CCCcEEEEEEeccCCCcchHHH--HHHHHHHhhcC-CCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE-KTAQVVAVKQLDRNGLQGNKEF--IVEVLMLSLLH-HDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 157 (427)
..+|.....||.|.|+.|+....+ .++..|++|...+.......++ ..|+-+...+. |.++++++..+...+..|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888899999999999998866 6788999998866544433332 34666666655 8889998888888888889
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC-CCeeEeecCCccc
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLAKL 236 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkl~DFG~a~~ 236 (427)
-.|||.++++...+. ....+++...+.+..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||+...
T Consensus 344 p~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred chhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999998876652 3345677788899999999999999999 9999999999999775 7788999999863
Q ss_pred CCCCCccceecccccccccc--CccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYC--APEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
.... .......-.+. +++......+..+.|++|||..+.+.++|..--.. .+.|..-.- +..
T Consensus 417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~~i~~---~~~ 480 (524)
T KOG0601|consen 417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSLTIRS---GDT 480 (524)
T ss_pred ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcc--------cccceeeec---ccc
Confidence 1111 11122222334 55555667788999999999999999998642111 111110000 000
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
+ ..+.. ...+..+...++..++..||.+.+...+....
T Consensus 481 p---------~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 P---------NLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred c---------CCCch-HHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0 11111 25667788889999999999998887776543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.7e-13 Score=141.61 Aligned_cols=250 Identities=20% Similarity=0.181 Sum_probs=173.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.+.+.+.+-+-+|.++.++.+.-..+|...++|......... .+....+-.++-.-.+|-++....-+......+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 355677778889999999999888888777777654322211 12222232333333456666655556667888999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
++|+.+++|...|+... ..+..-....+..+..+++|||... ++|+|++|.|+|...++..+++|||......
T Consensus 883 ~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999887643 3444444556667788999999998 9999999999999999999999998432110
Q ss_pred CC-----------------------------CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 042519 239 IG-----------------------------DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAI 289 (427)
Q Consensus 239 ~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~ 289 (427)
.. +.........||+.|.+||.+.+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0001122357999999999999999999999999999999999999999
Q ss_pred CCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 042519 290 DTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMS 353 (427)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ 353 (427)
+...+... +.+-.. ..+..+ .-+........+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~----------f~ni~~-~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQI----------FENILN-RDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhh----------hhcccc-CCCCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 87655421 111000 000000 12233445677888899999999998776
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.7e-11 Score=109.73 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=108.8
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCC--CeeeEEEEEEcCC---eeEEEEeec
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHD--NLVNLIGYCADGE---QRLLVYEYM 162 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~ 162 (427)
+.|+.|.++.||++...+ |..+++|....... .....+..|+.++..+.+. ++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998864 67899999765432 1345678899999999753 4577777776543 568999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA-------------------------------------- 204 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 204 (427)
+|.+|.+.+.. ..++......++.+++.+|.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888775421 34666677778888888888888531
Q ss_pred ---------------CCCeEeccCCCCceEeCC--CCCeeEeecCCccc
Q 042519 205 ---------------NPPVIYRDLKSSNILLDC--EFNAKLSDFGLAKL 236 (427)
Q Consensus 205 ---------------~~~ivH~Dlkp~NIll~~--~~~vkl~DFG~a~~ 236 (427)
...++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134899999999999998 66789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.6e-11 Score=102.23 Aligned_cols=131 Identities=24% Similarity=0.281 Sum_probs=98.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEe-ccCCCc-c------hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQL-DRNGLQ-G------NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~-~~~~~~-~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
..+++|+-+.+|.+.+. |..+++|.= .+.... . ...-.+|+.++.++.--.|..-+=+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 36889999999999775 444666653 222111 0 1223569999998876565555556667788899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
|++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99988888888542 2456777888899999999 99999999999997765 99999999975
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.5e-11 Score=99.52 Aligned_cols=143 Identities=22% Similarity=0.218 Sum_probs=104.8
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--------cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--------QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
...+|-+|+-+.|+++.+. |+.+.||.-..... -......+|+..|.++.--.|.--.=+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678999999999999987 77778886322111 1123346788998888755554444467777778899
Q ss_pred EeecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC---eeEeecCCc
Q 042519 159 YEYMPL-RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN---AKLSDFGLA 234 (427)
Q Consensus 159 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkl~DFG~a 234 (427)
|||++| .++.+++...... .........++..|-+.|.-||.++ |+|+||..+||+|..++. +.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999985 4888888764321 2222223678888999999999999 999999999999966553 589999998
Q ss_pred cc
Q 042519 235 KL 236 (427)
Q Consensus 235 ~~ 236 (427)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 75
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.6e-10 Score=111.90 Aligned_cols=218 Identities=17% Similarity=0.156 Sum_probs=153.3
Q ss_pred ceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEE----cCCeeEEEEeecCC-CChhhh
Q 042519 96 FGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA----DGEQRLLVYEYMPL-RSLEDH 170 (427)
Q Consensus 96 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~ 170 (427)
-.+.|++..+-+|..|++|+++............-+++++++.|.|||++.++|. .+..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4678999999999999999995444343334455678999999999999998876 45678999999985 577665
Q ss_pred hhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 171 LLDIG-----------PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 171 l~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
-.... ......++...|.++.|+..||.++|+.| +.-+-|.|.+||++.+..++|+..|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 44322 22345778999999999999999999999 88899999999999999999998888764322
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.. + |-+.. -.+-|.=.||.+++.|.||...-...... +.. .
T Consensus 446 d~---------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~--~~s---~--------------- 486 (655)
T KOG3741|consen 446 DP---------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST--QSS---H--------------- 486 (655)
T ss_pred CC---------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccch--HHH---H---------------
Confidence 11 0 11111 24568999999999999996521110000 000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
....-..+..++.+++.-.....+.+ -++.+++.++
T Consensus 487 ---~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 ---LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ---HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 00111233456667777777777776 6777777766
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.6e-10 Score=104.07 Aligned_cols=265 Identities=15% Similarity=0.150 Sum_probs=162.3
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEE------EE-cCCeeEEE
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGY------CA-DGEQRLLV 158 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~-~~~~~~lv 158 (427)
..+.||+|+-+.+|-.-.-. ..+.|++.........+. +..|... .||-+-.-+.| .- .+..+.+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 45679999999999654332 245677765543332222 2333333 35533321111 11 12236677
Q ss_pred EeecCCCChhhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 159 YEYMPLRSLEDHLLD---IGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
|..+.+..--..+.+ .+......+|...++.+..++.+.+-||..| .+-+|+.++|+|+.+++.|.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 777765422111111 1123344689999999999999999999999 9999999999999999999999877655
Q ss_pred cCCCCCccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhC-CCCCCCCCCcccc--hhh-hhhhh
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITG-RRAIDTTRPTYEQ--NLV-TWAQP 306 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g-~~p~~~~~~~~~~--~~~-~~~~~ 306 (427)
.. .........+|...|.+||.-. +-.-+...|.|.||+++++||.| ++||......... ... ..+..
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 43 3334455678999999999654 34456789999999999999986 9999643221110 000 11111
Q ss_pred hhcCCCC-CCcccccccCCCCCH-HHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHhhcCCC
Q 042519 307 FFKDPNR-YPQLADPLLQGEFPV-RGLNQAVAVSAMCVQE--ESSVRPLMSDVVSALSFLGSD 365 (427)
Q Consensus 307 ~~~~~~~-~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~--~P~~RPs~~evl~~L~~~~~~ 365 (427)
.|....+ -....- -....|- ..+..+..+...|... .+.-|||++-++..|..+...
T Consensus 243 ~f~ya~~~~~g~~p--~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 243 RFAYASDQRRGLKP--PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeeechhccCCCCC--CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 1111111 000000 0112222 2345666777777765 367899999999999877543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.5e-09 Score=99.23 Aligned_cols=141 Identities=17% Similarity=0.119 Sum_probs=98.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-----------chHHHHHHHHHHhhcCCCCe--eeEEEEEEc----
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-----------GNKEFIVEVLMLSLLHHDNL--VNLIGYCAD---- 151 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~---- 151 (427)
+++-......|+++... |+.|.||........ ....+.+|...+..|..-+| +.++.+++.
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34444444456676654 678999976432211 01136788888888754333 344555543
Q ss_pred -CCeeEEEEeecCCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-------
Q 042519 152 -GEQRLLVYEYMPLR-SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC------- 222 (427)
Q Consensus 152 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------- 222 (427)
....+||+|++++. +|.+++.... ....+......++.+++..+.-||..| |+|+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23578999999975 7988875432 234455667789999999999999999 999999999999975
Q ss_pred CCCeeEeecCCccc
Q 042519 223 EFNAKLSDFGLAKL 236 (427)
Q Consensus 223 ~~~vkl~DFG~a~~ 236 (427)
++.+.|+||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46799999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.7e-09 Score=93.42 Aligned_cols=124 Identities=23% Similarity=0.212 Sum_probs=78.9
Q ss_pred EEEEEEECCCCcEEEEEEeccCCC-------------c--------c-----hHHHHHHHHHHhhcCCC--CeeeEEEEE
Q 042519 98 RVYKGKLEKTAQVVAVKQLDRNGL-------------Q--------G-----NKEFIVEVLMLSLLHHD--NLVNLIGYC 149 (427)
Q Consensus 98 ~V~~~~~~~~~~~vavK~~~~~~~-------------~--------~-----~~~~~~E~~~l~~l~h~--niv~l~~~~ 149 (427)
.||.|...+ |..+|||+...... . . .....+|+..|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 489998854 78999998742110 0 0 02246799999999865 456666543
Q ss_pred EcCCeeEEEEeecC--CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeEeccCCCCceEeCCCCCe
Q 042519 150 ADGEQRLLVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY-LHDKANPPVIYRDLKSSNILLDCEFNA 226 (427)
Q Consensus 150 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlkp~NIll~~~~~v 226 (427)
..+|||||++ |..+.. |.... ++......++.+++..+.. +|..| |+|+||.+.|||++.+ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 3479999998 655544 33211 1122345667777775555 57888 9999999999999887 89
Q ss_pred eEeecCCccc
Q 042519 227 KLSDFGLAKL 236 (427)
Q Consensus 227 kl~DFG~a~~ 236 (427)
.|+|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999999875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.6e-10 Score=114.15 Aligned_cols=152 Identities=18% Similarity=0.244 Sum_probs=104.5
Q ss_pred HHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc-------ceeccccccccccCcccccc
Q 042519 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT-------HVSSRVMGTYGYCAPEYQRT 263 (427)
Q Consensus 191 ~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 263 (427)
.+++.||.|+|.... +||+.|.|++|.++.++.+||+.|+++......... .......-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999998764 999999999999999999999999987653321110 11111234567999999999
Q ss_pred CCCCccchHHHHHHHHHHHHhCCCC-CCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHcc
Q 042519 264 GQLTVKSDVYTFGVVLLELITGRRA-IDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCV 342 (427)
Q Consensus 264 ~~~~~~~DvwSlGvil~ell~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 342 (427)
...+.++|+||+||++|-+..|..+ +...... ..... ....+..-....+...+.++.+-+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~---------~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSF---------SRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhh---------hhcccccccccccccCcHHHHHHHHHHh
Confidence 8889999999999999999954443 3322111 00000 0111111111233556678889999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 042519 343 QEESSVRPLMSDVVSA 358 (427)
Q Consensus 343 ~~~P~~RPs~~evl~~ 358 (427)
..++..||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999987776554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-08 Score=91.53 Aligned_cols=134 Identities=20% Similarity=0.109 Sum_probs=96.3
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC----------------------cchHHHHHHHHHHhhcCCC--
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL----------------------QGNKEFIVEVLMLSLLHHD-- 140 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~-- 140 (427)
+.++..||-|.-+.||.|.... |..+|||.-+.... .......+|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 5667899999999999999874 88899997421100 0112356799999998744
Q ss_pred CeeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 141 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
.+.+.+++ +...+||||++|-.|...- ++....-.++..|+.-+.-+-..| |||+|+.+-|||+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 56666553 5668999999976664421 122233345555666666666778 9999999999999
Q ss_pred CCCCCeeEeecCCcc
Q 042519 221 DCEFNAKLSDFGLAK 235 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~ 235 (427)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999996654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.2e-08 Score=88.68 Aligned_cols=105 Identities=24% Similarity=0.232 Sum_probs=81.2
Q ss_pred HHHHHHHHHHhhcCCCC--eeeEEEEEEcC----CeeEEEEeecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 042519 125 KEFIVEVLMLSLLHHDN--LVNLIGYCADG----EQRLLVYEYMPL-RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197 (427)
Q Consensus 125 ~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l 197 (427)
....+|...+..|..-+ ..+.+++.... ...+||+|++++ .+|.+++..... .+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence 45677888777775333 34555655542 245899999987 478888865221 55566778999999999
Q ss_pred HHHhhCCCCCeEeccCCCCceEeCCCC---CeeEeecCCccc
Q 042519 198 EYLHDKANPPVIYRDLKSSNILLDCEF---NAKLSDFGLAKL 236 (427)
Q Consensus 198 ~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkl~DFG~a~~ 236 (427)
.-||..| |+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999998887 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.9e-08 Score=85.18 Aligned_cols=145 Identities=17% Similarity=0.136 Sum_probs=105.0
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccC---C---CcchHHHHHHHHHHhhcCCCC--eeeEEEEEE-c---
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN---G---LQGNKEFIVEVLMLSLLHHDN--LVNLIGYCA-D--- 151 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~--- 151 (427)
++...---|+||-+.|+..... |..+-+|.-..- . ......|.+|+..|..|..-+ +.++. ++. .
T Consensus 19 ~wve~pN~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~ 95 (216)
T PRK09902 19 DWVEEPNYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIE 95 (216)
T ss_pred ceecCCCcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccC
Confidence 3333334577999999998776 446888875311 0 235678999999999886333 44444 332 1
Q ss_pred -CCeeEEEEeecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC--ee
Q 042519 152 -GEQRLLVYEYMPL-RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN--AK 227 (427)
Q Consensus 152 -~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--vk 227 (427)
....+||+|-+++ .+|.+++.+. ...+.+......++.+|+..|.-||+.| +.|+|+-+.|||++.++. ++
T Consensus 96 ~~~rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 96 GEWRALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred CceEEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEE
Confidence 2346899997753 5888887542 2235566777889999999999999999 999999999999987777 99
Q ss_pred EeecCCccc
Q 042519 228 LSDFGLAKL 236 (427)
Q Consensus 228 l~DFG~a~~ 236 (427)
++||--++.
T Consensus 171 lIDlEk~r~ 179 (216)
T PRK09902 171 FLDLEKSRR 179 (216)
T ss_pred EEEhhccch
Confidence 999987664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.1e-07 Score=82.61 Aligned_cols=139 Identities=14% Similarity=0.146 Sum_probs=86.0
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--eeeEEEEEEcCCeeEEEEeecCCCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN--LVNLIGYCADGEQRLLVYEYMPLRS 166 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 166 (427)
..||+|..+.||+.. |..+++|...... ......+|..+++.+..-+ +.+.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 478999999999832 4457889875432 3455788999998887433 4677888888888899999999863
Q ss_pred -hhhh---------------------hhhcCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhhC-CCCCeEec
Q 042519 167 -LEDH---------------------LLDIGPEQKPIDWFTRMK-IAL----------GAAK-GLEYLHDK-ANPPVIYR 211 (427)
Q Consensus 167 -L~~~---------------------l~~~~~~~~~l~~~~~~~-i~~----------~i~~-~l~~LH~~-~~~~ivH~ 211 (427)
+... |+........+. .... +.. .+.. ...+|... ....++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~--~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQ--SYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHH--HHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 2111 111100111111 0000 000 0011 12222211 12347899
Q ss_pred cCCCCceEeCCCCCeeEeecCCccc
Q 042519 212 DLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 212 Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
|+.|.||+++.++ +.|+||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.3e-07 Score=79.05 Aligned_cols=139 Identities=12% Similarity=0.087 Sum_probs=92.6
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHH---------HHHHHHHHhhcC---CCCeeeEEE
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---------FIVEVLMLSLLH---HDNLVNLIG 147 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~ 147 (427)
....+|.+.+++-......|.+.... |..+++|..........+. ..+.+..+..+. --.+..++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 34678888899988888888877665 6889999876543222222 223333333332 222223222
Q ss_pred EE-----EcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC
Q 042519 148 YC-----ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC 222 (427)
Q Consensus 148 ~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 222 (427)
+. .-....+++|||++|..|.+... ++. .++..+++++.-||..| ++|+|+.|.|++++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence 22 22245578999999988876531 222 24456778899999999 999999999999986
Q ss_pred CCCeeEeecCCccc
Q 042519 223 EFNAKLSDFGLAKL 236 (427)
Q Consensus 223 ~~~vkl~DFG~a~~ 236 (427)
++ ++++||+..+.
T Consensus 171 ~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 171 NG-IRIIDTQGKRM 183 (229)
T ss_pred Cc-EEEEECccccc
Confidence 55 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.1e-07 Score=93.60 Aligned_cols=139 Identities=18% Similarity=0.137 Sum_probs=89.9
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch------------------------------H----------HHH
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN------------------------------K----------EFI 128 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~ 128 (427)
+-|+.++-|.||+|+.+. |+.||||+.+.+-.... + ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999987 99999999854311100 0 134
Q ss_pred HHHHHHhhcC-----CCCeeeEEEEE-EcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 042519 129 VEVLMLSLLH-----HDNLVNLIGYC-ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202 (427)
Q Consensus 129 ~E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 202 (427)
+|..-+.+++ .+++ ++-.++ +-.....|+|||++|-.+.+...- ....++...+.....++ -+..+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~--f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRA--FLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHH--HHHHHHh
Confidence 4555554442 2332 333333 334567899999999888877322 11334433322222221 1223333
Q ss_pred CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 203 ~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
.| ++|.|..|.||+++.+|.+.+.|||+....
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 56 999999999999999999999999998653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=1e-06 Score=80.07 Aligned_cols=145 Identities=21% Similarity=0.253 Sum_probs=84.3
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCC--CeeeEEEEEEc---CCeeEEEEeec
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHD--NLVNLIGYCAD---GEQRLLVYEYM 162 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~ 162 (427)
.+.|+.|..+.||++...+ ..+++|..... .....+..|+.+++.|... .+.+++.+... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3579999999999999875 47999997544 4456777888888888633 35566664432 33568999999
Q ss_pred CCCChhh----------------hh---hhcCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHh
Q 042519 163 PLRSLED----------------HL---LDIGPEQKPIDWFTR---------MKI------------ALGAAK-GLEYLH 201 (427)
Q Consensus 163 ~~gsL~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~~i~~-~l~~LH 201 (427)
+|..+.. .+ +.............. ... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9887766 11 111111111111100 000 011122 233333
Q ss_pred h----CCCCCeEeccCCCCceEeC-CCCCeeEeecCCccc
Q 042519 202 D----KANPPVIYRDLKSSNILLD-CEFNAKLSDFGLAKL 236 (427)
Q Consensus 202 ~----~~~~~ivH~Dlkp~NIll~-~~~~vkl~DFG~a~~ 236 (427)
. .....++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 1233499999999999999 666678999988764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.2e-06 Score=78.90 Aligned_cols=141 Identities=19% Similarity=0.130 Sum_probs=85.0
Q ss_pred eccCCc-eEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEeecCCCChh
Q 042519 91 IGEGGF-GRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYEYMPLRSLE 168 (427)
Q Consensus 91 Lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 168 (427)
|..|.. ..||+.... +..+.||+..... ...+.+|+.++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 445555 789998764 3578888875432 345677888888875 444667788777766789999999987775
Q ss_pred hhh-------------------hhcCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHhh----C
Q 042519 169 DHL-------------------LDIGPEQKPIDW--FTRMKIAL--------------------GAAKGLEYLHD----K 203 (427)
Q Consensus 169 ~~l-------------------~~~~~~~~~l~~--~~~~~i~~--------------------~i~~~l~~LH~----~ 203 (427)
... +.......++.. ...+.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 111100111110 00000000 01111122211 1
Q ss_pred CCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 204 ~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
..+.++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999987788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.6e-06 Score=77.74 Aligned_cols=151 Identities=18% Similarity=0.116 Sum_probs=98.2
Q ss_pred ccCHHHHHHHhhCccccce---eccCCceEEEEEEECCCCcEEEEEEeccCCCcc-------------------hHH---
Q 042519 72 TFTFRELATATKNFRQECL---IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG-------------------NKE--- 126 (427)
Q Consensus 72 ~~~~~~~~~~~~~y~~~~~---Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------~~~--- 126 (427)
..+...+....++..+..+ |+.|.-+.||+|... ++..+|+|++....... .+.
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 3445556666666666655 456667789998874 47899999985432111 111
Q ss_pred --HHHHHHHHhhcC--CCCeeeEEEEEEcCCeeEEEEeecCCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 042519 127 --FIVEVLMLSLLH--HDNLVNLIGYCADGEQRLLVYEYMPLR-SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201 (427)
Q Consensus 127 --~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 201 (427)
...|+.-|.++. +-.+.+-+.+. .-.|||||+... .-.-.|. ..++...+...+..++++.+.-|-
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHH
Confidence 245777777664 33344444443 247999998643 1111121 122233356677788888888888
Q ss_pred h-CCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 202 D-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 202 ~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
. .+ +||+||+.-|||+. ++.+.|+|||-|..
T Consensus 184 ~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 184 KEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HhcC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 7 55 99999999999999 88999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-08 Score=99.92 Aligned_cols=187 Identities=14% Similarity=0.068 Sum_probs=133.9
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC-eeeEEEEEEcCCeeEEEEeec
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN-LVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~ 162 (427)
-+....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..++...++++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 3444556899999999998876544433 6655332 45667899999999999 677777777778889999999
Q ss_pred CCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 163 PLR-SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 163 ~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
.++ +-..... .....+...+...+...-.+++++||+.- =+|+| ||+..+ +..+..||+.........
T Consensus 317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 866 2211111 11122333344445555678899999885 58998 777655 679999999986533222
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAID 290 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~ 290 (427)
......+|+.++|||+...+.+....|+|++|+-..+|--|-.|-.
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3456789999999999999999999999999987777777766653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.6e-06 Score=73.56 Aligned_cols=130 Identities=21% Similarity=0.223 Sum_probs=91.8
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCe-eeEEEEEEcCCeeEEEEeecC
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL-VNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 163 (427)
.+..+.|++|++|.||+|.+. |..+|+|+-..+ .....+..|+++|..+.--++ .+++.|.. .++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence 345678999999999999998 568999986544 345678889999999886555 34554443 345699999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC-CCceEeCCCCCeeEeecCCccc
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLK-SSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk-p~NIll~~~~~vkl~DFG~a~~ 236 (427)
|-.|.+.-.. .+. +-+..+++.---|-..| |-|+.|. |..++|..++.+.|+||..|+.
T Consensus 96 G~~L~~~~~~-------~~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIG-------GDR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhc-------ccH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8888775421 011 23345556655566667 9999997 5555555555999999999874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.36 E-value=8.1e-06 Score=88.22 Aligned_cols=80 Identities=16% Similarity=0.258 Sum_probs=58.2
Q ss_pred cceeccCCceEEEEEEECCCC--cEEEEEEeccCC-CcchHHHHHHHHHHhhcC-CCCe--eeEEEEEEcC---CeeEEE
Q 042519 88 ECLIGEGGFGRVYKGKLEKTA--QVVAVKQLDRNG-LQGNKEFIVEVLMLSLLH-HDNL--VNLIGYCADG---EQRLLV 158 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 158 (427)
.+.|+.|.++.+|+......+ ..+++|+..... ......+.+|+.+++.|. |.++ .+++.+|.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 467899999999998776432 467788764432 223456889999999996 6665 7788888764 457899
Q ss_pred EeecCCCCh
Q 042519 159 YEYMPLRSL 167 (427)
Q Consensus 159 ~e~~~~gsL 167 (427)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999997643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.6e-06 Score=74.91 Aligned_cols=104 Identities=27% Similarity=0.258 Sum_probs=82.5
Q ss_pred HHHHHHHhhcCC-CCeeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 042519 128 IVEVLMLSLLHH-DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206 (427)
Q Consensus 128 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 206 (427)
..|..+++.+++ +++.+++|+|- .++|.||...+++...-.. ...-...+|..+.+|+.++++.+.+|+..-..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358889999986 69999999994 3778999987766432000 01223468999999999999999999986544
Q ss_pred CeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 207 ~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
.+.-.|++++|+-++++|++|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 589999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.6e-05 Score=70.20 Aligned_cols=129 Identities=20% Similarity=0.231 Sum_probs=91.2
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEEEEeccCC----------------CcchHHHHHHHHHHhhcC------CCCeee
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG----------------LQGNKEFIVEVLMLSLLH------HDNLVN 144 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~ 144 (427)
-...||+|+.-.||.--. .....||+..... .....+..+|+.....+. +.+|.+
T Consensus 5 ~~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 346799999999997433 4458899987654 122355666766655555 788999
Q ss_pred EEEEEEcCCeeEEEEeecC------CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCce
Q 042519 145 LIGYCADGEQRLLVYEYMP------LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNI 218 (427)
Q Consensus 145 l~~~~~~~~~~~lv~e~~~------~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 218 (427)
++|+.+......+|+|.+. ..+|.+++.. ..++. . +...+-+-..||-..+ |+.+||+|.||
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NI 149 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNI 149 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccE
Confidence 9999999999999999863 2367777733 33444 3 3333445567888888 99999999999
Q ss_pred EeCCC--C--CeeEee
Q 042519 219 LLDCE--F--NAKLSD 230 (427)
Q Consensus 219 ll~~~--~--~vkl~D 230 (427)
++... + .+.|+|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 99433 2 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.1e-05 Score=69.02 Aligned_cols=125 Identities=23% Similarity=0.373 Sum_probs=88.0
Q ss_pred hCccccceeccCCc-eEEEEEEECCCCcEEEEEEecc---CCC------------------cchHHHHHHHHHHhhcC--
Q 042519 83 KNFRQECLIGEGGF-GRVYKGKLEKTAQVVAVKQLDR---NGL------------------QGNKEFIVEVLMLSLLH-- 138 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~-g~V~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~-- 138 (427)
.+++..+.||.|.- |.||+++.. |..||+|.+.. ... .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 56888999999999 999999987 67999999421 100 01124677877776665
Q ss_pred -CCCe--eeEEEEEEcC------------------CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 042519 139 -HDNL--VNLIGYCADG------------------EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197 (427)
Q Consensus 139 -h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l 197 (427)
+.++ |+.+||..-. ....||.||++... .+. ..-+.++.+-|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHH
Confidence 5566 8999987422 12356777765322 112 22345677888
Q ss_pred HHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 198 ~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
..+|..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999999 999999999975 2489999865
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.2e-05 Score=73.61 Aligned_cols=73 Identities=14% Similarity=0.121 Sum_probs=45.8
Q ss_pred ceeccCCce-EEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCC---CeeeEEEEEEcC---CeeEEEEee
Q 042519 89 CLIGEGGFG-RVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHD---NLVNLIGYCADG---EQRLLVYEY 161 (427)
Q Consensus 89 ~~Lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~ 161 (427)
+.|+.||.. .||+. +..+++|..... .....+.+|+.++..|... -+.++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 467877776 48975 234778875432 2345788899998887632 234444443332 234889999
Q ss_pred cCCCChh
Q 042519 162 MPLRSLE 168 (427)
Q Consensus 162 ~~~gsL~ 168 (427)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.4e-05 Score=80.40 Aligned_cols=139 Identities=19% Similarity=0.135 Sum_probs=85.5
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch---------------------------H----------HHHHHH
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---------------------------K----------EFIVEV 131 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------------------------~----------~~~~E~ 131 (427)
+.||.-+.|.||+|+.++ |+.||||+-+..-.... + +|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999998 99999998643211110 0 123333
Q ss_pred HH----HhhcCCCC---eeeEEEEE-EcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 042519 132 LM----LSLLHHDN---LVNLIGYC-ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203 (427)
Q Consensus 132 ~~----l~~l~h~n---iv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 203 (427)
.- ...+.|-+ -|.+-.++ .-.....|+||||+|..+.+.-.- ....++...+..-+.++.. .-|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHH--HHHHhc
Confidence 22 22334555 12222222 223567899999999877654221 2233444443333333221 122234
Q ss_pred CCCCeEeccCCCCceEeCC----CCCeeEeecCCccc
Q 042519 204 ANPPVIYRDLKSSNILLDC----EFNAKLSDFGLAKL 236 (427)
Q Consensus 204 ~~~~ivH~Dlkp~NIll~~----~~~vkl~DFG~a~~ 236 (427)
| ++|+|-.|.||+++. ++.+.+-|||+...
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 5 999999999999984 66799999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.3e-05 Score=83.60 Aligned_cols=196 Identities=22% Similarity=0.196 Sum_probs=135.6
Q ss_pred HHHHHHHhhcCCCCeeeEEEEEEcCCeeE----EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 042519 128 IVEVLMLSLLHHDNLVNLIGYCADGEQRL----LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203 (427)
Q Consensus 128 ~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 203 (427)
..|+..+.++.|+|++.++.|........ +..+++...++...+.. -..++..+.+.+..++.+||.|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 44777888899999999999887654333 33567777777777743 34577888888999999999999998
Q ss_pred CCCCeEeccCCCC---ceEeCCCCCeeEe--ecCCcccCCCCCccceeccccccccccCccccccCCCCc--cchHHHHH
Q 042519 204 ANPPVIYRDLKSS---NILLDCEFNAKLS--DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTV--KSDVYTFG 276 (427)
Q Consensus 204 ~~~~ivH~Dlkp~---NIll~~~~~vkl~--DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwSlG 276 (427)
. ..|.-|... +...+.++.+.++ ||+.++........ ....-+..+.++|......+.. ..|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 7 666666555 5555677777777 99988764332222 1222344578888777655544 47999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 042519 277 VVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVV 356 (427)
Q Consensus 277 vil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 356 (427)
..+..+..|..+-... ......+..... ..+.+....|+..++++|++..+++
T Consensus 380 ll~~~~~~~~~i~~~~-----------------------~~~~~~l~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKS-----------------------AVPVSLLDVLST----SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHhhhhhcCcccccc-----------------------cchhhhhccccc----hhhhhhhhhhcchhhhhccchhhhh
Confidence 9999999886432211 111111111111 1566788899999999999999999
Q ss_pred HHHh
Q 042519 357 SALS 360 (427)
Q Consensus 357 ~~L~ 360 (427)
.+.-
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 9763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.8e-05 Score=69.49 Aligned_cols=74 Identities=19% Similarity=0.181 Sum_probs=48.3
Q ss_pred ceeccCCceEEEEEEECC-CCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC-eeeEEEEEEcCCeeEEEEeecCCCC
Q 042519 89 CLIGEGGFGRVYKGKLEK-TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN-LVNLIGYCADGEQRLLVYEYMPLRS 166 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~gs 166 (427)
+.|..|-...+|++.... .+..|++|+..... .......+|+.++..+...+ ..++++.+. -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567888889999987653 35678899765432 22223457888888886333 344544432 247999999876
Q ss_pred h
Q 042519 167 L 167 (427)
Q Consensus 167 L 167 (427)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.08 E-value=6.4e-05 Score=73.58 Aligned_cols=76 Identities=21% Similarity=0.158 Sum_probs=52.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccC-------CCcchHHHHHHHHHHhhcC---CCCeeeEEEEEEcCCeeEEE
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN-------GLQGNKEFIVEVLMLSLLH---HDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 158 (427)
+.||.|.+..||++...+.++.|+||.-... .....+....|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998754468999984311 1123345667888877764 2456777666 44667899
Q ss_pred EeecCCCC
Q 042519 159 YEYMPLRS 166 (427)
Q Consensus 159 ~e~~~~gs 166 (427)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.3e-05 Score=69.36 Aligned_cols=140 Identities=14% Similarity=0.030 Sum_probs=79.4
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCe-eeEEEEEEcCCeeEEEEeecCCCChh
Q 042519 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL-VNLIGYCADGEQRLLVYEYMPLRSLE 168 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~ 168 (427)
.+..|-.+.+|+... ++..+++|........-.-...+|..+++.+...++ .+++..+. .++||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 356677889998873 366788997644322211235678888888864333 34444332 36899999976653
Q ss_pred hh-----------------hhhcCCCCCCCCHHHH-HHHHHHH---------HHHHHHHhhC-----CCCCeEeccCCCC
Q 042519 169 DH-----------------LLDIGPEQKPIDWFTR-MKIALGA---------AKGLEYLHDK-----ANPPVIYRDLKSS 216 (427)
Q Consensus 169 ~~-----------------l~~~~~~~~~l~~~~~-~~i~~~i---------~~~l~~LH~~-----~~~~ivH~Dlkp~ 216 (427)
.. |+.......+++.... ..+..++ ...+..+-.. ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 1221111122222211 1111111 1112222111 1224899999999
Q ss_pred ceEeCCCCCeeEeecCCccc
Q 042519 217 NILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 217 NIll~~~~~vkl~DFG~a~~ 236 (427)
||+++.++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00011 Score=69.62 Aligned_cols=78 Identities=13% Similarity=0.048 Sum_probs=56.2
Q ss_pred cccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCC---CCeeeEEEEEEcC---CeeEEEE
Q 042519 86 RQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH---DNLVNLIGYCADG---EQRLLVY 159 (427)
Q Consensus 86 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~ 159 (427)
...+.||.|..+.||.....+ + .+.+|..+ . ......+..|...|+.|.- -.+.++++++..+ +..+|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMAR-S-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEec-c-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 334579999999999986543 3 46777743 2 1133578889999988863 3578888887643 5689999
Q ss_pred eecCCCCh
Q 042519 160 EYMPLRSL 167 (427)
Q Consensus 160 e~~~~gsL 167 (427)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.93 E-value=8.3e-05 Score=70.52 Aligned_cols=144 Identities=16% Similarity=0.105 Sum_probs=84.1
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--eeeEEEE------EEcCCeeEEEE
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN--LVNLIGY------CADGEQRLLVY 159 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~ 159 (427)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..|.+.+ +.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 456777888899998764 34688998754 23345667888777775332 3444331 12344568999
Q ss_pred eecCCCChhh--------------hhhhcCCC-------CCCCCHHHHH----------HHHHHHHHHHHHHhhC----C
Q 042519 160 EYMPLRSLED--------------HLLDIGPE-------QKPIDWFTRM----------KIALGAAKGLEYLHDK----A 204 (427)
Q Consensus 160 e~~~~gsL~~--------------~l~~~~~~-------~~~l~~~~~~----------~i~~~i~~~l~~LH~~----~ 204 (427)
+|++|..+.. .++..... .....|.... .....+...+.++... -
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999766532 01111000 0111111110 0111123344454431 1
Q ss_pred CCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 205 ~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 23499999999999999887778999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0011 Score=63.35 Aligned_cols=157 Identities=16% Similarity=0.154 Sum_probs=87.1
Q ss_pred HHHHHHhhCccc-----cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--eeeEEEE
Q 042519 76 RELATATKNFRQ-----ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN--LVNLIGY 148 (427)
Q Consensus 76 ~~~~~~~~~y~~-----~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~ 148 (427)
..+......|.+ .+.++.|....+|++... +| .+++|+.... .....+..|+.++..|...+ +.+++..
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEeC-CC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 444444445544 345777777899998754 23 5888986542 12345556777777764222 3343331
Q ss_pred ------EEcCCeeEEEEeecCCCChhh-----------h---hhhcCCC---C--C--C-CCHHHHH------------H
Q 042519 149 ------CADGEQRLLVYEYMPLRSLED-----------H---LLDIGPE---Q--K--P-IDWFTRM------------K 188 (427)
Q Consensus 149 ------~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~~~---~--~--~-l~~~~~~------------~ 188 (427)
....+..+++++|++|..+.. . ++..... . . . -.|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 122456789999998754321 1 1111100 0 0 0 0111100 0
Q ss_pred HHHHHHHHHHHHhh----CCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 189 IALGAAKGLEYLHD----KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 189 i~~~i~~~l~~LH~----~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
....+...++++.. .....++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 01123344555543 1123499999999999999888778999998864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00042 Score=65.88 Aligned_cols=143 Identities=24% Similarity=0.237 Sum_probs=83.4
Q ss_pred ceeccCCceEEEEEEECC------CCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCe-eeEEEEEEcCCeeEEEEee
Q 042519 89 CLIGEGGFGRVYKGKLEK------TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL-VNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 161 (427)
+.|..|-...||++.... .++.|++|+..... .......+|+.++..+...++ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456677777899987653 25789999975542 233456778888888763333 345555532 358999
Q ss_pred cCCCChhhh-----------------hhhcCCCC--C---CCC--HHHHHH--------------------------HHH
Q 042519 162 MPLRSLEDH-----------------LLDIGPEQ--K---PID--WFTRMK--------------------------IAL 191 (427)
Q Consensus 162 ~~~gsL~~~-----------------l~~~~~~~--~---~l~--~~~~~~--------------------------i~~ 191 (427)
++|.++... ++...... . ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 987766431 11111110 0 110 101000 111
Q ss_pred HHHHHHHHHhh------CCCCCeEeccCCCCceEeCCC----CCeeEeecCCccc
Q 042519 192 GAAKGLEYLHD------KANPPVIYRDLKSSNILLDCE----FNAKLSDFGLAKL 236 (427)
Q Consensus 192 ~i~~~l~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~vkl~DFG~a~~ 236 (427)
.+...+.+|-. .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 123458999999999999885 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.65 E-value=8.5e-06 Score=88.67 Aligned_cols=158 Identities=14% Similarity=0.016 Sum_probs=118.1
Q ss_pred HHHHHhhcCCCCeeeEEEEEEc--CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC--
Q 042519 130 EVLMLSLLHHDNLVNLIGYCAD--GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN-- 205 (427)
Q Consensus 130 E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-- 205 (427)
|...++...|+++...+.-... ....+.+++|+.+|.+.+.|.+...+...++..-+...-.+.+.+..-+|+..+
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 4445556689988877665543 345578899999999999998766566666655554444444566666666542
Q ss_pred CCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhC
Q 042519 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITG 285 (427)
Q Consensus 206 ~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g 285 (427)
...+|++||+-|.+|..+..+|++++|+.++. ...........+++.|++|++.+.-.++.++|+|..|+.+|++.-|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 34799999999999999999999999999841 1122234456688899999999988899999999999999999888
Q ss_pred CCCC
Q 042519 286 RRAI 289 (427)
Q Consensus 286 ~~p~ 289 (427)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 7655
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0014 Score=62.90 Aligned_cols=157 Identities=14% Similarity=0.104 Sum_probs=81.8
Q ss_pred HHHHHHHhhCccc-----cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--eeeEEE
Q 042519 75 FRELATATKNFRQ-----ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN--LVNLIG 147 (427)
Q Consensus 75 ~~~~~~~~~~y~~-----~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 147 (427)
..++......|.+ .+.|+.|....+|+....+ | .+++|++.. .....+..|+.++..|...+ +.+.+.
T Consensus 9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQ-G-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred HHHHHHHHHhcCCchhhccchhccccccceEEEEeCC-C-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 3444444455644 2456677778999987653 3 688998752 12233444555555553211 223332
Q ss_pred ------EEEcCCeeEEEEeecCCCChh-----------hh---hhhcCCC-------CCCCCH-HHHHH-----------
Q 042519 148 ------YCADGEQRLLVYEYMPLRSLE-----------DH---LLDIGPE-------QKPIDW-FTRMK----------- 188 (427)
Q Consensus 148 ------~~~~~~~~~lv~e~~~~gsL~-----------~~---l~~~~~~-------~~~l~~-~~~~~----------- 188 (427)
+....+..+++++|++|..+. +. ++..... ...+.+ .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 122345678999999976442 11 1111100 011111 11111
Q ss_pred -HHHH-HHHHHHHHhhC----CCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 189 -IALG-AAKGLEYLHDK----ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 189 -i~~~-i~~~l~~LH~~----~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
.+.+ +...++.+... -..++||+|+.|.|||++.+...-|+||+.+..
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11122333211 123499999999999998665568999998864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00092 Score=63.32 Aligned_cols=139 Identities=18% Similarity=0.204 Sum_probs=83.1
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEEEEecc--CCCcchHHHHHHHHHHhhcCC--CCeeeEEEEEEcCC--eeEEEEe
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHH--DNLVNLIGYCADGE--QRLLVYE 160 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e 160 (427)
+.+.+..|..-.+|..... ++.+++. ... ..........+|+.++..+.- --+...+++|.++. ..|.||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3344434433445555443 6778888 321 122333455678888887753 23445667777766 6799999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHH-HHHHHHHHHHhh-------------------------------------
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIA-LGAAKGLEYLHD------------------------------------- 202 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~-~~i~~~l~~LH~------------------------------------- 202 (427)
|+.|..+.+.+... ... .+++ ..++..|.-||+
T Consensus 106 ~veGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 106 WVEGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EecceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 99975443332110 000 0111 234444444443
Q ss_pred -------------CC-----CCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 203 -------------KA-----NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 203 -------------~~-----~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
+. ...++|+|+.+.||+++.++-+=|.||+++...
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 22 235999999999999999988999999999863
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0012 Score=63.54 Aligned_cols=73 Identities=16% Similarity=0.082 Sum_probs=46.9
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEecc-------CCCcchHHHHHHHHHHhhcC--CCC-eeeEEEEEEcCCeeEEEE
Q 042519 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDR-------NGLQGNKEFIVEVLMLSLLH--HDN-LVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~ 159 (427)
.||.|....||++.....++.|+||.-.. +..-.......|...|+... -|. +.+++ +.+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 57999999999999865446899997421 11222344456777776654 343 44443 34456667999
Q ss_pred eecCC
Q 042519 160 EYMPL 164 (427)
Q Consensus 160 e~~~~ 164 (427)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0014 Score=63.54 Aligned_cols=143 Identities=15% Similarity=0.147 Sum_probs=81.7
Q ss_pred ceeccCCceEEEEEEECC----CCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCe-eeEEEEEEcCCeeEEEEeecC
Q 042519 89 CLIGEGGFGRVYKGKLEK----TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL-VNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 163 (427)
..|..|-...+|++.... .++.|++|+..... ...-....|..++..+..-++ .++++.+..+ .|++|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 356568888999987543 24679999876543 222234678888888864444 3556665432 5799998
Q ss_pred CCChhhh-----------------hhhcCCCC-C-CCCHHHHHHHHHH-----------------HHHHHHHH----hh-
Q 042519 164 LRSLEDH-----------------LLDIGPEQ-K-PIDWFTRMKIALG-----------------AAKGLEYL----HD- 202 (427)
Q Consensus 164 ~gsL~~~-----------------l~~~~~~~-~-~l~~~~~~~i~~~-----------------i~~~l~~L----H~- 202 (427)
+.+|... ++...... . ...+.....+..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666421 11111011 1 1112222222211 11111122 21
Q ss_pred CCCCCeEeccCCCCceEeCC-CCCeeEeecCCccc
Q 042519 203 KANPPVIYRDLKSSNILLDC-EFNAKLSDFGLAKL 236 (427)
Q Consensus 203 ~~~~~ivH~Dlkp~NIll~~-~~~vkl~DFG~a~~ 236 (427)
.....++|+|+++.|||++. ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11234899999999999976 46899999988864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0013 Score=61.81 Aligned_cols=74 Identities=16% Similarity=0.185 Sum_probs=48.6
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC---CCCeeeEEEEEEcCCeeEEEEeecC
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH---HDNLVNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 163 (427)
..+.|+.|....+|+.. .+++.+.||+-. ......|..|+.-|+.|. --.+.+++++....+..+||+||++
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 34568999999999987 557889999865 233456788888888884 3457788888887777899999987
Q ss_pred CC
Q 042519 164 LR 165 (427)
Q Consensus 164 ~g 165 (427)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 65
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0014 Score=61.50 Aligned_cols=31 Identities=29% Similarity=0.410 Sum_probs=26.0
Q ss_pred CCeEeccCCCCceEeCCCCC-eeEeecCCccc
Q 042519 206 PPVIYRDLKSSNILLDCEFN-AKLSDFGLAKL 236 (427)
Q Consensus 206 ~~ivH~Dlkp~NIll~~~~~-vkl~DFG~a~~ 236 (427)
..++|+|++|.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999987555 45999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00018 Score=67.12 Aligned_cols=147 Identities=15% Similarity=0.058 Sum_probs=97.4
Q ss_pred ccccCHHHHHHHhh---CccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---------C--------cc-----h
Q 042519 70 AQTFTFRELATATK---NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---------L--------QG-----N 124 (427)
Q Consensus 70 ~~~~~~~~~~~~~~---~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~--------~~-----~ 124 (427)
..-+.|-.+++..+ -+.+++.||-|.-+.||.+.+.. |...++|.-.... . .. +
T Consensus 76 y~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR 154 (465)
T KOG2268|consen 76 YAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR 154 (465)
T ss_pred eccchHHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH
Confidence 33455555555443 35678899999999999998875 7888888642110 0 00 0
Q ss_pred HHHHHHHHHHhhcC-CCC-eeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 042519 125 KEFIVEVLMLSLLH-HDN-LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202 (427)
Q Consensus 125 ~~~~~E~~~l~~l~-h~n-iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 202 (427)
-...+|+..|+.|. |.. +.+.++ .+..++|||++.+-.|.+.-+ ..+.. .+...+..-+.-|-.
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~---~ly~~lm~~Iv~la~ 220 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPP---TLYDDLMGLIVRLAN 220 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee-------cCChH---HHHHHHHHHHHHHHH
Confidence 12356888888886 322 333443 356789999999877765321 11222 233344444556777
Q ss_pred CCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 203 ~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
+| +||+|..-=||++++++.++++||--.
T Consensus 221 ~G---lIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 221 HG---LIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred cC---ceecccchheeEEecCCCEEEeechHh
Confidence 88 999999999999999999999999644
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.003 Score=61.48 Aligned_cols=74 Identities=20% Similarity=0.140 Sum_probs=48.5
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEecc------CCCcchHHHHHHHHHHhhcC--CCC-eeeEEEEEEcCCeeEEE
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR------NGLQGNKEFIVEVLMLSLLH--HDN-LVNLIGYCADGEQRLLV 158 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv 158 (427)
.+.||.|.-.-||++.+...++.|+||.-.. +..-.......|.+.|+.+. .|. +.+++ +.+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence 3578999999999999854356799997421 11223345566777777664 443 44453 3445666788
Q ss_pred EeecC
Q 042519 159 YEYMP 163 (427)
Q Consensus 159 ~e~~~ 163 (427)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 99885
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0042 Score=59.22 Aligned_cols=140 Identities=16% Similarity=0.124 Sum_probs=89.7
Q ss_pred cccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--ch-------------------H-----HHHHHHHHHhhcCC
Q 042519 86 RQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GN-------------------K-----EFIVEVLMLSLLHH 139 (427)
Q Consensus 86 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~-------------------~-----~~~~E~~~l~~l~h 139 (427)
.+...|..|.-+.||.|...+ |..+|||+++-+-.. .+ + ....|+.-|.+|+.
T Consensus 147 ~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 344567888899999988765 888999997432110 00 0 12346666777653
Q ss_pred CCeeeEEEEEEcCCeeEEEEeecCCCCh-hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCce
Q 042519 140 DNLVNLIGYCADGEQRLLVYEYMPLRSL-EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNI 218 (427)
Q Consensus 140 ~niv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI 218 (427)
..|.----... ....|||+|+..... .-.| ....++...+..+-.+++.-+.-|-..+. +||.||.--|+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~ 296 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL 296 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence 33211000000 234789999863211 1112 23446666777778888888888877765 99999999999
Q ss_pred EeCCCCCeeEeecCCccc
Q 042519 219 LLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 219 ll~~~~~vkl~DFG~a~~ 236 (427)
|+ .+|.+.|+|-+-+..
T Consensus 297 Ly-hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LY-HDGKLYIIDVSQSVE 313 (520)
T ss_pred eE-ECCEEEEEEcccccc
Confidence 99 566899999987754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.012 Score=57.67 Aligned_cols=73 Identities=15% Similarity=0.093 Sum_probs=48.3
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCC-------cchHHHHHHHHHHhhcC---CCCeeeEEEEEEcCCeeEE
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-------QGNKEFIVEVLMLSLLH---HDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 157 (427)
.+.||.|....||+.... +..|+||.-..... .....-..|+..|+.+. ..++.+++.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 457899999999998874 45688998541110 12233344566665553 246788888776 44688
Q ss_pred EEeecCC
Q 042519 158 VYEYMPL 164 (427)
Q Consensus 158 v~e~~~~ 164 (427)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999975
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0064 Score=58.62 Aligned_cols=143 Identities=19% Similarity=0.194 Sum_probs=79.9
Q ss_pred ceeccCCceEEEEEEECCC---CcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCe-eeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL-VNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 164 (427)
+.|..|=...+|+....+. +..|++|+...... ..-...+|..+++.+..-++ .++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 3555577788998876532 33789998755422 22334678888888875444 4556555322 58899887
Q ss_pred CChhh-----------------hhhhcCCC-CC-CCCHHHHHHHHHHH----------------------HHHHHH----
Q 042519 165 RSLED-----------------HLLDIGPE-QK-PIDWFTRMKIALGA----------------------AKGLEY---- 199 (427)
Q Consensus 165 gsL~~-----------------~l~~~~~~-~~-~l~~~~~~~i~~~i----------------------~~~l~~---- 199 (427)
.+|.. .++..... .. .-.+..+..+..++ ..-+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65521 11111101 11 11122222222111 111111
Q ss_pred HhhCC-CCCeEeccCCCCceEeCC-CCCeeEeecCCccc
Q 042519 200 LHDKA-NPPVIYRDLKSSNILLDC-EFNAKLSDFGLAKL 236 (427)
Q Consensus 200 LH~~~-~~~ivH~Dlkp~NIll~~-~~~vkl~DFG~a~~ 236 (427)
+...+ ...++|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111 223799999999999974 57899999998864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.016 Score=55.21 Aligned_cols=29 Identities=24% Similarity=0.266 Sum_probs=25.4
Q ss_pred CeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 207 ~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
.++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 4999999999999987 6789999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.003 Score=56.62 Aligned_cols=30 Identities=33% Similarity=0.398 Sum_probs=21.4
Q ss_pred CeEeccCCCCceEe-CCCCCeeEeecCCccc
Q 042519 207 PVIYRDLKSSNILL-DCEFNAKLSDFGLAKL 236 (427)
Q Consensus 207 ~ivH~Dlkp~NIll-~~~~~vkl~DFG~a~~ 236 (427)
.++|+||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 38999999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.014 Score=55.68 Aligned_cols=30 Identities=20% Similarity=0.213 Sum_probs=27.7
Q ss_pred CeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 207 ~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
.++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.048 Score=52.25 Aligned_cols=141 Identities=20% Similarity=0.279 Sum_probs=81.2
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCe---ee---EEE----EEEcCCeeEEEEe
Q 042519 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL---VN---LIG----YCADGEQRLLVYE 160 (427)
Q Consensus 91 Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni---v~---l~~----~~~~~~~~~lv~e 160 (427)
|.+ .-..||+....+ |. +++|+.... ....++..|...+..|.-.+| +. +-| ........+-+++
T Consensus 34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 566789888765 44 489987655 455667777777777642221 11 111 1222236778899
Q ss_pred ecCCCChhh-h--------------hhhcC--------CCCCCCCHHH-------------HHHHHHHHHHHHHHHhhCC
Q 042519 161 YMPLRSLED-H--------------LLDIG--------PEQKPIDWFT-------------RMKIALGAAKGLEYLHDKA 204 (427)
Q Consensus 161 ~~~~gsL~~-~--------------l~~~~--------~~~~~l~~~~-------------~~~i~~~i~~~l~~LH~~~ 204 (427)
|++|..+.. . |+... .......|.. ......++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999877762 1 11100 0011122320 0112233444455544432
Q ss_pred ----C---CCeEeccCCCCceEeCCCCC-eeEeecCCccc
Q 042519 205 ----N---PPVIYRDLKSSNILLDCEFN-AKLSDFGLAKL 236 (427)
Q Consensus 205 ----~---~~ivH~Dlkp~NIll~~~~~-vkl~DFG~a~~ 236 (427)
. ..+||+|+.|.|||++.+.. +.++|||-+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1 12899999999999999885 88999998864
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.013 Score=52.11 Aligned_cols=153 Identities=16% Similarity=0.113 Sum_probs=91.9
Q ss_pred CCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCChhhhhh
Q 042519 94 GGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLL 172 (427)
Q Consensus 94 G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 172 (427)
|+-++...++.+- | ...+|++...... ...-|..+..++.++. .|+++..- +...+.++.|+|---..
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----- 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----
Confidence 3344444444332 3 3456666544444 4455677888888875 57777632 44556788898852111
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceecccccc
Q 042519 173 DIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT 252 (427)
Q Consensus 173 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt 252 (427)
.. ..++.-=+..|.-.|+.. ...+|+|..|+|||-|..|.+||.|=+..-. .+
T Consensus 142 --------~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~ 194 (308)
T PF07387_consen 142 --------NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQ 194 (308)
T ss_pred --------ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------he
Confidence 00 011111146678889543 2399999999999999999999999765431 01
Q ss_pred ccccCccccccCCCCccchHHHHHHHHHHHHhCCC
Q 042519 253 YGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRR 287 (427)
Q Consensus 253 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~ 287 (427)
..|.--| ....|.++.+=+|-.-+++++....
T Consensus 195 V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 195 VNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eeEEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 1122211 1345777888888777777776543
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.027 Score=53.77 Aligned_cols=106 Identities=20% Similarity=0.141 Sum_probs=68.3
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
...|++|++- |++|.- + ....+.+++.++.+.+..+.-+..+-. .-|||+.-.||||+ +|+|.|+||-
T Consensus 299 ~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf~--fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKKFP--FEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcCC--cccccccccceeee-cCceEEEEee
Confidence 3445666654 344432 2 234578888999998887777776643 89999999999999 9999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHH
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVV 278 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 278 (427)
+++.....+. .... ..--|-.+.| .-+..-|||-+--.
T Consensus 367 lsRl~~~q~~--isy~-----rldhp~lF~G-~dd~QFeIYrlMr~ 404 (488)
T COG5072 367 LSRLSYSQGI--ISYN-----RLDHPDLFNG-VDDYQFEIYRLMRR 404 (488)
T ss_pred eeecccCCce--eecc-----ccCchhhhcC-ccceeeeHHHHHHH
Confidence 9986322211 1111 1223334443 33667788875433
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.009 Score=59.32 Aligned_cols=48 Identities=29% Similarity=0.393 Sum_probs=37.3
Q ss_pred HHHHHHHHHHhhcCCCCeeeEEEEEEcC-CeeEEEEeecCCCChhhhhhh
Q 042519 125 KEFIVEVLMLSLLHHDNLVNLIGYCADG-EQRLLVYEYMPLRSLEDHLLD 173 (427)
Q Consensus 125 ~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~ 173 (427)
..+.-...+++.+.|+|+...+++-... ....+|+|++. .||++.+..
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHh
Confidence 4455667889999999999998876543 44678999986 799988754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.075 Score=52.20 Aligned_cols=75 Identities=17% Similarity=0.207 Sum_probs=45.7
Q ss_pred ceeccCCceEEEEEEECCCC-cE-----EEEEEeccCCCcchHHHHHHHHHHhhcCCCCe-eeEEEEEEcCCeeEEEEee
Q 042519 89 CLIGEGGFGRVYKGKLEKTA-QV-----VAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL-VNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~-~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 161 (427)
+.|..|-...+|++...... .. |.++... ......-+..+|+.++..|...++ .++++.+.. ++|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 45666888899999764321 22 4444321 111112234568899999875554 456666543 589999
Q ss_pred cCCCChh
Q 042519 162 MPLRSLE 168 (427)
Q Consensus 162 ~~~gsL~ 168 (427)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987664
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.19 Score=48.27 Aligned_cols=72 Identities=17% Similarity=0.117 Sum_probs=42.5
Q ss_pred cCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--eeeEE---E--EEEcCCeeEEEEeecCCC
Q 042519 93 EGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN--LVNLI---G--YCADGEQRLLVYEYMPLR 165 (427)
Q Consensus 93 ~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~---~--~~~~~~~~~lv~e~~~~g 165 (427)
.+.-..||+....+ |..+++|+.... ......+..|+..+..|.... ++... | +...++..+.++++++|.
T Consensus 35 ~s~eN~vy~v~~~~-~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 35 NSYENRVYQFGDED-GRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred ccccceEEEEecCC-CCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 34556799887653 667999987533 234456677777777664211 12211 1 122245677889998865
Q ss_pred C
Q 042519 166 S 166 (427)
Q Consensus 166 s 166 (427)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 4
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.15 Score=45.85 Aligned_cols=75 Identities=23% Similarity=0.268 Sum_probs=51.0
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC---CCCeeeEEEEEEcCCeeEEEEeecCCC
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH---HDNLVNLIGYCADGEQRLLVYEYMPLR 165 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 165 (427)
+.+..|.--..|...+- ...+.||+-.. .....|..|+.-|..|. --++.+++.+..+..+.|+|+||++-+
T Consensus 22 ~~v~gG~inea~~v~dg--~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 22 EEVSGGDINEAWRLRDG--TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred cccCCccccceeEeecC--CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34555555555655443 45688887432 33456778887776664 345778888888999999999999876
Q ss_pred Chh
Q 042519 166 SLE 168 (427)
Q Consensus 166 sL~ 168 (427)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.14 Score=56.90 Aligned_cols=30 Identities=40% Similarity=0.447 Sum_probs=25.8
Q ss_pred CeEeccCCCCceEeCCCC--Cee-EeecCCccc
Q 042519 207 PVIYRDLKSSNILLDCEF--NAK-LSDFGLAKL 236 (427)
Q Consensus 207 ~ivH~Dlkp~NIll~~~~--~vk-l~DFG~a~~ 236 (427)
.+||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 399999999999998875 565 999998864
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.19 Score=50.43 Aligned_cols=76 Identities=12% Similarity=0.064 Sum_probs=47.5
Q ss_pred ccceeccCCceEEEEEEECCC--------CcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCee-eEEEEEEcCCeeEE
Q 042519 87 QECLIGEGGFGRVYKGKLEKT--------AQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV-NLIGYCADGEQRLL 157 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~l 157 (427)
..+.|..|-.-.+|++..... ++.|.+++...... ..-....|..++..+..-+|- ++++.+. -+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te-~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD-ELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc-ceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence 345677787888999876522 46788998754322 222345677777777644443 4555553 245
Q ss_pred EEeecCCCCh
Q 042519 158 VYEYMPLRSL 167 (427)
Q Consensus 158 v~e~~~~gsL 167 (427)
|.+|++|.+|
T Consensus 184 I~efi~g~~l 193 (442)
T PTZ00296 184 IEEWLYGDPL 193 (442)
T ss_pred EEEeeCCccC
Confidence 7899987644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 427 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-60 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-59 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-45 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-44 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-43 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-42 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 523 bits (1350), Expect = 0.0
Identities = 112/304 (36%), Positives = 166/304 (54%), Gaps = 20/304 (6%)
Query: 71 QTFTFRELATATKNFRQEC------LIGEGGFGRVYKGKLEKTAQVVAVKQL----DRNG 120
+F+F EL T NF + +GEGGFG VYKG + VAVK+L D
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITT 70
Query: 121 LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP 180
+ ++F E+ +++ H+NLV L+G+ +DG+ LVY YMP SL D L + P
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPP 129
Query: 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240
+ W R KIA GAA G+ +LH+ I+RD+KS+NILLD F AK+SDFGLA+
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL 300
+T ++SR++GT Y APE G++T KSD+Y+FGVVLLE+ITG A+D R Q L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLL 243
Query: 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
+ + + D + + + +V++ C+ E+ + RP + V L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 361 FLGS 364
+ +
Sbjct: 303 EMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 510 bits (1316), Expect = 0.0
Identities = 116/307 (37%), Positives = 167/307 (54%), Gaps = 5/307 (1%)
Query: 55 ANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVK 114
+ N+ ++ + +L AT NF + LIG G FG+VYKG L VA+K
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALK 69
Query: 115 QLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDI 174
+ QG +EF E+ LS H +LV+LIG+C + + +L+Y+YM +L+ HL
Sbjct: 70 RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 175 GPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234
+ W R++I +GAA+GL YLH +I+RD+KS NILLD F K++DFG++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRP 294
K G D+TH+S+ V GT GY PEY G+LT KSDVY+FGVVL E++ R AI + P
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 295 TYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSD 354
NL WA + + Q+ DP L + L + + C+ S RP M D
Sbjct: 247 REMVNLAEWAVESHNN-GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 355 VVSALSF 361
V+ L +
Sbjct: 306 VLWKLEY 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 497 bits (1281), Expect = e-177
Identities = 129/293 (44%), Positives = 180/293 (61%), Gaps = 6/293 (2%)
Query: 70 AQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK-EFI 128
+ F+ REL A+ NF + ++G GGFG+VYKG+L +VAVK+L QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQ 75
Query: 129 VEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMK 188
EV M+S+ H NL+ L G+C +RLLVY YM S+ L + Q P+DW R +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 189 IALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR 248
IALG+A+GL YLHD +P +I+RD+K++NILLD EF A + DFGLAKL D THV++
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTA 194
Query: 249 VMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ--NLVTWAQP 306
V GT G+ APEY TG+ + K+DV+ +GV+LLELITG+RA D R + L+ W +
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
K+ + L D LQG + + Q + V+ +C Q RP MS+VV L
Sbjct: 255 LLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 5e-89
Identities = 73/311 (23%), Positives = 114/311 (36%), Gaps = 29/311 (9%)
Query: 73 FTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVL 132
L + + + G FG V+K +L + VAVK Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 133 MLSLLHHDNLVNLIGYCADGE----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMK 188
L + H+N++ IG G L+ + SL D L + + W
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCH 125
Query: 189 IALGAAKGLEYLH-------DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241
IA A+GL YLH D P + +RD+KS N+LL A ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 242 KTHVSSRVMGTYGYCAPEYQRTG-----QLTVKSDVYTFGVVLLELITGRRAIDTTRPTY 296
+ +GT Y APE ++ D+Y G+VL EL + A D Y
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 297 EQNL--VTWAQPFFKDPNRY--PQLADPLLQGEFPVRGLNQAVAVSAM-CVQEESSVRPL 351
P +D + P+L+ + + + C ++ R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 352 MSDVVSALSFL 362
V ++ +
Sbjct: 306 AGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 6e-71
Identities = 78/344 (22%), Positives = 132/344 (38%), Gaps = 54/344 (15%)
Query: 73 FTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI--VE 130
E + N + LIG G +G VYKG L++ + VAVK + FI
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSF---ANRQNFINEKN 57
Query: 131 VLMLSLLHHDNLVNLIGYCADGE-----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFT 185
+ + L+ HDN+ I + LLV EY P SL +L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVS 112
Query: 186 RMKIALGAAKGLEYLH------DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK---- 235
++A +GL YLH D P + +RDL S N+L+ + +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 236 --LGPIGDKTHVSSRVMGTYGYCAPEY-------QRTGQLTVKSDVYTFGVVLLELITGR 286
L G++ + + +GT Y APE + + D+Y G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 287 RAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP----LLQG---EFPVRGLNQAVAVSA 339
+ E + F + +P D + +FP ++AV +
Sbjct: 233 TDLFPGESVPEYQM-----AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 340 M------CVQEESSVRPLMSDVVSALSFLGSDPDADTATAPVPH 377
+ C +++ R ++ L + + + +P H
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-64
Identities = 73/211 (34%), Positives = 113/211 (53%), Gaps = 25/211 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN-------KEFIVEVLMLSLLHHDNLV 143
IG+GGFG V+KG+L K VVA+K L +G +EF EV ++S L+H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
L G +V E++P L LLD + PI W ++++ L A G+EY+ ++
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 204 ANPPVIYRDLKSSNILLD-----CEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
NPP+++RDL+S NI L AK++DFGL++ H S ++G + + AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 259 E--YQRTGQLTVKSDVYTFGVVLLELITGRR 287
E T K+D Y+F ++L ++TG
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-64
Identities = 78/249 (31%), Positives = 118/249 (47%), Gaps = 15/249 (6%)
Query: 40 LKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRV 99
+K P D+ N G + + +L K IG G FG V
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK-------IGAGSFGTV 53
Query: 100 YKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157
++ + VAVK L EF+ EV ++ L H N+V +G +
Sbjct: 54 HRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111
Query: 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSN 217
V EY+ SL L G ++ +D R+ +A AKG+ YLH++ NPP+++R+LKS N
Sbjct: 112 VTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPN 169
Query: 218 ILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGV 277
+L+D ++ K+ DFGL++L + S+ GT + APE R KSDVY+FGV
Sbjct: 170 LLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEKSDVYSFGV 227
Query: 278 VLLELITGR 286
+L EL T +
Sbjct: 228 ILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-61
Identities = 83/313 (26%), Positives = 127/313 (40%), Gaps = 54/313 (17%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V K K A+ VA+KQ++ + K FIVE+ LS ++H N+V L G C
Sbjct: 16 VGRGAFGVVCKAKW--RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
+ LV EY SL + L P M L ++G+ YLH +I+
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 211 RDLKSSNILLDCEFN-AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVK 269
RDLK N+LL K+ DFG A D + G+ + APE + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 270 SDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD---------PNRYPQLADP 320
DV+++G++L E+IT R +P ++ + A P+ +
Sbjct: 184 CDVFSWGIILWEVITRR------KP-FD-EIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL-----SFLGSDPDADTATAPV 375
L+ C ++ S RP M ++V + F G+D P
Sbjct: 236 LMT----------------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY---PC 276
Query: 376 PHKPPPCDHQNMN 388
H PP + +
Sbjct: 277 QHSLPPGEDGRVE 289
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-60
Identities = 45/203 (22%), Positives = 85/203 (41%), Gaps = 19/203 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVNLIGY 148
+ E G ++KG+ + + VK L ++F E L + H N++ ++G
Sbjct: 18 LNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 149 CADGEQRLL--VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
C + +MP SL + L + +D +K AL A+G+ +LH P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE---YQRT 263
+ L S ++++D + A++S + + S M + APE +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPEALQKKPE 185
Query: 264 GQLTVKSDVYTFGVVLLELITGR 286
+D+++F V+L EL+T
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE 208
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-60
Identities = 71/208 (34%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQL----DRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
IG GGFG+VY+ VAVK D + Q + E + ++L H N++ L
Sbjct: 15 IGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
G C LV E+ L L K I + A+ A+G+ YLHD+A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 207 PVIYRDLKSSNILLDCEF--------NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
P+I+RDLKSSNIL+ + K++DFGLA+ +T S G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAP 183
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGR 286
E R + SDV+++GV+L EL+TG
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-58
Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 24/210 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVNLIGY 148
IG+G FG+VY G+ VA++ +D + K F EV+ H+N+V +G
Sbjct: 41 IGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
C ++ R+L + D + +D +IA KG+ YLH +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKL---GPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+++DLKS N+ D ++DFGL + G + G + APE R
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 266 L---------TVKSDVYTFGVVLLELITGR 286
+ SDV+ G + EL
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-58
Identities = 70/307 (22%), Positives = 111/307 (36%), Gaps = 36/307 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G+G FG+ K +T +V+ +K+L R + + F+ EV ++ L H N++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
++ + EY+ +L + W R+ A A G+ YLH +I+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKL------------GPIGDKTHVSSRVMGTYGYCAP 258
RDL S N L+ N ++DFGLA+L V+G + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318
E K DV++FG+VL E+I A P F D P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR--TMDFGLNVRGFLDRYC-PPNC 248
Query: 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDADTATAPVPHK 378
P ++ C + RP + L L P+ +
Sbjct: 249 PPSF------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH---LPLGPQ 293
Query: 379 PPPCDHQ 385
D
Sbjct: 294 LEQLDRG 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-57
Identities = 70/201 (34%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVNLIGY 148
IG G FG VYKGK VAVK L+ + F EV +L H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
Q +V ++ SL HL + + + IA A+G++YLH K +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE---YQRTGQ 265
I+RDLKS+NI L + K+ DFGLA +H ++ G+ + APE Q +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 266 LTVKSDVYTFGVVLLELITGR 286
+ +SDVY FG+VL EL+TG+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-56
Identities = 69/309 (22%), Positives = 115/309 (37%), Gaps = 49/309 (15%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI--VEVLMLSLLHHDNLVNLIG 147
IG+G +G V+ GK + VAVK + E+ L+ H+N++ I
Sbjct: 44 QIGKGRYGEVWMGKWRG--EKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 148 YCADGE----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH-- 201
G Q L+ +Y SL D+L + +D + +K+A + GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 202 ---DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH--VSSRVMGTYGYC 256
+ P + +RDLKS NIL+ ++D GLA + +GT Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 257 APE------YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310
PE + Q + +D+Y+FG++L E+ R Y+ P+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQ-------LPYHDL 265
Query: 311 PNRYPQLADP----LLQG---EFPVRGLNQAV--AVSAM---CVQEESSVRPLMSDVVSA 358
P D ++ FP R + + + C + R V
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 359 LSFLGSDPD 367
L+ + D
Sbjct: 326 LAKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-55
Identities = 70/314 (22%), Positives = 120/314 (38%), Gaps = 53/314 (16%)
Query: 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI--VEVLMLSLL 137
T ++ +G+G +G V++G + + VAVK + K + E+ +L
Sbjct: 5 TVARDITLLECVGKGRYGEVWRGSWQG--ENVAVKIFSS---RDEKSWFRETELYNTVML 59
Query: 138 HHDNLVNLIGYCADGE----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGA 193
H+N++ I Q L+ Y + SL D+L + +D + ++I L
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSI 114
Query: 194 AKGLEYLH-----DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL---GPIGDKTHV 245
A GL +LH + P + +RDLKS NIL+ ++D GLA +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 246 SSRVMGTYGYCAPE------YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN 299
+ RV GT Y APE + D++ FG+VL E+ R + Y+
Sbjct: 175 NPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYK-- 230
Query: 300 LVTWAQPFFKDPNRYPQLADP----LLQG---EFPVRGLNQAVAVSAM------CVQEES 346
PF+ P D + P R + ++++ C +
Sbjct: 231 -----PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPT-LTSLAKLMKECWYQNP 284
Query: 347 SVRPLMSDVVSALS 360
S R + L+
Sbjct: 285 SARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-53
Identities = 72/311 (23%), Positives = 117/311 (37%), Gaps = 53/311 (17%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFI--VEVLMLSLLHHDNLVNLIG 147
IG+G FG V++GK + VAVK + + + E+ +L H+N++ I
Sbjct: 49 SIGKGRFGEVWRGKWRG--EEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 148 YCADGE----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH-- 201
Q LV +Y SL D+L + + +K+AL A GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 202 ---DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL---GPIGDKTHVSSRVMGTYGY 255
+ P + +RDLKS NIL+ ++D GLA + RV GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRY 217
Query: 256 CAPE------YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK 309
APE + + ++D+Y G+V E+ R +I Y+ P++
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQ-------LPYYD 269
Query: 310 DPNRYPQLAD-----------PLLQGEFPVRGLNQAVAVSAM--CVQEESSVRPLMSDVV 356
P + + P + + + +A M C + R +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA-KIMRECWYANGAARLTALRIK 328
Query: 357 SALSFLGSDPD 367
LS L
Sbjct: 329 KTLSQLSQQEG 339
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-41
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 7/203 (3%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDN 141
++ IG G FG V+ G+L +VAVK + +F+ E +L H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
+V LIG C + +V E + L G + +++ AA G+EYL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKT---LLQMVGDAAAGMEYLE 230
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
K I+RDL + N L+ + K+SDFG+++ G + APE
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 262 RTGQLTVKSDVYTFGVVLLELIT 284
G+ + +SDV++FG++L E +
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 44/279 (15%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNL 142
+ + IG G F VYKG +T VA +L L + + F E ML L H N+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 143 VNLIGYCAD---GEQRLLVY-EYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAKGL 197
V G++ +++ E M +L+ +L + K + + R +I KGL
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR-QI----LKGL 142
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
++LH + PP+I+RDLK NI + + K+ D GLA + + + V+GT +
Sbjct: 143 QFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKA-VIGTPEFM 197
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK-----DP 311
APE DVY FG+ +LE+ T Y AQ + + P
Sbjct: 198 APEMYEEK-YDESVDVYAFGMCMLEMATS-------EYPY-SECQNAAQIYRRVTSGVKP 248
Query: 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP 350
+ ++A P ++ E + C+++ R
Sbjct: 249 ASFDKVAIPEVK-EI----IEG-------CIRQNKDERY 275
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 6e-39
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 91 IGEGGFGRVYKGKL----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+G G FG VYKG EK VA+K+L + + NKE + E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+G C L+ + MP L D++ + + + AKG+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLEDRR- 137
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+++RDL + N+L+ + K++DFGLAKL +K + + + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 266 LTVKSDVYTFGVVLLELIT-GRR 287
T +SDV+++GV + EL+T G +
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-39
Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 91 IGEGGFGRVYKGKL----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
+G+G FG V + + T +VAVKQL +G ++F E+ +L LH D +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 147 GYCADGEQR--LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
G ++ LV EY+P L D L + + KG+EYL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL---LLYSSQICKGMEYLGSRR 147
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG-----YCAPE 259
++RDL + NIL++ E + K++DFGLAKL P+ +V G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200
Query: 260 YQRTGQLTVKSDVYTFGVVLLELIT 284
+ +SDV++FGVVL EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G +G VY+G +K + VAVK L + +EF+ E ++ + H NLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
++ E+M +L D+L + ++ + + +A + +EYL K I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKS 270
R+L + N L+ K++DFGL++L GD + + APE + ++KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 271 DVYTFGVVLLELIT 284
DV+ FGV+L E+ T
Sbjct: 401 DVWAFGVLLWEIAT 414
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 91 IGEGGFGRVYKGKL----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
+G+G FG V + + T +VVAVK+L + + ++F E+ +L L HDN+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 147 GYCADGEQR--LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
G C +R L+ EY+P SL D+L I ++ KG+EYL K
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYLGTKR 134
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG-----YCAPE 259
I+RDL + NIL++ E K+ DFGL K+ P + G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187
Query: 260 YQRTGQLTVKSDVYTFGVVLLELIT 284
+ +V SDV++FGVVL EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-38
Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 91 IGEGGFGRVYKGKL----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
+G+G FG V + + T +VVAVK+L + + ++F E+ +L L HDN+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 147 GYCADGEQR--LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
G C +R L+ EY+P SL D+L I ++ KG+EYL K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYLGTKR 165
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG-----YCAPE 259
I+RDL + NIL++ E K+ DFGL K+ P + + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPE 218
Query: 260 YQRTGQLTVKSDVYTFGVVLLELIT 284
+ +V SDV++FGVVL EL T
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 91 IGEGGFGRVYKGKL----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG+V + + T + VAVK L +G + E+ +L L+H+N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 146 IGYCADGEQR--LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
G C + L+ E++P SL+++L + ++K A+ KG++YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQICKGMDYLGSR 145
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG-----YCAP 258
++RDL + N+L++ E K+ DFGL K + + + AP
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAP 198
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQ 298
E + + SDV++FGV L EL+T +
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IG G FG V+ G +V A+K + R G ++FI E ++ L H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
+ LV E+M L D+L + + L +G+ YL + VI+
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIH 127
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRTGQLT 267
RDL + N L+ K+SDFG+ + + D + SS GT + +PE + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSST--GTKFPVKWASPEVFSFSRYS 183
Query: 268 VKSDVYTFGVVLLELIT-GRR 287
KSDV++FGV++ E+ + G+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI 204
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 91 IGEGGFGRVYKGKL----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG+V + T ++VAVK L G Q + E+ +L L+H++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 146 IGYC--ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
G C A LV EY+PL SL D+L + I + A +G+ YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG-----YCAP 258
I+RDL + N+LLD + K+ DFGLAK P G + + + G + AP
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAP 206
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELIT 284
E + + SDV++FGV L EL+T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 65/304 (21%), Positives = 109/304 (35%), Gaps = 35/304 (11%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
K++ +GEGGF V + A+K++ + Q +E E M L +H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 143 VNLIGYCADGEQR----LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
+ L+ YC L+ + +L + + + + + + + LG +GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM-------G 251
+H +RDLK +NILL E L D G I + + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 252 TYGYCAPE---YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE-QNLVTWAQPF 307
T Y APE Q + ++DV++ G VL ++ G D + L Q
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL-GSDP 366
R+ LL + + RP + ++S L L P
Sbjct: 266 IPQSPRHSSALWQLLN----------------SMMTVDPHQRPHIPLLLSQLEALQPPAP 309
Query: 367 DADT 370
T
Sbjct: 310 GQHT 313
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G +G VY+G +K + VAVK L + +EF+ E ++ + H NLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
++ E+M +L D+L + ++ M A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM--ATQISSAMEYLEKKN---FIH 134
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRTGQLT 267
RDL + N L+ K++DFGL++L + T+ + G + APE + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFS 190
Query: 268 VKSDVYTFGVVLLELIT-GRR 287
+KSDV+ FGV+L E+ T G
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS 211
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-37
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 91 IGEGGFGRVYKGKL----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+G G FG V+KG E V +K + D++G Q + +L + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+G C G LV +Y+PL SL DH+ P + + AKG+ YL +
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLEEHG- 135
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+++R+L + N+LL +++DFG+A L P DK + S + A E G+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 266 LTVKSDVYTFGVVLLELIT-GRR 287
T +SDV+++GV + EL+T G
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V GK + V AVK + + G EF E + L H LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDV-AVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
+V EY+ L ++L G +P +++ +G+ +L I+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ---LLEMCYDVCEGMAFLESHQ---FIH 127
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRTGQLT 267
RDL + N L+D + K+SDFG+ + + D +VSS GT + APE + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSV--GTKFPVKWSAPEVFHYFKYS 183
Query: 268 VKSDVYTFGVVLLELIT-GRR 287
KSDV+ FG+++ E+ + G+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 91 IGEGGFGRVYKGKL----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+G G FG VYKG EK VA+K+L + + NKE + E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+G C L+ + MP L D++ + + I + + AKG+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+++RDL + N+L+ + K++DFGLAKL +K + + + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 266 LTVKSDVYTFGVVLLELIT-GRR 287
T +SDV+++GV + EL+T G +
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V GK V A+K + + G EFI E ++ L H+ LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDV-AIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
++ EYM L ++L ++ + +++ + +EYL K ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLEMCKDVCEAMEYLESKQ---FLH 143
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRTGQLT 267
RDL + N L++ + K+SDFGL++ + D + SS G+ + PE + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSV--GSKFPVRWSPPEVLMYSKFS 199
Query: 268 VKSDVYTFGVVLLELIT-GRR 287
KSD++ FGV++ E+ + G+
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKM 220
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 91 IGEGGFGRVYKGKL---EKTAQVVAVKQL---DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
+G+G FG V +G+ VAVK L + + +FI EV + L H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
L G +V E PL SL D L T + A+ A+G+ YL K
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLG---TLSRYAVQVAEGMGYLESKR 141
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQ 261
I+RDL + N+LL K+ DFGL + P D +V + +CAPE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 262 RTGQLTVKSDVYTFGVVLLELIT-GRR 287
+T + SD + FGV L E+ T G+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 72/313 (23%), Positives = 127/313 (40%), Gaps = 39/313 (12%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
+G G FG VY+G++ + + VAVK L + Q +F++E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQ---KPIDWFTRMKIALGAAKGLEYLH 201
IG R ++ E M L+ L + P + + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 202 DKANPPVIYRDLKSSNILLDCE---FNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
+ I+RD+ + N LL C AK+ DFG+A+ M + P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317
E G T K+D ++FGV+L E+ + G P+ N+ ++
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGY------------------MPYPSKSNQ--EV 254
Query: 318 ADPLLQG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDADTATAP 374
+ + G + P + C Q + RP + ++ + + DPD P
Sbjct: 255 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 314
Query: 375 VPHKPPPCDHQNM 387
+ + P + + +
Sbjct: 315 IEYGPLVEEEEKV 327
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 61/194 (31%), Positives = 95/194 (48%), Gaps = 9/194 (4%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G+G FG V+ G T +V A+K L + G + F+ E ++ L H+ LV L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 248
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
E +V EYM SL D L + + M A A G+ Y+ ++
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAYVERMN---YVH 303
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKS 270
RDL+++NIL+ K++DFGLA+L ++ + APE G+ T+KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 271 DVYTFGVVLLELIT 284
DV++FG++L EL T
Sbjct: 363 DVWSFGILLTELTT 376
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 87 QECLIGEGGFGRVYKGKL--EKTAQVVAVKQL--DRNGLQGNKEFIVEVLMLSLLHHDNL 142
++ +G G FG V KG +K + VAVK L + N E + E ++ L + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
V +IG C + E +LV E L L +L + + + +++ + G++YL +
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG------YC 256
++RDL + N+LL + AK+SDFGL+K + + + +
Sbjct: 136 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWY 187
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELIT-GRR 287
APE + + KSDV++FGV++ E + G++
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 25/271 (9%)
Query: 23 GSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATAT 82
GS + + S A + + A+ +N+ + + +RE
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKL--QRLGPETEDNEGVLLTEKLKPVDYEYRE---EV 57
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
+ +G G FG V++ K ++T AVK++ L+ + E++ + L +
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR---LEVFRV--EELVACAGLSSPRI 112
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKP-IDWFTRMKIALGAAKGLEYLH 201
V L G +G + E + SL + +G + ++ AL +GLEYLH
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ--AL---EGLEYLH 167
Query: 202 DKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLAK-LGPIGDKTHVSSR--VMGTYGYCA 257
+ +++ D+K+ N+LL + A L DFG A L P G + + + GT + A
Sbjct: 168 TRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 258 PE-YQRTGQLTVKSDVYTFGVVLLELITGRR 287
PE K D+++ ++L ++ G
Sbjct: 225 PEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH 254
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 59/254 (23%), Positives = 100/254 (39%), Gaps = 38/254 (14%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHH 139
NFR E IG G F VY+ VA+K++ L K I E+ +L L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG------PEQKPIDWFTRMKIALGA 193
N++ + + +V E L + PE+ +F ++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL------ 145
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
LE++H + V++RD+K +N+ + KL D GL + KT + ++GT
Sbjct: 146 CSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTP 200
Query: 254 GYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313
Y +PE KSD+++ G +L E+ + PF+ D
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS------------------PFYGDKMN 242
Query: 314 YPQLADPLLQGEFP 327
L + Q ++P
Sbjct: 243 LYSLCKKIEQCDYP 256
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 88 ECLIGEGGFGRVYKGKLEKTAQV--VAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLV 143
+ +G G FG V +G + VA+K L + G + +E + E ++ L + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
LIG C E +LV E L L+ E I ++ + G++YL +K
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK 129
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG------YCA 257
++RDL + N+LL AK+SDFGL+K D + + + A
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYA 181
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELIT-GRR 287
PE + + +SDV+++GV + E ++ G++
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQV-------VAVKQLDRNGLQGNKEFIVEVLMLS 135
++ +G+G F +++KG + V +K LD+ ++ F M+S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 136 LLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK 195
L H +LV G C G++ +LV E++ SL+ +L + ++++A A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW---KLEVAKQLAA 124
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFN--------AKLSDFGLAKLGPIGDKTHVSS 247
+ +L + +I+ ++ + NILL E + KLSD G++ + K +
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQE 179
Query: 248 RVMGTYGYCAPE---YQRTGQLTVKSDVYTFGVVLLELIT-GRR 287
R+ PE + L + +D ++FG L E+ + G +
Sbjct: 180 RIPWV----PPECIENPKN--LNLATDKWSFGTTLWEICSGGDK 217
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 81/404 (20%), Positives = 141/404 (34%), Gaps = 61/404 (15%)
Query: 1 MSCFSCFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNK 60
MS + + E SP + L+T + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTS 60
Query: 61 EAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQ 115
+ + + T +G G FG VY+G++ + + VAVK
Sbjct: 61 SISDLKEVPRKNITLIRG------------LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT 108
Query: 116 L-DRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDI 174
L + Q +F++E L++S +H N+V IG R ++ E M L+ L +
Sbjct: 109 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 168
Query: 175 GPEQKPIDWFTR---MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE---FNAKL 228
P + +A A G +YL + I+RD+ + N LL C AK+
Sbjct: 169 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225
Query: 229 SDFGLAKLGPIGDKTHVSSRVMGTYGY-----CAPEYQRTGQLTVKSDVYTFGVVLLELI 283
DFG+A+ D G PE G T K+D ++FGV+L E+
Sbjct: 226 GDFGMAR-----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
Query: 284 T-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG---EFPVRGLNQAVAVSA 339
+ G P+ N+ ++ + + G + P +
Sbjct: 281 SLGY------------------MPYPSKSNQ--EVLEFVTSGGRMDPPKNCPGPVYRIMT 320
Query: 340 MCVQEESSVRPLMSDVVSALSFLGSDPDADTATAPVPHKPPPCD 383
C Q + RP + ++ + + DPD P+ + P +
Sbjct: 321 QCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEE 364
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V+ K +V AVK + + G + F+ E ++ L HD LV L
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
E ++ E+M SL D L E + + A+G+ ++ + I+
Sbjct: 254 -KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRTGQLT 267
RDL+++NIL+ K++DFGLA++ I D + + G + APE G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEAINFGSFT 363
Query: 268 VKSDVYTFGVVLLELIT-GRR 287
+KSDV++FG++L+E++T GR
Sbjct: 364 IKSDVWSFGILLMEIVTYGRI 384
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 51/211 (24%), Positives = 86/211 (40%), Gaps = 22/211 (10%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEV-LMLSLLH 138
++F++ +G G +G V+K + ++ ++ AVK+ +G K+ + EV +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQ 115
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG---PEQKPIDWFTRMKIALGAAK 195
H V L +G L E SL+ H G PE + +
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDT------LL 168
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
L +LH + +++ D+K +NI L KL DFGL V G Y
Sbjct: 169 ALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRY 222
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
APE + G +DV++ G+ +LE+
Sbjct: 223 MAPELLQ-GSYGTAADVFSLGLTILEVACNM 252
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 20/222 (9%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIV-EVLMLSLLHHD 140
+++ IG G +GR K + + +++ K+LD + + K+ +V EV +L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 141 NLVNLIGYCADGEQRLL--VYEYMPLRSLEDHLLDIG------PEQKPIDWFTRMKIALG 192
N+V D L V EY L + E+ + T++
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL----- 120
Query: 193 AAKGLEYLHDKANPP--VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM 250
L+ H +++ V++RDLK +N+ LD + N KL DFGLA++ + T + +
Sbjct: 121 -TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFV 177
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTT 292
GT Y +PE KSD+++ G +L EL
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 44/342 (12%), Positives = 95/342 (27%), Gaps = 59/342 (17%)
Query: 27 NKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATA-TKNF 85
+ P + A + + + + Q F +
Sbjct: 16 FQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTL 75
Query: 86 RQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE------------------- 126
+ ++G+ + ++T + V +
Sbjct: 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 127 ---------FIVEVLMLSLLHHDNLVNLIGYCADGE--QRLLVYEYM--PLRSLEDHLLD 173
FI ++ ++ + D R +Y M L++ + LL
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 174 IGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233
K + R+++ L + L LH +++ L+ +I+LD L+ F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 234 AKLGPIGDKTHVSSRVMGTYGYCAPEY-----------QRTGQLTVKSDVYTFGVVLLEL 282
G + + G+ PE R +T D + G+V+ +
Sbjct: 253 LV--RDGARV----VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 283 ITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324
P + + ++ F+ PQ LL+G
Sbjct: 307 WCAD------LPITKDAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 91 IGEGGFGRVYKGKL---EKTAQVVAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVNLI 146
IG+G FG VY G+ + A+K L R +Q + F+ E L++ L+H N++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 147 GYCADGE-QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
G E ++ YM L + D + L A+G+EYL ++
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYLAEQK- 144
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG--------TYGYCA 257
++RDL + N +LD F K++DFGLA+ I D+ + S + T A
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWT----A 196
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELIT 284
E +T + T KSDV++FGV+L EL+T
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G G FG V+ G +V AVK L + G F+ E ++ L H LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
E ++ EYM SL D L P + + +A A+G+ ++ ++ I+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRTGQLT 267
RDL+++NIL+ + K++DFGLA+L I D + + G + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARL--IEDNEYTARE--GAKFPIKWTAPEAINYGTFT 188
Query: 268 VKSDVYTFGVVLLELIT-GRR 287
+KSDV++FG++L E++T GR
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI 209
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 91 IGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLI 146
+GEG FG VY+G + VAVK ++ NK +F+ E +++ L H ++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
G + E ++ E P L +L K + + +L K + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYLESIN-- 133
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG------YCAPEY 260
++RD+ NIL+ KL DFGL++ I D+ + + + +PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPES 185
Query: 261 QRTGQLTVKSDVYTFGVVLLELIT-GRR 287
+ T SDV+ F V + E+++ G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-34
Identities = 61/194 (31%), Positives = 95/194 (48%), Gaps = 9/194 (4%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
+G+G FG V+ G T +V A+K L + G + F+ E ++ L H+ LV L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 331
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
E +V EYM SL D L + + M A A G+ Y+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAYVERMN---YVH 386
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKS 270
RDL+++NIL+ K++DFGLA+L ++ + APE G+ T+KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 271 DVYTFGVVLLELIT 284
DV++FG++L EL T
Sbjct: 446 DVWSFGILLTELTT 459
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIV-EVLMLSLLHHD 140
+ + + IGEG FG+ K + + +K+++ + + +E EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG----PEQKPIDWFTRMKIALGAAKG 196
N+V + +V +Y L + E + +DWF ++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLA 137
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
L+++HD+ +++RD+KS NI L + +L DFG+A++ + ++ +GT Y
Sbjct: 138 LKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYL 192
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELITGRRA 288
+PE KSD++ G VL EL T + A
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN 141
+F + ++G+G FG+V K + ++ A+K++ + + EV++L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 142 LVNLIGYCADGEQRL-------------LVYEYMPLRSLEDHLLDIG---PEQKPIDWFT 185
+V + + + EY +L D + + F
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 186 RMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL--------- 236
++ + L Y+H + +I+RDLK NI +D N K+ DFGLAK
Sbjct: 124 QI------LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 237 ----GPIGDKTHVSSRVMGTYGYCAPE-YQRTGQLTVKSDVYTFGVVLLELITG 285
G +++S + GT Y A E TG K D+Y+ G++ E+I
Sbjct: 175 LDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-34
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 24/205 (11%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK---EFIVEVLMLSLLHHDNLVNLI 146
+G+G FG VY + +++ ++A+K L + L+ + EV + S L H N++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
GY D + L+ EY PL ++ L + EQ+ + T + A L Y H K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ANALSYCHSKR 129
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM---GTYGYCAPEYQ 261
VI+RD+K N+LL K++DFG + P SSR GT Y PE
Sbjct: 130 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSRRTDLCGTLDYLPPEMI 179
Query: 262 RTGQLTVKSDVYTFGVVLLELITGR 286
K D+++ GV+ E + G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
+G+G FG VY+G ++ VA+K + + ++ EF+ E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------MKIALGAAKGLE 198
L+G + G+ L++ E M L+ +L + P +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD--KTHVSSRV----MGT 252
YL+ ++RDL + N ++ +F K+ DFG+ + D + + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 253 YGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+PE + G T SDV++FGVVL E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IG+G FG V G VAVK + + + F+ E +++ L H NLV L+G
Sbjct: 201 IGKGEFGDVMLGDYRGN--KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 151 DGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
+ + L +V EYM SL D+L + + +K +L + +EYL +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 210 YRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV----MGTYGYCAPEYQRTGQ 265
+RDL + N+L+ + AK+SDFGL K T + ++ APE R +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 362
Query: 266 LTVKSDVYTFGVVLLELIT-GRR 287
+ KSDV++FG++L E+ + GR
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRV 385
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV----EVLMLSLLHHDNLVNL 145
+G GG VY + VA+K + + +E + EV S L H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
I + + LV EY+ +L +++ P+ T + G+++ HD
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+++RD+K NIL+D K+ DFG+AK T + V+GT Y +PE +
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEA 188
Query: 266 LTVKSDVYTFGVVLLELITGRR 287
+D+Y+ G+VL E++ G
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEP 210
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 12/213 (5%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDN 141
++ + +IG G V + VA+K+++ Q + + ++ E+ +S HH N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDW-FTRMKIAL---GAAKGL 197
+V+ ++ LV + + S+ D + I + + IA +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSR--VMGTYG 254
EYLH I+RD+K+ NILL + + +++DFG+ A L GD T R +GT
Sbjct: 135 EYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 255 YCAPE-YQRTGQLTVKSDVYTFGVVLLELITGR 286
+ APE ++ K+D+++FG+ +EL TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 88 ECLIGEGGFGRVYKGKL--EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
+ +G G FG V +G K VA+K L +E + E ++ L + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
LIG C E +LV E L L+ E I ++ + G++YL +K
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKN 456
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQ 261
++R+L + N+LL AK+SDFGL+K D + + + APE
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECI 511
Query: 262 RTGQLTVKSDVYTFGVVLLELIT-GRR 287
+ + +SDV+++GV + E ++ G++
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 91 IGEGGFGRVYKGKL---EKTAQVVAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVNLI 146
IG G FG VY G L + AVK L+R + +F+ E +++ H N+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 147 GYCADGE-QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
G C E L+V YM L + + + D + L AKG++YL K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKK- 148
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG------TYGYCAPE 259
++RDL + N +LD +F K++DFGLA+ + V ++ A E
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALE 202
Query: 260 YQRTGQLTVKSDVYTFGVVLLELIT 284
+T + T KSDV++FGV+L EL+T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 91 IGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLHHDNLVNLI 146
IG G G V G+L + VA+K L + + +F+ E ++ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
G G ++V EYM SL+ L + + + + G G+ YL D
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ---LVGMLRGVGAGMRYLSDLG-- 171
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQRT 263
++RDL + N+L+D K+SDFGL+++ + D + G + APE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 264 GQLTVKSDVYTFGVVLLELIT-GRR 287
+ SDV++FGVV+ E++ G R
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
+F++ LIG GGFG+V+K K + +K++ N N++ EV L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 143 VNLIGYCADGEQRL----------------LVYEYMPLRSLEDHLLDIG----PEQKPID 182
V+ G + + E+ +LE + + ++
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 183 WFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242
F ++ KG++Y+H K +I RDLK SNI L K+ DFGL
Sbjct: 127 LFEQI------TKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKN 174
Query: 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRR 287
+R GT Y +PE + + D+Y G++L EL+
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IG+G FG V G VAVK + +N + F+ E +++ L H NLV L+G
Sbjct: 29 IGKGEFGDVMLGDYRGN--KVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 151 DGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
+ + L +V EYM SL D+L G D + +L + +EYL +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF--SLDVCEAMEYLEGNN---FV 139
Query: 210 YRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV----MGTYGYCAPEYQRTGQ 265
+RDL + N+L+ + AK+SDFGL K T + ++ APE R +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWT------APEALREKK 190
Query: 266 LTVKSDVYTFGVVLLELIT-GRR 287
+ KSDV++FG++L E+ + GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 91 IGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVNL 145
+G+G FG V + +L + + VAVK L + + + +EF+ E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 146 IGYCADGEQR------LLVYEYMPLRSLEDHLLDIGPEQKP--IDWFTRMKIALGAAKGL 197
+G + +++ +M L LL + P + T ++ + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD--KTHVSSRV----MG 251
EYL + I+RDL + N +L + ++DFGL++ GD + +S++ +
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 252 TYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
A E TV SDV+ FGV + E++T
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG+V+ + K +VAVK L L K+F E +L+ L H+++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGA 193
G C DG+ ++V+EYM L L GP + + + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV---- 249
A G+ YL + ++RDL + N L+ K+ DFG+++ D V
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 250 --MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
M PE + T +SDV++FGV+L E+ T
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 91 IGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNL 145
IGEG FG V++G E A VA+K +N ++F+ E L + H ++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
IG ++ E L L L + A + L YL K
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLAS---LILYAYQLSTALAYLESKR- 136
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG------YCAPE 259
++RD+ + N+L+ KL DFGL++ + D T+ + + APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPE 187
Query: 260 YQRTGQLTVKSDVYTFGVVLLELIT-GRR 287
+ T SDV+ FGV + E++ G +
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 91 IGEGGFGRVYKGKL---EKTAQVVAVKQL--DRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG V +G L + T+ VAVK + D + + +EF+ E + H N++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 146 IGYCADGEQR-----LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR--MKIALGAAKGLE 198
+G C + + +++ +M L +LL E P + +K + A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD--KTHVSSRV----MGT 252
YL ++ ++RDL + N +L + ++DFGL+K GD + +++ +
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 253 YGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
A E T KSDV+ FGV + E+ T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 20/212 (9%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLM-----LSLLHH 139
+G G +G V K + + Q++AVK++ N + +LM + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLLMDLDISMRTVDC 65
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
V G + E M SL+ + + + I KIA+ K LE+
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYCAP 258
LH K + VI+RD+K SN+L++ K+ DFG+ L G Y AP
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAP 178
Query: 259 E----YQRTGQLTVKSDVYTFGVVLLELITGR 286
E +VKSD+++ G+ ++EL R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 47/247 (19%), Positives = 99/247 (40%), Gaps = 29/247 (11%)
Query: 57 NNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL 116
+++ + ++ + F+ ++ + + IG GG +V++ L + Q+ A+K +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYV 60
Query: 117 DRNGLQGN--KEFIVEVLMLSLL--HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLL 172
+ + E+ L+ L H D ++ L Y + +V E + L L
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-DLNSWLK 119
Query: 173 DIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSD 230
+ ++ M + + +H +++ DLK +N L+ + KL D
Sbjct: 120 KKKSIDPWERKSYWKNM------LEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 169
Query: 231 FGLAKLGPIGDKTHVSSRVMGTYGYCAPE-----------YQRTGQLTVKSDVYTFGVVL 279
FG+A + V +GT Y PE + +++ KSDV++ G +L
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 280 LELITGR 286
+ G+
Sbjct: 230 YYMTYGK 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 75/271 (27%), Positives = 122/271 (45%), Gaps = 44/271 (16%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHD 140
+ F + IG+G FG V+KG +T +VVA+K +D + E I E+ +LS
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAAKGL 197
+ G + ++ EY+ S D LL+ GP +IA KGL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGP-------LDETQIATILREILKGL 132
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYC 256
+YLH + I+RD+K++N+LL KL+DFG+ +L K + +GT +
Sbjct: 133 DYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWM 186
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELITGR---------RAIDTTR----PTYEQNLVTW 303
APE + K+D+++ G+ +EL G + + PT E N +
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN---Y 243
Query: 304 AQPF--F------KDPNRYPQLADPLLQGEF 326
++P F K+P+ P A LL+ +F
Sbjct: 244 SKPLKEFVEACLNKEPSFRPT-AKELLKHKF 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-33
Identities = 44/219 (20%), Positives = 91/219 (41%), Gaps = 31/219 (14%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-----------------EVLM 133
+ +G F ++ + K + A+K+ +++ L+ ++F E+ +
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 134 LSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL-- 191
++ + ++ + G + ++ ++YEYM S+ K F +++
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 192 --GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV 249
Y+H++ N + +RD+K SNIL+D KLSDFG ++ K S
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKGS--- 210
Query: 250 MGTYGYCAPE--YQRTGQLTVKSDVYTFGVVLLELITGR 286
GTY + PE + K D+++ G+ L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNL 145
+GEG FG+V+ + E+ +VAVK L ++F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR-----------MKIALGAA 194
G C +G L+V+EYM L L GP+ K + + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV----- 249
G+ YL ++RDL + N L+ K+ DFG+++ D V R
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 250 -MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
M PE + T +SDV++FGVVL E+ T
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 91 IGEGGFGRVYKGKL----EKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVN 144
IG G FG VYKG L K VA+K L + G + +F+ E ++ H N++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
L G + + +++ EYM +L+ L + E + + + G A G++YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ---LVGMLRGIAAGMKYLANMN 167
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT---YGYCAPEYQ 261
++RDL + NIL++ K+SDFGL+++ + D + G + APE
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 262 RTGQLTVKSDVYTFGVVLLELIT-GRR 287
+ T SDV++FG+V+ E++T G R
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 74/269 (27%), Positives = 117/269 (43%), Gaps = 39/269 (14%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN 141
K + + IG+G G VY T Q VA++Q++ + I E+L++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAAKGLE 198
+VN + G++ +V EY+ SL D ++ +IA + LE
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC-------MDEGQIAAVCRECLQALE 130
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYCA 257
+LH VI+RD+KS NILL + + KL+DFG A++ P K ++GT + A
Sbjct: 131 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMA 184
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGR---------RA---IDTTRPTYEQNLVTWAQ 305
PE K D+++ G++ +E+I G RA I T QN +
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 306 PF--F------KDPNRYPQLADPLLQGEF 326
F F D + A LLQ +F
Sbjct: 245 IFRDFLNRCLEMDVEKRGS-AKELLQHQF 272
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 91 IGEGGFGRVYKGKL---EKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNL 145
+G G FG V G+L K VA+K L + G + ++F+ E ++ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
G + ++V EYM SL+ L + I + + G A G++YL D
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSDMG- 167
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGYCAPEYQRTG 264
++RDL + NIL++ K+SDFGL + L + + + + +PE
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 265 QLTVKSDVYTFGVVLLELIT-GRR 287
+ T SDV+++G+VL E+++ G R
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGER 249
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 90 LIGEGGFGRVYKGKLEK--TAQVVAVKQL-DRNGLQGNKEFIVEV-LMLSLLHHDNLVNL 145
+IGEG FG+V K +++K A+K++ + +++F E+ ++ L HH N++NL
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------------MKIALGA 193
+G C L EY P +L D L + + + A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV---- 249
A+G++YL K I+RDL + NIL+ + AK++DFGL++ + K R+
Sbjct: 152 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MGRLPVRW 207
Query: 250 MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
M A E T SDV+++GV+L E+++
Sbjct: 208 M------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 58/274 (21%), Positives = 105/274 (38%), Gaps = 61/274 (22%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDN 141
+F +G GGFG V++ K + A+K++ + +E ++ EV L+ L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 142 LVNLIGYCADGE---------QRLLVY---EYMPLRSLEDHL-----LDIGPEQKPIDWF 184
+V + ++ +Y + +L+D + ++ + F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 185 TRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL-------- 236
++ A+ +E+LH K +++RDLK SNI + K+ DFGL
Sbjct: 125 LQI------AEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 237 --GPIGDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTR 293
+ +GT Y +PE Q G + K D+++ G++L EL+
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY--------- 225
Query: 294 PTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFP 327
PF R L D + +FP
Sbjct: 226 ------------PFSTQMERVRTLTD-VRNLKFP 246
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 34/347 (9%), Positives = 72/347 (20%), Gaps = 55/347 (15%)
Query: 19 QQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFREL 78
G ++ + A + EA T L
Sbjct: 3 HMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQN------AETTVDSL 56
Query: 79 AT-ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLML 134
+ + + + G V+ + + + A+K E
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116
Query: 135 SLLHHDNLVNLIGYC--------------------------ADGEQRLLVYEYMP--LRS 166
+ L ++ LL+ L
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176
Query: 167 LEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226
L L + + + + L K +++ N+ + +
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRL 233
Query: 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY--QRTGQLTVKSDVYTFGVVLLELIT 284
L D +G + SS Y E+ T T + + G+ + +
Sbjct: 234 MLGDVSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 285 GR-------RAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324
I + + F P L+
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 91 IGEGGFGRVYKGKL---EKTAQVVAVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVNLI 146
IG G FG VY G L + AVK L+R + +F+ E +++ H N+++L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 147 GYCADGE-QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
G C E L+V YM L + + + D + L AKG+++L K
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASKK- 212
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG------TYGYCAPE 259
++RDL + N +LD +F K++DFGLA+ + V ++ A E
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALE 266
Query: 260 YQRTGQLTVKSDVYTFGVVLLELIT 284
+T + T KSDV++FGV+L EL+T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 45/342 (13%), Positives = 94/342 (27%), Gaps = 58/342 (16%)
Query: 26 PNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTF-RELATATKN 84
+P + A + + + + Q F EL +
Sbjct: 20 RGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRT 79
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE------------------ 126
+ ++G+ + ++T + V +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 127 ----------FIVEVLMLSLLHHDNLVNLIGYCADG--EQRLLVYEYM--PLRSLEDHLL 172
FI ++ ++ + D R +Y M L++ + LL
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 173 DIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232
K + R+++ L + L LH +++ L+ +I+LD L+ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEY----------QRTGQLTVKSDVYTFGVVLLEL 282
G G+ PE +T D +T G+ + +
Sbjct: 257 HLV--RDGASA----VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
Query: 283 ITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324
P + + ++ F+ PQ LL+G
Sbjct: 311 WCAD------LPNTDDAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK---EFIVEVLMLSLLHHDNLVNLI 146
+G+G FG VY + ++ ++A+K L ++ L+ + E+ + S L H N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
Y D ++ L+ E+ P L L G EQ+ + + A L Y H++
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-----SATFMEE-LADALHYCHERK 134
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG 264
VI+RD+K N+L+ + K++DFG + P + GT Y PE
Sbjct: 135 ---VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPEMIEGK 187
Query: 265 QLTVKSDVYTFGVVLLELITGR 286
K D++ GV+ E + G
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGM 209
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 39/269 (14%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN 141
IGEG G V + + + + VAVK +D Q + EV+++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAAKGLE 198
+V + GE+ ++ E++ +L D ++ +IA + L
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVR-------LNEEQIATVCEAVLQALA 155
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYCA 257
YLH + VI+RD+KS +ILL + KLSDFG A++ K ++GT + A
Sbjct: 156 YLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS---LVGTPYWMA 209
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGR---------RA---IDTTRPTYEQNLVTWAQ 305
PE + D+++ G++++E++ G +A + + P +N +
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSP 269
Query: 306 PF--F------KDPNRYPQLADPLLQGEF 326
F +DP A LL F
Sbjct: 270 VLRDFLERMLVRDPQERAT-AQELLDHPF 297
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 76/269 (28%), Positives = 120/269 (44%), Gaps = 39/269 (14%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN 141
+ F +GEG +G VYK ++T Q+VA+KQ+ +E I E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAAKGLE 198
+V G +V EY S+ D ++ + + T +IA KGLE
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKT-----LTEDEIATILQSTLKGLE 139
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYCA 257
YLH I+RD+K+ NILL+ E +AKL+DFG+ +L K + V+GT + A
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMA 193
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGR---------RA---IDTTRPTYEQNLVTWAQ 305
PE + +D+++ G+ +E+ G+ RA I T P + W+
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSD 253
Query: 306 PF--F------KDPNRYPQLADPLLQGEF 326
F F K P + A LLQ F
Sbjct: 254 NFTDFVKQCLVKSPEQRAT-ATQLLQHPF 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYC 149
++G+G +G VY G+ +A+K++ + ++ E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 150 ADGEQRLLVYEYMPLRSLEDHL-LDIGPEQKP---IDWFTRMKIALGAAKGLEYLHDKAN 205
++ + E +P SL L GP + I ++T+ +I L +GL+YLHD
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QI-L---EGLKYLHDNQ- 142
Query: 206 PPVIYRDLKSSNILLDCEF-NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE--YQR 262
+++RD+K N+L++ K+SDFG +K + + GT Y APE +
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 263 TGQLTVKSDVYTFGVVLLELITGRR 287
+D+++ G ++E+ TG+
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 71/300 (23%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN 141
+ + +G+G FG+VYK K ++T + A K ++ + +++IVE+ +L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAAKGLE 198
+V L+G + ++ E+ P +++ ++ T +I + + L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRG-----LTEPQIQVVCRQMLEALN 131
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDK--THVSSRVMGTYGY 255
+LH K +I+RDLK+ N+L+ E + +L+DFG+ AK K + + GT +
Sbjct: 132 FLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYW 183
Query: 256 CAPE-----YQRTGQLTVKSDVYTFGVVLLELITGR---------RA---IDTTRPTYEQ 298
APE + K+D+++ G+ L+E+ R I + P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL 243
Query: 299 NLVTWAQPF--F------KDPNRYPQLADPLLQGEF-----PVRGLNQAVAVSAMCVQEE 345
W+ F F K+P P A LL+ F + L + VA + V EE
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPS-AAQLLEHPFVSSITSNKALRELVAEAKAEVMEE 302
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 62/273 (22%), Positives = 106/273 (38%), Gaps = 39/273 (14%)
Query: 41 KTKPAQEPADDHKEANNNNKEAAGNNNIAAQTF-----------TFRELATATKNFRQEC 89
K + + NN K+ ++ ++ T+ +T ++E
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391
Query: 90 L-----IGEGGFGRVYKGKL---EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHD 140
+ IGEG FG V++G E A VA+K + ++F+ E L + H
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
++V LIG ++ E L L L + A + L YL
Sbjct: 452 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLAS---LILYAYQLSTALAYL 507
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG-----Y 255
K ++RD+ + N+L+ KL DFGL++ + D T+ + G +
Sbjct: 508 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKLPIKW 558
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRR 287
APE + T SDV+ FGV + E++ G +
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 91 IGEGGFGRVYKGKL-------EKTAQVVAVKQL-DRNGLQGNKEFIVEV-LMLSLLHHDN 141
+GEG FG+V + K A VAVK L D + + + E+ +M + H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------------MKI 189
++NL+G C ++ EY +L ++L P + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 190 ALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD--KTHVSS 247
A+G+EYL + I+RDL + N+L+ K++DFGLA+ D K +
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 248 RV----MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
R+ M APE T +SDV++FGV++ E+ T
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
+GE FG+VYKG L + Q VA+K L D+ +EF E ++ + L H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------------MKIALG 192
L+G + +++ Y L + L+ P + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 193 AAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD--KTHVSSRV- 249
A G+EYL V+++DL + N+L+ + N K+SD GL + D K +S +
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 250 ---MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
M APE G+ ++ SD++++GVVL E+ +
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 46/287 (16%)
Query: 19 QQSPGSPPNKEPA--SPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFR 76
S G P + A + + DD +A+++ E
Sbjct: 5 HHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG--------- 55
Query: 77 ELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLML 134
+ + IG GG +V++ L + Q+ A+K ++ + E+ L
Sbjct: 56 ------RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 135 SLLHH--DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIA 190
+ L D ++ L Y + +V E L L + ++ M
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNM--- 164
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM 250
+ + +H +++ DLK +N L+ + KL DFG+A + V +
Sbjct: 165 ---LEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 251 GTYGYCAPE-----------YQRTGQLTVKSDVYTFGVVLLELITGR 286
G Y PE + +++ KSDV++ G +L + G+
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEV-LMLSLLHHDNLV 143
+G G FG+V + E VAVK L + + E+ +M L H+N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR----------MKIALGA 193
NL+G C G L++ EY L + L + F + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
A+G+ +L K I+RD+ + N+LL AK+ DFGLA+ +M
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDS 218
Query: 254 GYC------------APEYQRTGQLTVKSDVYTFGVVLLELIT 284
Y APE TV+SDV+++G++L E+ +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLV 143
F + +G G G V+K + + V+A K + + I E+ +L + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
G + + E+M SL+ L G + I K+++ KGL YL +K
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREK 150
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD---KTHVSSRVMGTYGYCAPEY 260
+++RD+K SNIL++ KL DFG++ G + D + V GT Y +PE
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV-----GTRSYMSPER 201
Query: 261 QRTGQLTVKSDVYTFGVVLLELITGR 286
+ +V+SD+++ G+ L+E+ GR
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 32/227 (14%)
Query: 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLH 138
T+ + ++G+G V++G+ +KT + A+K + + + E +L L+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 139 HDNLVNLIGYCADGEQRL--LVYEYMPLRSLEDHLLDIG-----PEQKPIDWFTRMKIAL 191
H N+V L + R L+ E+ P SL L + PE + + +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV---- 121
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILL----DCEFNAKLSDFGLAKLGPIGDKTHVSS 247
G+ +L + +++R++K NI+ D + KL+DFG A+ + D S
Sbjct: 122 --VGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVS 174
Query: 248 RVMGTYGYCAPE-YQRTGQL-------TVKSDVYTFGVVLLELITGR 286
GT Y P+ Y+R D+++ GV TG
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 50/228 (21%)
Query: 91 IGEGGFGRVYKGKL-------EKTAQVVAVKQL-DRNGLQGNKEFIVEV-LMLSLLHHDN 141
+GEG FG+V + K A VAVK L D + + + E+ +M + H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKI 189
++NL+G C ++ EY +L ++L P ++ + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 190 ALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV 249
A+G+EYL + I+RDL + N+L+ K++DFGLA R
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA-------------RD 252
Query: 250 MGTYGYC-------------APEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ Y APE T +SDV++FGV++ E+ T
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 50/202 (24%), Positives = 79/202 (39%), Gaps = 13/202 (6%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV----EVLMLSLLHHDNLVNL 145
L+G GG G VY+ + ++VA+K + L + F E L ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+ Q + + L L GP + + I L+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAAG- 154
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+RD+K NIL+ + A L DFG+A T + + +GT Y APE
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESH 211
Query: 266 LTVKSDVYTFGVVLLELITGRR 287
T ++D+Y VL E +TG
Sbjct: 212 ATYRADIYALTCVLYECLTGSP 233
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-31
Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 21/214 (9%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLM-----LSLLH 138
+ + IG G +G V K + + Q++AVK++ +++ ++LM +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMRSSD 79
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQ-KPIDWFTRMKIALGAAKGL 197
+V G + E M S + + I KI L K L
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVMGTYGYC 256
+L + +I+RD+K SNILLD N KL DFG+ +L KT R G Y
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT----RDAGCRPYM 192
Query: 257 APE----YQRTGQLTVKSDVYTFGVVLLELITGR 286
APE V+SDV++ G+ L EL TGR
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 58/227 (25%), Positives = 87/227 (38%), Gaps = 48/227 (21%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEV-LMLSLLHHDNLV 143
+G G FG+V + A VAVK L L + + E+ ++ L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR--------------MKI 189
NL+G C G L++ EY L + L +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 190 ALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV 249
+ AKG+ +L K I+RDL + NILL K+ DFGLA+ +
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD------------I 195
Query: 250 MGTYGYC------------APEYQRTGQLTVKSDVYTFGVVLLELIT 284
Y APE T +SDV+++G+ L EL +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-31
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 41/226 (18%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
+GEG FG+V K VAVK L + ++ + E +L ++H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------------------ 186
L G C+ LL+ EY SL L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 187 --MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD--K 242
+ A ++G++YL + +++RDL + NIL+ K+SDFGL++ D
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 243 THVSSRV----MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
R+ M A E T +SDV++FGV+L E++T
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 46/221 (20%), Positives = 88/221 (39%), Gaps = 29/221 (13%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLL--H 138
+ + IG GG +V++ L + Q+ A+K ++ + E+ L+ L H
Sbjct: 9 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKG 196
D ++ L Y + +V E + L L + ++ M +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNM------LEA 120
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
+ +H +++ DLK +N L+ + KL DFG+A + V +GT Y
Sbjct: 121 VHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 257 APE-----------YQRTGQLTVKSDVYTFGVVLLELITGR 286
PE + +++ KSDV++ G +L + G+
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV----EVLMLSLLHHDNLVNL 145
++G GG V+ + + + VAVK L R L + F + E + L+H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 146 --IGYCADGEQRLLVY---EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
G A+ L Y EY+ +L D + + P+ +++ A + L +
Sbjct: 78 YDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFS 132
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGYCAPE 259
H +I+RD+K +NI++ K+ DFG+A+ + G+ ++ V+GT Y +PE
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGRR 287
R + +SDVY+ G VL E++TG
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 22/219 (10%)
Query: 82 TKNFRQECLIGEG--GFGRVYKGKLEKTAQVVAVKQLD-RNGLQGNKEFIV-EVLMLSLL 137
+ +IG+G V + + T + V V++++ F+ E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAA 194
+H N+V + +V +M S +D L+ + IA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDG----MNELAIAYILQGVL 138
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG-LAKLGPIGDKTHV----SSRV 249
K L+Y+H ++R +K+S+IL+ + LS + G + V
Sbjct: 139 KALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 250 MGTYGYCAPE--YQRTGQLTVKSDVYTFGVVLLELITGR 286
+ + +PE Q KSD+Y+ G+ EL G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 66/273 (24%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 55 ANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVK 114
++ ++ + G I Q + + +G G G+V+K + KT V+AVK
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 115 QLDRNGLQGNKEFIV---EVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHL 171
Q+ R+G + + I+ +V++ +V G + E M E
Sbjct: 57 QMRRSGNKEENKRILMDLDVVL-KSHDCPYIVQCFGTFITNTDVFIAMELMG-TCAEKLK 114
Query: 172 LDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231
+ PI K+ + K L YL +K VI+RD+K SNILLD KL DF
Sbjct: 115 KRMQ---GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDF 169
Query: 232 GL-AKLGPIGDKTHVSSRVMGTYGYCAPE-----YQRTGQLTVKSDVYTFGVVLLELITG 285
G+ +L K R G Y APE +++DV++ G+ L+EL TG
Sbjct: 170 GISGRLVDDKAKD----RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 286 RRAIDTTRPTYEQ--NLVTWAQPFFKDPNRYPQ 316
+ + +E ++ P +
Sbjct: 226 QFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 32/227 (14%)
Query: 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLH 138
T+ + ++G+G V++G+ +KT + A+K + + + E +L L+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 139 HDNLVNLIGYCADGEQRL--LVYEYMPLRSLEDHLLDIG-----PEQKPIDWFTRMKIAL 191
H N+V L + R L+ E+ P SL L + PE + + +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV---- 121
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILL----DCEFNAKLSDFGLAKLGPIGDKTHVSS 247
G+ +L + +++R++K NI+ D + KL+DFG A+ + D S
Sbjct: 122 --VGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVS 174
Query: 248 RVMGTYGYCAPE-YQRTGQL-------TVKSDVYTFGVVLLELITGR 286
GT Y P+ Y+R D+++ GV TG
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 44/273 (16%)
Query: 21 SPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELAT 80
+P P A PA+E + + +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR---------------------- 40
Query: 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK---EFIVEVLMLSLL 137
+ + + +G+GGF + ++ T +V A K + ++ L + +E+ + L
Sbjct: 41 --RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 98
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAK 195
H ++V G+ D + +V E RSL + E + R
Sbjct: 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-----AR-YYLRQIVL 152
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA-KLGPIGDKTHVSSRVMGTYG 254
G +YLH VI+RDLK N+ L+ + K+ DFGLA K+ G++ V GT
Sbjct: 153 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPN 206
Query: 255 YCAPE-YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y APE + G + + DV++ G ++ L+ G+
Sbjct: 207 YIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 238
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 62/314 (19%), Positives = 102/314 (32%), Gaps = 39/314 (12%)
Query: 90 LIGEGGFGRVYKGK-LEKTAQVVAVKQLDRNGLQGNKE-FIVEVLMLSLLHHDNLVNLIG 147
I GG G +Y + V +K L +G + + E L+ + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 148 YCADGEQRL-----LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
+ ++ +V EY+ +SL+ + + + L L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
++Y DLK NI+L E KL D G I + GT G+ APE
Sbjct: 201 I---GLVYNDLKPENIMLT-EEQLKLIDLGAVS--RINS----FGYLYGTPGFQAPE-IV 249
Query: 263 TGQLTVKSDVYTFGVVLLELITGRRAI--DTTRPTYEQNLVTWAQPFF---------KDP 311
TV +D+YT G L L E + V + DP
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDP 309
Query: 312 -NRYP---QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPD 367
R+ +++ L V + V + S D++ A + + D
Sbjct: 310 RQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQ 369
Query: 368 ADTATAPVPHKPPP 381
Sbjct: 370 VHAEKLTANEIVTA 383
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK---EFIVEVLMLSLLHH 139
+ + + +G+GGF + ++ T +V A K + ++ L + +E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGL 197
++V G+ D + +V E RSL + E + + ++ G
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGC 128
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA-KLGPIGDKTHVSSRVMGTYGYC 256
+YLH VI+RDLK N+ L+ + K+ DFGLA K+ G++ V GT Y
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYI 182
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELITGR 286
APE + + DV++ G ++ L+ G+
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 25/226 (11%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEV-LMLSLLHHDN 141
R ++ EGGF VY+ + + + A+K+L N + N+ I EV M L H N
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 142 LVNLIGYCADGEQR-------LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA 194
+V + G++ L+ + L + L + + P+ T +KI
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTC 146
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA---KLGPIGDKTHVSSRVM- 250
+ ++++H + PP+I+RDLK N+LL + KL DFG A P + ++
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 251 ------GTYGYCAPE----YQRTGQLTVKSDVYTFGVVLLELITGR 286
T Y PE Y + K D++ G +L L +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQ 250
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEV-LMLSLLHHDNLV 143
+G G FG+V + T + VAVK L + ++ + E+ +++ + HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 144 NLIGYCADGEQ-RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------------MKIA 190
NL+G C +++ E+ +L +L E P + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD--KTHVSSR 248
AKG+E+L + I+RDL + NILL + K+ DFGLA+ +R
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 249 V----MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ M APE T++SDV++FGV+L E+ +
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 91 IGEGGFGRVYKGKL-------EKTAQVVAVKQL-DRNGLQGNKEFIVEV-LMLSLLHHDN 141
+GEG FG+V + VAVK L + + I E+ +M + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------------MKI 189
++NL+G C ++ EY +L ++L P + +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 190 ALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD--KTHVSS 247
A A+G+EYL K I+RDL + N+L+ + K++DFGLA+ D K +
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 248 RV----MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
R+ M APE T +SDV++FGV+L E+ T
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-30
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK---EFIVEVLMLSLLHH 139
++F+ L+G+G F VY+ + T VA+K +D+ + EV + L H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG---PEQKPIDWFTRMKIALGAAKG 196
+++ L Y D LV E + +L + E + + ++ G
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITG 124
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA-KLGPIGDKTHVSSRVMGTYGY 255
+ YLH +++RDL SN+LL N K++DFGLA +L +K + GT Y
Sbjct: 125 MLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNY 178
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
+PE ++SDV++ G + L+ GR
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
IGEG FGRV++ + + +VAVK L + +F E +++ + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------------------ 186
L+G CA G+ L++EYM L + L + P +
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 187 --MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD--K 242
+ IA A G+ YL ++ ++RDL + N L+ K++DFGL++ D K
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 243 THVSSRV----MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
+ + M PE + T +SDV+ +GVVL E+ +
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 53/232 (22%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEV-LMLSLLHHDNLV 143
+G G FG+V + VAVK L ++ + + E+ +M L H+N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR----------------- 186
NL+G C L++EY L ++L + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 187 --MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244
+ A AKG+E+L K+ ++RDL + N+L+ K+ DFGLA+
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD-------- 221
Query: 245 VSSRVMGTYGYC------------APEYQRTGQLTVKSDVYTFGVVLLELIT 284
+M Y APE G T+KSDV+++G++L E+ +
Sbjct: 222 ----IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 39/231 (16%), Positives = 72/231 (31%), Gaps = 26/231 (11%)
Query: 76 RELATATKNFRQECLIGEGGFGRVYKGK-----LEKTAQVVAVKQLDRNGLQGNKEFIVE 130
E +K L+GEG F +VY+ K Q +K EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIG 114
Query: 131 VLMLSLL---HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG-PEQKPIDWFTR 186
++ L + +LV E +L + + +K +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 187 MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL-----------DCEFNAKLSDFGLAK 235
+ A+ +E +HD +I+ D+K N +L D L D G +
Sbjct: 175 ISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
+ K + + T G+ E + D + + ++ G
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-29
Identities = 46/230 (20%), Positives = 80/230 (34%), Gaps = 36/230 (15%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN--GLQGNKEFIVEV-LMLSLLH 138
T F + IG G FG V+K + A+K+ + G + + EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
H ++V A+ + L+ EY SL D + + + L +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 199 YLHDKANPPVIYRDLKSSNILLD-------------------CEFNAKLSDFGLAKLGPI 239
Y+H + +++ D+K SNI + + K+ D G
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV----- 181
Query: 240 GDKTHVSSR--VMGTYGYCAPE-YQRTGQLTVKSDVYTFGVVLLELITGR 286
T +SS G + A E Q K+D++ + ++
Sbjct: 182 ---TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 8e-29
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNL 142
+ + +G GGFG V + + T + VA+KQ + N+E E+ ++ L+H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 143 VNLI------GYCADGEQRLLVYEYMPLRSLEDHLLDIG-----PEQKPIDWFTRMKIAL 191
V+ A + LL EY L +L E + +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI---- 130
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA---KLSDFGLAKLGPIGDKTHVSSR 248
+ L YLH+ +I+RDLK NI+L K+ D G AK + +
Sbjct: 131 --SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEF 183
Query: 249 VMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRR 287
V GT Y APE + TV D ++FG + E ITG R
Sbjct: 184 V-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLS-LLHHD 140
F L+G G +G+VYKG+ KT Q+ A+K +D G +E E+ ML HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 141 NLVNLIG-----YCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL--- 191
N+ G + +L LV E+ S+ D L+ IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNT----LKEEWIAYICR 136
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL-AKLGPIGDKTHVSSRVM 250
+GL +LH VI+RD+K N+LL KL DFG+ A+L + + +
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FI 190
Query: 251 GTYGYCAPE-----YQRTGQLTVKSDVYTFGVVLLELITG 285
GT + APE KSD+++ G+ +E+ G
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 65/215 (30%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLH 138
K F IG G FG VY + + ++VVA+K++ +G Q N ++ I EV L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL---GAAK 195
H N + G LV EY + + + P ++IA GA +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-------LQEVEIAAVTHGALQ 165
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR--VMGTY 253
GL YLH +I+RD+K+ NILL KL DFG A + ++ +GT
Sbjct: 166 GLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTP 214
Query: 254 GYCAPE---YQRTGQLTVKSDVYTFGVVLLELITG 285
+ APE GQ K DV++ G+ +EL
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 75/291 (25%), Positives = 118/291 (40%), Gaps = 33/291 (11%)
Query: 5 SCFSSRRINTSKKLQQSPGSPPNKEPASPAPR--HQNLKTKPAQEPADDHKEANNNNKEA 62
Q P K+ R H+ L P + D +
Sbjct: 116 DLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKW 175
Query: 63 AGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ 122
+ TF +R ++G+GGFG V ++ T ++ A K+L++ ++
Sbjct: 176 LERQPVTKNTFRQ---------YR---VLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223
Query: 123 GNKEF---IVEVLMLSLLHHDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQ 178
K + E +L ++ +V+L Y + + L LV M L+ H+ +G
Sbjct: 224 KRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAG 282
Query: 179 KPIDWFTRMKIALGAAK---GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235
F + AA+ GLE LH + ++YRDLK NILLD + ++SD GLA
Sbjct: 283 -----FPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAV 334
Query: 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
P G RV GT GY APE + + T D + G +L E+I G+
Sbjct: 335 HVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHH 139
F ++G GGFG V+ +++ T ++ A K+L++ L+ K + +VE +L+ +H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 140 DNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK--- 195
+V+L Y + + L LV M + H+ ++ + F + A+
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG---FQEPRAIFYTAQIVS 300
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
GLE+LH + +IYRDLK N+LLD + N ++SD GLA G GT G+
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGF 355
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
APE + D + GV L E+I R
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV----------EVL 132
++F+ ++GEG F V + T++ A+K L+ K I+ E
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERD 82
Query: 133 MLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIA 190
++S L H V L D E+ Y L ++ IG E TR A
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA 137
Query: 191 -LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRV 249
+ +A LEYLH K +I+RDLK NILL+ + + +++DFG AK+ K ++
Sbjct: 138 EIVSA--LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 250 MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
+GT Y +PE SD++ G ++ +L+ G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 81/294 (27%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 2 SCFSCFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANN-NNK 60
+C FS I + PP+ QNL+ Q+ + K K
Sbjct: 119 ACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWK 178
Query: 61 EAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG 120
N ++ F+ R +IG GGFG VY + T ++ A+K LD+
Sbjct: 179 NVELNIHLTMNDFSV---------HR---IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226
Query: 121 LQGNKEF---IVEVLMLSLLHHDN---LVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLD 173
++ + + E +MLSL+ + +V + Y +L + + M L HL
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQ 285
Query: 174 IGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233
G + F +I LG LE++H++ V+YRDLK +NILLD + ++SD GL
Sbjct: 286 HGVFSEADMRFYAAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL 338
Query: 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKS-DVYTFGVVLLELITGR 286
A K H + V GT+GY APE + G S D ++ G +L +L+ G
Sbjct: 339 ACDFS-KKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/243 (23%), Positives = 100/243 (41%), Gaps = 20/243 (8%)
Query: 52 HKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVV 111
H + N G+ F + ++ +++ +G G +G V + + T
Sbjct: 6 HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65
Query: 112 AVKQLDRNGLQGNKEFIV--EVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLED 169
A+K + + + + + EV +L LL H N++ L + D LV E L D
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 170 HLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEF 224
++ E +K L + YLH +++RDLK N+LL + +
Sbjct: 126 EIIHRMKFNEVDAAVI---IKQVLSG---VTYLHKHN---IVHRDLKPENLLLESKEKDA 176
Query: 225 NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284
K+ DFGL+ + + +GT Y APE R + K DV++ GV+L L+
Sbjct: 177 LIKIVDFGLSA---VFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232
Query: 285 GRR 287
G
Sbjct: 233 GYP 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 49/240 (20%), Positives = 93/240 (38%), Gaps = 33/240 (13%)
Query: 56 NNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQ 115
++ E + +F +++ +G G G + + + VAVK+
Sbjct: 9 QDDGDEETSVVIVGKISFCPKDV------------LGHGAEGTIVY-RGMFDNRDVAVKR 55
Query: 116 LDRNGLQG-NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDI 174
+ ++E V++L H N++ D + + + E +L++++
Sbjct: 56 ILPECFSFADRE--VQLLR-ESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQK 111
Query: 175 GPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL-----DCEFNAKLS 229
++ + + GL +LH +++RDLK NIL+ + A +S
Sbjct: 112 DFAHLGLE---PITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMIS 165
Query: 230 DFGLAK-LGPIGDKTHVSSRVMGTYGYCAPEY---QRTGQLTVKSDVYTFGVVLLELITG 285
DFGL K L S V GT G+ APE T D+++ G V +I+
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLIGY 148
+GEG +G V T + VAVK +D E I E+ + +L+H+N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
+G + L EY L D + PE +F ++ +A G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MA-----GVVYLHGIG-- 125
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRTGQ 265
+ +RD+K N+LLD N K+SDFGLA + ++ + +++ GT Y APE +R
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 266 LTVKSDVYTFGVVLLELITGR 286
DV++ G+VL ++ G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 42/217 (19%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHDNLVNLI 146
IG+G FG+V + T ++ A+K +++ E E+ ++ L H LVNL
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 147 GYCADGEQRL-LVYEYMP---LRSLEDHLLDIG--PEQKPIDWFTRMK-----IALGAAK 195
Y E+ + +V + + LR HL E+ +K + +
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRY---HLQQNVHFKEE-------TVKLFICELVMA--- 127
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
L+YL ++ +I+RD+K NILLD + ++DF +A + P + + GT Y
Sbjct: 128 -LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPY 180
Query: 256 CAPE-YQRTGQL----TVKSDVYTFGVVLLELITGRR 287
APE + V D ++ GV EL+ GRR
Sbjct: 181 MAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV--EVLMLSLLHHDNLVNLIGY 148
IG+G F +V + T + VA+K +D+ L + EV ++ +L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
+ L+ EY + D+L+ G E++ F ++ ++Y H K
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCHQKR-- 134
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRTGQ 265
+++RDLK+ N+LLD + N K++DFG + +G K G Y APE +Q
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQGKKY 190
Query: 266 LTVKSDVYTFGVVLLELITGR 286
+ DV++ GV+L L++G
Sbjct: 191 DGPEVDVWSLGVILYTLVSGS 211
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLIGY 148
+GEG +G V T + VAVK +D E I E+ + +L+H+N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
+G + L EY L D + PE +F ++ +A G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MA-----GVVYLHGIG-- 125
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRTGQ 265
+ +RD+K N+LLD N K+SDFGLA + ++ + +++ GT Y APE +R
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 266 LTVKSDVYTFGVVLLELITGR 286
DV++ G+VL ++ G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 56/258 (21%), Positives = 99/258 (38%), Gaps = 37/258 (14%)
Query: 52 HKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQ----ECLIGEGGFGRVYKGKLEKT 107
H +++ +E IA + + + +G G +G V K +
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMY--VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 108 AQVVAVKQLDRNGLQGNKEFIV-------------EVLMLSLLHHDNLVNLIGYCADGEQ 154
A+K + ++ + E+ +L L H N++ L D +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 155 RLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRD 212
LV E+ L + +++ E + MK L + YLH +++RD
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANI---MKQILSG---ICYLHKHN---IVHRD 171
Query: 213 LKSSNILL---DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVK 269
+K NILL + N K+ DFGL+ K + +GT Y APE + + K
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRLGTAYYIAPEVLK-KKYNEK 227
Query: 270 SDVYTFGVVLLELITGRR 287
DV++ GV++ L+ G
Sbjct: 228 CDVWSCGVIMYILLCGYP 245
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHHDNLVNLIG 147
+G+G FG V K + T Q AVK + + ++ + + EV +L L H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
+ D LV E L D ++ E ++ L + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI---IRQVLSG---ITYMHKNK- 146
Query: 206 PPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
+++RDLK N+LL + N ++ DFGL+ + + +GT Y APE
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVLH 201
Query: 263 TGQLTVKSDVYTFGVVLLELITGR 286
G K DV++ GV+L L++G
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGC 224
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-----FIVEVLMLSLL 137
+ + + IGEG +G V+K K +T ++VA+K++ R L + E + E+ +L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-R--LDDDDEGVPSSALREICLLKEL 58
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMP--LRS-LEDHLLDIGPEQKPIDWFTRMKIALGAA 194
H N+V L ++ LV+E+ L+ + D+ PE + F +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI--VKSFLFQLL----- 111
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKTHVSSRVMGT 252
KGL + H + V++RDLK N+L++ KL++FGLA+ P+ + V+ T
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-T 164
Query: 253 YGYCAPEYQRTGQLTVKSDVYTFGV-------VLLELITGRRAI 289
Y P+ + + +Y+ + + EL R +
Sbjct: 165 LWYRPPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 41/221 (18%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-----FIVEVLMLSLL 137
+ +++ +GEG +G VYK K + ++VA+K++ R L E I E+ +L L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRI-R--LDAEDEGIPSTAIREISLLKEL 76
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMP--LRS-LEDHLLDIGPEQKPIDWFTRMKIALGAA 194
HH N+V+LI LV+E+M L+ L+++ + Q I + +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQ--IKIYLYQLL----- 129
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKTHVSSRVMGT 252
+G+ + H +++RDLK N+L++ + KL+DFGLA+ P+ TH V+ T
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-T 182
Query: 253 YGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y AP+ Y + D+++ G + E+ITG+
Sbjct: 183 LWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 67/260 (25%), Positives = 100/260 (38%), Gaps = 38/260 (14%)
Query: 39 NLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGR 98
N + KE KE T + F + +G G FGR
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQ-----LDQFDRIKTLGTGSFGR 56
Query: 99 VYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV----------EVLMLSLLHHDNLVNLIGY 148
V K +++ A+K L +K+ +V E +L ++ LV L
Sbjct: 57 VMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
D +V EY+ + HL IG +P F +I L EYLH +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHSLD---L 162
Query: 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRTG-QL 266
IYRDLK N+L+D + +++DFG AK + +T + GT APE G
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---LCGTPEALAPEIILSKGYNK 217
Query: 267 TVKSDVYTFGVVLLELITGR 286
V D + GV++ E+ G
Sbjct: 218 AV--DWWALGVLIYEMAAGY 235
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 54/276 (19%), Positives = 101/276 (36%), Gaps = 24/276 (8%)
Query: 19 QQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFREL 78
+ + P P R + + ++N + + + + +
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDI---WKQYYPQPV 148
Query: 79 ATATKNFRQ----ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLML 134
+ +G G FG V++ T A K + + E+ +
Sbjct: 149 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTM 208
Query: 135 SLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG---PEQKPIDWFTRMKIAL 191
S+L H LVNL D + +++YE+M L + + D E + +++ M+
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY---MRQVC 265
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGPIGDKTHVSSRV 249
KGL ++H+ ++ DLK NI+ KL DFGL V
Sbjct: 266 ---KGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---T 316
Query: 250 MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITG 285
GT + APE + +D+++ GV+ L++G
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 91 IGEGGFGRVYKG--KLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIG- 147
+G G +G VYK K K + A+KQ++ G+ + E+ +L L H N+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 148 YCADGEQRL-LVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRM--KIALGAAKGLEYLHD 202
+ + ++++ L+++Y L + +KP+ M + G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 203 KANPPVIYRDLKSSNILLDCEFNA----KLSDFGLAKL--GPIGDKTHVSSRVMGTYGYC 256
V++RDLK +NIL+ E K++D G A+L P+ + V+ T+ Y
Sbjct: 147 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 202
Query: 257 APE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
APE Y T D++ G + EL+T
Sbjct: 203 APELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 41/221 (18%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-----FIVEVLMLSLL 137
+ + IGEG +G VYK + + A+K++ R L+ E I E+ +L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKI-R--LEKEDEGIPSTTIREISILKEL 57
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMP--LRS-LEDHLLDIGPEQKPIDWFTRMKIALGAA 194
H N+V L ++ +LV+E++ L+ L+ + F +
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT--AKSFLLQLL----- 110
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKTHVSSRVMGT 252
G+ Y HD+ V++RDLK N+L++ E K++DFGLA+ P+ TH ++ T
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-T 163
Query: 253 YGYCAPEYQRTGQLTVKSDVYTFGV-------VLLELITGR 286
Y AP+ + + S Y+ + + E++ G
Sbjct: 164 LWYRAPD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 24/223 (10%)
Query: 76 RELATATKNFRQ----ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-- 129
RE F + C++G+G FG V K K T Q AVK +++ + +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 130 EVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRM 187
EV +L L H N++ L D +V E L D ++ E D +
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH---DAARII 127
Query: 188 KIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLGPIGDKTH 244
K + Y+H +++RDLK NILL + + + K+ DFGL+ +
Sbjct: 128 KQVFSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNT 178
Query: 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRR 287
+GT Y APE R G K DV++ GV+L L++G
Sbjct: 179 KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTP 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 38/225 (16%)
Query: 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQ--LDRNGLQGNKE-----FIVEVL 132
+++ F+Q +G G + VYKG + T VA+K+ LD ++E I E+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD------SEEGTPSTAIREIS 55
Query: 133 MLSLLHHDNLVNLIGYCADGEQRLLVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRMKIA 190
++ L H+N+V L + LV+E+M L+ D +G + ++
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSR-TVGNTPRGLELNLVKYFQ 114
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKTHVSSR 248
+GL + H+ +++RDLK N+L++ KL DFGLA+ P+ +
Sbjct: 115 WQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---E 168
Query: 249 VMGTYGYCAPEYQRTGQLTVKSDVYTFGV-------VLLELITGR 286
V+ T Y AP+ + + S Y+ + +L E+ITG+
Sbjct: 169 VV-TLWYRAPD------VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 56 NNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQ 115
+++ + ++ + F+ + + + L+GEG +G V K + + T ++VA+K+
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKK 57
Query: 116 L----DRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMP---LRSLE 168
D + K + E+ +L L H+NLVNL+ C ++ LV+E++ L LE
Sbjct: 58 FLESDDDKMV--KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE 115
Query: 169 DHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKL 228
+ + + + I G+ + H +I+RD+K NIL+ KL
Sbjct: 116 LFPNGLDYQV--VQKYLFQII-----NGIGFCHSHN---IIHRDIKPENILVSQSGVVKL 165
Query: 229 SDFGLAKL--GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGV-------VL 279
DFG A+ P V T Y APE L V Y V ++
Sbjct: 166 CDFGFARTLAAPGEVYDD---EVA-TRWYRAPE------LLVGDVKYGKAVDVWAIGCLV 215
Query: 280 LELITGR 286
E+ G
Sbjct: 216 TEMFMGE 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 69/302 (22%), Positives = 115/302 (38%), Gaps = 44/302 (14%)
Query: 8 SSRRINTSKKLQQSPGSPPNKEPASPA----PRHQNLKTKPAQEPADDHKEANNNNKEAA 63
SS N K ++ P ++L+ P+Q + N+ +
Sbjct: 8 SSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67
Query: 64 GNNNIAAQTFTFRE---LATATKNFRQE----CLIGEGGFGRVYKGKLEKTAQVVAVKQL 116
G N+ Q+ + A K F Q+ +IG G V + T AVK +
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 117 DRNGLQGNKEFIVEVL---------MLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSL 167
+ + + E + EV + + H +++ LI LV++ M L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 168 EDHLLDIG--PEQKPIDWFTR--MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE 223
D+L + E++ TR M+ L A + +LH +++RDLK NILLD
Sbjct: 188 FDYLTEKVALSEKE-----TRSIMRSLLEA---VSFLHANN---IVHRDLKPENILLDDN 236
Query: 224 FNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE------YQRTGQLTVKSDVYTFGV 277
+LSDFG + + + GT GY APE + + D++ GV
Sbjct: 237 MQIRLSDFGFSCH--LEPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
Query: 278 VL 279
+L
Sbjct: 294 IL 295
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 71/291 (24%), Positives = 112/291 (38%), Gaps = 67/291 (23%)
Query: 22 PGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATA 81
P + E P + + D K G +
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDR------------PQ 52
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN 141
++ +IG G FG VY+ KL + ++VA+K++ LQ + E+ ++ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108
Query: 142 LVNLIGY-CADGEQRL-----LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA- 194
+V L + + GE++ LV +Y+P E + + ++R K L
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP----ET-V------YRVARHYSRAKQTLPVIY 157
Query: 195 ---------KGLEYLHDKANPPVIYRDLKSSNILLDCEFNA-KLSDFGLAK-LGPIGDKT 243
+ L Y+H + +RD+K N+LLD + KL DFG AK L
Sbjct: 158 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 244 H-VSSRVMGTYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
+ SR Y Y APE Y T DV++ G VL EL+ G+
Sbjct: 215 SYICSR----Y-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 61/284 (21%), Positives = 112/284 (39%), Gaps = 28/284 (9%)
Query: 13 NTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQT 72
N + ++ G ++ + A + + P + + A
Sbjct: 18 NLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA-----PPAP 72
Query: 73 FTFRELATATKNFR------QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE 126
F R + + ++G G FG+V+K + T +A K + G++ +E
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 127 FIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG---PEQKPIDW 183
E+ +++ L H NL+ L +LV EY+ L D ++D E I +
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 184 FTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA--KLSDFGLAKLGPIGD 241
MK G+ ++H +++ DLK NIL K+ DFGLA+ +
Sbjct: 193 ---MKQICE---GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITG 285
K V GT + APE ++ +D+++ GV+ L++G
Sbjct: 244 KLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 48/229 (20%), Positives = 84/229 (36%), Gaps = 34/229 (14%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEV-LMLSLLHHDN 141
E ++G G G V + + VAVK++ ++E+ L+ H N
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPN 70
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRM---KIALGAAKGLE 198
++ + E L +L+D + + + + A G+
Sbjct: 71 VIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 199 YLHDKANPPVIYRDLKSSNILLD-------------CEFNAKLSDFGLAKLGPIGDKTHV 245
+LH +I+RDLK NIL+ +SDFGL K G +
Sbjct: 130 HLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 246 SSR--VMGTYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITG 285
++ GT G+ APE Q +LT D+++ G V +++
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-23
Identities = 61/212 (28%), Positives = 88/212 (41%), Gaps = 38/212 (17%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQL----DRNGLQGNKEFIVEVLMLSLLHHDNLVNLI 146
IGEG +G V+K + T Q+VA+K+ D + K + E+ ML L H NLVNL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLKHPNLVNLL 68
Query: 147 GYCADGEQRLLVYEYMP---LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
+ LV+EY L L+ + + + T + + + + H
Sbjct: 69 EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL--VKSITWQTL-----QAVNFCHKH 121
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKTHVSSRVMGTYGYCAPEYQ 261
I+RD+K NIL+ KL DFG A+L GP V T Y +PE
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD---EVA-TRWYRSPE-- 172
Query: 262 RTGQLTVKSDVYTFGV-------VLLELITGR 286
L V Y V V EL++G
Sbjct: 173 ----LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 32/220 (14%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV--------EVLML 134
+ + +G G FG V+ ++ + V VK + + + + E+ +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 135 SLLHHDNLVNLIGYCADGEQRLLVYE-YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGA 193
S + H N++ ++ + LV E + L + ++ P R+ L +
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-----DRHP-----RLDEPLAS 133
Query: 194 AK------GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247
+ YL K +I+RD+K NI++ +F KL DFG A G +
Sbjct: 134 YIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190
Query: 248 RVMGTYGYCAPE-YQRTGQLTVKSDVYTFGVVLLELITGR 286
GT YCAPE + ++++ GV L L+
Sbjct: 191 ---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV----EVLMLSLLHHDNLVNL 145
L+GEG +G+V + +T AVK L + L+ E+ +L L H N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 146 --IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK------GL 197
+ Y + ++ +V EY E +LD PE+ R + GL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQAHGYFCQLIDGL 122
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
EYLH + ++++D+K N+LL K+S G+A+ G+ +
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 258 PEYQRTGQL--TVKSDVYTFGVVLLELITGR 286
PE K D+++ GV L + TG
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 1e-22
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 47/216 (21%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV----------EVLMLSLLHH 139
+G G FGRV+ + + A+K L KE +V E LMLS++ H
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMK-----IALG 192
++ + G D +Q ++ +Y+ L L P K + L
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-------VAKFYAAEVCLA 118
Query: 193 AAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT 252
LEYLH K +IYRDLK NILLD + K++DFG AK + D T+ + GT
Sbjct: 119 ----LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYT---LCGT 166
Query: 253 YGYCAPE-YQRTG-QLTVKSDVYTFGVVLLELITGR 286
Y APE ++ D ++FG+++ E++ G
Sbjct: 167 PDYIAPEVVSTKPYNKSI--DWWSFGILIYEMLAGY 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 45/223 (20%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQ--LDRNGLQGNKE-----FIVEVLMLS 135
+ + + +GEG + VYKGK + T +VA+K+ L+ ++E I EV +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLE------HEEGAPCTAIREVSLLK 55
Query: 136 LLHHDNLVNLIGYCADGEQRLLVYEYMP--LRS-LEDHLLDIGPEQKPIDWFTRMKIALG 192
L H N+V L + LV+EY+ L+ L+D I + F +
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN--VKLFLFQLL--- 110
Query: 193 AAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKTHVSSRVM 250
+GL Y H + V++RDLK N+L++ KL+DFGLA+ P + V+
Sbjct: 111 --RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV 162
Query: 251 GTYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
T Y P+ Y + + D++ G + E+ TGR
Sbjct: 163 -TLWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 37/221 (16%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-----FIVEVLMLSLL 137
K + + +GEG F VYK + + T Q+VA+K++ K+ + E+ +L L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMP--LRSL-EDHLLDIGPEQKPIDWFTRMKIALGAA 194
H N++ L+ LV+++M L + +D+ L + P I + M +
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH--IKAYMLMTL----- 122
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKTHVSSRVMGT 252
+GLEYLH +++RDLK +N+LLD KL+DFGLAK P TH +V+ T
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-T 175
Query: 253 YGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y APE Y V D++ G +L EL+
Sbjct: 176 RWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIV-EVLMLSLLHHDNLVNLI 146
+G G FG+V G+ + T VAVK L+R ++ I E+ L L H +++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
+ +V EY+ L D++ G E + F + ++ ++Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF-QQILS-----AVDYCHRHM 131
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRT 263
V++RDLK N+LLD NAK++DFGL+ + G+ S G+ Y APE
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGR 185
Query: 264 GQLTVKSDVYTFGVVLLELITGR 286
+ D+++ GV+L L+ G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGT 208
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 53/255 (20%), Positives = 102/255 (40%), Gaps = 26/255 (10%)
Query: 45 AQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKL 104
+ A N+ A + +E ++ L+G GGFG VY G
Sbjct: 5 HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIR 64
Query: 105 EKTAQVVAVKQLDRNGLQGNKEFIV------EVLMLSLLHHD--NLVNLIGYCADGEQRL 156
VA+K ++++ + E EV++L + ++ L+ + + +
Sbjct: 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124
Query: 157 LVYEY-MPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDL 213
L+ E P++ L D + + G E+ +F ++ + + + H+ V++RD+
Sbjct: 125 LILERPEPVQDLFDFITERGALQEELARSFFWQV------LEAVRHCHNCG---VLHRDI 175
Query: 214 KSSNILLDCE-FNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY-QRTGQLTVKSD 271
K NIL+D KL DFG L GT Y PE+ + +
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIRYHRYHGRSAA 231
Query: 272 VYTFGVVLLELITGR 286
V++ G++L +++ G
Sbjct: 232 VWSLGILLYDMVCGD 246
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 71/285 (24%), Positives = 113/285 (39%), Gaps = 14/285 (4%)
Query: 6 CFSSRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGN 65
F R + + ++++ +E Q + ++ A + + + + +G
Sbjct: 72 TFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGA 131
Query: 66 NNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK 125
+ + T F L+G+G FG+V K + T + A+K L + +
Sbjct: 132 EEMEVSLAKPKHRVTMN-EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD 190
Query: 126 EF---IVEVLMLSLLHHDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPI 181
E + E +L H L L Y RL V EY L HL +
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR 249
Query: 182 DWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241
F +I L+YLH + N V+YRDLK N++LD + + K++DFGL K G
Sbjct: 250 ARFYGAEIVS----ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303
Query: 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
T GT Y APE D + GVV+ E++ GR
Sbjct: 304 AT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 60/257 (23%), Positives = 106/257 (41%), Gaps = 36/257 (14%)
Query: 52 HKEANNNNKEAAGNNNIAAQTF---TFRELATATKNFRQE----CLIGEGGFGRVYKGKL 104
+ NNN++ A + F T + + K R E +G G G V
Sbjct: 97 RRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFE 156
Query: 105 EKTAQVVAVKQLDRNGLQGNKEFIV--------EVLMLSLLHHDNLVNLIGYCADGEQRL 156
KT + VA++ + + E+ +L L+H ++ + + D E
Sbjct: 157 RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYY 215
Query: 157 LVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLK 214
+V E M L D ++ E +F +M ++YLH+ +I+RDLK
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQM------LLAVQYLHENG---IIHRDLK 266
Query: 215 SSNILL---DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE---YQRTGQLTV 268
N+LL + + K++DFG +K+ +G+ + + + GT Y APE T
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNR 323
Query: 269 KSDVYTFGVVLLELITG 285
D ++ GV+L ++G
Sbjct: 324 AVDCWSLGVILFICLSG 340
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 48/259 (18%), Positives = 105/259 (40%), Gaps = 23/259 (8%)
Query: 36 RHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQ----ECLI 91
R + + + N+ + + + + + + + +
Sbjct: 2 RGSHHHHHHGSKVRGKYDGPKINDYDKFYED--IWKKYVPQPVEVKQGSVYDYYDILEEL 59
Query: 92 GEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD 151
G G FG V++ + T +V K ++ E+ +++ LHH L+NL D
Sbjct: 60 GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED 119
Query: 152 GEQRLLVYEYMPLRSLEDHLLDIG---PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
+ +L+ E++ L D + E + I++ M+ A GL+++H+ + +
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY---MRQACE---GLKHMHEHS---I 170
Query: 209 IYRDLKSSNILLDCEFNA--KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL 266
++ D+K NI+ + + + K+ DFGLA + + T + APE +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 267 TVKSDVYTFGVVLLELITG 285
+D++ GV+ L++G
Sbjct: 228 GFYTDMWAIGVLGYVLLSG 246
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 44/224 (19%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-----FIVEVLMLSLLH 138
+R+ +GEG +G VYK T + VA+K++ R L+ +E I EV +L L
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-R--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
H N++ L + L++EY L+ D D+ I F I G
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRV--IKSFLYQLI-----NG 144
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNA-----KLSDFGLAKL--GPIGDKTHVSSRV 249
+ + H + ++RDLK N+LL + K+ DFGLA+ PI TH +
Sbjct: 145 VNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EI 198
Query: 250 MGTYGYCAPEYQRTGQLTVKSDVYTFGV-------VLLELITGR 286
+ T Y PE + + S Y+ V + E++
Sbjct: 199 I-TLWYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-22
Identities = 46/195 (23%), Positives = 87/195 (44%), Gaps = 18/195 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYC 149
++G G F V+ K T ++ A+K + ++ + E+ +L + H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPP 207
LV + + L D +L+ G E+ ++ ++YLH+
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV------LSAVKYLHENG--- 126
Query: 208 VIYRDLKSSNILL---DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG 264
+++RDLK N+L + ++DFGL+K+ ++ + S GT GY APE
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQK 182
Query: 265 QLTVKSDVYTFGVVL 279
+ D ++ GV+
Sbjct: 183 PYSKAVDCWSIGVIT 197
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 68/279 (24%), Positives = 106/279 (37%), Gaps = 54/279 (19%)
Query: 36 RHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGG 95
H+ + + + + T +NF ++G G
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGA 66
Query: 96 FGRVY---KGKLEKTAQVVAVKQLDRNGLQGNKEFIVE-------------VLMLSLLHH 139
+G+V+ K T ++ A+K L K IV+ VL
Sbjct: 67 YGKVFLVRKISGHDTGKLYAMKVL-------KKATIVQKAKTTEHTRTERQVLEHIR-QS 118
Query: 140 DNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMK-----IAL 191
LV L Y E +L L+ +Y+ L HL E ++ I L
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-------EVQIYVGEIVL 170
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG 251
LE+LH +IYRD+K NILLD + L+DFGL+K + D+T + G
Sbjct: 171 A----LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCG 222
Query: 252 TYGYCAPE---YQRTGQLTVKS-DVYTFGVVLLELITGR 286
T Y AP+ +G K+ D ++ GV++ EL+TG
Sbjct: 223 TIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 60/290 (20%), Positives = 106/290 (36%), Gaps = 37/290 (12%)
Query: 16 KKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTF 75
++L+Q P + L ++ T
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKV 66
Query: 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVL 132
+++ ++F +IG G FG V KL+ +V A+K L++ + E F E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 133 MLSLLHHDNLVNLIGYCA--DGEQRLLVYEYMP-------LRSLEDHLLDIGPEQKPIDW 183
+L + L + A D LV +Y L ED L P +
Sbjct: 127 VLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL--------PEEM 176
Query: 184 --FTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241
F ++ + ++ +H ++RD+K NIL+D + +L+DFG + D
Sbjct: 177 ARFYLAEMVIA----IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL-MED 228
Query: 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKS-----DVYTFGVVLLELITGR 286
T SS +GT Y +PE + + D ++ GV + E++ G
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN 141
F+ E + G+G FG V GK + T VA+K++ ++ N+E + + L++LHH N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 142 LVNLI------GYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA 194
+V L G + L +V EY+P + L + + R ++A
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-L------HRCCRNYYRRQVAPPPI 129
Query: 195 ----------KGLEYLHDK-ANPPVIYRDLKSSNILLDCEFNA-KLSDFGLAK-LGPIGD 241
+ + LH N V +RD+K N+L++ KL DFG AK L P
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 242 KTH-VSSRVMGTYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
+ SR Y Y APE Y T D+++ G + E++ G
Sbjct: 188 NVAYICSR----Y-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 62/249 (24%), Positives = 102/249 (40%), Gaps = 56/249 (22%)
Query: 64 GNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG 123
N I + + +IG G FG V++ KL ++ + VA+K++ LQ
Sbjct: 21 PNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV----LQD 75
Query: 124 NKEFIVEVLMLSLLHHDNLVNLIGY-----CADGEQRL-LVYEYMPLRSLEDHLLDIGPE 177
+ E+ ++ ++ H N+V+L + E L LV EY+P E +
Sbjct: 76 KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ET-V------ 124
Query: 178 QKPIDWFTRMKIALGAA----------KGLEYLHDKANPPVIYRDLKSSNILLDCEFNA- 226
+ + ++K + + L Y+H + +RD+K N+LLD
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIG--ICHRDIKPQNLLLDPPSGVL 181
Query: 227 KLSDFGLAK-LGPIGDKTH-VSSRVMGTYGYCAPE-------YQRTGQLTVKSDVYTFGV 277
KL DFG AK L + SR Y Y APE Y T D+++ G
Sbjct: 182 KLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELIFGATNY------TTNIDIWSTGC 230
Query: 278 VLLELITGR 286
V+ EL+ G+
Sbjct: 231 VMAELMQGQ 239
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQ--LDRNGLQGNKEF----IVEV---LML 134
+ IG G +G VYK + + VA+K + G G + EV L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG-GGGGGLPISTVREVALLRRL 68
Query: 135 SLLHHDNLVNLI----GYCADGEQRL-LVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRM 187
H N+V L+ D E ++ LV+E++ LR+ D G + I R
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 188 KIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247
+ +GL++LH +++RDLK NIL+ KL+DFGLA+ + ++
Sbjct: 129 FL-----RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTP 178
Query: 248 RVMGTYGYCAPE------YQRTGQLTVKSDVYTFGVVLLELITGR 286
V+ T Y APE Y D+++ G + E+ +
Sbjct: 179 VVV-TLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRK 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 29/225 (12%)
Query: 76 RELATATKNFRQ----ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-E 130
RE + +G G FG V+ + + +K ++++ Q E I E
Sbjct: 11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE 70
Query: 131 VLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLD-IGPEQKPIDWFTR--- 186
+ +L L H N++ + D +V E E LL+ I Q +
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC--EGGE--LLERIVSAQARGKALSEGYV 126
Query: 187 ---MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLGPIG 240
MK + A L Y H + V+++DLK NIL K+ DFGLA+ +
Sbjct: 127 AELMKQMMNA---LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LF 177
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITG 285
S+ GT Y APE + +T K D+++ GVV+ L+TG
Sbjct: 178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 49/194 (25%), Positives = 76/194 (39%), Gaps = 18/194 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IG G +G V + T A K++ + ++ F E+ ++ L H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 151 DGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208
D LV E L + ++ E D MK L A + Y H V
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRES---DAARIMKDVLSA---VAYCHKLN---V 127
Query: 209 IYRDLKSSNILL---DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
+RDLK N L + KL DFGLA + +GT Y +P+ G
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVLE-GL 183
Query: 266 LTVKSDVYTFGVVL 279
+ D ++ GV++
Sbjct: 184 YGPECDEWSAGVMM 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 54/244 (22%), Positives = 89/244 (36%), Gaps = 52/244 (21%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-----EVLMLSLLHHDNLVNL 145
IG+G +G V +T + A+K +++N ++ V EV ++ LHH N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALG------------- 192
D + LV E L D L + +K +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 193 ----------------AAK-------GLEYLHDKANPPVIYRDLKSSNILLDCEFNA--K 227
+ L YLH++ + +RD+K N L + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 228 LSDFGLAKL---GPIGDKTHVSSRVMGTYGYCAPE--YQRTGQLTVKSDVYTFGVVLLEL 282
L DFGL+K G+ ++++ GT + APE K D ++ GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 283 ITGR 286
+ G
Sbjct: 270 LMGA 273
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 33/213 (15%)
Query: 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEV-LMLSLLHHDNLVNL 145
QE ++GEG RV T+Q AVK +++ EV ++ H N++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------MKIALGAAKGLEY 199
I + + ++ LV+E M S+ H+ F ++ A L++
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRR-------HFNELEASVVVQDVASA---LDF 126
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNA---KLSDFGLAK-LGPIGDKTHVSSRVM----G 251
LH+K + +RDLK NIL + K+ DF L + GD + +S+ + G
Sbjct: 127 LHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 252 TYGYCAPEYQRTGQLTVKS-----DVYTFGVVL 279
+ Y APE D+++ GV+L
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 76 RELATATKNFRQE----CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-- 129
RE F + C++G+G FG V K K T Q AVK +++ + +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 130 EVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRM 187
EV +L L H N++ L D +V E L D ++ E D +
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH---DAARII 127
Query: 188 KIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLGPIGDKTH 244
K + Y+H +++RDLK NILL + + + K+ DFGL+ +
Sbjct: 128 KQVFSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNT 178
Query: 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVL 279
+GT Y APE R G K DV++ GV+L
Sbjct: 179 KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 54/210 (25%), Positives = 83/210 (39%), Gaps = 23/210 (10%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHHDNLVNLI 146
+IG G F V K+++T QV A+K +++ + E F E +L + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 147 GYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDW--FTRMKIALGAAKGLEYLHDK 203
+ E L LV EY L L G + P + F +I + ++ +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMA----IDSVHRL 181
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQR 262
++RD+K NILLD + +L+DFG V GT Y +PE Q
Sbjct: 182 G---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQA 237
Query: 263 TGQLTVKS------DVYTFGVVLLELITGR 286
G D + GV E+ G+
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 5e-21
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 84 NFRQECLIGEGGFGRVY---KGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLM----LSL 136
F ++G+G FG+V+ K Q+ A+K L + L+ V M L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILVE 82
Query: 137 LHHDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMK----- 188
++H +V L Y E +L L+ +++ L L E+ +K
Sbjct: 83 VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------DVKFYLAE 134
Query: 189 IALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR 248
+AL L++LH +IYRDLK NILLD E + KL+DFGL+K +K +
Sbjct: 135 LALA----LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYS 185
Query: 249 VMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
GT Y APE T +D ++FGV++ E++TG
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 34/221 (15%)
Query: 84 NFRQECLIGEGGFGRVYKGK-LEKTAQVVAVKQLDRNGLQGNKE-----FIVEV---LML 134
+ IGEG +G+V+K + L+ + VA+K++ R +Q +E I EV L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-R--VQTGEEGMPLSTIREVAVLRHL 68
Query: 135 SLLHHDNLVNLI----GYCADGEQRL-LVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRM 187
H N+V L D E +L LV+E++ L + D + + G + I
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 188 KIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSS 247
+ +GL++LH V++RDLK NIL+ KL+DFGLA+ + ++S
Sbjct: 129 LL-----RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTS 178
Query: 248 RVMGTYGYCAPE--YQRTGQLTVKSDVYTFGVVLLELITGR 286
V+ T Y APE Q + V D+++ G + E+ +
Sbjct: 179 VVV-TLWYRAPEVLLQSSYATPV--DLWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 46/222 (20%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-F----IVEVLMLSLLHHDNLVNL 145
IG+G FG V+K + KT Q VA+K++ ++ KE F + E+ +L LL H+N+VNL
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 146 IGYCADGEQRL--------LVYEYMP--LRSL-EDHLLDIGPEQKPIDWFTRMKIALGAA 194
I C LV+++ L L + L+ + I +M +
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLL----- 134
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV---SSRVMG 251
GL Y+H +++RD+K++N+L+ + KL+DFGLA+ + + ++RV+
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190
Query: 252 TYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
T Y PE Y D++ G ++ E+ T
Sbjct: 191 TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 65/217 (29%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---IVEVLMLSLLHHD 140
+F L+G+G FG+V + + T + A+K L + + E + E +L H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 141 NLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMK-----IALG 192
L L Y RL V EY L HL E+ R + I
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------RARFYGAEIVS- 116
Query: 193 AAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT 252
LEYLH + V+YRD+K N++LD + + K++DFGL K G T GT
Sbjct: 117 ---ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGT 168
Query: 253 YGYCAPE---YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y APE G+ V D + GVV+ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR 202
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 29/234 (12%)
Query: 64 GNNNIAAQTFTFRELATATKNFRQE----CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN 119
G+ I+ ++A F +IG+G F V + +T Q AVK +D
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 120 GLQGNKEFIV-----EVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDI 174
+ E + +L H ++V L+ + +V+E+M L +I
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF---EI 117
Query: 175 GPEQKPIDWFTR------MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFN 225
++ M+ L A L Y HD +I+RD+K +LL +
Sbjct: 118 VKRADAGFVYSEAVASHYMRQILEA---LRYCHDNN---IIHRDVKPHCVLLASKENSAP 171
Query: 226 AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVL 279
KL FG+A +G+ V+ +GT + APE + DV+ GV+L
Sbjct: 172 VKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 59/283 (20%), Positives = 99/283 (34%), Gaps = 49/283 (17%)
Query: 13 NTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQT 72
N+ + P P P P P + +P P + + + N I
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63
Query: 73 FTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEV- 131
++ +G G G+V + ++T + A+K L EV
Sbjct: 64 KVTSQV------------LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVE 106
Query: 132 LMLSLLHHDNLVNLIGYCADGEQR----LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR- 186
L ++V ++ + L+V E + L + D G + FT
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-----FTER 161
Query: 187 -----MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NA--KLSDFGLAKLGP 238
MK A ++YLH + +RD+K N+L + NA KL+DFG AK
Sbjct: 162 EASEIMKSIGEA---IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 239 IGD--KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVL 279
+ T T Y APE + D+++ GV++
Sbjct: 216 SHNSLTTPC-----YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 74/313 (23%), Positives = 122/313 (38%), Gaps = 58/313 (18%)
Query: 26 PNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNF 85
+ ++ KEA N + ++++ Q F L
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDL--LR------ 58
Query: 86 RQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVE------------VLM 133
+IG G + +V +L+KT ++ A++ + KE + + V
Sbjct: 59 ----VIGRGSYAKVLLVRLKKTDRIYAMRVV-------KKELVNDDEDIDWVQTEKHVFE 107
Query: 134 LSLLHHDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALG 192
+ +H LV L C E RL V EY+ L H+ + F +I+L
Sbjct: 108 QA-SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL- 164
Query: 193 AAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT 252
L YLH++ +IYRDLK N+LLD E + KL+D+G+ K G T +S GT
Sbjct: 165 ---ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGT 216
Query: 253 YGYCAPE------YQRTGQLTVKSDVYTFGVVLLELITGR---RAIDTTRPTYEQNLVTW 303
Y APE Y +V D + GV++ E++ GR + ++ +
Sbjct: 217 PNYIAPEILRGEDYGF----SV--DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270
Query: 304 AQPFFKDPNRYPQ 316
Q + R P+
Sbjct: 271 FQVILEKQIRIPR 283
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV------EVLMLSLLH----H 139
L+G+GGFG V+ G VA+K + RN + G EV +L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 140 DNLVNLIGYCADGEQRLLVYEY-MPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKG 196
++ L+ + E +LV E +P + L D++ + G E +F ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQV------VAA 151
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNA-KLSDFGLAKLGPIGD-KTHVSSRVMGTYG 254
+++ H + V++RD+K NIL+D KL DFG L GT
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-----GTRV 203
Query: 255 YCAPEY-QRTGQLTVKSDVYTFGVVLLELITGR 286
Y PE+ R + + V++ G++L +++ G
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 55/252 (21%), Positives = 103/252 (40%), Gaps = 23/252 (9%)
Query: 37 HQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQE----CLIG 92
H + + ++ + ++ A+ A+ + + +G
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELG 62
Query: 93 EGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG 152
G VY+ K + T + A+K L + K E+ +L L H N++ L
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 153 EQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIY 210
+ LV E + L D +++ G E+ D ++ + + YLH+ +++
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI------LEAVAYLHENG---IVH 171
Query: 211 RDLKSSNILL---DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT 267
RDLK N+L + K++DFGL+K I + + V GT GYCAPE R
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 268 VKSDVYTFGVVL 279
+ D+++ G++
Sbjct: 229 PEVDMWSVGIIT 240
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV---EVLMLSLLHHDNLVNLI 146
+GEG FG+V KT Q VA+K + R L+ + + E+ L LL H +++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
++V EY L D++++ E + +F + I +EY H
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFF-QQIIC-----AIEYCHRHK 128
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRT 263
+++RDLK N+LLD N K++DFGL+ + G+ S G+ Y APE
Sbjct: 129 ---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVINGK 182
Query: 264 GQLTVKSDVYTFGVVLLELITGR 286
+ DV++ G+VL ++ GR
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 72/264 (27%), Positives = 102/264 (38%), Gaps = 63/264 (23%)
Query: 46 QEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLE 105
PA + N + N + F F L +IG+G FG+V + +
Sbjct: 13 ANPAPPPAPSQQINLGPSSNPHAKPSDFHF--LK----------VIGKGSFGKVLLARHK 60
Query: 106 KTAQVVAVKQLDRNGLQGNKEFIVE------------VLMLSLLHHDNLVNLIGYCADGE 153
AVK L K+ I++ VL+ ++ H LV L +
Sbjct: 61 AEEVFYAVKVL-------QKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLH-FSFQTA 111
Query: 154 QRL-LVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMK-----IALGAAKGLEYLHDKAN 205
+L V +Y+ L HL E R + IA L YLH
Sbjct: 112 DKLYFVLDYINGGELFYHLQRERCFLEP-------RARFYAAEIASA----LGYLHSLN- 159
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE---YQR 262
++YRDLK NILLD + + L+DFGL K + T +S GT Y APE Q
Sbjct: 160 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQP 215
Query: 263 TGQLTVKSDVYTFGVVLLELITGR 286
+ TV D + G VL E++ G
Sbjct: 216 YDR-TV--DWWCLGAVLYEMLYGL 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 45/209 (21%), Positives = 80/209 (38%), Gaps = 23/209 (11%)
Query: 82 TKNFRQE----CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV--EVLMLS 135
+ F +G+G F V + + T A K ++ L + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 136 LLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGA 193
L H N+V L + LV++ + L + ++ E ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI------ 114
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA---KLSDFGLAKLGPIGDKTHVSSRVM 250
+ + Y H +++R+LK N+LL + KL+DFGLA + D
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA- 168
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVL 279
GT GY +PE + + D++ GV+L
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 43/300 (14%), Positives = 87/300 (29%), Gaps = 53/300 (17%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLHHDN 141
+R G + ++ + VA+ +D G+ + +E + L LS +
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
+ ++ L+V E++ SL++ + D P P+ ++ A + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQE-VADTSPS--PVG---AIRAMQSLAAAADAAH 146
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
V S + +S G L
Sbjct: 147 RA---GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA-- 179
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321
+ D+ G L L+ R + L + P P D
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLP--EAGVRSGLAPAERDTAGQPIE-PADIDRD 231
Query: 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDADTATAPVPHKPPP 381
+ + AVA ++ Q + +R S +++ + + D P+ P
Sbjct: 232 IPFQI------SAVAARSV--QGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVS 282
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIV-EVLMLSLLHHDNLVNLI 146
+G G FG+V GK E T VAVK L+R ++ I E+ L L H +++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
+ +V EY+ L D++ G E++ F + ++ G++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF-QQILS-----GVDYCHRHM 136
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE-YQRT 263
V++RDLK N+LLD NAK++DFGL+ + G+ S G+ Y APE
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGR 190
Query: 264 GQLTVKSDVYTFGVVLLELITGR 286
+ D+++ GV+L L+ G
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGT 213
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 70/299 (23%), Positives = 110/299 (36%), Gaps = 39/299 (13%)
Query: 9 SRRINTSKKLQQSPGSPPNKEPASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNI 68
S S+ + E ++ ++ K G
Sbjct: 259 SLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAP 318
Query: 69 AAQTFTFRELATATKNFRQ------ECL--IGEGGFGRVYKGKLEKTAQVVAVKQLDRNG 120
+T N + L +G+G FG+V + + T ++ AVK L
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---- 374
Query: 121 LQGNKEFIVE------------VLMLSLLHHDNLVNLIGYCADGEQRL-LVYEYMPLRSL 167
K+ +++ VL L L L C RL V EY+ L
Sbjct: 375 ---KKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL 429
Query: 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK 227
H+ +G ++P F +IA+G L +L K +IYRDLK N++LD E + K
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQSKG---IIYRDLKLDNVMLDSEGHIK 482
Query: 228 LSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
++DFG+ K T + GT Y APE D + FGV+L E++ G+
Sbjct: 483 IADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 46/225 (20%)
Query: 84 NFRQECLIGEGGFGRVY---KGKLEKTAQVVAVKQLDRNGLQGNKEFIV----------- 129
F ++G+GG+G+V+ K T ++ A+K L K IV
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL-------KKAMIVRNAKDTAHTKA 70
Query: 130 EVLMLSLLHHDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIG--PEQKPIDWFTR 186
E +L + H +V+LI Y +L L+ EY+ L L G E
Sbjct: 71 ERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-------T 122
Query: 187 MK-----IALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241
I++ L +LH K +IYRDLK NI+L+ + + KL+DFGL K
Sbjct: 123 ACFYLAEISMA----LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175
Query: 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
+ GT Y APE D ++ G ++ +++TG
Sbjct: 176 TV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 75 FRELATATKNFRQE----CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVE 130
++L + F IG G + + + T AVK +D++ +E +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IE 67
Query: 131 VLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR---- 186
+ +L H N++ L DG+ +V E M L D +L F+
Sbjct: 68 I-LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-------FSEREAS 119
Query: 187 --MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL-DCEFNA---KLSDFGLAKLGPIG 240
+ +EYLH + V++RDLK SNIL D N ++ DFG AK +
Sbjct: 120 AVLFTITKT---VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LR 171
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVL 279
+ + T + APE D+++ GV+L
Sbjct: 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 37/165 (22%), Positives = 71/165 (43%), Gaps = 19/165 (11%)
Query: 135 SLLHHDNLVNLIGYCADGEQRLLVY---EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL 191
+ + N +G ++ +Y + +L+D ++ + + + I +
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHIFI 171
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-----------LGPIG 240
A+ +E+LH K +++RDLK SNI + K+ DFGL L P+
Sbjct: 172 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITG 285
+ +V GT Y +PE + K D+++ G++L EL+
Sbjct: 229 AYATHTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 1/66 (1%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDN 141
+F +G GGFG V++ K + A+K++ + +E ++ EV L+ L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 142 LVNLIG 147
+V
Sbjct: 66 IVRYFN 71
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 26/207 (12%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV--EV-LMLSLLHHDNLVNLIG 147
+G G F V + + T Q A K L + + + E+ ++ ++NL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------MKIALGAAKGLEYLH 201
+ + +L+ EY + L + + + +K L G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLP-----ELAEMVSENDVIRLIKQILE---GVYYLH 148
Query: 202 DKANPPVIYRDLKSSNILLDCEF---NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
+++ DLK NILL + + K+ DFG+++ IG + + GT Y AP
Sbjct: 149 QNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAP 202
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITG 285
E +T +D++ G++ L+T
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVE------------V 131
+F ++G+G FG+V+ + +KT Q A+K L K+ ++ V
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL-------KKDVVLMDDDVECTMVEKRV 70
Query: 132 LMLSLLHHDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIA 190
L L+ H L ++ ++ L V EY+ L H+ F +I
Sbjct: 71 LSLA-WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM 250
L GL++LH K ++YRDLK NILLD + + K++DFG+ K +GD ++
Sbjct: 129 L----GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFC 179
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
GT Y APE + D ++FGV+L E++ G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHHDNLVNLI 146
+IG G FG V + + T +V A+K L + + + F E +++ + +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 147 GYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQK---PIDW--FTRMKIALGAAKGLEYL 200
Y ++ L +V EYMP L + + P W F ++ L L+ +
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLM------SNYDVPEKWARFYTAEVVLA----LDAI 184
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE- 259
H I+RD+K N+LLD + KL+DFG + V GT Y +PE
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEV 240
Query: 260 YQRTGQLTV--KS-DVYTFGVVLLELITGR 286
+ G + D ++ GV L E++ G
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 35/201 (17%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLIGYC 149
+G G FG V++ + + K + G ++ + E+ +L++ H N+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESF 70
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGP---EQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
E+ ++++E++ + + + E++ + + + + L++LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY---VHQVC---EALQFLHSHN-- 122
Query: 207 PVIYRDLKSSNILLDCEFNA--KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG 264
+ + D++ NI+ ++ K+ +FG A+ GD + + Y APE +
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHD 178
Query: 265 QLTVKSDVYTFGVVLLELITG 285
++ +D+++ G ++ L++G
Sbjct: 179 VVSTATDMWSLGTLVYVLLSG 199
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 68/249 (27%), Positives = 107/249 (42%), Gaps = 46/249 (18%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVE------------VLMLSLL 137
+IG G + +V +L+KT ++ A+K + KE + + V +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVV-------KKELVNDDEDIDWVQTEKHVFEQA-S 67
Query: 138 HHDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
+H LV L C E RL V EY+ L H+ + F +I+L
Sbjct: 68 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL----A 122
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
L YLH++ +IYRDLK N+LLD E + KL+D+G+ K G T +S GT Y
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYI 177
Query: 257 APE------YQRTGQLTVKSDVYTFGVVLLELITGR---RAIDTTRPTYEQNLVTWAQPF 307
APE Y +V D + GV++ E++ GR + ++ + Q
Sbjct: 178 APEILRGEDYGF----SV--DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231
Query: 308 FKDPNRYPQ 316
+ R P+
Sbjct: 232 LEKQIRIPR 240
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK------EFIVEVLMLSLLHHDNLVN 144
+G G F V K + + T + A K + + L ++ E EV +L + H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHD 202
L + +L+ E + L D L + E + + +K L G+ YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF---LKQILD---GVHYLHS 126
Query: 203 KANPPVIYRDLKSSNILL---DCEFNA-KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
K + + DLK NI+L + KL DFG+A G++ + GT + AP
Sbjct: 127 KR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAP 180
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITG 285
E L +++D+++ GV+ L++G
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVE------------VLMLSLL 137
++G+G FG+V + + T ++ AVK L K+ +++ VL L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPG- 78
Query: 138 HHDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
L L C RL V EY+ L H+ +G ++P F +IA+G
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG---- 133
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
L +L K +IYRDLK N++LD E + K++DFG+ K T + GT Y
Sbjct: 134 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYI 188
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELITGR 286
APE D + FGV+L E++ G+
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVE------------VLMLSLL 137
++G+G FG+V ++++T + AVK L K+ I++ +L L+
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVL-------KKDVILQDDDVECTMTEKRILSLA-R 81
Query: 138 HHDNLVNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
+H L L C RL V E++ L H+ + F +I
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS----A 136
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
L +LHDK +IYRDLK N+LLD E + KL+DFG+ K G T ++ GT Y
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYI 191
Query: 257 APE---YQRTGQLTVKSDVYTFGVVLLELITGR 286
APE G V D + GV+L E++ G
Sbjct: 192 APEILQEMLYGP-AV--DWWAMGVLLYEMLCGH 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 51/207 (24%), Positives = 79/207 (38%), Gaps = 28/207 (13%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-EVLMLSLLHHDNLVNLIGY 148
IG G FG + + T ++VAVK ++R E + E++ L H N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK------GLEYLHD 202
++ EY L + + + G R G+ Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAG----------RFSEDEARFFFQQLLSGVSYCHS 134
Query: 203 KANPPVIYRDLKSSNILLDCEF--NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE- 259
+ +RDLK N LLD K+ DFG +K + + + GT Y APE
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEV 188
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGR 286
R +DV++ GV L ++ G
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 55/236 (23%), Positives = 91/236 (38%), Gaps = 57/236 (24%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-------------------- 129
IG+G +G V E A+K L + L F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 130 ------EVLMLSLLHHDNLVNLIGYCADGEQRLL--VYEYMPLRSLEDHLLDI---GP-- 176
E+ +L L H N+V L+ D + L V+E + ++++ P
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV--NQGP--VMEVPTLKPLS 135
Query: 177 EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236
E + +F + I G+EYLH + +I+RD+K SN+L+ + + K++DFG++
Sbjct: 136 EDQARFYF-QDLIK-----GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 237 GPIGD---KTHVSSRVMGTYGYCAPEYQRTGQLTV---KSDVYTFGVVLLELITGR 286
D V GT + APE + DV+ GV L + G+
Sbjct: 187 FKGSDALLSNTV-----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV--------EVLMLSLLHHDNL 142
+G G G V KT + VA+K + + E+ +L L+H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYL 200
+ + + D E +V E M L D ++ E +F +M ++YL
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM------LLAVQYL 130
Query: 201 HDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
H+ +I+RDLK N+LL + + K++DFG +K+ +G+ + + + GT Y A
Sbjct: 131 HENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLA 184
Query: 258 PE---YQRTGQLTVKSDVYTFGVVL 279
PE T D ++ GV+L
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV------EVLMLSLLHHDNLVN 144
+G G F V K + + T A K + + + ++ + EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHD 202
L + +L+ E + L D L E++ + +K L G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF---IKQILD---GVNYLHT 133
Query: 203 KANPPVIYRDLKSSNILL----DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
K + + DLK NI+L + KL DFGLA G + + GT + AP
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAP 187
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITG 285
E L +++D+++ GV+ L++G
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 49/221 (22%), Positives = 85/221 (38%), Gaps = 34/221 (15%)
Query: 81 ATKNFRQE----CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVL---- 132
+T F + ++G G V + + T + AVK +D G V+ L
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 133 ------MLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWF 184
+ + H N++ L LV++ M L D+L + E++
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 185 TRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244
+ + + LH +++RDLK NILLD + N KL+DFG + +
Sbjct: 131 RAL------LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEK 179
Query: 245 VSSRVMGTYGYCAPE------YQRTGQLTVKSDVYTFGVVL 279
+ GT Y APE + D+++ GV++
Sbjct: 180 LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 23/214 (10%)
Query: 78 LATA-TKNFRQE----CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV--E 130
+AT F +E +G+G F V + Q A ++ L + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 131 VLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP--EQKPIDWFTRMK 188
+ LL H N+V L ++ L+++ + L + ++ E ++
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC---IQ 117
Query: 189 IALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLGPIGDKTHV 245
L A + + H V++R+LK N+LL KL+DFGLA + +
Sbjct: 118 QILEA---VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQA 169
Query: 246 SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVL 279
GT GY +PE R D++ GV+L
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 45/196 (22%), Positives = 79/196 (40%), Gaps = 19/196 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV--EVLMLSLLHHDNLVNLIGY 148
+G+G F V + + T A K ++ L + E + L H N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 149 CADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
+ LV++ + L + ++ E ++ L + + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILES---IAYCHSNG-- 148
Query: 207 PVIYRDLKSSNILLDCEFNA---KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT 263
+++R+LK N+LL + KL+DFGLA + D GT GY +PE +
Sbjct: 149 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKK 204
Query: 264 GQLTVKSDVYTFGVVL 279
+ D++ GV+L
Sbjct: 205 DPYSKPVDIWACGVIL 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK------EFIVEVLMLSLLHHDNLVN 144
+G G F V K + + T A K + + + ++ E EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHD 202
L + +L+ E + L D L E++ + +K L G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF---IKQILD---GVNYLHT 133
Query: 203 KANPPVIYRDLKSSNILL-DCEFNA---KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
K + + DLK NI+L D KL DFGLA G + + GT + AP
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAP 187
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITG 285
E L +++D+++ GV+ L++G
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 47/199 (23%), Positives = 76/199 (38%), Gaps = 28/199 (14%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEV-LMLSLLHHDNLVNLIGYC 149
+GEG F K +K+ Q AVK + + ++ E+ + H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------MKIALGAAKGLEYLHDK 203
D LV E + L + + F+ M+ + A + ++HD
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKH-------FSETEASYIMRKLVSA---VSHMHDV 125
Query: 204 ANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
V++RDLK N+L + K+ DFG A+L T Y APE
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAAPEL 180
Query: 261 QRTGQLTVKSDVYTFGVVL 279
D+++ GV+L
Sbjct: 181 LNQNGYDESCDLWSLGVIL 199
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 44/235 (18%), Positives = 85/235 (36%), Gaps = 41/235 (17%)
Query: 65 NNNIAAQTFTFRELATATKNFRQ-----ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN 119
+++ + F+ + ++G G G+V + +T Q A+K L +
Sbjct: 6 HHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS 65
Query: 120 GLQGNKEFIVEV-LMLSLLHHDNLVNLIGYCADGEQR----LLVYEYMPLRSLEDHLLDI 174
EV ++V ++ + L++ E M L +
Sbjct: 66 PKARQ-----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ-- 118
Query: 175 GPEQKPIDWFTR------MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFN 225
++ FT M+ A +++LH + +RD+K N+L + +
Sbjct: 119 ---ERGDQAFTEREAAEIMRDIGTA---IQFLHSHN---IAHRDVKPENLLYTSKEKDAV 169
Query: 226 AKLSDFGLAKLGPIGD-KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVL 279
KL+DFG AK +T T Y APE + D+++ GV++
Sbjct: 170 LKLTDFGFAKETTQNALQTPC-----YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK------EFIVEVLMLSLLHHDNLVN 144
+G G F V K + + T A K + + + ++ + EV +L + H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHD 202
L + +L+ E + L D L + E++ ++ +K L + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF---LKQILNG---VYYLHS 132
Query: 203 KANPPVIYRDLKSSNILL---DCEFNA-KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
+ + DLK NI+L + K+ DFGLA D + + GT + AP
Sbjct: 133 LQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAP 186
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITG 285
E L +++D+++ GV+ L++G
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 56/265 (21%), Positives = 100/265 (37%), Gaps = 87/265 (32%)
Query: 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH 139
T++K + +G G FG V + ++ + A+K++ LQ + E+ ++ +L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDH 59
Query: 140 DNLVNLIGY-------------------------------------CADGEQRL-LVYEY 161
N++ L+ Y + L ++ EY
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA----------KGLEYLHDKANPPVIYR 211
+P + L K + F R ++ + + ++H + +R
Sbjct: 120 VP----DT--L-----HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLG--ICHR 165
Query: 212 DLKSSNILLDCEFNA-KLSDFGLAK-LGPIGDKTH-VSSRVMGTYGYCAPE-------YQ 261
D+K N+L++ + N KL DFG AK L P + SR + Y APE Y
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEY- 219
Query: 262 RTGQLTVKSDVYTFGVVLLELITGR 286
T D+++ G V ELI G+
Sbjct: 220 -----TPSIDLWSIGCVFGELILGK 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 58/268 (21%), Positives = 108/268 (40%), Gaps = 29/268 (10%)
Query: 31 ASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECL 90
+ P + + + D A + N + +N T K ++
Sbjct: 10 SEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKP 69
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNLVNLI-- 146
IG G G V + VA+K+L R K E++++ ++H N+++L+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 147 ----GYCADGEQRLLVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
+ + LV E M L + L + + + + + G+++L
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQML-----CGIKHL 180
Query: 201 HDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
H A +I+RDLK SNI++ DC K+ DFGLA+ G ++ V+ T Y AP
Sbjct: 181 HS-AG--IIHRDLKPSNIVVKSDCTL--KILDFGLAR--TAGTSFMMTPYVV-TRYYRAP 232
Query: 259 EYQRTGQLTVKSDVYTFGVVLLELITGR 286
E D+++ G ++ E++ +
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 31/209 (14%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLML-SLLHHDNLVNLIGYC 149
+G G + V++ + V VK L K+ E+ +L +L N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 150 ADGEQR---LLVYEYMP--LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
D R L+ + L L D I ++ M L K L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTD-----YDIRFY--MYEIL---KALDYCHSMG 150
Query: 205 NPPVIYRDLKSSNILLDCEFNA-KLSDFGLAKLG-PIGDKTH-VSSRVMGTYGYCAPEYQ 261
+++RD+K N+++D E +L D+GLA+ P + V+SR + PE
Sbjct: 151 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELL 202
Query: 262 RTGQLTVKS-DVYTFGVVLLELITGRRAI 289
Q+ S D+++ G +L +I +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 53/238 (22%), Positives = 99/238 (41%), Gaps = 60/238 (25%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLD--RNGLQGNKEFIVEVLMLSLLHH 139
+ +F+ + L+GEG +G V + T ++VA+K+++ L + E+ +L H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLREIKILKHFKH 68
Query: 140 DNLVNLIG-YCADGEQRL----LVYEYMP------LRS---LEDHLLDIGPEQKPIDWFT 185
+N++ + D + ++ E M + + +DH I +F
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH----------IQYFI 118
Query: 186 RMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLA----KLGPI 239
+ + ++ LH +N VI+RDLK SN+L+ +C+ K+ DFGLA +
Sbjct: 119 YQTL-----RAVKVLHG-SN--VIHRDLKPSNLLINSNCDL--KVCDFGLARIIDESAAD 168
Query: 240 GDKTHVSSRVMGTY----GYCAPEYQRTGQLTVKSDVYTFGV-------VLLELITGR 286
+ M + Y APE + + S Y+ + +L EL R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPE------VMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 58/299 (19%), Positives = 102/299 (34%), Gaps = 82/299 (27%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHH 139
N+ + LIG G +G VY + T + VA+K+++R L K + E+ +L+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 140 DNLVNLIG-YCADGEQRL----LVYEYMP------LRSL----EDH-------LLDIGPE 177
D ++ L D + +V E ++ E+H LL
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL----- 139
Query: 178 QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAK 235
G ++H+ + +I+RDLK +N LL DC K+ DFGLA+
Sbjct: 140 -----------------LGENFIHE-SG--IIHRDLKPANCLLNQDCSV--KVCDFGLAR 177
Query: 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT--------------VKSDVYTFGV---- 277
T++ + + QLT + + YT +
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 278 ---VLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQ 333
+ EL+ ++ P F + +P D + +Q
Sbjct: 238 TGCIFAELLNMLQSHINDPTN--------RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQ 288
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 56/242 (23%), Positives = 92/242 (38%), Gaps = 66/242 (27%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN 141
+ +G GG G V+ + VA+K++ Q K + E+ ++ L HDN
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 142 LVNLI-------GYCADGEQRL-------LVYEYMP------LRS---LEDHLLDIGPEQ 178
+V + D L +V EYM L LE+H
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH-------- 121
Query: 179 KPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAK 235
F + +GL+Y+H AN V++RDLK +N+ + D K+ DFGLA+
Sbjct: 122 --ARLFMYQLL-----RGLKYIHS-AN--VLHRDLKPANLFINTEDLVL--KIGDFGLAR 169
Query: 236 LGPIGDKTHVSSRVMGTY----GYCAPEYQRTGQLTVKSDVYTFGV-------VLLELIT 284
I D + + Y +P L + + YT + + E++T
Sbjct: 170 ---IMDPHYSHKGHLSEGLVTKWYRSPR------LLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 285 GR 286
G+
Sbjct: 221 GK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 73/241 (30%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLD--RNGLQGNKEFIVEVLMLSLLHH 139
+ IGEG +G V VA+K++ + + + E+ +L H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLREIKILLRFRH 84
Query: 140 DNLVNLIG-YCADGEQRL----LVYEYMP------LRS---LEDH-------LLDIGPEQ 178
+N++ + A +++ +V + M L++ DH +L
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL------ 138
Query: 179 KPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKL 236
+GL+Y+H AN V++RDLK SN+LL C+ K+ DFGLA+
Sbjct: 139 ----------------RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDL--KICDFGLAR- 176
Query: 237 GPIGDKTHVSSRVMGTY----GYCAPEYQRTGQLTVKSDVYTFGV-------VLLELITG 285
+ D H + + Y Y APE + + S YT + +L E+++
Sbjct: 177 --VADPDHDHTGFLTEYVATRWYRAPE------IMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 286 R 286
R
Sbjct: 229 R 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 49/273 (17%), Positives = 88/273 (32%), Gaps = 69/273 (25%)
Query: 31 ASPAPRHQNLKTKPAQEPADDHKEANNNNKEAAGNNNIAAQTFTFRELATATKNFRQECL 90
+S Q ++ K+ + A+ + + L
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDW-QIPDRYEIRHL 60
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF---------IVEVLMLSLLHHDN 141
IG G +G V + + +VVA+K++ + F + E+ +L+ L+HD+
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 142 LVNL----IGYCADGEQRL-LVYEYMP------LRSL----EDH-------LLDIGPEQK 179
+V + I + L +V E R+ E H LL
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL------- 166
Query: 180 PIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA----- 234
G++Y+H A +++RDLK +N L++ + + K+ DFGLA
Sbjct: 167 ---------------VGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208
Query: 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT 267
QLT
Sbjct: 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 38/159 (23%), Positives = 62/159 (38%), Gaps = 30/159 (18%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEV-LMLSLLHHDNLVNLIGYC 149
+G G G+V + ++T + A+K L EV L ++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 80
Query: 150 ADGEQR----LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------MKIALGAAKGLEY 199
+ L+V E + L + + FT MK A ++Y
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQ-----DRGDQAFTEREASEIMKSIGEA---IQY 132
Query: 200 LHDKANPPVIYRDLKSSNILLDCEF-NA--KLSDFGLAK 235
LH + +RD+K N+L + NA KL+DFG AK
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHHDNLVNLI-- 146
IG G G V + VA+K+L R K E++++ ++H N++ L+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 147 ----GYCADGEQRLLVYEYMP------LRS--LEDHLLDIGPEQKPIDWFTRMKIALGAA 194
+ + +V E M ++ + + + +
Sbjct: 93 FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER----------MSYLLYQML----- 137
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG 254
G+++LH A +I+RDLK SNI++ + K+ DFGLA+ G ++ V+ T
Sbjct: 138 CGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRY 191
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
Y APE D+++ G ++ E+I G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 54/229 (23%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHH 139
K + +G G +G V +++ + VA+K+L R K E+L+L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 140 DNLVNLI------GYCADGEQRLLVYEYMP------LRS--LEDHLLDIGPEQKPIDWFT 185
+N++ L+ + LV +M + E+ I +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK----------IQYLV 132
Query: 186 RMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH- 244
+ KGL+Y+H A V++RDLK N+ ++ + K+ DFGLA+ + T
Sbjct: 133 YQML-----KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGY 183
Query: 245 VSSRVMGTYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
V +R + Y APE Y D+++ G ++ E++TG+
Sbjct: 184 VVTR----W-YRAPEVILSWMHY------NQTVDIWSVGCIMAEMLTGK 221
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 53/229 (23%), Positives = 88/229 (38%), Gaps = 60/229 (26%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIV-----------EVLMLSLLHH 139
I G +G V G ++ VA+K++ G I+ E+ +L+ HH
Sbjct: 30 ISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 140 DNLVNLIG-YCADGEQRL----LVYEYMP------LRSLEDHLLDIGPEQKPIDWFTRMK 188
N++ L + E + LV E M + + I +F
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ-----HIQYFMYHI 143
Query: 189 IALGAAKGLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLA-KLGPIGDKT-H 244
+ GL LH+ A V++RDL NILL + + + DF LA + +KT +
Sbjct: 144 L-----LGLHVLHE-AG--VVHRDLHPGNILLADNNDI--TICDFNLAREDTADANKTHY 193
Query: 245 VSSRVMGTYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
V+ R Y APE + T D+++ G V+ E+ +
Sbjct: 194 VTHRW-----YRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHH 139
+ ++ +G G +G V KT VAVK+L R + K E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 140 DNLVNLI------GYCADGEQRLLVYEYMP------LRS---LEDHLLDIGPEQKPIDWF 184
+N++ L+ + LV M ++ +DH + +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH----------VQFL 137
Query: 185 TRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGPIGDK 242
+ +GL+Y+H A+ +I+RDLK SN+ + DCE K+ DFGLA+ +
Sbjct: 138 IYQIL-----RGLKYIHS-AD--IIHRDLKPSNLAVNEDCEL--KILDFGLAR-HTADEM 186
Query: 243 T-HVSSRVMGTYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
T +V++R Y APE Y D+++ G ++ EL+TGR
Sbjct: 187 TGYVATRW-----YRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGR 227
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 34/126 (26%), Positives = 56/126 (44%), Gaps = 3/126 (2%)
Query: 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNI 218
E L +E+ + + + + AKG+E+L + I+RDL + NI
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 224
Query: 219 LLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVV 278
LL + K+ DFGLA+ + APE T++SDV++FGV+
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284
Query: 279 LLELIT 284
L E+ +
Sbjct: 285 LWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 91 IGEGGFGRVYKGKL-----EKTAQVVAVKQL-DRNGLQGNKEFIVEV-LMLSLLHHDNLV 143
+G G FG+V + T + VAVK L + ++ + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 144 NLIGYCAD-GEQRLLVYEYMPLRSLEDHLLDIGPEQKP 180
NL+G C G +++ E+ +L +L E P
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 57/231 (24%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLHH 139
+R +G G +G V +T VA+K+L R K E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 140 DNLVNLI------GYCADGEQRLLVYEYMP------LRS---LEDHLLDIGPEQKPIDWF 184
+N++ L+ D LV +M ++ ED I +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR----------IQFL 133
Query: 185 TRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGPIGDK 242
+ KGL Y+H A +I+RDLK N+ + DCE K+ DFGLA+
Sbjct: 134 VYQML-----KGLRYIHA-AG--IIHRDLKPGNLAVNEDCEL--KILDFGLARQADSEMT 183
Query: 243 THVSSRVMGTYGYCAPE-------YQRTGQLTVKSDVYTFGVVLLELITGR 286
+V +R Y APE Y T D+++ G ++ E+ITG+
Sbjct: 184 GYVVTRW-----YRAPEVILNWMRY------TQTVDIWSVGCIMAEMITGK 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 45/159 (28%), Positives = 64/159 (40%), Gaps = 17/159 (10%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV 143
NFR IG G FG + GK T + VA+K L D +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIP 68
Query: 144 NLIGYCADGEQRLLVYEYMPL--RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
+ + G+ +V + L SLED L D+ + T + IA+ +EY+H
Sbjct: 69 QVYYFGPCGKYNAMV---LELLGPSLED-LFDLCDRTFSLK--TVLMIAIQLISRMEYVH 122
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAK-----LSDFGLAK 235
K +IYRD+K N L+ N + DF LAK
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 27/176 (15%), Positives = 63/176 (35%), Gaps = 31/176 (17%)
Query: 83 KNFRQECLIGEGGFGRVYKG--------KLEKTAQVVAVKQLDRNG----------LQGN 124
+ ++ + G +Y+ Q ++K ++G
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 125 KEFIVEVLMLSLLHHDNLVNLIGY-CADGEQRLLVYEYMPL--RSLEDHLLDIGPEQKPI 181
+ + L + +G+ + R LV +P RSL+ L + +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQSALDVSP--KHVL 156
Query: 182 DWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK--LSDFGLAK 235
+ +++A LE+LH+ ++ ++ + NI +D E ++ L+ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 24/216 (11%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH-DNL 142
+++ IGEG FG +++G Q VA+K R + E LL +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGI 68
Query: 143 VNLIGYCADGEQRLLVYEYMPL--RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
N+ + +G +LV + L SLED LLD+ + + T A ++ +
Sbjct: 69 PNVYYFGQEGLHNVLV---IDLLGPSLED-LLDLCGRKFSVK--TVAMAAKQMLARVQSI 122
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAK-----LSDFGLAKL-GPIGDKTHVSSR----VM 250
H+K+ ++YRD+K N L+ + + DFG+ K K H+ R +
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
GT Y + + + + D+ G V + + G
Sbjct: 180 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 22/214 (10%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH-DNL 142
+R IG G FG +Y G + VA+K + + +E + ++ +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGI 67
Query: 143 VNLIGYCADGEQRLLVYEYMPL--RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
+ A+G+ ++V M L SLED L + + + T + +A +EY+
Sbjct: 68 PTIRWCGAEGDYNVMV---MELLGPSLED-LFNFCSRKFSLK--TVLLLADQMISRIEYI 121
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAK---LSDFGLAKL-GPIGDKTHVSSR----VMGT 252
H K I+RD+K N L+ + DFGLAK H+ R + GT
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 253 YGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
Y + + + + D+ + G VL+ G
Sbjct: 179 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 55/249 (22%), Positives = 102/249 (40%), Gaps = 72/249 (28%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDR--NGLQGNKEFIVEVLMLSLLH- 138
+ + +G+G +G V+K +T +VVAVK++ + E+++L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 139 HDNLVNLIG-YCADGEQRL-LVYEYMP------LRS---LEDH-------LLDIGPEQKP 180
H+N+VNL+ AD ++ + LV++YM +R+ H L+
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI-------- 119
Query: 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGP 238
K ++YLH +++RD+K SNILL +C K++DFGL++
Sbjct: 120 --------------KVIKYLHS-GG--LLHRDMKPSNILLNAECHV--KVADFGLSRSFV 160
Query: 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLT--------------VKSDVYTFGV------- 277
+ + + + LT + S YT G+
Sbjct: 161 NIRRVTNNIPLSINENTENFDDD-QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219
Query: 278 VLLELITGR 286
+L E++ G+
Sbjct: 220 ILGEILCGK 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 38/214 (17%), Positives = 73/214 (34%), Gaps = 44/214 (20%)
Query: 52 HKEANNNNKEAAGNNNIAAQTFTFRELATAT----KNFRQECLIGEGGFGRVYKGKLEKT 107
H ++++ G N+ Q+ F E + IG GGFG +Y
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNK 61
Query: 108 AQVVAVK----------QLDR-----NGLQGNKEFIVEVLMLSLLHHDNLVNLIGY---- 148
+ A L + K+ I + + L + + G
Sbjct: 62 PEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDCIKKWIERKQLDYLGIPLFYGSGLTE 120
Query: 149 CADGEQRLLVYEYMPL--RSLEDHLLDIGPEQKPIDWFTR---MKIALGAAKGLEYLHDK 203
R +V M L+ G F + +++ + LEY+H+
Sbjct: 121 FKGRSYRFMV---MERLGIDLQKISGQNGT-------FKKSTVLQLGIRMLDVLEYIHEN 170
Query: 204 ANPPVIYRDLKSSNILLDCEFNAK--LSDFGLAK 235
++ D+K++N+LL + + L+D+GL+
Sbjct: 171 E---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 2e-11
Identities = 44/257 (17%), Positives = 72/257 (28%), Gaps = 55/257 (21%)
Query: 71 QTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNK----- 125
F T+ ++ IGEG FG V++ + T + + ++ L
Sbjct: 9 GPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 126 -EFIVEVLMLSLLH---------HDNLVNLIG-YCADG---EQRLLVYEYMPLR--SLED 169
E + E+++ L + + L +C G L +++ S D
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 170 HLLDIGPEQKPI-------------------DWFTRMKIALGAAKGLEYLHDKANPPVIY 210
+Q I T I L +
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEH 185
Query: 211 RDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK-------THVSSRVM--GTYGYC---AP 258
RDL N+LL KL K I + SR+ G +C
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 259 EYQRTGQLTVKSDVYTF 275
E TG + D+Y
Sbjct: 246 EDLFTGDGDYQFDIYRL 262
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 41/224 (18%), Positives = 89/224 (39%), Gaps = 44/224 (19%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH----------- 138
+G G F V+ K VA+K + R + E+ +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 139 HDNLVNLIGY----CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA 194
++++ L+ + +G ++V+E + +L + P+ + + +I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLI-YVK-QISKQLL 141
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLD------CEFNAKLSDFGLAKLGPIGDKTHVSSR 248
GL+Y+H + +I+ D+K N+L++ K++D G A + +R
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 249 VMGTYGYCAPE------YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y +PE + +D+++ ++ ELITG
Sbjct: 200 E-----YRSPEVLLGAPW------GCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNL 142
FR IG G FG +Y G +T + VA+K + + + + E + +L +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGI 65
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
N+ + +G+ +LV + + SLED + + T + +A +E++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLG-PSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHS 121
Query: 203 KANPPVIYRDLKSSNILLDCEFNAK---LSDFGLAKL-GPIGDKTHVSSR----VMGTYG 254
K+ ++RD+K N L+ A + DFGLAK H+ R + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
Y + + + + D+ + G VL+ + G
Sbjct: 179 YASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 35/177 (19%), Positives = 65/177 (36%), Gaps = 33/177 (18%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQV-----VAVKQLDRNGLQ-----------GNKE 126
++ IG+GGFG +Y + + V VK + E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 127 FIVEVLMLSLLHHDNLVNLIGYCADGEQ----RLLVYEYMPL--RSLEDHLLDIGPEQKP 180
I + + L + + G + R ++ M L+ K
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI---MDRFGSDLQKIYEANA---KR 148
Query: 181 IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK--LSDFGLAK 235
T ++++L LEY+H+ ++ D+K+SN+LL+ + + L D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 48/219 (21%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HD-----NLV 143
+IG+G FG+V K K Q VA+K + RN + +++ E+ +L L D N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 144 NLIGY-------CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
+++ C + +E + + +L + + + + R K A +
Sbjct: 163 HMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKFQGFSLP-LVR-KFAHSILQC 212
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNA---KLSDFGLAKLGPIGDKTHVSSRVMGTY 253
L+ LH +I+ DLK NILL + K+ DFG + T++ SR
Sbjct: 213 LDALHKNR---IIHCDLKPENILL-KQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF---- 264
Query: 254 GYCAPE------YQRTGQLTVKSDVYTFGVVLLELITGR 286
Y APE Y + D+++ G +L EL+TG
Sbjct: 265 -YRAPEVILGARY------GMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 52/227 (22%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF----IVEVLMLSLL-HH 139
+ + LIG+G FG+V K + VA+K + +N K F +EV +L L+ H
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN----KKAFLNQAQIEVRLLELMNKH 110
Query: 140 D-----NLVNLIGY-------CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRM 187
D +V+L + C LV+E + +L D L + ++ TR
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRGVSLN-LTR- 160
Query: 188 KIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA--KLSDFGLAKLGPIGDKTHV 245
K A L +L +I+ DLK NILL + K+ DFG + ++
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 246 SSRVMGTYGYCAPE------YQRTGQLTVKSDVYTFGVVLLELITGR 286
SR Y +PE Y + D+++ G +L+E+ TG
Sbjct: 220 QSRF-----YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 43/268 (16%), Positives = 83/268 (30%), Gaps = 76/268 (28%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYC- 149
+G G F V+ + + VA+K + ++ + + E+ +L + + + N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSD-PNDPNREM 102
Query: 150 ------------ADGEQRLLVYEYMPLR-SLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
+G +V+E L L ++ + P+ + I +G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQG 158
Query: 197 LEYLHDKANPPVIYRDLKSSNILL------------------------------------ 220
L+YLH K +I+ D+K NILL
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 221 -------------DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT 267
+ K++D G A H + + T Y + E
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDIQ-TRQYRSLEVLIGSGYN 271
Query: 268 VKSDVYTFGVVLLELITGRRAIDTTRPT 295
+D+++ + EL TG +
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGE 299
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 59/246 (23%), Positives = 90/246 (36%), Gaps = 82/246 (33%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEF----IVEVLMLSLLHHD----- 140
+G+G FGRV + + AVK + RN K++ +E +L + +D
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-RN----IKKYTRSAKIEADILKKIQNDDINNN 96
Query: 141 NLVNLIGY-------CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGA 193
N+V G C L++E + SL + + I+ + +
Sbjct: 97 NIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNNYNGFHIE-DIK-LYCIEI 146
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA-------------------------KL 228
K L YL + + + DLK NILLD + KL
Sbjct: 147 LKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 229 SDFGLAKLGPIGDKTH---VSSRVMGTYGYCAPE------YQRTGQLTVKSDVYTFGVVL 279
DFG A H +++R Y APE + V SD+++FG VL
Sbjct: 204 IDFGCATF---KSDYHGSIINTRQ-----YRAPEVILNLGW------DVSSDMWSFGCVL 249
Query: 280 LELITG 285
EL TG
Sbjct: 250 AELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 46/242 (19%), Positives = 83/242 (34%), Gaps = 78/242 (32%)
Query: 90 LIGEGGFGRVYKGK-LEKTAQVVAVKQLDRNGLQGNKEF----IVEVLMLSLL-HHD--- 140
+GEG FG+V + + VA+K + RN ++ +E+ +L + D
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-RN----VGKYREAARLEINVLKKIKEKDKEN 80
Query: 141 --NLVNLIGY-------CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL 191
V + + C + +E + + + L + + P+ R +A
Sbjct: 81 KFLCVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKENNFQPYPLP-HVR-HMAY 130
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA-------------------KLSDFG 232
L +LH+ + + DLK NIL +++DFG
Sbjct: 131 QLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 233 LAKLGPIGDKTH---VSSRVMGTYGYCAPE------YQRTGQLTVKSDVYTFGVVLLELI 283
A + H V++R Y PE + DV++ G +L E
Sbjct: 188 SATFD---HEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYY 233
Query: 284 TG 285
G
Sbjct: 234 RG 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 427 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.87 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.56 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.5 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.49 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.34 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.15 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.04 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.73 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.69 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.63 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.49 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.44 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.34 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.2 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.19 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.51 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.22 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.82 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.09 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.25 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 83.58 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=448.36 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=217.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
..|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+.+|+.|+|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998766666677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
+||+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.... .
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--E 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS--S
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCC--C
Confidence 99999998864 35899999999999999999999999 99999999999999999999999999986432 2
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
.......+||+.|+|||++.+..|+.++||||||||+|||++|+.||....+. .....+.... .+.+
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~~--~~~~----- 290 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRDNL--PPRL----- 290 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSS--CCCC-----
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcCC--CCCC-----
Confidence 22345679999999999999999999999999999999999999999754321 1111111110 0000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.........+.+||.+||+.||++|||+.|++++-+...
T Consensus 291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 112234467889999999999999999999999877643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-60 Score=450.25 Aligned_cols=262 Identities=26% Similarity=0.381 Sum_probs=217.2
Q ss_pred hhCccccceeccCCceEEEEEEEC-----CCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE-----KTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.++|.+.+.||+|+||+||+|++. .++..||||+++.......+.|.+|+.+|++|+|||||+++++|.+.+..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 367899999999999999999975 357889999998766566678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCee
Q 042519 157 LVYEYMPLRSLEDHLLDIG---------PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
||||||++|+|.++|...+ .....+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997642 23467999999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhh
Q 042519 228 LSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQP 306 (427)
Q Consensus 228 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~ 306 (427)
|+|||+|+.....+.........||+.|||||++.++.|+.++|||||||+||||+| |+.||...... +....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~ 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIEC 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 999999986443333333445679999999999999999999999999999999998 89999764321 11111
Q ss_pred hhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+.. +.. . ..|..++..+.+|+..||+.||++|||+.+|++.|+.+.
T Consensus 243 i~~-~~~-~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 243 ITQ-GRV-L---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHH-TCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHc-CCC-C---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111 111 1 123345568899999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-60 Score=453.29 Aligned_cols=262 Identities=28% Similarity=0.431 Sum_probs=211.0
Q ss_pred hCccccceeccCCceEEEEEEEC-----CCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLE-----KTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
++|.+.++||+|+||+||+|+++ .++..||||+++.......+.|.+|+.+|++|+|||||+++++|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56888899999999999999975 3578999999987666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCe
Q 042519 158 VYEYMPLRSLEDHLLDIGP-----------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 226 (427)
|||||++|+|.++|..... ...++++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 2356999999999999999999999999 9999999999999999999
Q ss_pred eEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhh
Q 042519 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 227 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~ 305 (427)
||+|||+++.....+........+||+.|||||++.+..|+.++|||||||+||||+| |+.||...... +...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAID 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence 9999999986544444444556789999999999999999999999999999999999 89999754321 1111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.+.. .... ..|..++..+.+|+.+||+.||++|||+.||+++|+.+..
T Consensus 272 ~i~~-g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 CITQ-GREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHH-TCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHc-CCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1111 1111 1233445688999999999999999999999999998754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-59 Score=439.86 Aligned_cols=250 Identities=23% Similarity=0.286 Sum_probs=213.3
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.++||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.|+|||||+++++|.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999997542 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|||+||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999753 46999999999999999999999999 99999999999999999999999999987544
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
..........+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ......+....-.+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~~~----- 253 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLEYDF----- 253 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC-----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCC-----
Confidence 4444445678999999999999999999999999999999999999999975322 22222233322222
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVS 357 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 357 (427)
+......+.+||.+||+.||++|||+.|++.
T Consensus 254 -------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 254 -------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -------CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 2223457889999999999999999998643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=448.39 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=209.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.++++|+|||||+++++|.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999999999999999999765433 34568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
||+||+|.++|... ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+...
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-- 176 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-- 176 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC--
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec--
Confidence 99999999999753 3456789999999999999999999999 9999999999999999999999999998632
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.........+||+.|+|||++.+..|+.++||||||||||||++|+.||..... ......+... .++.
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~--~~~~---- 244 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISG--SFPP---- 244 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHT--CCCC----
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcC--CCCC----
Confidence 222234557899999999999999999999999999999999999999975432 2222222221 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.+...+..+.+||.+||+.||++|||+.|++++-+.
T Consensus 245 -----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 280 (350)
T 4b9d_A 245 -----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280 (350)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred -----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence 122334678899999999999999999999987544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=453.85 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=217.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
+.|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998776667778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
+||+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.... .
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~ 300 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--E 300 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCS--S
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCC--C
Confidence 99999998854 35899999999999999999999999 99999999999999999999999999986432 2
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
.......+||+.|||||++.+..|+.++||||||||+|||++|+.||....+. .....+.... .+.+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~~--~~~~----- 367 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRDNL--PPRL----- 367 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC--CCCC-----
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcCC--CCCC-----
Confidence 22345678999999999999999999999999999999999999999754321 1111111110 0000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.........+.+||.+||+.||++|||+.|+++|-+...
T Consensus 368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 011223467889999999999999999999999876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-59 Score=438.57 Aligned_cols=261 Identities=30% Similarity=0.435 Sum_probs=206.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||+||+|++++ .||||+++.... ...+.|.+|+.++++++|||||++++++.+ +.++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3578889999999999999999864 499999865432 334678999999999999999999998865 5689999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|||++|+|.++|.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999975 3456999999999999999999999999 99999999999999999999999999987544
Q ss_pred CCccceeccccccccccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT---GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
..........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||....+.. ............+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYASPD 258 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCCCC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCC
Confidence 333344556789999999999864 468999999999999999999999997543221 11111121111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+ ...+..++..+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus 259 ~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 L------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp S------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred c------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 11233455788999999999999999999999999998765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=443.27 Aligned_cols=260 Identities=26% Similarity=0.387 Sum_probs=214.8
Q ss_pred hCccccceeccCCceEEEEEEEC-----CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLE-----KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.++++.+.||+|+||+||+|++. .+++.||||+++.... ...+.|.+|+.++++|+|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45778899999999999999974 3578899999965432 34578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC
Q 042519 157 LVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF 224 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 224 (427)
||||||++|+|.++|..... ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975431 1346899999999999999999999999 99999999999999999
Q ss_pred CeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 042519 225 NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTW 303 (427)
Q Consensus 225 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~ 303 (427)
.+||+|||+++.....+........+||+.|+|||++.++.|+.++|||||||+||||+| |+.||...... .+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~- 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVE- 258 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHH-
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHH-
Confidence 999999999986544333344556789999999999999999999999999999999998 89999764321 1111
Q ss_pred hhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 304 AQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
. ....... ..|..++..+.+|+..||+.||++|||+.||+++|+..
T Consensus 259 --~-i~~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 --M-IRNRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --H-HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --H-HHcCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 1221111 12344567889999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=438.39 Aligned_cols=253 Identities=20% Similarity=0.210 Sum_probs=208.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
+.|++.++||+|+||+||+|+++.+|+.||||+++..... .+|+.+++.|+|||||+++++|.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 5688999999999999999999999999999999765322 46999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-CeeEeecCCcccCCCCC
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DFG~a~~~~~~~ 241 (427)
+||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|+......
T Consensus 133 ~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999753 46999999999999999999999999 99999999999999988 59999999998643322
Q ss_pred cc---ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 242 KT---HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 242 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. .....++||+.|||||++.+..|+.++|||||||++|||++|+.||........ ...+...+....
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~~~~~--- 276 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL------CLKIASEPPPIR--- 276 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC------HHHHHHSCCGGG---
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHcCCCCch---
Confidence 11 122346899999999999999999999999999999999999999976433211 111122111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+..++..+.+++.+||+.||.+|||+.|++++|...
T Consensus 277 ------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 277 ------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp ------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 12233456788999999999999999999999988654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=423.02 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=198.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||+||+|+++.+|+.||||++++... .....+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976532 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 5899999865 346999999999999999999999999 99999999999999999999999999986332
Q ss_pred CCccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.......+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.... ..............+
T Consensus 165 ---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~~~~---- 231 (275)
T 3hyh_A 165 ---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGVYTL---- 231 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCC----
T ss_pred ---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCCC----
Confidence 223345789999999999998776 579999999999999999999997532 122222222221111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
+...+..+.+++.+||+.||++|||+.|++++-|.-
T Consensus 232 --------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 232 --------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp --------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred --------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 222345788999999999999999999999987653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-58 Score=428.23 Aligned_cols=252 Identities=27% Similarity=0.374 Sum_probs=203.5
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc----CCeeEEE
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD----GEQRLLV 158 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 158 (427)
|++.++||+|+||+||+|.++.++..||+|++..... ...+.+.+|+.++++|+|||||+++++|.+ ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4677889999999999999999999999999975433 234568899999999999999999999865 3568999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-CCCeeEeecCCcccC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-EFNAKLSDFGLAKLG 237 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkl~DFG~a~~~ 237 (427)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++ ++||||||||+||||+. +|.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999999753 46899999999999999999999976 35999999999999974 799999999999863
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... ....... .... .+..
T Consensus 183 ~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i-~~~~-~~~~ 250 (290)
T 3fpq_A 183 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRV-TSGV-KPAS 250 (290)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHH-TTTC-CCGG
T ss_pred CC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHH-HcCC-CCCC
Confidence 22 22345789999999999875 6999999999999999999999999653221 1111111 1111 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
. +.....++.+|+.+||+.||++|||+.|+++|-+.
T Consensus 251 ~--------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 251 F--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp G--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred C--------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1 11123468899999999999999999999998654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=428.75 Aligned_cols=253 Identities=25% Similarity=0.273 Sum_probs=204.9
Q ss_pred hCccccceeccCCceEEEEEEEC---CCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
++|++.+.||+|+||+||+|++. .+++.||||++++... .....+.+|+.++++|+|||||++++++.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 4688999999976432 223467889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
|||||+||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999753 46899999999999999999999999 999999999999999999999999999863
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .+....+......+
T Consensus 177 ~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~~~--- 245 (304)
T 3ubd_A 177 ID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKAKLGM--- 245 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC---
T ss_pred cC--CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcCCCCC---
Confidence 22 22234567899999999999999999999999999999999999999975432 22222222222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhc
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFL 362 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~ 362 (427)
|...+..+.+|+.+||+.||++||| ++|+++|-+.-
T Consensus 246 ---------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~ 286 (304)
T 3ubd_A 246 ---------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286 (304)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred ---------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence 2233467889999999999999998 57888876653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-57 Score=437.55 Aligned_cols=270 Identities=25% Similarity=0.343 Sum_probs=218.5
Q ss_pred CHHHHHHHhhCccccceeccCCceEEEEEEECCC-----CcEEEEEEeccCCCc-chHHHHHHHHHHhhcCC-CCeeeEE
Q 042519 74 TFRELATATKNFRQECLIGEGGFGRVYKGKLEKT-----AQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHH-DNLVNLI 146 (427)
Q Consensus 74 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~niv~l~ 146 (427)
.........++|++.+.||+|+||+||+|.+.++ ++.||||.+...... ..+.+.+|+.+|.++.| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 3333444467899999999999999999998654 368999999765433 34668999999999975 8999999
Q ss_pred EEEEc-CCeeEEEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC
Q 042519 147 GYCAD-GEQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDL 213 (427)
Q Consensus 147 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 213 (427)
++|.+ ++.++||||||++|+|.++|..... ....+++..++.++.||+.||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 99976 4578999999999999999976421 2356899999999999999999999999 999999
Q ss_pred CCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 042519 214 KSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTT 292 (427)
Q Consensus 214 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~ 292 (427)
||+||||+.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987544444444556789999999999999999999999999999999998 99999764
Q ss_pred CCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 293 RPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
... ..+ ......+... ..|..++.++.+++..||+.||++|||+.+|+++|+.+
T Consensus 292 ~~~--~~~----~~~i~~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 292 KID--EEF----CRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCS--HHH----HHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHH--HHH----HHHHHcCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 322 111 1112211111 12333456889999999999999999999999999865
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=418.26 Aligned_cols=270 Identities=24% Similarity=0.293 Sum_probs=200.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC----eeEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE----QRLLV 158 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 158 (427)
++|.+.+.||+|+||+||+|+++ |+.||||+++... .....+..|+..+..++|||||+++++|.+.+ .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 56889999999999999999985 8899999996542 11122344666677899999999999998654 57999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA-----NPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
||||++|+|.++|.. ..+++..++.++.|++.||+|||++. .++||||||||+||||+.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999964 45899999999999999999999871 22399999999999999999999999999
Q ss_pred cccCCCCCcc--ceeccccccccccCccccccC------CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc-------
Q 042519 234 AKLGPIGDKT--HVSSRVMGTYGYCAPEYQRTG------QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ------- 298 (427)
Q Consensus 234 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~------- 298 (427)
++........ ......+||+.|+|||++.+. .++.++|||||||+||||+||..||.........
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 9864333221 123346899999999998754 3678999999999999999998887543321100
Q ss_pred -hhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 299 -NLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 299 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
................+.+.+. ..+......+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGG----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCcc----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0000111111111111111110 1123566789999999999999999999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-55 Score=412.53 Aligned_cols=257 Identities=21% Similarity=0.322 Sum_probs=194.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCC-------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGE------- 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 153 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35699999999999999999999999999999999765433 3356889999999999999999999987544
Q ss_pred -----eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeE
Q 042519 154 -----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKL 228 (427)
Q Consensus 154 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl 228 (427)
.+|+|||||++|+|.+++.... ......+..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 3689999999999999997543 2234566778899999999999999999 999999999999999999999
Q ss_pred eecCCcccCCCCCcc----------ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccc
Q 042519 229 SDFGLAKLGPIGDKT----------HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ 298 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~ 298 (427)
+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----- 231 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----- 231 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----
Confidence 999999864332211 11234689999999999999999999999999999999996 664311
Q ss_pred hhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 299 NLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
........ ... ..++.. .......+.+++.+||+.||++|||+.|++++-+.
T Consensus 232 ~~~~~~~~-~~~-~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 232 ERVRTLTD-VRN-LKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp HHHHHHHH-HHT-TCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHH-Hhc-CCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 11111111 111 111110 12233467789999999999999999999997553
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=421.09 Aligned_cols=271 Identities=21% Similarity=0.266 Sum_probs=207.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEc------CC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCAD------GE 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 153 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||++++.... ..+.+.+|+.+|+.|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999999999999999999765332 23567889999999999999999998763 46
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
.+|||||||+ |+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 7899999997 789998853 457999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCC--ccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 234 AKLGPIGD--KTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 234 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
|+...... ........+||+.|+|||++.+. .|+.++||||+|||+|||++|+.||........ +.. .......
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~--l~~-I~~~~g~ 281 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ--LQL-IMMVLGT 281 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHH-HHHHHCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHhcCC
Confidence 98643221 12234567999999999998765 579999999999999999999999975432211 110 0000000
Q ss_pred CCC-C-Cc--------cccccc-CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 311 PNR-Y-PQ--------LADPLL-QGEFP-----VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 311 ~~~-~-~~--------~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+.. . .. ...... ....+ ......+.+|+.+||+.||++|||+.|+++|-+.-.
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 000 0 00 000000 00000 112357889999999999999999999999976543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=407.54 Aligned_cols=269 Identities=22% Similarity=0.256 Sum_probs=202.4
Q ss_pred HhhCccccceeccCCceEEEEEEEC---CCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 156 (427)
..++|++.+.||+|+||+||+|+++ .+++.||||.+... .....+.+|+.+|..+ +|||||+++++|.+.+.+|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4678999999999999999999875 46789999998654 3345678899999988 5999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC-CCeeEeecCCcc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLAK 235 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkl~DFG~a~ 235 (427)
+||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999883 4889999999999999999999999 9999999999999877 799999999997
Q ss_pred cCCCCCc--------------------------cceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCC
Q 042519 236 LGPIGDK--------------------------THVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRA 288 (427)
Q Consensus 236 ~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p 288 (427)
....... .......+||+.|+|||++.+. .|+.++||||+|||+|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 5322111 1112346799999999999775 589999999999999999999999
Q ss_pred CCCCCCcccch--hhh---------hh----------------------hhhhcCCCCCCccccccc----CCCCCHHHH
Q 042519 289 IDTTRPTYEQN--LVT---------WA----------------------QPFFKDPNRYPQLADPLL----QGEFPVRGL 331 (427)
Q Consensus 289 ~~~~~~~~~~~--~~~---------~~----------------------~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 331 (427)
|........+. +.. +. ..........+....... .........
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 96544321110 000 00 000000000000000000 000111234
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 332 NQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 332 ~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.++.+|+.+||+.||++|||+.|+++|-+.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 578899999999999999999999998764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=424.70 Aligned_cols=258 Identities=19% Similarity=0.218 Sum_probs=216.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+.+.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999999999999999999876655667788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC--CCeeEeecCCcccCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE--FNAKLSDFGLAKLGPI 239 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~vkl~DFG~a~~~~~ 239 (427)
|+||+|.++|.. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999854 3456999999999999999999999999 9999999999999854 8999999999987433
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
. ......+||+.|+|||++.+..|+.++||||||||+|||++|+.||...... .....+......++...
T Consensus 310 ~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~- 379 (573)
T 3uto_A 310 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWNMDDSA- 379 (573)
T ss_dssp T---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCCCCSGG-
T ss_pred C---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCCCCCccc-
Confidence 2 2344578999999999999999999999999999999999999999754321 11222222111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.......+.+||.+||+.||.+|||+.|+++|-+.-
T Consensus 380 -------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~ 415 (573)
T 3uto_A 380 -------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415 (573)
T ss_dssp -------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred -------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence 112345788999999999999999999999986643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=422.24 Aligned_cols=259 Identities=24% Similarity=0.271 Sum_probs=210.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHH---HHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIV---EVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.++||+|+||+||+|+++.+|+.||||++.+... .....+.+ ++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 3679999999999999999999999999999999975422 12222333 45677788999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
|||||||+||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999753 46899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
..... .....+||+.|||||++.. ..|+.++||||||||||||++|+.||....... ..............
T Consensus 341 ~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~~~~~- 412 (689)
T 3v5w_A 341 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMAVE- 412 (689)
T ss_dssp ECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHHCCCC-
T ss_pred ecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcCCCCC-
Confidence 64322 2345789999999999964 579999999999999999999999996532221 11112222222211
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhcCCCC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFLGSDP 366 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~~~~~ 366 (427)
++......+.+||..||+.||.+|++ +.||++|-++-.-++
T Consensus 413 -----------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 413 -----------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred -----------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 12233467889999999999999998 799999887655433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=392.43 Aligned_cols=281 Identities=41% Similarity=0.658 Sum_probs=242.8
Q ss_pred HHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 79 ATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 79 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
....++|++.+.||+|+||.||+|+++ +|..||||++........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 345688999999999999999999975 5889999998777666677899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999999999999765545567999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
............||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........|...... ...+...+
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 269 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIV 269 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCCCSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccHHHhc
Confidence 33333334456799999999999988999999999999999999999999987766655556666544333 34556667
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
++.+....+......+.+++.+||+.||++||++.+++++|+.+..
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 7777777788999999999999999999999999999999987643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=383.29 Aligned_cols=288 Identities=45% Similarity=0.739 Sum_probs=243.4
Q ss_pred ccccCHHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEE
Q 042519 70 AQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGY 148 (427)
Q Consensus 70 ~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~ 148 (427)
...+++.++....++|++.+.||+|+||.||+|++. +|+.||||++...... ....+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 346788899999999999999999999999999865 5889999998764332 23468899999999999999999999
Q ss_pred EEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---CCCCeEeccCCCCceEeCCCCC
Q 042519 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK---ANPPVIYRDLKSSNILLDCEFN 225 (427)
Q Consensus 149 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~~~~ivH~Dlkp~NIll~~~~~ 225 (427)
+.+.+..++||||+.+|+|.+++.........+++..++.++.|++.||.|||++ + |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence 9999999999999999999999987766667799999999999999999999999 7 999999999999999999
Q ss_pred eeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC--Ccccchhhhh
Q 042519 226 AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTR--PTYEQNLVTW 303 (427)
Q Consensus 226 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~--~~~~~~~~~~ 303 (427)
+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .........|
T Consensus 173 ~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999998643322 233445679999999999988899999999999999999999999996321 1222344455
Q ss_pred hhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 304 AQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
....... .....+.+..+...++......+.+++..||+.||.+|||+.+|+++|+...
T Consensus 252 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 252 VKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 5444443 4556677777777888999999999999999999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=375.61 Aligned_cols=262 Identities=25% Similarity=0.364 Sum_probs=215.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.++||+|+||+||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46799999999999999999999999999999998766556667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999763 456899999999999999999999999 9999999999999999999999999998643222
Q ss_pred ccc------------eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc
Q 042519 242 KTH------------VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK 309 (427)
Q Consensus 242 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 309 (427)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+........ ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~~ 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFLD 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhcccc
Confidence 111 1124679999999999999999999999999999999999999987543322111000 000000
Q ss_pred CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 310 DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
...+..++..+.+++..||+.||++||++.++++.|+.+..
T Consensus 242 --------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 242 --------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp --------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01122233468899999999999999999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=373.69 Aligned_cols=256 Identities=24% Similarity=0.319 Sum_probs=215.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999999999999999999776666677889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999865 35889999999999999999999999 9999999999999999999999999987643222
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+... ......... ..
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~--~~----- 235 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT--PE----- 235 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCS--CC-----
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCC--CC-----
Confidence 233456899999999999999999999999999999999999999975432211 111111000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...+......+.+++.+||+.||++|||+.+++++-+.-
T Consensus 236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~ 274 (297)
T 3fxz_A 236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274 (297)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence 011233446788999999999999999999999987653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=372.68 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=213.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4679999999999999999999999999999999976532 23456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999998653 45899999999999999999999999 99999999999999999999999999976433
Q ss_pred CCccceeccccccccccCccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLT-VKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... ..............
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~---- 233 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGKYRI---- 233 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC----
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC----
Confidence 22 23557899999999999887765 799999999999999999999975432 22222222221111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+......+.+++.+||+.||.+|||+.+++++-+...
T Consensus 234 --------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 234 --------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp --------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred --------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 2223457889999999999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=373.93 Aligned_cols=256 Identities=25% Similarity=0.288 Sum_probs=214.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999997542 23456688899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999999998653 46899999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 157 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~----- 223 (337)
T 1o6l_A 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEIR----- 223 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC-----
T ss_pred cC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCC-----
Confidence 21 2234457899999999999999999999999999999999999999975322 1122222222111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLGS 364 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~ 364 (427)
++......+.+++..||+.||++|| ++.+++++-+...-
T Consensus 224 -------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 224 -------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 1223346788999999999999999 89999999776544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=364.97 Aligned_cols=269 Identities=22% Similarity=0.300 Sum_probs=220.9
Q ss_pred ccccCHHHHHHHhhC----------ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCC
Q 042519 70 AQTFTFRELATATKN----------FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH 139 (427)
Q Consensus 70 ~~~~~~~~~~~~~~~----------y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 139 (427)
...++++++..+.+. |...+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 345777777776653 7788899999999999999998999999999987766667789999999999999
Q ss_pred CCeeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceE
Q 042519 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNIL 219 (427)
Q Consensus 140 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl 219 (427)
|||+++++++...+..++||||+++++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 999999999999999999999999999999884 346899999999999999999999999 999999999999
Q ss_pred eCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch
Q 042519 220 LDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN 299 (427)
Q Consensus 220 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~ 299 (427)
++.++.+||+|||++...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---- 247 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---- 247 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----
T ss_pred ECCCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 999999999999998764322 12234567999999999999999999999999999999999999999754321
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.......... .+.+ .........+.+++.+||+.||++||++.+++++.+...
T Consensus 248 --~~~~~~~~~~--~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 248 --QAMKRLRDSP--PPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp --HHHHHHHHSS--CCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred --HHHHHHhcCC--CCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 1111111110 0000 011223457889999999999999999999999877643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=362.28 Aligned_cols=285 Identities=39% Similarity=0.621 Sum_probs=231.0
Q ss_pred ccccCHHHHHHHhhCcccc------ceeccCCceEEEEEEECCCCcEEEEEEeccCC----CcchHHHHHHHHHHhhcCC
Q 042519 70 AQTFTFRELATATKNFRQE------CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG----LQGNKEFIVEVLMLSLLHH 139 (427)
Q Consensus 70 ~~~~~~~~~~~~~~~y~~~------~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 139 (427)
...|++.++..++++|... +.||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+++.++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4568889999999988877 89999999999999874 7899999986532 2234678899999999999
Q ss_pred CCeeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceE
Q 042519 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNIL 219 (427)
Q Consensus 140 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl 219 (427)
|||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 999999999999999999999999999999986532 3456899999999999999999999999 999999999999
Q ss_pred eCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch
Q 042519 220 LDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN 299 (427)
Q Consensus 220 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~ 299 (427)
++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ..
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~ 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QL 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS--SB
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch--HH
Confidence 99999999999999986443333333445679999999998875 5899999999999999999999999765432 22
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+..+..........+...++..+ ...+......+.+++..||+.||.+||++.+++++|+.+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22222222222222223333333 23567788899999999999999999999999999988754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=379.16 Aligned_cols=262 Identities=26% Similarity=0.381 Sum_probs=214.0
Q ss_pred hhCccccceeccCCceEEEEEEEC-------CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE-------KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 152 (427)
.++|++.+.||+|+||.||+|++. .++..||||++..... .....+.+|+.+++.+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999974 3456899999976532 2345688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 1345899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~ 299 (427)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999986443332223344567889999999999999999999999999999999 99999754321 1
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+.. ....... ...+..+...+.+++..||+.||.+||++.++++.|+.+.
T Consensus 314 ~~~----~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 LFK----LLKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHH----HHHTTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH----HHhcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 1111111 1122334567899999999999999999999999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=377.05 Aligned_cols=260 Identities=18% Similarity=0.212 Sum_probs=199.6
Q ss_pred hhCcccc-ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHH-hhcCCCCeeeEEEEEEc----CCee
Q 042519 82 TKNFRQE-CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLML-SLLHHDNLVNLIGYCAD----GEQR 155 (427)
Q Consensus 82 ~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 155 (427)
.++|.+. ++||+|+||+||+|.++.+|+.||||++.. ...+.+|+.++ +.++||||++++++|.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 789999999999999999999999999853 24567888886 44579999999999875 5678
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---CCCeeEeecC
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---EFNAKLSDFG 232 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkl~DFG 232 (427)
++||||+++|+|.+++... ....+++..+..|+.||+.||.|||+++ |+||||||+||||+. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999753 2356899999999999999999999999 999999999999987 7899999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
+++.... .......+||+.|+|||++.+..++.++||||||||+|+|++|+.||.......... .....+.....
T Consensus 210 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~i~~~~~ 284 (400)
T 1nxk_A 210 FAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRMGQY 284 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC--SHHHHHHHTCC
T ss_pred cccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH--HHHHHHHcCcc
Confidence 9986332 122345789999999999999999999999999999999999999997654322110 00011111111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 313 RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.++. . ........+.+|+..||+.||++|||+.+++++.+....
T Consensus 285 ~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 285 EFPN---P-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CCCT---T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCCC---c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1110 0 011234678899999999999999999999999887643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=371.61 Aligned_cols=257 Identities=21% Similarity=0.227 Sum_probs=212.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ------GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.+.|++.+.||+|+||.||+|+++.+|..||+|++.+.... ..+.+.+|+.++..++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 57799999999999999999999999999999999765432 246788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC----CeeEeec
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF----NAKLSDF 231 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkl~DF 231 (427)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999853 456899999999999999999999999 99999999999998877 7999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
|++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 164 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITAVS 234 (361)
T ss_dssp SSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTC
T ss_pred CCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC
Confidence 999864332 2234567999999999999999999999999999999999999999754221 1111111111
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..++. .. .......+.++|..||+.||.+|||+.+++++-+..
T Consensus 235 ~~~~~----~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 235 YDFDE----EF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp CCCCH----HH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred CCCCc----hh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 11110 00 012235788999999999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=371.06 Aligned_cols=261 Identities=24% Similarity=0.338 Sum_probs=212.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 4689999999999999999999999999999999865433 223567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999885 3456899999999999999999999999 999999999999999999999999999864333
Q ss_pred CccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... .....+. .......
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~----~~~~~~~---- 229 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK----EKKTYLN---- 229 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHH----TTCTTST----
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHh----cccccCC----
Confidence 33333456789999999999987765 789999999999999999999997643321 1111111 1100000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
........+.+++.+||+.||++|||+.|++++-+....
T Consensus 230 ------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 012234577899999999999999999999998876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=377.89 Aligned_cols=262 Identities=25% Similarity=0.334 Sum_probs=212.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.++||+|+||+||+|+++.+++.||||++.+... .....+..|..++.++ +||||++++++|.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4679999999999999999999999999999999976532 2334578899998877 79999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999998753 46899999999999999999999999 999999999999999999999999999852
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc--ch-hhhhhhhhhcCCCCC
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE--QN-LVTWAQPFFKDPNRY 314 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~--~~-~~~~~~~~~~~~~~~ 314 (427)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ..............
T Consensus 204 ~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 280 (396)
T 4dc2_A 204 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 280 (396)
T ss_dssp CC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-
T ss_pred cc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-
Confidence 22 22234567899999999999999999999999999999999999999965432211 11 11112222222211
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHhhcCC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM------SDVVSALSFLGS 364 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~~L~~~~~ 364 (427)
++......+.+++..||+.||.+||++ .+++++-++-.-
T Consensus 281 -----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 281 -----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred -----------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 222344678899999999999999985 788888766443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=374.17 Aligned_cols=264 Identities=26% Similarity=0.413 Sum_probs=212.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc---EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ---VVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|++..++. .||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 4679999999999999999999975554 599999976432 334568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999865 3356899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCc-cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 238 PIGDK-THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 238 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .+ .... ......
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~---~~~~-~~~~~~- 273 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DV---ISSV-EEGYRL- 273 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH---HHHH-HTTCCC-
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HH---HHHH-HcCCCC-
Confidence 33221 122233456788999999998899999999999999999999 99999754322 11 1111 111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDA 368 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 368 (427)
..+..++..+.+++..||+.||.+||++.+|++.|+.+...+..
T Consensus 274 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 274 ---------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ---------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 11223456889999999999999999999999999988765443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=373.91 Aligned_cols=267 Identities=26% Similarity=0.342 Sum_probs=209.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC----eeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE----QRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 157 (427)
.++|++.++||+|+||+||+|++. ++.||||++.... ........|+.++..++||||+++++++.+.. ..++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 478999999999999999999886 7899999996542 23344566888999999999999999998754 4699
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCeEeccCCCCceEeCCCCCee
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK----------ANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999965 3589999999999999999999999 8 99999999999999999999
Q ss_pred EeecCCcccCCCCCccceeccccccccccCccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 042519 228 LSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-----QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT 302 (427)
Q Consensus 228 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~ 302 (427)
|+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999765443333334456799999999999863 45678999999999999999999997654432211111
Q ss_pred h---------hhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 303 W---------AQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 303 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
. ...........+.+. .. .........+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLR-DY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCC-GG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCcc-cc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 000011111111111 00 012345677999999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=371.71 Aligned_cols=261 Identities=21% Similarity=0.220 Sum_probs=212.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-----CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-----LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999999999999999986421 124567899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC---eeEeecCC
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN---AKLSDFGL 233 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkl~DFG~ 233 (427)
+||||+++++|.+++.........+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888765444566899999999999999999999999 999999999999987655 99999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
+...... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ............
T Consensus 180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIKGKYK 250 (351)
T ss_dssp CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHHTCCC
T ss_pred eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHcCCCC
Confidence 9864322 2223456799999999999999999999999999999999999999975321 111111111111
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.. +... ......+.+++.+||+.||++||++.+++++-+..
T Consensus 251 ~~----~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 251 MN----PRQW----SHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp CC----HHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CC----cccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 10 0000 11235788999999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=366.74 Aligned_cols=263 Identities=32% Similarity=0.447 Sum_probs=204.7
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
..++|++.+.||+|+||+||+|++. |..||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3578999999999999999999874 788999998765432 235688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999986522 1224899999999999999999999986 359999999999999999999999999997532
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.. ... ........
T Consensus 191 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~---~~~~~~~~----- 257 (309)
T 3p86_A 191 S--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVA---AVGFKCKR----- 257 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHH---HHHHSCCC-----
T ss_pred c--cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhcCCC-----
Confidence 2 2222345679999999999999999999999999999999999999997643221 111 11000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 365 (427)
...+......+.+++..||+.||.+||++.++++.|+.+...
T Consensus 258 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 -----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 012223446788999999999999999999999999887653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=375.17 Aligned_cols=255 Identities=26% Similarity=0.357 Sum_probs=208.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.++||+|+||+||+|+++.+|+.||||++.+.. ......+..|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999999999999999997542 23345677899999988 69999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999998653 45899999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......+
T Consensus 175 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~~--- 243 (353)
T 3txo_A 175 IC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEVVY--- 243 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC---
T ss_pred cc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCC---
Confidence 22 22234567899999999999988999999999999999999999999975432 12222222222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHhhcC
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM------SDVVSALSFLG 363 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~~L~~~~ 363 (427)
+......+.+++..||+.||.+||++ .+++++-+.-.
T Consensus 244 ---------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 244 ---------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred ---------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 22234578899999999999999998 88998876644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=377.71 Aligned_cols=272 Identities=25% Similarity=0.354 Sum_probs=216.6
Q ss_pred cCHHHHHHHhhCccccceeccCCceEEEEEE-----ECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCeeeE
Q 042519 73 FTFRELATATKNFRQECLIGEGGFGRVYKGK-----LEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLL-HHDNLVNL 145 (427)
Q Consensus 73 ~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l 145 (427)
+.........++|++.+.||+|+||.||+|+ ...+++.||||++...... ..+.+.+|+.++..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3444455567899999999999999999999 4566789999999764332 335688999999999 79999999
Q ss_pred EEEEEcCCe-eEEEEeecCCCChhhhhhhcCCC-----------------------------------------------
Q 042519 146 IGYCADGEQ-RLLVYEYMPLRSLEDHLLDIGPE----------------------------------------------- 177 (427)
Q Consensus 146 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------- 177 (427)
++++.+.+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 89999999999999999764321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 178 ---------------QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 178 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999999 99999999999999999999999999986544333
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
........||+.|+|||++.+..++.++|||||||++|||++ |..||....... .... ........
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~~------- 315 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTRM------- 315 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTCCC-------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCCCC-------
Confidence 344556778999999999999999999999999999999998 999997643221 1111 11111100
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..+......+.+++..||+.||++||++.+++++|+.+.
T Consensus 316 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 316 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 112223457889999999999999999999999998653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=374.28 Aligned_cols=256 Identities=25% Similarity=0.322 Sum_probs=211.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+.. ......+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999999999999999986532 23446788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999864 356899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRT---GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
.. ......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||..........+. ..+......
T Consensus 167 ~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~---~~~~~~~~~-- 238 (384)
T 4fr4_A 167 RE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV---HTFETTVVT-- 238 (384)
T ss_dssp TT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH---HHHHHCCCC--
T ss_pred CC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH---HHHhhcccC--
Confidence 22 23455789999999999863 46899999999999999999999999754332222111 111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhhc
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-MSDVVSALSFL 362 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~~L~~~ 362 (427)
++......+.+++..||+.||.+||+ +.+++++-+.-
T Consensus 239 ----------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~ 276 (384)
T 4fr4_A 239 ----------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276 (384)
T ss_dssp ----------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred ----------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence 12233467899999999999999998 88888765543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=363.62 Aligned_cols=258 Identities=15% Similarity=0.214 Sum_probs=213.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999999999999999986542 3445678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC--CCCeeEeecCCcccCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC--EFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~vkl~DFG~a~~~~~ 239 (427)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999854 3346899999999999999999999999 999999999999987 78999999999986433
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+......+....
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~- 226 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFDEEA- 226 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCCHHH-
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCCCCChhh-
Confidence 22 234567999999999999888999999999999999999999999754321 11222222111111000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
....+..+.+++.+||+.||.+|||+.|++++-+...
T Consensus 227 -------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 227 -------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 0122457889999999999999999999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=364.58 Aligned_cols=253 Identities=27% Similarity=0.352 Sum_probs=213.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999999999999999997542 23446678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999965 346899999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......+
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~---- 222 (318)
T 1fot_A 158 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELRF---- 222 (318)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCCC----
T ss_pred C-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC----
Confidence 2 23356899999999999999999999999999999999999999975322 12222222221111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLGS 364 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~ 364 (427)
+......+.+++.+||+.||++|| ++.+++++-+....
T Consensus 223 --------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 223 --------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp --------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred --------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 222345788999999999999999 89999998776543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=360.17 Aligned_cols=274 Identities=18% Similarity=0.212 Sum_probs=218.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC--eeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE--QRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 158 (427)
.++|++.++||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999999999999999997543 234567789999999999999999999998765 78999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe----CCCCCeeEeecCCc
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL----DCEFNAKLSDFGLA 234 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~vkl~DFG~a 234 (427)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999987643 2334899999999999999999999999 9999999999999 88888999999999
Q ss_pred ccCCCCCccceeccccccccccCccccc--------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQR--------TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~ 306 (427)
+...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||......... ......
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~ 238 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK 238 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHH
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHH
Confidence 8643322 233467999999999886 578999999999999999999999999754332211 111111
Q ss_pred hh-cCCCCCCcc----------c--ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 307 FF-KDPNRYPQL----------A--DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 307 ~~-~~~~~~~~~----------~--~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.. ..+...... . ........+......+.+++..||+.||++|||+.|++++......
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 11 111110000 0 1111224567888899999999999999999999999999976544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=357.62 Aligned_cols=268 Identities=21% Similarity=0.285 Sum_probs=208.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||+||+|+++.+|+.||||++...... ....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999999999999999999765432 23667899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~- 153 (292)
T 3o0g_A 82 FCD-QDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI- 153 (292)
T ss_dssp CCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS-
T ss_pred cCC-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC-
Confidence 998 566666654 3456999999999999999999999999 99999999999999999999999999986432
Q ss_pred CccceeccccccccccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC--CC----
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQ-LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP--NR---- 313 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---- 313 (427)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ .+.... .....+ ..
T Consensus 154 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~-~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 154 -PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIF-RLLGTPTEEQWPSM 230 (292)
T ss_dssp -CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHH-HHHCCCCTTTCTTG
T ss_pred -ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH-HHhCCCChhhhhhh
Confidence 222334567899999999997765 89999999999999999999888644322111 111111 111100 00
Q ss_pred --------CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 314 --------YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 314 --------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.+..................+.+++..||+.||++|||+.|++++-+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 000000001111223345678899999999999999999999998765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=383.59 Aligned_cols=266 Identities=26% Similarity=0.413 Sum_probs=213.2
Q ss_pred hhCccccceeccCCceEEEEEEE-----CCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||.||+|++ ..++..||||++..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46799999999999999999994 45678899999865422 3345688899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC---CeeEe
Q 042519 156 LLVYEYMPLRSLEDHLLDIGP---EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF---NAKLS 229 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkl~ 229 (427)
++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986542 2356899999999999999999999999 99999999999999555 49999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~~i- 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFV- 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHH-
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-
Confidence 9999974322222222344668999999999999999999999999999999998 99999754321 111111
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPD 367 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 367 (427)
...... ..+..++..+.+++..||+.||.+||++.+|+++|+.+...+.
T Consensus 300 ~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 300 TSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HcCCCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 111110 1122334578899999999999999999999999998876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=368.14 Aligned_cols=254 Identities=24% Similarity=0.295 Sum_probs=210.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|.+..+|+.||||++.+.. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367999999999999999999999999999999986532 22345788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+ +|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 68999988653 46899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ +.. +
T Consensus 160 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------~~~------i 220 (336)
T 3h4j_B 160 DG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------FKK------V 220 (336)
T ss_dssp TS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------BCC------C
T ss_pred CC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------HHH------H
Confidence 22 22345679999999999988776 7899999999999999999999975322110 000 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
... ....+......+.+++.+||+.||.+|||+.|++++-+.-..
T Consensus 221 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 NSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp CSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000 001223344678899999999999999999999999887554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=361.46 Aligned_cols=256 Identities=20% Similarity=0.241 Sum_probs=211.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ------GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||.||+|.++.+|..||+|++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 46799999999999999999999999999999999764332 356788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC----CeeEeec
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF----NAKLSDF 231 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkl~DF 231 (427)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999853 456899999999999999999999999 99999999999998887 7999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..........
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~ 233 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVN 233 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHTC
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHHhcC
Confidence 9998643222 234467999999999999999999999999999999999999999753221 1111111111
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..... . ........+.+++..||+.||.+|||+.+++++-+.
T Consensus 234 ~~~~~---~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 234 YEFED---E-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp CCCCH---H-----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CCcCc---c-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 11110 0 001223578899999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=377.96 Aligned_cols=271 Identities=21% Similarity=0.209 Sum_probs=217.5
Q ss_pred HHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC
Q 042519 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG 152 (427)
Q Consensus 76 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 152 (427)
.++....++|++.++||+|+||+||+|+++.+++.||||++.+... .....+.+|..++..++||||++++++|.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3444456899999999999999999999999999999999965321 2223478899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
+..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999965 2356899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
+++..... ........+||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+
T Consensus 221 la~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~i 293 (437)
T 4aw2_A 221 SCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKI 293 (437)
T ss_dssp TCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH
T ss_pred hhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHhh
Confidence 99764322 222344578999999999987 5678999999999999999999999997543221 11111
Q ss_pred hcC--CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhhcCCCCCC
Q 042519 308 FKD--PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSV--RPLMSDVVSALSFLGSDPDA 368 (427)
Q Consensus 308 ~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~L~~~~~~~~~ 368 (427)
... ...++.. .......+.++|.+||..+|++ ||++.|++++-+.-.-++..
T Consensus 294 ~~~~~~~~~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 294 MNHKERFQFPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp HTHHHHCCCCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred hhccccccCCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 110 0011111 0113357889999999988888 99999999998876655543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=359.14 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=202.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--------------------------chHHHHHHHHHHh
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--------------------------GNKEFIVEVLMLS 135 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 135 (427)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46799999999999999999999999999999999654321 1246789999999
Q ss_pred hcCCCCeeeEEEEEEc--CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC
Q 042519 136 LLHHDNLVNLIGYCAD--GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDL 213 (427)
Q Consensus 136 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 213 (427)
.++||||+++++++.+ .+..++||||+++++|.+++ ....+++..++.++.||+.||.|||+++ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999986 67899999999999998865 3457999999999999999999999999 999999
Q ss_pred CCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCC---CCccchHHHHHHHHHHHHhCCCCCC
Q 042519 214 KSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ---LTVKSDVYTFGVVLLELITGRRAID 290 (427)
Q Consensus 214 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell~g~~p~~ 290 (427)
||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999864322 22334567999999999998655 4788999999999999999999997
Q ss_pred CCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 291 TTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.... ..............+. .......+.+++.+||+.||++||++.+++++-+
T Consensus 242 ~~~~------~~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 242 DERI------MCLHSKIKSQALEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp CSSH------HHHHHHHHHCCCCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred CccH------HHHHHHHhcccCCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 5321 1111111111111111 1123357889999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=361.46 Aligned_cols=266 Identities=29% Similarity=0.432 Sum_probs=209.9
Q ss_pred hhCccccceeccCCceEEEEEE----ECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGK----LEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 155 (427)
.++|++.+.||+|+||+||+|+ ...+++.||||++........+.+.+|+.++..++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 5789999999999999999999 566799999999987655556778999999999999999999999865 3568
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999763 345899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc---------cchhhhhhh
Q 042519 236 LGPIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY---------EQNLVTWAQ 305 (427)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~---------~~~~~~~~~ 305 (427)
........ .......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 64322211 22334457888999999999999999999999999999999999886432110 000111111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
........ ...+..++..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 243 ~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 243 ELLKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCc----------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111111 1223344578999999999999999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=377.27 Aligned_cols=264 Identities=20% Similarity=0.235 Sum_probs=214.2
Q ss_pred HHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 78 LATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 78 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
+....++|++.++||+|+||+||+|+++.+++.||+|++.+.. ......+.+|+.++..++||||++++++|.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3344678999999999999999999999999999999986522 1233457889999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||++
T Consensus 144 ~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999864 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceeccccccccccCccccccCC----CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ----LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
+...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .....+...
T Consensus 216 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~ 288 (410)
T 3v8s_A 216 MKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNH 288 (410)
T ss_dssp EECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTH
T ss_pred EeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhc
Confidence 8643222 22334678999999999997655 889999999999999999999999754321 111111110
Q ss_pred C--CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhhcCCCC
Q 042519 311 P--NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSV--RPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 311 ~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~L~~~~~~~ 366 (427)
. ..++. .......+.+||..||+.+|.+ ||++.||++|-++-.-.+
T Consensus 289 ~~~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 289 KNSLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp HHHCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred cccccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 0 00110 0122357889999999999988 999999999988765444
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=366.67 Aligned_cols=262 Identities=25% Similarity=0.335 Sum_probs=212.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|+++.+++.||||++.+..... ...+.+|..++..+ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367999999999999999999999999999999997654322 34577899999887 79999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999998653 46899999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc--chhh-hhhhhhhcCCCCC
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE--QNLV-TWAQPFFKDPNRY 314 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~--~~~~-~~~~~~~~~~~~~ 314 (427)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... ............
T Consensus 161 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 237 (345)
T 3a8x_A 161 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 237 (345)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-
T ss_pred cCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-
Confidence 221 2234557899999999999999999999999999999999999999975322111 0111 111122222111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHhhcCC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM------SDVVSALSFLGS 364 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~~L~~~~~ 364 (427)
++......+.+++..||+.||.+||++ .+++++-+.-.-
T Consensus 238 -----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 238 -----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred -----------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 222344678899999999999999995 788888766443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=369.17 Aligned_cols=258 Identities=27% Similarity=0.369 Sum_probs=212.6
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCee
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 155 (427)
...++|++.++||+|+||+||+|+++.+|+.||||++++.. ......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999999999999999997542 23445677888988876 899999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999998653 45899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+......
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~~-- 236 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMDNPF-- 236 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC--
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCCC--
Confidence 532222 2245678999999999999999999999999999999999999999754321 112222222111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHhhcCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMS-DVVSALSFLGS 364 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~~L~~~~~ 364 (427)
++......+.+++..||+.||++||++. +++++-+...-
T Consensus 237 ----------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 237 ----------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp ----------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ----------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 1222346788999999999999999998 88887665443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=367.82 Aligned_cols=259 Identities=20% Similarity=0.237 Sum_probs=213.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.++.+|+.||+|++..........+.+|+.++..++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999999999999999999766545556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC--CCCeeEeecCCcccCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC--EFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~vkl~DFG~a~~~~~ 239 (427)
+.+|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999998854 3346899999999999999999999999 999999999999974 47799999999986433
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...............
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~~~~~~~--- 271 (387)
T 1kob_A 204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDWEFDE--- 271 (387)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCCCCCS---
T ss_pred Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCc---
Confidence 22 233457999999999999999999999999999999999999999754321 111111111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.........+.+++..||+.||.+|||+.+++++-+...
T Consensus 272 -----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 272 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred -----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 111223467889999999999999999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=380.53 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=211.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|.+.+.||+|+||.||+|+++.+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 5689999999999999999999998899999999865422 223457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999753 345889999999999999999999999 999999999999999999999999999863222
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
..........+++.|+|||++.++.++.++|||||||++|||++ |..||...... ... .........
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~----- 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTR----EFVEKGGRL----- 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHH----HHHHTTCCC-----
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCC-----
Confidence 11111122345778999999998899999999999999999998 99999764321 111 111211111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..+..++..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 335 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 -----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 112234467889999999999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=375.36 Aligned_cols=259 Identities=20% Similarity=0.202 Sum_probs=210.9
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
...++|++.+.||+|+||.||+|.++.+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3467899999999999999999999999999999999765432 23567899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC---CCCCeeEeecCCc
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD---CEFNAKLSDFGLA 234 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~vkl~DFG~a 234 (427)
||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999999998753 45899999999999999999999999 99999999999998 4678999999999
Q ss_pred ccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+......+
T Consensus 161 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~ 232 (444)
T 3soa_A 161 IEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAGAYDF 232 (444)
T ss_dssp BCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCCCC
T ss_pred EEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhCCCCC
Confidence 764322 2223456899999999999999999999999999999999999999965322 11111222211111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+. +. .......+.+++..||+.||++|||+.+++++-+.
T Consensus 233 ~~---~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 233 PS---PE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp CT---TT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred Cc---cc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 11 00 01234578899999999999999999999998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=365.78 Aligned_cols=258 Identities=19% Similarity=0.228 Sum_probs=211.6
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
..++|++.+.||+|+||.||+|.++.+|..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 457899999999999999999999999999999999765432 335678999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC---CeeEeecCCcc
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF---NAKLSDFGLAK 235 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkl~DFG~a~ 235 (427)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999998853 356899999999999999999999999 99999999999997654 59999999998
Q ss_pred cCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+......++
T Consensus 180 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 250 (362)
T 2bdw_A 180 EVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYDYP 250 (362)
T ss_dssp CCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCC
T ss_pred EecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCCC
Confidence 64322 2234568999999999999989999999999999999999999999754221 11111111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
... .......+.+++..||+.||++||++.+++++-+..
T Consensus 251 ~~~--------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 251 SPE--------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp TTG--------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred ccc--------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 100 112345788999999999999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=368.89 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=205.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcE----EEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQV----VAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.++|++.++||+|+||+||+|++..++.. ||+|.+.... ......+.+|+.+++.++||||++++++|.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 46799999999999999999999877765 4777775432 244567899999999999999999999998765 78
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+|+||+.+|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 899999999999999763 456899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..............||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +.. ........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~~- 238 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL- 238 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCCCC-
Confidence 544443333445567889999999999999999999999999999999 999997643321 111 11111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 365 (427)
..+..+...+.+++.+||+.||.+||++.+++++|+.+...
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11223445788999999999999999999999999887654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=356.31 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=210.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|++..++..||+|++....... .+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999999999999999986543322 35678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999653 46899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ......... ..+...
T Consensus 163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~--~~~~~~ 233 (294)
T 4eqm_A 163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQD--SVPNVT 233 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSS--CCCCHH
T ss_pred ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhc--cCCCcc
Confidence 221 12234467999999999999999999999999999999999999999754321 111111111 111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcCCCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-LMSDVVSALSFLGSDP 366 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~~ 366 (427)
. ..+...+..+.+++.+||+.||.+|| ++.++.+.|..+....
T Consensus 234 -~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 234 -T----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -H----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -h----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0 11122346788999999999999999 8999999998765533
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=367.65 Aligned_cols=256 Identities=25% Similarity=0.313 Sum_probs=212.8
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 156 (427)
..++|++.++||+|+||+||+|+++.+|+.||||++.+.. ......+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999999999999999997542 23446678899999887 7999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999999999999753 35899999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~--- 239 (353)
T 2i0e_A 171 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNVA--- 239 (353)
T ss_dssp CCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---
T ss_pred cccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCCC---
Confidence 3221 2234567899999999999999999999999999999999999999975322 1222222222111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhcC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFLG 363 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~~ 363 (427)
++......+.+++..||+.||.+||+ +.+++++-+.-.
T Consensus 240 ---------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 240 ---------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred ---------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 12234467889999999999999995 688988876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=360.59 Aligned_cols=254 Identities=25% Similarity=0.285 Sum_probs=214.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999996542 23446788899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999999999753 35899999999999999999999999 9999999999999999999999999998642
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~----- 256 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKVR----- 256 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC-----
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCCCC-----
Confidence 21 2356899999999999999999999999999999999999999975432 1122222222111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhcCCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFLGSD 365 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~~~~ 365 (427)
++......+.+++..||+.||.+||+ +.+++++-+....+
T Consensus 257 -------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 257 -------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp -------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 12233467889999999999999998 99999988765443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=364.88 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=208.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcE----EEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQV----VAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.++|++.+.||+|+||.||+|++..++.. ||+|.+.... ......+.+|+.++..++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 46799999999999999999999887775 7777775432 233456778999999999999999999986 45689
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999998652 346888899999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..............||+.|+|||++.+..++.++|||||||++|+|++ |+.||....... .... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~- 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDL----LEKGERL- 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHH----HHTTCBC-
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHH----HHcCCCC-
Confidence 654444444556678889999999999999999999999999999999 999997643321 1111 1111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
..+..+...+.+++..||+.||.+||++.+++++|+.+...+
T Consensus 237 ---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 237 ---------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ---------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ---------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 001112235668999999999999999999999999887643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=363.30 Aligned_cols=262 Identities=27% Similarity=0.384 Sum_probs=214.2
Q ss_pred hhCccccceeccCCceEEEEEEE-----CCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|.+.+.||+|+||.||+|.+ +.++..||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 57799999999999999999998 34568999999975432 2346688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCC
Q 042519 156 LLVYEYMPLRSLEDHLLDIGP--------------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKS 215 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 215 (427)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976532 1245899999999999999999999999 99999999
Q ss_pred CceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCC
Q 042519 216 SNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRP 294 (427)
Q Consensus 216 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~ 294 (427)
+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986543333333344567889999999998899999999999999999999 9999976543
Q ss_pred cccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 295 TYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.. +.. ....... ...+......+.+++..||+.||.+||++.+++++|+.+.
T Consensus 259 ~~---~~~----~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 ER---LFN----LLKTGHR----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GG---HHH----HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHH----HhhcCCc----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 21 111 1111110 0112234467899999999999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=367.70 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=212.8
Q ss_pred hhCccccceeccCCceEEEEEEE-----CCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 154 (427)
.++|++.+.||+|+||.||+|.+ ..++..||||++.... ......+.+|+.++..+ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 57899999999999999999997 3457789999997542 23456788999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCC
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPE-------------------QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKS 215 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 215 (427)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 99999999999999999764321 134799999999999999999999999 99999999
Q ss_pred CceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCC
Q 042519 216 SNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRP 294 (427)
Q Consensus 216 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~ 294 (427)
+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999986443333334455678899999999998999999999999999999998 9999976532
Q ss_pred cccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 295 TYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
. ..... ....... ...+......+.+++..||+.||.+||++.+++++|+.+..
T Consensus 281 ~--~~~~~----~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 281 D--ANFYK----LIQNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp S--HHHHH----HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred H--HHHHH----HHhcCCC----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 2 11111 1111111 01122334678999999999999999999999999998765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=366.30 Aligned_cols=252 Identities=21% Similarity=0.256 Sum_probs=203.8
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCCCC
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRS 166 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 166 (427)
..++||+|+||.||+|.+..+|..||+|++........+.+.+|+.++..++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 36789999999999999999999999999987655566788999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe--CCCCCeeEeecCCcccCCCCCccc
Q 042519 167 LEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL--DCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 167 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 173 L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 173 LFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp EHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 9998865 3346899999999999999999999999 9999999999999 677889999999998643322
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCC
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (427)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+......... ..
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~~~~---~~--- 311 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWDLED---EE--- 311 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCSCS---GG---
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCCCCh---hh---
Confidence 233457999999999999889999999999999999999999999754321 111222221111110 00
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.......+.+++..||+.||.+||++.+++++-+.
T Consensus 312 --~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~ 346 (373)
T 2x4f_A 312 --FQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346 (373)
T ss_dssp --GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred --hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence 11234678899999999999999999999998664
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=368.70 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=214.5
Q ss_pred HhhCccccceeccCCceEEEEEEEC-----CCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLE-----KTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
..++|++.+.||+|+||.||+|++. .++..||||++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3578999999999999999999997 34589999999765332 34568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPE--------------------QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLK 214 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 214 (427)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 99999999999999999764321 267899999999999999999999999 9999999
Q ss_pred CCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 042519 215 SSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTR 293 (427)
Q Consensus 215 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~ 293 (427)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999975432222223345678999999999998899999999999999999999 999997543
Q ss_pred CcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 294 PTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.. ..... .... ... ..+..++..+.+++..||+.||++||++.+++++|+.+..
T Consensus 282 ~~------~~~~~-~~~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 HE------EVIYY-VRDG-NIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HH------HHHHH-HHTT-CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hH------HHHHH-HhCC-CcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 21 11111 1111 111 1122344678999999999999999999999999998765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=360.65 Aligned_cols=274 Identities=23% Similarity=0.290 Sum_probs=198.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||.||+|.++.+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4679999999999999999999999999999999975433 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 161 YMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|++ ++|.+++.... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999886532 23346899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC-----
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN----- 312 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 312 (427)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ + .........+.
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~-~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ--L-KLIFDIMGTPNESLWP 234 (317)
T ss_dssp SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCSCCTTTCG
T ss_pred CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHhCCCChhHhh
Confidence 22 122344678999999999876 4689999999999999999999999976433211 1 10000000000
Q ss_pred ------C----CCc----ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 313 ------R----YPQ----LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 313 ------~----~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
. ... .+...+....+......+.+++..||+.||++|||+.+++++-+.-..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 0 000 000000001111234578999999999999999999999998765443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.51 Aligned_cols=268 Identities=22% Similarity=0.319 Sum_probs=205.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||+||+|++.. |+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4789999999999999999999965 899999998654322 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9998 588888765 3456899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC--CCCCc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP--NRYPQ 316 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 316 (427)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +... ......+ ...+.
T Consensus 172 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i-~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 172 P--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKI-FSILGTPNPREWPQ 246 (311)
T ss_dssp C--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHH-HHHHCCCCTTTSGG
T ss_pred C--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHHCCCChHHhhh
Confidence 2 222344678999999999876 5689999999999999999999999976543321 1111 1111100 00000
Q ss_pred c-------------cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 317 L-------------ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 317 ~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
. ...............++.+++..||+.||++|||+.|++++-+.-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 305 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 0 000000000112335788999999999999999999999987653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=359.81 Aligned_cols=260 Identities=21% Similarity=0.210 Sum_probs=211.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+|+.+++.| +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 468999999999999999999999999999999987553 234688999999999 89999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC-----eeEeecCCcc
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN-----AKLSDFGLAK 235 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----vkl~DFG~a~ 235 (427)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 89999998763 457999999999999999999999999 999999999999998887 9999999998
Q ss_pred cCCCCCccc-----eeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh-hhhhc
Q 042519 236 LGPIGDKTH-----VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA-QPFFK 309 (427)
Q Consensus 236 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~ 309 (427)
......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 643322211 124578999999999999999999999999999999999999999865432211111111 10000
Q ss_pred CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 310 DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+ ...+.. ..+ .+.+++..||+.||.+||++.+|++.|+.+
T Consensus 239 ~~-------~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TP-------IEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SC-------HHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CC-------HHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 000011 122 789999999999999999999999999765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=371.17 Aligned_cols=263 Identities=26% Similarity=0.372 Sum_probs=215.5
Q ss_pred hhCccccceeccCCceEEEEEEECC-------CCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-------TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 152 (427)
.++|.+.+.||+|+||.||+|++.. .+..||||++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4789999999999999999999753 345799999976533 2336688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999986542 1346899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~ 299 (427)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---- 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999986544333333445668899999999999999999999999999999999 99999754321
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.... ........ ..+..+...+.+++..||+.||++||++.+|+++|+.+..
T Consensus 301 --~~~~-~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 --ELFK-LLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp --HHHH-HHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHH-HHHcCCCC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 11111111 1122334678899999999999999999999999988764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=368.59 Aligned_cols=254 Identities=26% Similarity=0.299 Sum_probs=202.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHH-HhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLM-LSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.++||+|+||+||+|+++.+++.||||++.+.... ....+..|..+ ++.++||||++++++|.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 36799999999999999999999999999999999765432 22345566666 577899999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999998653 45889999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
... .......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+......+
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~~--- 258 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPLQL--- 258 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSCCCC---
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcccCC---
Confidence 221 2234567899999999999999999999999999999999999999975321 12222222221111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHhhc
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM----SDVVSALSFL 362 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~----~evl~~L~~~ 362 (427)
+......+.+++..||+.||.+||++ .+++++-++-
T Consensus 259 ---------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 259 ---------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp ---------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred ---------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 12234578899999999999999997 4666665543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=367.34 Aligned_cols=261 Identities=21% Similarity=0.255 Sum_probs=204.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||+||+++++.+++.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999999999999999997653 3346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC--eeEeecCCcccCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN--AKLSDFGLAKLGPI 239 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--vkl~DFG~a~~~~~ 239 (427)
+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999998653 35899999999999999999999999 999999999999987776 99999999974221
Q ss_pred CCccceeccccccccccCccccccCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVK-SDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ................+.
T Consensus 171 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~-- 243 (361)
T 3uc3_A 171 ---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKYSIPD-- 243 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCCCCCT--
T ss_pred ---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCCCCCC--
Confidence 122344679999999999988877655 899999999999999999997644321 122222222221111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 365 (427)
.......+.+++.+||+.||.+|||+.+++++-+.....
T Consensus 244 --------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 244 --------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp --------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred --------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 111235788999999999999999999999998876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=374.30 Aligned_cols=270 Identities=22% Similarity=0.193 Sum_probs=215.1
Q ss_pred HHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC
Q 042519 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG 152 (427)
Q Consensus 76 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 152 (427)
.+.....++|++.++||+|+||+||+|+++.+|+.||||++.+... .....+.+|..++..++||||++++++|.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 3344456889999999999999999999999999999999965321 2234478899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
+..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999763 246899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeccccccccccCccccc-------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQR-------TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~ 305 (427)
+++...... .......+||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...
T Consensus 208 la~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~ 280 (412)
T 2vd5_A 208 SCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TYG 280 (412)
T ss_dssp TCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH
T ss_pred hheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HHH
Confidence 998643222 22234568999999999987 3578999999999999999999999997543221 111
Q ss_pred hhhc--CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHHhhcCCCCCC
Q 042519 306 PFFK--DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVR---PLMSDVVSALSFLGSDPDA 368 (427)
Q Consensus 306 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~evl~~L~~~~~~~~~ 368 (427)
.+.. ....++. .+...+..+.++|.+||+ +|.+| |++.|+++|-++-.-++..
T Consensus 281 ~i~~~~~~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 281 KIVHYKEHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp HHHTHHHHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred HHHhcccCcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 1110 0000110 011234678899999999 99998 5999999998776554443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=350.82 Aligned_cols=257 Identities=24% Similarity=0.329 Sum_probs=212.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.++. +..||+|++.... .....+.+|+.++..++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 5789999999999999999998875 6789999997654 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999763 346899999999999999999999999 9999999999999999999999999998643322
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ........ ...
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~-~~~------ 224 (268)
T 3sxs_A 159 -YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQG-HRL------ 224 (268)
T ss_dssp -EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTT-CCC------
T ss_pred -hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcC-CCC------
Confidence 222334557788999999998899999999999999999999 999997543221 11111111 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+......+.+++..||+.||++|||+.+++++|+.+..
T Consensus 225 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 ----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0111223578899999999999999999999999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=380.46 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=217.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.++||+|+||.||+|+++.+|+.||||++.+... .....+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3679999999999999999999999999999999965422 3346688899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||++||+|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999876555667999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...............
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~~~----- 411 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQAVT----- 411 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCCCC-----
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcccC-----
Confidence 222 22344689999999999999999999999999999999999999997653221 112222222222111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHhhcC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM-----SDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~~L~~~~ 363 (427)
++......+.+++..||+.||++||++ .+++++-+.-.
T Consensus 412 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 412 -------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred -------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 122334678899999999999999965 78888766543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=379.41 Aligned_cols=256 Identities=25% Similarity=0.286 Sum_probs=204.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccC---CCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN---GLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.++||+|+||.||+|++..+|+.||||++... .......+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999999753 223345677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999998653 468999999999999999999998 88 999999999999999999999999999853
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......+
T Consensus 300 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~--- 368 (446)
T 4ejn_A 300 IK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEIRF--- 368 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC---
T ss_pred cC--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCCC---
Confidence 22 22234457899999999999999999999999999999999999999975432 11222222222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcCC
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLGS 364 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~ 364 (427)
+......+.+++..||+.||.+|| ++.+++++-+...-
T Consensus 369 ---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 369 ---------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 222346788999999999999999 99999998876544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=361.38 Aligned_cols=263 Identities=26% Similarity=0.350 Sum_probs=214.7
Q ss_pred hhCccccceeccCCceEEEEEEE-----CCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 154 (427)
.++|++.+.||+|+||.||+|.+ ..++..||||++..... ...+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46799999999999999999985 45678999999976543 2346688999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGP--------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999976432 1235899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~ 299 (427)
+.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 9999999999999986544433333445668889999999999999999999999999999999 999997643221 1
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..... ..... ...+...+..+.+++..||+.||.+||++.+++++|+.+.
T Consensus 257 ~~~~~----~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 FYKMI----KEGFR----------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHH----HHTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHh----ccCCC----------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11111 11000 0112223467899999999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=353.09 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=211.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4679999999999999999999975 7789999997653 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 159 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD- 159 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc-
Confidence 999999999865 3456899999999999999999999999 999999999999999999999999999863221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.........||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ......... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~-~~------- 225 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG-FR------- 225 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT-CC-------
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcC-cc-------
Confidence 1122334567888999999998999999999999999999999 99999764322 111111111 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+......+.+++..||+.||++||++.+++++|+.+.
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 226 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 0111223457889999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=374.13 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=201.9
Q ss_pred hhCccccceeccCCceEEEEEEEC---CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|+++ .++..||||+++.... ...+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999987 4577899999975432 234578899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999975 3456899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 238 PIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 238 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
...... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.... .....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i----~~~~~-- 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAV----DEGYR-- 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHH----HTTEE--
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCC--
Confidence 322111 11222345778999999999999999999999999999998 99999754321 111111 11100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
...+..++..+.+++..||+.||.+||++.+|++.|+.+...+
T Consensus 269 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 --------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred --------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 1112234567899999999999999999999999999886543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=351.37 Aligned_cols=256 Identities=33% Similarity=0.548 Sum_probs=207.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch-------HHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN-------KEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
.++|++.+.||+|+||.||+|++..+++.||||++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4679999999999999999999999999999999865433221 56889999999999999999999997665
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC-----eeEe
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN-----AKLS 229 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----vkl~ 229 (427)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999998865 3457899999999999999999999986 35999999999999988876 9999
Q ss_pred ecCCcccCCCCCccceeccccccccccCcccc--ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ--RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
|||+++.... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||......... .....
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~ 242 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FINMI 242 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHHHH
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHHHH
Confidence 9999975221 23456799999999998 4456789999999999999999999999754332111 11111
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.... .....+...+..+.+++..||+.||.+||++.++++.|+.+
T Consensus 243 ~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEG----------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSC----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccC----------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1110 01112233446889999999999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=353.10 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=202.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhh--cCCCCeeeEEEEEEc----CCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSL--LHHDNLVNLIGYCAD----GEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~ 155 (427)
.++|++.+.||+|+||+||+|++ +|+.||||++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 57899999999999999999988 4889999998643 33455566666655 889999999998654 3568
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeccCCCCceEeCCCCCee
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH--------DKANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
++||||+++|+|.+++. ...+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 99999999999999993 356999999999999999999999 888 99999999999999999999
Q ss_pred EeecCCcccCCCCCccc--eeccccccccccCccccccC------CCCccchHHHHHHHHHHHHhC----------CCCC
Q 042519 228 LSDFGLAKLGPIGDKTH--VSSRVMGTYGYCAPEYQRTG------QLTVKSDVYTFGVVLLELITG----------RRAI 289 (427)
Q Consensus 228 l~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~ell~g----------~~p~ 289 (427)
|+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997533222211 12335799999999999876 455799999999999999999 7777
Q ss_pred CCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 290 DTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
....+..... .. ...........+.+.. ...+......+.+++..||+.||++|||+.++++.|+.+
T Consensus 234 ~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSF-ED-MRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCH-HH-HHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcch-hh-hhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 5543322111 11 1111111111111111 112345778899999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=361.63 Aligned_cols=261 Identities=22% Similarity=0.261 Sum_probs=189.6
Q ss_pred hCcccc---ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEE
Q 042519 83 KNFRQE---CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 83 ~~y~~~---~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 158 (427)
++|++. +.||+|+||.||+|.++.+|+.||||++... ....+.+|+.++..+. ||||+++++++.+....++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 446654 7899999999999999999999999999643 3456788999999997 99999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC---CeeEeecCCcc
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF---NAKLSDFGLAK 235 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkl~DFG~a~ 235 (427)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 85 MELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp ECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 999999999999975 356899999999999999999999999 99999999999997765 79999999998
Q ss_pred cCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc-chhhhhhhhhhcCCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE-QNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 314 (427)
..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .........+.......
T Consensus 158 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 158 LKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred ecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 64322 2233456789999999999999999999999999999999999999976543221 11112222221111100
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.. .........+.+++..||+.||.+||++.+++++-+...
T Consensus 236 ~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 236 EG--------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp CS--------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred Cc--------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 00 000123467899999999999999999999999877543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=359.61 Aligned_cols=255 Identities=22% Similarity=0.262 Sum_probs=195.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|+++.+++.||||++.... ..+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 577999999999999999999999999999999997643 345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---CCCeeEeecCCcccCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---EFNAKLSDFGLAKLGP 238 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkl~DFG~a~~~~ 238 (427)
+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 130 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999854 356899999999999999999999999 999999999999975 8899999999998632
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... .....+....... .
T Consensus 203 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~~~~---~ 271 (349)
T 2w4o_A 203 H---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCEYYF---I 271 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTCCCC---C
T ss_pred c---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCCCcc---C
Confidence 2 122345679999999999999999999999999999999999999997543221 0111111111110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
. .........+.+++.+||+.||++||++.+++++-+.
T Consensus 272 ~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 272 S-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp T-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred C-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 0 1112234578899999999999999999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=367.98 Aligned_cols=274 Identities=18% Similarity=0.205 Sum_probs=209.8
Q ss_pred hhCccccceeccC--CceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEG--GFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.++||+| +||.||+|+++.+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5679999999999 999999999999999999999976532 223567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999998764 2356899999999999999999999999 999999999999999999999999987642
Q ss_pred CCCCc-----cceeccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc-
Q 042519 238 PIGDK-----THVSSRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK- 309 (427)
Q Consensus 238 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~- 309 (427)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCc
Confidence 21111 111233578999999999987 6799999999999999999999999976433211 1111000000
Q ss_pred --CCCC------------------CCccc---------ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 310 --DPNR------------------YPQLA---------DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 310 --~~~~------------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
+... ..... ........+......+.+|+.+||+.||++|||+.|++++-+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 0000 00000 000000122334567899999999999999999999999865
Q ss_pred hc
Q 042519 361 FL 362 (427)
Q Consensus 361 ~~ 362 (427)
.-
T Consensus 337 f~ 338 (389)
T 3gni_B 337 FK 338 (389)
T ss_dssp GG
T ss_pred HH
Confidence 53
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=362.93 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=196.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc---EEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee-
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ---VVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR- 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 155 (427)
.++|++.+.||+|+||.||+|++..++. .||||++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 5679999999999999999999887665 89999987642 23456788999999999999999999999887665
Q ss_pred -----EEEEeecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeE
Q 042519 156 -----LLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKL 228 (427)
Q Consensus 156 -----~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl 228 (427)
++||||+.+|+|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 99999999999999986533 22336899999999999999999999999 999999999999999999999
Q ss_pred eecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhh
Q 042519 229 SDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYL 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH------HHHHH
Confidence 99999986443333333344567889999999999999999999999999999999 999997643321 11111
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
... ... ..+......+.+++..||+.||++||++.++++.|+.+...+
T Consensus 253 ~~~-~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 IGG-NRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HTT-CCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcC-CCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111 110 112233467899999999999999999999999998875544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=360.11 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=210.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEE----cCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA----DGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 578999999999999999999999999999999987665556677899999999999999999999987 3457899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+.+|+|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999875555678999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCccc-------eeccccccccccCccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 042519 238 PIGDKTH-------VSSRVMGTYGYCAPEYQRTGQ---LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 238 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ .... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----A 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----H
Confidence 2111000 012345799999999987554 68999999999999999999999953211100 0110 0
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.......+ .+......+.+++..||+.||.+||++.+++++|+.+..
T Consensus 260 ~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQNQLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHCC--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhccCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 11111110 112234678999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=381.86 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=215.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
..+|++.+.||+|+||.||+|.++.++..||||++.... ...+.+.+|+.++++++||||++++++|.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 467999999999999999999999989999999997653 3467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 298 ~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 371 (495)
T 1opk_A 298 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD- 371 (495)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC-
T ss_pred cCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC-
Confidence 9999999999763 3356899999999999999999999999 999999999999999999999999999864322
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||...... .+.. .......
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~------- 437 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE----LLEKDYR------- 437 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----HHHTTCC-------
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCC-------
Confidence 2222334556789999999999999999999999999999999 99999764322 1111 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+..++..+.+++..||+.||++||++.+|++.|+.+.
T Consensus 438 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1123344568899999999999999999999999998654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=353.35 Aligned_cols=263 Identities=18% Similarity=0.180 Sum_probs=213.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.++..+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 467999999999999999999999999999999986543 334678899999999 69999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC-----eeEeecCCcc
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN-----AKLSDFGLAK 235 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----vkl~DFG~a~ 235 (427)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 89999999763 346899999999999999999999999 999999999999987776 9999999998
Q ss_pred cCCCCCcc-----ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh-hhhc
Q 042519 236 LGPIGDKT-----HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ-PFFK 309 (427)
Q Consensus 236 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~ 309 (427)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 64332221 12345679999999999999999999999999999999999999998754332221111111 0000
Q ss_pred CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 310 DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
. .. ..+. ...+..+.+++..||+.||++||++.+|++.|+.+..
T Consensus 240 ~--~~-----~~~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 240 T--PL-----RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp S--CH-----HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred c--cH-----HHHH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0 00 0000 1234678899999999999999999999999987643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=362.23 Aligned_cols=269 Identities=28% Similarity=0.387 Sum_probs=214.3
Q ss_pred hhCccccceeccCCceEEEEEE----ECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEE--cCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGK----LEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA--DGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 155 (427)
.++|++.+.||+|+||.||+|+ ...++..||||++........+.+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4689999999999999999999 46778999999998766555677899999999999999999999887 45678
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999753 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc---------chhhhhhh
Q 042519 236 LGPIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE---------QNLVTWAQ 305 (427)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~---------~~~~~~~~ 305 (427)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..... ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR-LL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH-HH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH-HH
Confidence 64333221 123345688899999999998999999999999999999999999864321100 00000 00
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPD 367 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 367 (427)
..... ......+..+...+.+++..||+.||++||++.+++++|+.+.....
T Consensus 255 ~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 255 ELLEE----------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHhhc----------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11111 11112233455788999999999999999999999999998866443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=358.66 Aligned_cols=256 Identities=23% Similarity=0.293 Sum_probs=203.4
Q ss_pred hhCccccceeccCCceEEEEEEEC---CCCcEEEEEEeccCCC----cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL----QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
.++|++.+.||+|+||.||+|++. .+|+.||+|++.+... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999999985 6799999999976532 233457789999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999998653 45889999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
+.... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+......
T Consensus 169 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~- 239 (327)
T 3a62_A 169 KESIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCKLN- 239 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCC-
T ss_pred ccccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCC-
Confidence 75322 122234568999999999999989999999999999999999999999754321 112222222111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcCC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLGS 364 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~ 364 (427)
++......+.+++.+||+.||.+|| ++.+++++-+.-..
T Consensus 240 -----------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 240 -----------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp -----------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred -----------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 1222346788999999999999999 78899998776443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=352.66 Aligned_cols=266 Identities=23% Similarity=0.331 Sum_probs=202.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||.||+|++ .+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999998 5689999999865432 224678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLD-QDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCS-EEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 998 599888865 3356899999999999999999999999 999999999999999999999999999753221
Q ss_pred CccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC--CCCCcc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP--NRYPQL 317 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 317 (427)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.... .....+ ...+..
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIF-RILGTPNSKNWPNV 228 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCCCCTTTSTTG
T ss_pred --ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHHCCCChhhchhh
Confidence 122334578999999999876 458999999999999999999999997543211 111111 000000 000000
Q ss_pred -----ccccc-------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 318 -----ADPLL-------QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 318 -----~~~~~-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.++.. ...+.......+.+++.+||+.||++|||+.+++++-+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 00000 001112344678899999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=371.65 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=212.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999999999999999996542 22345788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999853 456899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .....+......
T Consensus 168 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~---- 234 (476)
T 2y94_A 168 DG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKICDGIFY---- 234 (476)
T ss_dssp TT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHHHTTCCC----
T ss_pred cc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCCcC----
Confidence 22 22345689999999999988766 68999999999999999999999754321 111222211111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.+......+.+++..||+.||.+|||+.+++++-+....
T Consensus 235 --------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 --------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 112233578899999999999999999999998776543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=351.22 Aligned_cols=254 Identities=30% Similarity=0.399 Sum_probs=197.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC----cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL----QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|.+. |..||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 467999999999999999999986 78999999865432 224678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC--------CCCeeEe
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC--------EFNAKLS 229 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~vkl~ 229 (427)
||||+++++|.+++. ...+++..++.++.|++.||.|||+++..+|+||||||+|||++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999883 457899999999999999999999998555889999999999986 7789999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK 309 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 309 (427)
|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .......
T Consensus 159 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~ 228 (271)
T 3dtc_A 159 DFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVAM 228 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHT
T ss_pred cCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhhc
Confidence 99999753222 1224579999999999999999999999999999999999999997543211 1111111
Q ss_pred CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 310 DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
... ....+...+..+.+++..||+.||.+||++.+++++|+.+
T Consensus 229 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 NKL----------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SCC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCC----------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 100 0112233446789999999999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=359.24 Aligned_cols=268 Identities=22% Similarity=0.194 Sum_probs=208.5
Q ss_pred HHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccC-----CCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC
Q 042519 78 LATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN-----GLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG 152 (427)
Q Consensus 78 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 152 (427)
+....++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345678899999999999999999999999999999998653 234456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPE------------------------------------QKPIDWFTRMKIALGAAKG 196 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~~ 196 (427)
+..++||||+++|+|.+++...... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988521111 2234577788999999999
Q ss_pred HHHHhhCCCCCeEeccCCCCceEeCCCC--CeeEeecCCcccCCCCC--ccceeccccccccccCcccccc--CCCCccc
Q 042519 197 LEYLHDKANPPVIYRDLKSSNILLDCEF--NAKLSDFGLAKLGPIGD--KTHVSSRVMGTYGYCAPEYQRT--GQLTVKS 270 (427)
Q Consensus 197 l~~LH~~~~~~ivH~Dlkp~NIll~~~~--~vkl~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 270 (427)
|+|||+++ |+||||||+|||++.++ .+||+|||++....... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 89999999997532211 1112345679999999999875 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 042519 271 DVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP 350 (427)
Q Consensus 271 DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 350 (427)
|||||||++|+|++|+.||...... ............... + ........+.+++..||+.||.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~~---~-----~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFEN---P-----NYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTTS---G-----GGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccCC---c-----ccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999754322 111122222111111 0 0112345788999999999999999
Q ss_pred CHHHHHHHHhhc
Q 042519 351 LMSDVVSALSFL 362 (427)
Q Consensus 351 s~~evl~~L~~~ 362 (427)
++.+++++-+.-
T Consensus 324 s~~~~l~hp~~~ 335 (345)
T 3hko_A 324 DAMRALQHPWIS 335 (345)
T ss_dssp CHHHHHHSHHHH
T ss_pred CHHHHhcChhhc
Confidence 999999987653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=351.99 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=207.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCC-------cEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTA-------QVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
.++|++.+.||+|+||.||+|++..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 468999999999999999999998776 4799999977666666789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC--------e
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN--------A 226 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------v 226 (427)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999762 344899999999999999999999999 999999999999998887 9
Q ss_pred eEeecCCcccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 042519 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 227 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~ 305 (427)
||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..|+...... ... .
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~----~ 228 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRK----L 228 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHH----H
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHH----H
Confidence 9999999875321 233568999999999987 67999999999999999999965544322111 111 1
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.........+.. ....+.+++..||+.||++|||+.+++++|+.+..
T Consensus 229 ~~~~~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 QFYEDRHQLPAP------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHTTCCCCCC------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHhhccCCCCCC------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111111111 12357799999999999999999999999998765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=359.46 Aligned_cols=250 Identities=20% Similarity=0.240 Sum_probs=198.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.++||+|+||+||+|++..+|+.||||++....... ......|+..+..+ +|+||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999986543322 23344555555554 899999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 57999988764 356999999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .... ... ...+
T Consensus 209 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~-----~~~-~~~~--- 270 (311)
T 3p1a_A 209 TA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQ-----LRQ-GYLP--- 270 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHH-----HTT-TCCC---
T ss_pred cC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHH-----Hhc-cCCC---
Confidence 22 22345679999999999876 79999999999999999999977664321 1111 111 0000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
. .++......+.+++.+||+.||++|||+.+++++-+.
T Consensus 271 -~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 271 -P----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp -H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred -c----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 0 0111234678999999999999999999999997653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=362.11 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=203.2
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC------
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE------ 153 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 153 (427)
..++|++.+.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+++.++||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 35779999999999999999999999999999999975433 34467899999999999999999999986543
Q ss_pred ---------------------------------------------------eeEEEEeecCCCChhhhhhhcCCCCCCCC
Q 042519 154 ---------------------------------------------------QRLLVYEYMPLRSLEDHLLDIGPEQKPID 182 (427)
Q Consensus 154 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~ 182 (427)
..++||||+++++|.+++.... ......
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence 3799999999999999987643 334456
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc----------ceecccccc
Q 042519 183 WFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT----------HVSSRVMGT 252 (427)
Q Consensus 183 ~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~----------~~~~~~~gt 252 (427)
+..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++........ .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7778999999999999999999 999999999999999999999999999864433211 122346799
Q ss_pred ccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHH
Q 042519 253 YGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLN 332 (427)
Q Consensus 253 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (427)
+.|+|||++.+..++.++|||||||++|+|++|..|+... ...... ... ...+ ........
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~-~~~-~~~~---------~~~~~~~~ 300 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITD-VRN-LKFP---------LLFTQKYP 300 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHH-HHT-TCCC---------HHHHHHCH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHH-hhc-cCCC---------cccccCCh
Confidence 9999999999999999999999999999999987654210 111111 111 0111 01123445
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 333 QAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 333 ~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.+.+++..||+.||++||++.+++++-+
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 7789999999999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=348.66 Aligned_cols=258 Identities=23% Similarity=0.269 Sum_probs=206.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 4679999999999999999999999999999999876532 345778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---CCCCCeeEeecCCcccC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkl~DFG~a~~~ 237 (427)
|+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998764434567999999999999999999999999 9999999999999 55678999999999753
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
... .......||+.|+|||++. +.++.++||||||+++|+|++|+.||....... ...............
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~ 247 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKEPNYAVE 247 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCC-
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCCcccccc
Confidence 322 2234567999999999886 578999999999999999999999997543211 111111111111000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
... ....+.+++..||+.||++||++.|++++-+.
T Consensus 248 -----~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f 282 (285)
T 3is5_A 248 -----CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282 (285)
T ss_dssp ------CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred -----cCc----CCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence 001 23577899999999999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=379.00 Aligned_cols=261 Identities=26% Similarity=0.350 Sum_probs=215.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.++||+|+||.||+|+++.+|+.||||++.+.. ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999999999999999996532 23345678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999998753 2345899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...........+..
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~~~~~----- 407 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEVPEE----- 407 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHHCCCC-----
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhccccc-----
Confidence 222 23346899999999999998999999999999999999999999976533211 11111111121111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLGS 364 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~ 364 (427)
++......+.+++..||+.||.+|| ++.|++++-+.-.-
T Consensus 408 -------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 408 -------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred -------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 1223346788999999999999999 78999998776543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=361.48 Aligned_cols=260 Identities=22% Similarity=0.230 Sum_probs=208.8
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 159 (427)
..++|++.+.||+|+||.||+|.++.+|+.||||++.+.... ..+|+.++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 357899999999999999999999999999999999765432 34678888877 7999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC----CCeeEeecCCcc
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE----FNAKLSDFGLAK 235 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~vkl~DFG~a~ 235 (427)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+..+ +.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999864 346899999999999999999999999 9999999999998433 349999999998
Q ss_pred cCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ......+.......
T Consensus 169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~~~~~~- 242 (342)
T 2qr7_A 169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EEILARIGSGKFSL- 242 (342)
T ss_dssp ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HHHHHHHHHCCCCC-
T ss_pred cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HHHHHHHccCCccc-
Confidence 643222 223456899999999999888899999999999999999999999975432211 11121221111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
...........+.+++..||+.||++||++.+++++-+...+
T Consensus 243 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 243 -------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 011112344678899999999999999999999999887543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=363.31 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=205.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEE----EEEEeccC-CCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVV----AVKQLDRN-GLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.++|++.++||+|+||.||+|.+..+++.| |+|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999998877654 67766443 2345577899999999999999999999998765 78
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+|++|+.+|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 899999999999999763 356899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..............||+.|+|||++.+..++.++|||||||++|+|++ |..||....... +.. ........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~~~~- 238 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL- 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCC-
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCC-
Confidence 543333333444567889999999999999999999999999999999 999997643321 111 11111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
..+......+.+++..||+.||.+||++.++++.|+.+...+
T Consensus 239 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 239 ---------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 112233457889999999999999999999999999887543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=352.48 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=209.4
Q ss_pred hhCccccceeccCCceEEEEEE----ECCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--Ce
Q 042519 82 TKNFRQECLIGEGGFGRVYKGK----LEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 154 (427)
.+.|++.+.||+|+||.||+|+ ...+++.||||++.... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4569999999999999999999 46679999999997543 23446788999999999999999999999876 67
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 89999999999999999653 346899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCC--------cccchhhhhhh
Q 042519 235 KLGPIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRP--------TYEQNLVTWAQ 305 (427)
Q Consensus 235 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~--------~~~~~~~~~~~ 305 (427)
......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+..... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 864433221 223456688899999999998999999999999999999999988643210 00011111111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
....... ....+...+..+.+++..||+.||.+|||+.++++.|+.+
T Consensus 254 ~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 254 NTLKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111111 1112334456889999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=353.01 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=215.8
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
..++|++.+.||+|+||.||+|.++.++..||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 367899999999999999999999999999999999654 3445778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999763 3456899999999999999999999999 999999999999999999999999999864322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... .... ......
T Consensus 165 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~----~~~~~~------ 230 (288)
T 3kfa_A 165 -TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKDYR------ 230 (288)
T ss_dssp -SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHTTCC------
T ss_pred -ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhccCC------
Confidence 2233445567889999999999999999999999999999999 999997643221 1111 111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...+...+..+.+++..||+.||.+||++.++++.|+.+
T Consensus 231 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 231 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 111223346789999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=351.69 Aligned_cols=256 Identities=21% Similarity=0.231 Sum_probs=210.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ------GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+.+.+|+.++..++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 56799999999999999999999999999999999764332 346789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC----CeeEeec
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF----NAKLSDF 231 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkl~DF 231 (427)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999864 356899999999999999999999999 99999999999999888 7999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITSVS 234 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTC
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcc
Confidence 9998643221 234467999999999999999999999999999999999999999754221 1111111111
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...+. .. .......+.+++..||+.||++|||+.+++++-+.
T Consensus 235 ~~~~~----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 235 YDFDE----EF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp CCCCH----HH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred cccCh----hh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 11100 00 01223578899999999999999999999997653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=347.27 Aligned_cols=254 Identities=25% Similarity=0.352 Sum_probs=189.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467999999999999999999999899999999986532 12346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999865 3356899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .......
T Consensus 164 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~-------- 227 (278)
T 3cok_A 164 MPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------LNKVVLA-------- 227 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSS--------
T ss_pred CCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------HHHHhhc--------
Confidence 221 122346799999999999988999999999999999999999999975432110 0000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+. ..+......+.+++.+||+.||++||++.+++++-+.
T Consensus 228 ~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 228 DY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred cc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccc
Confidence 00 1122334678899999999999999999999997654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=353.38 Aligned_cols=272 Identities=20% Similarity=0.211 Sum_probs=215.2
Q ss_pred cCHHHHHHHhhCcccc-ceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcC-CCCeeeEEEE
Q 042519 73 FTFRELATATKNFRQE-CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLH-HDNLVNLIGY 148 (427)
Q Consensus 73 ~~~~~~~~~~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~ 148 (427)
..+.......++|.+. +.||+|+||.||+|+++.+|+.||||++..... .....+.+|+.++..+. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344556667888888 899999999999999999999999999875432 33567889999999985 6999999999
Q ss_pred EEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---CCC
Q 042519 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---EFN 225 (427)
Q Consensus 149 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 225 (427)
+.+.+..++||||+.+|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 99999999999999999999988542 3467899999999999999999999999 999999999999987 789
Q ss_pred eeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 042519 226 AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 226 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~ 305 (427)
+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 173 ~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~ 243 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYL 243 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH
T ss_pred EEEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHH
Confidence 999999999864322 12334679999999999999999999999999999999999999997543211 111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
........... .........+.+++..||+.||.+|||+.+++++-+.-....
T Consensus 244 ~i~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 244 NISQVNVDYSE--------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HHHHTCCCCCT--------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred HHHhcccccCc--------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 11111111110 111223457889999999999999999999999987654433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=352.10 Aligned_cols=256 Identities=24% Similarity=0.336 Sum_probs=207.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 4679999999999999999998874 7789999997653 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~- 173 (283)
T 3gen_A 101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD- 173 (283)
T ss_dssp CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-
T ss_pred cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc-
Confidence 9999999998652 346899999999999999999999999 999999999999999999999999999864321
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ........ ..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~-~~------- 239 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQG-LR------- 239 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTT-CC-------
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHHhcc-cC-------
Confidence 1122233457788999999998899999999999999999998 999997643221 11111111 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+......+.+++..||+.+|.+||++.+++++|..+.
T Consensus 240 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 240 ---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 0111222357889999999999999999999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=348.19 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=211.8
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 35789999999999999999999999999999999865432 34467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999998843 456899999999999999999999999 99999999999999999999999999976433
Q ss_pred CCccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
...........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....... .....+. .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~~~~~~--- 229 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK----EKKTYLN--- 229 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHH----TTCTTST---
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhh----hcccccC---
Confidence 222223445679999999999987665 789999999999999999999997643321 1111111 1100000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
........+.+++..||+.||++|||+.+++++.+.
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 230 -------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp -------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred -------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 012234578899999999999999999999997654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=373.17 Aligned_cols=274 Identities=19% Similarity=0.248 Sum_probs=191.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc-----CCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-----GEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 154 (427)
.++|++.++||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999999999999999999965432 234568899999999999999999999943 357
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 899999986 799988853 356999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-------------------------ceeccccccccccCcccc-ccCCCCccchHHHHHHHHHHHHh----
Q 042519 235 KLGPIGDKT-------------------------HVSSRVMGTYGYCAPEYQ-RTGQLTVKSDVYTFGVVLLELIT---- 284 (427)
Q Consensus 235 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ell~---- 284 (427)
+........ ......+||+.|+|||++ ....++.++||||||||+|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 864322110 123456789999999976 56679999999999999999999
Q ss_pred -------CCCCCCCCCCccc-----------------chhhhhhhhhhcCCC-----------------CCCcccccccC
Q 042519 285 -------GRRAIDTTRPTYE-----------------QNLVTWAQPFFKDPN-----------------RYPQLADPLLQ 323 (427)
Q Consensus 285 -------g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~ 323 (427)
|+.+|........ ..........+..+. .++......+.
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 5555533221000 000000000000000 00000000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 324 GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
. ........+.+|+.+||+.||++|||+.|++++-+.-..
T Consensus 364 ~-~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 364 E-RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp G-GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred H-HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 0 011234678899999999999999999999999876544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=356.86 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=199.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe----
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ---- 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 154 (427)
.++|++.+.||+|+||.||+|++..+++.||||++....... ...+.+|+.++..++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999999999999999997654332 3467889999999999999999999876543
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999998653 46899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCc-cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 235 KLGPIGDK-THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 235 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
+....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....+. ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCC
Confidence 76432221 12233467999999999999999999999999999999999999999754321 111111221111
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
... .. ....+..+.+++.+||+.||.+||+..+++.+-.
T Consensus 238 ~~~----~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 238 PPS----AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp CHH----HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred Ccc----cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 100 00 1123457889999999999999998777665544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=356.18 Aligned_cols=268 Identities=22% Similarity=0.322 Sum_probs=205.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|.+..+|..||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 3579999999999999999999999999999999975332 2345678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998765445667899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. ........|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .......... ...+...
T Consensus 188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~--~~~~~~~ 259 (310)
T 2wqm_A 188 SK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ--CDYPPLP 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT--TCSCCCC
T ss_pred CC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc--ccCCCCc
Confidence 21 12233457899999999999999999999999999999999999999643211 1111111111 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDA 368 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 368 (427)
.......+.+++..||+.||.+||++.+|++.|+.+......
T Consensus 260 --------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 260 --------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp --------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 122345788999999999999999999999999988764443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=344.72 Aligned_cols=256 Identities=20% Similarity=0.231 Sum_probs=212.1
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
..++|++.+.||+|+||.||+|.++.++..||+|++........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35789999999999999999999999999999999987666667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---CCCCCeeEeecCCcccC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkl~DFG~a~~~ 237 (427)
|+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 99999999988653 45899999999999999999999999 9999999999999 88899999999999764
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... .............+..
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~ 229 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTFTFPEK 229 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCHH
T ss_pred cCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCCCch
Confidence 3222 2344679999999999875 4999999999999999999999999754321 1111111111111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.. ......+.+++..||+.||++||++.+++++-+.
T Consensus 230 ~~--------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 230 DW--------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp HH--------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred hh--------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 00 0124678899999999999999999999987654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.49 Aligned_cols=270 Identities=26% Similarity=0.355 Sum_probs=214.8
Q ss_pred HHHHHHHhhCccccceeccCCceEEEEEEE-----CCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCeeeEEE
Q 042519 75 FRELATATKNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLL-HHDNLVNLIG 147 (427)
Q Consensus 75 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~ 147 (427)
........++|++.+.||+|+||.||+|++ ..+++.||||++...... ....+.+|+.++..+ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334444568899999999999999999985 356789999999765332 335688999999999 6999999999
Q ss_pred EEEcCC-eeEEEEeecCCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 042519 148 YCADGE-QRLLVYEYMPLRSLEDHLLDIGPE------------QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLK 214 (427)
Q Consensus 148 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 214 (427)
++...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 988754 589999999999999999764321 223889999999999999999999999 9999999
Q ss_pred CCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 042519 215 SSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTR 293 (427)
Q Consensus 215 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~ 293 (427)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999986443333334455678999999999999999999999999999999998 999997543
Q ss_pred CcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 294 PTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
... .... . ....... ..+......+.+++..||+.||.+||++.+++++|+.+.
T Consensus 256 ~~~--~~~~---~-~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 256 IDE--EFCR---R-LKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CSH--HHHH---H-HHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhH--HHHH---H-hccCccC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 221 1111 1 1111100 111223457889999999999999999999999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=361.02 Aligned_cols=272 Identities=21% Similarity=0.240 Sum_probs=209.8
Q ss_pred CHHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-----CCCeeeEEEE
Q 042519 74 TFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-----HDNLVNLIGY 148 (427)
Q Consensus 74 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~ 148 (427)
++.......++|++.++||+|+||+||+|++..+++.||||++... ......+..|+.++..+. ||||++++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 3344444568899999999999999999999999999999998643 233456778999999886 9999999999
Q ss_pred EEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC------
Q 042519 149 CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC------ 222 (427)
Q Consensus 149 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------ 222 (427)
+...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 99999999999999 89999999764 2345899999999999999999999999 999999999999975
Q ss_pred -------------------CCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHH
Q 042519 223 -------------------EFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELI 283 (427)
Q Consensus 223 -------------------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 283 (427)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 78899999999986322 123467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcccchhhhhhhhhhcC----------CCCCCcccc-c----ccCCCC-------------C---HHHHH
Q 042519 284 TGRRAIDTTRPTYEQNLVTWAQPFFKD----------PNRYPQLAD-P----LLQGEF-------------P---VRGLN 332 (427)
Q Consensus 284 ~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~-~----~~~~~~-------------~---~~~~~ 332 (427)
+|+.||......... ......... ........+ . ...... + .....
T Consensus 254 ~g~~pf~~~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 254 TGSLLFRTHEHMEHL---AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HSSCSCCCSSHHHHH---HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HCCCCCCCCcHHHHH---HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 999999764322110 000000000 000000000 0 000000 0 00115
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 333 QAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 333 ~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.+.+|+..||+.||++|||+.|++++-+
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 6789999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=363.97 Aligned_cols=262 Identities=25% Similarity=0.351 Sum_probs=212.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc-----EEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ-----VVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 154 (427)
.++|++.+.||+|+||.||+|.+..++. .||+|.+..... ...+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 5789999999999999999999977664 799999976532 2345688999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGP----------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF 224 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 224 (427)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 9999999999999999875321 1346899999999999999999999999 99999999999999999
Q ss_pred CeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 042519 225 NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTW 303 (427)
Q Consensus 225 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~ 303 (427)
.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~ 279 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYKL 279 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHHH
Confidence 999999999986433333333445667889999999998999999999999999999998 999997543221 11111
Q ss_pred hhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 304 AQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...... ...+...+..+.+++..||+.||.+||++.+++++|+.+
T Consensus 280 ----~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 280 ----VKDGYQ----------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ----HHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HhcCCC----------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111100 011122346788999999999999999999999999764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=365.30 Aligned_cols=270 Identities=23% Similarity=0.311 Sum_probs=196.7
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCC--e
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGE--Q 154 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 154 (427)
...++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 346789999999999999999999999999999999865422 23455778999999998 999999999997544 7
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.|+||||+. ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999998 699988864 36889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC-------------------ccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 042519 235 KLGPIGD-------------------KTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRP 294 (427)
Q Consensus 235 ~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~ 294 (427)
+...... ........+||+.|+|||++.+ ..++.++||||||||+|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 7642210 1112344689999999999876 6799999999999999999999999975432
Q ss_pred cccchhhhhhhhhhcCCC----------------------------CCCccccc----ccCCCCCHHHHHHHHHHHHHcc
Q 042519 295 TYEQNLVTWAQPFFKDPN----------------------------RYPQLADP----LLQGEFPVRGLNQAVAVSAMCV 342 (427)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl 342 (427)
.. .+.... .....+. ....+... .............+.+|+.+||
T Consensus 237 ~~--~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 MN--QLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HH--HHHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred HH--HHHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 11 111000 0000000 00000000 0000000122457889999999
Q ss_pred CCCCCCCCCHHHHHHHHhh
Q 042519 343 QEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 343 ~~~P~~RPs~~evl~~L~~ 361 (427)
+.||++|||+.|++++-+.
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFV 332 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTT
T ss_pred ccCcccCCCHHHHhCCHHH
Confidence 9999999999999998654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=370.72 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=207.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC-eeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE-QRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 160 (427)
.++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 467899999999999999999986 6799999997653 5578999999999999999999999987665 7899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999997642 345789999999999999999999999 999999999999999999999999999853211
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ... .......
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~~~------ 404 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYK------ 404 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTTCC------
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCC------
Confidence 122367889999999999999999999999999999998 999997643221 111 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+..++..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 405 ----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 405 ----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1123345578899999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=351.75 Aligned_cols=267 Identities=21% Similarity=0.250 Sum_probs=206.2
Q ss_pred hhCcccc-ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQE-CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.+.|++. ++||+|+||.||+|++..+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678884 7899999999999999999999999999876656667889999999885 7999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC---eeEeecCCccc
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN---AKLSDFGLAKL 236 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkl~DFG~a~~ 236 (427)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999753 46899999999999999999999999 999999999999988776 99999999875
Q ss_pred CCCCCc-----cceeccccccccccCcccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-------
Q 042519 237 GPIGDK-----THVSSRVMGTYGYCAPEYQRT-----GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN------- 299 (427)
Q Consensus 237 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~------- 299 (427)
...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 322111 111234569999999999875 568899999999999999999999997654322100
Q ss_pred --hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 300 --LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 300 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.......+......++. ... ......+.+++.+||+.||.+||++.+++++-+...
T Consensus 244 ~~~~~~~~~i~~~~~~~~~---~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPD---KDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCH---HHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred hHHHHHHHHHhccCcccCc---hhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 00011111111111110 000 113457889999999999999999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=351.73 Aligned_cols=269 Identities=22% Similarity=0.276 Sum_probs=205.4
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-----cchHHHHHHHHHHhhcC---CCCeeeEEEEEEcC
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-----QGNKEFIVEVLMLSLLH---HDNLVNLIGYCADG 152 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 152 (427)
..++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46789999999999999999999999999999999864321 12345677877777665 99999999999876
Q ss_pred C-----eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCee
Q 042519 153 E-----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 153 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
. ..++||||+. ++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 5 5799999998 6999998753 2344899999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 042519 228 LSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 228 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+..... .
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~-~ 234 (308)
T 3g33_A 161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-L 234 (308)
T ss_dssp ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHH-H
T ss_pred EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-H
Confidence 9999999864322 22345689999999999999999999999999999999999999997643321 1111111 1
Q ss_pred hcCC--CCCCcc---cccccCC--C-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 308 FKDP--NRYPQL---ADPLLQG--E-----FPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 308 ~~~~--~~~~~~---~~~~~~~--~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...+ ...+.. ....... . ........+.+++.+||+.||++|||+.|++++-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 1100 000000 0000000 0 011234678899999999999999999999998654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=359.62 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=211.8
Q ss_pred hhCccccceeccCCceEEEEEEEC-------CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE-------KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 152 (427)
.++|++.+.||+|+||.||+|++. .++..||||++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999985 3567899999975532 2345688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPE------------QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999764321 235899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~ 299 (427)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence 9999999999999986443332233344567889999999998899999999999999999999 99999754321
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
......... .. ...+..+...+.+++..||+.||.+||++.++++.|+.+..
T Consensus 267 --~~~~~~~~~-~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 --ELFKLLKEG-HR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp --HHHHHHHHT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHhcC-CC----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111111 00 01122334678899999999999999999999999988744
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=351.71 Aligned_cols=272 Identities=24% Similarity=0.290 Sum_probs=204.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999999999999999986554322 355778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999887753 356899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhh--------hhhhhcC
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTW--------AQPFFKD 310 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~--------~~~~~~~ 310 (427)
. ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.............. ....+..
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 155 P--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 2 222345679999999999875 6789999999999999999999999976543221110000 0000110
Q ss_pred CCCCCc--ccccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 311 PNRYPQ--LADPLLQGE---FPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 311 ~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...... +.++..... ........+.+++..||+.||++|||+.+++++-+.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 289 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence 000000 000000000 0012345688999999999999999999999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=360.41 Aligned_cols=271 Identities=19% Similarity=0.269 Sum_probs=201.0
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
..++|++.+.||+|+||+||+|++..+++.||||++....... ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3578999999999999999999999999999999996543322 34567899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe-----CCCCCeeEeecCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL-----DCEFNAKLSDFGL 233 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~vkl~DFG~ 233 (427)
|||++ |+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99998 6999998653 45899999999999999999999999 9999999999999 4555699999999
Q ss_pred cccCCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC-
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP- 311 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 311 (427)
++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+...... ...+
T Consensus 184 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~-~~~~~ 258 (329)
T 3gbz_A 184 ARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEV-LGLPD 258 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHH-HCCCC
T ss_pred ccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHH-hCCCc
Confidence 9763221 2223445789999999999874 58999999999999999999999997643221 11111110 0000
Q ss_pred -CC-------------CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 312 -NR-------------YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 312 -~~-------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.. ++......+....+......+.+++..||+.||++|||+.|++++-+.-..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 00 000000000000111134678899999999999999999999998765443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=357.71 Aligned_cols=272 Identities=25% Similarity=0.311 Sum_probs=204.7
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc-----hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG-----NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
..++|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999999999999999986533221 24678899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+. ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFME-TDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCS-EEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCC-CCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999998 488888754 3356888899999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc-CCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK-DPNR 313 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 313 (427)
..... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .+......... ....
T Consensus 161 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTT
T ss_pred eccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCCCChhh
Confidence 64322 2233456799999999998654 58999999999999999999999987543211 11111111000 0000
Q ss_pred CCc---ccccccCC---CCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 314 YPQ---LADPLLQG---EFP-----VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 314 ~~~---~~~~~~~~---~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+. +.+..... ..+ ......+.+++..||+.||++|||+.|++++.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 000 00100000 111 223468899999999999999999999999987644
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=347.99 Aligned_cols=261 Identities=30% Similarity=0.435 Sum_probs=196.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||.||+|++.. .||||++..... ...+.+.+|+.+++.++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4679999999999999999998764 499999865433 2335688999999999999999999965 456689999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999864 3456899999999999999999999999 99999999999999999999999999976433
Q ss_pred CCccceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
...........||+.|+|||++. +..++.++||||||+++|+|++|+.||....... .+.... ........
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~----~~~~~~~~ 246 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMV----GRGSLSPD 246 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHH----HHTSCCCC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHh----cccccCcc
Confidence 23333344567999999999986 5678999999999999999999999997643221 111111 11000000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
. ......++..+.+++..||+.+|.+||++.++++.|+.+..
T Consensus 247 -~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 -L-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -T-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -h-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 01122344688999999999999999999999999987653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=354.56 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=212.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|.+.+.||+|+||.||++.+..+++.||+|++..... ...+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999875432 2345678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999988653 46899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ............+
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~---- 260 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEYSI---- 260 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCC----
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhcCCCCC----
Confidence 221 2234467999999999999989999999999999999999999999754321 1111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+......+.+++..||+.||++||++.+++++-+...
T Consensus 261 --------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 261 --------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred --------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1223357889999999999999999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=361.00 Aligned_cols=254 Identities=29% Similarity=0.362 Sum_probs=208.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.+.|+..+.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 356999999999999999999999999999999997653322 35678999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+. |+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99998 7888887652 356899999999999999999999999 9999999999999999999999999997632
Q ss_pred CCCccceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
. .....||+.|+|||++. .+.++.++|||||||++|||++|+.||...... .......... .+
T Consensus 206 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~--~~ 271 (348)
T 1u5q_A 206 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE--SP 271 (348)
T ss_dssp S------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC--CC
T ss_pred C------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC--CC
Confidence 2 23457999999999884 567999999999999999999999999754321 1111111111 01
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
... +......+.+++..||+.||++|||+.+++++.+....
T Consensus 272 ~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 272 ALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp CCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCC--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 110 11234578899999999999999999999999876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=363.09 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=200.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCC--CCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHH--DNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|.+. ++..||||++...... ....+.+|+.++..++| +||+++++++.+....++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467999999999999999999985 4889999998755332 23568899999999986 999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
|||+ .+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++..
T Consensus 87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9994 56899999975 346899999999999999999999999 99999999999997 678999999999865
Q ss_pred CCCCccceeccccccccccCcccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRT-----------GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~ 306 (427)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~ 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHA 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHH
Confidence 43333333445689999999999864 67899999999999999999999999753221 111111
Q ss_pred hhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.... .....++......+.+++..||+.||.+|||+.+++++.+.-.
T Consensus 233 ~~~~----------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 233 IIDP----------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HHCT----------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HhcC----------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 1111 1111112222357889999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=356.14 Aligned_cols=248 Identities=21% Similarity=0.263 Sum_probs=208.1
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--------chHHHHHHHHHHhhcCCCCeeeEEEEEEcC
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--------GNKEFIVEVLMLSLLHHDNLVNLIGYCADG 152 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 152 (427)
..++|++.+.||+|+||.||+|++..+++.||||++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 467899999999999999999999999999999999765321 223567899999999999999999999999
Q ss_pred CeeEEEEeecCCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 153 EQRLLVYEYMPLR-SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 153 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
+..++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999766 99998864 346899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
|++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ....
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~ 239 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------TVEA 239 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------GTTT
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------HHhh
Confidence 9998643322 2334679999999999988777 8899999999999999999999964211 0010
Q ss_pred CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
... .+......+.+++..||+.||++||++.+++++-+.-
T Consensus 240 ~~~------------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 279 (335)
T 3dls_A 240 AIH------------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279 (335)
T ss_dssp CCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred ccC------------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 000 1111345788999999999999999999999987653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=344.63 Aligned_cols=262 Identities=21% Similarity=0.254 Sum_probs=208.5
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC----CcchHHHHHHHHHHhhcCCCCeeeEEEEEE--cCCe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG----LQGNKEFIVEVLMLSLLHHDNLVNLIGYCA--DGEQ 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 154 (427)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999999999999999996542 234567889999999999999999999984 4567
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.++||||+.++ |.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999865 77777654 3457899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceeccccccccccCccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ--LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
................||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ......+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~~~ 230 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGKGSY 230 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCC
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhcCCC
Confidence 8644333333344567999999999987644 47899999999999999999999975321 111111111111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 313 RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
..+......+.+++.+||+.||.+||++.+++++-+.....+
T Consensus 231 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 231 ------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp ------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 112223457889999999999999999999999877655433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=350.69 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=197.7
Q ss_pred hhCccccceeccCCceEEEEEEECCC---CcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 57899999999999999999998653 55799999865432 23456889999999999999999999985 467899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999752 346899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ... .. ......
T Consensus 167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~---~i-~~~~~~-- 236 (281)
T 1mp8_A 167 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---RI-ENGERL-- 236 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---HH-HTTCCC--
T ss_pred Cccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHH---HH-HcCCCC--
Confidence 3221 112233457789999999998899999999999999999997 999997643221 111 11 111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+...+..+.+++..||+.||++||++.++++.|+.+
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11223446788999999999999999999999999865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=343.64 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=208.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|.+..++..||||++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4679999999999999999999999999999999865321 2345688899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999998653 45899999999999999999999999 9999999999999999999999999986532
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ............
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~----- 225 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFT----- 225 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC-----
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHHhCCCC-----
Confidence 21 234467999999999999999999999999999999999999999754321 111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
++......+.+++..||+.||.+||++.+++++-+.-.
T Consensus 226 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 226 -------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp -------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred -------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 12223457889999999999999999999999987543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.65 Aligned_cols=274 Identities=18% Similarity=0.212 Sum_probs=216.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC--eeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE--QRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 158 (427)
.++|++.++||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999999999999999999975432 33566789999999999999999999998755 78999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe----CCCCCeeEeecCCc
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL----DCEFNAKLSDFGLA 234 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~vkl~DFG~a 234 (427)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999986532 2234899999999999999999999999 9999999999999 78888999999999
Q ss_pred ccCCCCCccceeccccccccccCcccccc--------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRT--------GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~ 306 (427)
+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ......
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~ 238 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK 238 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH
Confidence 864322 22344679999999998864 56788999999999999999999999754332211 111111
Q ss_pred hhc-CCCCCCccc------------ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 307 FFK-DPNRYPQLA------------DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 307 ~~~-~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
... .+....... +.......+......+.+++..||+.||++||++.++++.++.+-.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 111 111100000 0111224557788899999999999999999999999999987643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=373.97 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=210.9
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
..++|++.+.||+|+||.||+|.++. +..||||+++... ...+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 35789999999999999999999975 6789999997653 45678999999999999999999999986 567899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999643 1235788899999999999999999999 999999999999999999999999999864321
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.........+|+.|+|||++....++.++|||||||++|||++ |+.||...... .+. ..+.. ....
T Consensus 338 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~---~~i~~-~~~~----- 404 (454)
T 1qcf_A 338 -EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI---RALER-GYRM----- 404 (454)
T ss_dssp -HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH---HHHHH-TCCC-----
T ss_pred -ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHc-CCCC-----
Confidence 1111233456788999999998999999999999999999999 99999754321 111 11111 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+..++..+.+++..||+.||++|||+.+|++.|+.+..
T Consensus 405 -----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 -----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1123345688999999999999999999999999998755
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=342.61 Aligned_cols=259 Identities=19% Similarity=0.235 Sum_probs=211.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||.||+|.++.+|..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999999999999999998654332 3356788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC---eeEeecCCccc
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN---AKLSDFGLAKL 236 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkl~DFG~a~~ 236 (427)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999888653 45899999999999999999999999 999999999999977665 99999999976
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .............+.
T Consensus 158 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 158 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYDYPS 228 (284)
T ss_dssp CCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCCT
T ss_pred cccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhccccCCc
Confidence 4322 2233467999999999999999999999999999999999999999654321 111111111111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+ ........+.+++..||+.||++||++.+++++-+....
T Consensus 229 ---~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 229 ---P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp ---T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred ---h-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 0 011233578899999999999999999999998766443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=384.44 Aligned_cols=257 Identities=25% Similarity=0.311 Sum_probs=214.9
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 156 (427)
..++|++.++||+|+||+||+|+++.+++.||||++.+.. ....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999999999999999997532 23446678899999887 6999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999753 45899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... .......+||+.|+|||++.+..|+.++||||||||||||++|+.||..... ......+......
T Consensus 492 ~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~--- 560 (674)
T 3pfq_A 492 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNVA--- 560 (674)
T ss_dssp CCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSCCC---
T ss_pred cccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCCC---
Confidence 3222 2234567899999999999999999999999999999999999999975432 2222233332211
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHhhcCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM-----SDVVSALSFLGS 364 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~~L~~~~~ 364 (427)
++......+.+||..||+.||++||++ .+|+++-++-.-
T Consensus 561 ---------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 561 ---------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp ---------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred ---------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 223345678999999999999999998 888888765443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=365.80 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=201.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcC--CCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLH--HDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 157 (427)
..+|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+|+.++..|+ ||||+++++++...+..++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3569999999999999999999876 89999999976533 23466889999999997 5999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||| +.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++..
T Consensus 134 v~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 5678999998753 36888999999999999999999999 99999999999995 589999999999864
Q ss_pred CCCCccceeccccccccccCcccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRT-----------GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~ 306 (427)
............+||+.|+|||++.+ ..++.++||||||||+|||++|+.||...... ......
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~ 279 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHA 279 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHH
Confidence 43332223445689999999999865 46899999999999999999999999753211 111111
Q ss_pred hhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
....... ..++......+.+++..||+.||.+||++.+++++.+...
T Consensus 280 ~~~~~~~----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 280 IIDPNHE----------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp HHCTTSC----------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HhCcccc----------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 1111100 1111112357889999999999999999999999987643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=372.05 Aligned_cols=268 Identities=21% Similarity=0.250 Sum_probs=201.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC------C
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG------E 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 153 (427)
.++|++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999999999999999997542 23345678899999999999999999999654 4
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 67999999984 5766663 23889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hh-----------
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LV----------- 301 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~----------- 301 (427)
++.... .......+||+.|+|||++.+..|+.++||||||||+|||++|+.||.......... +.
T Consensus 211 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 986432 223445789999999999999999999999999999999999999997543211000 00
Q ss_pred ----hhhhhhhcCCCCCC-----cccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 302 ----TWAQPFFKDPNRYP-----QLADPLLQG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 302 ----~~~~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.....+........ ......+.. .........+.+|+.+||+.||++|||+.|++++-+.-
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 00011111100000 000000000 00112356789999999999999999999999997654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=363.65 Aligned_cols=268 Identities=17% Similarity=0.188 Sum_probs=204.6
Q ss_pred hhCccccceeccCCceEEEEEEECCC-----CcEEEEEEeccCCCcch-----------HHHHHHHHHHhhcCCCCeeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT-----AQVVAVKQLDRNGLQGN-----------KEFIVEVLMLSLLHHDNLVNL 145 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l 145 (427)
.++|++.+.||+|+||.||+|.+..+ ++.||||++........ ..+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 46799999999999999999999764 57899999865532111 123456667788899999999
Q ss_pred EEEEEcC----CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC
Q 042519 146 IGYCADG----EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD 221 (427)
Q Consensus 146 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~ 221 (427)
++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998764 4589999999 8999999876 3456999999999999999999999999 99999999999998
Q ss_pred --CCCCeeEeecCCcccCCCCCcc-----ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 042519 222 --CEFNAKLSDFGLAKLGPIGDKT-----HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRP 294 (427)
Q Consensus 222 --~~~~vkl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~ 294 (427)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999764322111 112345699999999999999999999999999999999999999975322
Q ss_pred cccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 295 TYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
. ..........+. .....+.+..+. ....+..+.+++..||+.+|.+||++.++++.|+.+.
T Consensus 267 ~--~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 D--PKYVRDSKIRYR--ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp C--HHHHHHHHHHHH--HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred C--HHHHHHHHHHhh--hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 1 111111111111 111122222211 1122467889999999999999999999999997764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=350.01 Aligned_cols=255 Identities=30% Similarity=0.395 Sum_probs=199.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 367999999999999999999986 688999998643 345678999999999999999999998874 47999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh---CCCCCeEeccCCCCceEeCCCCC-eeEeecCCcccC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD---KANPPVIYRDLKSSNILLDCEFN-AKLSDFGLAKLG 237 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~~~~ivH~Dlkp~NIll~~~~~-vkl~DFG~a~~~ 237 (427)
+++++|.+++.... ....+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++. +||+|||++...
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999987532 22347889999999999999999999 66 999999999999998887 799999999753
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ........ .....
T Consensus 157 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~--~~~~~- 224 (307)
T 2eva_A 157 QT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVHN--GTRPP- 224 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHHT--TCCCC-
T ss_pred cc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHhc--CCCCC-
Confidence 21 12335699999999999999999999999999999999999999975432211 11111111 11111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCC
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDP 366 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 366 (427)
.+...+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 225 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 225 --------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp --------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred --------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 11223457889999999999999999999999998876533
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=344.61 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=212.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4679999999999999999999999999999999876432 2345678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999988653 46899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ............
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~----- 233 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEYS----- 233 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC-----
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhccCC-----
Confidence 221 2234467999999999999889999999999999999999999999754321 111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.+......+.+++..||+.||++||++.+++++.+....
T Consensus 234 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 234 -------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred -------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 112233578899999999999999999999998766443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=342.14 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=211.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|++..++..||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999999999999999986532 22346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999998753 35899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ...........
T Consensus 166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~------ 229 (284)
T 2vgo_A 166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNVDL------ 229 (284)
T ss_dssp SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCC------
T ss_pred cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhcccc------
Confidence 21 123467999999999999999999999999999999999999999754321 11111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.++......+.+++..||+.||.+||++.+++++-+...
T Consensus 230 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 230 ------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred ------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 112223467889999999999999999999999876543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=362.05 Aligned_cols=269 Identities=22% Similarity=0.271 Sum_probs=205.8
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc--------
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-------- 151 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 151 (427)
...++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+|+.+++.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999999999999999998654322 2369999999999999999999843
Q ss_pred ------------------------------CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 042519 152 ------------------------------GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201 (427)
Q Consensus 152 ------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 201 (427)
....++||||++ ++|.+.+.........+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 344889999998 6888888765445678999999999999999999999
Q ss_pred hCCCCCeEeccCCCCceEeC-CCCCeeEeecCCcccCCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHH
Q 042519 202 DKANPPVIYRDLKSSNILLD-CEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVL 279 (427)
Q Consensus 202 ~~~~~~ivH~Dlkp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil 279 (427)
+++ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 99999999999997 68899999999998643222 23446789999999988764 589999999999999
Q ss_pred HHHHhCCCCCCCCCCcccchhhhhhhh--------hhc-----CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCC
Q 042519 280 LELITGRRAIDTTRPTYEQNLVTWAQP--------FFK-----DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEES 346 (427)
Q Consensus 280 ~ell~g~~p~~~~~~~~~~~~~~~~~~--------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P 346 (427)
|+|++|+.||....... .+...... +.. ....++.+........++...+..+.+++.+||+.||
T Consensus 233 ~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999997643221 11111100 000 0011111111111111233345678999999999999
Q ss_pred CCCCCHHHHHHHHhh
Q 042519 347 SVRPLMSDVVSALSF 361 (427)
Q Consensus 347 ~~RPs~~evl~~L~~ 361 (427)
.+|||+.|++++-+.
T Consensus 311 ~~R~t~~e~l~hp~f 325 (383)
T 3eb0_A 311 DLRINPYEAMAHPFF 325 (383)
T ss_dssp GGSCCHHHHHTSGGG
T ss_pred hhCCCHHHHhcCHHH
Confidence 999999999987654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=363.82 Aligned_cols=201 Identities=25% Similarity=0.324 Sum_probs=170.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----Ce
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG-----EQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 154 (427)
.++|++.+.||+|+||.||+|+++.+|+.||||++..... .....+.+|+.+++.++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4789999999999999999999999999999999975432 2335678999999999999999999999776 57
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999997 699998853 356899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc--------------------ceeccccccccccCcccc-ccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 042519 235 KLGPIGDKT--------------------HVSSRVMGTYGYCAPEYQ-RTGQLTVKSDVYTFGVVLLELITGRRAID 290 (427)
Q Consensus 235 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ell~g~~p~~ 290 (427)
+........ ......+||+.|+|||++ ....++.++||||||||+|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 864332211 123567899999999986 56679999999999999999998766553
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=355.23 Aligned_cols=263 Identities=26% Similarity=0.363 Sum_probs=200.6
Q ss_pred HhhCccccceeccCCceEEEEEEECC---CCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe-
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEK---TAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ- 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 154 (427)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 35789999999999999999998764 566899999875432 233568899999999999999999999987653
Q ss_pred ----eEEEEeecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeE
Q 042519 155 ----RLLVYEYMPLRSLEDHLLDIG--PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKL 228 (427)
Q Consensus 155 ----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl 228 (427)
.++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 499999999999999985432 34467999999999999999999999999 999999999999999999999
Q ss_pred eecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhh
Q 042519 229 SDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||....... . ....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~~~ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M---YDYL 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H---HHHH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H---HHHH
Confidence 99999986433332233344567889999999999999999999999999999999 888987543221 1 1111
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
... ... ..+...+..+.+++..||+.||.+||++.+++++|+.+.
T Consensus 263 ~~~-~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 263 LHG-HRL----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HTT-CCC----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcC-CCC----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 110 112233467899999999999999999999999998763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=354.66 Aligned_cols=270 Identities=25% Similarity=0.348 Sum_probs=202.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc-hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG-NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
++|++.+.||+|+||.||+|++..+++.||||++....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999999999999999986543221 12345799999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
++ |+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-- 152 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI-- 152 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC--
Confidence 98 6999988763 456899999999999999999999999 99999999999999999999999999975322
Q ss_pred ccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC--CCCCccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP--NRYPQLA 318 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 318 (427)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ...........+ ...+...
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhh
Confidence 2222344578999999999876 568999999999999999999999997643221 111111111110 0011100
Q ss_pred cc---------ccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 319 DP---------LLQG----EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 319 ~~---------~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.. .... .........+.+++..||+.||++|||+.|++++-+....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00 0000 0011234578899999999999999999999998876544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=356.28 Aligned_cols=269 Identities=24% Similarity=0.372 Sum_probs=206.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999999999999999986554332 345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99998888877543 346899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh----------hhhh
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA----------QPFF 308 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~----------~~~~ 308 (427)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ +.... ...+
T Consensus 177 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 177 P--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHH
T ss_pred C--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHh
Confidence 1 2223456799999999998775 789999999999999999999999976543211 11000 0000
Q ss_pred c-----CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 309 K-----DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 309 ~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
. .....+.+................+.+++.+||+.||++|||+.|++++-+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0 1111111111100000111235678999999999999999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=356.84 Aligned_cols=264 Identities=23% Similarity=0.369 Sum_probs=213.2
Q ss_pred HhhCccccceeccCCceEEEEEEEC-----CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLE-----KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
..++|++.+.||+|+||.||+|.+. .++..||||.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 4578999999999999999999886 3578899999875432 233568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeE
Q 042519 155 RLLVYEYMPLRSLEDHLLDIG------PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKL 228 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl 228 (427)
.++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 999999999999999987532 12256789999999999999999999999 999999999999999999999
Q ss_pred eecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhh
Q 042519 229 SDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~ 253 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFV 253 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHHHHH
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HHHHHH
Confidence 99999975432222222334567889999999999999999999999999999999 88998754321 111111
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.. ... . ..+...+..+.+++..||+.||.+||++.+++++|+.+..
T Consensus 254 ~~-~~~-~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 ME-GGL-L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HT-TCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred Hc-CCc-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 111 0 1122344678899999999999999999999999987644
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=345.75 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=209.8
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
..++|.+.+.||+|+||.||+|++..+|+.||+|++..........+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 35789999999999999999999999999999999986654555678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---CCCCCeeEeecCCcccC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkl~DFG~a~~~ 237 (427)
|+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999998653 35889999999999999999999999 9999999999999 78899999999999753
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+........
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~~~-- 227 (304)
T 2jam_A 160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEGYYEFE-- 227 (304)
T ss_dssp CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHCCCCCC--
T ss_pred CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCCCC--
Confidence 221 223457999999999999999999999999999999999999999754321 11111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.......+..+.+++..||+.||++||++.+++++-+..
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 228 ------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp ------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred ------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence 011123346788999999999999999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=351.86 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=210.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEE--cCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCA--DGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4689999999999999999999999999999999976543 23456889999999999999999999885 4678999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA--NPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
||||+++++|.+++.........+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999765545566999999999999999999999976 2349999999999999999999999999997
Q ss_pred cCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .+ ...+... ...
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~i~~~--~~~ 234 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL---AGKIREG--KFR 234 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHT--CCC
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HH---HHHHhhc--ccc
Confidence 64322 12223457899999999999889999999999999999999999999764321 11 1111111 111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+......+.+++..||+.||.+||++.+++++++..
T Consensus 235 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 235 ---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11223346788999999999999999999999988653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=348.77 Aligned_cols=271 Identities=24% Similarity=0.287 Sum_probs=204.2
Q ss_pred HHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhh--cCCCCeeeEEEEEEcC
Q 042519 75 FRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSL--LHHDNLVNLIGYCADG 152 (427)
Q Consensus 75 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 152 (427)
........++|++.+.||+|+||.||+|++. |+.||||++... ....+..|.+++.. ++||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3334455688999999999999999999986 889999998543 23344555555554 4899999999999887
Q ss_pred ----CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CCCCeEeccCCCCceEe
Q 042519 153 ----EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK--------ANPPVIYRDLKSSNILL 220 (427)
Q Consensus 153 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~~~~ivH~Dlkp~NIll 220 (427)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ + |+||||||+|||+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill 175 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILV 175 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEE
Confidence 789999999999999999954 3589999999999999999999998 7 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccc--eeccccccccccCccccccCCCCcc------chHHHHHHHHHHHHhC-------
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTH--VSSRVMGTYGYCAPEYQRTGQLTVK------SDVYTFGVVLLELITG------- 285 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~ell~g------- 285 (427)
+.++.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999997543222111 1234579999999999987766665 9999999999999999
Q ss_pred ---CCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 286 ---RRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 286 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..||....+.... ... ...........+... ....+..+...+.+++..||+.||++||++.+++++|+.+
T Consensus 256 ~~~~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPS-YED-MREIVCIKKLRPSFP----NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCCCCTTTTTSCSSCC-HHH-HHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccHhhhcCCCCc-hhh-hHHHHhhhccCcccc----ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 5555433222111 000 111111100000000 0011236778899999999999999999999999999887
Q ss_pred CC
Q 042519 363 GS 364 (427)
Q Consensus 363 ~~ 364 (427)
..
T Consensus 330 ~~ 331 (337)
T 3mdy_A 330 SE 331 (337)
T ss_dssp HH
T ss_pred Hh
Confidence 55
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=344.44 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=210.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 467999999999999999999997 47789999997654 3446789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD- 157 (267)
T ss_dssp CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-
Confidence 9999999999763 356889999999999999999999999 999999999999999999999999999864221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.........|++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ......... ..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~~-~~------- 223 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG-FR------- 223 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT-CC-------
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhcC-Cc-------
Confidence 1122234567889999999998899999999999999999999 89999754321 111111111 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+......+.+++..||+.||++||++.+++++|+.+.
T Consensus 224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 224 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111223457889999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=355.58 Aligned_cols=260 Identities=26% Similarity=0.396 Sum_probs=209.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEE--EEEEeccCC-CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVV--AVKQLDRNG-LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~v--avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|++..+|..+ |+|.+.... ....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367999999999999999999999888765 999986532 23446688999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC
Q 042519 158 VYEYMPLRSLEDHLLDIG------------PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN 225 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 225 (427)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999997643 23457899999999999999999999999 999999999999999999
Q ss_pred eeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 042519 226 AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 226 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~ 304 (427)
+||+|||+++... .........+++.|+|||++.+..++.++|||||||++|+|++ |+.||...... ...
T Consensus 181 ~kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~ 251 (327)
T 1fvr_A 181 AKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY 251 (327)
T ss_dssp EEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH
T ss_pred EEEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHH
Confidence 9999999987421 1112233457889999999998889999999999999999998 99999754321 111
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
...... .. ...+......+.+++..||+.||.+||++.+++++|..+..
T Consensus 252 ~~~~~~-~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 252 EKLPQG-YR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HHGGGT-CC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhcC-CC----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111110 00 01122334678999999999999999999999999987754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=348.67 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=208.2
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc---------
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD--------- 151 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 151 (427)
...+|++.+.||+|+||.||+|++..+|+.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4678999999999999999999999899999999997542 456789999999999999999998864
Q ss_pred -------CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC
Q 042519 152 -------GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF 224 (427)
Q Consensus 152 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 224 (427)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 44579999999999999999753 2356899999999999999999999999 99999999999999999
Q ss_pred CeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 042519 225 NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 225 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~ 304 (427)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+... ....
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~ 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFF 228 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHH
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHH
Confidence 99999999998643322 233457999999999999989999999999999999999999876421 1111
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPD 367 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 367 (427)
... .. ... +......+.+++..||+.||.+||++.+++++|+.+...+.
T Consensus 229 ~~~-~~-~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 229 TDL-RD-GII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHH-HT-TCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHh-hc-ccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 111 11 111 11223567899999999999999999999999998876544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=356.03 Aligned_cols=272 Identities=25% Similarity=0.352 Sum_probs=201.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHH--HhhcCCCCeeeEEEEEEc-----CCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLM--LSLLHHDNLVNLIGYCAD-----GEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~ 154 (427)
.++|++.+.||+|+||.||+|++ +++.||||++... ....+..|..+ +..++|+||+++++++.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46799999999999999999987 4789999998643 23344444444 556899999999986542 235
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCCeEeccCCCCceEeCCCCC
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK---------ANPPVIYRDLKSSNILLDCEFN 225 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~ivH~Dlkp~NIll~~~~~ 225 (427)
.++||||+++|+|.+++.. ...++..++.++.||+.||.|||+. + |+||||||+||||+.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 7899999999999999964 3458899999999999999999999 8 999999999999999999
Q ss_pred eeEeecCCcccCCCCC------ccceeccccccccccCcccccc-------CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 042519 226 AKLSDFGLAKLGPIGD------KTHVSSRVMGTYGYCAPEYQRT-------GQLTVKSDVYTFGVVLLELITGRRAIDTT 292 (427)
Q Consensus 226 vkl~DFG~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~g~~p~~~~ 292 (427)
+||+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999997643221 1122334579999999999976 45678899999999999999998877543
Q ss_pred CCcccch--hh---------hhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 293 RPTYEQN--LV---------TWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 293 ~~~~~~~--~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
....... .. .............+.+.... .........+.+++..||+.||++|||+.++++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 3221100 00 00011111111111111110 1133567789999999999999999999999999999
Q ss_pred cCCCCCCC
Q 042519 362 LGSDPDAD 369 (427)
Q Consensus 362 ~~~~~~~~ 369 (427)
+...+..-
T Consensus 316 ll~~~~~~ 323 (336)
T 3g2f_A 316 LMMIWERN 323 (336)
T ss_dssp HHHCCCC-
T ss_pred HHHHHHhc
Confidence 87655543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=344.62 Aligned_cols=264 Identities=20% Similarity=0.223 Sum_probs=205.7
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEE-EEcCCeeEEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGY-CADGEQRLLVY 159 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~~~lv~ 159 (427)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..++|++++..+.+ +.+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4678999999999999999999999999999999875543 23457889999999998776665554 46778889999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---CCCCCeeEeecCCccc
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKL 236 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkl~DFG~a~~ 236 (427)
||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 89999998752 346899999999999999999999999 9999999999999 7899999999999986
Q ss_pred CCCCCcc-----ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchh-hhhhhhhhcC
Q 042519 237 GPIGDKT-----HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL-VTWAQPFFKD 310 (427)
Q Consensus 237 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~ 310 (427)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 4333221 122356799999999999999999999999999999999999999986544322221 1111111111
Q ss_pred CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+ ...+. ...+..+.+++..||+.||++||++.++++.|+.+..
T Consensus 238 ~-------~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 238 P-------IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp C-------HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred h-------hhhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 00000 1123578899999999999999999999999987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=370.56 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=204.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||+||+|+++.++..||||++.+.. ......+.+|+.+++.++||||++++++|.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 567999999999999999999999999999999997643 233567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC---CCeeEeecCCccc
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE---FNAKLSDFGLAKL 236 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkl~DFG~a~~ 236 (427)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999988653 45899999999999999999999999 9999999999999764 4599999999986
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... ......+||+.|+|||++. +.++.++|||||||++|+|++|..||...... ............+..
T Consensus 189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKYTFDS 258 (494)
T ss_dssp CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCCS
T ss_pred CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCc
Confidence 4322 2234567999999999986 57999999999999999999999999764321 111112111111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+.. ......+.+++..||+.||.+|||+.+++++-+.
T Consensus 259 ---~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 259 ---PEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp ---GGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred ---hhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 000 1223578899999999999999999999988654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=354.60 Aligned_cols=260 Identities=23% Similarity=0.270 Sum_probs=192.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEE--------cC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCA--------DG 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~ 152 (427)
..+|++.++||+|+||.||+|++..+|+.||||++..........+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 467999999999999999999999999999999987665555677889999999996 999999999994 34
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
...++||||+. |+|.+++.... ....+++..++.++.||+.||.|||+++ ++|+||||||+||||+.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45799999997 79999886532 3456999999999999999999999875 349999999999999999999999999
Q ss_pred CcccCCCCCccc----------eeccccccccccCcccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch
Q 042519 233 LAKLGPIGDKTH----------VSSRVMGTYGYCAPEYQ---RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN 299 (427)
Q Consensus 233 ~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~ 299 (427)
+++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 998643222111 11245699999999998 56678999999999999999999999996532210
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
....... ..........+.+++..||+.||.+||++.+++++|+.+..
T Consensus 261 ---~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ---IVNGKYS--------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------CC--------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hhcCccc--------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000000 00011112347789999999999999999999999988764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=343.57 Aligned_cols=262 Identities=21% Similarity=0.209 Sum_probs=203.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999999999999999987543222 35688899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999998753 46899999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..............
T Consensus 186 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~-- 255 (309)
T 2h34_A 186 DEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPS-- 255 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGG--
T ss_pred ccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCcc--
Confidence 221 12233457999999999999999999999999999999999999999753211 11111111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcCCCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-LMSDVVSALSFLGSDP 366 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~~ 366 (427)
..+...+..+.+++.+||+.||++|| ++.++++.|+.+....
T Consensus 256 ------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 256 ------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11122335788999999999999999 9999999998765533
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=348.90 Aligned_cols=255 Identities=26% Similarity=0.353 Sum_probs=212.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.+.|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++..++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3569999999999999999999999999999999976543 345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999984 356899999999999999999999999 999999999999999999999999999764322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.. . ....... .. +
T Consensus 173 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~~~~~--~~-----~ 237 (303)
T 3a7i_A 173 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---V---LFLIPKN--NP-----P 237 (303)
T ss_dssp B--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHHHS--CC-----C
T ss_pred c--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---H---HHHhhcC--CC-----C
Confidence 1 22345679999999999999999999999999999999999999997543211 1 1111111 00 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+ +......+.+++..||+.||.+||++.+++++.+...
T Consensus 238 ~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 238 TL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp CC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred CC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 11 1123357889999999999999999999999877543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=360.05 Aligned_cols=266 Identities=26% Similarity=0.417 Sum_probs=207.8
Q ss_pred hhCccccceeccCCceEEEEEE-----ECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGK-----LEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||.||+|+ ...++..||||.+..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4789999999999999999999 456788999999965432 3345688899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---CCCeeEe
Q 042519 156 LLVYEYMPLRSLEDHLLDIGP---EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---EFNAKLS 229 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkl~ 229 (427)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986532 2245899999999999999999999999 999999999999984 4469999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...... .... . .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~---~-~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE---F-V 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH---H-H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHH---H-H
Confidence 9999875332222223344568999999999998899999999999999999998 99999754321 1111 1 1
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPD 367 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 367 (427)
...... ..+......+.+++..||+.||.+||++.+++++|+.+...+.
T Consensus 259 ~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 259 TSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred hcCCCC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 111110 1122334678899999999999999999999999998866443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=347.22 Aligned_cols=252 Identities=19% Similarity=0.237 Sum_probs=204.9
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 157 (427)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 35789999999999999999999999999999999976432 3345678899999998 89999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC--------------
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE-------------- 223 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-------------- 223 (427)
||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999765433467899999999999999999999999 9999999999999844
Q ss_pred -----CCeeEeecCCcccCCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCccc
Q 042519 224 -----FNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE 297 (427)
Q Consensus 224 -----~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~ 297 (427)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 47999999999864321 224599999999999765 56789999999999999999987764321
Q ss_pred chhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 298 QNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.... ... ...+ ..+......+.+++..||+.||++||++.+++++-+.
T Consensus 236 -~~~~----~~~--~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 236 -QWHE----IRQ--GRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp -HHHH----HHT--TCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred -HHHH----HHc--CCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 1111 111 1111 1122234678899999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=343.48 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=206.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC--CeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG--EQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 157 (427)
.++|++.+.||+|+||.||+|++. +..||||++..... ...+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 467999999999999999999986 78899999976532 2345688999999999999999999999887 78899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999753 2346899999999999999999999875 34999999999999999999999999887542
Q ss_pred CCCCccceeccccccccccCccccccCCCCc---cchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTV---KSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
. .....||+.|+|||++.+..++. ++|||||||++|+|++|+.||...... ............
T Consensus 164 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~- 229 (271)
T 3kmu_A 164 Q-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLR- 229 (271)
T ss_dssp S-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCC-
T ss_pred c-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCC-
Confidence 1 12356899999999998765544 799999999999999999999754321 111111111111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
...+...+..+.+++..||+.||++|||+.++++.|+.+..
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 ---------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11222344678999999999999999999999999987653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=363.94 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=197.8
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--------cchHHHHHHHHHHhhcCCCCeeeEEEEEEc
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--------QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD 151 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 151 (427)
...++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456899999999999999999999999999999999865321 112347889999999999999999999865
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC---CeeE
Q 042519 152 GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF---NAKL 228 (427)
Q Consensus 152 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~vkl 228 (427)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 558999999999999998853 456899999999999999999999999 99999999999997544 5999
Q ss_pred eecCCcccCCCCCccceeccccccccccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 042519 229 SDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT---GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~ 305 (427)
+|||+++.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+...
T Consensus 284 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~-- 356 (419)
T 3i6u_A 284 TDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ-- 356 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH--
T ss_pred eecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH--
Confidence 99999986432 223345789999999999853 678899999999999999999999997543221 11111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
... ..... . +.. .......+.+++.+||+.||++||++.+++++-+.
T Consensus 357 --i~~-~~~~~-~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 357 --ITS-GKYNF-I-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp --HHT-TCCCC-C-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred --Hhc-CCCCC-C-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 111 00000 0 000 01124578899999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=342.55 Aligned_cols=263 Identities=20% Similarity=0.227 Sum_probs=209.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEE-EEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGY-CADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+|+.++..++|++++..+.+ +......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 578999999999999999999999999999999986543 33568899999999998876555554 467788899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---CCCCCeeEeecCCcccC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkl~DFG~a~~~ 237 (427)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 89999998752 356899999999999999999999999 9999999999999 58899999999999864
Q ss_pred CCCCcc-----ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hhhhhhhhhcCC
Q 042519 238 PIGDKT-----HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LVTWAQPFFKDP 311 (427)
Q Consensus 238 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~ 311 (427)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... +..........+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 433221 11245679999999999999999999999999999999999999998654332221 111111111110
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
...+. ...+..+.+++..||+.||++||++.++++.|+.+..
T Consensus 239 -------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 239 -------IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp -------HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred -------hHHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 00001 1123578899999999999999999999999987644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=339.75 Aligned_cols=255 Identities=20% Similarity=0.243 Sum_probs=206.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc------chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ------GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 46799999999999999999999999999999998754322 356789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC----CeeEeec
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF----NAKLSDF 231 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkl~DF 231 (427)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 9999999999999998652 46899999999999999999999999 99999999999998877 7999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+....
T Consensus 157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~ 227 (283)
T 3bhy_A 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNISAVN 227 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC
T ss_pred ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhHhcc
Confidence 9998643221 233457999999999999999999999999999999999999999754321 1111111111
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.... ... .......+.+++.+||+.||++||++.+++++-+
T Consensus 228 ~~~~----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 268 (283)
T 3bhy_A 228 YDFD----EEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268 (283)
T ss_dssp CCCC----HHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred cCCc----chh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence 1100 000 0122357889999999999999999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=357.78 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=210.1
Q ss_pred hhCccccceeccCCceEEEEEEEC---CCCcEEEEEEeccCCC----cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE---KTAQVVAVKQLDRNGL----QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGE 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 153 (427)
.++|++.+.||+|+||.||+|++. .+|+.||||+++.... .....+.+|+.++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 467999999999999999999984 5789999999865321 2335567799999999 6999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999999753 35889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
++..... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 206 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 206 SKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE 282 (355)
T ss_dssp EEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCC
T ss_pred CeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhccC
Confidence 9864222 1222345679999999999985 357899999999999999999999997543321 1222222222211
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcCCC
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLGSD 365 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~~ 365 (427)
. .++......+.+++.+||+.||.+|| ++.+++++.+.....
T Consensus 283 ~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 283 P------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred C------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 1 11223345788999999999999999 999999998876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=358.88 Aligned_cols=254 Identities=17% Similarity=0.149 Sum_probs=205.3
Q ss_pred HhhCccccceeccCCceEEEEEE-----ECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC---CCCeeeEEEEEEcC
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGK-----LEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH---HDNLVNLIGYCADG 152 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 152 (427)
..++|.+.++||+|+||+||+|. ...+++.||||++... ....+..|+.++..++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35789999999999999999994 6677899999999654 3456777888877776 99999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---------
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGP-EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC--------- 222 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------- 222 (427)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999975432 3567999999999999999999999999 999999999999998
Q ss_pred --CCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 042519 223 --EFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL 300 (427)
Q Consensus 223 --~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~ 300 (427)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999975433333444566789999999999999999999999999999999999999985432110
Q ss_pred hhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhhc
Q 042519 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVR-PLMSDVVSALSFL 362 (427)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-Ps~~evl~~L~~~ 362 (427)
+ . ....+... .....+.+++..||+.+|.+| |++.++.+.|+.+
T Consensus 293 --~-----~--------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 --C-----K--------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --E-----E--------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --e-----e--------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0 0 00011111 124567789999999999999 5788888777654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=346.99 Aligned_cols=259 Identities=28% Similarity=0.373 Sum_probs=205.0
Q ss_pred CccccceeccCCceEEEEEEECCCCc---EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee-EEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQ---VVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR-LLV 158 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 158 (427)
.|.+.++||+|+||.||+|.+..++. .||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46777999999999999999765444 799999875433 2346688999999999999999999999876665 999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+.+++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999865 3466899999999999999999999999 9999999999999999999999999997533
Q ss_pred CCC--ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 239 IGD--KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 239 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
... .........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+...... ...... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~----~~~~~~~-- 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHF----LAQGRRL-- 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHH----HHTTCCC--
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHH----hhcCCCC--
Confidence 221 111233456889999999999999999999999999999999966654332211 111111 1111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+......+.+++..||+.||.+|||+.++++.|+.+..
T Consensus 248 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 248 --------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1122234578899999999999999999999999987744
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=353.89 Aligned_cols=268 Identities=17% Similarity=0.172 Sum_probs=202.1
Q ss_pred hhCccccceeccCCceEEEEEEECC---CCcEEEEEEeccCCCc-----------chHHHHHHHHHHhhcCCCCeeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK---TAQVVAVKQLDRNGLQ-----------GNKEFIVEVLMLSLLHHDNLVNLIG 147 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 147 (427)
.++|++.+.||+|+||.||+|.+.. ++..||||++...... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4679999999999999999999987 7889999998765322 1233567888899999999999999
Q ss_pred EEEc----CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC
Q 042519 148 YCAD----GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE 223 (427)
Q Consensus 148 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 223 (427)
++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9987 78899999999 89999998653 27899999999999999999999999 9999999999999888
Q ss_pred C--CeeEeecCCcccCCCCCc-----cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc
Q 042519 224 F--NAKLSDFGLAKLGPIGDK-----THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY 296 (427)
Q Consensus 224 ~--~vkl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~ 296 (427)
+ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999976432111 111245679999999999999899999999999999999999999996422111
Q ss_pred cchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 297 EQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
............. .+........ ....+..+.+++..||+.||++||++.+|++.|+.+..
T Consensus 268 -~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 -VAVQTAKTNLLDE---LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -HHHHHHHHHHHHT---TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -HHHHHHHHhhccc---ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111111110 1111100000 01234578999999999999999999999999986543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.82 Aligned_cols=261 Identities=27% Similarity=0.417 Sum_probs=204.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCC----cEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTA----QVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
..+|++.+.||+|+||.||+|.++.++ ..||||++..... .....+.+|+.++..++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 457888999999999999999987543 4699999975432 23356889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999875 3356899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCc-cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 237 GPIGDK-THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 237 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
...... ........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...... .+ ... .......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~---~~~-~~~~~~~ 269 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EV---MKA-INDGFRL 269 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HHH-HHTTCCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HH---HHH-HHCCCcC
Confidence 432211 111223456788999999998999999999999999999999 99999654321 11 111 1111111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 365 (427)
..+...+..+.+++..||+.+|.+||++.+++++|+.+...
T Consensus 270 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 ----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11223446788999999999999999999999999887543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=352.20 Aligned_cols=266 Identities=29% Similarity=0.441 Sum_probs=211.7
Q ss_pred hhCccccceeccCCceEEEEEEE----CCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC--ee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKL----EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE--QR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 155 (427)
.++|++.+.||+|+||.||+|++ ..+|+.||||++........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999994 5679999999998766556678899999999999999999999987654 78
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999763 346899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc---------cchhhhhhh
Q 042519 236 LGPIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY---------EQNLVTWAQ 305 (427)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~---------~~~~~~~~~ 305 (427)
........ .......++..|+|||++.+..++.++||||||+++|+|++|..||....... .........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 64332221 11233457788999999998889999999999999999999999886421100 000011111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
......... ..+..++..+.+++..||+.||++||++.++++.|+.+.
T Consensus 274 ~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 274 ELLKNNGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHTTCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcCCCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111 122334568899999999999999999999999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=346.63 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=204.3
Q ss_pred hhCccccceeccCCceEEEEEEECC---CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK---TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|++.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 5789999999999999999998753 345699999876532 3446788999999999999999999998754 5689
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999763 346899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... .... ... ....
T Consensus 164 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~---~~~-~~~~-- 233 (281)
T 3cc6_A 164 EDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV---LEK-GDRL-- 233 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH---HHH-TCCC--
T ss_pred cccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH---Hhc-CCCC--
Confidence 3222 112334567889999999998899999999999999999998 999997543221 1111 111 0110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+......+.+++..||+.||++||++.+++++|+.+
T Consensus 234 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 --------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 01122345788999999999999999999999999865
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=346.57 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=195.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++....... .+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 578999999999999999999999999999999997543222 123444555688899999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
||++ |+|.+++.........+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9998 699888766444567899999999999999999999998 8 9999999999999999999999999997633
Q ss_pred CCCccceeccccccccccCcccc----ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQ----RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
.. .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... ..... .......
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~-- 231 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQLK-QVVEEPS-- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHHHH-HHHHSCC--
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHHHH-HHhccCC--
Confidence 22 223345799999999996 5667899999999999999999999999753221 11111 1111110
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
... ........+.+++..||+.||++|||+.+++++-+.
T Consensus 232 ~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f 270 (290)
T 3fme_A 232 PQL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270 (290)
T ss_dssp CCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred CCc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence 000 011234578899999999999999999999997654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=345.88 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=208.6
Q ss_pred hhCccccc-eeccCCceEEEEEEEC--CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQEC-LIGEGGFGRVYKGKLE--KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~-~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|.+.+ .||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEE
Confidence 35677766 9999999999999864 4678899999976532 33466889999999999999999999994 566899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999864 3456899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 238 PIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 238 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
...... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ..... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----i~~~~~-- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKR-- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTCC--
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HhcCCc--
Confidence 332221 11233457899999999998899999999999999999998 99999764322 11111 111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
...+...+..+.+++..||+.||++||++.+++++|+.+-.
T Consensus 232 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 232 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11223345688999999999999999999999999987743
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=368.53 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=206.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.++. +..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 5679999999999999999999986 4679999997653 345779999999999999999999999876 678999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999642 2245889999999999999999999999 9999999999999999999999999998643221
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
........+++.|+|||++.++.++.++|||||||++|||++ |+.||...... ..... .......
T Consensus 335 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~-i~~~~~~------ 400 (452)
T 1fmk_A 335 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQ-VERGYRM------ 400 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHH-HHTTCCC------
T ss_pred -eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcCCCC------
Confidence 112233457889999999999999999999999999999999 99999754321 11111 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+..++..+.+++..||+.||++|||+.++++.|+.+..
T Consensus 401 ----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 401 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 1223445688999999999999999999999999987754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=344.80 Aligned_cols=264 Identities=19% Similarity=0.258 Sum_probs=208.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEc--CCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCAD--GEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 47799999999999999999999999999999998643 3567889999999997 9999999999997 6778999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-CeeEeecCCcccC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDFGLAKLG 237 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DFG~a~~~ 237 (427)
|||+.+++|.+++. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999874 3788999999999999999999999 99999999999999777 8999999999864
Q ss_pred CCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--------hhh
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ--------PFF 308 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~--------~~~ 308 (427)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +..... ...
T Consensus 182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHH
T ss_pred CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHH
Confidence 3322 2334578999999999876 67899999999999999999999999654332111 000000 000
Q ss_pred -cCCCC------------CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 309 -KDPNR------------YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 309 -~~~~~------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..... .............+......+.+++..||+.||.+|||+.+++++-+.-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~ 324 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence 00000 0011111122222233457889999999999999999999999987653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=363.77 Aligned_cols=267 Identities=24% Similarity=0.315 Sum_probs=202.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC------Cee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG------EQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 155 (427)
..+|++.++||+|+||.||+|++..+|+.||||++..... ...+|+.+++.++||||++++++|... ..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 3469999999999999999999999999999999865422 234699999999999999999988532 236
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC-CCeeEeecCCc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLA 234 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~vkl~DFG~a 234 (427)
++||||++ ++|.+.+.........+++..+..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 78999998 5777766544345577999999999999999999999999 9999999999999965 56899999999
Q ss_pred ccCCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh-------
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP------- 306 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~------- 306 (427)
+...... ......||+.|+|||++.+. .++.++||||||||+|||++|+.||...... ..+......
T Consensus 205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHH
T ss_pred hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 8643222 22346789999999998764 7999999999999999999999999764321 111111110
Q ss_pred -hhc-CC----CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 307 -FFK-DP----NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 307 -~~~-~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+.. .+ ..++.+........++......+.+|+.+||+.||.+||++.|++++-+.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 000 00 01111111000001222335688999999999999999999999998765
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=342.27 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=205.8
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecC
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMP 163 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 163 (427)
+|....+||+|+||.||+|.+..++..||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 35555699999999999999999999999999987665666788999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-CCCeeEeecCCcccCCCCCc
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-EFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkl~DFG~a~~~~~~~~ 242 (427)
+++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 176 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-- 176 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence 999999987642 3345678899999999999999999999 999999999999987 899999999999864322
Q ss_pred cceeccccccccccCccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQ--LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+.........
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~-------- 245 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGMFKVHP-------- 245 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHHHCCCC--------
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhccccccc--------
Confidence 12234567999999999987643 88999999999999999999999964322111 011111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+......+.+++..||+.||++||++.+++++-+..
T Consensus 246 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 283 (295)
T 2clq_A 246 ----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283 (295)
T ss_dssp ----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred ----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 11223346788999999999999999999999986553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=350.84 Aligned_cols=271 Identities=21% Similarity=0.300 Sum_probs=206.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc--------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-------- 151 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 151 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4679999999999999999999999999999999865433 224567899999999999999999999987
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 152 GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 152 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
.+..++||||+. ++|.+.+.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 456899999998 588777754 3356899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCC--ccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 042519 232 GLAKLGPIGD--KTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 232 G~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
|+++...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ........
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~ 245 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLC 245 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHh
Confidence 9998643222 1222345678999999998876 4589999999999999999999999976433211 11111111
Q ss_pred cC--CCCCCcccc--------cccCCCCC-HH------HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 309 KD--PNRYPQLAD--------PLLQGEFP-VR------GLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 309 ~~--~~~~~~~~~--------~~~~~~~~-~~------~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.. ....+.... ........ .. ....+.+|+.+||+.||++|||+.|++++-+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 10 000000000 00000001 01 134588999999999999999999999998763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=366.08 Aligned_cols=256 Identities=24% Similarity=0.318 Sum_probs=211.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.++||+|+||.||+|+++.+|+.||||++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 5679999999999999999999999999999999965432 3456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---CCCCCeeEeecCCcc
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAK 235 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkl~DFG~a~ 235 (427)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998864 356899999999999999999999999 9999999999999 567899999999998
Q ss_pred cCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .....+......+.
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKVEKGKYTFE 247 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCC
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCCCC
Confidence 643322 2344679999999999876 7999999999999999999999999764321 11111111111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
. + ........+.+++..||+.||.+|||+.+++++-+..
T Consensus 248 ~---~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 248 L---P-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286 (484)
T ss_dssp S---G-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred C---c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence 0 0 0112346788999999999999999999999987764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=368.27 Aligned_cols=258 Identities=21% Similarity=0.277 Sum_probs=208.1
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-------------cchHHHHHHHHHHhhcCCCCeeeEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-------------QGNKEFIVEVLMLSLLHHDNLVNLIG 147 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 147 (427)
..++|++.+.||+|+||+||+|+++.++..||||++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999999999999999976432 23466889999999999999999999
Q ss_pred EEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC---
Q 042519 148 YCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF--- 224 (427)
Q Consensus 148 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 224 (427)
++.+....++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999988653 45899999999999999999999999 99999999999998776
Q ss_pred CeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 042519 225 NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 225 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~ 304 (427)
.+||+|||++...... .......||+.|+|||++. +.++.++|||||||++|+|++|..||...... ...
T Consensus 187 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~ 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DII 256 (504)
T ss_dssp SEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred cEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence 6999999999864332 2234567999999999987 46999999999999999999999999764321 111
Q ss_pred hhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 305 QPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.........+.... ....+..+.+++..||+.||.+|||+.+++++-+...
T Consensus 257 ~~i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 257 KKVEKGKYYFDFND--------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHHHHCCCCCCHHH--------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHcCCCCCCccc--------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 11111111110000 0112357889999999999999999999999877643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=346.87 Aligned_cols=274 Identities=24% Similarity=0.321 Sum_probs=212.3
Q ss_pred ccCHHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhh--cCCCCeeeEEEEE
Q 042519 72 TFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSL--LHHDNLVNLIGYC 149 (427)
Q Consensus 72 ~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~ 149 (427)
...+.......++|++.+.||+|+||.||+|++. |+.||||++... ....+.+|..++.. ++||||+++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 3344445566789999999999999999999984 889999998643 34567788888877 7899999999999
Q ss_pred EcCC----eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeccCCCCc
Q 042519 150 ADGE----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH--------DKANPPVIYRDLKSSN 217 (427)
Q Consensus 150 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlkp~N 217 (427)
.... ..++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~N 177 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKN 177 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGG
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHH
Confidence 8876 78999999999999999964 35899999999999999999999 788 9999999999
Q ss_pred eEeCCCCCeeEeecCCcccCCCCCccc--eeccccccccccCccccccC------CCCccchHHHHHHHHHHHHhC----
Q 042519 218 ILLDCEFNAKLSDFGLAKLGPIGDKTH--VSSRVMGTYGYCAPEYQRTG------QLTVKSDVYTFGVVLLELITG---- 285 (427)
Q Consensus 218 Ill~~~~~vkl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~ell~g---- 285 (427)
|||+.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 999999999999999997643322211 23445799999999998765 234789999999999999999
Q ss_pred ------CCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 286 ------RRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 286 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..||....+... ....+...... ....+.+... .........+.+++..||+.||++||++.+|+++|
T Consensus 258 ~~~~~~~~p~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDP-SVEEMRKVVCE-QKLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp TBCCCCCCTTTTTSCSSC-CHHHHHHHHTT-SCCCCCCCGG----GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred CcccccccCccccCcCcc-cHHHHHHHHHH-HHhCCCCccc----ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 667755432211 11111111111 1111111110 11346778899999999999999999999999999
Q ss_pred hhcCC
Q 042519 360 SFLGS 364 (427)
Q Consensus 360 ~~~~~ 364 (427)
+.+..
T Consensus 332 ~~i~~ 336 (342)
T 1b6c_B 332 SQLSQ 336 (342)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=364.99 Aligned_cols=257 Identities=24% Similarity=0.311 Sum_probs=208.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.++||+|+||+||+|+++.+++.||||++.+.. ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 577999999999999999999999999999999986432 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC---CCCCeeEeecCCccc
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD---CEFNAKLSDFGLAKL 236 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~vkl~DFG~a~~ 236 (427)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988653 46899999999999999999999999 99999999999995 456799999999986
Q ss_pred CCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... ......+||+.|+|||++.+ .++.++||||||||+|+|++|..||...... ...............
T Consensus 174 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 174 FQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAFDL 243 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCSCS
T ss_pred CCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCC
Confidence 4322 22345679999999999975 5999999999999999999999999754321 111111111111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+ ........+.+++..||+.||.+|||+.+++++-+...
T Consensus 244 ---~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 244 ---P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp ---G-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred ---c-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 0 01123457889999999999999999999999877643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=345.79 Aligned_cols=257 Identities=25% Similarity=0.328 Sum_probs=207.3
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
..++|++.+.||+|+||.||+|.+..+|+.||||.+... .....+.+|+.++..++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 357799999999999999999999999999999999764 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999864 2356899999999999999999999999 999999999999999999999999999764322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .......... ...
T Consensus 179 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~--~~~--- 245 (314)
T 3com_A 179 --MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTNPP--PTF--- 245 (314)
T ss_dssp --BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC--CCC---
T ss_pred --ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCC--ccc---
Confidence 122344679999999999999899999999999999999999999997543211 0111111100 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+......+.+++..||+.||.+||++.+++++-+..
T Consensus 246 ----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 246 ----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp ----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 11222346788999999999999999999999987653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=359.54 Aligned_cols=258 Identities=9% Similarity=0.001 Sum_probs=186.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc---chHHHHHHHHHHhhc--CCCCeeeEE-------EEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ---GNKEFIVEVLMLSLL--HHDNLVNLI-------GYCA 150 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~ 150 (427)
.+|++.+.||+|+||.||+|++..+|+.||||++...... ....+.+|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999875432 234567785555544 699988865 4444
Q ss_pred cC-----------------CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCC
Q 042519 151 DG-----------------EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR------MKIALGAAKGLEYLHDKANPP 207 (427)
Q Consensus 151 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ 207 (427)
.. ...++||||++ |+|.+++.... ..+.+..+ +.++.||+.||+|||+++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 32 34799999999 89999997642 22344445 677799999999999999
Q ss_pred eEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhC
Q 042519 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITG 285 (427)
Q Consensus 208 ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g 285 (427)
|+||||||+||||+.++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999986321 1224567799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 286 RRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 286 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+.||....+.......... .. ...............+..+.+++.+||+.||++||++.+++++-+.
T Consensus 290 ~~Pf~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRPS---LR------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp SCSTTBCCTTCTTCCCBCC---TT------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred CCCCCCcCcccccchhhhh---hh------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 9999865433211111000 00 0000000001112345688999999999999999999999887553
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=357.43 Aligned_cols=267 Identities=17% Similarity=0.191 Sum_probs=209.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC--------CCCeeeEEEEEE---
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH--------HDNLVNLIGYCA--- 150 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 150 (427)
.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999999999999999999643 233466788999999885 788999999988
Q ss_pred -cCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeCCCC----
Q 042519 151 -DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDCEF---- 224 (427)
Q Consensus 151 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~---- 224 (427)
+....++||||+. ++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 6678999999995 6777776553 335689999999999999999999998 8 99999999999998775
Q ss_pred ---------------------------------------------CeeEeecCCcccCCCCCccceeccccccccccCcc
Q 042519 225 ---------------------------------------------NAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259 (427)
Q Consensus 225 ---------------------------------------------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE 259 (427)
.+||+|||++..... ......||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCCh
Confidence 799999999986322 133457999999999
Q ss_pred ccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhh---h------------------hhhhcCCCCCCccc
Q 042519 260 YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTW---A------------------QPFFKDPNRYPQLA 318 (427)
Q Consensus 260 ~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~---~------------------~~~~~~~~~~~~~~ 318 (427)
++.+..++.++|||||||++|+|++|+.||.............. . ..++........+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 99999999999999999999999999999976543321111110 0 01111111111111
Q ss_pred cccc---------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 319 DPLL---------QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 319 ~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
+... ....+......+.+|+.+||+.||++|||+.|++++-+
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 1000 11345677889999999999999999999999998765
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=348.56 Aligned_cols=256 Identities=21% Similarity=0.362 Sum_probs=205.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.+..++..||+|++..........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 57899999999999999999999999999999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.... .
T Consensus 98 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--~ 169 (302)
T 2j7t_A 98 CPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--K 169 (302)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHH--H
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccc--c
Confidence 9999999988653 346899999999999999999999999 9999999999999999999999999875311 1
Q ss_pred ccceeccccccccccCcccc-----ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQ-----RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.........||+.|+|||++ .+..++.++||||||+++|+|++|..||...... .......... .+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--~~~ 241 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSD--PPT 241 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC--CCC
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccC--Ccc
Confidence 11122345799999999988 4677899999999999999999999999764321 1111111111 000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
. ..+......+.+++..||+.||.+|||+.+++++-+
T Consensus 242 ~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 242 L-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp C-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred c-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 0 112233467889999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=380.04 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=203.6
Q ss_pred hCccccc-eeccCCceEEEEEEEC--CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 83 KNFRQEC-LIGEGGFGRVYKGKLE--KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 83 ~~y~~~~-~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
+++.+.+ .||+|+||.||+|.++ .++..||||+++.... ...+.+.+|+.+++.++|||||+++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4455555 7999999999999875 4567799999976533 345789999999999999999999999986 568999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999864 3456899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 239 IGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 239 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +.. .+.....
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~----~i~~~~~--- 557 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----FIEQGKR--- 557 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHH----HHHTTCC---
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCC---
Confidence 22211 11223346689999999999999999999999999999998 999997654321 111 1111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...+..++..+.+++..||+.+|++||++.+|++.|+.+
T Consensus 558 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 558 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112334557899999999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=348.78 Aligned_cols=262 Identities=21% Similarity=0.275 Sum_probs=210.5
Q ss_pred HHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--------chHHHHHHHHHHhhc-CCCCeeeEE
Q 042519 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--------GNKEFIVEVLMLSLL-HHDNLVNLI 146 (427)
Q Consensus 76 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~ 146 (427)
.......++|++.+.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.++..+ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34455668899999999999999999999989999999998754321 134567899999999 799999999
Q ss_pred EEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCe
Q 042519 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226 (427)
Q Consensus 147 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 226 (427)
+++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999998653 46899999999999999999999999 9999999999999999999
Q ss_pred eEeecCCcccCCCCCccceeccccccccccCcccccc------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 042519 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT------GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNL 300 (427)
Q Consensus 227 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~ 300 (427)
||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 240 kl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----- 311 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----- 311 (365)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred EEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-----
Confidence 999999988643322 2345689999999998863 36889999999999999999999999753221
Q ss_pred hhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.............. .+.. ......+.+++..||+.||++||++.+++++-+.
T Consensus 312 -~~~~~i~~~~~~~~---~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 312 -LMLRMIMEGQYQFS---SPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp -HHHHHHHHTCCCCC---HHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred -HHHHHHHhCCCCCC---Cccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 11111111110000 0000 0123568899999999999999999999997653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=365.21 Aligned_cols=247 Identities=15% Similarity=0.148 Sum_probs=194.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHH---HHHhhcCCCCeeeEE-------EE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEV---LMLSLLHHDNLVNLI-------GY 148 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 148 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999999899999999997432 23446788999 455566799999998 77
Q ss_pred EEcCCe-----------------eEEEEeecCCCChhhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 042519 149 CADGEQ-----------------RLLVYEYMPLRSLEDHLLDIG---PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPV 208 (427)
Q Consensus 149 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 208 (427)
+.+.+. .++||||+ +|+|.+++.... .....+++..++.|+.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 766542 78999999 589999997532 11233456888899999999999999999 9
Q ss_pred EeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccC-----------CCCccchHHHHHH
Q 042519 209 IYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-----------QLTVKSDVYTFGV 277 (427)
Q Consensus 209 vH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGv 277 (427)
+||||||+||||+.++.+||+|||+++... ......+| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998521 12345678 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 042519 278 VLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVS 357 (427)
Q Consensus 278 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 357 (427)
++|||++|+.||........ ........ ...+..+.+++..||+.||++||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~------~~~~~~~~----------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG------SEWIFRSC----------------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC------SGGGGSSC----------------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc------hhhhhhhc----------------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999965432111 00011100 112357889999999999999999999998
Q ss_pred HHh
Q 042519 358 ALS 360 (427)
Q Consensus 358 ~L~ 360 (427)
+-+
T Consensus 360 hp~ 362 (377)
T 3byv_A 360 TPE 362 (377)
T ss_dssp SHH
T ss_pred ChH
Confidence 654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=346.40 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=204.5
Q ss_pred hhCccccc-eeccCCceEEEEEEE--CCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 82 TKNFRQEC-LIGEGGFGRVYKGKL--EKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~-~Lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
.++|.+.+ .||+|+||.||+|.+ ..+++.||||++...... ..+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 999999999999954 566889999999765322 246788999999999999999999999 556789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999975 245899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 237 GPIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 237 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
....... .......|++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .... .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGER- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCC-
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCC-
Confidence 4332221 11223456789999999998889999999999999999999 99999764321 1111 1111111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...+...+..+.+++..||+.||.+||++.++++.|+.+
T Consensus 239 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011233456789999999999999999999999999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=353.86 Aligned_cols=262 Identities=29% Similarity=0.403 Sum_probs=206.6
Q ss_pred ccccceeccCCceEEEEEEE----CCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCeeEE
Q 042519 85 FRQECLIGEGGFGRVYKGKL----EKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQRLL 157 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 157 (427)
|++.+.||+|+||+||++.+ ..+++.||||++..... .....+.+|+.+++.++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 49999999999999988764 45788999999976532 234568899999999999999999999987 467899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999854 34899999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc--------chhhhhhhhhh
Q 042519 238 PIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE--------QNLVTWAQPFF 308 (427)
Q Consensus 238 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~--------~~~~~~~~~~~ 308 (427)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 433221 223445688899999999998999999999999999999999999864321100 00000011111
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.. ......+..++..+.+++..||+.||++||++.++++.|+.+..
T Consensus 265 ~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 265 ER----------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hc----------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 11112233445689999999999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=355.19 Aligned_cols=271 Identities=22% Similarity=0.248 Sum_probs=209.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 4679999999999999999999999999999999976532 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~- 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI- 183 (360)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH-
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc-
Confidence 99999999999753 3588999999999999999999996 8 9999999999999999999999999986421
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh---------h----
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ---------P---- 306 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~---------~---- 306 (427)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||................ .
T Consensus 184 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 184 ---DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ---HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ---cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 112334679999999999999999999999999999999999999997643221100000000 0
Q ss_pred -----hhcC----CCCCCcccc----cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 307 -----FFKD----PNRYPQLAD----PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 307 -----~~~~----~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.+.. ........+ ..............+.+++..||+.||++|||+.+++++-+.-.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 0000 000000000 00000111123457899999999999999999999999887543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.43 Aligned_cols=267 Identities=21% Similarity=0.254 Sum_probs=199.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE------ 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 153 (427)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999999999999999999975432 22356788999999999999999999998665
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999998 57888774 24889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhh----------
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTW---------- 303 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~---------- 303 (427)
++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ +...
T Consensus 174 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 174 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPE 248 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHH
T ss_pred cccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 985322 1223456799999999999999999999999999999999999999976432110 0000
Q ss_pred --------hhhhhcCCCCCC-----cccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 304 --------AQPFFKDPNRYP-----QLADPLLQG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 304 --------~~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+........ ......... ..+......+.+|+.+||+.||++|||+.+++++-+.-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 000011000000 000000000 011234678999999999999999999999999987643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=345.24 Aligned_cols=260 Identities=29% Similarity=0.397 Sum_probs=202.7
Q ss_pred hhCccccceeccCCceEEEEEEECCC---CcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEE-cCCeeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCA-DGEQRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 156 (427)
..+|++.++||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35689999999999999999997543 34689999875433 23466889999999999999999999865 456789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999965 3456889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCc--cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 237 GPIGDK--THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 237 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
...... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||....... .. ...... ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~---~~~~~~-~~ 250 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT---VYLLQG-RR 250 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH---HHHHTT-CC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH---HHHhcC-CC
Confidence 432221 112334567889999999999999999999999999999999 555555432211 11 111111 00
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
...+...+..+.+++..||+.||.+||++.++++.|+.+..
T Consensus 251 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 ----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01112234578899999999999999999999999987644
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=355.20 Aligned_cols=263 Identities=22% Similarity=0.286 Sum_probs=200.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCC------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGE------ 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 153 (427)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999999999999999998654322 2356788999999999999999999998653
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 6899998864 45889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.... .....+.
T Consensus 175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~-~~~g~~~ 246 (367)
T 1cm8_A 175 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIM-KVTGTPP 246 (367)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCCCC
T ss_pred cccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HhcCCCC
Confidence 986322 1334678999999999876 689999999999999999999999997543211 010000 0000000
Q ss_pred -----------------CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 313 -----------------RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 313 -----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.++......+. .........+.+++.+||+.||.+|||+.+++++-+.-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~ 312 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence 00000000000 11122346788999999999999999999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=357.86 Aligned_cols=259 Identities=29% Similarity=0.408 Sum_probs=197.1
Q ss_pred hCccccceeccCCceEEEEEEECCC---CcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEc-CCeeEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-GEQRLL 157 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 157 (427)
..|++.++||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4578889999999999999997543 3468999986533 2345678899999999999999999998754 567899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999965 3456889999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCcc--ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 238 PIGDKT--HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 238 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... .... . ......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~---~-~~~~~~ 315 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---L-LQGRRL 315 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH---H-HTTCCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH---H-HcCCCC
Confidence 322211 12234567889999999999999999999999999999999 677776543221 1111 1 111110
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+..++..+.+++..||+.||++||++.++++.|+.+..
T Consensus 316 ----------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 316 ----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122334678899999999999999999999999988754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=336.32 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=201.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999999899999999986532 23345788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999998653 35889999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... .............
T Consensus 163 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~---- 229 (276)
T 2h6d_A 163 DG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKIRGGVFY---- 229 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC----
T ss_pred CC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCccc----
Confidence 22 12334578999999999987765 6899999999999999999999975321 1111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+......+.+++..||+.||.+||++.+++++-+.-
T Consensus 230 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 230 --------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred --------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 1122335788999999999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=343.20 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=208.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 4789999999999999999999864 6789999996543 345778999999999999999999999874 568999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999998542 1236899999999999999999999999 9999999999999999999999999998643222
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ...... .....
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~-~~~~~------- 228 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNL-ERGYR------- 228 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHH-HTTCC-------
T ss_pred -cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHH-hcccC-------
Confidence 122334557889999999998899999999999999999999 99999754321 111111 11100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
...+...+..+.+++..||+.||++||++.++++.|+.+..
T Consensus 229 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 229 ---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 01122334678899999999999999999999999987643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=357.91 Aligned_cols=277 Identities=21% Similarity=0.281 Sum_probs=191.5
Q ss_pred hhCccc-cceeccCCceEEEEEEEC--CCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEE--cCCeeE
Q 042519 82 TKNFRQ-ECLIGEGGFGRVYKGKLE--KTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA--DGEQRL 156 (427)
Q Consensus 82 ~~~y~~-~~~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 156 (427)
.+.|++ .++||+|+||+||+|+++ .++..||||++.... ....+.+|+.+++.|+||||+++++++. .....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 455776 458999999999999976 468899999997543 3356889999999999999999999995 477899
Q ss_pred EEEeecCCCChhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe----CCCCCee
Q 042519 157 LVYEYMPLRSLEDHLLDIG-----PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL----DCEFNAK 227 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~vk 227 (427)
+||||+. ++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999997 68888775321 12235899999999999999999999999 9999999999999 7788999
Q ss_pred EeecCCcccCCCCCc-cceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCccc------ch
Q 042519 228 LSDFGLAKLGPIGDK-THVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE------QN 299 (427)
Q Consensus 228 l~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~------~~ 299 (427)
|+|||+++....... .......+||+.|+|||++.+ ..++.++||||||||+|+|++|+.||........ ..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999986432211 122345689999999999887 4589999999999999999999999975443210 00
Q ss_pred hhhhhhhhhcCCCC--CCcccc---------cc---cCCCCC---------HHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 042519 300 LVTWAQPFFKDPNR--YPQLAD---------PL---LQGEFP---------VRGLNQAVAVSAMCVQEESSVRPLMSDVV 356 (427)
Q Consensus 300 ~~~~~~~~~~~~~~--~~~~~~---------~~---~~~~~~---------~~~~~~l~~li~~cl~~~P~~RPs~~evl 356 (427)
........+..+.. ...+.. .. ...... ......+.+|+..||+.||.+|||+.|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000011111000 000000 00 000000 00134678999999999999999999999
Q ss_pred HHHhhcCC
Q 042519 357 SALSFLGS 364 (427)
Q Consensus 357 ~~L~~~~~ 364 (427)
++-+....
T Consensus 333 ~hp~f~~~ 340 (405)
T 3rgf_A 333 QDPYFLED 340 (405)
T ss_dssp TSGGGTSS
T ss_pred cChhhccC
Confidence 99887654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=348.71 Aligned_cols=270 Identities=24% Similarity=0.349 Sum_probs=191.7
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++..++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 35789999999999999999999988899999999865432 33456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 160 EYMPLRSLEDHLLDIG----PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 9999999999886421 13456899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCc---cceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 236 LGPIGDK---THVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 236 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ... ......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---~~~~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LML---TLQNDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHH---HHTSSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHH---HhccCC
Confidence 5432211 112334679999999999875 5689999999999999999999999976543211 100 111111
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.... ...............+.+++..||+.||.+||++.+++++-+.
T Consensus 245 ~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 291 (303)
T 2vwi_A 245 PSLE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291 (303)
T ss_dssp CCTT---C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred Cccc---cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 1110 0000011112234578899999999999999999999997653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=343.02 Aligned_cols=257 Identities=21% Similarity=0.280 Sum_probs=201.9
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--------cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--------QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG 152 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 152 (427)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 45789999999999999999999999999999999865422 1223478899999999999999999999876
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC---eeEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN---AKLS 229 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkl~ 229 (427)
. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999998853 457899999999999999999999999 999999999999987665 9999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~ 306 (427)
|||++..... ........||+.|+|||++. ...++.++|||||||++|+|++|..||....... .+....
T Consensus 160 Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~-- 232 (322)
T 2ycf_A 160 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI-- 232 (322)
T ss_dssp CCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH--
T ss_pred cCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH--
Confidence 9999986422 12233467999999999873 5678999999999999999999999997543221 111111
Q ss_pred hhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 307 FFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
........ +.. .......+.+++..||+.||++||++.+++++-+.
T Consensus 233 -~~~~~~~~----~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~ 278 (322)
T 2ycf_A 233 -TSGKYNFI----PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278 (322)
T ss_dssp -HHTCCCCC----HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred -HhCccccC----chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence 11000000 000 01124578899999999999999999999986543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=382.44 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=198.8
Q ss_pred ceeccCCceEEEEEEE--CCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKL--EKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
+.||+|+||.||+|.+ +.+++.||||+++.... ...+.+.+|+.++..++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999955 45678999999976433 234678999999999999999999999975 458899999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc-c
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK-T 243 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~-~ 243 (427)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999964 346899999999999999999999999 99999999999999999999999999986433222 1
Q ss_pred ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 244 HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +. ........
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~~~--------- 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT----AMLEKGER--------- 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----HHHHTTCC---------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCC---------
Confidence 22333457889999999999999999999999999999998 999997643221 11 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...+..++..+.+++..||+.||++||++.+|++.|+.+
T Consensus 591 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112334457889999999999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.59 Aligned_cols=268 Identities=20% Similarity=0.239 Sum_probs=207.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc------CCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL------HHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 155 (427)
..+|++.++||+|+||.||+|.+..+++.||||++... ......+.+|+.++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 46799999999999999999999999999999999653 23345677788888777 577999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC--eeEeecCC
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN--AKLSDFGL 233 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--vkl~DFG~ 233 (427)
++||||+. ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999997 7999988763 2345899999999999999999999999 999999999999999987 99999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh---------
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA--------- 304 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~--------- 304 (427)
+..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .+....
T Consensus 249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~--~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD--QLACMIELLGMPSQK 321 (429)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHH
Confidence 975322 1234679999999999999999999999999999999999999997653321 111000
Q ss_pred --------hhhhcCCCCCCcc------c-----------------ccccCC----CCCHHHHHHHHHHHHHccCCCCCCC
Q 042519 305 --------QPFFKDPNRYPQL------A-----------------DPLLQG----EFPVRGLNQAVAVSAMCVQEESSVR 349 (427)
Q Consensus 305 --------~~~~~~~~~~~~~------~-----------------~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~R 349 (427)
..++.. ...+.. . .+.... ..+......+.+|+.+||+.||++|
T Consensus 322 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 322 LLDASKRAKNFVSS-KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHTBTTHHHHBCT-TSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhhhhhhhccCC-CCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 001110 000000 0 000000 0011124578899999999999999
Q ss_pred CCHHHHHHHHhhcCC
Q 042519 350 PLMSDVVSALSFLGS 364 (427)
Q Consensus 350 Ps~~evl~~L~~~~~ 364 (427)
||+.|++++-+....
T Consensus 401 pta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 401 MTPGQALRHPWLRRR 415 (429)
T ss_dssp CCHHHHHTSTTTC--
T ss_pred CCHHHHhCChhhccC
Confidence 999999998876443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=351.66 Aligned_cols=257 Identities=26% Similarity=0.374 Sum_probs=202.4
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEc------CC
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCAD------GE 153 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~ 153 (427)
..++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+|+.++..+ +||||+++++++.. .+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3678999999999999999999999999999999986543 3456788999999999 79999999999986 56
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 889999999999999998763 2356889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
+...... ........||+.|+|||++. +..++.++|||||||++|+|++|..||....+.. ......
T Consensus 176 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~ 247 (326)
T 2x7f_A 176 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLIP 247 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH
T ss_pred ceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHhh
Confidence 8753221 11233457999999999986 5678999999999999999999999997543211 111111
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
... .+... +......+.+++..||+.||.+||++.+++++-+.
T Consensus 248 ~~~--~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 248 RNP--APRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp HSC--CCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred cCc--cccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 111 01111 11223578899999999999999999999997654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=340.27 Aligned_cols=255 Identities=27% Similarity=0.375 Sum_probs=204.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc----CCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD----GEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 155 (427)
...|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3458889999999999999999999999999999875432 234568899999999999999999999875 4568
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC-CCCCeeEeecCCc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD-CEFNAKLSDFGLA 234 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkl~DFG~a 234 (427)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++
T Consensus 105 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999999653 45889999999999999999999986 3499999999999997 7899999999999
Q ss_pred ccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
...... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... ......... .. .
T Consensus 180 ~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~-~ 247 (290)
T 1t4h_A 180 TLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTS-GV-K 247 (290)
T ss_dssp GGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTT-TC-C
T ss_pred cccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhc-cC-C
Confidence 753222 223467999999999887 46999999999999999999999999754321 111111111 10 0
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+.. ++......+.+++..||+.||.+||++.+++++-+.
T Consensus 248 ~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 248 PAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp CGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ccc--------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 110 111123578899999999999999999999998654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=348.08 Aligned_cols=266 Identities=20% Similarity=0.253 Sum_probs=206.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----Cee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADG-----EQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 155 (427)
.++|++.+.||+|+||.||+|.+..++..||||++...... ....+.+|+.++..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46799999999999999999999999999999999754322 236688999999999999999999999754 468
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999998 699998854 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCc-cceeccccccccccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC-
Q 042519 236 LGPIGDK-THVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN- 312 (427)
Q Consensus 236 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 312 (427)
....... ........||+.|+|||++. ...++.++|||||||++|+|++|+.||........ +... ......+.
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i-~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHI-LGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHH-HHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHH-HHHhCCCCH
Confidence 6432211 11124468999999999865 45589999999999999999999999976543221 1110 00000000
Q ss_pred -------------------CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 313 -------------------RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 313 -------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
......... ........+.+++.+||+.||++|||+.+++++-+.-.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNR----LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHH----HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHH----hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 000000000 01123457889999999999999999999999987644
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=361.52 Aligned_cols=261 Identities=20% Similarity=0.250 Sum_probs=209.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCC-CCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH-DNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.++||+|+||.||+|++..+++.||||++..... ...+..|+.++..|+| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4789999999999999999999999999999999865432 3457889999999986 667777777888899999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---CCCCCeeEeecCCcccC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL---DCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~vkl~DFG~a~~~ 237 (427)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 89999998752 456999999999999999999999999 9999999999999 68899999999999864
Q ss_pred CCCCcc-----ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhh-hhhhhhcCC
Q 042519 238 PIGDKT-----HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT-WAQPFFKDP 311 (427)
Q Consensus 238 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 311 (427)
...... .......||+.|+|||++.+..++.++||||||||||||++|+.||............. ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT- 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-
Confidence 433221 11235789999999999999999999999999999999999999998654432221111 11111110
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.... +. ..++..+.+++..||+.+|++||++.+|++.|+.+
T Consensus 236 -----~~~~-l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 236 -----SIEA-LC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp -----CHHH-HH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred -----cHHH-Hh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0000 00 11235789999999999999999999999998776
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=341.51 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=199.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-CeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADG-EQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 160 (427)
.++|++.+.||+|+||.||+|.+. |+.||||++... ...+.+.+|+.+++.++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 467999999999999999999885 789999998754 3456788999999999999999999997654 47899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++++|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999986531 223788999999999999999999999 999999999999999999999999998753221
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ... .. ......
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~---~~-~~~~~~------ 232 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV---PR-VEKGYK------ 232 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH---HH-HTTTCC------
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HH-HhcCCC------
Confidence 223467889999999998899999999999999999998 99999754321 111 11 111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+...+..+.+++..||+.||.+||++.++++.|+.+.
T Consensus 233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 233 ----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 1112234467889999999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=372.56 Aligned_cols=257 Identities=27% Similarity=0.383 Sum_probs=208.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||.||+|.++. +..||||+++... ...+.+.+|+.+++.|+|+||+++++++.+ +..+|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3457788899999999999999986 4679999997654 345789999999999999999999999876 678999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+.+|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 343 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 416 (535)
T 2h8h_A 343 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN- 416 (535)
T ss_dssp CTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-
T ss_pred hcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC-
Confidence 9999999999642 2245889999999999999999999999 999999999999999999999999999864321
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
.........++..|+|||++.+..++.++|||||||+||||++ |+.||...... +.... +......
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~-i~~~~~~------ 483 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQ-VERGYRM------ 483 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHH-HHTTCCC------
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcCCCC------
Confidence 1111233457788999999999999999999999999999999 99999754321 11111 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+..+...+.+|+..||+.||++||++.+|++.|+.+..
T Consensus 484 ----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1123345678899999999999999999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=347.62 Aligned_cols=277 Identities=20% Similarity=0.229 Sum_probs=199.7
Q ss_pred HHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe--
Q 042519 77 ELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ-- 154 (427)
Q Consensus 77 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 154 (427)
......++|++.+.||+|+||.||+|++..+|..||||++.... .......+++..+..++||||++++++|.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34455789999999999999999999999999999999986543 333456778888899999999999999975433
Q ss_pred -----eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEeccCCCCceEeCC-CCCe
Q 042519 155 -----RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH--DKANPPVIYRDLKSSNILLDC-EFNA 226 (427)
Q Consensus 155 -----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~v 226 (427)
.++||||+++ +|...+.........+++..+..++.|++.||.||| +++ |+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999984 666655544345677899999999999999999999 888 999999999999996 8999
Q ss_pred eEeecCCcccCCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 042519 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 227 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~ 305 (427)
||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+.....
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVR 246 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHH
Confidence 999999998643222 23456789999999998654 48999999999999999999999997643321 1111111
Q ss_pred hh----------hc-CCCCCC-----cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 306 PF----------FK-DPNRYP-----QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 306 ~~----------~~-~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.. .. ...... ...........+......+.+++..||+.||.+|||+.|++++-+.-.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 00 00 000000 000000111122235678999999999999999999999999876643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=353.15 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=199.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC------ee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE------QR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 155 (427)
..+|++.++||+|+||+||+|++..++. ||+|++...... ..+|+.+++.++||||++++++|.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3579999999999999999999988666 888887543222 236999999999999999999996433 37
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC-CCCCeeEeecCCc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD-CEFNAKLSDFGLA 234 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkl~DFG~a 234 (427)
++||||+++ +|...+.........+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||++
T Consensus 114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 899999985 555544433334567999999999999999999999999 99999999999998 7999999999999
Q ss_pred ccCCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--------
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ-------- 305 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~-------- 305 (427)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.....
T Consensus 190 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 190 KILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSRE 264 (394)
T ss_dssp EECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred ccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 8643222 23346789999999998764 58999999999999999999999997643221 1111110
Q ss_pred ------hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 306 ------PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 306 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
+.+.. ..++......+...++......+.+|+.+||+.||.+|||+.|++++-+.-
T Consensus 265 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 265 QIKTMNPNYME-HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHHHHCGGGSS-SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHhhChhhhh-hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 00000 111111111111112223456889999999999999999999999986653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=335.28 Aligned_cols=257 Identities=22% Similarity=0.242 Sum_probs=209.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---------cchHHHHHHHHHHhhcC-CCCeeeEEEEEEc
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---------QGNKEFIVEVLMLSLLH-HDNLVNLIGYCAD 151 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 151 (427)
.++|++.+.||+|+||.||+|.++.+|+.||||++..... ...+.+.+|+.++.++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 5789999999999999999999999999999999975431 11345678999999996 9999999999999
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 152 GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 152 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999998653 46899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR------TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~ 305 (427)
|++....... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||...... ....
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~ 239 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLR 239 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HHHH
Confidence 9998643222 234467999999999885 457899999999999999999999999654221 1111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
........... ......+..+.+++..||+.||.+||++.+++++-+..
T Consensus 240 ~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 240 MIMSGNYQFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp HHHHTCCCCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHhcCCcccCc--------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 11111111100 01123446788999999999999999999999976653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=351.11 Aligned_cols=265 Identities=17% Similarity=0.213 Sum_probs=208.1
Q ss_pred hhCccccceeccCCceEEEEEEECC--------CCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeee---------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK--------TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVN--------- 144 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 144 (427)
.++|++.+.||+|+||.||+|++.. .++.||||++... ..+.+|+.++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999987 3789999998654 46788999999999999887
Q ss_pred ------EEEEEEc-CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCc
Q 042519 145 ------LIGYCAD-GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSN 217 (427)
Q Consensus 145 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 217 (427)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6777765 78899999999 89999999753 2356899999999999999999999999 9999999999
Q ss_pred eEeCCCC--CeeEeecCCcccCCCCCcc-----ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 042519 218 ILLDCEF--NAKLSDFGLAKLGPIGDKT-----HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAID 290 (427)
Q Consensus 218 Ill~~~~--~vkl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~ 290 (427)
||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999764322111 11234579999999999999999999999999999999999999997
Q ss_pred CCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 291 TTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
...+.. ..+......+..... .+...... .......+.+++..||+.||++||++.++++.|+.+..
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDKPG---PFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHSCC---CEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCCcCH-HHHHHHHHhccCChh---hhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 654221 112222222222211 11111100 11223678899999999999999999999999987754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=343.52 Aligned_cols=270 Identities=20% Similarity=0.236 Sum_probs=200.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEE-----------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA----------- 150 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 150 (427)
.++|++.+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999999999999999997665555677889999999999999999999874
Q ss_pred ---cCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC-CCCCe
Q 042519 151 ---DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD-CEFNA 226 (427)
Q Consensus 151 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~v 226 (427)
+....++||||+. |+|.+++. ...+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 4467899999998 69999884 356899999999999999999999999 99999999999997 56799
Q ss_pred eEeecCCcccCCCCCc-cceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 042519 227 KLSDFGLAKLGPIGDK-THVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA 304 (427)
Q Consensus 227 kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~ 304 (427)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLIL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 9999999986432111 112234567999999998865 6789999999999999999999999976543211 10000
Q ss_pred hhhhcC--------CCCCCcccccccC-CC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 305 QPFFKD--------PNRYPQLADPLLQ-GE-----FPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 305 ~~~~~~--------~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...... ....+........ .. ........+.+++..||+.||++||++.+++++-+.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 000000 0000000000000 00 0112346789999999999999999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=352.74 Aligned_cols=263 Identities=23% Similarity=0.285 Sum_probs=189.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC------C
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG------E 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 153 (427)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999999999999999865432 2345678899999999999999999999754 5
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
..++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 5899988743 56899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.. .......+.
T Consensus 179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~-i~~~~g~p~ 250 (367)
T 2fst_X 179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKL-ILRLVGTPG 250 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCSCC
T ss_pred cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCC
Confidence 986321 1344679999999999876 678999999999999999999999997643211 1110 001110000
Q ss_pred -----------------CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 313 -----------------RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 313 -----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+.......+. .........+.+|+.+||+.||++|||+.+++++-+.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 00000000000 00011235788999999999999999999999987654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=348.43 Aligned_cols=271 Identities=17% Similarity=0.214 Sum_probs=207.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-----------CCCeeeEEEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-----------HDNLVNLIGYCA 150 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 150 (427)
.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.++..++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46799999999999999999999999999999998643 233456788999988876 899999999988
Q ss_pred cCC----eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeC----
Q 042519 151 DGE----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK-ANPPVIYRDLKSSNILLD---- 221 (427)
Q Consensus 151 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~---- 221 (427)
..+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 654 789999999 799999987642 34589999999999999999999998 8 99999999999994
Q ss_pred --CCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch
Q 042519 222 --CEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN 299 (427)
Q Consensus 222 --~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~ 299 (427)
..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 444799999999986322 1234579999999999999999999999999999999999999997654221110
Q ss_pred ----hhhhh-----------------hhhhcCCCCCCccccc---------ccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 042519 300 ----LVTWA-----------------QPFFKDPNRYPQLADP---------LLQGEFPVRGLNQAVAVSAMCVQEESSVR 349 (427)
Q Consensus 300 ----~~~~~-----------------~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~R 349 (427)
+.... ..++........+... .....++......+.+|+..||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 10000 0011111111110000 00113567788899999999999999999
Q ss_pred CCHHHHHHHHhhcCC
Q 042519 350 PLMSDVVSALSFLGS 364 (427)
Q Consensus 350 Ps~~evl~~L~~~~~ 364 (427)
||+.+++++-+....
T Consensus 326 pt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDT 340 (373)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred CCHHHHhhChhhhcc
Confidence 999999998776543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=345.05 Aligned_cols=264 Identities=19% Similarity=0.260 Sum_probs=208.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcch-----------------HHHHHHHHHHhhcCCCCeee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN-----------------KEFIVEVLMLSLLHHDNLVN 144 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~E~~~l~~l~h~niv~ 144 (427)
.++|++.+.||+|+||.||+|.+ +|+.||||++........ ..+.+|+.++..++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 699999999865322111 77899999999999999999
Q ss_pred EEEEEEcCCeeEEEEeecCCCChhhh------hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCc
Q 042519 145 LIGYCADGEQRLLVYEYMPLRSLEDH------LLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSN 217 (427)
Q Consensus 145 l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~N 217 (427)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .+ |+||||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 99999999999999999999999998 432 125679999999999999999999999 88 9999999999
Q ss_pred eEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccC-CCCc-cchHHHHHHHHHHHHhCCCCCCCCCCc
Q 042519 218 ILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTV-KSDVYTFGVVLLELITGRRAIDTTRPT 295 (427)
Q Consensus 218 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~ell~g~~p~~~~~~~ 295 (427)
||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|+.||......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999864322 34456799999999999877 6666 999999999999999999999765431
Q ss_pred ccchhhhhhhhhhcCCCCCCc----ccccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 296 YEQNLVTWAQPFFKDPNRYPQ----LADPLLQ---GEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
... ...+.......+. ....... ..........+.+++..||+.||.+||++.+++++-+.
T Consensus 259 --~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 259 --VEL---FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp --HHH---HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred --HHH---HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 111 1111111111110 0000000 01112345688999999999999999999999998654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=342.97 Aligned_cols=260 Identities=29% Similarity=0.375 Sum_probs=199.5
Q ss_pred hhCccccceeccCCceEEEEEEECC-CC--cEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-TA--QVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||.||+|++.. ++ ..||||++.... ....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4679999999999999999998643 33 369999987543 233467889999999999999999999998765 8
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999998753 346889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 236 LGPIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCC
Confidence 64333222 12234567889999999998889999999999999999999 99999754321 111122121111
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
. ..+...+..+.+++..||+.||.+||++.+++++|..+..
T Consensus 244 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 244 L----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred C----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1 1122344678999999999999999999999999987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=349.47 Aligned_cols=274 Identities=21% Similarity=0.235 Sum_probs=203.5
Q ss_pred CHHHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc-----------hHHHHHHHHHHhhcCCCCe
Q 042519 74 TFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG-----------NKEFIVEVLMLSLLHHDNL 142 (427)
Q Consensus 74 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~ni 142 (427)
...++....++|++.+.||+|+||.||+|.+.. |..||||++....... .+.+.+|+.+++.++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 356677888999999999999999999999876 8999999986533221 2678899999999999999
Q ss_pred eeEEEEEEc-----CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCc
Q 042519 143 VNLIGYCAD-----GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSN 217 (427)
Q Consensus 143 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 217 (427)
+++++++.. ....++||||+. |+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 999999853 346899999998 788888864 3457899999999999999999999999 9999999999
Q ss_pred eEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc
Q 042519 218 ILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTY 296 (427)
Q Consensus 218 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~ 296 (427)
||++.++.+||+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999975322 222344679999999999876 678999999999999999999999997643211
Q ss_pred cchhhhhhhhhhcCC------------------CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 297 EQNLVTWAQPFFKDP------------------NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 297 ~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
. +... ......+ .......... ...........+.+++..||+.||++|||+.+++++
T Consensus 242 ~--~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 Q--LNKI-VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARA-WTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp H--HHHH-HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC-HHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H--HHHH-HHHcCCCChHHhhhccchhhhHHHHhhcccCChhh-HHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1 0000 0000000 0000000000 000111234578899999999999999999999998
Q ss_pred Hhhc
Q 042519 359 LSFL 362 (427)
Q Consensus 359 L~~~ 362 (427)
-+.-
T Consensus 318 p~f~ 321 (362)
T 3pg1_A 318 PYFE 321 (362)
T ss_dssp GGGT
T ss_pred chhh
Confidence 7653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=342.22 Aligned_cols=270 Identities=20% Similarity=0.271 Sum_probs=205.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----Cee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADG-----EQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 155 (427)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 5789999999999999999999999999999999965432 2235677899999999999999999988754 678
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999998 699998854 46899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccc--------eeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 042519 236 LGPIGDKTH--------VSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306 (427)
Q Consensus 236 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~ 306 (427)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+ .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~-~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QL-LLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH-HHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH-HHHHH
Confidence 643221110 1223578999999998754 678999999999999999999999997643211 00 00111
Q ss_pred hhcCCC---CCCcccc--------ccc--C-C---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 307 FFKDPN---RYPQLAD--------PLL--Q-G---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 307 ~~~~~~---~~~~~~~--------~~~--~-~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
....+. ....... ... . . .........+.+++.+||+.||++|||+.+++++-+.-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 111100 0000000 000 0 0 001123467889999999999999999999999876643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=342.24 Aligned_cols=262 Identities=25% Similarity=0.320 Sum_probs=185.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc-chHHHHHHHH-HHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ-GNKEFIVEVL-MLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||.||+|.++.+|+.||||++...... ....+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46799999999999999999999999999999999765322 2234555555 778889999999999999999999999
Q ss_pred eecCCCChhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 160 EYMPLRSLEDHLLDIG-PEQKPIDWFTRMKIALGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||+. ++|.+++.... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9998 58887775321 1346789999999999999999999998 8 999999999999999999999999999763
Q ss_pred CCCCccceeccccccccccCcccc----ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQ----RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
... .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........ ....... ..
T Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~--~~ 246 (327)
T 3aln_A 177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVVK--GD 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCC--SC
T ss_pred ccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHhc--CC
Confidence 221 122334799999999998 456789999999999999999999999975432110 0000000 00
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+. +...........+.+++..||+.||++||++.+++++-+..
T Consensus 247 ~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 247 PPQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp CCC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred CCC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 111 11111122346789999999999999999999999876554
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.63 Aligned_cols=263 Identities=21% Similarity=0.296 Sum_probs=202.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee----
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR---- 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 155 (427)
.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999999999999999999764332 235678899999999999999999999887655
Q ss_pred --EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 156 --LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 156 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 78887762 34899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.... .....+.
T Consensus 191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~-~~~~~~~ 262 (371)
T 4exu_A 191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQIL-KVTGVPG 262 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCCCC
T ss_pred cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-HHhCCCc
Confidence 985322 2344678999999999877 689999999999999999999999997643211 111100 0000000
Q ss_pred C-C-Cc--------ccc---cccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 313 R-Y-PQ--------LAD---PLLQG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 313 ~-~-~~--------~~~---~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
. . .. ... ..... .........+.+|+..||+.||++|||+.+++++-+.-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 0 0 00 000 00000 00112346789999999999999999999999997754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=334.09 Aligned_cols=258 Identities=21% Similarity=0.325 Sum_probs=198.7
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc---------
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD--------- 151 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 151 (427)
..++|++.+.||+|+||.||+|++..+|+.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 357899999999999999999999999999999998643 2334668899999999999999999998865
Q ss_pred ----CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCee
Q 042519 152 ----GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAK 227 (427)
Q Consensus 152 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vk 227 (427)
....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 3567999999999999999975 3356788899999999999999999999 99999999999999999999
Q ss_pred EeecCCcccCCCCC------------ccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 042519 228 LSDFGLAKLGPIGD------------KTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRP 294 (427)
Q Consensus 228 l~DFG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~ 294 (427)
|+|||++....... .........||+.|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-- 231 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-- 231 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--
Confidence 99999997543211 01123346799999999999764 78999999999999999998 44321
Q ss_pred cccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 295 TYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.........+......+ ...++......+.+++..||+.||.+|||+.+++++-+.
T Consensus 232 ---~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 232 ---MERVNILKKLRSVSIEF--------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp ---HHHHHHHHHHHSTTCCC--------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred ---hhHHHHHHhcccccccc--------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 11111111111111111 112233445678899999999999999999999997653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=338.44 Aligned_cols=270 Identities=23% Similarity=0.303 Sum_probs=206.1
Q ss_pred HhhCccccceeccCCceEEEEEEEC-CCCcEEEEEEeccCCC--cchHHHHHHHHHHhhc---CCCCeeeEEEEEE----
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLE-KTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLL---HHDNLVNLIGYCA---- 150 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 150 (427)
..++|++.+.||+|+||.||+|++. .+|+.||||++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3578999999999999999999995 6789999999865322 2234566777777666 8999999999987
Q ss_pred -cCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEe
Q 042519 151 -DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLS 229 (427)
Q Consensus 151 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~ 229 (427)
.....++||||+. |+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5677899999998 69999987642 345899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK 309 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 309 (427)
|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+.... ....
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~-~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKIL-DVIG 236 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHC
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-HHcC
Confidence 9999975321 222345679999999999999999999999999999999999999997643221 111110 0000
Q ss_pred CC--------CCCCc-cccc---ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 310 DP--------NRYPQ-LADP---LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 310 ~~--------~~~~~-~~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+ ...+. .... .....+.......+.+++.+||+.||.+||++.+++++-+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 301 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence 00 00000 0000 000011223456788999999999999999999999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=339.36 Aligned_cols=265 Identities=20% Similarity=0.226 Sum_probs=207.2
Q ss_pred hhCccccceeccCCceEEEEEEE-CCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCC------CeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKL-EKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHD------NLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 154 (427)
.++|++.+.||+|+||.||+|.+ ..+++.||||++... ......+.+|+.++..++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999998 567899999998643 23346678899999888765 49999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC------------
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC------------ 222 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------------ 222 (427)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 79999998763 2346889999999999999999999999 999999999999987
Q ss_pred -------CCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc
Q 042519 223 -------EFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPT 295 (427)
Q Consensus 223 -------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~ 295 (427)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 67899999999986322 123467999999999999999999999999999999999999999764332
Q ss_pred ccchhhhhhhhhhcC--------CCC----------CCc----------ccccc-cCCCCCHHHHHHHHHHHHHccCCCC
Q 042519 296 YEQNLVTWAQPFFKD--------PNR----------YPQ----------LADPL-LQGEFPVRGLNQAVAVSAMCVQEES 346 (427)
Q Consensus 296 ~~~~~~~~~~~~~~~--------~~~----------~~~----------~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P 346 (427)
... ......... ... ... ..... .....+......+.+++..||+.||
T Consensus 241 ~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 241 EHL---AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HHH---HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HHH---HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 111 100000000 000 000 00000 0011234567889999999999999
Q ss_pred CCCCCHHHHHHHHhh
Q 042519 347 SVRPLMSDVVSALSF 361 (427)
Q Consensus 347 ~~RPs~~evl~~L~~ 361 (427)
.+|||+.|++++-+.
T Consensus 318 ~~Rpt~~ell~hp~f 332 (339)
T 1z57_A 318 AKRITLREALKHPFF 332 (339)
T ss_dssp TTSCCHHHHTTSGGG
T ss_pred ccccCHHHHhcCHHH
Confidence 999999999987543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.14 Aligned_cols=259 Identities=17% Similarity=0.166 Sum_probs=180.1
Q ss_pred hhCcccc-ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc----CCeeE
Q 042519 82 TKNFRQE-CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD----GEQRL 156 (427)
Q Consensus 82 ~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 156 (427)
.++|.+. ++||+|+||.||+|+++.+|+.||||++... .....+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 5779985 4699999999999999999999999998643 1222223344667789999999999876 45689
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---CCCeeEeecCC
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---EFNAKLSDFGL 233 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkl~DFG~ 233 (427)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999763 2357899999999999999999999999 999999999999976 45599999999
Q ss_pred cccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
++.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ............
T Consensus 178 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~ 251 (336)
T 3fhr_A 178 AKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRLGQYG 251 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------C
T ss_pred ceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhccccc
Confidence 986332 12334678999999999988899999999999999999999999996543221100 000000000000
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
............+.+++..||+.||.+|||+.+++++-+...
T Consensus 252 --------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 252 --------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp --------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred --------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 000111233467889999999999999999999999887644
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.48 Aligned_cols=257 Identities=25% Similarity=0.318 Sum_probs=207.4
Q ss_pred HHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 80 TATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 80 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
...++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34678999999999999999999999999999999986543 2345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC---CCeeEeecCCc
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE---FNAKLSDFGLA 234 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~vkl~DFG~a 234 (427)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999988653 35899999999999999999999999 9999999999999764 46999999999
Q ss_pred ccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+.......
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAF 241 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCCC
Confidence 8643221 1233468999999999875 5899999999999999999999999754321 1111111111100
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.. + . .......+.+++..||+.||++||++.+++++-+.
T Consensus 242 ~~---~-~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 242 DL---P-Q----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp CS---G-G----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred Cc---h-h----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence 00 0 0 01224578899999999999999999999997543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=340.21 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=199.8
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcC--CCCeeeEEEEEEcCCeeE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLH--HDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 156 (427)
..++|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+|+.++..++ |+||+++++++.+.+..+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 35789999999999999999999865 88999999975433 23466889999999997 599999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||| +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++..
T Consensus 105 lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeecccccc
Confidence 9999 5578999998753 46899999999999999999999999 99999999999996 48999999999986
Q ss_pred CCCCCccceeccccccccccCcccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRT-----------GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~ 305 (427)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~ 250 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH 250 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHH
Confidence 433332223345679999999999875 478899999999999999999999997543211 1111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..... .. ...++......+.+++..||+.||.+||++.+++++.+...
T Consensus 251 ~~~~~-~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 251 AIIDP-NH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp HHHCT-TS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred HHHhc-cc---------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 11111 11 01111122357889999999999999999999999887643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=342.38 Aligned_cols=270 Identities=22% Similarity=0.246 Sum_probs=205.9
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CC-----CeeeEEEEEEcCCe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HD-----NLVNLIGYCADGEQ 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 154 (427)
..++|++.+.||+|+||+||+|++..+++.||||++... ......+..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 457899999999999999999999999999999999643 223456677888888875 55 49999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh--CCCCCeEeccCCCCceEeC--CCCCeeEee
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD--KANPPVIYRDLKSSNILLD--CEFNAKLSD 230 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~~~~ivH~Dlkp~NIll~--~~~~vkl~D 230 (427)
.++||||+. ++|.+++... ....+++..+..++.||+.||.|||+ .+ |+||||||+||||+ .++.+||+|
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred eEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999997 6999998764 23458999999999999999999995 56 99999999999994 578899999
Q ss_pred cCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-hhhhh-----
Q 042519 231 FGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-LVTWA----- 304 (427)
Q Consensus 231 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~~~~~----- 304 (427)
||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +....
T Consensus 205 FG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 205 FGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp CTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999986422 1234679999999999999999999999999999999999999998643321100 00000
Q ss_pred ---------hhhhcC-CCC----------CCccccc--------------------ccCCCCCHHHHHHHHHHHHHccCC
Q 042519 305 ---------QPFFKD-PNR----------YPQLADP--------------------LLQGEFPVRGLNQAVAVSAMCVQE 344 (427)
Q Consensus 305 ---------~~~~~~-~~~----------~~~~~~~--------------------~~~~~~~~~~~~~l~~li~~cl~~ 344 (427)
..++.. +.. ......+ .-...........+.+|+.+||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 000000 000 0000000 000012234456889999999999
Q ss_pred CCCCCCCHHHHHHHHhhc
Q 042519 345 ESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 345 ~P~~RPs~~evl~~L~~~ 362 (427)
||++|||+.|++++-+.-
T Consensus 360 dP~~Rpta~e~L~hp~f~ 377 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFFK 377 (382)
T ss_dssp CTTTSCCHHHHTTSGGGC
T ss_pred ChhhCCCHHHHhcCcccc
Confidence 999999999999987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=339.66 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=202.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe-----
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ----- 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 154 (427)
.++|.+.+.||+|+||.||+|.++.+|+.||||++...... ....+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999999999999999999999764322 23567889999999999999999999987654
Q ss_pred -eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 155 -RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 155 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 68887763 24899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh-------
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ------- 305 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~------- 305 (427)
++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.....
T Consensus 173 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 173 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGT 245 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCH
T ss_pred ccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 975321 1234678999999999876 678999999999999999999999997643211 0100000
Q ss_pred ------------hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 306 ------------PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 306 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.++.. .+......+ ..........+.+++.+||+.||++|||+.+++++-+.-
T Consensus 246 ~~~~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQS---LPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp HHHTTCSCHHHHHHHHT---SCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHhhHHHHHHHHh---CcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 00000 000000000 011223456889999999999999999999999987653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=338.10 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=199.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||.||+|.+.+ .||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4679999999999999999999875 399999865422 23355778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999864 3346889999999999999999999999 99999999999998 67999999999875321
Q ss_pred CC---ccceeccccccccccCcccccc---------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 042519 240 GD---KTHVSSRVMGTYGYCAPEYQRT---------GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 240 ~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
.. .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ......
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHh
Confidence 11 1122334569999999999864 45789999999999999999999999754321 111111
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 365 (427)
.. . ..+.... ......+.+++..||+.||.+||++.++++.|+.+...
T Consensus 256 ~~-~-~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 256 GT-G-MKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HT-T-CCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred cc-C-CCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1 1111111 11224678999999999999999999999999887653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=337.12 Aligned_cols=267 Identities=17% Similarity=0.201 Sum_probs=206.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCC-cEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC------eeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTA-QVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN------LVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 154 (427)
.++|++.+.||+|+||.||+|.+..++ ..||||++... ......+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999998776 68999998643 233466788999999987665 9999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe--------------
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL-------------- 220 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-------------- 220 (427)
.++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 99999999 57777777653 2356899999999999999999999999 9999999999999
Q ss_pred -----CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc
Q 042519 221 -----DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPT 295 (427)
Q Consensus 221 -----~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~ 295 (427)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5678999999999986322 123467999999999999999999999999999999999999999764322
Q ss_pred ccchhhhhhhhhhcCC--------C----------CCCcc----------ccc-ccCCCCCHHHHHHHHHHHHHccCCCC
Q 042519 296 YEQNLVTWAQPFFKDP--------N----------RYPQL----------ADP-LLQGEFPVRGLNQAVAVSAMCVQEES 346 (427)
Q Consensus 296 ~~~~~~~~~~~~~~~~--------~----------~~~~~----------~~~-~~~~~~~~~~~~~l~~li~~cl~~~P 346 (427)
.. ........... . ..... ..+ .............+.+++.+||+.||
T Consensus 246 ~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 246 EH---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp HH---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HH---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 11 11000100000 0 00000 000 00001223456689999999999999
Q ss_pred CCCCCHHHHHHHHhhcC
Q 042519 347 SVRPLMSDVVSALSFLG 363 (427)
Q Consensus 347 ~~RPs~~evl~~L~~~~ 363 (427)
++|||+.+++++-+.-.
T Consensus 323 ~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAG 339 (355)
T ss_dssp TTSCCHHHHTTSGGGGG
T ss_pred hhCcCHHHHhcChhhcC
Confidence 99999999999876543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=334.57 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=197.7
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc------hHHHHHHHHHHhhc----CCCCeeeEEEEEE
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG------NKEFIVEVLMLSLL----HHDNLVNLIGYCA 150 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l----~h~niv~l~~~~~ 150 (427)
..++|++.+.||+|+||.||+|++..+++.||||++....... ...+.+|+.++.++ +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3578999999999999999999999999999999997654322 22345688888888 8999999999999
Q ss_pred cCCeeEEEEee-cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC-CCCCeeE
Q 042519 151 DGEQRLLVYEY-MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD-CEFNAKL 228 (427)
Q Consensus 151 ~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkl 228 (427)
+.+..++|||+ +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 99999999999 7889999999753 35899999999999999999999999 99999999999999 8899999
Q ss_pred eecCCcccCCCCCccceeccccccccccCccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 042519 229 SDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT-VKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307 (427)
Q Consensus 229 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~ 307 (427)
+|||++...... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.... ..
T Consensus 182 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~ 245 (312)
T 2iwi_A 182 IDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EI 245 (312)
T ss_dssp CCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HH
T ss_pred EEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HH
Confidence 999999864322 22346799999999999876664 58999999999999999999996421 01
Q ss_pred hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 308 FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
..... .++......+.+++.+||+.||++||++.+++++-+...
T Consensus 246 ~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 246 LEAEL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp HHTCC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred hhhcc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 11111 112223457889999999999999999999999876543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=367.67 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=204.2
Q ss_pred hhCccccceeccCCceEEEEEEECCC---CcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|.+..+ +..||||.+..... ...+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 57899999999999999999998643 46799999865432 233668899999999999999999999854 56899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 468 v~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 468 IMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 9999999999999975 3356899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.... ........||+.|+|||++.+..++.++|||||||++|||++ |..||...... .. ...+... ...
T Consensus 542 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~---~~~i~~~-~~~-- 611 (656)
T 2j0j_A 542 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DV---IGRIENG-ERL-- 611 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HHHHHHT-CCC--
T ss_pred CCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HH---HHHHHcC-CCC--
Confidence 3222 122234557889999999998999999999999999999997 99999754321 11 1111111 110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+..++..+.+++..||+.||.+||++.++++.|+.+
T Consensus 612 --------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11223446888999999999999999999999999765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=334.98 Aligned_cols=247 Identities=21% Similarity=0.340 Sum_probs=204.5
Q ss_pred HhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc------chHHHHHHHHHHhhcC--CCCeeeEEEEEEcC
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ------GNKEFIVEVLMLSLLH--HDNLVNLIGYCADG 152 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 152 (427)
..++|++.+.||+|+||.||+|++..+++.||||++...... ....+.+|+.+++.++ |+||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 457899999999999999999999999999999999764322 2244667999999996 59999999999999
Q ss_pred CeeEEEEeecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC-CCCCeeEee
Q 042519 153 EQRLLVYEYMPL-RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD-CEFNAKLSD 230 (427)
Q Consensus 153 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkl~D 230 (427)
+..++|||++.+ ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 999999999976 8999998653 46899999999999999999999999 99999999999998 789999999
Q ss_pred cCCcccCCCCCccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhc
Q 042519 231 FGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFK 309 (427)
Q Consensus 231 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 309 (427)
||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ....
T Consensus 194 fg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~ 257 (320)
T 3a99_A 194 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIR 257 (320)
T ss_dssp CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHH
T ss_pred Cccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhc
Confidence 9999864321 2234679999999999987666 688999999999999999999996421 0111
Q ss_pred CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 310 DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.... ++......+.+++.+||+.||++||++.+++++-+..
T Consensus 258 ~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~ 298 (320)
T 3a99_A 258 GQVF------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298 (320)
T ss_dssp CCCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred cccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence 1000 1112235788999999999999999999999987643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=345.05 Aligned_cols=258 Identities=20% Similarity=0.257 Sum_probs=191.1
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEee
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
+.|.+.++||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.++..+ +||||+++++++.+.+..++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 456777899999999998754 446899999998643 235678899999876 799999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCC---CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC-------------CC
Q 042519 162 MPLRSLEDHLLDIGPEQKP---IDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE-------------FN 225 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~ 225 (427)
+. |+|.+++......... ..+..++.++.||+.||+|||+++ |+||||||+||||+.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 6999999764322211 133345789999999999999999 9999999999999654 47
Q ss_pred eeEeecCCcccCCCCCccc--eeccccccccccCcccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCCc
Q 042519 226 AKLSDFGLAKLGPIGDKTH--VSSRVMGTYGYCAPEYQRT-------GQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPT 295 (427)
Q Consensus 226 vkl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~ 295 (427)
+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998744322111 1234679999999999865 678999999999999999999 99999754321
Q ss_pred ccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 296 YEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
. ... ......... .....+......+.+++.+||+.||.+||++.+++++-+.
T Consensus 247 ~----~~i----~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 247 E----SNI----IRGIFSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp H----HHH----HHTCCCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred H----HHH----hcCCCCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 1 111 111111111 1112245677889999999999999999999999987654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=329.70 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=185.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc-h-HHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG-N-KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||.||+|+++.+|+.||||++....... . +.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999999999999999997653322 1 23344556788889999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK-ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
||+ ++.+..+... ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 4555554433 235689999999999999999999995 8 9999999999999999999999999997532
Q ss_pred CCCccceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
.. .......||+.|+|||++. ...++.++|||||||++|+|++|+.||...... ............
T Consensus 177 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~- 247 (318)
T 2dyl_A 177 DD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP- 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC-
T ss_pred CC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC-
Confidence 22 1233457999999999984 457899999999999999999999999753221 111111222110
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+.+.. .......+.+++..||+.||.+||++.+++++-+.
T Consensus 248 -~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 248 -PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp -CCCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred -CCCCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 00000 01233578899999999999999999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=342.54 Aligned_cols=254 Identities=22% Similarity=0.237 Sum_probs=189.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 160 (427)
..+|.+.++||+|+||+||.. ...+|+.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 456999999999999997643 334589999999865432 2356799999999 79999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---C--CCeeEeecCCcc
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---E--FNAKLSDFGLAK 235 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~vkl~DFG~a~ 235 (427)
|+. |+|.+++.... ..+.+..++.++.||+.||.|||+++ |+||||||+||||+. + ..+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 997 69999987532 23444456789999999999999999 999999999999943 2 357799999998
Q ss_pred cCCCCCcc-ceeccccccccccCccccc---cCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 236 LGPIGDKT-HVSSRVMGTYGYCAPEYQR---TGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||....... .......
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhcc
Confidence 64332211 2234567999999999997 4567889999999999999999 999996432211 1111111
Q ss_pred CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..... ..........+.+++.+||+.||.+||++.+++++-+.
T Consensus 245 -~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 245 -CSLDC-------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp -CCCTT-------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred -CCccc-------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 01000 01123455668899999999999999999999987544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=318.55 Aligned_cols=236 Identities=15% Similarity=0.094 Sum_probs=186.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.+.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999999999999999997654332 36688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++++|.+++.. . ....++..++.||+.||+|||+++ |+||||||+||||+.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999843 2 355678899999999999999999 9999999999999999999998543
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
|++ .++.++|||||||++|+|++|+.||......... . ........ ....
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--~-~~~~~~~~--~~~~-- 224 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--A-PAERDTAG--QPIE-- 224 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--E-ECCBCTTS--CBCC--
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--H-HHHHHhcc--CCCC--
Confidence 333 3689999999999999999999999865432100 0 00000000 0000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPD 367 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 367 (427)
.. ......+..+.+++.+||+.||.+| |+.++++.|..+.....
T Consensus 225 ~~----~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 225 PA----DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HH----HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hh----hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00 0112234678999999999999999 99999999998766443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.01 Aligned_cols=262 Identities=23% Similarity=0.260 Sum_probs=201.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEc------CCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD------GEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 154 (427)
.++|++.+.||+|+||.||+|.+..+|..||||++.... ......+.+|+.++..++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999999999999999986542 2334568889999999999999999998765 677
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCC---eeEeec
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFN---AKLSDF 231 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---vkl~DF 231 (427)
.++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999987643 2346888899999999999999999999 999999999999987765 899999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|........
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~ 240 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKS 240 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC---
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhccc
Confidence 9998643222 234567999999999999999999999999999999999999999653211 11111110000
Q ss_pred -----------CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 042519 312 -----------NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDV 355 (427)
Q Consensus 312 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev 355 (427)
+.....................+.+++..||+.||++|||+.++
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000000011123455678899999999999999999999873
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.87 Aligned_cols=235 Identities=19% Similarity=0.241 Sum_probs=186.3
Q ss_pred hhCcccc-ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHH-hhcCCCCeeeEEEEEEc----CCee
Q 042519 82 TKNFRQE-CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLML-SLLHHDNLVNLIGYCAD----GEQR 155 (427)
Q Consensus 82 ~~~y~~~-~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 155 (427)
.++|.+. ++||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 789999999999999999999999999853 34677888887 56689999999999886 6778
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---CCCeeEeecC
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---EFNAKLSDFG 232 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkl~DFG 232 (427)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999763 2356899999999999999999999999 999999999999998 7889999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
++.... +..++.++|||||||++|+|++|+.||......... . .
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---~---------~ 209 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---P---------G 209 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------C---------C
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---H---------H
Confidence 986421 245788999999999999999999999654321100 0 0
Q ss_pred CCCcccccccCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 313 RYPQLADPLLQGEFP----VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 313 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
....+... ....+ ......+.+++..||+.||.+||++.+++++.+....
T Consensus 210 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 210 MKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SCCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred HHHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 00000000 00111 1235678999999999999999999999998776443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=353.91 Aligned_cols=239 Identities=23% Similarity=0.320 Sum_probs=192.7
Q ss_pred hhCccccceeccCCceEEEEEEECC-CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe-----
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ----- 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 154 (427)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.++..++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999976 789999999865432 334567889999999999999999999987655
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.||||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+||||+.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999887632 6899999999999999999999999 9999999999999885 8999999999
Q ss_pred ccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
+..... ....||+.|+|||++.++ ++.++|||||||++|+|++|..||...... ..
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~~ 284 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------GL 284 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------SC
T ss_pred hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------------cc
Confidence 864321 346799999999998765 489999999999999999998887632100 00
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhh
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-MSDVVSALSF 361 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~~L~~ 361 (427)
+ ...........+.+++.+||+.||.+||+ +.++...|..
T Consensus 285 ~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 P-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp C-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred c-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 00111223467889999999999999996 5555555543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=331.72 Aligned_cols=244 Identities=17% Similarity=0.164 Sum_probs=183.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHHHHHHHhhcCC-CCe----------------
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHH-DNL---------------- 142 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------------- 142 (427)
..|...++||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.++..++| +|.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458888999999999999999999999999999874332 235678899999999987 221
Q ss_pred -----eeEEEEEEc-----CCeeEEEEeecCCCChhhhhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 042519 143 -----VNLIGYCAD-----GEQRLLVYEYMPLRSLEDHLLDI---GPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209 (427)
Q Consensus 143 -----v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 209 (427)
..++.++.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111111221 22457777766 48999888522 234556888899999999999999999999 99
Q ss_pred eccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCcccc----------ccCCCCccchHHHHHHHH
Q 042519 210 YRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ----------RTGQLTVKSDVYTFGVVL 279 (427)
Q Consensus 210 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvil 279 (427)
||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++ ....++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999875321 1445678 999999999 555688999999999999
Q ss_pred HHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 042519 280 LELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSA 358 (427)
Q Consensus 280 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 358 (427)
|||++|+.||....... .....+... .. .+..+.+++..||+.||++||++.+++++
T Consensus 308 ~elltg~~Pf~~~~~~~------~~~~~~~~~------------~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALG------GSEWIFRSC------------KN----IPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHSSCCCCTTGGGS------CSGGGGSSC------------CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcchhh------hHHHHHhhc------------cc----CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999997543211 111111110 01 22678999999999999999997776554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=312.69 Aligned_cols=246 Identities=15% Similarity=0.109 Sum_probs=189.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--------cchHHHHHHHHHHhhcC---------CCCeee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--------QGNKEFIVEVLMLSLLH---------HDNLVN 144 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~ 144 (427)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 589999999976532 22367889999988885 888888
Q ss_pred EEEEEE------------------------------cCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHH
Q 042519 145 LIGYCA------------------------------DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA 194 (427)
Q Consensus 145 l~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~ 194 (427)
+.+.+. +.+..++||||+++|++.+.+.. ..+++..+..++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 888653 26789999999999987777632 5689999999999999
Q ss_pred HHHHHHh-hCCCCCeEeccCCCCceEeCCCC--------------------CeeEeecCCcccCCCCCccceeccccccc
Q 042519 195 KGLEYLH-DKANPPVIYRDLKSSNILLDCEF--------------------NAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253 (427)
Q Consensus 195 ~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~ 253 (427)
.||.||| +++ |+||||||+||||+.++ .+||+|||+++.... ...+||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 899 99999999999999887 899999999986432 2347999
Q ss_pred cccCccccccCCCCccchHHHHHHH-HHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHH
Q 042519 254 GYCAPEYQRTGQLTVKSDVYTFGVV-LLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLN 332 (427)
Q Consensus 254 ~y~aPE~~~~~~~~~~~DvwSlGvi-l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (427)
.|+|||++.+.. +.++||||||++ .++++.|..||... ............. .... .............
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQ-MTFK----TKCNTPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHT-CCCS----SCCCSHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhh-hccC----cccchhhhhhcCH
Confidence 999999998766 899999998777 77888899888421 0000011111111 0000 0001112345778
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHH-HHHh
Q 042519 333 QAVAVSAMCVQEESSVRPLMSDVV-SALS 360 (427)
Q Consensus 333 ~l~~li~~cl~~~P~~RPs~~evl-~~L~ 360 (427)
.+.+|+.+||+.| |+.|++ ++-+
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred HHHHHHHHHhccC-----CHHHHHhcCCC
Confidence 9999999999976 999999 7643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.92 Aligned_cols=187 Identities=17% Similarity=0.082 Sum_probs=134.2
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeccCCC----------cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEE
Q 042519 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL----------QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 90 ~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 158 (427)
.++.|++|.+..++..-.|+.|++|++.+... ...+++.+|+.+|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46778888888888877899999999975432 1235688999999999 599999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||++|++|.++|... .+++.. .|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999653 455553 58899999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAI 289 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~ 289 (427)
. ........+||+.|+|||++.+ .+..++|+||+|+++++|.++..++
T Consensus 391 ~--~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 Q--DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred C--CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2 2223456789999999999975 5678899999999998887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=262.47 Aligned_cols=185 Identities=20% Similarity=0.244 Sum_probs=144.1
Q ss_pred cccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc--------hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 86 RQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG--------NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 86 ~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
...++||+|+||.||+|... +..+++|......... .+.+.+|+.++++++||||+++..++...+..+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34568999999999999554 6789999865432211 2347899999999999999966556667777899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999853 4579999999999999999 999999999999998 9999999999874
Q ss_pred CCCCccc-----eeccccccccccCcccccc--CCCCccchHHHHHHHHHHHHhCCCCC
Q 042519 238 PIGDKTH-----VSSRVMGTYGYCAPEYQRT--GQLTVKSDVYTFGVVLLELITGRRAI 289 (427)
Q Consensus 238 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ell~g~~p~ 289 (427)
....... .....+||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3321111 1245789999999999986 56888899999999999988877655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=217.61 Aligned_cols=161 Identities=15% Similarity=0.048 Sum_probs=124.7
Q ss_pred HHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc------------------chHHHHHHHHHHhhcCCC
Q 042519 79 ATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ------------------GNKEFIVEVLMLSLLHHD 140 (427)
Q Consensus 79 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~ 140 (427)
......|.+.+.||+|+||.||+|.+ .+|+.||||++...... ....+.+|+.+++.++|
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 33445677779999999999999999 77999999998643211 23457899999999984
Q ss_pred CeeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 141 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
+++.+++.. +..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+|||+
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 555554433 55699999999999988 421 123469999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCcccccc----------CCCCccchHHH
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT----------GQLTVKSDVYT 274 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DvwS 274 (427)
+ ++.+||+|||+++. +..|.|||++.. ..|...+|+|.
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9 99999999999873 334788998753 33455556654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.2e-22 Score=183.49 Aligned_cols=137 Identities=15% Similarity=0.066 Sum_probs=106.6
Q ss_pred CccccceeccCCceEEEEEEECCCCcE--EEEEEeccCCCcc------------------------hHHHHHHHHHHhhc
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQV--VAVKQLDRNGLQG------------------------NKEFIVEVLMLSLL 137 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l 137 (427)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++...... ...+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999999777888 9999975432110 12577899999999
Q ss_pred CCCCe--eeEEEEEEcCCeeEEEEeecCC-C----ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeE
Q 042519 138 HHDNL--VNLIGYCADGEQRLLVYEYMPL-R----SLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH-DKANPPVI 209 (427)
Q Consensus 138 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iv 209 (427)
.|+++ ..++++ +..+|||||+.+ | +|.++... .++..+..++.||+.+|.||| +.+ |+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 88754 444443 356899999942 4 66655432 123456789999999999999 999 99
Q ss_pred eccCCCCceEeCCCCCeeEeecCCccc
Q 042519 210 YRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 210 H~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
||||||+|||++. .++|+|||+|..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999988 899999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-19 Score=173.55 Aligned_cols=135 Identities=13% Similarity=0.092 Sum_probs=99.0
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-----c---------chHH--------HHHHHHHHhhcCCCC
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-----Q---------GNKE--------FIVEVLMLSLLHHDN 141 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~---------~~~~--------~~~E~~~l~~l~h~n 141 (427)
-|++.+.||+|+||.||+|.+. +|+.||||+++.... . .... ..+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3899999999999999999986 489999998753210 0 0011 134666677775444
Q ss_pred e--eeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceE
Q 042519 142 L--VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNIL 219 (427)
Q Consensus 142 i--v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl 219 (427)
+ ...+++ ...+|||||++|++|.++.. . .....++.||+.+|.|||+.| ||||||||.|||
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL 237 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL 237 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence 3 222322 12379999999988866431 1 123567899999999999999 999999999999
Q ss_pred eCCCCC----------eeEeecCCccc
Q 042519 220 LDCEFN----------AKLSDFGLAKL 236 (427)
Q Consensus 220 l~~~~~----------vkl~DFG~a~~ 236 (427)
|+.+|. +.|+||+-+..
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 988773 88999997764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=7.2e-14 Score=128.82 Aligned_cols=147 Identities=16% Similarity=0.018 Sum_probs=114.6
Q ss_pred HHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEE
Q 042519 79 ATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 79 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 157 (427)
......|++...++.|+++.||++... +..+++|+...........+.+|+.+++.|. +..+.++++++.+.+..++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 344567988899999999999999754 6789999986532233346888999999885 6778899999998899999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA--------------------------------- 204 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------- 204 (427)
||||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999999875311 1123467889999999999811
Q ss_pred -----------------------CCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 205 -----------------------NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 205 -----------------------~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
...++|+|++|.|||++.++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13389999999999998765667999998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=4.8e-12 Score=116.05 Aligned_cols=137 Identities=15% Similarity=0.076 Sum_probs=100.3
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--eeeEEEEEEcCCeeEEEEee
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN--LVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 161 (427)
.|.+..+.+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +.++++++..++..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 455544444666799999965 34678999997543 2345778999998886544 56688988888889999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA------------------------------------- 204 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 204 (427)
++|.+|. ... .. ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 211 11 1256677888888888753
Q ss_pred ------------------CCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 205 ------------------NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 205 ------------------~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
...++|+|++|.|||++.++.+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.9e-11 Score=116.67 Aligned_cols=142 Identities=14% Similarity=0.163 Sum_probs=106.5
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEEEEec--cCCC-cchHHHHHHHHHHhhcC--CCCeeeEEEEEEcC---CeeEEE
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLD--RNGL-QGNKEFIVEVLMLSLLH--HDNLVNLIGYCADG---EQRLLV 158 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv 158 (427)
..+.|+.|.++.||++... +..+++|+.. .... .....+.+|+.+++.|. +..+.+++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3567999999999998875 4578899875 3221 22346788999999987 45578899988776 347999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA---------------------------------- 204 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------- 204 (427)
|||++|..+.+.. ...++......++.+++..|..||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999988875422 123677788889999999999999731
Q ss_pred ---------------------CCCeEeccCCCCceEeCCCCC--eeEeecCCccc
Q 042519 205 ---------------------NPPVIYRDLKSSNILLDCEFN--AKLSDFGLAKL 236 (427)
Q Consensus 205 ---------------------~~~ivH~Dlkp~NIll~~~~~--vkl~DFG~a~~ 236 (427)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 234999999999999987754 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.16 E-value=1.8e-11 Score=115.25 Aligned_cols=187 Identities=19% Similarity=0.199 Sum_probs=120.8
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCC--eeeEEEEEEcCC---eeEEEEee
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDN--LVNLIGYCADGE---QRLLVYEY 161 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~ 161 (427)
.+.++.|.+..||++. ..+++|+.... .....+.+|+.+++.+. +.. +.+++......+ ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999863 34889986432 33466888999998874 332 445555544333 34889999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA------------------------------------- 204 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 204 (427)
++|.+|..... ..++..++..++.+++..|..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988875432 23566677778888888888888621
Q ss_pred ------------------CCCeEeccCCCCceEeCC--CCCeeEeecCCcccCCCCCccceec------------ccccc
Q 042519 205 ------------------NPPVIYRDLKSSNILLDC--EFNAKLSDFGLAKLGPIGDKTHVSS------------RVMGT 252 (427)
Q Consensus 205 ------------------~~~ivH~Dlkp~NIll~~--~~~vkl~DFG~a~~~~~~~~~~~~~------------~~~gt 252 (427)
...++|+|++|.||+++. ++.+.|+||+.+............. .+...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 134899999999999988 4567899999987532211000000 00000
Q ss_pred ccccC-ccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 042519 253 YGYCA-PEYQRTGQLTVKSDVYTFGVVLLELITGRRAI 289 (427)
Q Consensus 253 ~~y~a-PE~~~~~~~~~~~DvwSlGvil~ell~g~~p~ 289 (427)
.++.. |+... ......+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01111 22111 1122368999999999999998755
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=1.5e-07 Score=86.47 Aligned_cols=136 Identities=17% Similarity=0.103 Sum_probs=98.8
Q ss_pred eeccCCce-EEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEeecCCCCh
Q 042519 90 LIGEGGFG-RVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYEYMPLRSL 167 (427)
Q Consensus 90 ~Lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 167 (427)
.+..|..| .||+......+..+++|+-... ....+.+|...|+.|. +--+.+++.++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555554 6999887776778999986432 3456788999998885 33467888999999999999999998888
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------------
Q 042519 168 EDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA------------------------------------------- 204 (427)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 204 (427)
.+..... ......+..+++..|.-||...
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7654321 1122345566667777777521
Q ss_pred ------------CCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 205 ------------NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 205 ------------~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01379999999999999877777999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.8e-07 Score=87.85 Aligned_cols=136 Identities=19% Similarity=0.153 Sum_probs=93.3
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCC---CeeeEEEEEE-cCCeeEEEEeecC
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHD---NLVNLIGYCA-DGEQRLLVYEYMP 163 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~ 163 (427)
.+.++.|....||+. |..+++|+... ......+..|+.+|..|.+. .+.+++.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356888999999987 45588888532 12345688899999999752 3566777664 4456789999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 042519 164 LRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA--------------------------------------- 204 (427)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 204 (427)
|.+|.+... ..++......++.++...|..||+..
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988866321 11234444455555555555555422
Q ss_pred ------------------CCCeEeccCCCCceEeCC---CCCe-eEeecCCccc
Q 042519 205 ------------------NPPVIYRDLKSSNILLDC---EFNA-KLSDFGLAKL 236 (427)
Q Consensus 205 ------------------~~~ivH~Dlkp~NIll~~---~~~v-kl~DFG~a~~ 236 (427)
...++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223799999999999987 4554 7999998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=3.9e-07 Score=87.42 Aligned_cols=82 Identities=9% Similarity=0.006 Sum_probs=56.4
Q ss_pred ccee-ccCCceEEEEEEEC--C----CCcEEEEEEeccCC---CcchHHHHHHHHHHhhcC-C--CCeeeEEEEEEcC--
Q 042519 88 ECLI-GEGGFGRVYKGKLE--K----TAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLH-H--DNLVNLIGYCADG-- 152 (427)
Q Consensus 88 ~~~L-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 152 (427)
.+.| +.|....+|+.... . ++..+++|+..... ......+..|+.+++.|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999988764 1 15678899864432 112245678888888875 3 3467788887665
Q ss_pred -CeeEEEEeecCCCChhh
Q 042519 153 -EQRLLVYEYMPLRSLED 169 (427)
Q Consensus 153 -~~~~lv~e~~~~gsL~~ 169 (427)
...++||||++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999876643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=7.3e-07 Score=86.88 Aligned_cols=76 Identities=16% Similarity=0.068 Sum_probs=49.5
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCC-------cchHHHHHHHHHHhhcCC--CC-eeeEEEEEEcCCeeEE
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-------QGNKEFIVEVLMLSLLHH--DN-LVNLIGYCADGEQRLL 157 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 157 (427)
.+.||.|.++.||++....++..++||....... .....+..|..++..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4579999999999997765578899998643211 123456778888887742 33 4456544 3455689
Q ss_pred EEeecCCC
Q 042519 158 VYEYMPLR 165 (427)
Q Consensus 158 v~e~~~~g 165 (427)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.34 E-value=4.9e-06 Score=78.93 Aligned_cols=142 Identities=17% Similarity=0.246 Sum_probs=79.2
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-----CCCeeeEE-E--EEEcCCeeEEEEe
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-----HDNLVNLI-G--YCADGEQRLLVYE 160 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e 160 (427)
+.|+.|..+.||++...+ | .+++|+.... ...+..|+.++..|. .|.++... + +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~-~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDS-G-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETT-E-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCC-C-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 446667789999988753 3 5899998642 233444555555443 24443310 0 1234567899999
Q ss_pred ecCCCChh--------------hhhhhcCCC---C-------CCCCHHHH------------------------------
Q 042519 161 YMPLRSLE--------------DHLLDIGPE---Q-------KPIDWFTR------------------------------ 186 (427)
Q Consensus 161 ~~~~gsL~--------------~~l~~~~~~---~-------~~l~~~~~------------------------------ 186 (427)
|++|.++. ..++..... . ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 112221110 0 00122111
Q ss_pred -HHHHHHHHHHHHHHhh--------C--CCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 187 -MKIALGAAKGLEYLHD--------K--ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 187 -~~i~~~i~~~l~~LH~--------~--~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
..+...+..++.+|+. . ....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111123345666653 0 123499999999999998888999999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.5e-05 Score=74.84 Aligned_cols=139 Identities=17% Similarity=0.155 Sum_probs=91.9
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC---CCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH---HDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
.+.|+.|....+|+.... +..+++|+.... ....+..|+..|+.|. ...+.+++.++...+..++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456899999999998753 667889986533 3456788999888885 25688888888888889999999998
Q ss_pred CChh-----------hhhhhcCC-CCC-----------------CCCHHHHH---HHH----------------HHHHHH
Q 042519 165 RSLE-----------DHLLDIGP-EQK-----------------PIDWFTRM---KIA----------------LGAAKG 196 (427)
Q Consensus 165 gsL~-----------~~l~~~~~-~~~-----------------~l~~~~~~---~i~----------------~~i~~~ 196 (427)
..+. ..|+.... ... .-+|.... ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7652 12333221 100 11343321 111 112222
Q ss_pred H-HHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 197 L-EYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 197 l-~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|+||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23432 2235599999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.07 E-value=3.5e-05 Score=71.39 Aligned_cols=80 Identities=20% Similarity=0.225 Sum_probs=57.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCC---CCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH---DNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~ 159 (427)
......+.+|.|..+.||+....+ |+.|.+|+...........+..|+..|+.|.- --+.+++++. ..++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 455666789999999999998764 88999998755444444567889999988852 1245555543 237899
Q ss_pred eecCCCCh
Q 042519 160 EYMPLRSL 167 (427)
Q Consensus 160 e~~~~gsL 167 (427)
||+.++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99886543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.04 E-value=3e-05 Score=76.04 Aligned_cols=74 Identities=16% Similarity=0.220 Sum_probs=46.8
Q ss_pred eEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccceeccccc--cccccCccccccC---CCCccchHHHHHHHHHHH
Q 042519 208 VIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMG--TYGYCAPEYQRTG---QLTVKSDVYTFGVVLLEL 282 (427)
Q Consensus 208 ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwSlGvil~el 282 (427)
++|+|++|.|||++.++ ++|+||+.+......... ....+ ...|++|+..... .-....++..+...+|+.
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 99999999999998876 999999998763211100 00111 1346666655311 112235566888888888
Q ss_pred HhC
Q 042519 283 ITG 285 (427)
Q Consensus 283 l~g 285 (427)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00014 Score=70.08 Aligned_cols=143 Identities=19% Similarity=0.220 Sum_probs=83.2
Q ss_pred ceeccCCceEEEEEEECC-------CCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEe
Q 042519 89 CLIGEGGFGRVYKGKLEK-------TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 160 (427)
+.|..|-...+|++.... .+..|++|+... .......+.+|..+++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 467778888999988742 357899998633 2234566778999988876 3334667776654 28999
Q ss_pred ecCCCChhhh-----------------hhhcCC-CCCCCC--HHHHHHHHHHHH-------------------HHHHHH-
Q 042519 161 YMPLRSLEDH-----------------LLDIGP-EQKPID--WFTRMKIALGAA-------------------KGLEYL- 200 (427)
Q Consensus 161 ~~~~gsL~~~-----------------l~~~~~-~~~~l~--~~~~~~i~~~i~-------------------~~l~~L- 200 (427)
|++|.+|... |+.... ...... +.++.++..++. ..+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9997655311 111110 111122 334444443331 122333
Q ss_pred ---hhC-CCCCeEeccCCCCceEeCCC----CCeeEeecCCccc
Q 042519 201 ---HDK-ANPPVIYRDLKSSNILLDCE----FNAKLSDFGLAKL 236 (427)
Q Consensus 201 ---H~~-~~~~ivH~Dlkp~NIll~~~----~~vkl~DFG~a~~ 236 (427)
... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 12348999999999999876 7899999988864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00011 Score=72.23 Aligned_cols=74 Identities=20% Similarity=0.302 Sum_probs=50.8
Q ss_pred cceeccCCceEEEEEEECC-------CCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCe-eeEEEEEEcCCeeEEEE
Q 042519 88 ECLIGEGGFGRVYKGKLEK-------TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL-VNLIGYCADGEQRLLVY 159 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 159 (427)
.+.|+.|....||++.... .+..+++|+.... .....+..|+.++..|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888899999998753 2568999987432 111556689888888863333 567776543 3899
Q ss_pred eecCCCCh
Q 042519 160 EYMPLRSL 167 (427)
Q Consensus 160 e~~~~gsL 167 (427)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00018 Score=71.06 Aligned_cols=75 Identities=13% Similarity=0.026 Sum_probs=49.2
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCe-eeEEEEEEcCCeeEEEEeecCCCC
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL-VNLIGYCADGEQRLLVYEYMPLRS 166 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 166 (427)
.+.|+.|-...+|++...+.+..+++|+..... ...-....|+.++..|...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 356888888999999886545789999874432 111223578888888875444 56777663 2 35999998755
Q ss_pred h
Q 042519 167 L 167 (427)
Q Consensus 167 L 167 (427)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00049 Score=64.51 Aligned_cols=160 Identities=13% Similarity=0.075 Sum_probs=86.5
Q ss_pred cCHHHHHHHhhCccc-----cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--eeeE
Q 042519 73 FTFRELATATKNFRQ-----ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN--LVNL 145 (427)
Q Consensus 73 ~~~~~~~~~~~~y~~-----~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 145 (427)
++...+......|.+ .+.|+.|....+|++...+ | .+++|+.... .....+..|+.++..|...+ +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 344555555555655 2456778889999988753 3 5889988652 12334566777776664212 2222
Q ss_pred EEE------EEcCCeeEEEEeecCCCChhh--------------hhhhcCCC---C--CCC---CHHHHHH---------
Q 042519 146 IGY------CADGEQRLLVYEYMPLRSLED--------------HLLDIGPE---Q--KPI---DWFTRMK--------- 188 (427)
Q Consensus 146 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~---~--~~l---~~~~~~~--------- 188 (427)
+.. ....+..+++++|++|..+.. .++..... . ... .|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 211 122356789999999765421 12221100 0 001 1221110
Q ss_pred ---HHHHHHHHHHHHhhC----CCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 189 ---IALGAAKGLEYLHDK----ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 189 ---i~~~i~~~l~~LH~~----~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+...+...+++++.. ....++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133445555532 123499999999999998876668999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.0001 Score=68.73 Aligned_cols=71 Identities=7% Similarity=0.013 Sum_probs=44.6
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCe-eeEEEEEEcCCeeEEEEeec-CCC
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL-VNLIGYCADGEQRLLVYEYM-PLR 165 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g 165 (427)
.+.|+.|....+|++ ..+++|+...... .......|+.+++.+...++ .+++.++ .+.-++|+||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 578999999999998 3488998754321 11223467777776652222 4555443 33457899999 665
Q ss_pred Ch
Q 042519 166 SL 167 (427)
Q Consensus 166 sL 167 (427)
+|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 55
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00069 Score=63.89 Aligned_cols=32 Identities=34% Similarity=0.380 Sum_probs=27.4
Q ss_pred CCeEeccCCCCceEeCCC----CCeeEeecCCcccC
Q 042519 206 PPVIYRDLKSSNILLDCE----FNAKLSDFGLAKLG 237 (427)
Q Consensus 206 ~~ivH~Dlkp~NIll~~~----~~vkl~DFG~a~~~ 237 (427)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 349999999999999874 67899999998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0016 Score=61.01 Aligned_cols=143 Identities=15% Similarity=0.103 Sum_probs=79.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC--eeeEEEE-----EEcCCeeEEEEee
Q 042519 89 CLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN--LVNLIGY-----CADGEQRLLVYEY 161 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~ 161 (427)
..|+ |....||++... +|+.+++|...... .....+..|..++..|.... +++++.. ....+..+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3576 888899987654 36679999986332 23456677888877765222 3333332 1224566889999
Q ss_pred cCCCChhh-----------h---hhhcCC-----CCCCCCHHHH----------------------HHHHHHHHHHHHHH
Q 042519 162 MPLRSLED-----------H---LLDIGP-----EQKPIDWFTR----------------------MKIALGAAKGLEYL 200 (427)
Q Consensus 162 ~~~gsL~~-----------~---l~~~~~-----~~~~l~~~~~----------------------~~i~~~i~~~l~~L 200 (427)
++|.++.. . ++.... ....+++... ...+..++..+.-+
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98754320 0 111100 0111222111 11111222222222
Q ss_pred hh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 201 HD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 201 H~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11 1223389999999999999 4 899999998865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00057 Score=65.50 Aligned_cols=75 Identities=12% Similarity=0.034 Sum_probs=44.8
Q ss_pred cceeccCCceEEEEEEECC--------CCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC-eeeEEEEEEcCCeeEEE
Q 042519 88 ECLIGEGGFGRVYKGKLEK--------TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN-LVNLIGYCADGEQRLLV 158 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 158 (427)
.+.|+.|....+|++...+ .+..+++|+..... ........|..+++.|...+ ..++++.+. -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 3467888889999998753 12678899864421 11122457888887775333 446665542 3689
Q ss_pred EeecCCCCh
Q 042519 159 YEYMPLRSL 167 (427)
Q Consensus 159 ~e~~~~gsL 167 (427)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00094 Score=58.27 Aligned_cols=99 Identities=14% Similarity=0.084 Sum_probs=65.4
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCccc
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTH 244 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 244 (427)
-||.+.|.. ...++++.++|.++.|.+.+|.-+-.... -..+=+.|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 478888876 45789999999999999998877622111 11233457899999999988764 1111
Q ss_pred eeccccccccccCccccccCCCCccchHHHHHHHHHHHHh
Q 042519 245 VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT 284 (427)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 284 (427)
.....+.+||... ...+.+.=|||||++||.-+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122367888764 355788899999999998875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0012 Score=62.59 Aligned_cols=31 Identities=19% Similarity=0.230 Sum_probs=27.6
Q ss_pred CCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 206 ~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999988765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.011 Score=57.67 Aligned_cols=75 Identities=12% Similarity=0.039 Sum_probs=48.8
Q ss_pred cceeccCCceEEEEEEECCC-------CcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEE
Q 042519 88 ECLIGEGGFGRVYKGKLEKT-------AQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 159 (427)
.+.|..|-...+|++..... +..|++|+..... ...-...+|..+++.|. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 35677788899999987631 4779999864332 22223457888887775 333455665442 27899
Q ss_pred eecCCCCh
Q 042519 160 EYMPLRSL 167 (427)
Q Consensus 160 e~~~~gsL 167 (427)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.22 E-value=0.08 Score=51.09 Aligned_cols=29 Identities=28% Similarity=0.309 Sum_probs=24.9
Q ss_pred eEeccCCCCceEe------CCCCCeeEeecCCccc
Q 042519 208 VIYRDLKSSNILL------DCEFNAKLSDFGLAKL 236 (427)
Q Consensus 208 ivH~Dlkp~NIll------~~~~~vkl~DFG~a~~ 236 (427)
++|+|+.+.|||+ +.+..+.++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.82 E-value=1.1 Score=38.79 Aligned_cols=115 Identities=9% Similarity=0.109 Sum_probs=78.9
Q ss_pred CCCCeeeEEEEEEcCCeeEEEEeecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCC
Q 042519 138 HHDNLVNLIGYCADGEQRLLVYEYMPL-RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSS 216 (427)
Q Consensus 138 ~h~niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 216 (427)
.||+++.. .+-.+.+.+.+.++.-+. -++.. + ..++...+++++.+|+....+++. -+|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 58888876 566667766666665432 22322 3 346788999999999887754443 378899999
Q ss_pred ceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 042519 217 NILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAID 290 (427)
Q Consensus 217 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~ 290 (427)
||+++.++.+++.-.|+-.. ++|. .++...=+-.+=|++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987766432 1222 12233334567788999999988775
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.09 E-value=2.4 Score=36.80 Aligned_cols=115 Identities=9% Similarity=0.078 Sum_probs=75.9
Q ss_pred CCCCeeeEEEEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEeccCCCC
Q 042519 138 HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE-YLHDKANPPVIYRDLKSS 216 (427)
Q Consensus 138 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~Dlkp~ 216 (427)
.||++ -...-.+++.+.+.++.-+++.=+..+ ..++...+++++.+|+.... +++ . -+|-=|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~--~---r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA--R---RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS--S---SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh--C---ceeEEEeCc
Confidence 58888 334456777777777654333222333 34678889999988877555 333 3 578899999
Q ss_pred ceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 042519 217 NILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAID 290 (427)
Q Consensus 217 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~ 290 (427)
||+++.++.++|.-.|+-.. ++|.- .+..-=+-.+=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987776432 23332 1222224467788888888887664
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.25 E-value=0.082 Score=52.09 Aligned_cols=61 Identities=7% Similarity=0.058 Sum_probs=17.3
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEE------EEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEE
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAV------KQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 150 (427)
+.+.|| ||.||+|.+......||+ |....... .....+.+|..++..++|+|+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345676 999999999865567888 66543221 22345778888889999999999877654
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=83.58 E-value=3.3 Score=38.32 Aligned_cols=142 Identities=15% Similarity=0.135 Sum_probs=72.7
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEE----------------
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGY---------------- 148 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~---------------- 148 (427)
++..+..-.|.. .||.+... +..|+||-. . ....+.+-.++...-.+.-|+..-+.-.
T Consensus 71 v~~I~~s~~Gst-gvff~~td--~~~~VVK~s--~-~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~~~ 144 (342)
T 1cja_A 71 FKGIERSEKGTE-GLFFVETE--SGVFIVKRS--T-NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDK 144 (342)
T ss_dssp EEEEEECCSTTS-CEEEEEES--SCEEEEECC--T-THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCS
T ss_pred eeEEEeccCCCC-CeEEEEeC--CCEEEEeCc--H-HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHhhh
Confidence 444455556654 45555553 678999954 1 1222333444444445556654322211
Q ss_pred ------EEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC-CeEe-ccCCCCceEe
Q 042519 149 ------CADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP-PVIY-RDLKSSNILL 220 (427)
Q Consensus 149 ------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH-~Dlkp~NIll 220 (427)
.......+++|+|.+|..|...-... ....+.......+ +-+-+++.+..+..+ +.+. .--.++|||+
T Consensus 145 ~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~--~~~~f~~~~~k~L--G~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~ 220 (342)
T 1cja_A 145 SFRVITTLANQANILLMELVRGITLNKLTTTS--APEVLTKSTMQQL--GSLMALDVIVNNSDRLPIAWTNEGNLDNIML 220 (342)
T ss_dssp SSCHHHHHTTCSEEEEEECCCEEESTTCCSSS--HHHHSCHHHHHHH--HHHHHHHHHHTCCSSSCSSSCSCCCGGGEEE
T ss_pred hhHHHHHhhcccceehhhhcCCCccccchhhh--hhhhcCHHHHHhh--chhheehhhhcCCccCcccccCCCChhheEE
Confidence 00122467999999976665421100 0011222222211 123456666666532 2222 1257899999
Q ss_pred CCCCC-eeEeecCCccc
Q 042519 221 DCEFN-AKLSDFGLAKL 236 (427)
Q Consensus 221 ~~~~~-vkl~DFG~a~~ 236 (427)
+.++. +.++|-+++..
T Consensus 221 ~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 221 SERGATVVPIDSKIIPL 237 (342)
T ss_dssp ESBTTCEEECSCCCCCC
T ss_pred eCCCCeEEEEcCCcccc
Confidence 76554 88999998865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 427 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 2e-73
Identities = 78/284 (27%), Positives = 123/284 (43%), Gaps = 27/284 (9%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDN 141
IG G FG VYKGK VAVK L+ Q + F EV +L H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
++ +GY Q +V ++ SL HL + + + IA A+G++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 121
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY- 260
K +I+RDLKS+NI L + K+ DFGLA + +H ++ G+ + APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 261 --QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318
Q + +SDVY FG+VL EL+TG+ + + D ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362
+ A C++++ RPL +++++ L
Sbjct: 239 PK------------AMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-65
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 25/277 (9%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
+ + +G G FG V+ G VAVK L + G F+ E ++ L H L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
V L E ++ EYM SL D L P + + +A A+G+ ++ +
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
+ I+RDL+++NIL+ + K++DFGLA+L ++ + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 263 TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322
G T+KSDV++FG++L E++T R E P+ P+ L+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
+ +C +E RP + S L
Sbjct: 244 R----------------LCWKERPEDRPTFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (526), Expect = 2e-64
Identities = 67/313 (21%), Positives = 128/313 (40%), Gaps = 38/313 (12%)
Query: 72 TFTFRELATATKNFRQEC---------LIGEGGFGRVYKGKLEKTAQ---VVAVKQLDRN 119
FTF + A + F +E +IG G FG V G L+ + VA+K L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 120 GLQGN-KEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQ 178
+ ++F+ E ++ H N+++L G +++ E+M SL+ L
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---ND 122
Query: 179 KPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238
+ + G A G++YL + ++RDL + NIL++ K+SDFGL++
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 239 IGDKTHVSSRV---MGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPT 295
+ + APE + + T SDV+++G+V+ E+++ RP
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPY 234
Query: 296 YEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDV 355
++ +D P+ + + C Q++ + RP +
Sbjct: 235 WDMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 356 VSALSFLGSDPDA 368
V+ L + +P++
Sbjct: 284 VNTLDKMIRNPNS 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-64
Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 13/282 (4%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN-KEFIVEVLMLSLLHHDNL 142
+F + +G G G V+K + + V+A K + + I E+ +L + +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
V G + + E+M SL+ L + I K+++ KGL YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
K +++RD+K SNIL++ KL DFG++ +++ +GT Y +PE +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 263 TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ--PFFKDPNRYPQLADP 320
+V+SD+++ G+ L+E+ GR I + + + P R P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362
L R + V E P + F+
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-63
Identities = 64/280 (22%), Positives = 114/280 (40%), Gaps = 31/280 (11%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
K+ +G G FG V GK + VA+K + EFI E ++ L H+ L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKL 61
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
V L G C ++ EYM L ++L + +++ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
K ++RDL + N L++ + K+SDFGL++ D+ S + PE
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLM 174
Query: 263 TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322
+ + KSD++ FGV++ E+ + + P+ + N + A+ +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGK-----------------MPYERFTN--SETAEHIA 215
Query: 323 QG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
QG P + + C E++ RP ++S +
Sbjct: 216 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 2e-62
Identities = 61/279 (21%), Positives = 110/279 (39%), Gaps = 25/279 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDN 141
++ IG G +GR K + + +++ K+LD + + + EV +L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 142 LVNLIGYCADGEQRLL--VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
+V D L V EY L + E++ +D +++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 200 LHDK--ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
H + V++RDLK +N+ LD + N KL DFGLA++ + T + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317
PE KSD+++ G +L EL + F + P RY
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDE 241
Query: 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVV 356
+ ++ + + RP + +++
Sbjct: 242 LNEIIT----------------RMLNLKDYHRPSVEEIL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-62
Identities = 67/291 (23%), Positives = 108/291 (37%), Gaps = 29/291 (9%)
Query: 91 IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCA 150
IG+G FG V++GK + VAVK + + E+ +L H+N++ I
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 151 DGE----QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA-- 204
Q LV +Y SL D+L + + +K+AL A GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 205 ---NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT--HVSSRVMGTYGYCAPE 259
P + +RDLKS NIL+ ++D GLA T + +GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 260 Y------QRTGQLTVKSDVYTFGVVLLELITGRR----AIDTTRPTYEQNLVTWAQPFFK 309
+ + ++D+Y G+V E+ D P Y+ + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 310 DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
+L + L + C + R + LS
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 1e-61
Identities = 69/291 (23%), Positives = 126/291 (43%), Gaps = 27/291 (9%)
Query: 71 QTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVE 130
+ + + + + +G G +G VY+G +K + VAVK L + ++ +EF+ E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 131 VLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIA 190
++ + H NLV L+G C ++ E+M +L D+L + + + + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMA 121
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM 250
+ +EYL K I+RDL + N L+ K++DFGL++L GD +
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 177
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF-- 308
+ APE + ++KSDV+ FGV+L E+ T +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM------------------SPYPG 219
Query: 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
D ++ +L + + E P + + C Q S RP +++ A
Sbjct: 220 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-61
Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 27/279 (9%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
IG G FG V+ G VA+K + R G ++FI E ++ L H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
V L G C + LV+E+M L D+L ++ T + + L +G+ YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
VI+RDL + N L+ K+SDFG+ + D+ S+ + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFS 175
Query: 263 TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ-NLVTWAQPFFKDPNRYPQLADPL 321
+ + KSDV++FGV++ E+ + + R E ++ +K + +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235
Query: 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
C +E RP S ++ L+
Sbjct: 236 NH-----------------CWKERPEDRPAFSRLLRQLA 257
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 5e-61
Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 31/281 (11%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
K + IG+G FG V G VAVK + + + F+ E +++ L H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 143 VNLIGYCADGEQRL-LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
V L+G + + L +V EYM SL D+L G + + +K +L + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
++RDL + N+L+ + AK+SDFGL K T + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEAL 172
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321
R + + KSDV++FG++L E+ + R P + P+ P +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232
Query: 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362
++ C ++++RP + L +
Sbjct: 233 MK----------------NCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 7e-61
Identities = 61/278 (21%), Positives = 113/278 (40%), Gaps = 26/278 (9%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLD-RNGLQGNKEFIVEVLMLSLLHHDN 141
+++ +GEG +G V T + VAVK +D + + + E+ + +L+H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
+V G+ +G + L EY L D + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
+ +RD+K N+LLD N K+SDFGLA + ++ + +++ GT Y APE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 262 RTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ-NLVTWAQPFFKDPNRYPQLAD 319
+ + DV++ G+VL ++ G D + ++ + + + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVS 357
LL + E S R + D+
Sbjct: 238 ALLHK----------------ILVENPSARITIPDIKK 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-60
Identities = 69/304 (22%), Positives = 117/304 (38%), Gaps = 48/304 (15%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKT-----AQVVAVKQLDRNGLQGNKE-FIVEV-LMLSL 136
N ++G G FG+V + VAVK L +E + E+ +M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 137 LHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHL-------------------LDIGPE 177
H+N+VNL+G C L++EY L ++L L+ +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 178 QKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237
+ + + A AKG+E+L K ++RDL + N+L+ K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE 297
V + APE G T+KSDV+++G++L E+ +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV---------- 264
Query: 298 QNLVTWAQPFFKDPNR--YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDV 355
P+ P + +L + + P + + C +S RP ++
Sbjct: 265 -------NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 356 VSAL 359
S L
Sbjct: 318 TSFL 321
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-60
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 32/278 (11%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLHH 139
++F +G+G FG VY + +++ ++A+K L + L+ + EV + S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
N++ L GY D + L+ EY PL ++ L + D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259
H K VI+RD+K N+LL K++DFG + P + + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRT---TLCGTLDYLPPE 174
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319
K D+++ GV+ E + G+ + ++ + F P+ + A
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--PDFVTEGAR 232
Query: 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVS 357
L+ ++ S RP++ +V+
Sbjct: 233 DLISR----------------LLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-60
Identities = 69/285 (24%), Positives = 114/285 (40%), Gaps = 38/285 (13%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHD 140
+ + + IG G F VYKG +T VA +L L + + F E ML L H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 141 NLVNLIGYCADGEQR----LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
N+V + +LV E M +L+ +L K + KG
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKG 124
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
L++LH + PP+I+RDLK NI + + K+ D GLA L + + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR-- 313
APE + DVY FG+ +LE+ T P+ + N
Sbjct: 180 MAPEMYE-EKYDESVDVYAFGMCMLEMATSEY------------------PYSECQNAAQ 220
Query: 314 -YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVS 357
Y ++ + F + + + C+++ R + D+++
Sbjct: 221 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 7e-60
Identities = 80/281 (28%), Positives = 126/281 (44%), Gaps = 35/281 (12%)
Query: 90 LIGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGLQGN-KEFIVEVLMLSLLHHDNLVNL 145
+IG G FG VY G L + AVK L+R G +F+ E +++ H N+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 146 IGYCADGEQR-LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
+G C E L+V YM L + I E + L AKG+++L
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMKFLA--- 147
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL--GPIGDKTHVSSRVMGTYGYCAPEYQR 262
+ ++RDL + N +LD +F K++DFGLA+ D H + + A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 263 TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322
T + T KSDV++FGV+L EL+T P + D N + + LL
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA------------------PPYPDVNTF-DITVYLL 248
Query: 323 QGEFPVRGLN---QAVAVSAMCVQEESSVRPLMSDVVSALS 360
QG ++ V C ++ +RP S++VS +S
Sbjct: 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (495), Expect = 7e-60
Identities = 67/305 (21%), Positives = 115/305 (37%), Gaps = 51/305 (16%)
Query: 84 NFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQGN-KEFIVEVLMLSLL 137
N IGEG FGRV++ + + +VAVK L +F E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 138 HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQ------------------- 178
+ N+V L+G CA G+ L++EYM L + L + P
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 179 -KPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237
P+ ++ IA A G+ YL ++RDL + N L+ K++DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE 297
D + PE + T +SDV+ +GVVL E+ +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL---------- 240
Query: 298 QNLVTWAQPFFKDPNRYPQLADPLLQG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSD 354
QP++ + ++ + G P + + +C + + RP
Sbjct: 241 -------QPYYGMAHE--EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 355 VVSAL 359
+ L
Sbjct: 292 IHRIL 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-59
Identities = 70/292 (23%), Positives = 125/292 (42%), Gaps = 34/292 (11%)
Query: 76 RELATATKNFR-QECLIGEGGFGRVYKG--KLEKTAQVVAVKQLDRNGLQGN-KEFIVEV 131
++L N + +G G FG V +G ++ K VA+K L + + + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 132 LMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIAL 191
++ L + +V LIG C E +LV E L L+ +++ I ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 192 GAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVM 250
+ G++YL +K ++RDL + N+LL AK+SDFGL+K LG S
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310
+ APE + + +SDV+++GV + E ++ + +P+ K
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----------------KPYKKM 216
Query: 311 PNRYPQLADPLLQG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
P++ + QG E P + A+ + C + RP V +
Sbjct: 217 KG--PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-59
Identities = 55/246 (22%), Positives = 108/246 (43%), Gaps = 14/246 (5%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV 143
+ +G+G FG+VYK + ++T+ + A K +D + ++++VE+ +L+ H N+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
L+ ++ E+ +++ +L++ +P+ + L YLHD
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN 129
Query: 204 ANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY--- 260
+I+RDLK+ NIL + + KL+DFG++ +GT + APE
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 261 --QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE-QNLVTWAQPFFKDPNRYPQL 317
+ K+DV++ G+ L+E+ P + P P+R+
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 318 ADPLLQ 323
L+
Sbjct: 245 FKDFLK 250
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 1e-58
Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 35/282 (12%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLH 138
K F IG G FG VY + + ++VVA+K++ +G Q N ++ I EV L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
H N + G LV EY + + + +KP+ + GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 129
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAP 258
YLH +I+RD+K+ NILL KL DFG A + ++ +GT + AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAP 180
Query: 259 EY---QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315
E GQ K DV++ G+ +EL + + + + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVS 357
+ + C+Q+ RP ++
Sbjct: 241 EYFRNFVDS----------------CLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-58
Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 30/307 (9%)
Query: 85 FRQECLIGEGGFGRVYKGKL----EKTAQVVAVKQLDR-NGLQGNKEFIVEVLMLSLLHH 139
F++ ++G G FG VYKG EK VA+K+L + NKE + E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
++ L+G C +L + + MP L D++ + + I + + AKG+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259
L D+ +++RDL + N+L+ + K++DFGLAKL +K + + + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319
T +SDV+++GV + EL+T P E + + P
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 243
Query: 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDADTATAP--VPH 377
++ C ++ RP +++ S + DP H
Sbjct: 244 MIMV----------------KCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
Query: 378 KPPPCDH 384
P P D
Sbjct: 288 LPSPTDS 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-58
Identities = 69/299 (23%), Positives = 128/299 (42%), Gaps = 44/299 (14%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKT--AQVVAVKQLDRNGL-QGNKEFIVEV-LMLSLLH 138
+ + + +IGEG FG+V K +++K A+K++ +++F E+ ++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLD------------IGPEQKPIDWFTR 186
H N++NL+G C L EY P +L D L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 187 MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS 246
+ A A+G++YL K I+RDL + NIL+ + AK++DFGL++ + K +
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 185
Query: 247 SRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP 306
+ A E T SDV+++GV+L E+++
Sbjct: 186 --GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------------------T 225
Query: 307 FFKDPNRYPQLADPLLQG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362
+ +L + L QG E P+ ++ + C +E+ RP + ++ +L+ +
Sbjct: 226 PYCGMTC-AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-58
Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 29/274 (10%)
Query: 91 IGEGGFGRVYKGKLE--KTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDNLVNLI 146
+G G FG V KG + K + VAVK L E + E ++ L + +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANP 206
G C + E +LV E L L +L + + + +++ + G++YL +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
++RDL + N+LL + AK+SDFGL+K L + + + APE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 266 LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQGE 325
+ KSDV++FGV++ E + + E + P P+ L+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN-- 244
Query: 326 FPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
+C + RP + V L
Sbjct: 245 --------------LCWTYDVENRPGFAAVELRL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-58
Identities = 75/287 (26%), Positives = 119/287 (41%), Gaps = 27/287 (9%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNL 142
++ R E +G+G FG V+ G T VA+K L + G + F+ E ++ L H+ L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD 202
V L E +V EYM SL D G K + + +A A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDF--LKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 203 KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQR 262
++RDL+++NIL+ K++DFGLA+L ++ + APE
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 263 TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322
G+ T+KSDV++FG++L EL T R E P P+ L+
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247
Query: 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS--FLGSDPD 367
C ++E RP + + L F ++P
Sbjct: 248 C----------------QCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-58
Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 28/290 (9%)
Query: 84 NFRQECLIGEGGFGRVYKGKL----EKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSLLH 138
++ +IG G FG VYKG L K VA+K L + + +F+ E ++
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 139 HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLE 198
H N++ L G + + +++ EYM +L+ L + + + + G A G++
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMK 124
Query: 199 YLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGYCA 257
YL N ++RDL + NIL++ K+SDFGL++ L + T+ +S + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 258 PEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317
PE + T SDV++FG+V+ E++T + + +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPY----------------WELSNHEVMKA 225
Query: 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPD 367
+ + P+ + + C Q+E + RP +D+VS L L PD
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-58
Identities = 67/291 (23%), Positives = 111/291 (38%), Gaps = 39/291 (13%)
Query: 90 LIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQGNKE-FIVEVLMLS-LLHHDNL 142
+G G FG+V + A VAVK L + +E + E+ +LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 143 VNLIGYCADGEQRLLVYEYMPLRSLEDHL--------------LDIGPEQKPIDWFTRMK 188
VNL+G C G L++ EY L + L + ++ +D +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 189 IALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSR 248
+ AKG+ +L K I+RDL + NILL K+ DFGLA+ V
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 249 VMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF 308
+ APE T +SDV+++G+ L EL + + P +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---------- 256
Query: 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
+ ++ + P + + C + RP +V +
Sbjct: 257 -----FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-58
Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 11/243 (4%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN 141
K + + IG+G G VY T Q VA++Q++ + I E+L++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
+VN + G++ +V EY+ SL D + + +D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH 133
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
VI+RD+KS NILL + + KL+DFG I + S ++GT + APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVV 188
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYE-QNLVTWAQPFFKDPNRYPQLADP 320
K D+++ G++ +E+I G P + T P ++P + +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 321 LLQ 323
L
Sbjct: 249 FLN 251
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-58
Identities = 79/284 (27%), Positives = 113/284 (39%), Gaps = 29/284 (10%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGL---QGNKEFIVEVLMLSL 136
K+ R +G+G FG V +G+ + VAVK L + L + +FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 137 LHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
L H NL+ L G ++ V E PL SL D L Q T + A+ A+G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHV-SSRVMGTYGY 255
+ YL K I+RDL + N+LL K+ DFGL + P D +V + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315
CAPE +T + SD + FGV L E+ T + P N K+ R P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLP 235
Query: 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
+ P V C + RP + L
Sbjct: 236 R----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 3e-53
Identities = 62/289 (21%), Positives = 119/289 (41%), Gaps = 31/289 (10%)
Query: 83 KNFRQECLIGEGGFGRVYKGKL-----EKTAQVVAVKQLDRNGLQGNK-EFIVEVLMLSL 136
+ +G+G FG VY+G ++ VA+K ++ + EF+ E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 137 LHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHL------LDIGPEQKPIDWFTRMKIA 190
+ ++V L+G + G+ L++ E M L+ +L + P P +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 191 LGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVM 250
A G+ YL+ ++RDL + N ++ +F K+ DFG+ + D + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 251 GTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310
+ +PE + G T SDV++FGVVL E+ T +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
P+ P + L++ MC Q +RP +++S++
Sbjct: 257 PDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-53
Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 38/299 (12%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGLQG-NKEFIVEV-LMLSL 136
+ +G G FG+V + T + VAVK L ++ + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 137 LHHDNLVNLIGYCA-DGEQRLLVYEYMPLRSLEDHLLDIGPE------------QKPIDW 183
HH N+VNL+G C G +++ E+ +L +L E + +
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 184 FTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT 243
+ + AKG+E+L + I+RDL + NILL + K+ DFGLA+
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 244 HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTW 303
+ APE T++SDV++FGV+L E+ + P +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEE 245
Query: 304 AQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362
K+ R P + C E S RP S++V L L
Sbjct: 246 FCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 9e-53
Identities = 65/278 (23%), Positives = 110/278 (39%), Gaps = 30/278 (10%)
Query: 90 LIGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGLQGNKE-FIVEVLMLSLLHHDNLVNL 145
IGEG FG V++G E A VA+K +E F+ E L + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 146 IGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN 205
IG + ++ E L L L + +D + + A + L YL K
Sbjct: 74 IGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 206 PPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQ 265
++RD+ + N+L+ KL DFGL++ + +S+ + APE +
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRR 185
Query: 266 LTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQG 324
T SDV+ FGV + E++ G + + + + PN P L + +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK- 244
Query: 325 EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362
C + S RP +++ + LS +
Sbjct: 245 ----------------CWAYDPSRRPRFTELKAQLSTI 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-52
Identities = 54/243 (22%), Positives = 97/243 (39%), Gaps = 12/243 (4%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHD 140
+F+ ++GEG F V + T++ A+K L++ + E ++S L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
V L D E+ Y L ++ IG F A+ + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-------FDETCTRFYTAEIVSAL 121
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
+I+RDLK NILL+ + + +++DFG AK+ K ++ +GT Y +PE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 261 QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320
SD++ G ++ +L+ G + + F P ++ A
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--PEKFFPKARD 239
Query: 321 LLQ 323
L++
Sbjct: 240 LVE 242
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-51
Identities = 70/298 (23%), Positives = 115/298 (38%), Gaps = 40/298 (13%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKT-------AQVVAVKQLDRNGLQGN-KEFIVEV-LML 134
+GEG FG+V + VAVK L + + + + I E+ +M
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 135 SLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGP------------EQKPID 182
+ H N++NL+G C ++ EY +L ++L P ++ +
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 183 WFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242
+ A A+G+EYL K I+RDL + N+L+ + K++DFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT 302
++ + APE T +SDV++FGV+L E+ T Y V
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------GSPYPGVPVE 244
Query: 303 WAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
K+ +R P N+ + C S RP +V L
Sbjct: 245 ELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (433), Expect = 4e-50
Identities = 50/244 (20%), Positives = 92/244 (37%), Gaps = 13/244 (5%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV 143
++ +G G FG V++ T A K + + E+ +S+L H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
NL D + +++YE+M L + + D E + ++ KGL ++H+
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 204 ANPPVIYRDLKSSNILLDCEFN--AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
++ DLK NI+ + + KL DFGL D GT + APE
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVA 197
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRR--AIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319
+ +D+++ GV+ L++G + T + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 320 PLLQ 323
++
Sbjct: 258 DFIR 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 3e-49
Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 19/249 (7%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLH-- 138
+F +IG GGFG VY + T ++ A+K LD+ + QG + E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 139 -HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197
+V + ++ + + M L HL + A GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGL 120
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCA 257
E++H++ V+YRDLK +NILLD + ++SD GLA +GT+GY A
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMA 173
Query: 258 PEYQRTGQ-LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF-FKDPNRYP 315
PE + G +D ++ G +L +L+ G + + + + P+ +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 316 QLADPLLQG 324
LL+G
Sbjct: 234 PELRSLLEG 242
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (417), Expect = 2e-48
Identities = 58/252 (23%), Positives = 107/252 (42%), Gaps = 17/252 (6%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN---KEFIVEVLMLSLLH 138
+ + ++G GG V+ + + + VAVK L + + F E + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 139 HDNLVNLIGYCAD----GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA 194
H +V + G +V EY+ +L D + GP + +++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTY 253
+ L + H +I+RD+K +NI++ K+ DFG+A+ + G+ ++ V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 254 GYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAI--DTTRPTYEQNLVTWAQPFFKDP 311
Y +PE R + +SDVY+ G VL E++TG D+ Q++ P
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238
Query: 312 NRYPQLADPLLQ 323
D ++
Sbjct: 239 EGLSADLDAVVL 250
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (422), Expect = 2e-48
Identities = 44/206 (21%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV 143
+ +G G FG V++ + T +V K ++ E+ +++ LHH L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 144 NLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
NL D + +L+ E++ L D + E + + A +GL+++H+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 204 ANPPVIYRDLKSSNILLDCEFNA--KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
+++ D+K NI+ + + + K+ DFGLA + T + APE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIV 200
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRR 287
+ +D++ GV+ L++G
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS 226
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 8e-48
Identities = 68/245 (27%), Positives = 110/245 (44%), Gaps = 15/245 (6%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSL-LHH 139
+F ++G+G FG+V+ + +KT Q A+K L ++ + + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
L ++ E V EY+ L H+ D A GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQF 118
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259
LH K ++YRDLK NILLD + + K++DFG+ K +GD + GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319
+ D ++FGV+L E++ G+ + + PF+ P + A
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--PRWLEKEAK 231
Query: 320 PLLQG 324
LL
Sbjct: 232 DLLVK 236
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (413), Expect = 1e-47
Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 17/245 (6%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHH 139
++F+ +G G FGRV+ + + A+K L + + K+ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
++ + G D +Q ++ +Y+ L + + + A LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259
LH K +IYRDLK NILLD + K++DFG AK P T GT Y APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPE 171
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319
T D ++FG+++ E++ G + + A+ F P + +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFNEDVK 229
Query: 320 PLLQG 324
LL
Sbjct: 230 DLLSR 234
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 7e-47
Identities = 52/253 (20%), Positives = 98/253 (38%), Gaps = 10/253 (3%)
Query: 75 FRELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-FIVEVLM 133
+++ + ++G G F V + ++T ++VA+K + + L+G + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 134 LSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGA 193
L + H N+V L G L+ + + L D ++ E+ ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQV 116
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
++YLHD + LD + +SDFGL+K+ D V S GT
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTP 173
Query: 254 GYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAI--DTTRPTYEQNLVTWAQPFFKDP 311
GY APE + D ++ GV+ L+ G + +EQ L +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233
Query: 312 NRYPQLADPLLQG 324
+ A ++
Sbjct: 234 DDISDSAKDFIRH 246
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-46
Identities = 37/236 (15%), Positives = 96/236 (40%), Gaps = 13/236 (5%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYC 149
+G G FG V++ + + K + G E+ +L++ H N+++L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 150 ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVI 209
E+ ++++E++ + + + ++ + + L++LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 210 YRDLKSSNILLDCEFNA--KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLT 267
+ D++ NI+ ++ K+ +FG A+ GD + + Y APE + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVS 181
Query: 268 VKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLLQ 323
+D+++ G ++ L++G + A+ F D + +++ +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-DEEAFKEISIEAMD 236
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (400), Expect = 4e-46
Identities = 58/258 (22%), Positives = 99/258 (38%), Gaps = 28/258 (10%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---------QGNKEFIVEV-LM 133
N+ + ++G G V + + T + AVK +D G + + + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 134 LSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGA 193
+ H N++ L LV++ M L D+L E+ + KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRAL 119
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTY 253
+ + LH +++RDLK NILLD + N KL+DFG + D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTP 173
Query: 254 GYCAPEYQRTGQL------TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPF 307
Y APE + D+++ GV++ L+ G + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 308 FKDP--NRYPQLADPLLQ 323
F P + Y L+
Sbjct: 234 FGSPEWDDYSDTVKDLVS 251
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-44
Identities = 71/305 (23%), Positives = 119/305 (39%), Gaps = 27/305 (8%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE-----FIVEVLMLSLLHHDNLVN 144
+GEG F VYK + + T Q+VA+K++ K+ + E+ +L L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 145 LIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
L+ LV+++M D + I + L +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 205 NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTG 264
+++RDLK +N+LLD KL+DFGLAK G + + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 265 QL-TVKSDVYTFGVVLLELITGRRAI--DTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321
++ V D++ G +L EL+ + D+ + T P + L D +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 322 LQGEFPVRGLN--------QAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDA-DTAT 372
FP L+ + + R + + + + + P
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL-KMKYFSNRPGPTPGCQ 294
Query: 373 APVPH 377
P P+
Sbjct: 295 LPRPN 299
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 8e-44
Identities = 56/260 (21%), Positives = 101/260 (38%), Gaps = 31/260 (11%)
Query: 85 FRQECL---------IGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN------KEFIV 129
FRQE + +G G F V K + + T A K + + + + ++
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 130 EVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKI 189
EV +L + H N++ L + +L+ E + L D E++ + +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVA----GGELFDFLAEKESLTEEEATEF 118
Query: 190 ALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE----FNAKLSDFGLAKLGPIGDKTHV 245
G+ YLH + + DLK NI+L K+ DFGLA G++
Sbjct: 119 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 174
Query: 246 SSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305
+ GT + APE L +++D+++ GV+ L++G V+
Sbjct: 175 --NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232
Query: 306 PFFKD--PNRYPQLADPLLQ 323
F+D + LA ++
Sbjct: 233 YEFEDEYFSNTSALAKDFIR 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (379), Expect = 7e-43
Identities = 47/289 (16%), Positives = 88/289 (30%), Gaps = 30/289 (10%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLL-HHDN 141
+++ IGEG FG +++G Q VA+K R + E LL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
+ N+ + +G +LV + + + + T A ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 202 DKANPPVIYRDLKSSNILLD-----CEFNAKLSDFGLAKLGPIGD-----KTHVSSRVMG 251
+K ++YRD+K N L+ + DFG+ K + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 252 TYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311
T Y + + + + D+ G V + + G + T Q + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA------ATNKQKYERIG 229
Query: 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360
+ L FP + P + S
Sbjct: 230 EKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-42
Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 7/208 (3%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN-KEFIVEVLMLSLLHHD 140
+ IGEG +G V VA+K++ Q + + E+ +L H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
N++ + + Y+ + L + + + + +GL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL-LKTQHLSNDHICYFLYQILRGLKYI 125
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK-LGPIGDKTHVSSRVMGTYGYCAPE 259
H V++RDLK SN+LL+ + K+ DFGLA+ P D T + + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 260 YQRTGQLTVKS-DVYTFGVVLLELITGR 286
+ KS D+++ G +L E+++ R
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 1e-42
Identities = 51/284 (17%), Positives = 95/284 (33%), Gaps = 28/284 (9%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVN 144
+R IG G FG +Y G + VA+K + + +E + ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66
Query: 145 LIGYC-ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDK 203
I +C A+G+ ++V E + + T + +A +EY+H K
Sbjct: 67 TIRWCGAEGDYNVMVMELLG----PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 204 ANPPVIYRDLKSSNIL---LDCEFNAKLSDFGLAKLGPIGD-----KTHVSSRVMGTYGY 255
I+RD+K N L + DFGLAK + + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 256 CAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315
+ + + + D+ + G VL+ G + T Q + + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA------ATKRQKYERISEKKM 233
Query: 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359
+L +P ++ C +P S +
Sbjct: 234 STPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 1e-42
Identities = 60/292 (20%), Positives = 103/292 (35%), Gaps = 23/292 (7%)
Query: 81 ATKNFRQECLIGEGGFGRVYKGKLEKTA-QVVAVKQLDRNGLQGN--KEFIVEVLMLSLL 137
A + + IGEG +G+V+K + K + VA+K++ + I EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 138 ---HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLD--IGPEQKPIDWFTRMKIALG 192
H N+V L C + ++ L + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 193 AAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGT 252
+GL++LH V++RDLK NIL+ KL+DFGLA+ I + V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVT 178
Query: 253 YGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRP--TYEQNLVTWAQPFFKD 310
Y APE D+++ G + E+ + + + L P +D
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAM-------CVQEESSVRPLMSDV 355
R L + + + C+ + R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-42
Identities = 57/281 (20%), Positives = 105/281 (37%), Gaps = 44/281 (15%)
Query: 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE------FIVEVLMLSLLH 138
++ L+G GGFG VY G VA+K ++++ + E +EV++L +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 139 --HDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKG 196
++ L+ + + +L+ E + E+ + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEA 122
Query: 197 LEYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGY 255
+ + H+ V++RD+K NIL+D KL DFG L K V + GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVY 175
Query: 256 CAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314
PE+ R + + V++ G++L +++ G P + Q FF R
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFF--RQRV 227
Query: 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDV 355
L++ C+ S RP ++
Sbjct: 228 SSECQHLIRW----------------CLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-41
Identities = 62/244 (25%), Positives = 98/244 (40%), Gaps = 18/244 (7%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHH 139
+F L+G+G FG+V + + T + A+K L + + E + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
L L ++ V EY L HL FT + A+ +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFYGAEIVSA 117
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259
L + V+YRD+K N++LD + + K++DFGL K G T GT Y APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPE 175
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319
D + GVV+ E++ GR P Y Q+ + + R+P+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFPRTLS 229
Query: 320 PLLQ 323
P +
Sbjct: 230 PEAK 233
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-41
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 17/211 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV 143
++ +IG G FG VY+ KL + ++VA+K++ ++ + E+ ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 144 NLIGYCADGEQR------LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197
L + ++ LV +Y+P ++ + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 198 EYLHDKANPPVIYRDLKSSNILLDCE-FNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
Y+H + +RD+K N+LLD + KL DFG AK + S + Y
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRA 190
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELITGRR 287
T DV++ G VL EL+ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-41
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 9/206 (4%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDN 141
NF++ IGEG +G VYK + + T +VVA+K++ + I E+ +L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
+V L+ + LV+E++ + I +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
V++RDLK N+L++ E KL+DFGLA+ + +T+ + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILL 175
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRR 287
+ D+++ G + E++T R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-41
Identities = 57/340 (16%), Positives = 118/340 (34%), Gaps = 51/340 (15%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEV-LMLSLLHHDNLVNLIGY 148
++G G G+V + ++T + A+K L + EV L ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 149 C----ADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA 204
A + L+V E + L + D G + +I + ++YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 205 NPPVIYRDLKSSNILLDCEFN---AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
+ +RD+K N+L + KL+DFG AK + T Y APE
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRR------AIDTTRPTYEQNLVTWAQPFFKDPNRYP 315
+ D+++ GV++ L+ G + + + + + + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSDPDADTATAPV 375
+ L++ ++ E + R +++ ++ + S V
Sbjct: 246 EEVKMLIRN----------------LLKTEPTQRMTITEFMNHPWIMQS--------TKV 281
Query: 376 PHKPPPCDHQNMNMMDQNGYYQDEEKSQMERKRAVAEAIQ 415
P P ++ ++E S + R E I+
Sbjct: 282 PQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIK 321
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (358), Expect = 7e-40
Identities = 50/248 (20%), Positives = 99/248 (39%), Gaps = 11/248 (4%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQL--DRNGLQGNKEFIVEVLMLSLLHHDN 141
+ IGEG +G VYK + + A+K++ ++ I E+ +L L H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 142 LVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLH 201
+V L ++ +LV+E++ + + + ++ T L G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 202 DKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQ 261
D+ V++RDLK N+L++ E K++DFGLA+ I + + ++ +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173
Query: 262 RTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321
+ + + D+++ G + E++ G + + N P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 322 LQGEFPVR 329
F V
Sbjct: 234 YDPNFTVY 241
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-40
Identities = 52/247 (21%), Positives = 101/247 (40%), Gaps = 10/247 (4%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHD 140
+ + + IGEG +G V+K K +T ++VA+K++ + + E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
N+V L ++ LV+E+ +D +D KGL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
H + V++RDLK N+L++ KL++FGLA+ I + + S+ V+ +
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVL 173
Query: 261 QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320
+ D+++ G + EL R + +Q + ++P +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 321 LLQGEFP 327
+P
Sbjct: 234 PDYKPYP 240
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-38
Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 20/231 (8%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHHDN 141
+ + IG+G FG V+K + KT Q VA+K++ + + E+ +L LL H+N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 142 LVNLIGYCADGEQR--------LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGA 193
+VNLI C LV+++ + FT +I
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-------FTLSEIKRVM 123
Query: 194 AKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS--SRVMG 251
L L+ +++RD+K++N+L+ + KL+DFGLA+ + + + + +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 252 TYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV 301
T Y PE + D++ G ++ E+ T + ++ L+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 2e-38
Identities = 59/243 (24%), Positives = 94/243 (38%), Gaps = 17/243 (6%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKE---FIVEVLMLSLLHHD 140
F + +G G FGRV K +++ A+K LD+ + K+ + E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 141 NLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
LV L D +V EY+ + HL A EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 201 HDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEY 260
H +IYRDLK N+L+D + +++DFG AK T + GT APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 261 QRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320
+ D + GV++ E+ G +P + + F P+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSHFSSDLKD 267
Query: 321 LLQ 323
LL+
Sbjct: 268 LLR 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-37
Identities = 45/220 (20%), Positives = 88/220 (40%), Gaps = 13/220 (5%)
Query: 73 FTFRELATAT----KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KE 126
F +E+ +R +G G +G V +T VA+K+L R K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 127 FIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTR 186
E+ +L + H+N++ L+ E ++ + L + + +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 187 MKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVS 246
+ KGL Y+H +RDLK N+ ++ + K+ DFGLA+ + ++
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMT 176
Query: 247 SRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR 286
V+ + + T D+++ G ++ E+ITG+
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (324), Expect = 1e-34
Identities = 42/220 (19%), Positives = 88/220 (40%), Gaps = 21/220 (9%)
Query: 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEV-LMLSLLHHDNL 142
+++ +G G + V++ + V VK L K+ E+ ++ +L N+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNI 92
Query: 143 VNLIGYCADGEQRL--LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYL 200
+ L D R LV+E++ + + + + K L+Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 145
Query: 201 HDKANPPVIYRDLKSSNILLDCEFN-AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259
H +++RD+K N+++D E +L D+GLA+ G + + + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPE 199
Query: 260 YQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQ 298
Q+ D+++ G +L +I + Y+Q
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 7e-34
Identities = 62/253 (24%), Positives = 106/253 (41%), Gaps = 20/253 (7%)
Query: 83 KNFRQECLIGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGL----QGNKEFIVEVLMLS 135
+NF ++G G +G+V+ + T ++ A+K L + + + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 136 LL-HHDNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA 194
+ LV L + L+ +Y+ L HL +++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIV 139
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG 254
LE+LH +IYRD+K NILLD + L+DFGL+K + D+T + GT
Sbjct: 140 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 255 YCAPEYQRTGQ--LTVKSDVYTFGVVLLELITGRR--AIDTTRPTYEQNLVTWAQPFFKD 310
Y AP+ R G D ++ GV++ EL+TG +D + + + +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255
Query: 311 PNRYPQLADPLLQ 323
P LA L+Q
Sbjct: 256 PQEMSALAKDLIQ 268
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-32
Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 9/207 (4%)
Query: 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGN--KEFIVEVLMLSLLHH 139
+ ++ +G G +G V KT VAVK+L R K E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 140 DNLVNLIGYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEY 199
+N++ L+ + + L L+ + + + + +GL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 200 LHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPE 259
+H +RDLK SN+ ++ + K+ DFGLA+ + V +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEI 189
Query: 260 YQRTGQLTVKSDVYTFGVVLLELITGR 286
D+++ G ++ EL+TGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 8e-31
Identities = 53/262 (20%), Positives = 104/262 (39%), Gaps = 37/262 (14%)
Query: 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHD 140
K ++ IG G G V + VA+K+L R K E++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 141 NLVNLIGYCA------DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAA 194
N+++L+ + + LV E M + Q +D +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQML 129
Query: 195 KGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYG 254
G+++LH + +I+RDLK SNI++ + K+ DFGLA+ + + + + T
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRY 183
Query: 255 YCAPEYQRTGQLTVKSDVYTFGVVLLELITGR----------------RAIDTTRPTYEQ 298
Y APE D+++ G ++ E++ + + T P + +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 299 NLVTWAQPFFKDPNRYPQLADP 320
L + + ++ +Y L P
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFP 265
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 2e-29
Identities = 40/210 (19%), Positives = 79/210 (37%), Gaps = 16/210 (7%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYC 149
+G G F V+ K VA+K + + + + E+ +L ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 150 ADGEQRLLVYEY------------MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGL 197
A+ +LL + + L E + I +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 198 EYLHDKANPPVIYRDLKSSNILLD-CEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYC 256
+Y+H + +I+ D+K N+L++ + L +A LG + + T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 257 APEYQRTGQLTVKSDVYTFGVVLLELITGR 286
+PE +D+++ ++ ELITG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.2 bits (197), Expect = 3e-18
Identities = 24/160 (15%), Positives = 46/160 (28%), Gaps = 30/160 (18%)
Query: 90 LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL----------QGNKEFIVEVLMLSLLHH 139
L+GEG V+ E VK G+ F V + +
Sbjct: 7 LMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 140 DNLVNLIGYCA----DGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAK 195
L L G E ++ E + E + ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELID-----------AKELYRVRVENPDEVLDMILE 114
Query: 196 GLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235
+ + + +++ DL N+L+ E + DF +
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 427 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.88 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.43 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.99 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-58 Score=425.29 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=211.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 3679999999999999999999999999999999976533 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999985 3457999999999999999999999999 999999999999999999999999999875444
Q ss_pred CccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ .... .... ....
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~----~~~~-~~~~---- 226 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD----WKEK-KTYL---- 226 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHH----HHTT-CTTS----
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHH----HhcC-CCCC----
Confidence 44444556789999999999988776 5789999999999999999999975432211 1111 1111 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.........+.+|+.+||+.||++|||+.|++++-+.
T Consensus 227 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 227 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred -----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 0112234578899999999999999999999887654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-57 Score=422.53 Aligned_cols=254 Identities=25% Similarity=0.330 Sum_probs=214.8
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+++.++|||||+++++|.+.+..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+++.....
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-- 169 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--
Confidence 99999998754 35899999999999999999999999 999999999999999999999999999864322
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...... ........... +.+
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~--~~~----- 236 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT--PEL----- 236 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS--CCC-----
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCC--CCC-----
Confidence 22345578999999999999999999999999999999999999999754321 11111111100 000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+......+.+++.+||+.||.+|||+.|++++-+.
T Consensus 237 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred --CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 1123345678899999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-57 Score=415.39 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=211.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999986532 234467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999998653 46899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~------ 222 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFT------ 222 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC------
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCC------
Confidence 2 234568999999999999999999999999999999999999999754321 111222221111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
++...+..+.+++.+||+.||++|||+.|++++-+.
T Consensus 223 ------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 223 ------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred ------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 122334678899999999999999999999987543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-57 Score=422.03 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=213.4
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
+.|++.+.||+|+||+||+|+++.+|..||||++........+.+.+|+.++++++|||||++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56999999999999999999999999999999998776677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++|+|.+++.+. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+... ..
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~--~~ 163 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RT 163 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH--HH
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC--CC
Confidence 999999987653 356999999999999999999999999 9999999999999999999999999997522 11
Q ss_pred cceeccccccccccCccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 243 THVSSRVMGTYGYCAPEYQR-----TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.......+||+.|+|||++. +..|+.++|||||||++|||++|+.||....+.. ......... .+.+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~--~~~~ 235 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSE--PPTL 235 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSC--CCCC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCC--CCCC
Confidence 12234578999999999984 4568999999999999999999999997654321 111112111 0111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..+...+..+.+|+.+||+.||++|||+.|++++-+
T Consensus 236 -------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 236 -------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp -------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred -------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 112334568899999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-57 Score=420.65 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=208.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.++++++||||++++++|.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999996532 234467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999988653 46899999999999999999999999 99999999999999999999999999987544
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
..........+||+.|+|||++.+..|+.++|||||||++|||++|+.||....+. .....+......
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~------ 228 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKIIKLEYD------ 228 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTCCC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHHcCCCC------
Confidence 44444445678999999999999999999999999999999999999999754321 112222222111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
++......+.+||.+||+.||++|||+.|++++.+
T Consensus 229 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 229 ------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 12223457889999999999999999999765543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=418.05 Aligned_cols=261 Identities=30% Similarity=0.459 Sum_probs=205.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC--CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG--LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
.++|++.+.||+|+||+||+|++++ .||||+++... ....+.|.+|+.++++++|||||++++++.+ +..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 4679999999999999999998753 49999986543 3345678999999999999999999998765 5689999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999975 3356999999999999999999999999 99999999999999999999999999987544
Q ss_pred CCccceeccccccccccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT---GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
...........||+.|+|||++.+ ..|+.++|||||||++|||+||+.||....+... +... .......+.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~----~~~~~~~p~ 230 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFM----VGRGYLSPD 230 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHH----HHHTSCCCC
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHH----HhcCCCCCc
Confidence 444444556789999999999864 3589999999999999999999999976533211 1111 111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
+. ..+..++..+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus 231 ~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 LS------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GG------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ch------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 10 1122344688999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-57 Score=423.97 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=216.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.+. ...+.+.+|+.+|++++|||||+++++|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 467999999999999999999999999999999997653 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.... .
T Consensus 95 ~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~-~ 168 (287)
T d1opja_ 95 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-D 168 (287)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS-S
T ss_pred ccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC-C
Confidence 9999999998763 3467899999999999999999999999 99999999999999999999999999986433 2
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.........||+.|+|||++.++.|+.++|||||||++|||++|..||...... ..+. ........
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~----~~i~~~~~-------- 234 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVY----ELLEKDYR-------- 234 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH----HHHHTTCC--------
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHH----HHHhcCCC--------
Confidence 233344566899999999999999999999999999999999987776433221 1111 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+...+..+.+|+..||+.||++|||+.+|++.|+.+.
T Consensus 235 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1223334568899999999999999999999999998654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-57 Score=416.95 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=201.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEc--CCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCAD--GEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 157 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.++++++|||||++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36799999999999999999999999999999999766433 23568899999999999999999999975 456899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA--NPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
|||||++|+|.+++.........+++..++.++.||+.||.|||+++ ..+|+||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998765445678999999999999999999999864 1249999999999999999999999999998
Q ss_pred cCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 236 LGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
.... ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... +....+... ...
T Consensus 163 ~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~~~--~~~ 232 (269)
T d2java1 163 ILNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREG--KFR 232 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHT--CCC
T ss_pred eccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHHcC--CCC
Confidence 7432 222344578999999999999999999999999999999999999999754321 111111111 111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSAL 359 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 359 (427)
..+...+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 233 ---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 233 ---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 11223346789999999999999999999998763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=412.45 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=200.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
++|++.+.||+|+||+||+|++++ +..||||+++... ...+++.+|+.++++++|||||+++++|.+.+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 579999999999999999999874 6789999997643 45578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 99999999865 3466899999999999999999999999 9999999999999999999999999998643322
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
........||+.|+|||++.+..|+.++|||||||++|||+|+..|+...... ..+.. .... ...
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~---~i~~-~~~--------- 220 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVE---DIST-GFR--------- 220 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHH---HHHH-TCC---------
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHH---HHHh-cCC---------
Confidence 22234467999999999999999999999999999999999965444322111 11111 1111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
...+..++..+.+++..||+.||++|||+++|+++|+.+.
T Consensus 221 -~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 221 -LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 0112233467899999999999999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.4e-55 Score=418.17 Aligned_cols=257 Identities=19% Similarity=0.207 Sum_probs=214.8
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|++|+|||||++++++.+.+.+++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999876655667788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC--CCCCeeEeecCCcccCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD--CEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~vkl~DFG~a~~~~~ 239 (427)
|++|+|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999998854 3456999999999999999999999999 99999999999995 467899999999986432
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.......+..
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~-- 247 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWNMDDS-- 247 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCSCCG--
T ss_pred c---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCCcc--
Confidence 2 234457899999999999999999999999999999999999999975422 11222222211111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.....+..+.+|+.+||+.||++|||+.|++++-+.
T Consensus 248 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~ 283 (350)
T d1koaa2 248 ------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283 (350)
T ss_dssp ------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTT
T ss_pred ------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 112234578899999999999999999999998554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-56 Score=419.64 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=201.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCc---EEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQ---VVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
++|++.++||+|+||+||+|+++.+|+ .||||.+..... ...+.|.+|+.+|++++|||||+++++|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568888999999999999999986654 689998865433 3346789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
||||++|+|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998865 3456999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccc---eeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCC
Q 042519 239 IGDKTH---VSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRY 314 (427)
Q Consensus 239 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (427)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+... .......
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~----i~~~~~~ 252 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINA----IEQDYRL 252 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHTTCCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC
Confidence 322211 1223468999999999999999999999999999999998 89999764322 11111 1111111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 315 PQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+..++..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 253 ----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 253 ----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1233455688999999999999999999999999987654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-56 Score=422.22 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=211.3
Q ss_pred hhCccccceeccCCceEEEEEEECCCCc-----EEEEEEeccCC-CcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQ-----VVAVKQLDRNG-LQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 154 (427)
.++|++.++||+|+||+||+|++..+++ .||+|.+.... ......+.+|+.++.++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3679999999999999999999876543 69999986543 33446788999999998 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCC
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGP-------------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKS 215 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 215 (427)
.++|||||++|+|.++|..... ....+++..++.++.||+.||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999976432 1245899999999999999999999999 99999999
Q ss_pred CceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCC
Q 042519 216 SNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRP 294 (427)
Q Consensus 216 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~ 294 (427)
+|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++ |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987544444444556779999999999999999999999999999999997 8999975432
Q ss_pred cccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 295 TYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
. ..+. ......... ..+..++..+.+|+.+||+.||++|||+.||+++|.
T Consensus 273 ~--~~~~----~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D--ANFY----KLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S--HHHH----HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HHHH----HHHhcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 1111 112221111 123344568899999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-56 Score=421.26 Aligned_cols=267 Identities=22% Similarity=0.272 Sum_probs=209.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||+||+|+++.+|+.||+|+++.... .....+.+|+.+|+.++|||||+++++|.+.+.+++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5789999999999999999999999999999999976533 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+ ++ |+||||||+||||+.+|.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999753 458999999999999999999997 48 99999999999999999999999999985321
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC----
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP---- 315 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 315 (427)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........+.. +...........+
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDAAETPPRPR 231 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH--C----------------
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHHHhcCCcccCCcccc
Confidence 223457899999999999999999999999999999999999999976432211000 0000000000000
Q ss_pred --------------------cccccccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 316 --------------------QLADPLLQG----EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 316 --------------------~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+..+..... ........++.+++.+||+.||.+|||+.|+++|-+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 000000000 0011123578899999999999999999999997543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-55 Score=413.58 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=197.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc-hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG-NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
.+.|++.+.||+|+||+||+|+++.+|+.||||++.+..... ...+.+|+.+++.++|||||++++++.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999999999999999997654332 3457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC---CCCCeeEeecCCcccC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD---CEFNAKLSDFGLAKLG 237 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~vkl~DFG~a~~~ 237 (427)
||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. .++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999964 457999999999999999999999999 99999999999994 5789999999999863
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .....+.......+
T Consensus 161 ~~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-- 229 (307)
T d1a06a_ 161 DP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAEYEFD-- 229 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTCCCCC--
T ss_pred cC---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccCCCCC--
Confidence 32 22334578999999999999999999999999999999999999999753321 11112222111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.......+..+.+++.+||+.||++|||+.|++++-+.
T Consensus 230 ------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 230 ------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp ------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred ------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 11122334678899999999999999999999998543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-54 Score=417.81 Aligned_cols=257 Identities=19% Similarity=0.227 Sum_probs=214.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.........+.+|+.+|++|+|||||+++++|.+++.+||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999876555566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC--CCCCeeEeecCCcccCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD--CEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~vkl~DFG~a~~~~~ 239 (427)
|++|+|.+++.. ...++++..++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999887754 3456999999999999999999999999 99999999999997 678999999999987433
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+......++.
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~~--- 249 (352)
T d1koba_ 182 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDWEFDE--- 249 (352)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCCCCCS---
T ss_pred C---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCc---
Confidence 2 2345578999999999999999999999999999999999999999754321 112222221111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
......+..+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 250 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~ 286 (352)
T d1koba_ 250 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286 (352)
T ss_dssp -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 1112334678899999999999999999999998543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=407.98 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=201.8
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc----CCeeEEE
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD----GEQRLLV 158 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 158 (427)
|++.+.||+|+||+||+|+++.++..||+|.+..... ...+.+.+|+.++++++|||||+++++|.+ ...+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4677889999999999999999999999999876432 234568899999999999999999999865 4567999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC-CCCCeeEeecCCcccC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD-CEFNAKLSDFGLAKLG 237 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~vkl~DFG~a~~~ 237 (427)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ .+|+||||||+||||+ .++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999999653 46899999999999999999999875 4499999999999996 5789999999999863
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQL 317 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (427)
.. ......+||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ......... .. .+..
T Consensus 166 ~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~i~~-~~-~~~~ 233 (270)
T d1t4ha_ 166 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTS-GV-KPAS 233 (270)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTT-TC-CCGG
T ss_pred cC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHHHHc-CC-CCcc
Confidence 22 12345789999999999875 6999999999999999999999999754321 111111111 11 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 318 ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
++......+.+++.+||+.||++|||+.|++++-+
T Consensus 234 --------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 234 --------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp --------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred --------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 11122346889999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=404.99 Aligned_cols=256 Identities=20% Similarity=0.228 Sum_probs=212.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC------cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL------QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||++++... ...+.+.+|+.+|++++|||||+++++|.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999999999999999975432 2346789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC----CeeEeec
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF----NAKLSDF 231 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~vkl~DF 231 (427)
+||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 9999999999999998653 46999999999999999999999999 99999999999998776 4999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP 311 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 311 (427)
|++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....
T Consensus 162 G~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVN 232 (293)
T ss_dssp TTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTC
T ss_pred hhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHHHhcC
Confidence 999864322 2334567999999999999999999999999999999999999999754321 1111111111
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...+.. .+...+..+.+|+.+||+.||++|||+.|++++-+.
T Consensus 233 ~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 233 YEFEDE--------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp CCCCHH--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCCch--------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 111110 011234578899999999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-55 Score=415.32 Aligned_cols=251 Identities=28% Similarity=0.357 Sum_probs=207.4
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
..|+..+.||+|+||+||+|++..+|+.||||++....... .+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999999999999999997654433 245788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
|||.+|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999998766543 356999999999999999999999999 99999999999999999999999999986322
Q ss_pred CCccceeccccccccccCcccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRT---GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
....+||+.|+|||++.+ +.|+.++|||||||++|||++|+.||...... .......... .+.
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~--~~~ 233 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE--SPA 233 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC--CCC
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC--CCC
Confidence 234679999999999864 46899999999999999999999999754321 1111111111 111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
+. +...+..+.+|+.+||+.||++|||+.|++++-+..
T Consensus 234 ~~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 234 LQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp CS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CC--------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence 11 112345788999999999999999999999976543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=407.26 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=207.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||+||+|++++ +..||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 4679999999999999999999874 7789999997643 445779999999999999999999998865 567999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++|+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 89 ~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~- 162 (272)
T d1qpca_ 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN- 162 (272)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS-
T ss_pred CCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC-
Confidence 9999999987542 2345899999999999999999999999 999999999999999999999999999875332
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
.........||+.|+|||++.++.++.++|||||||++|||+||..|+...... ..+.. . .......
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~---~-i~~~~~~------- 229 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQ---N-LERGYRM------- 229 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH---H-HHTTCCC-------
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHH---H-HHhcCCC-------
Confidence 223344567999999999999999999999999999999999976655432211 11111 1 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 230 ---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 ---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11223446789999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=411.77 Aligned_cols=255 Identities=25% Similarity=0.288 Sum_probs=215.2
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 158 (427)
.++|++.++||+|+||+||+|+++.+|+.||||++++.. ......+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999999999999999997542 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999999998753 46899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .............+
T Consensus 157 ~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~~~~~~~---- 224 (337)
T d1o6la_ 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEIRF---- 224 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC----
T ss_pred cC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHhcCCCCC----
Confidence 22 2234567899999999999999999999999999999999999999976432 12222222222222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhcC
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFLG 363 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~~ 363 (427)
|......+.+||..||+.||.+||+ +.++++|-+...
T Consensus 225 --------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 225 --------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred --------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 2233457889999999999999995 899999866543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-55 Score=409.30 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=204.1
Q ss_pred hCccccceeccCCceEEEEEEECCCC----cEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTA----QVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
+.|++.++||+|+||+||+|.++.++ ..||||++...... ....+.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 56889999999999999999987654 47999999654333 23468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+.+++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999988765 3457999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCc-cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDK-THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
..... ........||+.|+|||++.++.++.++|||||||++|||++|..|+...... ..+.. ...++..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~----~i~~~~~--- 231 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMK----AINDGFR--- 231 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH----HHHTTCC---
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHH----HHhccCC---
Confidence 33221 22234457899999999999999999999999999999999976665433211 11111 1121111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGSD 365 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 365 (427)
...+..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 232 -------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 122333456789999999999999999999999999876553
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-55 Score=400.83 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=212.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeec
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYM 162 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 162 (427)
++|++.+.||+|+||+||+|+++ ++..||||++++... ..+++.+|+.++++++||||++++++|.+.+..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57999999999999999999986 578899999976543 4578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 154 (258)
T d1k2pa_ 82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 154 (258)
T ss_dssp TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-
T ss_pred CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC-
Confidence 99999998765 3456889999999999999999999999 9999999999999999999999999998643322
Q ss_pred cceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 243 THVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +....+ ......
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~~~~i-~~~~~~------- 220 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHI-AQGLRL------- 220 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHH-HTTCCC-------
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------HHHHHH-HhCCCC-------
Confidence 223345679999999999999999999999999999999998 89999765322 111111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..|...+..+.+++.+||+.||++|||+.+++++|..
T Consensus 221 ---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 ---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1122334688999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-55 Score=406.59 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=208.6
Q ss_pred hhCccccce-eccCCceEEEEEEECC--CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECL-IGEGGFGRVYKGKLEK--TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~-Lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|.+.++ ||+|+||+||+|.++. ++..||||+++.... ...+.+.+|+.+|++++|||||++++++.+ +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 356778775 9999999999998754 455899999976533 334678999999999999999999999975 46899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999998754 3457999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 238 PIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 238 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
...... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+.. .+..+...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~----~i~~~~~~- 231 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRM- 231 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH----HHHTTCCC-
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC-
Confidence 433322 22344678999999999999999999999999999999998 99999764322 1111 11211111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 232 ---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 232 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22334557889999999999999999999999988643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-53 Score=404.56 Aligned_cols=250 Identities=27% Similarity=0.360 Sum_probs=211.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||+||+|+++.+|+.||||++++.. ....+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 67999999999999999999999999999999996532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+.||+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999988864 345788888999999999999999999 99999999999999999999999999987432
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... .............+
T Consensus 157 -----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~~~----- 220 (316)
T d1fota_ 157 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELRF----- 220 (316)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCCC-----
T ss_pred -----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCCCCC-----
Confidence 23457899999999999999999999999999999999999999975432 12222222222111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhc
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFL 362 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~ 362 (427)
+...+..+.+++.+||+.||.+|+ +++++++|-+.-
T Consensus 221 -------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~ 261 (316)
T d1fota_ 221 -------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261 (316)
T ss_dssp -------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred -------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccc
Confidence 222345788999999999999996 899999986543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=401.29 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=198.6
Q ss_pred ceeccCCceEEEEEEEC--CCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEeecCC
Q 042519 89 CLIGEGGFGRVYKGKLE--KTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEYMPL 164 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 164 (427)
+.||+|+||+||+|.++ .+++.||||+++.... ...+.+.+|+.++++++|||||+++++|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 4567899999965432 234678999999999999999999999975 457899999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCcc-
Q 042519 165 RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDKT- 243 (427)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~- 243 (427)
|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999864 356899999999999999999999999 999999999999999999999999999864333222
Q ss_pred ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccccc
Q 042519 244 HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPLL 322 (427)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (427)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. .+..+...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~----~i~~~~~~-------- 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGERM-------- 229 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCC--------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHH----HHHcCCCC--------
Confidence 22344679999999999999999999999999999999998 89999764321 1111 11211111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 323 QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
..+..++..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 230 --~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1233345688999999999999999999999888753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-54 Score=407.07 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=205.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCc----EEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQ----VVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.+|++.++||+|+||+||+|.+..+|+ .||+|.++... ....+.+.+|+.++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999988776 58888886532 34567899999999999999999999999875 4678
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
++||+.+|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998876 4567999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
.............||+.|+|||++.++.|+.++|||||||++|||+| |..||....... +.. ....+...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~~~-- 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL-- 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTCCC--
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCC--
Confidence 54444444455679999999999999999999999999999999998 788887543221 111 11111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+..++..+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus 233 --------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1223345678999999999999999999999999987754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=398.77 Aligned_cols=256 Identities=15% Similarity=0.213 Sum_probs=211.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+|+.++|||||+++++|.+.+.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999999999999999997653 3345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCC--CCeeEeecCCcccCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCE--FNAKLSDFGLAKLGPI 239 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~vkl~DFG~a~~~~~ 239 (427)
|+||+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999864 2346899999999999999999999999 9999999999999854 4799999999986432
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
. .......||+.|+|||.+.+..|+.++|||||||++|+|++|..||...... .....+......++....
T Consensus 157 ~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~ 227 (321)
T d1tkia_ 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFDEEAF 227 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCCHHHH
T ss_pred C---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCChhhc
Confidence 2 2344567999999999999999999999999999999999999999764321 122222222111111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
......+.+|+..||+.||++|||+.|++++-+.
T Consensus 228 --------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 228 --------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp --------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred --------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 1123568899999999999999999999997654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=397.81 Aligned_cols=258 Identities=27% Similarity=0.381 Sum_probs=204.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.++|++.+.||+|+||+||+|+++++ ..||||+++... ...+.|.+|+.++++++|||||+++++|.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 36799999999999999999999864 569999996553 455789999999999999999999999865 567999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+++|+|..++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++......
T Consensus 93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999888653 2346899999999999999999999999 9999999999999999999999999998643222
Q ss_pred ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccccc
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADPL 321 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (427)
........||+.|+|||++..+.++.++|||||||++|||++|..|+...... ..+... + ......
T Consensus 168 -~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~---i-~~~~~~------- 233 (285)
T d1fmka3 168 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ---V-ERGYRM------- 233 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH---H-HTTCCC-------
T ss_pred -ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHH---H-HhcCCC-------
Confidence 22334567999999999999999999999999999999999977766543221 111111 1 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 322 LQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 322 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+..++..+.+++.+||+.||++||++.+|+++|+..-.
T Consensus 234 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 234 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1223344678999999999999999999999999986543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-52 Score=399.42 Aligned_cols=251 Identities=24% Similarity=0.278 Sum_probs=212.5
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 159 (427)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999999999999999986532 234467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPI 239 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~ 239 (427)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999998653 46899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 240 GDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ......+.......
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~~~----- 257 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKVRF----- 257 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC-----
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCCCCC-----
Confidence 22356899999999999999999999999999999999999999975422 12222222221111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhhcC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~~~ 363 (427)
+......+.+++..||+.||.+|+ ++.++++|-++-.
T Consensus 258 -------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 258 -------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp -------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred -------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 222346788999999999999994 8999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.5e-53 Score=392.34 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=204.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---hHHHHHHHHHHhhcCCCCeeeEEEEEEcCC----e
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---NKEFIVEVLMLSLLHHDNLVNLIGYCADGE----Q 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 154 (427)
.++|++.+.||+|+||+||+|++..+|+.||||++++..... ...+.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999997654432 346889999999999999999999987643 4
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.|+||||++|++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 78999999999999988653 46899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCC-ccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 235 KLGPIGD-KTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 235 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
....... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||....+. ............
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCC
Confidence 7533222 222344568999999999999999999999999999999999999999754321 122222222211
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhc
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-LMSDVVSALSFL 362 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~ 362 (427)
.+... ....+..+.+++.+||+.||++|| ++++++..|..+
T Consensus 233 ~~~~~--------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 PPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CGGGT--------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCchh--------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 11111 112346788999999999999999 899999888764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-53 Score=403.29 Aligned_cols=263 Identities=25% Similarity=0.379 Sum_probs=213.1
Q ss_pred HhhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCe
Q 042519 81 ATKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 81 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 154 (427)
..++|++.+.||+|+||+||+|++++ ++..||||+++..... ..+.+.+|+.+++.++||||++++++|.+...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 35789999999999999999999863 4678999999765433 24568999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGP--------------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLK 214 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk 214 (427)
.++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+++ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 9999999999999999865321 2345889999999999999999999999 9999999
Q ss_pred CCceEeCCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCCC
Q 042519 215 SSNILLDCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR-RAIDTTR 293 (427)
Q Consensus 215 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~-~p~~~~~ 293 (427)
|+||||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|. .||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998644333334445678999999999999999999999999999999999986 5676543
Q ss_pred CcccchhhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 294 PTYEQNLVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+. +.... ..... .+ ..+..++.++.+|+..||+.+|++|||+.||+++|+.+.
T Consensus 248 ~~------e~~~~-v~~~~-~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HE------EVIYY-VRDGN-IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HH------HHHHH-HHTTC-CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH------HHHHH-HHcCC-CC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22 11111 12211 11 122334467899999999999999999999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=402.01 Aligned_cols=262 Identities=26% Similarity=0.349 Sum_probs=199.9
Q ss_pred hhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcC-C
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADG-E 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 153 (427)
.++|++.+.||+|+||.||+|.+.. +++.||||+++.... ...+.+..|..++.++ +|+||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 4789999999999999999999754 457899999875433 2345577787777776 589999999988764 5
Q ss_pred eeEEEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD 221 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~ 221 (427)
..++|||||++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999975431 2345899999999999999999999999 99999999999999
Q ss_pred CCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCCCCcccchh
Q 042519 222 CEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR-RAIDTTRPTYEQNL 300 (427)
Q Consensus 222 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~-~p~~~~~~~~~~~~ 300 (427)
.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++|. .||...... ..+
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~ 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 99999999999998654444444445678999999999999999999999999999999999975 567643321 111
Q ss_pred hhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 301 VTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
. .....+... ..+...+..+.+++.+||+.||++|||+.||+++|+.+
T Consensus 247 ~----~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 247 C----RRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp H----HHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHhcCCCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 111111111 11223346789999999999999999999999999865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-52 Score=386.92 Aligned_cols=255 Identities=22% Similarity=0.236 Sum_probs=210.6
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc---------hHHHHHHHHHHhhcC-CCCeeeEEEEEEc
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG---------NKEFIVEVLMLSLLH-HDNLVNLIGYCAD 151 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 151 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999997654321 134778999999997 9999999999999
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 152 GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 152 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
.+..||||||+++|+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 99999999999999999999753 46999999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCccceeccccccccccCcccccc------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRT------GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~ 305 (427)
|+++..... ......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+. ....
T Consensus 155 G~a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~ 225 (277)
T d1phka_ 155 GFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLR 225 (277)
T ss_dssp TTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred hheeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHH
Confidence 999864332 22345789999999998853 45789999999999999999999999764321 1111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.+.......+ .......+..+.+++.+||+.||++|||+.|++++-+
T Consensus 226 ~i~~~~~~~~--------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 226 MIMSGNYQFG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp HHHHTCCCCC--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HHHhCCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 2222211111 1112234468899999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=393.94 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=199.4
Q ss_pred hhCccccceeccCCceEEEEEEECCC---CcEEEEEEeccCCCc-chHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGLQ-GNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 157 (427)
.++|++.+.||+|+||.||+|++..+ +..||||.++..... ..+.+.+|+.++++++|||||++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 46799999999999999999998654 457999998654333 34568899999999999999999999964 67899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLG 237 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 237 (427)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998765 3457899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCc
Q 042519 238 PIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQ 316 (427)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (427)
... .........||+.|+|||++.+..++.++|||||||++|||++ |..||....... +.. . .......
T Consensus 159 ~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~---~-i~~~~~~-- 228 (273)
T d1mp8a_ 159 EDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---R-IENGERL-- 228 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---H-HHTTCCC--
T ss_pred cCC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH---H-HHcCCCC--
Confidence 322 2223445678999999999999999999999999999999998 899997654321 111 1 1111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 317 LADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
..+..++..+.+|+..||+.||++|||+.+|+++|+.+
T Consensus 229 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12334456889999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=393.08 Aligned_cols=263 Identities=24% Similarity=0.282 Sum_probs=199.2
Q ss_pred ccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc-----hHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEee
Q 042519 87 QECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG-----NKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYEY 161 (427)
Q Consensus 87 ~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 161 (427)
.+++||+|+||+||+|+++.+|+.||||+++...... .+.+.+|+.+++.++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999999999999999986543322 24578999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCC
Q 042519 162 MPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGD 241 (427)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 241 (427)
+.++++...+. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~- 153 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 153 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC-
Confidence 99777665542 4466888899999999999999999999 999999999999999999999999999863322
Q ss_pred ccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCC--CCCC---
Q 042519 242 KTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDP--NRYP--- 315 (427)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~--- 315 (427)
.......+||+.|+|||++.. ..|+.++|||||||++|||++|..||....+.. .+.... .....+ ....
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~-~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 154 -NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIF-ETLGTPTEEQWPDMC 229 (299)
T ss_dssp -CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCCCCTTTSSSTT
T ss_pred -cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHH-HhcCCCChhhccchh
Confidence 223345689999999998865 467999999999999999999999997543221 111111 110000 0000
Q ss_pred ccccccc---CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 316 QLADPLL---QGEFP-----VRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 316 ~~~~~~~---~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
....... ....+ ......+.+|+.+||+.||++|||+.|+++|-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 0000000 00011 1234678999999999999999999999998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-53 Score=399.40 Aligned_cols=251 Identities=27% Similarity=0.370 Sum_probs=207.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCC---CcchHHHHHHHHHHh-hcCCCCeeeEEEEEEcCCeeEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNG---LQGNKEFIVEVLMLS-LLHHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 158 (427)
++|++.+.||+|+||+||+|+++.+|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999997532 233455666766654 68999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCC
Q 042519 159 YEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGP 238 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 238 (427)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999999653 45889999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccc
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLA 318 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (427)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....+. ............+
T Consensus 155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~~~~---- 222 (320)
T d1xjda_ 155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMDNPFY---- 222 (320)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC----
T ss_pred cc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCCC----
Confidence 22 23345578999999999999999999999999999999999999999754321 1111222221111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHh
Q 042519 319 DPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMS-DVVSALS 360 (427)
Q Consensus 319 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~~L~ 360 (427)
+...+..+.+|+.+||+.||++||++. ++++|-+
T Consensus 223 --------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpf 257 (320)
T d1xjda_ 223 --------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257 (320)
T ss_dssp --------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred --------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCch
Confidence 222346788999999999999999995 7877644
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=399.88 Aligned_cols=258 Identities=17% Similarity=0.180 Sum_probs=204.3
Q ss_pred hhCccccc-eeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhh-cCCCCeeeEEEEEEc----CCee
Q 042519 82 TKNFRQEC-LIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSL-LHHDNLVNLIGYCAD----GEQR 155 (427)
Q Consensus 82 ~~~y~~~~-~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 155 (427)
.++|.+.+ +||+|+||+||+|++..+|+.||||+++. ...+.+|+.++.+ ++|||||+++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46798864 69999999999999999999999999853 3567789988655 579999999999875 4678
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC---CCCeeEeecC
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC---EFNAKLSDFG 232 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~vkl~DFG 232 (427)
|+|||||+||+|.++|... ....+++..+..|+.||+.||+|||+++ |+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999753 2357999999999999999999999999 999999999999975 5679999999
Q ss_pred CcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 233 LAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 233 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......... .........
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~--~~~~~i~~~-- 232 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRMG-- 232 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC--
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH--HHHHHHhcC--
Confidence 998643322 2345789999999999999999999999999999999999999997543221100 000000000
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 313 RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
............+..+.+|+.+||+.||++|||+.|++++-+..
T Consensus 233 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 233 ------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp ------SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred ------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 00000011123456899999999999999999999999986553
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-52 Score=405.50 Aligned_cols=254 Identities=24% Similarity=0.293 Sum_probs=205.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC---cchHHHHH---HHHHHhhcCCCCeeeEEEEEEcCCeeE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL---QGNKEFIV---EVLMLSLLHHDNLVNLIGYCADGEQRL 156 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 156 (427)
++|++.++||+|+||+||+|+++.+|+.||||++.+... .....+.+ ++.+++.++|||||+++++|.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 679999999999999999999999999999999864321 12223333 467777888999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
+||||+++|+|.++|... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999653 46789999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCC
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYP 315 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (427)
.... .....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||......... ...........
T Consensus 157 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~~~~~~~~--- 226 (364)
T d1omwa3 157 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTMAV--- 226 (364)
T ss_dssp CSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHHHHSSSCCC---
T ss_pred cCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcccCCC---
Confidence 4322 2345689999999999864 56899999999999999999999999764332211 11111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhhc
Q 042519 316 QLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPL-----MSDVVSALSFL 362 (427)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~L~~~ 362 (427)
.++...+..+.+||.+||+.||++||| +.|+++|-+.-
T Consensus 227 ---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~ 269 (364)
T d1omwa3 227 ---------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269 (364)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence 112223457889999999999999999 69999886653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=391.92 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=200.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc-CCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-GEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 160 (427)
.++|++.+.||+|+||.||+|+++ |..||||+++.+ ...+.+.+|+.++++++||||++++++|.+ .+.+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 467999999999999999999996 678999999654 345779999999999999999999999865 456899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+++|+|.++|... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-
Confidence 99999999999653 2345899999999999999999999999 99999999999999999999999999986322
Q ss_pred CccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCCCCcccc
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLAD 319 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (427)
......+|+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+...+ .+. ..+
T Consensus 156 ----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~-~~~---- 219 (262)
T d1byga_ 156 ----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKG-YKM---- 219 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTT-CCC----
T ss_pred ----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcC-CCC----
Confidence 2234568899999999999999999999999999999998 67777654322 222221 111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 320 PLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 320 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.++...+..+.+|+.+||+.||.+|||+.+++++|+.++
T Consensus 220 -----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 -----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 223334468889999999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=392.53 Aligned_cols=262 Identities=27% Similarity=0.378 Sum_probs=209.9
Q ss_pred hhCccccceeccCCceEEEEEEECCCC-------cEEEEEEeccCCCc-chHHHHHHHHHHhhc-CCCCeeeEEEEEEcC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTA-------QVVAVKQLDRNGLQ-GNKEFIVEVLMLSLL-HHDNLVNLIGYCADG 152 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 152 (427)
.++|++.+.||+|+||.||+|+...++ ..||||+++..... ...++.+|+..+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 468999999999999999999986544 47999999765432 346688898888888 799999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 153 EQRLLVYEYMPLRSLEDHLLDIGP------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 153 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
+..++||||+.+|+|.++|..... ....+++..++.++.||+.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975432 2356899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~ 299 (427)
+.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |..||...... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence 9999999999999987544444444556789999999999999999999999999999999998 68888654321 1
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
+. ..+.++... ..+...+..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 246 ~~----~~i~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 LF----KLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HH----HHHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHHHcCCCC----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 11 122222111 112233467899999999999999999999999998763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=396.06 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=207.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcE--EEEEEeccC-CCcchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCeeEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQV--VAVKQLDRN-GLQGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQRLLV 158 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 158 (427)
++|++.++||+|+||+||+|+++.+|.. ||||.+... .....+.+.+|+.+|+++ +|||||+++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6799999999999999999999888764 778887543 233456789999999998 699999999999999999999
Q ss_pred EeecCCCChhhhhhhc------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCe
Q 042519 159 YEYMPLRSLEDHLLDI------------GPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226 (427)
Q Consensus 159 ~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 226 (427)
|||+++|+|.++|... ......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 234567999999999999999999999999 9999999999999999999
Q ss_pred eEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCC-CCCCCCCcccchhhhhhh
Q 042519 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRR-AIDTTRPTYEQNLVTWAQ 305 (427)
Q Consensus 227 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~-p~~~~~~~~~~~~~~~~~ 305 (427)
||+|||+++.... ........||..|+|||.+.++.++.++|||||||++|||++|.. ||...... ....
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE 237 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH
T ss_pred EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH------HHHH
Confidence 9999999985322 222234568999999999999999999999999999999999765 56543211 1111
Q ss_pred hhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 306 PFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
.+.. ... ...+..++..+.+||.+||+.||++|||+.+|+++|+.+..
T Consensus 238 ~i~~-~~~----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 238 KLPQ-GYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HGGG-TCC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh-cCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 111 11223345689999999999999999999999999988754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=395.86 Aligned_cols=262 Identities=26% Similarity=0.341 Sum_probs=212.8
Q ss_pred hhCccccceeccCCceEEEEEEEC-----CCCcEEEEEEeccCCC-cchHHHHHHHHHHhhc-CCCCeeeEEEEEEcCCe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLE-----KTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLL-HHDNLVNLIGYCADGEQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 154 (427)
.++|++.++||+|+||.||+|++. .+++.||||+++.... .....+.+|+.++..+ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 468999999999999999999863 4677999999976543 2345688999999999 69999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGP--------------EQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILL 220 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll 220 (427)
.++|||||++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999976432 2346899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCC-CCCCCCcccch
Q 042519 221 DCEFNAKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRA-IDTTRPTYEQN 299 (427)
Q Consensus 221 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p-~~~~~~~~~~~ 299 (427)
+.++.+||+|||+++..............+||+.|+|||++.++.++.++|||||||++|||+|++.| |...... . .
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~-~ 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-S-K 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-H-H
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-H-H
Confidence 99999999999999875544444455667899999999999999999999999999999999995444 5433221 1 1
Q ss_pred hhhhhhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 300 LVTWAQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
+......+.. ...+...+..+.+|+.+||+.||++|||+.+|+++|+..
T Consensus 257 ----~~~~i~~~~~----------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 ----FYKMIKEGFR----------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ----HHHHHHHTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHhcCCC----------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111111111 111223446789999999999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=388.57 Aligned_cols=258 Identities=29% Similarity=0.387 Sum_probs=198.8
Q ss_pred hhCccccceeccCCceEEEEEEECCC---CcEEEEEEeccCCC---cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT---AQVVAVKQLDRNGL---QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||.||+|++... ...||||++.+... ...+.|.+|+.++++++|||||+++++|.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 36799999999999999999987533 24689999876432 334678999999999999999999999976 467
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcc
Q 042519 156 LLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAK 235 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~ 235 (427)
++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 8999999999999887653 356999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhcCCCC
Q 042519 236 LGPIGDKT-HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELIT-GRRAIDTTRPTYEQNLVTWAQPFFKDPNR 313 (427)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (427)
........ .......|+..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGER 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCC
Confidence 75333222 22344568889999999999999999999999999999998 89999754321 222222222211
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 314 YPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
. ..+...+..+.+++.+||+.||++|||+.+|++.|...
T Consensus 234 ~----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 L----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 11223346788999999999999999999999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=388.65 Aligned_cols=267 Identities=22% Similarity=0.308 Sum_probs=204.2
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||+||+|++..+|+.||||+++.... .....+.+|+.++++++|||||++++++.+.+.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 579999999999999999999999999999999965432 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
|+.+ ++.+++... ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9984 555555432 3467999999999999999999999999 999999999999999999999999999864322
Q ss_pred CccceeccccccccccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC--CCC--
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQ-LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN--RYP-- 315 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 315 (427)
........||+.|+|||++.... ++.++|||||||++|+|++|+.||....... .+..... ....+. ...
T Consensus 156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~-~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFR-TLGTPDEVVWPGV 230 (298)
T ss_dssp --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHCCCCTTTSTTG
T ss_pred --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHH-hcCCCchhhcccc
Confidence 22344568999999999877655 5889999999999999999999997543211 1111000 000000 000
Q ss_pred ----cccc---cccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 316 ----QLAD---PLLQGE---FPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 316 ----~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.... ...... ........+.+|+.+||+.||++|||+.|++++-+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence 0000 000000 00122357889999999999999999999999854
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=388.60 Aligned_cols=255 Identities=29% Similarity=0.403 Sum_probs=203.4
Q ss_pred cceeccCCceEEEEEEECCCC---cEEEEEEeccCC-CcchHHHHHHHHHHhhcCCCCeeeEEEEEEc-CCeeEEEEeec
Q 042519 88 ECLIGEGGFGRVYKGKLEKTA---QVVAVKQLDRNG-LQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-GEQRLLVYEYM 162 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 162 (427)
.++||+|+||+||+|++..++ ..||||++++.. ......+.+|+.++++++||||+++++++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 578999999999999986543 369999997532 3344679999999999999999999999875 56889999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCCCc
Q 042519 163 PLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIGDK 242 (427)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~ 242 (427)
++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999998865 4456788899999999999999999999 99999999999999999999999999986433222
Q ss_pred c--ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCCCCCccccc
Q 042519 243 T--HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPNRYPQLADP 320 (427)
Q Consensus 243 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (427)
. .......||+.|+|||++..+.++.++||||||+++|||++|+.||...... .++...... +...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~~~~~i~~-g~~~------ 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLLQ-GRRL------ 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHT-TCCC------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHc-CCCC------
Confidence 1 2233457899999999999999999999999999999999988887643221 111111111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 042519 321 LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLGS 364 (427)
Q Consensus 321 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 364 (427)
..+..++..+.+++.+||+.||++||++.||+++|+.+..
T Consensus 254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122334678899999999999999999999999988754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=383.38 Aligned_cols=245 Identities=21% Similarity=0.350 Sum_probs=201.7
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcc------hHHHHHHHHHHhhcC--CCCeeeEEEEEEcCC
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQG------NKEFIVEVLMLSLLH--HDNLVNLIGYCADGE 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 153 (427)
.++|++.++||+|+||+||+|++..+|+.||||++.+..... ...+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999999999999999997543221 233568999999987 899999999999999
Q ss_pred eeEEEEeecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-CCCeeEeec
Q 042519 154 QRLLVYEYMPL-RSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-EFNAKLSDF 231 (427)
Q Consensus 154 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~vkl~DF 231 (427)
..++||||+.+ +++.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999975 577777754 356899999999999999999999999 999999999999985 478999999
Q ss_pred CCcccCCCCCccceeccccccccccCccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 232 GLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQL-TVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 232 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
|+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .....
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~ 219 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG 219 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhc
Confidence 999863221 2345789999999999987765 577999999999999999999996421 11111
Q ss_pred CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
...+ +...+.++.+++.+||+.||++|||+.|++++-+.
T Consensus 220 ~~~~------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 220 QVFF------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp CCCC------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred ccCC------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 1111 11223578899999999999999999999997543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=383.19 Aligned_cols=269 Identities=25% Similarity=0.285 Sum_probs=200.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC----eeEE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE----QRLL 157 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 157 (427)
..+|.+.+.||+|+||.||+|++. |+.||||+++... ........|+..+..++|||||++++++.+.+ .+++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 357889999999999999999974 7899999986442 11122334555667789999999999998654 6799
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeccCCCCceEeCCCCCeeEeecC
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKA-----NPPVIYRDLKSSNILLDCEFNAKLSDFG 232 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~vkl~DFG 232 (427)
||||+++|+|.++|.. ..+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999965 35899999999999999999999741 1229999999999999999999999999
Q ss_pred CcccCCCCCcc--ceeccccccccccCccccccCC------CCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-----
Q 042519 233 LAKLGPIGDKT--HVSSRVMGTYGYCAPEYQRTGQ------LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN----- 299 (427)
Q Consensus 233 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~----- 299 (427)
+++........ .......||+.|+|||++.+.. ++.++|||||||+||||+||..||..........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99864333222 1234578999999999987542 6778999999999999999998885433221100
Q ss_pred ---hhhhhhhhhcCCCCCCcccccccCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 300 ---LVTWAQPFFKDPNRYPQLADPLLQG-EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 300 ---~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.............. ++.+.. ..+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~-----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKL-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SSCCHHHHHHHHTTSCC-----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhcccc-----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 00111111111111 111111 113346677999999999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=385.16 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=212.8
Q ss_pred hhCccccceeccCCceEEEEEEECC-----CCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCee
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEK-----TAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQR 155 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 155 (427)
.++|++.+.||+|+||+||+|.++. ++..||||+++.... .....+.+|+.++++++|||||+++++|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4689999999999999999999853 357899999975432 2334588999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEe
Q 042519 156 LLVYEYMPLRSLEDHLLDIG------PEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLS 229 (427)
Q Consensus 156 ~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~ 229 (427)
++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+++ |+||||||+||||+.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999886421 23356789999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCCCCcccchhhhhhhhhh
Q 042519 230 DFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGR-RAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 230 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~-~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
|||+++...............||+.|+|||.+.++.++.++|||||||++|||++|. .||..... .......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~i- 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFV- 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHH-
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-
Confidence 999998644433333445567999999999999999999999999999999999985 66654321 1222211
Q ss_pred cCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 042519 309 KDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFLG 363 (427)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 363 (427)
.++... . .+..++..+.+++.+||+.+|++|||+.+|+++|+...
T Consensus 249 ~~~~~~-~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 249 MEGGLL-D---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HTTCCC-C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HhCCCC-C---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 121111 1 12233467999999999999999999999999998653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=383.17 Aligned_cols=269 Identities=23% Similarity=0.259 Sum_probs=202.2
Q ss_pred hhCccccceeccCCceEEEEEEECCC-CcEEEEEEeccCCC--cchHHHHHHHHHHhhc---CCCCeeeEEEEEEc----
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKT-AQVVAVKQLDRNGL--QGNKEFIVEVLMLSLL---HHDNLVNLIGYCAD---- 151 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 151 (427)
.++|++.+.||+|+||+||+|++..+ ++.||||++..... .....+.+|+.+++.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57899999999999999999999655 67899999865322 2234566777777665 79999999999853
Q ss_pred -CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEee
Q 042519 152 -GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSD 230 (427)
Q Consensus 152 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~D 230 (427)
....+++|||+.++.+...... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3568999999997766544332 4567899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh----
Q 042519 231 FGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP---- 306 (427)
Q Consensus 231 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~---- 306 (427)
||+++... .........||+.|+|||++.+..|+.++|||||||++|||++|+.||....+... +......
T Consensus 160 fg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLP 234 (305)
T ss_dssp CCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCC
T ss_pred hhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCC
Confidence 99988532 22334567899999999999999999999999999999999999999976533211 1110000
Q ss_pred ---hhcCCCCCCccccccc----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 307 ---FFKDPNRYPQLADPLL----QGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 307 ---~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.+.............. ...+.......+.+|+.+||+.||++|||+.|++++-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 0000000000000000 001122334678899999999999999999999998543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-50 Score=377.95 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=201.8
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.++||+|+||+||+|+++ +|+.||||+++.... .....+.+|+.+|++++|||||+++++|.+.+..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999986 689999999966532 234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
++.++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 ~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 998766655542 3467999999999999999999999999 999999999999999999999999999864322
Q ss_pred CccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh-------cCCC
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF-------KDPN 312 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~ 312 (427)
........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ +........ ....
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGG
T ss_pred --ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchh
Confidence 222344578999999999865 4579999999999999999999999975432211 111000000 0000
Q ss_pred CCCcc------cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 313 RYPQL------ADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 313 ~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..... ................+.+++.+||+.||++|||++|++++-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 00000 0000001112233467889999999999999999999998754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=381.49 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=199.7
Q ss_pred CccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCeeeEEEEEEc------CCeeEE
Q 042519 84 NFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLVNLIGYCAD------GEQRLL 157 (427)
Q Consensus 84 ~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~l 157 (427)
+|+..++||+|+||+||+|+++.+|+.||||++...... +.+|+.+|++++||||++++++|.. ...++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588999999999999999999999999999999765322 2469999999999999999999853 335789
Q ss_pred EEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-CeeEeecCCccc
Q 042519 158 VYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDFGLAKL 236 (427)
Q Consensus 158 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DFG~a~~ 236 (427)
|||||+++ +.+.+.........+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999854 44444433335667999999999999999999999999 99999999999999775 899999999986
Q ss_pred CCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh-----------
Q 042519 237 GPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWA----------- 304 (427)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~----------- 304 (427)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+....
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhh
Confidence 43322 2344679999999998764 578999999999999999999999997543221 111100
Q ss_pred hhhhc--CCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 305 QPFFK--DPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 305 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
..... ....++..................+.+|+.+||+.||++|||+.|++++-+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 00000 001111111111111112234567889999999999999999999998754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=372.02 Aligned_cols=270 Identities=21% Similarity=0.265 Sum_probs=201.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEc--------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCAD-------- 151 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 151 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3789999999999999999999999999999999865432 334678899999999999999999998865
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeec
Q 042519 152 GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDF 231 (427)
Q Consensus 152 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DF 231 (427)
....++||||+.++.+.... .....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 34689999999876665443 24467889999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcc--ceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 042519 232 GLAKLGPIGDKT--HVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFF 308 (427)
Q Consensus 232 G~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 308 (427)
|+++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....+..... ......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~i~~~~ 238 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA---LISQLC 238 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHH---HHHHhc
Confidence 999764322211 223346799999999998754 68999999999999999999999997543321111 111111
Q ss_pred cC-CCC-CCcc--------cccccCCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 309 KD-PNR-YPQL--------ADPLLQGEFPV-------RGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 309 ~~-~~~-~~~~--------~~~~~~~~~~~-------~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.. ... .... ........... .....+.+|+.+||+.||++|||+.|+++|-++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 10 000 0000 00000001111 113466789999999999999999999999765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-48 Score=371.95 Aligned_cols=263 Identities=18% Similarity=0.265 Sum_probs=204.4
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEc--CCeeEEEE
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCAD--GEQRLLVY 159 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 159 (427)
++|++.++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|..++ ||||++++++|.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6799999999999999999999999999999999653 3567889999999996 9999999999974 45689999
Q ss_pred eecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCC-CeeEeecCCcccCC
Q 042519 160 EYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEF-NAKLSDFGLAKLGP 238 (427)
Q Consensus 160 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~vkl~DFG~a~~~~ 238 (427)
||+.+++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999997653 35899999999999999999999999 99999999999998655 59999999998643
Q ss_pred CCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhh--h---------hhhh
Q 042519 239 IGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV--T---------WAQP 306 (427)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~--~---------~~~~ 306 (427)
... .....+||+.|+|||.+.+. .++.++||||+||++|+|++|+.||........+... . +...
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 322 23456799999999998764 5799999999999999999999999765543221100 0 0000
Q ss_pred h-------hcC-C-CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 307 F-------FKD-P-NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 307 ~-------~~~-~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
. +.. . .....................++.+|+.+||+.||++|||++|+++|-++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0 000 0 00000011111111222344678899999999999999999999998665
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=365.76 Aligned_cols=268 Identities=21% Similarity=0.240 Sum_probs=209.7
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC--cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCCeeEEEEe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL--QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 160 (427)
++|++.+.||+|+||+||+|++..+|+.||||+++.... .....+.+|+.+++.++||||++++++|.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 579999999999999999999999999999999965443 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCcccCCCC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKLGPIG 240 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~ 240 (427)
++.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999888877764 3457889999999999999999999999 999999999999999999999999999874332
Q ss_pred CccceeccccccccccCccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC---------
Q 042519 241 DKTHVSSRVMGTYGYCAPEYQRTGQ-LTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD--------- 310 (427)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 310 (427)
. .......+++.|+|||++.... ++.++|||||||++|||++|+.||......... ..........
T Consensus 155 ~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTG
T ss_pred C--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhh
Confidence 2 2334456788999999887654 689999999999999999999998544332211 1111110000
Q ss_pred -----CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 311 -----PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 311 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
.......................+.+|+.+||+.||.+|||++|++++-+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 000000001111112223345678899999999999999999999998654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=372.02 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=197.4
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcCC------
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADGE------ 153 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 153 (427)
.++|++.+.||+|+||+||+|.++.+|+.||||++++.... ..+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999999999999999999764332 2356788999999999999999999998654
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCC
Q 042519 154 QRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGL 233 (427)
Q Consensus 154 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~ 233 (427)
.+++||||+ +.+|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 579999999 4677776643 46999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeccccccccccCcccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh------
Q 042519 234 AKLGPIGDKTHVSSRVMGTYGYCAPEYQRT-GQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQP------ 306 (427)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~------ 306 (427)
++.... ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +......
T Consensus 168 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 168 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPA 240 (346)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCH
T ss_pred eeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcH
Confidence 986422 2345679999999999875 4578999999999999999999999976532111 0000000
Q ss_pred -hhcCC---------CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 042519 307 -FFKDP---------NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSF 361 (427)
Q Consensus 307 -~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 361 (427)
+.... ..........+. .........+.+|+.+||+.||++|||+.|++++-+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 00000 000000000000 0112234567899999999999999999999998543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=373.32 Aligned_cols=266 Identities=19% Similarity=0.233 Sum_probs=199.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCC-cchHHHHHHHHHHhhcCCCCeeeEEEEEEcCC----eeE
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGL-QGNKEFIVEVLMLSLLHHDNLVNLIGYCADGE----QRL 156 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 156 (427)
+++|++.+.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.|+||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4679999999999999999999999999999999976432 23456789999999999999999999997543 234
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 157 LVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 157 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
++++++.+|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 45556678999999864 35899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcc-ceeccccccccccCccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh---------
Q 042519 237 GPIGDKT-HVSSRVMGTYGYCAPEYQR-TGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQ--------- 305 (427)
Q Consensus 237 ~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~--------- 305 (427)
....... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 4322211 1234567999999999984 4567899999999999999999999997654321110000000
Q ss_pred --------hh-hcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 042519 306 --------PF-FKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALS 360 (427)
Q Consensus 306 --------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 360 (427)
.. ...+........ .+ .......+.+|+.+||+.||++|||+.|++++-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWN-RL----FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHH-HH----CTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhhcccccCCccCCCCHH-Hh----CCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 00 000000000000 00 0112346889999999999999999999999854
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-48 Score=363.85 Aligned_cols=262 Identities=18% Similarity=0.184 Sum_probs=208.0
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCC-CCeeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH-DNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+.+|+..+..|+| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999999999999999986543 23457788999999975 899999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCC-----CCCeeEeecCCcc
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDC-----EFNAKLSDFGLAK 235 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~vkl~DFG~a~ 235 (427)
|+ +++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 5899998865 3356899999999999999999999999 999999999999964 5789999999998
Q ss_pred cCCCCCcc-----ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcC
Q 042519 236 LGPIGDKT-----HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKD 310 (427)
Q Consensus 236 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 310 (427)
........ ......+||+.|+|||++.+..++.++|||||||++|||++|..||....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ- 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-
Confidence 64332211 123456899999999999999999999999999999999999999976543322211111110000
Q ss_pred CCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 311 PNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.... ..+... .+.++.+++..|++.+|++||++..+.+.|+.+
T Consensus 234 ~~~~-----~~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 234 STPL-----RELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HSCH-----HHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCCh-----HHhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0000 011111 235788999999999999999999988887654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-48 Score=365.79 Aligned_cols=261 Identities=20% Similarity=0.226 Sum_probs=201.5
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCC-eeeEEEEEEcCCeeEEEEe
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDN-LVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 160 (427)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+..|+.+++.++|+| |+.+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 367999999999999999999999999999999987643 2345788999999998665 5566667788889999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeC---CCCCeeEeecCCcccC
Q 042519 161 YMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLD---CEFNAKLSDFGLAKLG 237 (427)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~vkl~DFG~a~~~ 237 (427)
|+. ++|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+..
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLG-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCC-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcC-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 995 677666654 3457899999999999999999999999 99999999999985 4557999999999874
Q ss_pred CCCCcc-----ceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhh-hhhhhhhcCC
Q 042519 238 PIGDKT-----HVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV-TWAQPFFKDP 311 (427)
Q Consensus 238 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~-~~~~~~~~~~ 311 (427)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 332221 1234568999999999999999999999999999999999999999765433222111 1111111100
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 312 NRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
.+.+. ..++.++.+++..||+.+|++||++.++.+.|+.+
T Consensus 237 -------~~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 -------IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -------HHHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -------hhHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00111 12335788999999999999999999888877654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=367.09 Aligned_cols=257 Identities=24% Similarity=0.316 Sum_probs=206.4
Q ss_pred hCccccceeccCCceEEEEEEE---CCCCcEEEEEEeccCCC----cchHHHHHHHHHHhhcCC-CCeeeEEEEEEcCCe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKL---EKTAQVVAVKQLDRNGL----QGNKEFIVEVLMLSLLHH-DNLVNLIGYCADGEQ 154 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 154 (427)
++|++.+.||+|+||+||+|++ +.+|+.||||++++... ...+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999987 45789999999865422 234567889999999976 899999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999998654 35678899999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceeccccccccccCccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhcCCC
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTG--QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVTWAQPFFKDPN 312 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 312 (427)
+...... ........|++.|+|||.+.+. .++.++|||||||+||+|++|+.||......... ............
T Consensus 177 ~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 177 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSEP 253 (322)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCCC
T ss_pred hhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccCCC
Confidence 8643222 2234456799999999998754 4788999999999999999999999765433221 111111111111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhh
Q 042519 313 RYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRP-----LMSDVVSALSF 361 (427)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~L~~ 361 (427)
..+......+.+++.+||+.||.+|| +++|+++|-+.
T Consensus 254 ------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 254 ------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 11233456889999999999999999 48999987554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=368.02 Aligned_cols=267 Identities=21% Similarity=0.251 Sum_probs=196.6
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEc------CCe
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCAD------GEQ 154 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 154 (427)
++|++.++||+|+||+||+|+++.+|+.||||++.+.... ....+.+|+.+++.++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999999999999999999765432 23457899999999999999999999963 468
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
+|+||||+.++ +.+.+. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 89999999854 444442 35789999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccch-h-------------
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQN-L------------- 300 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~-~------------- 300 (427)
+.... .......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.......... +
T Consensus 167 ~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 86332 223455679999999999999999999999999999999999999997543211000 0
Q ss_pred --hhhhhhhhcCCCCC-----CcccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 301 --VTWAQPFFKDPNRY-----PQLADPLLQG---EFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 301 --~~~~~~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
......+....... +......... .........+.+|+.+||+.||++|||++|+++|-+.-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 00000111111110 1111111111 11234567889999999999999999999999996553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=364.78 Aligned_cols=264 Identities=22% Similarity=0.291 Sum_probs=199.1
Q ss_pred hhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc--chHHHHHHHHHHhhcCCCCeeeEEEEEEcC-----Ce
Q 042519 82 TKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ--GNKEFIVEVLMLSLLHHDNLVNLIGYCADG-----EQ 154 (427)
Q Consensus 82 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 154 (427)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.... ..+.+.+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999999999999999999765432 234678999999999999999999998643 34
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCeeEeecCCc
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNAKLSDFGLA 234 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a 234 (427)
.+++++|+.+|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 466677788999999884 346999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCccceeccccccccccCccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhh-hh---------
Q 042519 235 KLGPIGDKTHVSSRVMGTYGYCAPEYQRTG-QLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLV-TW--------- 303 (427)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~-~~--------- 303 (427)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............ ..
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 7532 223456799999999987664 5689999999999999999999999754322110000 00
Q ss_pred -------hhhhhcCCCCCCcccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 042519 304 -------AQPFFKDPNRYPQLADPLLQGEFPVRGLNQAVAVSAMCVQEESSVRPLMSDVVSALSFL 362 (427)
Q Consensus 304 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 362 (427)
...............-... .......+.+||.+||+.||++|||+.|+++|-+.-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANV----FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHH----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hhccchhhhhhhhhcccCCCcchhhh----cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 0000000000000000000 012235688999999999999999999999986543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-42 Score=336.62 Aligned_cols=270 Identities=17% Similarity=0.174 Sum_probs=196.9
Q ss_pred hCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-----------CCCeeeEEEEEEc
Q 042519 83 KNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-----------HDNLVNLIGYCAD 151 (427)
Q Consensus 83 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 151 (427)
.+|++.++||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999999999999999997542 23456778888888775 5789999988764
Q ss_pred --CCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeCCCCC---
Q 042519 152 --GEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-KANPPVIYRDLKSSNILLDCEFN--- 225 (427)
Q Consensus 152 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~--- 225 (427)
....+++++++..+......... .....+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 35667777776554433332222 355678899999999999999999998 77 999999999999987654
Q ss_pred ---eeEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 042519 226 ---AKLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVLLELITGRRAIDTTRPTYEQNLVT 302 (427)
Q Consensus 226 ---vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell~g~~p~~~~~~~~~~~~~~ 302 (427)
++|+|||.+..... .....+||+.|+|||++.+..++.++||||+||++++|++|+.||.............
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999975321 2345679999999999999999999999999999999999999997543321111110
Q ss_pred hh---------------------hhhhcCCCCCCccccc---------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 042519 303 WA---------------------QPFFKDPNRYPQLADP---------LLQGEFPVRGLNQAVAVSAMCVQEESSVRPLM 352 (427)
Q Consensus 303 ~~---------------------~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 352 (427)
.. ...+........+... .............+.+|+.+||+.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 00 0001100000000000 01223456678899999999999999999999
Q ss_pred HHHHHHHhhc
Q 042519 353 SDVVSALSFL 362 (427)
Q Consensus 353 ~evl~~L~~~ 362 (427)
.|+++|-+.-
T Consensus 323 ~e~L~Hp~f~ 332 (362)
T d1q8ya_ 323 GGLVNHPWLK 332 (362)
T ss_dssp HHHHTCGGGT
T ss_pred HHHhcCcccC
Confidence 9999986543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=6.3e-26 Score=198.04 Aligned_cols=170 Identities=14% Similarity=0.039 Sum_probs=118.9
Q ss_pred ccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCc------------------chHHHHHHHHHHhhcCCCCeeeEE
Q 042519 85 FRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQ------------------GNKEFIVEVLMLSLLHHDNLVNLI 146 (427)
Q Consensus 85 y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~ 146 (427)
+.+.+.||+|+||+||+|++. +|+.||||+++..... .......|+..+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 356789999999999999986 5899999987532110 012234688889999999999988
Q ss_pred EEEEcCCeeEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeCCCCCe
Q 042519 147 GYCADGEQRLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNILLDCEFNA 226 (427)
Q Consensus 147 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~v 226 (427)
++.. .+++|||+++..+.+. +......++.|++.+|.|||+++ |+||||||+|||+++++ +
T Consensus 81 ~~~~----~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~ 141 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-I 141 (191)
T ss_dssp EEET----TEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-E
T ss_pred EecC----CEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-E
Confidence 7642 3799999997655432 22334578999999999999999 99999999999998654 8
Q ss_pred eEeecCCcccCCCCCccceeccccccccccCccccccCCCCccchHHHHHHHH
Q 042519 227 KLSDFGLAKLGPIGDKTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYTFGVVL 279 (427)
Q Consensus 227 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil 279 (427)
+|+|||+|.............+.+.. -.+.+ ...|+.++|+||+.--+
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~rd~~~----~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILERDVRN----IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHHHHHH----HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcHHHHHHHHHH----HHHHH-cCCCCCcccHHHHHHHH
Confidence 99999999753222111100000000 01112 25688999999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.88 E-value=6.6e-09 Score=93.05 Aligned_cols=150 Identities=16% Similarity=0.024 Sum_probs=104.5
Q ss_pred HHHHHHhhCccccceeccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCe
Q 042519 76 RELATATKNFRQECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQ 154 (427)
Q Consensus 76 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 154 (427)
.++......|++.+..+.++.+.||+... .+..++||+...........+.+|...+..|. +--+.+++.++.+++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 34556667788777655555678998764 35668889876554444455778888887775 3336778888888899
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC-----------------------------
Q 042519 155 RLLVYEYMPLRSLEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHDKAN----------------------------- 205 (427)
Q Consensus 155 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----------------------------- 205 (427)
.++||++++|.++.+.... ... ...++.+++..|..||+...
T Consensus 85 ~~lv~~~l~G~~~~~~~~~------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEecccccccccccc------ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999998887654321 011 22345556666666664210
Q ss_pred ---------------------------CCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 206 ---------------------------PPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 206 ---------------------------~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1379999999999998776667999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.24 E-value=2.6e-06 Score=75.14 Aligned_cols=131 Identities=17% Similarity=0.091 Sum_probs=85.4
Q ss_pred eeccCC-ceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCC--CCeeeEEEEEEcCCeeEEEEeecCCCC
Q 042519 90 LIGEGG-FGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH--DNLVNLIGYCADGEQRLLVYEYMPLRS 166 (427)
Q Consensus 90 ~Lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 166 (427)
.+..|. -+.||+....+ +..+++|...... ...+..|+..++.|.. -.+.+++.+..+.+..++||++++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 344554 36899887654 6678889865432 2346677777777653 235778888888889999999999766
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------------
Q 042519 167 LEDHLLDIGPEQKPIDWFTRMKIALGAAKGLEYLHD-------------------------------------------- 202 (427)
Q Consensus 167 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------------- 202 (427)
+.+.. ... ..++.++...|.-||+
T Consensus 93 ~~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 93 LLSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ccccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 64311 110 1122233333444442
Q ss_pred -------CC----CCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 203 -------KA----NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 203 -------~~----~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
.. ...++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 11379999999999998876678999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.07 E-value=5.2e-06 Score=78.38 Aligned_cols=78 Identities=17% Similarity=0.069 Sum_probs=48.8
Q ss_pred cceeccCCceEEEEEEECCCCcEEEEEEeccC-------CCcchHHHHHHHHHHhhcC-C--CCeeeEEEEEEcCCeeEE
Q 042519 88 ECLIGEGGFGRVYKGKLEKTAQVVAVKQLDRN-------GLQGNKEFIVEVLMLSLLH-H--DNLVNLIGYCADGEQRLL 157 (427)
Q Consensus 88 ~~~Lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 157 (427)
.+.||.|....||++....+++.|+||.-... ..........|+..|..+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 34689999999999998877888999964321 1112234456777777663 2 345566554 4456689
Q ss_pred EEeecCCCCh
Q 042519 158 VYEYMPLRSL 167 (427)
Q Consensus 158 v~e~~~~gsL 167 (427)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.43 E-value=0.00034 Score=65.55 Aligned_cols=73 Identities=19% Similarity=0.266 Sum_probs=50.9
Q ss_pred ceeccCCceEEEEEEECC-------CCcEEEEEEeccCCCcchHHHHHHHHHHhhcC-CCCeeeEEEEEEcCCeeEEEEe
Q 042519 89 CLIGEGGFGRVYKGKLEK-------TAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLH-HDNLVNLIGYCADGEQRLLVYE 160 (427)
Q Consensus 89 ~~Lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 160 (427)
+.|+.|-.-.+|++.... .+..|.+++.... .......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 578889999999998753 2456777776532 33345668888888886 4334577777753 68999
Q ss_pred ecCCCCh
Q 042519 161 YMPLRSL 167 (427)
Q Consensus 161 ~~~~gsL 167 (427)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9986554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.0008 Score=61.07 Aligned_cols=137 Identities=15% Similarity=0.057 Sum_probs=76.5
Q ss_pred ceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCCCCee--eEE-----EEEEcCCeeEEEEeecCCCChh
Q 042519 96 FGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHHDNLV--NLI-----GYCADGEQRLLVYEYMPLRSLE 168 (427)
Q Consensus 96 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~-----~~~~~~~~~~lv~e~~~~gsL~ 168 (427)
--.||++...+ |..|++|+.... .....++..|+..+..|...++. ..+ ..+..+...+.++++++|..+.
T Consensus 35 EN~vy~v~~~d-g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDED-RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTT-CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCC-CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 46899998854 788999997544 33456778888888777532221 111 1223456678899998764331
Q ss_pred h--------------hhhhc----C-CCCCCCCHH----------------------HHHHHHHHHHHHHHHHh-hCCCC
Q 042519 169 D--------------HLLDI----G-PEQKPIDWF----------------------TRMKIALGAAKGLEYLH-DKANP 206 (427)
Q Consensus 169 ~--------------~l~~~----~-~~~~~l~~~----------------------~~~~i~~~i~~~l~~LH-~~~~~ 206 (427)
. .++.. . .....++.. .....+..+...+.-+- .....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 0 01110 0 001111111 11222233333332221 12223
Q ss_pred CeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 207 PVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 207 ~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
.+||+|+.+.|||++.+ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 48999999999999743 45899998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.99 E-value=0.0014 Score=58.92 Aligned_cols=160 Identities=13% Similarity=-0.005 Sum_probs=81.1
Q ss_pred cCHHHHHHHhhCcccccee-----ccCCceEEEEEEECCCCcEEEEEEeccCCCcchHHHHHHHHHHhhcCC-----CCe
Q 042519 73 FTFRELATATKNFRQECLI-----GEGGFGRVYKGKLEKTAQVVAVKQLDRNGLQGNKEFIVEVLMLSLLHH-----DNL 142 (427)
Q Consensus 73 ~~~~~~~~~~~~y~~~~~L-----g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~ni 142 (427)
.+..++......|.++++. ..|---+.|+....+ | .+++|++... ....++..|+.++..|.. |..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccc
Confidence 3456777777888876543 456667889988764 4 4899998543 223445556666666542 222
Q ss_pred eeEEE---EEEcCCeeEEEEeecCCCChhh--------------hhhhcCC---CC--CCC------------------C
Q 042519 143 VNLIG---YCADGEQRLLVYEYMPLRSLED--------------HLLDIGP---EQ--KPI------------------D 182 (427)
Q Consensus 143 v~l~~---~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~---~~--~~l------------------~ 182 (427)
+...+ +.........++.++.+..... .++.... .. ... .
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 21100 1112344455666655432211 0110000 00 000 0
Q ss_pred HHHHHHHHHHHHHHHHHHhhCC-CCCeEeccCCCCceEeCCCCCeeEeecCCccc
Q 042519 183 WFTRMKIALGAAKGLEYLHDKA-NPPVIYRDLKSSNILLDCEFNAKLSDFGLAKL 236 (427)
Q Consensus 183 ~~~~~~i~~~i~~~l~~LH~~~-~~~ivH~Dlkp~NIll~~~~~vkl~DFG~a~~ 236 (427)
.......+..+...+.-.+... ..++||+|+.++||+++.+...-|+||+.+..
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0011122222223333332211 22499999999999999887778999998863
|